nicotine has been researched along with Smoking Cessation in 3767 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (0.24) | 18.7374 |
| 1990's | 640 (16.99) | 18.2507 |
| 2000's | 1389 (36.87) | 29.6817 |
| 2010's | 1273 (33.79) | 24.3611 |
| 2020's | 456 (12.11) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, EP; Brooks, PR; Chambers, LK; Coe, JW; Davis, TI; Fox, CB; Heym, JH; Huang, J; Lebel, LA; Lu, Y; Mansbach, RS; O'Neill, BT; Rollema, H; Rovetti, CC; Sands, SB; Schaeffer, E; Schulz, DW; Shrikhande, A; Tingley, FD; Vetelino, MG; Wirtz, MC | 1 |
| Arnold, EP; Bashore, CG; Brooks, PR; Coe, JW; Davis, TI; Fox, CB; Lebel, LA; O'Neill, BT; Rollema, H; Sands, SB; Schulz, DW; Tingley, FD; Vetelino, MG; Wirtz, MC | 1 |
| Arnold, EP; Bashore, CG; Bianco, KE; Brooks, PR; Coe, JW; Davis, TI; Fox, CB; Lebel, LA; Mansbach, RS; O'Neill, BT; Rollema, H; Sands, SB; Schulz, DW; Tingley, FD; Vetelino, MG; Wirtz, MC | 1 |
| Chenoweth, MJ; Hawk, LW; Novalen, M; Tyndale, RF; Zhao, B | 1 |
| Brouwer, AF; Cadham, C; Cook, S; Douglas, C; Fleischer, NL; Hirschtick, JL; Jeon, J; Knoll, M; Levy, DT; Li, Y; Liber, AC; Meza, R; Mistry, R; Sanchez-Romero, LM; Skolnick, S; Travis, N; Warner, KE; Yuan, Z | 1 |
| Alberg, AJ; Carpenter, MJ; Froeliger, B; Jones, SK; Wallace, K; Wolf, BJ | 2 |
| Eleftheriou, C; Zacharia, LC | 1 |
| Donny, EC; White, CM | 1 |
| Baker, A; Bonevski, B; Borland, R; Dunlop, A; Gartner, C; Guillaumier, A; Lum, A; Robinson, M; Skelton, E; Wilkinson, RB; Wynne, O | 1 |
| Lang, AE; Yakhkind, A | 1 |
| Aveyard, P; Farley, A; Hajek, P; Hajizadeh, A; Hartmann-Boyce, J; Heath, L; Jones, LL; Kudlek, L; Lycett, D; Schenkels, M; Theodoulou, A | 1 |
| Stöver, H | 1 |
| Rietveld, CA; Slob, EAW | 1 |
| Alexander, AC; Bhushan, T; Businelle, MS; Cole, AB; Frank-Pearce, S; Hébert, ET; Kendzor, DE; Ra, CK | 1 |
| Brown, J; Cox, S; Kock, L; Shahab, L | 1 |
| Bassil, NK; Bou Saba, TG; Ohanian, MLK | 1 |
| Evers-Casey, S; Leone, FT | 1 |
| Andrieu-Haller, C; Aouizerate, B; Arbus, C; Bellivier, F; Bennabi, D; Bougerol, T; Boyer, L; Breyton, M; Camus, V; Courtet, P; Doumy, O; El-Hage, W; Faugere, M; Fond, G; Garosi, A; Genty, JB; Godin, O; Haffen, E; Holtzmann, J; Horn, M; Korchia, T; Lancon, C; Leboyer, M; Llorca, PM; Maruani, J; Moirand, R; Moliere, F; Petrucci, J; Rey, R; Richieri, R; Samalin, L; Stephan, F; Suc, N; Vaiva, G; Walter, M; Yrondi, A | 1 |
| Allen, SI; Brosnan, P; Bullen, C; Chowdhury, N; Cobb, CO; Eissenberg, T; Foulds, J; Graham, JT; Hammett, E; Hrabovsky, S; Hummer, BL; Kang, L; Lester, C; Lopez, AA; Richie, JP; Sciamanna, C; Sun, S; Veldheer, S; Wang, X; Yen, MS; Yingst, J | 1 |
| Barrington-Trimis, JL; Bluthenthal, RN; Ceasar, RC; Kechter, A; Schiff, SJ; Simpson, KA; Smiley, SL; Yamaguchi, N | 1 |
| Cassidy, R; Colby, SM; DeAtley, T; Snell, LM; Tidey, JW | 1 |
| Kumari, P; Ravichandiran, V; Singh, S; Xavier, J | 1 |
| Colby, SM; DeAtley, T; Reed, GL; Snell, LM; Sokolovsky, AW; Tidey, JW | 1 |
| Bi, YZ; Hu, L; Kong, YZ; Lu, ZJ; Zhong, JH | 1 |
| Bursac, Z; Derefinko, KJ; Ebbert, JO; Hand, SB; Klesges, RC; Womack, C | 1 |
| Girard, M; Lacroix, A; Lourmière, G; Nubukpo, P | 1 |
| Kleinke, K; Klucken, T; Machulska, A; Margraf, J; Remeniuk, O; Rinck, M; Wunder, JC | 1 |
| Carroll, DM; Differding, M; Donny, EC; Hatsukami, DK; Katz, SJ; Strasser, AA; Strayer, LG; White, C | 1 |
| Castro, Y; Correa-Fernández, V; Guerra, ZC; Heydarian, NM; Leija, A; Londoño, T | 1 |
| Larsson, M | 2 |
| Castillo, J; Deshpande, HU; Fedota, JR; Ross, TJ; Salmeron, BJ; Stein, EA | 1 |
| Chen, MK; Cosgrove, KP; Gao, H; Huang, Y; Liu, H; Matuskey, D; Morris, ED; Nabulsi, N; Najafzadeh, S; Ropchan, J; Zakiniaeiz, Y | 1 |
| Benmarhnia, T; Chen, R; Leas, EC; McMenamin, SB; Messer, K; Pierce, JP; Stone, M; Strong, DR; Trinidad, DR; White, MM | 1 |
| Butler, J; Clark, PI; Cruz-Cano, R; Dyer, TV; Feldman, RH; Fryer, CS; Kidanu, AW; Lee, E; Shi, R; Varshney, A | 1 |
| Amos, CI; Baker, TB; Bierut, L; Bray, M; Carney, RM; Chang, Y; Chen, LS; Fox, L; Jorenby, D; Pham, G; Smock, N; Stoneking, F | 1 |
| Adams, L; Digard, H; Gaca, M; Hawkridge, L; Proctor, C; Williamson, J | 1 |
| Albin Nielsen, K; Arendt-Nielsen, L; Boucher, Y; Carstens, E; Clavé, P; Nielsen, TA; Proctor, G; Reeh, PW | 1 |
| Delnevo, CD; Gonsalves, NJ; Hrywna, M; Wackowski, OA | 1 |
| Erblich, J; Montgomery, GH; Schnur, JB | 1 |
| Beloate, LN; Doolittle, J; Froeliger, B; Garcia-Keller, C; Kalivas, PW; Meyerink, ME; Nall, RW; Penaloza, T | 1 |
| Kashyap, P; Kataria, S; Mahapatra, S; Marya, A; Marya, CM; Nagpal, R; Taneja, P | 1 |
| Egbe, CO; Hendlin, Y; Kim, M; Ling, PM; Patanavanich, R; Pinho, M | 1 |
| Fulone, I; Kantrow, S; Leone, FT; Lopes, LC; Murray, RL; O'Brien, KK; Pavalagantharajah, S; Ross, S; Zhang, Y; Zhang, YQ; Zhu, M | 1 |
| Boynton, MH; Byron, MJ; Enyioha, C; Goldstein, AO; Kistler, CE; Ranney, LM | 1 |
| Minami, H; Nahvi, S; Selva Kumar, D | 1 |
| Chakraborti, Y; Coffman, DL; Piper, ME | 1 |
| Hauke, T; Mütze, J; Pluym, N; Scherer, G; Scherer, M | 1 |
| Ashley, DL; Duong, HT; Henderson, KC; Loud, EE; Ntansah, CA; Popova, L; Reynolds, RM; Thrasher, JF; Yang, B | 1 |
| Galimov, A; Hanewinkel, R; Niederberger, K; Pedersen, A; Unger, JB | 1 |
| Bierut, L; Fowler, CD; Hall, WD; Jha, P; Le Foll, B; Lu, L; Piper, ME; Tonstad, S | 1 |
| Brose, LS; Langley, TE; McNeill, A; Perman-Howe, PR; Robson, D; Tildy, BE | 1 |
| Brandon, KO; Brandon, TH; Byrne, MM; Calixte-Civil, P; Casas, L; Martinez, U; Meade, CD; Medina-Ramirez, P; Simmons, VN; Sutton, SK | 1 |
| Bansal-Travers, M; Borland, R; East, K; Elton-Marshall, T; Fong, GT; Gartner, C; Gravely, S; Hyland, A; Michael Cummings, K; Tagliaferri, S; Yong, HH | 1 |
| Brown, J; Jackson, S; Kastaun, S; Kotz, D | 1 |
| Cohen, J; Kennedy, RD; Limaye, R; Moran, MB; Weiger, C | 1 |
| Chambers, MS | 1 |
| Baker, A; Bonevski, B; Borland, R; Clapham, M; Dunlop, A; Gartner, C; Guillaumier, A; Lum, A; Robinson, M; Skelton, E | 1 |
| Andreasen, JT | 1 |
| Munafò, M | 1 |
| Brown, J; Dockrell, M; Jackson, SE; Tattan-Birch, H | 1 |
| Mahinpey, N; Melamed, O; Minian, N; Selby, P; Veldhuizen, S; Zawertailo, L | 1 |
| Brown, J; Hayes, E; Jackson, S; Lindson, N; Livingstone-Banks, J; Norris, E | 1 |
| Hamidovic, A | 1 |
| Alsobaiei, M; Sivaramakrishnan, G; Sridharan, K | 1 |
| Engineer, A; Feng, Q; Greco, ER; Jones, DL; Lu, X; Saiyin, T; Zhang, M | 1 |
| Benowitz, NL; Blount, BC; Bravo Cardenas, R; Carpenter, MJ; Denlinger-Apte, RL; Donny, EC; Hatsukami, DK; Koopmeiners, JS; Ngac, P; Pacek, LR; Smith, TT; Valentin-Blasini, L; Watson, C; White, CM | 1 |
| Bai, XX; Liao, YH; Liu, JP; Robinson, N; Tang, WT; Wang, J; Zhang, H; Zhang, YY | 1 |
| Owotomo, O; Walley, S | 1 |
| Bauld, L; Clark, M; Coleman, T; Cooper, S; Griffiths, C; Hajek, P; Lewis, S; Manyonda, I; McRobbie, H; Myers Smith, K; Naughton, F; Pesola, F; Przulj, D; Sasieni, P; Seager, E; Sinclair, L; Ussher, M; Walton, R; Whitemore, R | 1 |
| Barker, J; Cruz, TB; Leventhal, AM; Pentz, MA; Unger, JB | 1 |
| Fry, JS; Lee, PN; Ljung, T | 1 |
| Abramson, MJ; Bonevski, B; George, J; Gobarani, RK; Ilomäki, J; Wood, S | 1 |
| Barrows, AJ; Bunn, JY; Gaalema, DE; Heil, SH; Higgins, ST; Lee, DC; Markesich, C; Oliver, AC; Sigmon, SC; Snow, MB; Tidey, JW; Villanti, AC; Wiley, RC | 1 |
| Jantrawut, P; Kheawfu, K; Panraksa, P | 1 |
| Cassidy, RN; Colby, SM; Denlinger-Apte, RL; Snell, LM; Tidey, JW | 1 |
| Braaten, G; Carroll, DM; Dorr, C; Frizzell, L; Hatsukami, D; Hernandez, C; Jacobson, PA; Meier, E; Murphy, S; Rhodes, K; Tyndale, RF | 1 |
| Cassidy, R; Colby, SM; DeAtley, TE; Snell, ML; Tidey, JW | 1 |
| Atlan, M; Cristofari, S; Guérif, V | 1 |
| Bunn, JY; Gaalema, D; Harfmann, RF; Heil, SH; Higgins, ST; Morgan, SL; Reed, GL; Sigmon, SC; Tidey, J | 1 |
| Abo Dena, AS; El Nashar, RM; El-Sherbiny, IM; Yahia, S | 1 |
| Cao, W; Duffy, KA; Epperson, CN; Johnson, RL; Kuzma, A; Loughead, J; Novick, AM; Sammel, MD; Sofuoglu, M; Strasser, AA | 1 |
| Ben Cheikh, A; Ben Rejeb, M; Bhiri, S; Ghali, H; Khefacha, S; Said Latiri, H | 1 |
| Das, S; de Filippis, R; Reddy, B | 1 |
| Jones, M; Kim, RS; Li, M; Pak, DJ; Robinson, CL; Ruan, QZ; Southerland, W; Surapaneni, S | 1 |
| Lam, TH | 1 |
| Humair, JP; Papachristou, C | 1 |
| Mang, T; Popp, S; Scharitzer, M | 1 |
| Guttentag, A; Kirchner, T; Shelley, D; Tseng, TY | 1 |
| Barnes, A; Breland, A; Cohen, J; Crabtree, M; Foulds, J; Lopez, AA; Soule, E; Underwood, M; Wang, X; Yingst, J | 1 |
| Tanne, JH | 1 |
| Behm, FM; Botts, DR; Botts, TL; McCarty, J; Rose, JE; Vocci, F; Willette, PN | 1 |
| Carpenter, MJ; Hughes, JR; Klemperer, EM; Lindson, N; Streck, JM; Su, A; West, JC | 1 |
| Beaumont, C; Mendelsohn, CP | 1 |
| Alberg, A; Borland, R; Cho, YJ; Cummings, KM; Fong, GT; Gravely, S; Hitchman, SC; Thrasher, JF; Yong, HH | 1 |
| Baler, G; Brewer, NT; Byron, MJ; Clark, SA; Goldstein, AO; Gourlay, M; Jarman, KL; Ranney, LM | 1 |
| Abroms, LC; Berg, CJ; Elmi, A; Klemperer, EM; Krishnan, N; Sherman, SE | 1 |
| Calder, D; Pechmann, C; Phillips, C; Prochaska, JJ | 1 |
| Abrams, D; Anderson, ED; Cao, P; Davis, KM; Jayasekera, J; Jeon, J; Li, T; Lobo, T; Luta, G; Mandelblatt, J; Meza, R; Niaura, R; Smith, L; Stanton, CA; Taylor, KL; Williams, RM | 1 |
| Cao, P; Jayasekera, J; Jeon, J; Levy, DT; Mandelblatt, JS; Meza, R; Smith, L; Taylor, KL; Williams, RM; Zhao, A | 1 |
| Bacon, S; Barrett, E; Bennett, J; Chamberlain, C; Field, B; Field, BG; Heris, C; Hussein, P; Kennedy, M; Longbottom, H; Maddox, R; Maidment, S; Ralph, F | 1 |
| Kierstead, E; Schillo, B; Silver, N; Sparrock, L; Tran, B; Vallone, D | 1 |
| Campbell, EH; Jin, MF; Somani, AK | 1 |
| Baker, P; Boyd, MA; Dean, JA; Edwards, S; Gartner, CE; Gilks, C; Howard, C; Puljević, C; Watts, P | 1 |
| al'Absi, M; Benowitz, NL; Cinciripini, PM; Donny, EC; Drobes, DJ; Hatsukami, DK; Jensen, J; Klemperer, EM; Luo, X; McClernon, J; Robinson, JD; Strasser, AA; Strayer, LG; Vandrey, R | 1 |
| Crotty Alexander, LE; Giovacchini, CX; Que, LG | 1 |
| Allen, SI; Bordner, C; Foulds, J; Grigson, PS; Hammett, E; Hummer, B; Lester, C; Livelsberger, C; Sciamanna, CN; Tan, HS; Trushin, N; Twining, RC; Veldheer, S; Wilson, SJ; Yingst, JM; Zhu, J | 1 |
| Borland, R; das Nair, R; Grech, L; Marck, CH; Weld-Blundell, I; White, SL | 1 |
| Apolone, G; Boeri, M; Boffi, R; Gallus, S; Ladisa, V; Ledda, RE; Marchianò, A; Milanese, G; Munarini, E; Pastorino, U; Rolli, L; Sabia, F; Sozzi, G; Suatoni, P; Trussardo, S; Valsecchi, C | 1 |
| Pluym, N; Rögner, N; Scherer, G; Scherer, M | 1 |
| Bendiks, S; Blokhina, E; Bryant, K; Cheng, DM; Freiberg, MS; Gnatienko, N; Hahn, J; Krupitsky, E; Lioznov, D; Patts, G; Samet, JH; So-Armah, K; Stein, MD; Tindle, HA; Yaroslavtseva, T | 1 |
| Begh, R; Bullen, C; Butler, AR; Fanshawe, TR; Hajek, P; Hartmann-Boyce, J; Lindson, N; McRobbie, H; Notley, C; Rigotti, NA; Theodoulou, A | 1 |
| Aamir, A; Bender, M; Billingsley, B; Bridgeman, MB; Rosen, RL; Shah, D; Shargo, K; Steinberg, ML | 1 |
| Brose, LS; Gumber, A; Klonizakis, M; McIntosh, E | 1 |
| Jongenelis, MI | 2 |
| DeSarno, M; Erath, TG; Gaalema, DE; Heil, SH; Higgins, ST; Reed, DD; Sigmon, SC; Tidey, JW | 1 |
| Foulds, J; Hayes, JE; Hobkirk, AL; Horn, K; Krebs, NM; Liao, J; Lin, W; Muscat, JE; Richie, JP; Zhu, J | 1 |
| Affentranger, A; Brambs, C; Christmann, C; Cortonesi, B; Fankhauser, CD; Gass, M; Held, U; Jeker, U; Jung, G; Minervini, F; Puhan, MA | 1 |
| Barrington-Trimis, JL; Cho, J; Han, DH; Harlow, AF; Lerman, C; Leventhal, AM; Tackett, AP; Unger, JB; Vogel, EA; Wong, M | 1 |
| Amos, J; Beckert, L; Burrowes, KS; Fuge, C; Murray, T; Pitama, S | 1 |
| Bouchier, B; Charvet, A; Dailler, F; Ritzenthaler, T | 1 |
| DiClemente, CC; Kolodner, G; Miller, MM | 1 |
| Douglas, CE; Kiessling, KA; Liber, AC; Warner, KE | 1 |
| Adsit, RT; An, LC; Baker, TB; Bernstein, SL; Bolt, DM; Boyd, AD; Brunzell, DH; Cai, Y; Carrillo, V; Chen, LS; Conner, KL; D'Angelo, H; Davis, JM; Deshmukh, VG; Dilip, D; Ellerbeck, EF; Eng, OD; Fiore, MC; Goldstein, AO; Gonzalez, A; Hayes-Birchler, T; Iturrate, E; Jorenby, DE; Jose, T; Kashyap, N; Kent, S; Khanna, N; Kim, H; King, A; Kirsch, JA; Klass, E; Lazuk, D; Lubanski, S; Mathew, JP; McMahan, G; Mermelstein, RJ; Nolan, MB; Piasecki, TM; Rolland, B; Slutske, WS; Smith, SS; Suk, Y; Theobald, WE; Tindle, HA; Tong, E; Tsoh, JY; Warren, GW; Williams, BS; Wilson, KM; Yu, M | 1 |
| Goyagi, T; Iida, H; Iida, M; Matsubara, T; Sugiyama, Y; Taniguchi, C; Yamada, N; Yamaguchi, S; Yonekura, H | 1 |
| Borland, R; Cummings, KM; Gartner, C; Levy, DT; Li, Y; Liber, AC; Sánchez-Romero, LM; Yuan, Z | 1 |
| Mir, H; Pipe, AL | 1 |
| Aiken, A; Anderson, J; Barker, D; Boland, VC; Borland, R; Courtney, RJ; Farrell, M; Gartner, C; Hall, W; Howard, BC; Mattick, RP; McRobbie, H; Mendelsohn, C; Naughton, F; Petrie, D; Richmond, RL; Shakeshaft, A; Tutka, P; Zwar, N | 1 |
| Burn, F; Cornuz, J; Eisenring, CV; Hamilton, PL; Herzog, P; Jacot-Sadowski, I; Nanchen, D; Oertel, MF; Schatlo, B | 1 |
| Hajek, P; Myers Smith, K; Pesola, F; Phillips-Waller, A; Przulj, D | 1 |
| Goodwin, RD; Walker, LK | 1 |
| Du, K; Wang, G; Wang, L; Yao, X | 1 |
| Pluym, N; Scherer, G; Scherer, M | 1 |
| Baliunas, D; Comans, T; Gartner, C; Hollingworth, SA; Pole, JD; Sullivan, C | 1 |
| Cheong, AT; Manap, AHA; Ngee Ling, BJ | 1 |
| Coleman-Cowger, VH; Monahan, E; Peters, EN; Pickworth, WB; Smith, CE; Triplett, CA | 1 |
| Colsoul, ML; Galanti, L; Goderniaux, N; Vanpee, D | 1 |
| Janwantanakul, P; Klinsophon, T; Thaveeratitham, P | 1 |
| al'Absi, M; Denlinger-Apte, R; Dermody, SS; Donny, EC; Drobes, D; Hatsukami, D; Hecht, SS; Jensen, J; Koopmeiners, J; Meier, E; Murphy, S; Rubin, N; Tessier, KM; Thorne, C; Tidey, JW; Vandrey, R | 1 |
| Bunn, JY; Gaalema, DE; Heil, SH; Higgins, ST; Hughes, JR; Lee, DC; Park, C; Sigmon, SC; Snell, LM; Tidey, JW | 1 |
| Stephenson, J | 1 |
| Hameed, A; Malik, D | 1 |
| Cheng, KJG; Estrada, MAG | 1 |
| Ahouagi, AEO; Blunk, PFF; Braga, DG; Ferreira, SG; Laborne-E-Valle, MEP; Lara-Júnior, CR; Nascimento, MMGD; Pinto, IVL; Ramalho-de-Oliveira, D; Reis, AMM; Reis, EA | 1 |
| Jia, C; Li, H; Li, S; Wang, Q | 2 |
| Chaiton, M; Cunningham, JA; Godinho, A; Leatherdale, ST; Schell, C; Tyndale, RF | 2 |
| Evans-Reeves, K; Fenton, E; Hoek, J; Joshi, A; Lee, E; Robertson, L | 1 |
| Peterson, EB; Pitzer, L; Zhao, X | 1 |
| Shaikh, S; Zaidi, AB | 1 |
| Acton, D; Alberg, AJ; Giuliani, M; Hatsukami, D; Herbst, RS; Moushey, A; Phillips, J; Sherwood, S; Toll, BA; Viswanath, K; Warren, GW; Warren, NJH | 1 |
| Driva, S; Katsaounou, P; Korkontzelou, A; Tentolouris, N; Tonstad, S | 1 |
| Baishya, ML; Collins, BN; Lepore, SJ | 1 |
| Allen, NB; Eiden, RD; Espy, KA; Estabrook, R; Level, RA; Massey, SH; Neiderhiser, JM; Pool, LR; Shisler, S; Stacks, AM; Wakschlag, LS | 1 |
| Baek, YH; Chae, SY; Choi, IS; Jo, MG; Kim, EJ; Kim, GW; Kim, JH; Moon, JH; Park, YC; Seo, BK; Sung, WS | 1 |
| Jang, TC; Lee, JE; Seo, YW | 1 |
| Grigg, J; Miles, E; Morris, EE | 1 |
| Corrêa, PCRP | 1 |
| Cox, S; Hastings, J; Notley, C; Soar, K; West, R | 1 |
| Diaz, D; Donny, EC; Hatsukami, DK; Luo, X; O'Connor, RJ | 1 |
| Barnett, P; Butler, AR; Hartmann-Boyce, J; Levy, DT; Liber, A; Lindson, N; Notley, C; Rigotti, NA; Theodoulou, A | 1 |
| Patwardhan, S | 1 |
| Bertolotti, R; Busacchio, D; Jemos, C; Lucchiari, C; Maisonneuve, P; Masiero, M; Mazzocco, K; Pravettoni, G; Salè, EO; Spina, S; Veronesi, G | 1 |
| Businelle, MS; Carpenter, MJ; Chana, SM; Cropsey, KL; Gajos, JM; Hawes, ES; Mrug, S; Wolford-Clevenger, C | 1 |
| Bian, H; Chen, H; Gao, L; Lai, K; Wang, J; Zhang, Y | 1 |
| Caspersen, IH; Galanti, MR; Ilmarinen, K; Kärkkäinen, S; Karvonen, S; Kestilä, L; Magnus, P; Parikka, S; Peña, S; Shaaban, AN | 1 |
| Hoek, J; Robertson, L; Sanford, KR; Waa, A | 1 |
| Bold, K; Krishnan-Sarin, S; Morean, M; O'Malley, S | 1 |
| Cassidy, RN; Cioe, PA; Colby, SM; Hatsukami, D; Jackson, KM; Krishnan-Sarin, S; Murphy, SE; Tidey, JW | 1 |
| Brose, LS; Brown, J; Cox, S; Kock, L; McNeill, A; Robson, D; Shahab, L; Tattan-Birch, H | 1 |
| Cinciripini, P; James, J; Krause, KJ; Lopez-Olivo, MA; Sharma, G; Singh, G; Suarez-Almazor, ME; Volk, RJ | 1 |
| Chellappan, S | 1 |
| Gex, KS; Gray, KM; McClure, EA; Walters, KJ | 1 |
| Kaerlev, L; Morales-Suárez-Varela, M; Peraita-Costa, I; Perales-Marín, A; Puig, BM | 1 |
| Cassidy, R; DeAtley, T; Harrison, A; Higgins, ST; Kuo, C; Tidey, JW | 1 |
| Babb, S; Malarcher, A; Salazar, E; Shin, H; Trigger, S; Xu, X | 1 |
| Bricker, JB; Mull, KE; Rigotti, NA; Santiago-Torres, M; Sullivan, BM | 1 |
| Coleman, T; Coleman-Haynes, T; Cooper, S; Emery, J; Mcdaid, L; Naughton, F; Phillips, L; Thomson, R | 1 |
| Albelda, B; Ashare, R; Audrain-McGovern, J; Manikandan, D; Perkins, KA; Wileyto, EP | 1 |
| Behal, A; Selby, P; Veldhuizen, S; Zawertailo, L | 1 |
| Ahluwalia, JS; Bejarano, G; Bluestein, MA; Duano, JC; Hébert, ET; Rawls, SG; Tackett, AP; Vandewater, EA | 1 |
| Li, D; Liu, P; Lou, X; Xie, Z | 1 |
| Benowitz, NL; McNeill, A; Rigotti, NA; Warner, KE | 1 |
| Chenoweth, MJ; Knight, J; Lerman, C; Tyndale, RF | 1 |
| Bowker, K; Brown, E; Clark, M; Coleman, T; Cooper, S; Dickinson, A; Emery, J; Kinahan-Goodwin, D; McDaid, L; Naughton, F; Phillips, L; Thomson, R | 1 |
| Chow, CK; Falster, MO; Filion, KB; Havard, A; Hsu, B; Jorm, L; Pearson, SA; Robijn, AL; Woodward, M | 1 |
| Bade, R; Gartner, C; Gerber, C; Mueller, JF; O'Brien, J; Thai, PK; Thomas, KV; Tscharke, BJ; Wang, Z; White, JM; Zheng, Q | 1 |
| Clausen, B; Gallagher, MW; Garey, L; Matoska, CT; Nizio, P; Rinck, M; Smits, JAJ; Zappi, C; Zvolensky, MJ | 1 |
| Brown, S; Crane, HM; Cropsey, K; Delaney, JAC; Dougherty, S; Drumright, LN; Fitzsimmons, E; Fredericksen, RJ; Hahn, A; Loo, S; Mayer, KH; Mugavero, MJ; Nance, RM; O'Cleirigh, C; Pearce, J; Ruderman, S; Whitney, BM | 1 |
| Margolis, KA; O'Brien, EK; Persoskie, A; Roditis, M | 1 |
| Copeland, A; Field, M; Stafford, T | 1 |
| Cassidy, RN; Colby, SM; DeAtley, T; Snell, LM; Tidey, JW | 1 |
| Banks, E; Beckwith, K; Brown, S; Campbell, S; Daluwatta, A; Joshy, G; Martin, M; Nguyen, M; Yazidjoglou, A | 1 |
| Aoike, M; Aoyama, Y; Ito, M; Kawamura, H; Kozai, H; Mori, Y; Shigeno, Y; Tanaka, M; Tsurudome, M | 1 |
| Attwells, S; Dragonetti, R; Kabir, T; Malat, L; Mei-Dan, E; Melamed, OC; Minian, N; Selby, P; Tanzini, E; Veldhuizen, S; Voci, S; Zawertailo, L | 1 |
| Benfatto, F; Busà, B; Caci, G; Campagna, D; Caponnetto, P; Caruso, M; Ceracchi, M; Emma, R; Maglia, M; Migliore, M; Pennisi, A; Signorelli, M | 1 |
| Brown, J; Bullen, C; Jackson, S; McNeill, A; Shahab, L | 1 |
| Ciervo, CA; Mueller, L | 1 |
| Ahluwalia, JS; Chenoweth, MJ; Cox, LS; El-Boraie, A; Fukunaga, K; Knight, J; Langlois, AWR; Mushiroda, T; Pouget, JG; Tyndale, RF | 1 |
| Shahab, L | 1 |
| Burkard, T; Christ-Crain, M; Coynel, D; Erlanger, TE; Hemkens, LG; Jeanloz, N; Lengsfeld, S; Meienberg, A; Speich, B; Vogt, DR; Winzeler, B; Zanchi, D | 1 |
| Canseco, JA; D'Antonio, ND; Heard, JC; Karamian, BA; Kepler, CK; Lambrechts, MJ; Levy, HA; Markova, DZ; Vaccaro, AR; Yalla, GR | 1 |
| Brath, H; Fasching, P; Fischer-See, S; Kaser, S; Tatschl, C | 1 |
| Bi, Y; Hu, L; Lu, Z; Tao, K; Wei, K; Zhu, C | 1 |
| Anandan, AS; Chan, GCK; Connor, JP; Hall, WD; Leung, J; Stjepanović, D; Sun, T | 1 |
| Fanshawe, TR; Hajizadeh, A; Hartman, L; Lindson, N; Livingstone-Banks, J; Theodoulou, A; Thomas, KH | 1 |
| Iyengar, A; Prashanth, R; Pruthvish, S; Sujatha, S | 1 |
| Eisenberg, MJ; Filion, KB; Levett, JY; Prell, C; Reynier, P | 1 |
| Gould, TJ | 1 |
| Bover-Manderski, MT; Delnevo, CD; Hrywna, M; Steinberg, MB; Wackowski, OA | 1 |
| Borland, R; Cummings, KM; Fong, GT; Gravely, S; Karmakar, C; Motin, MA; Yong, HH | 1 |
| Chang, Y; Davis, EM; Freiberg, MS; King, S; Lee, SS; Levy, DE; Rigotti, NA; Singer, DE; Tindle, HA; Tyndale, RF; Wells, QS | 1 |
| Brown, J; Jackson, SE; Shahab, L; Tattan-Birch, H | 1 |
| Etter, JF; Khazaal, Y; Vera Cruz, G | 1 |
| Aycock, CA; Ebbert, JO; Halbert, JP; Klesges, RC; Little, MA; Mallawaarachchi, IV; Patience, MA; Talcott, GW; Wang, XQ; Wiseman, KP | 1 |
| Ashburner, JM; Klemenc Ketiš, Z; Oreskovic, S; Oreskovic, T; Percac-Lima, S; Rifel, J; Tiljak, H | 1 |
| Alibhai, H; Cinciripini, PM; Kosten, TR; Lane, SD; Schmitz, JM; Suchting, R; Verrico, CD; Versace, F; Weaver, MF; Webber, HE; Yammine, L | 1 |
| Ahluwalia, JS; Cox, LS; Ellerbeck, EF; Greiner, KA; Leavens, ELS; Mayo, MS; Nollen, NL; Salzman, G; Shanks, D; Woodward, J | 1 |
| Bonevski, B; Guillaumier, A; Handley, T; Judd, L; Lum, A; Lye, A; McCarter, K; Skelton, E; Trigg, J | 1 |
| Ghotbi, N; Pilz, LK; Rabenstein, A; Roenneberg, T; Rüther, T | 1 |
| Feldman, I; Galanti, MR; Gebreslassie, M; Lager, A | 1 |
| Rodberg, D; Sharma, RH; Struik, LL | 1 |
| Catz, SL; Heffner, JL; Klasnja, P; Krakauer, C; McClure, JB; Mun, S | 1 |
| Funaro, MC; Khan, W; Moeller, JJ; Narrett, JA | 1 |
| Courtney, KE; Doran, N; Reed, BW | 1 |
| Benowitz, NL; Blumenstein, B; Cain, D; Clarke, A; Jacobs, C; Leischow, S; Nides, M; Prochaska, J; Rigotti, NA | 1 |
| Baler, R; García-Gómez, L; Hernández-Pérez, A; Osio-Echánove, J; Pérez-Padilla, R; Robles-Hernández, R; Rodríguez-Llamazares, S; Thirión-Romero, I | 1 |
| Campbell, D; Claerhout, S; Davis, JM; Frisbee, S; Rose, JE; Salley, A | 1 |
| Chirumbolo, S; Tirelli, U | 1 |
| Chaiton, M; Cunningham, JA; Godinho, A; Leatherdale, ST; Schell, C | 1 |
| Berlin, I; Colsoul, ML; Dupuis, S; Galanti, L; Goderniaux, N; Jamart, J; Onorati, S; Vanpee, D | 1 |
| Kelemen, O; Pócs, D; Tari, G; Watti, J | 1 |
| Bunn, J; Coleman, SRM; DeSarno, M; Higgins, ST; Nighbor, TD; Orr, E; Plucinski, S; Skelly, J | 1 |
| Alcocer Alkureishi, L; Hageman, JR; Montalto, GJ | 1 |
| Scherer, G; Yach, D | 1 |
| Boyd, LD; Martell, KM; Sundstrom, RM; Vineyard, J | 1 |
| Dennis, BB; Devereaux, PJ; Fairbairn, N; Lu, C; Mbuagbaw, L; Ofori, S; Olasupo, OO | 1 |
| Davis, JM; Masclans, L; Rose, JE | 1 |
| Agrawal, S; Aveyard, P; Fanshawe, TR; Freeman, SC; Hajizadeh, A; Hartmann-Boyce, J; Lindson, N; Livingstone-Banks, J; Ordóñez-Mena, JM; Sutton, AJ; Theodoulou, A; Zhu, S | 1 |
| Barnes, J; Bullen, C; Calder, A; Laking, G; Parag, V; Walker, N | 1 |
| Berkane, M; Gilligan, K; McKinney, WJ; Olson, CK; Sherwood, N | 1 |
| Gossa, W | 1 |
| Anderson, RT; Cohn, WF; Fahey, MC; Krukowski, RA; Little, MA; Porter, KJ; Reid, T; Rucker, TW; Wiseman, KP; Wood, CH; You, W | 1 |
| La Rosa, GRM; O'Leary, R; Polosa, R; Qureshi, MA; Vernooij, RWM | 1 |
| Beard, E; Hajek, P; Jarvis, M; Pesola, F; Phillips-Waller, A; Shahab, L; Sweanor, D | 1 |
| Ahluwalia, JS; Brown, A; Cruvinel, E; Funk, O; Lambart, L; Leavens, E; Mayo, MS; Nollen, NL; Sanderson Cox, L | 1 |
| Bauld, L; Clark, M; Coleman, T; Cooper, S; Griffith, C; Hajek, P; Lewis, S; Manyonda, I; McRobbie, H; Myers Smith, K; Naughton, F; Pesola, F; Przulj, D; Sasieni, P; Seager, E; Sinclair, L; Ussher, M; Walton, R; Whitemore, R | 1 |
| Borland, R; Diaz, D; East, K; Gartner, C; King, B; Le Grande, M; O'Connor, R; Taylor, E; Yong, HH | 1 |
| Brose, LS; Dregan, A; McNeill, A; Richardson, S; Robins, J; Tildy, BE | 1 |
| Addae-Konadu, K; Dotters-Katz, SK; Kuller, JA; Shirwani, A | 1 |
| Issabakhsh, M; Jeon, J; Levy, DT; Li, Y; Liber, AC; Meza, R; Sánchez-Romero, LM; Tam, J; Travis, N; Yuan, Z | 1 |
| Crape, BL; Jaxybayeva, A; la Fleur, P; Olickal, JJ; Purushothama, C; Stolyarov, V | 1 |
| Li, W; Noguez, J; Zhang, XS | 1 |
| Corey, A; Gaffey, AE; McCallum, M; Niaura, R; Stroud, LR; Vergara-Lopez, C | 1 |
| Cheung Li, WH; Cheung, YTD; Lam, TH; Wang, MP | 1 |
| Doncel, JC; Gómez-Chacón, MC; Panero, J; Perea, MD; Rebollar, A | 1 |
| MacDonald, A; Middlekauff, HR | 1 |
| Borges, AM; Farris, SG; Kibbey, MM; Leyro, TM; Rosen, RL; Steinberg, ML | 1 |
| Thirlway, F | 1 |
| Holder, T; Indes, JE; Muhs, B; Ochoa Chaar, CI; Rajaee, S; Sarac, T; Sumpio, B; Toll, BA | 1 |
| Allen, S; Cameron, J; Harrison, K; Petersen, A; Tosun, N | 1 |
| Taraseviciene-Stewart, L | 1 |
| Bergeria, CL; Davis, DR; DeSarno, MJ; Gaalema, DE; Heil, SH; Higgins, ST; Sigmon, SC; Stitzer, ML; Streck, JM; Tidey, JW | 1 |
| Bates, C; Beaglehole, R; Bonita, R; Youdan, B | 1 |
| Hanewinkel, R | 1 |
| Benowitz, NL | 9 |
| Conklin, CA; Davis, EM; Denlinger-Apte, RL; Donny, EC; Hatsukami, DK; Koopmeiners, JS; Lane, T; Murphy, SE; Smith, TT; Tessier, KM; Tidey, JW | 1 |
| Aveyard, P; Hong, B; Klemperer, E; Lindson, N; Ordóñez-Mena, JM | 1 |
| Benowitz, NL; Bernert, JT; Foulds, J; Hecht, SS; Jacob, P; Jarvis, MJ; Joseph, A; Oncken, C; Piper, ME | 1 |
| Eberg, M; Filion, KB; Platt, RW; Reynier, P | 1 |
| Dobbs, PD; Mamudu, HM; Sanborn, T | 1 |
| Barkat, SS; Eloma, AS; Tellier, SM | 1 |
| Beard, E; Brown, J; Hill, E; Jackson, SE; Michie, S; Shahab, L | 1 |
| Babal, P; Horvathova, L; Mravec, B; Tibensky, M | 1 |
| Pommer, P | 1 |
| Jang, M; Jeong, Y; Jung, T; Kim, I; Kim, W; Noh, J | 1 |
| Cioe, PA; Colby, SM; DeAtley, T; Denlinger-Apte, RL; Donny, EC; Goodwin, C; Hatsukami, DK; Lindgren, BR; Rubin, N; Tidey, JW | 1 |
| Cadet, M | 1 |
| Morris, A | 1 |
| Cavallo, DA; Krishnan-Sarin, S | 1 |
| Al'absi, M; Cinciripini, PM; Denlinger-Apte, RL; Donny, EC; Drobes, DJ; Hatsukami, DK; Jensen, JA; Kypriotakis, G; Leischow, SJ; Luo, X; McClernon, FJ; Pacek, LR; Robinson, JD; Severson, HH; Smith, TT; Strayer, LG | 1 |
| Belluzzi, JD; Cano, M; Cross, SJ; Leslie, FM; Reynaga, DD; Zaveri, NT | 1 |
| Cuccia, AF; Czaplicki, L; Donovan, EM; Hair, EC; Patel, M; Pitzer, L; Schillo, BA; Simard, B; Vallone, DM | 1 |
| Baker, TB; Cook, JW; Kim, N; Loh, WY; McCarthy, DE; Piper, ME; Schlam, TR | 1 |
| Bernard, A; Channan, EM; Chaumont, M; Colet, JM; Debbas, N; Deprez, G; Faoro, V; Morra, S; Schaefer, T; Tagliatti, V; van de Borne, P; Van Muylem, A | 1 |
| Ditre, JW; Heckman, BW; LaRowe, LR; Powers, JM | 2 |
| Hall, E; Hansson, A; Kraiczi, H; Perfekt, R; Rasmussen, T | 1 |
| Cuvillon, P; Gricourt, Y; Huteau, ME; Le Faou, AL; Stoebner, A | 1 |
| Karelitz, JL; Perkins, KA | 4 |
| Bentivegna, K; Goniewicz, ML; Waldman, RA | 1 |
| Ashack, KA; Visconti, MJ | 1 |
| Benowitz, NL; Dempsey, DA; Nardone, N; Shahid, M; Strasser, AA | 1 |
| Antoine, D; Bajon, D; Galera, O; Huet, I; Soukarie, L | 1 |
| Bertolotti, R; Jemos, C; Lucchiari, C; Maisonneuve, P; Masiero, M; Mazzocco, K; Omodeo Salè, E; Pravettoni, G; Spina, S; Veronesi, G | 1 |
| Andreu-Férnández, V; García-Algar, O; Sailer, S; Sebastiani, G | 1 |
| Kurti, AN | 1 |
| Davies, NM; Itani, T; Jones, T; Martin, RM; Munafò, MR; Rai, D; Taylor, AE; Taylor, GMJ; Thomas, KH | 1 |
| Benowitz, NL; Denlinger-Apte, RL; Donny, EC; Hatsukami, DK; Ikuemonisan, JO; Jensen, JA; Koopmeiners, JS; Kotlyar, M; Luo, X; Pacek, LR; Smith, TT; Tidey, JW; Vandrey, R | 1 |
| Cassidy, RN; Colby, SM; Denlinger-Apte, R; McClernon, FJ; Pacek, LR; Smith, TT; Tidey, JW | 1 |
| Hair, E; Naud, S; Niaura, RS; Pearson, JL; Rath, JM; Villanti, AC; Wackowski, OA; West, JC | 1 |
| Brewer, NT; Byron, JM; Hall, MG; Noar, SM; Ribisl, KM | 1 |
| Callas, PW; Hughes, JR; Klemperer, EM | 1 |
| Drobes, DJ; Piper, ME; Walker, N | 1 |
| Denlinger-Apte, RL; Evins, AE; Foulds, J; Gaalema, DE; Muscat, JE; Tidey, JW | 1 |
| Boatman, JA; Carroll, D; Colby, SM; Donny, EC; Hatsukami, DK; Koopmeiners, JS; Luo, X; Tidey, JW; Vock, DM | 1 |
| Cassidy, RN; Cioe, PA; Colby, SM; Denlinger-Apte, RL; Donny, EC; Goodwin, C; Hatsukami, DK; Hecht, SS; Lindgren, BR; Murphy, SE; Rubin, N; Swift, RM; Tidey, JW | 1 |
| Allen, AM; Carroll, DM; Denlinger-Apte, RL; Dermody, SS; Donny, EC; Hatsukami, DK; Koopmeiners, JS; Luo, X; McClernon, FJ; Pacek, LR; Smith, TT; Vandrey, R | 1 |
| Ashley, DL; Huang, J; Nyman, AL; Owusu, D; Popova, L; Weaver, SR; Yang, B | 1 |
| Davis, DR; Desarno, MJ; Diaz, V; Gaalema, DE; Heil, SH; Higgins, ST; Hughes, JR; Sigmon, SC; Stitzer, ML; Tidey, JW | 1 |
| Benowitz, NL; Donny, EC; Edwards, KC; Hatsukami, D; Smith, TT | 1 |
| Davis, DR; Gaalema, DE; Heil, SH; Higgins, ST; Parker, MA; Priest, JS; Sigmon, SC; Streck, JM; Tidey, JW; Villanti, AC | 1 |
| Johnson, AC; Luta, G; Mays, D; Mercincavage, M; Niaura, RS; Phan, L; Rehberg, K; Strasser, AA; Villanti, AC | 1 |
| Brewer, NT; Byron, MJ; Hall, MG; King, JL; Ribisl, KM | 1 |
| Berman, ML; Glasser, AM | 1 |
| Owusu, D; Popova, L; Yang, B | 1 |
| Abbasi, J | 1 |
| Kos, K | 1 |
| Armendáriz-Castillo, I; Cevallos-Vilatuña, T; García-Cárdenas, JM; Guerrero, S; Guevara-Ramírez, P; Leone, PE; López-Cortés, A; Paz-Y-Miño, C; Pérez-Villa, A; Vera-Guapi, A; Yumiceba, V; Zambrano, AK | 1 |
| Havard, A; Kennedy, D; Lee, ML; Tran, DT; Welsh, A | 1 |
| Lesage, E; Ross, TJ; Salmeron, BJ; Stein, EA; Sutherland, MT | 1 |
| Gilbert, DG; McDaniel, JT; Rabinovich, NE | 1 |
| Anand, A; Diab, N; Khan, MH; Stanbrook, MB | 1 |
| Berney, CR | 1 |
| Benowitz, NL; Jeong, BY; Lee, DH; Lim, MK; Park, E; Park, EY; Park, J | 1 |
| de Moura, FB; McMahon, LR; Wilkerson, JL | 1 |
| Gholap, V; Halquist, MS | 1 |
| Benowitz, NL; Blount, BC; Carpenter, MJ; De Jesús, VR; Denlinger-Apte, RL; Donny, EC; Hatsukami, DK; Koopmeiners, JS; Pacek, LR; Smith, TT; Wang, L; Watson, C; White, CM | 1 |
| Flitter, A; Lerman, C; Schnoll, RA; Siegel, SD | 1 |
| Bendtsen, M | 1 |
| Bullen, C; Laking, G; Laugesen, M; Parag, V; Verbiest, M; Walker, N | 1 |
| Cunningham, JA; Kushnir, V; Leatherdale, ST; Schell, C; Selby, P; Tyndale, RF; Zawertailo, L | 1 |
| Aronson Fischell, S; Deng, ZD; Ross, TJ; Salmeron, BJ; Stein, EA | 1 |
| McKee, SA; Moore, KE; Peltier, MR; Pittman, BP; Roberts, W; Verplaetse, TL | 1 |
| Goniewicz, MŁ; Kośmider, L; Koszowski, B; Sobczak, A | 1 |
| Chai, SH; D'Orazio, L; Eisenlohr-Moul, TA; Kirkpatrick, MG; Leventhal, AM; Pang, RD; Rapkin, AJ | 1 |
| Bals, R; Benowitz, N; Britz, H; Kohl, Y; Kovar, L; Lehr, T; Selzer, D; St Helen, G | 1 |
| Fagerström, K; Hughes, JR; Plurphanswat, N; Rodu, B | 1 |
| Eissenberg, T; Shihadeh, A; Soule, E | 1 |
| Pisinger, C; Vestbo, J | 1 |
| Alexander, AC; Businelle, MS; Hébert, ET; Kendzor, DE; Olurotimi, O; Ra, CK | 1 |
| Gould, GS; Havard, A; Kumar, R; Lim, LL | 1 |
| McMahon, LR; Moerke, MJ; Wilkerson, JL | 1 |
| Abney, LR; Adams, DW; Beaulieu, DB; Freiberg, MS; Gatskie, V; Gurwara, S; Horst, SN; King, S; Peyton, SC; Pointer, SO; Schwartz, DA; Scoville, EA; Tindle, HA; Wells, QS | 1 |
| Arifin, AJ; Dinniwell, RE; Louie, AV; McCracken, LC; Nesbitt, S; Palma, DA; Warner, A | 1 |
| Moore, D | 1 |
| Ashare, R; Benowitz, NL; Cinciripini, P; Fen Lubitz, S; George, TP; Gross, R; Hawk, LW; Hitsman, B; Lerman, C; Paul Wileyto, E; Schnoll, R; Tyndale, RF | 1 |
| Cepeda-Benito, A | 2 |
| Ferguson, SG; Hedeker, D; Mao, J; Scholl, SM; Shiffman, S; Tindle, HA | 1 |
| Hand, D; Kranzler, HR; Lynch, KG; Oncken, C; Schnoll, R; Tyndale, RF; Washio, Y; Zindel, LR | 1 |
| Carpenter, MJ; Dahne, J; Smith, TT; Wahlquist, AE | 1 |
| Freiberg, MS; Newhouse, PA; Tindle, HA | 1 |
| Bulteel, AJB; Freedberg, KA; Hou, T; Hyle, EP; Levy, DE; Osher, B; Paltiel, AD; Reddy, KP; Rigotti, NA; Shebl, FM; Torola, P; Walensky, RP; Weinstein, MC; Yu, L | 1 |
| Ariyaratnam, R; Khan, Z; Tebbutt, J | 1 |
| Brose, LS; McNeill, A; Simonavicius, E | 1 |
| Bonanno, C; Hemmy Asamsama, O; Krondilou, K; Miller, SC; Silvestri, MM | 1 |
| Herman, M; Tarran, R | 1 |
| Noll-Hussong, M | 1 |
| Dugas, EN; O'Loughlin, J; Sylvestre, MP | 1 |
| Hill, S; Lucherini, M; Smith, K | 1 |
| Hendershot, CS; Schlagintweit, HE; Tyndale, RF | 1 |
| de Miquel, C; Güler, D; Hasan, A; Papazova, I; Pross, B | 1 |
| Baker, TB; Bolt, DM; Cook, JW; Fiore, MC; Hayes-Birchler, T; McCarthy, DE; Piper, ME; Schlam, TR; Smith, SS | 1 |
| Hendershot, CS; Le Foll, B; Pipe, A; Reid, RD; Samokhvalov, AV; Selby, P; Thorpe, KE; Tyndale, RF; Zawertailo, L | 1 |
| Amos, CI; Baker, TB; Bierut, LJ; Bray, M; Carney, RM; Chen, J; Chen, LS; Culverhouse, RC; Jorenby, DE; Miller, JP; Saccone, NL; Smock, N; Stoneking, F | 1 |
| Eaglesham, G; Gerber, C; Li, J; O'Brien, JW; Reeks, T; Shimko, KM; Thai, PK; Thomas, KV; Thompson, J; Tscharke, BJ; Zheng, Q | 1 |
| Hughes, JR; Klemperer, EM; Nighbor, TD; Reed, EN; Simone, SJ; West, JC | 1 |
| Fornés-Vives, J; García-Pazo, P; Pérez-Pareja, FJ; Sesé, A | 1 |
| Dorner, TE; Grabovac, I; Haider, S; Sandner, I; Seiler-Ramadas, R | 1 |
| Cummings, KM; Heckman, BW; Levy, DT; Li, Y; Meza, R; Smith, TT; Yuan, Z | 1 |
| Berlin, I; Berveiller, P; Garabedian, C; Grangé, G; Guerby, P; Legendre, G | 1 |
| Germovsek, E; Hansson, A; Karlsson, MO; Kjellsson, MC; Soons, PA; Vermeulen, A; Westin, Å | 1 |
| Clark, PI; Feldman, R; Liu, J; Shi, R | 1 |
| Holloway, AC; Jamshed, L; Jamshed, S; Perono, GA | 1 |
| Bergeria, CL; Bunn, JY; Harfmann, RF; Heil, SH; Higgins, ST; Hughes, JR; Lee, DC; Tetreault, HJ | 1 |
| Boddu, SH; Bolla, PK; Cudjoe, E; Gionfriddo, E; Godage, NH; Neupane, R; Renukuntla, J | 1 |
| Baker, TB; Bierut, LJ; Bray, MJ; Chen, LS; Culverhouse, RC; Fox, L; Hancock, DB; Hartz, SM; Hokanson, JE; Johnson, EO; Liu, M; McKay, JD; Saccone, NL; Tyndale, RF; Vrieze, SI | 1 |
| Ali, MM; Cardenas, VM; Fischbach, LA; Nembhard, WN | 1 |
| Almeida, NL; Butler, PD; Fernandes, TP; Gomes, GH; Gonçalves, LM; Rodrigues, SJ; Santos, NA; Silverstein, SM; Sousa, IC | 1 |
| Firth, J; Kisely, S; Siskind, DJ; Wong, TT; Wu, BT | 1 |
| Bover Manderski, MT; Delnevo, CD; Singh, B; Steinberg, MB; Strasser, AA; Wackowski, OA | 1 |
| George, R; Gray, M; Manakil, J; Miliankos, A | 1 |
| Sohlberg, T; Wennberg, P | 1 |
| Ashley, DL; Berg, CJ; Cahn, Z; Douglas, CE; Drope, J; Eriksen, MP; Henson, R | 1 |
| Foulds, J; Horn, K; Krebs, NM; Lin, W; Muscat, JE; Zhu, J | 1 |
| Anzai, N; Baiocchi, M; Brown-Johnson, C; Chieng, A; Lazaro, AS; Prochaska, JJ; Stinson, S | 1 |
| Dawkins, L; Gentry, SV; Holland, R; Notley, C; Ward, E | 1 |
| Iwamoto, T; Kiyota, Y; Kobayashi, T; Matsumoto, M; Miyamoto, K; Miyamoto, T; Muramatsu, H; Nakamura, M; Sato, K; Sato, Y; Tateno, H | 1 |
| Brandon, TH; Conn, MR; Donny, EC; Drobes, DJ; Hatsukami, D; Lorenzo, YL; Sawyer, LE; Simmons, VN; Sutton, SK | 1 |
| Ahmed, J; Malik, F; Ochani, RK; Qureshi, SS | 1 |
| Barrows, A; Bergeria, CL; Bunn, JY; Cioe, P; Davis, DR; DeSarno, M; Gaalema, DE; Harfmann, RF; Heil, SH; Higgins, ST; Hughes, JR; Lee, D; MacLeod, D; Markesich, C; Miller, ME; Parker, MA; Priest, JS; Sigmon, SC; Streck, JM; Tidey, JW; Villanti, AC | 1 |
| Allen, A; Bonny, AE; Mallahan, S; Miller, H; Ortega, A; Saleh, A | 1 |
| Conklin, CA; Jakicic, JM; Joyce, CJ; Kupfer, DJ; Mumma, JM; Salkeld, RP; Soreca, I; Vella, EJ | 1 |
| Tonstad, S | 4 |
| Katsaounou, PA | 1 |
| Brady, KT | 1 |
| Addison, B; Burdalski, C; Butz, A; Galiatsatos, P; Jassal, MS; Lewis-Land, C; Oliver-Keyser, T | 1 |
| Borland, R; Cummings, KM; Elton-Marshall, T; Fong, GT; Karmakar, C; Motin, MA; Thompson, ME; Yong, HH | 1 |
| Baldassarri, SR; Fucito, LM; Herbst, RS; Malinosky, H | 1 |
| Ammerman, RT; Ding, L; Gordon, JS; Khoury, JC; Mahabee-Gittens, EM; Merianos, AL; Stone, L; Tabangin, ME | 1 |
| Borland, R; Carter, A; Gartner, C; Hall, W; Morphett, K; Puljević, C | 1 |
| Higgins, ST; Keith, DR; Kurti, AN; Skelly, J; Tang, KJ | 1 |
| Chen, TC; Kim, Y | 1 |
| Böhme, F; Grosskopf, CM; Kroemer, NB; Pooseh, S; Smolka, MN | 1 |
| al'Absi, M; Denlinger-Apte, RL; Dermody, SS; Donny, E; Drobes, DJ; Hatsukami, D; Jensen, J; Koopmeiners, JS; Meier, E; Pacek, LR; Tessier, KM; Tidey, JW; Vandrey, R | 1 |
| Hartmann-Boyce, J; Lindson, N | 1 |
| Lei, L; Liu, F | 1 |
| Corrigan, JR; Hackenberry, BN; Hammond, D; Lambert, VC; Rousu, MC; Thrasher, JF | 1 |
| Bascom, R; Fazzi, A; Foulds, J; Horn, K; Krebs, NM; Kuprewicz, R; Liao, J; Livelsberger, C; Martinez, DJ; Modesto, J; Muscat, JE; Reilly, SM; Reinhart, L; Richie, JP; Trushin, N; Veldheer, S; Wasserman, E; Zhu, J | 1 |
| Baer, CM; Cheney, MK; Dobbs, PD; Dunlap, CM; Hodges, E; Lu, Y; Newcombe, KV | 1 |
| Colby, SM; Denlinger-Apte, RL; Donny, EC; Hatsukami, DK; Jensen, JA; Joseph McClernon, F; Koopmeiners, JS; Luo, X; Pacek, LR; Severson, HH; Smith, TT; Tidey, JW | 1 |
| Nakamura, S; Nozaki, Y; Oze, I; Saka, H; Tanaka, H; Taniguchi, C | 1 |
| Lazarus, P; Perez-Paramo, YX | 1 |
| Habiballah, M; Ibrahim, S; Sayed, IE | 1 |
| Al-Halabi, S; Bobes Bascarán, T; Bobes, J; Díaz-Mesa, EM; Elizagarate, E; Galván, G; García-Álvarez, L; García-Portilla, MP; Jaén-Moreno, MJ; Sáiz Martínez, PA; Sarramea, F | 1 |
| Hansson, AC; Olsson Gisleskog, PO; Perez Ruixo, JJ; Soons, PA; Westin, Å | 1 |
| Antoniu, SA; Buculei, I; Crisan Dabija, R; Mihaltan, F; Trofor, AC | 1 |
| Benowitz, NL; Carpenter, MJ; Denlinger-Apte, RL; Donny, EC; Hatsukami, DK; Smith, TT; White, CM | 1 |
| Jaafari, N; Peiffer, G; Perriot, J; Underner, M | 1 |
| Coppens, R; Diggs, HA; Gilbert, DG; Healey, T; Huggenvik, J; Kanneganti, R; Rabinovich, NE; Rose, GM; Wiggs, K | 1 |
| Attwells, S; Ng, G; Selby, P; Zawertailo, L | 1 |
| Higgins, GA; Sellers, EM | 1 |
| Al-Obaidi, HJ; Al-Qudah, RA; Alfayoumi, I; Barakat, MM; Basheti, I; Jirjees, FJ | 1 |
| Carter, J; Jackson, CD; Kansagara, D | 1 |
| Cunningham, JA; Godinho, A; Kushnir, V; Leatherdale, ST; Schell, C; Selby, P; Tyndale, RF; Zawertailo, L | 1 |
| al'Absi, M; Allen, S; DeAngelis, B; Hatsukami, D; Nakajima, M | 1 |
| Balayssac, D | 1 |
| Almeida, NL; Fernandes, TP; Santos, NA; Silva, GM | 1 |
| Borland, R; Cummings, KM; Fong, GT; Goniewicz, ML; Gravely, S; Le Grande, M; Li, L; McNeill, A; Miller, CR; Quah, ACK | 1 |
| Caponnetto, P; DiPiazza, J; Kim, J; Maglia, M; Polosa, R | 1 |
| Paz Castro, R; Salis Gross, C; Schaub, MP | 1 |
| Blank, ML; Hoek, J | 1 |
| Bansal-Travers, M; Borland, R; Cummings, KM; Felicione, NJ; Fix, BV; Fong, GT; Goniewicz, ML; Gravely, S; Hammond, D; Heckman, BW; Hitchman, SC; Levy, DT; McNeill, A; O'Connor, R | 1 |
| Cao, Q; Cassidy, RN; Colby, SM; Dermody, S; Donny, EC; Hatsukami, D; Jensen, JA; Koopmeiners, JS; McClernon, FJ; Smith, TT; Strayer, LG; Tidey, JW | 1 |
| Chaffee, BW; Holliday, R; Jakubovics, NS; Kist, R; Preshaw, PM | 1 |
| Drazetic, A; Mache, S; Markstein, A; Pankow, W; Rohde, M; Vitzthum, K | 1 |
| East, KA; Hammond, D; Reid, JL; Rynard, VL | 1 |
| Benowitz, NL; Prochaska, JJ; Schnellbaecher, M; Skan, J; Vogel, EA | 1 |
| Bullen, C; Cobb, CO; Eissenberg, T; Foulds, J; Kang, L; Lopez, AA; Veldheer, S; Yen, MS; Yingst, JM | 1 |
| Cappella, JN; Delnevo, C; Donny, EC; Mercincavage, M; Pacek, LR; Strasser, AA; Thrasher, J | 1 |
| Ashley, DL; Duong, HT; Henderson, KC; Loud, EE; Popova, L; Thrasher, JF | 1 |
| Vlahos, R | 1 |
| Bars, M; Croghan, I; Dahne, J; Heffner, JL; Kelly, MM; McClure, JB; Meier, E; Thrul, J; Watson, NL | 1 |
| Behnood-Rod, A; Bruijnzeel, AW; Bruijnzeel, DM; Chellian, R; Pandy, V; Wilson, R | 1 |
| Brown, MB; Hayward, LF; Reyes, L; von Chamier, M | 1 |
| Gjedde, A; Majdi, A; Sadigh-Eteghad, S | 1 |
| Mahmood, S; Nik Mohamed, MH; Rahman, A | 1 |
| Barker, M; Minian, N; Selby, P; Tien, S; Veldhuizen, S; Voci, S; Zawertailo, L | 1 |
| Berlin, I; Blanc, J; Ekblad, MO; Netter, A; Tosello, B | 1 |
| Burki, TK | 2 |
| Byron, MJ; Hughes, JR | 1 |
| Donny, EC; Kollins, SH; Kozink, RV; Locey, E; McClernon, FJ; Pacek, LR; Sweitzer, MM | 1 |
| Rahmani, N; Selby, P; Veldhuizen, S; Wong, B; Zawertailo, L | 1 |
| Augustson, EM; Ding, Y; Goldenson, NI; Hatcher, C; Prakash, S; Shiffman, S | 1 |
| Barrington-Trimis, JL; Bluthenthal, RN; Braymiller, JL; Ceasar, RC; Kechter, A; Schiff, SJ; Simpson, KA; Yamaguchi, N | 1 |
| Azzopardi, D; Liu, C; Murphy, J | 1 |
| Aithal, A; Allem, JP; Boley Cruz, T; Choube, A; Dormanesh, A; Ferrara, E; Kirkpatrick, MG; Majmundar, A; Unger, JB | 1 |
| Araga, M; Armogida, M; Hamilton, A; Lai, PM | 1 |
| Maruyama, H; Neshige, R; Neshige, S; Ohshita, T | 1 |
| Hajek, P; McRobbie, H; Myers Smith, K; Orzol, M; Pesola, F; Phillips-Waller, A; Przulj, D | 1 |
| Ferris Wayne, G; Hatsukami, DK; Xu, D | 1 |
| Brown, K; Frederick, BB; Janes, AC; Kaiser, RH; Moran, LV; Olson, D; Pizzagalli, DA; Wang, KS | 1 |
| Belluati, A; Brandi, ML; Cariati, I; Ciolli, L; Falez, F; Gasbarra, E; Greggi, C; Maccauro, G; Momoli, A; Ripanti, S; Tarantino, U | 1 |
| de Chazeron, I; Jaafari, N; Peiffer, G; Perriot, J; Ruppert, AM; Underner, M | 1 |
| Bunn, JY; Davis, DR; DeSarno, M; Gaalema, DE; Harfmann, RF; Heil, SH; Higgins, ST; Hughes, JR; Lee, D; Leventhal, AM; Markesich, C; Orr, E; Sigmon, SC; Streck, JM; Tidey, JW | 1 |
| Burrows, CA; Newman, ST; Raiff, BR; Upton, CR | 1 |
| Dean, JA; Edwards, S; Fitzgerald, L; Ford, P; Gartner, C; Howard, C; Mutch, A; Watts, P | 1 |
| Bunn, JY; Davis, DR; DeSarno, M; Gaalema, DE; Gallagher, T; Heil, SH; Higgins, ST; Irvin, CG; Kaminsky, D; Lee, D; Oliver, AC; Sigmon, SC; Streck, JM; Tidey, JW | 1 |
| Homish, GG; Mahajan, SD; Quisenberry, A | 1 |
| Byers, JE; Parker, MA; Villanti, AC | 1 |
| Abroms, LC; Berg, CJ; Krishnan, N | 1 |
| Brose, LS; Horton, M; McDermott, MS; McNeill, A; Perman-Howe, PR; Robson, D | 1 |
| Borland, R; Cummings, KM; Felicione, NJ; Fong, GT; Gravely, S; Hammond, D; McNeill, A; O'Connor, RJ | 1 |
| Aveyard, P; Hollands, GJ; Sutton, S | 1 |
| Benowitz, NL; Liakoni, E; St Helen, G | 1 |
| Choi, SKY; Einarsdottir, K; Havard, A; Jorm, LR; Kemp-Casey, A; Preen, DB; Randall, D; Tran, DT | 1 |
| Claire, R; Clark, M; Coleman, T; Cooper, S; Dickinson, A; Emery, J; Kinahan-Goodwin, D; Lewis, S; McDaid, L; Naughton, F; Phillips, L; Slaich, B; Thomson, R | 1 |
| Karey, E | 1 |
| Neuberger, M | 3 |
| Begh, R; Bullen, C; Butler, AR; Hajek, P; Hartman-Boyce, J; Lindson, N; McRobbie, H; Notley, C; Rigotti, N; Theodoulou, A | 1 |
| Bickel, WK; Brandon, TH; Heckman, BW; MacKillop, J; MacQueen, DA; Marquinez, NS | 1 |
| Grace, RC; Laugesen, M; Tucker, MR | 1 |
| Chappell, K; Ferguson, SG; Jacobson, GA; Lu, W; Patel, R; Schüz, N; Walters, JAE | 1 |
| Camacho, OM; Hill, A | 1 |
| Chan, SS; Lam, TH; Li, WH; Wang, MP; Wu, Y | 1 |
| Addicott, MA; Brandon, TH; Drobes, DJ; Evans, DE; Oliver, JA; Potts, GF | 1 |
| Brose, LS; Crank, H; Gumber, A; Klonizakis, M | 1 |
| Palali, A; Van Ours, JC | 1 |
| Benowitz, N; Cummings, KM; Fix, BV; Fong, GT; Heckman, BW; O'Connor, RJ; Thrasher, JF | 1 |
| Boggs, DL; Cosgrove, K; D'Souza, DC; Esterlis, I; Pittman, B; Ranganathan, M; Sewell, RA; Surti, TS | 1 |
| Cunningham, JA; Kushnir, V | 1 |
| Aronson, SE; Lesage, E; Ross, TJ; Salmeron, BJ; Stein, EA; Sutherland, MT | 1 |
| Barrueco Ferrero, M; Hernández Mezquita, MÁ; López Zubizarreta, M; Miralles García, JM | 1 |
| Brossard, P; Felber Medlin, L; Franzon, M; Laugesen, M; Lüdicke, F; Sandalic, L; Teichert, A; Wynne, C | 1 |
| Baker, TB; Chu, W; Cook, JW; Lanza, ST; Piper, ME | 1 |
| Abrams, K; Cieslowski, K; Johnson, S; Krimmel, S; Kryder, C; Melum, A; Strnad, H | 1 |
| Blazekovic, S; Carroll, AJ; Hitsman, B; Jao, NC; Leone, FT; Schnoll, RA; Smith, MJ; Tyndale, RF; Veluz-Wilkins, AK | 1 |
| Colby, SM; MacKillop, J; Martin, RA; Murphy, CM; Rohsenow, DJ; Tidey, JW | 1 |
| Cohen, JE; Czaplicki, LM; Kennedy, RD; Lagasse, LP; Singh, H | 1 |
| Baraona, LK; Daniels, JL; Lovelace, D; McDaniel, L | 1 |
| Acuña Izcaray, A; Alfageme Michavila, I; Buljubasich, D; Casas, A; Chatkin, JM; de Granda Orive, JI; Guerreros Benavides, A; Jiménez Ruiz, CA; Noé, V; Núñez-Sánchez, I; Paez Espinel, N; Palomar Lever, A; Riesco Miranda, JA; Sánchez-Angarita, E; Sansores, RH; Zabert, G | 1 |
| Derisier, DM; Kim, HH; Larson, E; Monteiro, K | 1 |
| Fraser, T; Kira, A | 1 |
| Bell, SK; Boyd, M; Dean, J; Gartner, C; Gilks, C; Mena, G | 1 |
| Amu, R; Batsikadze, G; Grundey, J; Nitsche, MA; Paulus, W | 1 |
| Camporro, FA | 1 |
| Karelitz, JL; Michael, VC; Perkins, KA | 1 |
| Allen, SI; Bascom, R; Fazzi, A; Foulds, J; Horn, K; Hrabovsky, S; Kazi, A; Krebs, NM; Kuprewicz, R; Liao, J; Livelsberger, C; Martinez, DJ; Modesto, J; Moyer, RE; Muscat, JE; Reilly, SM; Reinhart, L; Richie, JP; Trushin, N; Veldheer, S; Wasserman, E; Wilhelm, A; Zhu, J | 1 |
| Benowitz, NL; Gubner, NR; Guydish, J; Hall, SM; Humfleet, GL | 1 |
| Cunningham, JA; Kushnir, V; Sproule, BA | 1 |
| Buchanan, C; Cummings, KM; Guille, C; McClure, EA; Nahhas, GJ; Wheeler, C | 1 |
| Muschamp, JW; Philogene-Khalid, HL; Rawls, SM; Simmons, SJ | 1 |
| Adriaens, K; Baeyens, F; Gucht, DV | 1 |
| Govind, AP; Green, WN; Stolz, JR; Swanson, GT; Vallejo, YF; Yan, JZ | 1 |
| Cunningham, JA; Kushnir, V; Leatherdale, ST; Selby, P; Tyndale, RF; Zawertailo, L | 1 |
| Benowitz, NL; Cinciripini, P; George, TP; Hawk, LW; Lerman, C; Morales, M; Nollen, NL; Peng, AR; Schnoll, R; Tyndale, RF; Wileyto, EP | 1 |
| Becoña, E; Fernández Del Río, E; López-Durán, A; Martínez, Ú; Martínez-Vispo, C; Míguez, MC; Piñeiro, B; Rodríguez-Cano, R | 1 |
| Bhugra, D; Castaldelli-Maia, JM; de Andrade, AG; Gonzalez, MO; Goudriaan, AE; Périco, CA; Waisman Campos, M | 1 |
| Arger, CA; Bunn, JY; Higgins, ST; Kurti, AN; Priest, JS; Redner, R | 1 |
| Gottlieb, S; Zeller, M | 1 |
| Proctor, RN | 1 |
| Arger, CA; Bergeria, CL; Bunn, JY; Davis, DR; Durand, H; Gaalema, DE; Heil, SH; Higgins, ST; Hughes, JR; Miller, ME; Priest, JS; Reed, DD; Sigmon, SC; Skelly, JM; Stitzer, ML; Streck, JM; Tidey, JW; Tursi, L | 1 |
| Alshbool, FZ; Karim, ZA; Khasawneh, FT; Qasim, H; Rivera, JO | 1 |
| Huh, J; Kirkpatrick, MG; Leventhal, AM; Liautaud, MM; Monterosso, J; Pang, RD | 1 |
| Bekiroglu, K; Lagoa, CM; Lanza, ST; Piper, ME; Russell, MA | 1 |
| Dušková, M; Jandíková, H; Stárka, L | 1 |
| Cahn, Z; Douglas, CE; Drope, J; Henson, R; Kennedy, R; Liber, AC; Stoklosa, M | 1 |
| Aubin, HJ; Boutron-Ruault, MC; Dupont, P; Guénel, P; Luquiens, A; Matrat, M | 1 |
| Blount, BC; Brown, J; Goniewicz, ML; Shahab, L; West, R | 1 |
| Coleman, B; Dickinson, DM; Johnson, SE; Tessman, GK | 1 |
| Balestrieri, SG; Bidwell, LC; Colby, SM; Knopik, VS; Tidey, JW | 1 |
| Cox, CM; Faulkner, P; Ghahremani, DG; Hellemann, GS; London, ED; Petersen, N; Tyndale, RF | 1 |
| Jaafari, N; Peiffer, G; Perriot, J; Pourrat, O; Underner, M | 1 |
| Davies, NM; Jones, T; Martin, RM; Munafò, MR; Taylor, AE; Taylor, GMJ; Thomas, KH; Windmeijer, F | 1 |
| Cornuz, J; Csajka, C; Dobrinas, M; Eap, CB; Gholamrezaee, M; Glatard, A; Lubomirov, R | 1 |
| Karelitz, JL; Kunkle, N; Perkins, KA | 1 |
| Gartner, C; Morphett, K; Pfeffer, D; Wigginton, B | 1 |
| Abney, L; Beaulieu, DB; Duncan, MS; Freiberg, MS; Gatskie, V; Greevy, RA; King, S; Kundu, S; Scoville, E; Tindle, HA; Tyndale, RF; Wells, QS | 1 |
| Bernstein, SL; Cooperman, NA; Lu, SE; Richter, KP; Williams, JM | 1 |
| Bagdas, D; Hamouda, AK; Imad Damaj, M; Jackson, A | 1 |
| Businelle, M; Garey, L; Goodwin, RD; Manning, K; Paulus, DJ; Raines, AM; Schmidt, NB; Shankman, SA; Zvolensky, MJ | 1 |
| Amos, A; Lucherini, M; Rooke, C | 1 |
| Carpenter, MJ; Cummings, KM; Froeliger, B; Goniewicz, ML; Gray, KM; Heckman, BW; Wagener, TL; Wahlquist, AE | 1 |
| Bakhshaie, J; Langdon, KJ; Leventhal, AM; Schmidt, NB; Zvolensky, MJ | 1 |
| Guillaumin, C; Urban, T | 1 |
| Hao, R; Li, QY; Ni, L; Shi, GC; Zhou, JP | 1 |
| Berlin, I; Heishman, SJ; Jacob, N | 1 |
| Bauld, L; McGowan, JA; McNeill, A; Mortimer, E; Shahab, L; Tyndale, RF | 1 |
| Bush, J; Koch, A; Martin, C; O'Connell, G; Savioz, R; Walele, T | 1 |
| Arger, CA; Bunn, JY; Durand, HJ; Gaalema, DE; Heil, SH; Higgins, ST; Ruggieri, EK; Sigmon, SC; Stitzer, ML; Tidey, JW | 1 |
| Bullen, C; Grace, RC; Laugesen, M; Tucker, MR | 1 |
| Berkovitch, M; Breysse, P; Brown, N; Guttman, N; Hovell, M; Myers, V; Ram, A; Rosen, L; Rule, A; Zucker, D | 1 |
| Adriaens, K; Baeyens, F; Van Gucht, D | 1 |
| Lippmann, S; Mekala, HM; Sarai, SK; Tegin, G | 1 |
| Hou, R; Liu, E; Wang, Z; Xing, C; Yu, Q; Zhang, G; Zhang, K | 1 |
| Baldassarri, SR; Bernstein, SL; Chupp, GL; Fucito, LM; Slade, MD; Toll, BA | 1 |
| Anderson, R; Hajek, P; McRobbie, H; Phillips-Waller, A; Przulj, D | 1 |
| George, O; Janda, KD; Kallupi, M; Miranda, PO; Smith, LC; Xue, S; Zhou, B | 1 |
| Das, M | 1 |
| Bareham, DW; Glantz, SA | 1 |
| Kaushik, A; Srivastava, R; Sukhija, M | 1 |
| Abrams, DB; Brewer, NT; Byron, MJ; Jeong, M | 1 |
| Battista, DR; Chen, P; Nelson, PR; Pillitteri, JL; Shiffman, S | 1 |
| Harris, CC | 1 |
| Abramson, MJ; Bonevski, B; Chui, CY; Dooley, MJ; George, J; Paul, E; Poole, SG; Taylor, S; Thomas, D; Weeks, GR | 1 |
| Glantz, SA; Kulik, MC; Lisha, NE | 1 |
| Bardo, MT; Baxter, TA; Bell, RL; Crooks, P; Dwoskin, LP; Maggio, SE; Newman, AH; Nixon, K; Prendergast, MA; Saunders, MA; Slack, RD; Zheng, G | 1 |
| Hyrup, B; Jacobsen, J; Janfelt, C; Jin, L; Marxen, E; Nicolazzo, JA | 1 |
| Abd Rahman, A; Abidin, EZ; Amer Nordin, AS; Karuppiah, K; Musbah, Z; Praveena, SM; Rasdi, I; Syed Ismail, SN; Zainol Abidin, N; Zulkifli, A; Zulkipli, NF | 1 |
| Hungin, APS; Maini, J; Rehan, HS | 1 |
| Dugast, E; Ingrand, I; Ingrand, P; Lafay-Chebassier, C; Pérault-Pochat, MC; Saulnier, PJ; Solinas, M | 1 |
| Benowitz, N; Dermody, SS; Donny, EC; Hatsukami, D; Luo, X; McClernon, FJ; Smith, TT; Tidey, JW; Vandrey, R | 1 |
| Boldry, MC; Karelitz, JL; Perkins, KA | 1 |
| Ding, X; Fedota, JR; Gu, H; Matous, AL; McKenna, MR; Ross, TJ; Salmeron, BJ; Stein, EA | 1 |
| Bickel, WK; Borland, R; Carpenter, MJ; Cummings, KM; Heckman, BW; Hirsch, AA; Nahas, GJ; O'Connor, RJ; Willemsen, MC | 1 |
| Odom-Maryon, T; Roll, JM; Shishani, K | 1 |
| Baker, NL; Germeroth, LJ; Saladin, ME | 1 |
| Forest, V; Pourchez, J | 1 |
| Andrade, AG; Bhugra, D; Carvalho, CFC; Castaldelli-Maia, JM; Frallonardo, FP; Gil, F; Guimarães-Pereira, BBS; Ismael, F; Loreto, AR; Richter, KP; Ventriglio, A | 1 |
| Copeland, AL; Jones, L; Peltier, MR; Roys, MR; Stewart, SA; Toups, RC; Vinci, C; Waldo, KM; Waters, AF | 1 |
| Abdul-Kader, J; Airagnes, G; D'almeida, S; Le Faou, AL; Limosin, F | 1 |
| Bertolotti, R; Jemos, C; Lucchiari, C; Maisonneuve, P; Masiero, M; Mazzocco, K; Pravettoni, G; Salè, EO; Spina, S; Veronesi, G | 1 |
| Bambs S, C; Cerda L, J; Corvalán B, MP; Pavié G, J; Véjar M, L; Zagolin B, M | 1 |
| Brandon, TH; Palmer, AM | 1 |
| Baker, TB; Bolt, DM; Cook, JW; Fiore, MC; Hayes-Birchler, T; Piper, ME; Schlam, TR; Smith, SS | 1 |
| Bickel, WK; DeHart, WB; Kaplan, BA; Koffarnus, MN; Pope, DA; Stein, JS | 1 |
| Audrain-McGovern, J; Lochbuehler, K; Mercincavage, M; Strasser, AA; Villanti, AC; Wileyto, EP | 1 |
| Cao, Q; Cassidy, RN; Colby, SM; Donny, EC; Hatsukami, D; Koopmeiners, JS; McClernon, FJ; Tidey, JW | 1 |
| Karnieg, T; Wang, X | 1 |
| Harika-Germaneau, G; Jaafari, N; Peiffer, G; Perriot, J; Underner, M | 1 |
| Cassidy, RN; Cioe, PA; Colby, SM; Hatsukami, D; Jackson, KM; Krishnan-Sarin, S; Tidey, JW | 1 |
| Carr, E | 1 |
| Ahluwalia, JS; Cox, LS; Ellerbeck, EF; Madhusudhana, S; Mayo, MS; Nollen, NL | 1 |
| Clark, A; Clyde, M; Els, C; Fu, A; Pipe, A; Reid, R; Tulloch, H | 1 |
| Bullen, C; Chepkin, SC; Hartmann-Boyce, J; Lancaster, T; Ye, W | 1 |
| McKee, SA; Moore, KE; Oberleitner, LMS; Roberts, W; Verplaetse, T | 1 |
| Jakšić, N; Mihaljević-Peleš, A; Pivac, N; Rojnić Kuzman, M; Šagud, M; Vuksan-Ćusa, B | 1 |
| Song, P; Yu, XY; Zou, MH | 1 |
| Kurland, BF; Mao, JM; Scholl, SM; Shiffman, S | 2 |
| De Jesus, S; Fitzgeorge, L; Prapavessis, H; Rollo, S | 1 |
| Al-Mrayat, YD; Khara, M; Okoli, CTC; Shelton, CI | 1 |
| Bowen, E; Camacho, OM; Eldridge, AC; Errington, G; Fearon, IM; Gale, N; Glew, J; Hedge, A; Holmes, E; Hossack, S; Liu, C; McAughey, J; McDermott, S; McEwan, M; Murphy, J; Proctor, CJ; Sherwood, N; Wakenshaw, L | 1 |
| Buchalter, ELF; Chanani, S; Chen, LS; David, SP; Espejo, G; Hartz, SM; Ismail, MS; Laine, RO; Nageeb, M; Salloum, NC; Srivastava, AB; Trapp, N; Trillo, L; Vance, E; Wenzinger, M | 1 |
| Bloom, EL; Brown, RA; Hayes, SC; Lejuez, CW; Minami, H; Palm Reed, KM; Strong, DR; Zvolensky, MJ | 1 |
| Abrams, DB; Glasser, AM; Niaura, RS; Pearson, JL; Rose, S; Villanti, AC | 1 |
| Baker, TE; Dagher, A; Holroyd, CB; Zeighami, Y | 1 |
| Allen, SI; Evins, AE; Foulds, J; Horn, K; Hrabovsky, S; Krebs, NM; Liao, J; Modesto, J; Muscat, JE; Putt, K; Reinhart, L; Richie, JP; Veldheer, S; Wasserman, E; Yingst, J | 1 |
| English, TM; Smith, TB; Song, X; Whitman, MV | 1 |
| Cinciripini, P; George, TP; Hawk, LW; Lerman, C; Peng, AR; Schnoll, R; Tyndale, RF | 1 |
| Britton, J | 2 |
| Callas, PW; Hughes, JR | 2 |
| Ditre, JW; Kosiba, JD; LaRowe, LR; Zale, EL | 1 |
| Baldassarri, SR; Galiatsatos, P; Leone, FT; Schnoll, R | 1 |
| Aveyard, P; Coleman, T; Hajek, P; Lewis, S; Lindson, N; Munafo, M | 1 |
| Baker, AL; Bathish, R; Bonevski, B; Borland, R; Gartner, C; Guillaumier, A; Lubman, DI; Manning, V; Moore, L; Segan, CJ; Skelton, E; Wynne, O | 1 |
| Adams, R; Ahmed, K; Alekna, R; Anderson, EC; Anderson, R; Ataya-Williams, A; Attwood, A; Aveyard, P; Banting, M; Bisal, N; Coleman, T; Coyle, D; Coyle, K; Dickinson, A; Easey, K; Fluharty, M; Freuler, T; Hajek, P; Healy, M; Homsey, C; Hurse, M; Khan, S; Khouja, J; Lacey, L; Lewis, S; Li, J; Lindson, N; Lycett, D; McEwen, A; McRobbie, HJ; Munafò, M; Myers-Smith, K; Orton, S; Perdue, J; Phillips, A; Pokhrel, S; Przulj, D; Rai, G; Randall, C; Tearne, S; Wood, C | 1 |
| McMahon, LR; Moerke, MJ | 1 |
| Cohn, AM; Coleman-Cowger, VH; Herrmann, ES; Koszowski, B; Peters, EN; Pickworth, WB; Smith, C | 1 |
| Ehrich, M; Harmon, T; Hu, Y; Pentel, PR; Zhang, C; Zhao, Z | 1 |
| al'Absi, M; Allen, S; Hodges, JS; Lemieux, A | 1 |
| al'Absi, M; Lemieux, A; Nakajima, M | 1 |
| Arger, CA; Heil, SH; Higgins, ST; Skelly, J; Taghavi, T; Tyndale, RF | 1 |
| Jung, IH; Jung, JH; Park, A | 1 |
| al'Absi, M; Allen, SS; Benowitz, NL; Carmella, SG; Chen, M; Cinciripini, PM; Denlinger-Apte, R; Donny, EC; Drobes, DJ; Hatsukami, DK; Hecht, SS; Jensen, JA; Koopmeiners, JS; Lane, T; Le, CT; Leischow, S; Luo, K; Luo, X; McClernon, FJ; Murphy, SE; Paiano, V; Robinson, JD; Severson, H; Sipe, C; Strasser, AA; Strayer, LG; Tang, MK; Vandrey, R | 1 |
| Chen, P; Round, EK; Schmidt, E; Taylor, AK | 1 |
| Brookman-May, S; Burger, M; Dombrowski, M; Fritsche, HM; Ganesh Kumar, M; Gilfrich, C; Maurer, O; May, M; Spachmann, PJ | 1 |
| Alfieri, T; Cano, S; Chrea, C; Emilien, G; Lüdicke, F; Mainy, N; Ramazzotti, A; Salzberger, T; Weitkunat, R | 1 |
| Benowitz, NL; Dempsey, DA; Edwards, KC; Liakoni, E; Nardone, N; St Helen, G; Tyndale, RF | 1 |
| Henningfield, JE; Higgins, ST; Villanti, AC | 1 |
| Cardenas, VM; Cen, R; Gammill, SK; Magann, EF; Phillips, AM; Simmons, PM; Whittington, JR | 1 |
| Bauld, L; McNeill, A; Shahab, L; Tyndale, RF | 1 |
| Inzamam Ali, M; Menakuru, S | 1 |
| Arceo, J; Hoh, E; Matt, GE; Quintana, PJE; Zakarian, JM | 1 |
| Carpenter, MJ; Dahne, J; Germeroth, LJ; Heckman, BW; Mathew, AR; Saladin, ME; Santa Ana, EJ | 1 |
| Higgins, ST | 1 |
| Hajek, P; McRobbie, H; Przulj, D; Wehbe, L | 1 |
| Atreya, A; Lagu, TC; Lindenauer, PK; Pack, QR; Pekow, PS; Priya, A; Rigotti, NA | 1 |
| Bedi, G; Comer, SD; Cooper, ZD; Foltin, RW; Haney, M; Herrmann, ES; Ramesh, D; Reed, SC | 1 |
| Denlinger-Apte, RL; Donny, EC; Hatsukami, DK; Koopmeiners, JS; McClernon, FJ; Pacek, LR; Smith, TT; Tidey, JW | 1 |
| Berrendero, F; Grande, MT; Maldonado, R; Saravia, R; Ten-Blanco, M | 1 |
| Löhler, J; Wollenberg, B | 1 |
| de Moura, FB; McMahon, LR | 1 |
| Printz, C | 2 |
| Baker, TB; Bierut, LJ; Chen, LS; Hartz, SM; L Saccone, N; Ma, Y | 1 |
| Danielsson, T; Kapikian, R; Leischow, SJ; Myers, A; Nides, M; Perfekt, R; Saunders, F; Solla, J | 1 |
| Bassett, DS; Hitsman, B; Lydon-Staley, DM; Schnoll, RA | 1 |
| O'Loughlin, JL; Wellman, RJ | 1 |
| Choi, K; Davis, DR; Fagan, P; Hickman, NJ; Nahvi, S; Okuyemi, KS; Patten, CA; Robinson, CD | 1 |
| Dempsey, OJ; Mathur, A | 1 |
| Alberg, AJ; Cummings, KM; Levy, DT; Li, Y; Yuan, Z | 1 |
| Cantor, SB; Chen, S; Frank-Pearce, SG; Marani, SK; Prokhorov, AV; Tahay, PD; Vidrine, DJ; Vidrine, JI; Yuan, Y | 1 |
| Aveyard, P; Blaha, M; Kralikova, E; Ovesna, P; Pankova, A; Stepankova, L; Zvolska, K | 1 |
| Davey Smith, G; Kaprio, J; Loukola, A; Munafò, MR; Palviainen, T; Relton, CL; Richmond, RC; Taylor, AE; Wootton, RE | 1 |
| Hartmann-Boyce, J; Livingstone-Banks, J; Ordóñez-Mena, JM | 1 |
| Ellerbeck, EF; Fitzgerald, SA; Hutcheson, TD; Nollen, N; Phadnis, M; Richter, KP; Salzman, GA; Sharpe, MR; Vacek, J | 1 |
| Wagener, TL | 1 |
| Chen, F; Han, W; Wang, D; Wang, H; Zhang, Y; Zhao, S | 1 |
| Leischow, SJ | 1 |
| Crume, T | 1 |
| Carroll, AJ; Hitsman, B; Hole, A; Jao, NC; Kalhan, R; Langer, C; Leone, F; Lubitz, SF; Miele, A; Patel, J; Paul Wileyto, E; Schnoll, R; Veluz-Wilkins, A | 1 |
| Buckner, JD; Ditre, JW; Hughes, MT; Kosiba, JD; LaRowe, LR; Norton, PJ; Smits, JAJ; Zvolensky, MJ | 1 |
| Calarco, CA; Picciotto, MR | 1 |
| Clemens, KJ; Ferguson, SG; Stuart, A | 1 |
| Bisal, N; Dawkins, L; Goniewicz, M; Hajek, P; Li, J; McRobbie, HJ; Myers Smith, K; Parrott, S; Pesola, F; Phillips-Waller, A; Przulj, D; Ross, L; Sasieni, P; Wu, Q | 1 |
| Borrelli, B; O'Connor, GT | 1 |
| Brynildsen, JK | 1 |
| Cropsey, KL; Hugley, MJ; Nguyen, AT; Sisson, ML; Wolford-Clevenger, C | 1 |
| Bedell, S; Breivogel, C; Liu, Q; Wells, J | 1 |
| Borland, R; Gartner, C; Morphett, K; Weier, M; Yong, HH | 1 |
| Mao, JM; Scholl, SM; Shiffman, S | 1 |
| Hajek, P; Hartmann-Boyce, J; Jarvis, M; Livingstone-Banks, J; Norris, E; West, R | 1 |
| Leyro, TM; Versella, MV | 1 |
| Adriaens, K; Baeyens, F; Chaumont, M; Smets, J; Van Gucht, D | 1 |
| Lund, KE; Vedoy, TF | 1 |
| Darville, A; Hahn, EJ | 1 |
| Branstetter, SA; Foulds, J; Kamens, HM; Miller, CN; Muscat, JE; Nye, RT; Richie, JP; Silva, CP; Singh, N; Sipko, J; Sun, D; Trushin, N | 1 |
| Gilbert, DG; Gilbert-Matuskowitz, EA; Klein, KP; Pergadia, ML; Rabinovich, NE | 1 |
| Blaha, MJ; Ratchford, EV | 1 |
| de Abreu, GR; de Souza Spinosa, H; Faria Waziry, PA; Flório, JC; Fukushima, AR; Lebrun, I; Moreira, N; Petrocelli, BM; Reis-Silva, TM; Ricci, EL; Sandini, TM; Zaccarelli-Magalhães, J | 1 |
| Bookser, ML; Kitzen, JM; McConaha, JL; Pergolizzi, JV; Raffa, RB; Taylor, R | 1 |
| Barrett, ST; Bevins, RA; Thompson, BM | 1 |
| Brath, H; Fasching, P; Kaser, S; Tatschl, C | 1 |
| Aveyard, P; Bauld, L; Brown, J; Dobbie, F; Jackson, SE; Uny, I; West, R | 1 |
| Thomas, SP | 1 |
| Baker, TB; Cook, JW; Piper, ME; Schlam, TR; Smith, SS | 1 |
| Barrett, SP; Darredeau, C; Perry, RN; Schlagintweit, HE | 1 |
| Dornelas, EA; Kranzler, HR; Kuo, CL; Mead, EL; Oncken, C; Sankey, HZ; Thurlow, S | 1 |
| De La Garza, R; Holst, M; Salas, R; Shuman, SL; Yammine, L; Yoon, JH | 1 |
| Upson, D; Zhang, Y | 1 |
| Korcarz, CE; Stein, JH | 1 |
| Gottlieb, MA | 1 |
| Hajek, P; Phillips-Waller, A; Przulj, D | 1 |
| Dannals, RF; Kuwabara, H; McCaul, ME; Wand, GS; Wong, D; Xu, X | 1 |
| Berlin, I; Claire, R; Coleman, T; Leonardi-Bee, J | 1 |
| Benner, JA; Callas, PW; Hughes, JR; Klemperer, EM; Morley, NE | 1 |
| Erly, BK; Prochazka, AV | 1 |
| Allenby, C; Ashare, RL; Bernardo, L; Cao, W; Falcone, M; Lerman, C; Loughead, J; Pruessner, J; Wileyto, EP | 1 |
| Mihaljevic Peles, A; Pivac, N; Sagud, M | 1 |
| Campbell, J; Holliday, RS; Preshaw, PM | 1 |
| Feng, Y; Jiang, Y; Lu, LM; Tong, Z; Yang, SY; Zeng, DC; Zhao, XS | 1 |
| Alkhlaif, Y; Contreras, KM; Damaj, MI; Jackson, AB; Toma, W | 1 |
| Cho, YJ; Cummings, M; Fong, GT; Hammond, D; Hardin, J; Hitchman, SC; Li, L; Lindblom, EN; McNeill, A; Thrasher, J; Yong, HH | 1 |
| Brousse, G; de Chazeron, I; Harika-Germaneau, G; Jaafari, N; Peiffer, G; Perriot, J; Schmitt, A; Underner, M | 1 |
| Lee, M; Levin, ED; McKinney, AA; Rezvani, AH; Rose, JE; Slade, S; Wells, C | 1 |
| Cornuz, J; Jacot Sadowski, I; Rat, C; Selby, K | 1 |
| Bergeria, CL; Bunn, JY; Davis, DR; Gaalema, DE; Heil, SH; Higgins, ST; Hughes, JR; Pang, RD; Reed, E; Sigmon, SC; Stitzer, ML; Streck, JM; Tidey, JW | 1 |
| Babalonis, S; Comer, SD; Fraser, H; Jones, JD; Kelsh, D; Lofwall, MR; Marcus, R; Martinez, DM; Martinez, S; Nunes, EV; Paterson, B; Vince, B; Walsh, SL | 1 |
| Avey, JP; Beans, JA; Claw, KG; Dillard, DA; El-Boraie, A; Lee, SB; Nickerson, DA; Robinson, RF; Scherer, SE; Stapleton, PA; Thummel, KE; Tyndale, RF | 1 |
| Le Foll, B; Trigo, JM | 1 |
| Chen, CJ; Connolly, ES; Ironside, N; Pucci, J | 1 |
| Fukao, K; Katamoto, S; Kobayashi, H; Naito, H; Nakagata, T | 1 |
| Davies, NM; Itani, T; Jones, T; Martin, RM; Munafò, MR; Rai, D; Taylor, AE; Taylor, GMJ; Thomas, KH; Windmeijer, F | 1 |
| Coleman, T; Cooper, S; Iyen, B; Lewis, S; Taggar, J; Vaz, LR | 1 |
| Brown, J; Jackson, SE; Kotz, D; West, R | 1 |
| Karam-Hage, M | 1 |
| Hoh, E; Mahabee-Gittens, EM; Matt, GE; Myers, M; Quintana, PJE; Zakarian, JM | 1 |
| Eissenberg, TT; Foulds, J; Hobkirk, AL; Hrabovsky, S; Nichols, TT; Richie, JP; Trushin, N; Veldheer, S; Williams, J; Wilson, SJ; Yingst, JM | 1 |
| Germovsek, E; Hansson, A; Karlsson, MO; Kjellsson, MC; Perez Ruixo, JJ; Soons, PA; Vermeulen, A; Westin, Å | 1 |
| Alshahrani, A | 1 |
| Ashford, K; Breland, A; McCubbin, A | 1 |
| Hajek, P; McRobbie, H; Myers, K | 1 |
| Milnerowicz, H; Sliwińska-Mossoń, M; Zieleń, I | 1 |
| Bois, F; Cosgrove, KP; D'Souza, DC; Esterlis, I; Hannestad, JO; Hatsukami, DM; O'Malley, SS; Perkins, E; Seibyl, JP; Tyndale, RF | 1 |
| Aveyard, P; Hollands, GJ; Marteau, TM; McDermott, MS; Sutton, S | 1 |
| Porwal, M; Tsoi, DT; Webster, AC | 2 |
| Tønnesen, P | 6 |
| Ammerman, S; Bailey, SR; Bryson, SW; Hagen, SA; Harrison, CT; Jeffery, CJ; Killen, DT; Killen, JD; Robinson, TN | 1 |
| Chenoweth, MJ; O'Loughlin, J; Sylvestre, MP; Tyndale, RF | 1 |
| Keane, H | 1 |
| de Villiers, S; Fagerström, KO; Giljam, H; Heggen, E; Lagerbäck, PÅ; Lindblom, N; Svensson, TH; Tonstad, S; Tønnesen, P; Wikingsson, LD | 1 |
| Cummins, S | 1 |
| Hitsman, B; Leone, FT; Schnoll, RA | 1 |
| Biener, L; Hatsukami, D; Nyman, AL; Stepanov, I | 1 |
| Carlin-Menter, S; Cummings, KM; Hyland, A; Krupski, L; Mahoney, MC; Toll, BA | 1 |
| Ling, PM; Popova, L | 1 |
| Langdon, KJ; Leventhal, AM; Rosenfield, D; Steeves, D; Stewart, S; Zvolensky, MJ | 1 |
| Cunningham, CS; McMahon, LR | 2 |
| Grebenstein, PE; Rowland, NE; Thompson, IE | 1 |
| Barbeau, AM; Burda, J; Siegel, M | 1 |
| Ebbert, JO; Hays, JT; Shuman, C; Stauter, E; Zirakzadeh, A | 1 |
| Carroll, AJ; Hong, LE; Ross, TJ; Salmeron, BJ; Stein, EA; Sutherland, MT | 1 |
| Coscas, S; Karila, L; Lowenstein, W; Petit, A; Reynaud, M; Zarmdini, R | 1 |
| Brown, VL; Cinciripini, PM; Engelmann, JM; Karam-Hage, M; Lam, C; Minnix, JA; Robinson, JD; Versace, F; Wetter, DW | 1 |
| Abrams, K; Bertoli, G; Cosci, F | 1 |
| Gates, KM; Molenaar, PC; Nichols, TT; Wilson, SJ | 1 |
| Beard, E; Brown, J; Bruguera, C; McNeill, A; West, R | 1 |
| Benowitz, NL; Henningfield, JE | 1 |
| de Boer, P; Edgar, CJ; Kezic, I; Salih, HM; Wesnes, KA | 1 |
| Fagerström, KO; Kuster, M; Meyer, A; Scherr, A; Seiffert, B; Stolz, D; Tamm, M | 1 |
| al'Absi, M; Allen, SS; Carmella, SG; Hatsukami, DK; Hecht, SS; Hertsgaard, LA; Jensen, JA; Joseph, AM; Murphy, SE; Vogel, RI | 1 |
| Chen, HK; Lee, SM; Wu, BJ | 1 |
| Ahmed, T; Allan, J; Gordon, R; Ragg, M | 1 |
| Blendy, JA; Carlson, GC; Gould, TJ; Poole, RL; Turner, JR; Wilkinson, DS | 1 |
| Abe, M | 1 |
| Miyasato, K | 1 |
| Handa, S | 1 |
| Mineur, YS; Picciotto, MR | 1 |
| Beard, E; Brown, J; Gillison, F; Hajek, P; Locker, J; McEwen, A; McRobbie, H; West, R | 1 |
| Schumacher, B | 1 |
| Bartone, A; Coutinho, MV; Geer, M; Hastrup, JL; Simms, LJ; Wisniewski, MG | 1 |
| Klinker, A | 1 |
| Berg, A; Foulds, J; Franzon, M; Galaznik, A; Hughes, JR; Russ, C; Yu, CR; Zou, KH | 1 |
| Liu, X | 1 |
| Fukami, T; Nakajima, M; Takahashi, K; Tatsumi, N; Yokoi, T; Yokota, S | 1 |
| D'Souza, MS; Markou, A | 1 |
| Nardini, S; Pacifici, R | 1 |
| Alamo, A; Amaradio, MD; Bruno, CM; Caponnetto, P; Polosa, R; Russo, C | 1 |
| Fagerström, KO; Jiménez-Ruiz, CA | 1 |
| Abrams, DB; Niaura, RS; Pearson, JL | 1 |
| Berndt, N; Bolman, C; Candel, M; de Vries, H; Froelicher, ES; Lechner, L; Mudde, A | 1 |
| Carpenter, MJ; Clark, CB; Cropsey, KL; Hendricks, PS; Jardin, B; Katiyar, N; Mugavero, M; Raper, JL; Saag, M; Willig, J | 1 |
| Chang, Y; Dempsey, J; Drehmer, J; Finch, S; Hipple, B; Klein, J; Murphy, S; Nabi-Burza, E; Ossip, D; Regan, S; Rigotti, NA; Wasserman, R; Weiley, V; Winickoff, JP; Woo, H | 1 |
| Burns, EK; Cook-Shimanek, M; Levinson, AH | 1 |
| Asarnow, J; Heinzerling, KG; London, ED; McCracken, J; Shoptaw, S; Swanson, AN; Wade, AC; Wilson, SA; Worley, M | 1 |
| Conti, DV; Quintana, MA | 1 |
| Benowitz, NL; Goniewicz, ML | 1 |
| Buhrmann, O; Jones, PM; Landry, J; Lee, SM; Morley-Forster, P | 2 |
| Brown, J; Kotz, D; West, R | 3 |
| Croghan, IT; Ebbert, JO; Hurt, RD; Schroeder, DR | 1 |
| Amos, A; Rooke, C | 1 |
| Bloom, EL; Brown, RA; Gifford, EV; Hayes, SC; Kahler, CW; Lejuez, CW; Minami, H; Reed, KM; Strong, DR; Zvolensky, MJ | 1 |
| Bailly, D; Bernard, P; Beziat, S; Courtet, P; Fond, G; Guillaume, S; Jaussent, I; Macgregor, A; Quantin, X | 1 |
| Andriash, K; Busto, UE; Persad, D; Selby, P; Zack, M; Zawertailo, L | 1 |
| Hajek, P; Hartmann-Boyce, J; Jarvis, M; Lancaster, T; Stead, LF; West, R | 1 |
| Benowitz, NL; Das, S; Prochaska, JJ | 1 |
| Des Jarlais, D; Everson-Rose, SA; Gelberg, L; Goldade, K; Guo, H; Joseph, AM; Okuyemi, KS; Thomas, J | 1 |
| Barclay, E; Goyarzu, P; Magallanes, N; Malin, DH; Mathews, H; Mills, WR; Moon, WD; Negrete, AP; Stephens, B; Vela, AJ | 1 |
| Wise, J | 1 |
| McCarthy, M | 2 |
| Bullen, C; Howe, C; Laugesen, M; McRobbie, H; Parag, V; Walker, N; Williman, J | 2 |
| Hajek, P | 3 |
| Baker, TB; Bierut, L; Bloom, AJ; Chen, LS; Goate, A; Hatsukami, D; Martinez, M; Piper, ME; Saccone, N; Smith, SS | 1 |
| Brookover, J; Cobb, CO; Cobb, NK | 1 |
| Grady, SR; Marks, MJ; Wageman, CR | 1 |
| Boccia, S; Capasso, L; Cicolini, G; Di Baldassarre, A; Flacco, ME; La Vecchia, C; Manzoli, L; Mezzetti, A; Simonetti, V; Villari, P | 1 |
| Stapleton, JA | 3 |
| Bennett, L | 1 |
| Annesi-Maesano, I; Becquemin, MH; Bertholon, JF; Dautzenberg, B | 1 |
| Ables, JL; Antolin-Fontes, B; Dougherty, JD; Frahm, S; Görlich, A; Ibañez-Tallon, I; Slimak, MA | 1 |
| Abdullah, AS; Chan, SS; Hedley, AJ; Lam, TH | 4 |
| Kim, AE; Lee, YO; Makarenko, O; Nonnemaker, J; Shafer, P | 1 |
| Berges, A; Boué, S; De León, H; Friedrichs, B; Hoeng, J; Lebrun, S; Martin, F; Meurrens, K; Moehring, M; Peck, MJ; Peitsch, MC; Schlage, WK; Schracke, N; Schueller, J; Steffen, Y; Vanscheeuwijck, P; Vuillaume, G; Weiler, H | 1 |
| Brose, LS; Shahab, L; West, R | 1 |
| Aveyard, P; Coleman, T; Cooper, S; Grainge, M; Leonardi-Bee, J; Vaz, LR | 1 |
| Bandrés, F; de Lucas Ramos, P; Gómez-Gallego, F; López Martín, S; Lucia, A; Rodríguez González-Moro, JM; Santiago, C; Verde, Z | 1 |
| Dow, WH; Rungruanghiranya, S; White, JS | 1 |
| Driskill, LM; Foster, S; Gillaspy, SR; Hale, JJ; Meier, E; Oliver, ER; Siegel, MB; Wagener, TL; Warner, ML | 1 |
| Nau, JY | 5 |
| Alberti, A; de Zeeuw, J; Deest, H; Gehrig, H; Jähne, A; Mulzer, K; Rüther, T | 1 |
| Abrams, DB; Azam, MM; Bock, BC; de Dios, MA; Fagan, M; Niaura, R; Papandonatos, GD; Stein, MD; Sweeney, PJ | 1 |
| Allen, AM; Kleppinger, A; Lando, H; Oncken, C | 1 |
| Wang, GB; Zhu, CJ | 1 |
| Gray, NJ | 1 |
| Abrams, DB; Colby, SM; Day, AM; Martin, RA; Monti, PM; Rohsenow, DJ; Sirota, AD; Swift, RM | 1 |
| Bullen, C; Etter, JF | 2 |
| Faletau, J; Glover, M; Nosa, V; Pienaar, F | 1 |
| Checa-Andrés, MD; Esparza-Martín, N; García-Cantón, C; Guerra-Rodríguez, R; Ramírez-Puga, A; Suria-González, S | 1 |
| Dunsiger, S; Emerson, J; Gwaltney, CJ; Miranda, R; Monti, PM; Ussher, M; Williams, DM | 1 |
| Goutier, W; Kloeze, MB; McCreary, AC | 1 |
| Brewer, NT; Pepper, JK | 1 |
| Bierut, LJ; Bloom, AJ; Chen, LS; Goate, A; Martinez, M; Murphy, SE | 1 |
| Cramp, A; De Jesus, S; Faulkner, G; Fitzgeorge, L; Harper, T; Mottola, MF; Prapavessis, H; Selby, P; Ussher, M | 1 |
| Ciccolo, JT; Comstock, BA; Dunn-Lewis, C; Flanagan, SD; Fragala, MS; Hatfield, DL; Ho, JY; Kraemer, WJ; Maladouangdock, J; Maresh, CM; Szivak, TK; Vingren, JL; Volek, JS | 1 |
| Brennan, PA; Reuther, WJ | 1 |
| Eapen, S; Mills, EJ; Prochaska, JJ; Thorlund, K; Wu, P | 1 |
| Giovino, GA; Homish, GG; Kozlowski, LT; Smith, PH | 1 |
| Hazeki, N; Kobayashi, K; Nishimura, Y; Ohta, M; Shinke, H; Yamamoto, M | 1 |
| Agaku, IT; Ayo-Yusuf, OA | 1 |
| Borghi, L; Cervellin, G; Favaloro, EJ; Lippi, G; Mattiuzzi, C; Meschi, T | 1 |
| Benowitz, NL; Delucchi, KL; Hall, SM; Hendricks, PS | 1 |
| Bam, TS; Bellew, W; Berezhnova, I; Jackson-Morris, A; Jones, A; Latif, E; Molinari, MA; Quan, G; Singh, RJ; Wisotzky, M | 1 |
| Chapman, S; Smith, AL | 1 |
| Ferguson, SG; Shiffman, S | 4 |
| Ferguson, SG; Schüz, N | 1 |
| David, SP | 2 |
| DeVito, EE; Herman, AI; Jensen, KP; Sofuoglu, M | 1 |
| LeSage, MG; Pentel, PR | 1 |
| Bialous, SA; Sarma, L | 1 |
| Auf, R | 1 |
| Doyle, C; Patterson, S; Scott, J | 1 |
| Dervisova, R; Durmus, E; Kivrak, T; Sari, I; Sunbul, M; Yesildag, O | 1 |
| Cieślewicz, A; Jabłecka, A; Korzeniowska, K | 1 |
| Daughton, DM; Rennard, SI | 2 |
| Steurer, J | 2 |
| Bambs S, C; Rivera M, S | 1 |
| Anestis, JC; Batten, SR; Guenthner, G; Kelly, TH; Lile, J; Martin, CA | 1 |
| Brody, JS | 1 |
| Goniewicz, M; Shahab, L | 1 |
| Choi, JS; Gwak, AR; Hwang, JY; Jung, HY; Kwon, JS; Lee, JY; Park, CB; Park, SM; Seol, JM | 1 |
| Chen, H; Sharp, BM; Yu, G | 1 |
| Douglas, IS; Leone, FT | 1 |
| Drummond, MB; Upson, D | 1 |
| de Wert, G; Horstman, K; van Schayck, O; Wolters, A | 1 |
| Engels, RC; Lugtig, P; Scherphof, CS; van den Eijnden, RJ; Vollebergh, WA | 1 |
| Chestnutt, IG; Lewis, MA; Shah, SB | 1 |
| Beard, E; Shahab, L; Silla, K | 1 |
| Carpenter, MJ; Cropsey, KL; Cummings, KM; Gray, KM; Jardin, BF; Silvestri, GA; Wahlquist, AE | 1 |
| Maurice, J | 1 |
| Ghahremani, DG; London, ED | 1 |
| Gu, H; Lerman, C; Loughead, J; Ruparel, K; Stein, EA; Yang, Y | 1 |
| Bowker, KA; Coleman, T; Cooper, S; Lewis, S; Vaz, LR | 1 |
| Branstetter, SA; Dino, G; Horn, K; Mercincavage, M | 1 |
| Grana, RA; Ling, PM | 1 |
| Arnold, KY; Kim, AE; Makarenko, O | 1 |
| Aguglia, E; Alamo, A; Auditore, R; Caponnetto, P; Maglia, M; Minutolo, G; Palermo, F; Polosa, R; Signorelli, M | 1 |
| Katz, MH | 1 |
| Grana, RA; Ling, PM; Popova, L | 1 |
| Møller, AM; Thomsen, T; Villebro, N | 2 |
| Altet Gómez, N; Barrueco Ferrero, M; de Granda Orive, JI; de Higes Martinez, E; de Lucas Ramos, P; Jimenez Ruiz, CA; Lorza Blasco, JJ; Riesco Miranda, JA; Signes-Costa Minaya, J; Solano Reina, S | 1 |
| Brokowski, L; Chen, J; Tanner, S | 1 |
| Gutierrez-Grobe, Y; Mendez-Sanchez, N; Paez-Martinez, N; Ponciano-Rodriguez, G; Villa-Romero, A | 1 |
| Ashare, RL; Schmidt, HD | 1 |
| Farsalinos, KE; Stimson, GV | 1 |
| Balfour, D; Curran, HV; Dockrell, M; Fagerstrom, K; Foulds, J; Letlape, K; Milton, A; Nutt, DJ; Phillips, LD; Polosa, R; Ramsey, J; Sweanor, D | 1 |
| Cressey, D | 1 |
| Bell, H | 1 |
| Delucchi, KL; Grady, ES; Hall, SM; Humfleet, GL; Muñoz, RF; Reus, VI | 1 |
| Dinakar, C; Joshi, AY; Nickels, AS | 1 |
| Abella, F; Alves, R; Cuadrado, J; Mateo, J; Solsona, F; Vilaplana, J | 1 |
| al'Absi, M; Allen, S; Dermody, SS; Hatsukami, DK; Hertsgaard, LA; Luo, X; Moua, L; Vogel, RI | 1 |
| Couraud, PO; Cucullo, L; Fofaria, N; Naik, P; Prasad, S; Romero, IA; Sajja, RK; Weksler, B | 1 |
| Chu, S; Li, S; Wang, C; Xiao, D | 1 |
| Engels, RC; Scherphof, CS; van den Eijnden, RJ; Vollebergh, WA | 1 |
| Jatlow, PI; Mayne, ST; O'Malley, SS; Wu, R | 1 |
| Addicott, MA; Froeliger, B; Kozink, RV; McClernon, FJ; Rose, JE; Van Wert, DM; Westman, EC | 1 |
| Cummins, SE; Gamst, AC; Myers, MG; Tedeschi, GJ; Zhu, SH | 1 |
| Lowry, JA | 1 |
| McQueen, A; Scott, MJ; Sumner, HM; Sumner, W | 1 |
| Driskill, LM; Grant, DM; Lechner, WV; Tackett, AP; Tahirkheli, NN; Wagener, TL | 1 |
| Gould, TJ; Simmons, SJ | 1 |
| Coups, EJ; Delnevo, CD; Foulds, J; Lewis, MJ; Shukla, P; Steinberg, MB; Zimmermann, MH | 1 |
| Gustavsson, G; Kruse, E; Tonstad, S; Walmsley, JM; Westin, Å | 1 |
| Adamson, SJ; Caldwell, BO; Crane, J | 1 |
| Borgerding, MF; Krautter, GR | 1 |
| Capasso, L; Flacco, ME; Gualano, MR; Manzoli, L; Siliquini, R | 1 |
| Arteaga, C; Brosky, G; Oh, P; Ranger, S; Raymond, V; Selby, P | 1 |
| Hartmann-Boyce, J; Lancaster, T; Stead, LF | 1 |
| Antici, D; Boccia, A; Bulzomì, V; Cafolla, M; Cattaruzza, MS; Colamesta, V; Conti, V; Cuccurullo, P; La Torre, G; Mannocci, A; Paone, G; Saulle, R; Terzano, C | 1 |
| Miller, A | 1 |
| Bars, MP; Forray, A; Foulds, J; Fucito, LM; Rojewski, AM; Selby, P; Shiffman, S; Toll, BA; West, R | 1 |
| Al'Absi, M; Nakajima, M | 2 |
| Rogers, T | 1 |
| Emery, SL; Huang, J; Kornfield, R; Szczypka, G | 1 |
| Brewer, NT; Emery, SL; Pepper, JK; Ribisl, KM; Southwell, BG | 1 |
| Chaloupka, FJ; Huang, J; Tauras, J | 1 |
| Baker, TB; Fiore, MC; Smith, SS | 1 |
| Kaur, J; Rinkoo, AV | 1 |
| Carlisle, HJ; Haglock-Adler, CJ; McMillin, GA; Ohman, T; Suh-Lailam, BB | 1 |
| Berg, CJ; Escoffery, C; Haardoerfer, R; Kegler, M; Zheng, P | 1 |
| Davis, JM; Goldberg, SB; Jorenby, DE; Manley, AR; Smith, SS | 1 |
| Farsalinos, KE; Kyrzopoulos, S; Savvopoulou, M; Tsiapras, D; Voudris, V | 1 |
| Benowitz, NL; Cassidy, RN; Donny, EC; Hatsukami, DK; Sved, AF; Tidey, JW | 1 |
| Bastian, LA; Oncken, C | 1 |
| Abdool-Gaffar, MS; Bateman, ED; Bruning, A; Emanuel, S; Esterhuizen, TM; Irusen, EM; Koegelenberg, CF; Noor, F; O'Brien, JA; Smith, C; van Zyl-Smit, RN | 1 |
| Blasi, F; Drummond, MB; Lam, DC; Latif, E; Rosen, MJ; Sansores, R; Schraufnagel, DE; Van Zyl-Smit, R | 1 |
| Chenoweth, MJ; Cinciripini, PM; George, TP; Hawk, LW; Lerman, C; Novalen, M; Schnoll, RA; Tyndale, RF | 2 |
| Bao, Y; Jia, Z; Lian, Z; Liu, Z; Wang, Z; Yan, S | 1 |
| Donny, EC; Hatsukami, DK; Smith, TT; Sved, AF | 1 |
| Eischen, S; Nguyen, N; Okuyemi, KS; Reitzel, LR; Thomas, J | 1 |
| Hearn, A; Moyses, C; Redfern, A | 2 |
| Gartner, C; Hall, W | 2 |
| Peres, J | 1 |
| Gartner, C; Malone, RE | 1 |
| Asal, NJ; Orr, KK | 1 |
| AhnAllen, CG; Bidwell, LC; Tidey, JW | 1 |
| Faessel, HM; Gastonguay, MR; Lee, TC; Niaura, R; Ravva, P | 1 |
| Jónsdóttir, H; Klinke, ME | 1 |
| Ballbè, M; Connolly, GN; Daynard, R; Fernández, E; Fu, M; Gottlieb, M; Martín-Sánchez, JC; Martínez-Sánchez, JM; Saltó, E | 1 |
| Britton, J; Coleman, T; Cooper, S; Dickinson, A; Essex, H; Grainge, MJ; Lewis, S; Marlow, N; Parrott, S; Taggar, J; Thornton, JG; Watts, K; Whitemore, R | 1 |
| Brandon, TH; Correa, JB; Harrell, PT; Marquinez, NS; Meltzer, LR; Simmons, VN; Sutton, SK; Unrod, M | 1 |
| Blasi, F; Ward, B | 2 |
| Dermody, SS; Donny, EC; Hatsukami, DK; Hertsgaard, LA | 1 |
| Etter, JF; Farsalinos, K; Hajek, P; le Houezec, J; McNeill, A; McRobbie, H | 1 |
| Caggiula, AR; Donny, EC; Levin, ME; Palmatier, MI; Schassburger, RL; Sved, AF; Weaver, MT | 1 |
| Guillot, CR; Leventhal, AM; Zvolensky, MJ | 1 |
| Jagpal, S; Mikhail, J; Pistun, O | 1 |
| Dube, SR; King, BA; Nguyen, KH; Patel, R | 1 |
| Barrett, SP; Dar, R | 1 |
| Anderson, C; Bauman, A; Crosbie, D; Ding, D; Dunlop, S; Grunseit, AC | 1 |
| Holm, AL; Lange, P; Tøttenborg, SS; Wibholm, NC | 1 |
| Baena, A; Masuet-Aumatell, C; Morchon, S; Ramon, JM | 1 |
| Bullen, C | 1 |
| Becoña, E; Brandon, TH; Fernández del Río, E; López-Durán, A; Martínez, Ú; Piñeiro, B | 1 |
| Abe, S; Imaizumi, S; Kawachi, E; Matsuo, Y; Miura, S; Noda, K; Saku, K; Shimizu, T; Suematsu, Y; Takata, K; Tsukahara, H; Uehara, Y; Yahiro, E; Zhang, B | 1 |
| Hecht, SS; Upadhyaya, P | 1 |
| Eissenberg, T; Foulds, J; Hrabovsky, S; Nichols, TT; Veldheer, S; Wilson, SJ; Yingst, J | 1 |
| Adams, S; Attwood, AS; Munafò, MR | 1 |
| Callas, PW; Dash, M; Hughes, JR | 1 |
| Abrams, DB; Bailey, WC; Clark, D; Connolly, GN; Djordjevic, MV; Eissenberg, TE; Fiore, MC; Goniewicz, ML; Hatsukami, DK; Haverkos, L; Hecht, SS; Henningfield, JE; Hughes, JR; Oncken, CA; Postow, L; Rose, JE; Walton, KM; Wanke, KL; Yang, L | 1 |
| Burris, JL; Carpenter, MJ; Heckman, BW; Mathew, AR | 1 |
| Bloom, EL; Brown, RA; Hayes, SC; Minami, H; Reed, KM | 1 |
| Adriaens, K; Baeyens, F; Declerck, P; Van Gucht, D | 1 |
| Balmford, J; Borland, R; Cummings, KM; Driezen, P; Fong, GT; Hitchman, S; McNeill, A; Thompson, ME; Yong, HH | 1 |
| Ambrose, BK; Apelberg, BJ; Bunnell, R; Choiniere, CJ; Coleman, BN; Green, KM; King, BA | 1 |
| Caponnetto, P; Maglia, M; Morjaria, JB; Polosa, R; Russo, C | 1 |
| Baker, TB; Cook, JW; Fiore, MC; Leventhal, AM; Piper, ME; Schlam, TR | 1 |
| Close, L; Lee, AH; Rahmati, R; Stater, BJ | 1 |
| Beard, E; Brown, J; Shahab, L; West, R | 1 |
| Dawkins, L; Kimber, C; Puwanesarasa, Y; Soar, K | 1 |
| Benedetto, IG; Gazzana, MB; Hoffmeister, MC; Knorst, MM | 1 |
| Benowitz, NL; Donny, EC; Hatsukami, DK; Nardone, N | 1 |
| Burns, EK; Goforth, E; Hood, NE; Levinson, AH | 1 |
| Barnett, TE; Moorhouse, MD; Pomeranz, JL; Soule, EK | 1 |
| Chaput, B; Chavoin, JP; Garrido, I; Grolleau, JL; Pauchot, J; Pluvy, I; Saboye, J; Tropet, Y | 1 |
| Coleman, T; Cooper, S; Essex, HN; Li, J; Parrott, S; Wu, Q | 1 |
| Aveyard, P; David, SP; Johnstone, EC; Munafò, MR; Murphy, MF; Strong, DR | 1 |
| Kanit, L; Nesil, T; Pogun, S | 1 |
| Drobes, DJ; Evans, DE; Oliver, JA; Sutton, SK | 1 |
| Clegg, CH; Miller, KD; Roque, R | 1 |
| Bullen, C; Hajek, P; Hartmann-Boyce, J; McRobbie, H | 1 |
| Barnes, J; Bassett, B; Bullen, C; Glover, M; Howe, C; McRobbie, H; Nosa, V; Parag, V; Walker, N | 1 |
| Rigotti, NA | 4 |
| Boumaza, S; Brazo, P; Lebain, P | 1 |
| Kobayashi, S; Kubota, Y; Mitsumoto, Y; Ohmoto, M; Takahashi, T | 1 |
| Bigman, CA; Henriksen, L; Sanders-Jackson, AN; Tan, AS | 1 |
| Fleck, F; Peruga, A | 1 |
| Barrett, SP; Good, KP; Greer, H; Schlagintweit, HE | 1 |
| Goryakin, Y; Koyanagi, A; Leinsalu, M; McKee, M; Roberts, B; Stickley, A | 1 |
| Galandiuk, S | 1 |
| Kadimpati, S; Nolan, M; Warner, DO | 1 |
| Brandon, TH; Goniewicz, ML; Hanna, NH; Hatsukami, DK; Herbst, RS; Hobin, JA; Ostroff, JS; Shields, PG; Toll, BA; Tyne, CA; Viswanath, K; Warren, GW | 2 |
| Davies, NM; Munafò, MR; Ware, JJ | 1 |
| Benowitz, NL; Cinciripini, P; George, TP; Hawk, LW; Heitjan, DF; Lerman, C; Schnoll, RA; Swan, GE; Tyndale, RF; Wileyto, EP | 1 |
| Aveyard, P; Coleman, T; Cooper, S; Leonardi-Bee, J; Vaz, LR | 2 |
| Etter, JF | 6 |
| Ehmke, B; Flemmig, T; Heuft, G; Kropff, B; Petersilka, G; Schneider, G | 1 |
| Markou, A; Stoker, AK | 1 |
| Gilmore, J; Grant, DM; Judah, MR; Lechner, WV; Meier, E; Mills, AC; Wagener, TL; Wiener, JL | 1 |
| Kalayasiri, R; Limsanon, T | 1 |
| Bulmer, SM; Camenga, DR; Cavallo, DA; Connell, CM; Kong, G; Krishnan-Sarin, S; Morean, ME; Simon, P | 1 |
| Adams, J; Cymbala, AA; Delate, T; Kurz, D; Olson, KL; Youngblood, M; Zadvorny, E | 1 |
| Daynard, R | 1 |
| Buljubasich, D | 1 |
| Fitzgeorge, L; Prapavessis, H; Tritter, A | 1 |
| Blazekovic, S; Gariti, P; Goelz, PM; Hitsman, B; Leone, FT; Powers, L; Schnoll, RA; Veluz-Wilkins, A; Wileyto, EP | 1 |
| Joossens, L; Nackaerts, K | 1 |
| Mulkey, Z; Nugent, K; Orellana-Barrios, MA; Payne, D | 2 |
| Chenoweth, MJ; Hamilton, DA; Hawk, LW; Heitjan, DF; Lerman, C; Mahoney, MC; Novalen, M; Tyndale, RF | 1 |
| Kohler, M | 1 |
| Foulds, J; Hrabovsky, S; Nichols, TT; Veldheer, S; Wilson, SJ; Yingst, JM | 1 |
| Zatoński, M; Zatoński, W | 1 |
| Blough, B; Carroll, FI; Damaj, MI; Malcolm, E; Shoaib, M | 1 |
| Baker, NL; Carpenter, MJ; Gray, KM; Hartwell, KJ; McClure, EA; Ramakrishnan, V; Saladin, ME | 1 |
| Carpenter, MJ; Gray, KM; McClure, EA; Saladin, ME; Tiffany, ST; Wray, JM | 1 |
| Ashare, RL; Kable, JW | 1 |
| Borland, R; Brady, K; Carpenter, MJ; Cummings, KM; Fong, GT; Hartwell, K; Hyland, A; Kasza, KA; McKee, SA; Smith, PH | 1 |
| Brown, RA; Delucchi, K; Fromont, SC; Hall, SM; Prochaska, JJ; Ramo, DE; Young-Wolff, KC | 1 |
| Cosgrove, KP; Mazure, CM; McKee, SA; Mineur, YS; Picciotto, MR; Smith, PH; Verplaetse, TL; Weinberger, AH | 1 |
| Bauld, L; Sinclair, L | 1 |
| Kozlowski, LT | 5 |
| Momose, Y; Tanihara, S | 1 |
| Hann, N; Mnatzaganian, G; Rahman, MA; Wilson, A; Worrall-Carter, L | 1 |
| Avdalovic, MV; Murin, S | 1 |
| Middlekauff, HR | 1 |
| Forlini, C; Gartner, C; Hall, W | 2 |
| Coleman, T; Dhalwani, NN; Fiaschi, L; Szatkowski, L; Tata, LJ | 1 |
| Ebssa, L; McCarthy, DE; Shiffman, S; Witkiewitz, K | 1 |
| Brown, JE; Karpinski, CD; Luo, W; Pankow, JF; Tierney, PA | 1 |
| Ahmed, J; Bitter, H; Crystal, RG; Fine, JS; Harvey, BG; Hilton, H; Hollmann, C; Kaner, RJ; Mezey, JG; Pillai, SG; Salit, J; Sridhar, S; Staudt, MR; Stevenson, CS; Strulovici-Barel, Y; Tilley, AE; Visvanathan, S; Wang, G; Wang, R; Wolff, G; Yee-Levin, J | 1 |
| Abramson, MJ; Bonevski, B; Dooley, MJ; George, J; Poole, SG; Taylor, S; Thomas, D; Weeks, GR | 1 |
| Bell, K; Stimson, GV | 1 |
| Aveyard, P; Broderick, P; Eisen, T; Houlston, RS; Munafò, MR; Ware, JJ | 1 |
| Shuster, JJ | 1 |
| Guadagno, RE; Janssen, E; Kaufman, AR; Muscanell, NL; Peterson, LM; Stock, ML; Waters, EA | 1 |
| Addicott, MA; Froeliger, B; Kozink, RV; McClernon, FJ; Rose, JE; Sweitzer, MM; Van Wert, DM; Westman, EC | 1 |
| Aveyard, P; McNeill, A; Munafò, MR; Taylor, A; Taylor, G | 1 |
| Anderson, A; Broadbent, B; Carmella, S; Hatsukami, DK; Hecht, SS; Jensen, J; Murphy, SE; Severson, H; Vogel, RI | 1 |
| Chang, Q; Hanania, T; Maillet, EL; Mash, DC | 1 |
| Bryce, R; Robson, SJ | 1 |
| Sedgwick, P | 1 |
| Beard, E; Brown, J; Goniewicz, ML; Nelson, VA; Shahab, L; Sheals, K; West, R | 1 |
| Mendelsohn, CP | 1 |
| Lewis, DF; Magee, JC; Winhusen, T | 1 |
| Agaku, IT; Alpert, HR; Connolly, GN | 1 |
| Blank, MD; Eissenberg, T | 2 |
| Bymaster, FP; Johnson, JE; Levin, ED; Rezvani, AH; Rose, JE; Wells, C | 1 |
| Michele, T; Raffaelli, RM; Roca, R; Winchell, C | 1 |
| Boulamery, A; Liachenko, N; Simon, N | 1 |
| de Granda-Orive, JI; Jiménez-Ruiz, CA; Solano-Reina, S | 1 |
| Baker, TB; Baurley, JW; Benowitz, NL; Bergen, AW; Conneely, KN; Conti, DV; Hall, SM; Hops, H; Javitz, HS; Krasnow, R; Lerman, C; Lessov-Schlaggar, CN; McClure, JB; Michel, M; Nishita, D; Swan, GE; Tyndale, RF; Zhu, AZ | 1 |
| Schuurmans, MM | 1 |
| Russi, EW | 1 |
| Fillon, M | 1 |
| Baum, CR; Kim, JW | 1 |
| al'Absi, M; Allen, S; Hatsukami, DK; Lemieux, A; Nakajima, M | 1 |
| Beatrice, F; Graziano, S; Massaro, G; Pacifici, R; Pellegrini, M; Pichini, S | 1 |
| Eissenberg, T; Lopez, AA | 1 |
| Ding, H; Kapaya, M; Tong, V | 1 |
| Benowitz, NL; Dains, KM; Dempsey, D; Hall, SM; Jacob, P; Nardone, N; Stewart, S | 1 |
| Eggers, ME; Kim, AE; Liedtke, C; Loomis, B; Porter, L; Rhodes, B | 1 |
| Anna Aldi, G; Cosci, F; Nardi, AE | 1 |
| Janda, KD; Schlosburg, JE; Xue, S | 1 |
| Tashkin, DP | 1 |
| Blazekovic, S; Gariti, P; Goelz, PM; Hitsman, B; Kaufmann, A; Leone, FT; Powers, L; Schnoll, RA; Tyndale, RF; Veluz-Wilkins, A | 1 |
| Richter, L | 1 |
| Berg, C; Bundy, L; Escoffery, C; Haardӧrfer, R; Kegler, MC; Mullen, PD; Williams, R | 1 |
| Beckham, JC; Calhoun, PS; Dennis, MF; Kirby, AC; Vrana, SR | 1 |
| Cosci, F; Ibrahim, HM; Nannini, A; Schruers, K | 1 |
| Prochaska, JJ | 2 |
| Kim, SS | 1 |
| Halpern-Felsher, BL; Lee, J; Roditis, M | 1 |
| Béguinot, E; Diethelm, P; Martinet, Y; Wirth, N | 1 |
| He, Y; Sun, S; Wu, L; Zeng, J | 1 |
| Breland, AB; Eissenberg, T; Hiler, MM; Karaoghlanian, N; Lipato, T; Lopez, AA; Ramôa, CP; Shihadeh, A; Spindle, TR | 1 |
| Benowitz, NL; Prochaska, JJ | 1 |
| Goniewicz, ML; Hajek, P; Knight-West, O; McRobbie, H; Phillips, A; Przulj, D; Smith, KM | 1 |
| Abdolahi, A; Benesch, CG; Block, RC; Scott, BE; Spitzer, EM; van Wijngaarden, E; Wang, HZ; Williams, GC | 1 |
| Hwang, SJ; Liu, KH | 1 |
| Bevins, RA; Dwoskin, LP; Pittenger, ST; Zeplin, LC | 1 |
| Amundson, EP | 1 |
| Hatsukami, DK; Jensen, JA; O'Connor, RJ; Severson, HH; Vogel, RI | 1 |
| Braillon, A | 2 |
| Bowker, K; Campbell, KA; Coleman, T; Cooper, S; Lewis, S; Naughton, F | 1 |
| Kawazoe, S; Shinkai, T | 1 |
| Buchwald, J; Gupta, R; Hällfors, J; Kaprio, J; Korhonen, T; Lehtimäki, T; Loukola, A; Ollikainen, M; Palviainen, T; Raitakari, O; Ripatti, S; Rose, RJ; Salomaa, V; Sarin, AP; Tikkanen, E; Tyndale, RF | 1 |
| D'Ruiz, CD; Graff, DW; Yan, XS | 1 |
| Bosdriesz, JR; Kunst, AE; Ooms, GI; Portrait, FR | 1 |
| Borland, R; Fraser, D; Gartner, C | 1 |
| Downey, LA; Hayley, AC | 1 |
| Aveyard, P; Begh, R; Lindson-Hawley, N | 1 |
| Magee, JC; Winhusen, T | 1 |
| Campagna, D; Caponnetto, P; Polosa, R | 1 |
| Brady, KT; Collins, HR; Cortese, BM; Hartwell, KJ; LeMatty, T; McClernon, FJ; Uhde, TW; Yang, QX | 1 |
| Eissenberg, T; Foulds, J; Hrabovsky, S; Nichols, TT; Richie, J; Veldheer, S; Wilson, SJ; Yingst, JM | 1 |
| Brown, RS; Glascoe, AL | 1 |
| Czoli, CD; Goniewicz, M; Hammond, D; Islam, T; Kotnowski, K | 1 |
| Blank, MD; Drobes, DJ; Evans, DE; Harrell, PT; Lin, HY; Park, JY | 1 |
| Cannon, DS; Hedeker, D; Medina, TR; Mermelstein, RJ; Pugach, O; Weiss, RB | 1 |
| Jo, CL; Ribisl, KM; Seidenberg, AB | 1 |
| Kim, AE; Lee, YO; MacMonegle, A; Nonnemaker, J | 1 |
| Choi, HD; Shin, WG | 1 |
| Eriksen, MP; Gregory, KR; Majeed, BA; Nyman, AL; Pechacek, TF; Weaver, SR | 1 |
| Bąk-Romaniszyn, L; Kaleta, D; Korytkowski, P; Polańska, K; Usidame, B | 1 |
| Jensen, KP; Sofuoglu, M | 1 |
| Bergman, J; Desai, RI | 1 |
| Bowman, J; Paul, C; Rose, S; Sherwood, E; Tzelepis, F; Wiggers, J; Wolfenden, L; Wye, P; Yoong, S | 1 |
| Leduc, C; Quoix, E | 1 |
| Lee, HS; Lee, M; Na, HK; Oh, WY; Park, SJ; Yang, M; Yi, B | 1 |
| Biener, L; Song, E; Spangler, J; Sutfin, EL; Wolfson, M | 1 |
| Kott, J; Myers, V; Rosen, LJ; Winickoff, JP | 1 |
| Martin, C; Savioz, R; Sharma, G; Walele, T; Williams, J | 2 |
| Abe, TO; Gaya, PV; Pereira, AC; Pinheiro, GG; Santos, PC; Scholz, J; Silva, AP | 1 |
| Campo, A; Gerard, M; Kirchner, T; Ostroff, JS; Rotrosen, J; Shelley, D; Tseng, TY | 1 |
| Berlin, I; Heishman, SJ; Singleton, EG | 2 |
| D'Souza, MS | 1 |
| Baker, TB; Bolt, DM; Fiore, MC; Fraser, DL; Piper, ME; Smith, SS; Stein, JH | 1 |
| Ditre, JW; Kosiba, JD; Maisto, SA; Zale, EL; Zvolensky, MJ | 1 |
| Haziza, C; Lüdicke, F; Magnette, J; Weitkunat, R | 1 |
| Campbell, K; Devji, T; Hopkins, R; Khoudigian, S; Lytvyn, L; O'Reilly, D | 1 |
| Balamurugan, A; Cardenas, VM; Delongchamp, RR; Evans, VL; Faramawi, MF; Wheeler, JG | 1 |
| Allenby, CE; Boylan, KA; Falcone, M; Lerman, C | 1 |
| Assion, HJ; Machulska, A; Margraf, J; Rinck, M; Zlomuzica, A | 1 |
| Anzai, NE; Fromont, SC; Prochaska, JJ; Soyster, P | 1 |
| al'Absi, M; Denlinger, RL; Dermody, SS; Donny, EC; Drobes, DJ; Hatsukami, DK; Pacek, LR; Tidey, JW; Vandrey, R | 1 |
| Ellis, BA; Eubanks, LM; Jacob, NT; Janda, KD; Lockner, JW; Schlosburg, JE | 1 |
| Dallagi, Y; Dkhili, H; El Fazaa, S; El May, MV; Golli, NE; Jrad-Lamine, A; Neffati, H; Rahali, D | 1 |
| Orlan, EN; Ribisl, KM; Seidenberg, AB | 1 |
| Seidler, FJ; Skavicus, S; Slotkin, TA; Stadler, A | 1 |
| Cassidy, RN; Miller, ME; Tidey, JW | 1 |
| Donny, EC; Karelitz, JL; Kunkle, N; Michael, VC; Perkins, KA | 1 |
| Abdallah, IA; Hammell, DC; Hassan, HE; Stinchcomb, AL | 1 |
| Barrett, SP; Schlagintweit, HE | 1 |
| Chow, S; Delnevo, C; Harrell, MB; Hinds, JT; Loukas, A; Pasch, KE; Perry, CL; Wackowski, OA | 1 |
| Abramowicz, S; Levy, JM | 1 |
| Beckham, JC; Calhoun, PS; Dedert, EA; Dennis, MF; Dennis, PA; Kimbrel, NA | 1 |
| Bayer, R; Fairchild, AL; Green, SH | 1 |
| Buhidma, Y; Shoaib, M | 1 |
| Farrer, LA; Gelernter, J; Herman, AI; Jensen, KP; Kranzler, HR; Smith, AH; Sofuoglu, M | 1 |
| Coleman, N; Rojewski, AM; Toll, BA | 1 |
| Benowitz, NL; Burbank, AD | 1 |
| De Cremer, KA; De Smedt, T; Dendale, P; Nackaerts, K; Van Laethem, DM; Van Loco, J; Van Overmeire, IP; Vanacker, H; Vanoeteren, JF | 1 |
| Asfar, T; Auf, R; Ben Taleb, Z; Jaber, R; Maziak, W; Ward, KD | 1 |
| Ashare, RL; Bernardo, L; Cao, W; Falcone, M; Gur, R; Hopson, R; Lerman, C; Loughead, J; Pruessner, JC; Ruparel, K | 1 |
| Carroll, ME; Smethells, JR; Swalve, N | 1 |
| Borland, R; Gartner, C | 1 |
| Abrams, DB; Anesetti-Rothermel, A; Davis, M; DeAtley, T; Elmasry, H; Harvey, E; Kirchner, T; Pearson, JL; Rubin, LF; Smiley, SL | 1 |
| Springer, BD | 1 |
| Eriksen, MP; Gregory, KR; Nayak, P; Pechacek, TF; Weaver, SR | 1 |
| Gartner, C | 1 |
| Freiberg, MS; Tindle, HA | 1 |
| Duaso, MJ; Walsh, H | 1 |
| Cahill, K; Fanshawe, TR; Lancaster, T; Lindson-Hawley, N; Thomas, KH | 1 |
| Abe, TO; Amorim, C; Buzo, CG; Gaya, PV; Lopes, NH; Pereira, AC; Pierri, H; Santos, PC; Scholz, J | 1 |
| Caldwell, BO; Crane, J | 1 |
| Bierut, L; Chen, LS; Horton, A | 1 |
| Barbouni, A; Farsalinos, KE; Kourea, K; Merakou, K; Moysidou, A; Voudris, V | 1 |
| Blazekovic, S; Brubaker, TR; Hitsman, B; Hole, A; Kalhan, R; Langer, C; Leone, F; Patel, J; Price, S; Schnoll, R; Veluz-Wilkins, A; Wileyto, EP | 1 |
| Aubin, HJ; Benyamina, A; Dupont, P | 1 |
| Barboza, JL; Hudmon, KS; Patel, P; Patel, R | 1 |
| Cunningham, JA | 2 |
| Benowitz, NL; Havel, CM; Jacob, P; St Helen, G | 1 |
| Bhatnagar, A | 1 |
| Blazekovic, S; Carroll, AJ; Gariti, P; Hitsman, B; Leone, FT; Powers, JM; Schnoll, RA; Veluz-Wilkins, AK | 1 |
| Cselkó, Z; Pénzes, M | 1 |
| Ban, N; Hamajima, N; Hasegawa, Y; Murohara, T; Oguri, T; Okada, Y; Sato, M; Shimadu, S | 1 |
| Kim, KW; Park, H; Yoon, IY | 1 |
| Besheer, J; Cannady, R; Randall, PA | 1 |
| Donny, E; Hatsukami, DK; Zaatari, G | 1 |
| Audrain-McGovern, JE; Blazekovic, S; Hitsman, B; Leone, FT; Schnoll, RA; Veluz-Wilkins, A; Wileyto, EP | 1 |
| MacKenzie, R; Rogers, W | 1 |
| Biechl, AC; Buadze, A; Eich, D; Fisher, CE; Frei, A; Hiestand, N; Huber, A; Liebrenz, M; Nellen, R | 1 |
| D'Ruiz, CD; Graff, DW; Robinson, E | 1 |
| Bérard, A; Sheehy, O; Zhao, JP | 1 |
| Hartung, T | 1 |
| Janssen, R | 1 |
| McEvoy, CT; Spindel, ER | 1 |
| Barnes, J; Bullen, C; Castaldelli-Maia, JM; Courtney, RJ; Etter, JF; McRobbie, H; Raw, M; Rigotti, NA; Selby, P; Sheridan, J; Siddiqi, K; Tutka, P; Walker, N | 1 |
| Freeman, B | 1 |
| Drobes, DJ; Evans, DE; Jentink, KG; Lin, HY; Park, JY; Sutton, SK | 1 |
| Cheung, CK; Cheung, YT; Lam, TH; Leung, JP; Li, WH; Wang, MP | 1 |
| Cobb, CO; Guy, MC; Lopez, AA; Soule, EK | 1 |
| Cucullo, L; Kaisar, MA; Liles, T; Prasad, S | 1 |
| Campos, MW; Castaldelli-Maia, JM; Serebrisky, D | 1 |
| Hughes, JR; Klemperer, EM | 1 |
| Akanni, OO; Olashore, AA; Opondo, PR | 1 |
| Calabro, KS; Prokhorov, AV; Tamí-Maury, I | 1 |
| Cunningham, JA; Kushnir, V; Leatherdale, ST; Selby, P; Sproule, BA; Tyndale, RF; Zawertailo, L | 1 |
| Kotz, D; van der Meer, RM; van Eerd, EA; van Schayck, OC | 1 |
| Benowitz, NL; Donny, EC; Hatsukami, DK | 1 |
| Balodis, IM; Carroll, KM; Krishnan-Sarin, S; Potenza, MN; Yip, SW | 1 |
| al'Absi, M; Bangdiwala, AS; Denlinger-Apte, RL; Dermody, SS; Donny, EC; Drobes, DJ; Hatsukami, DK; Koopmeiners, JS; Lemieux, A; McClernon, FJ; Pacek, LR; Strasser, AA; Tidey, JW; Vandrey, R | 1 |
| Binder, P; Boussageon, R; Brabant, Y; Freche, B; Jaafari, N; Langbourg, N; Underner, M; Vanderkam, P | 1 |
| Krosin, M; Leasure, J; Lilley, M; Lynch, TL | 1 |
| Allen, A; Anderson, A; Hatsukami, D; Jensen, J; Meier, E; Severson, HH; Vogel, RI | 1 |
| al'Absi, M; Benowitz, NL; Cassidy, R; Denlinger, RL; Dermody, SS; Donny, EC; Drobes, DJ; Hatsukami, DK; Koopmeiners, JS; Lemieux, A; Nardone, N; Pacek, LR; Tidey, JW; Vandrey, R | 1 |
| Abraham, P; Balali, S; Brody, AL; Enoki, R; Garcia, LY; Hellemann, GS; Hubert, R; Kawasaki, SS; McCreary, C; Young, P; Zorick, T | 1 |
| Emme, E; Mazure, CM; McKee, SA; Smith, PH; Weinberger, AH; Zhang, J | 1 |
| Benowitz, NL; Gawron, M; Goniewicz, ML; Jacob, P; Peng, M; Smith, DM | 1 |
| Baker, G; Lüdicke, F; Magnette, J; Picavet, P; Weitkunat, R | 1 |
| Donny, EC; Rupprecht, LE; Smith, TT; Sved, AF | 1 |
| Albelda, B; Audrain-McGovern, J; Cao, W; Falcone, M; Gur, RC; Kurtz, MM; Lerman, C; Loughead, J; Wileyto, EP | 1 |
| Cyders, MA; Hershberger, AR; Karyadi, KA; VanderVeen, JD | 1 |
| Fanshawe, TR; Hughes, JR; Stead, LF | 1 |
| Bullen, C; Donny, EC; Hatsukami, D; Walker, N | 1 |
| Chenoweth, MJ; Tyndale, RF | 1 |
| Begh, R; Fanshawe, TR; Farley, A; Hartmann-Boyce, J; Lancaster, T; Lindson-Hawley, N | 1 |
| Bush, J; Craige, S; Cravo, AS; Martin, C; Savioz, R; Sharma, G; Walele, T | 1 |
| Balis, DS; Businelle, MS; Kendzor, DE; Ma, P; Poonawalla, IB | 1 |
| Janssen, R; Oudijk, MA | 1 |
| Bauld, L; Breier, BH; Glover, M | 1 |
| Barrett, SP; Campbell, NK; Schlagintweit, HE | 1 |
| Gass, JC; Germeroth, LJ; Hawk, LW; Moore, FE; Motschman, CA; Munoz, DA; Rhodes, JD; Schlienz, NJ; Tiffany, ST; Wray, JM | 1 |
| Baker, TB; Fiore, MC; Jorenby, DE; Smith, SS | 1 |
| Carter, A; Gartner, C; Hall, W; Morphett, K | 1 |
| Muheim, L | 1 |
| Abrams, DB; Abudayyeh, H; Collins, L; Glasser, AM; Niaura, RS; Pearson, JL; Villanti, AC | 1 |
| Denlinger-Apte, RL; Donny, EC; Joel, DL; Strasser, AA | 1 |
| Baker, TB; Bolt, DM; Collins, LM; Cook, JW; Fiore, MC; Mermelstein, R; Piper, ME; Schlam, TR; Smith, SS | 1 |
| Baker, TB; Bolt, DM; Collins, LM; Cook, JW; Fiore, MC; Loh, WY; Mermelstein, R; Piper, ME; Schlam, TR; Smith, SS | 1 |
| Eriksen, MP; Jones, DM; Pechacek, TF; Spears, CA; Weaver, SR | 1 |
| Gilbert, DG; Rabinovich, NE; Zuo, Y | 1 |
| Bruijnzeel, AW | 1 |
| Dinakar, Ch; O’Connor, GT | 1 |
| Caponnetto, P; Polosa, R | 1 |
| Cobb, CO; Cohn, A; Ehlke, S | 1 |
| Bauld, L; Bourke, L; Bullen, C; Catto, JWF; Cumberbatch, M; Giovannucci, E; Islami, F; McRobbie, H; Silverman, DT | 1 |
| Allen, SI; Azzouz, N; Cather, C; Evins, AE; Foulds, J; Hameed, A; Hammett, E; Hrabovsky, S; Krebs, NM; Liao, J; Modesto, J; Muscat, JE; Pachas, GN; Richie, J; Veldheer, S; Yingst, J; Zhu, J | 1 |
| Bao, YP; Chen, YY; Deng, JH; Huang, GD; Lu, L; Luo, YX; Shaham, Y; Shi, J; Wang, YM; Wu, P; Xue, YX; Zhang, LB | 1 |
| Alwis, KU; Blount, BC; Brown, J; Feng, J; Goniewicz, ML; McNeill, A; Shahab, L; Wang, L; West, R | 1 |
| Clyde, M; Els, C; Pipe, A; Reid, R; Tulloch, H | 1 |
| Dicpinigaitis, PV | 1 |
| Buonocore, F; Calabrese, G; Kayyali, R; Marques Gomes, AC; Nabhani-Gebara, S | 1 |
| Górski, P | 1 |
| Zielonka, TM | 1 |
| Antczak, A; Pietras, T; Poznański, M | 1 |
| Baeyens, F; Van Gucht, D; Van Heel, M; Vanbrabant, K | 1 |
| Amiot, E; Hatsukami, DK; Kotlyar, M; Le, C; Lindgren, BR; Mills, AM; Vuchetich, JP | 1 |
| Bouaziz, H; Chaput, B; Dureuil, B; Le Maître, B; Martinet, Y; Masquelet, AC; Pierre, S; Rivera, C; Ruppert, AM; Saboye, J; Sautet, A; Tournier, JJ; Wirth, N | 1 |
| Allan, AM; Anderson, J; Brandon, V; Burge, MR; Hamidovic, A; Khafaja, M; Ray, G | 1 |
| Chen, TC; Hsia, SL; Myers, MG | 1 |
| D'Souza, MS; Norman, H | 1 |
| Gohritz, A; Knobloch, K; Reuss, E; Vogt, PM | 1 |
| David, SP; Drgon, T; Johnson, C; Lerman, C; Liu, QR; Niaura, R; Rose, JE; Uhl, GR; Walther, D | 1 |
| Hutchison, KE; McGeary, JE; Miranda, R; Monti, PM; Rohsenow, DJ; Sirota, AD; Swift, RM; Tidey, JW | 1 |
| Berrettini, W; Dackis, C; Gariti, P; Heitjan, DF; Leone, F; Lerman, C; Perkins, KA; Pinto, A; Schnoll, RA; Siegel, S; Wileyto, EP | 1 |
| Becker, ME; Beckham, JC; Bright, MA; Calhoun, PS; Drury, PD; Hamlett-Berry, KW; Kang, HK; McFall, ME; Moore, SD; Wiley, MT | 1 |
| Epstein, A; King, A; Munisamy, G; Walsh, Z | 1 |
| Bölcskei, PL; Walden, K | 1 |
| Harte, CB; Meston, CM | 1 |
| Pauly, JR; Slotkin, TA | 1 |
| Gupta, PC; Hatsukami, DK; Stead, LF | 1 |
| Ghin, HL; Robles, GI; Singh-Franco, D | 1 |
| Hatsukami, DK; Le, C; Li, ZZ; Mooney, ME; Murphy, SE; Pentel, PR | 1 |
| Aveyard, P; David, SP; Guo, B; Johnstone, EC; Lerman, C; Munafò, MR; Murphy, MF | 1 |
| Abrams, AL; Allen-Martinez, Z; Brody, AL; Costello, MR; Farahi, J; London, ED; Mandelkern, MA; Monterosso, J; Olmstead, RE; Saxena, S; Scheibal, D | 1 |
| Guay, A | 1 |
| Chelland Campbell, S; Moffatt, RJ; Stamford, BA | 1 |
| Hébert, R | 15 |
| Campbell, E; Freund, M; Knight, J; McElduff, P; Paul, C; Sakrouge, R; Walsh, RA; Wiggers, J | 1 |
| Carmody, TP; Delucchi, K; Duncan, C; Huggins, J; Lee, S; Simon, JA; Solkowitz, S | 1 |
| McEwen, A; McRobbie, H; West, R | 1 |
| Larsson, K; Nathell, L; Sundblad, BM | 1 |
| Gould, TJ; Portugal, GS | 2 |
| Bachmann, MF; Bangala, Y; Cerny, T; Cornuz, J; Guessous, I; Jungi, WF; Klingler, K; Maurer, P; Müller, P; Osterwalder, J; van Melle, G; Willers, J; Zwahlen, S | 1 |
| Bierut, L; Breslau, N; Fu, SS; Hatsukami, DK; Johnson, EO; Joseph, AM; Kodl, MM; Wu, B | 1 |
| Gilbert, DG; Hammersley, J; Rabinovich, NE; Radtke, R; Rzetelny, A; Small, SL | 1 |
| Adolfo, AB; Kaplan, GB; Rohsenow, DJ; Swift, RM; Tidey, JW | 1 |
| Cooney, JL; Cooney, NL; McKee, SA; O'Malley, SS; Toll, BA | 1 |
| Aldana, I; Estrada, M; Sherman, SE; York, L | 1 |
| Lundberg, GD | 1 |
| Bush, T; Deprey, TM; Fellows, JL; Mahoney, LD; McAfee, TA; McClure, JB; Zbikowski, SM | 1 |
| Bélisle, P; Eisenberg, MJ; Filion, KB; Gervais, A; Joseph, L; Mottillo, S; O'Loughlin, J; Paradis, G; Pilote, L; Rinfret, S; Yavin, D | 1 |
| Argacha, JF; Garcia, C; Goldman, S; Gujic, M; Preumont, N; van de Borne, P; Van Simaeys, G; Xhaët, O | 1 |
| Albino, AP; Becker, KM; Rose, JE | 1 |
| Perkins, KA; Scott, J | 2 |
| Cahill, K; Lancaster, T; Stead, LF | 5 |
| Earley, CA; Keyler, DE; Murtaugh, MP; Pentel, PR; Roiko, SA | 1 |
| Rose, JE | 6 |
| Bhowmik, A; Hillman, T; Rajakulasingam, K | 1 |
| Chavannes, NH; Frijling, BD; Goudswaard, AN; Kaper, J; van der Laan, JR; Wiersma, T; Wind, LA | 1 |
| Cashman, JR; Moore, MR; Na-Bangchang, K; Satarug, S; Tassaneeyakul, W | 1 |
| Ben Ayed, F; Ben Ayoub, W; Djoufelkit, K; Fakhfakh, R; Mansour Ben, A; Sancho Garnier, H; Stoebner-Delbarre, A | 1 |
| Cohen, SB; Gan, WQ; Man, SF; Sin, DD | 1 |
| Hall, S; Marteau, TM; Vogt, F | 3 |
| Barnett, D; Hamilton, S; McGowan, A; Nsofor, M; Proudfoot, J; Tappin, DM | 1 |
| Walsh, RA | 2 |
| Oztuna, F | 1 |
| Best, A; Cropsey, K; Eldridge, G; Stitzer, M; Villalobos, G; Weaver, M | 1 |
| Bhat, VM; Cole, JW; Giles, WH; Kittner, SJ; Malarcher, AM; Sorkin, JD; Stern, BJ; Wozniak, MA | 1 |
| Huang, CL; Lin, HH; Yang, YH | 1 |
| Abrams, AL; Brody, AL; Costello, MR; Farahi, J; London, ED; Mandelkern, MA; Mukhin, AG; Olmstead, RE; Rose, JE; Scheibal, D | 1 |
| Augustson, EM; Barzani, D; Marcus, S; Rutten, LJ | 1 |
| Siedentopf, JP | 1 |
| Apelberg, BJ; Avila-Tang, E; Katanoda, K; Samet, JM; Sobue, T; Yamaguchi, N | 1 |
| Auerback, GM; Benowitz, NL; Moscicki, AB; Rubinstein, ML | 1 |
| Fletcher, PJ; Higgins, GA; Lê, AD | 1 |
| Baker, TB; Fiore, MC; Jackson, T; Jorenby, DE; Pack, QR; Piper, ME; Weston, P | 1 |
| Semba, J; Wakuta, M | 1 |
| Adamson, KL; Coen, KM; Corrigall, WA | 1 |
| Reus, VI; Smith, BJ | 1 |
| Bonevski, B; Paul, CL; Tzelepis, F; Walsh, RA | 1 |
| Shiffman, S | 4 |
| Carrozzi, L; Corlando, A; Cosci, F; Fornai, E; Paoletti, P; Pistelli, F | 1 |
| Borland, R; Cummings, KM; Driezen, P; Fong, GT; Hammond, D; McNeill, A; Reid, JL | 1 |
| Hughes, JR | 20 |
| Chang, MD; Chin, M; Fahs, M; Nguyen, N; Peng, CH; Shelley, D | 1 |
| Dornelas, E; Feinn, R; Glasmann, A; Greene, J; Kranzler, HR; Oncken, C; Sankey, H | 1 |
| Abrams, DB; Brown, RA; Kahler, CW; LaChance, HR; Metrik, J; Monti, PM; Ramsey, SE | 1 |
| Steele-Moses, SK | 1 |
| Bader, P; McDonald, P; Selby, P | 1 |
| Baines, E | 1 |
| McKee, SA | 1 |
| Ferguson, SG; Gitchell, JG; Rohay, J; Shiffman, S | 1 |
| Foulds, J | 5 |
| Arredondo, C; Celio, M; Cromp, D; Fong, D; Fortmann, SP; Hayward, C; Killen, JD; Murphy, G; Pandurangi, M; Schatzberg, AF | 1 |
| Ashwin, CA; Watts, K | 1 |
| Ceylan, E; Gunay, T; Kilinc, O; Sahbaz, S | 1 |
| Aydin, C; Bhatti, AS; Hall, P; Isgor, C; Ma, Z; Oztan, O; Tao, R | 1 |
| Collins, CC; Heishman, SJ; Jaszyna-Gasior, M; Lo, S; Moolchan, ET; Schroeder, JR; Thorner, ED | 1 |
| Brug, J; Knut, IK; Lemmens, V; Oenema, A | 1 |
| Hering, T | 3 |
| Lesage, MG | 1 |
| Schunack, W | 1 |
| Polito, JR | 1 |
| Bluestein, D; Girdhar, G; Jesty, J; Xu, S | 1 |
| Brace, V; Danielian, P; Rore, C; Williams, D | 1 |
| Ebbert, JO; Hays, JT | 2 |
| Hironaka, N; Miyasato, K; Miyata, H; Nakamura, K; Takada, K; Yanagita, T | 1 |
| Benowitz, N; Lerman, C; Patterson, F; Schnoll, RA; Tyndale, RF; Wileyto, EP | 1 |
| Alpert, JE; Culhane, MA; Evins, AE; Farabaugh, A; Fava, M; Liese, BS; Pava, J | 1 |
| Atzori, G; Boyle, J; Durcan, MJ; Kotler, ML; Lemmonds, CA | 1 |
| Bardo, MT; Crooks, PA; Dwoskin, LP; Joyce, BM; Neugebauer, NM; Pivavarchyk, M; Zhang, Z; Zheng, G | 1 |
| Perkins, KA | 6 |
| Caggiula, AR; Chaudhri, N; Donny, EC; Liu, X; Palmatier, MI; Sved, AF | 1 |
| Ferguson, SG; Gitchell, JG; Sembower, MA; Shiffman, S; Sweeney, CT | 1 |
| Conti, V; De Marchis, L; Girardi, E; Paone, G; Principe, R; Puglisi, G; Schmid, G; Serpilli, M | 1 |
| Covey, LS; Jiang, H; Manubay, J; Nortick, M; Palumbo, D | 1 |
| Haw, SJ; Lewis, SA; McNeill, A | 1 |
| Bush, TM; Cushing, C; Deprey, M; Fellows, JL; Mahoney, L; McAfee, T; McClure, J | 1 |
| Lee, JH; Moon, J | 1 |
| Barr, RS; Cather, C; Culhane, MA; Deckersbach, T; Evins, AE; Freudenreich, O; Goff, DC; Rigotti, NA; Schoenfeld, DA | 1 |
| Knaapen, AM; Quaak, M; van Schayck, CP; van Schooten, FJ | 1 |
| Hajek, P; Locker, J; McRobbie, H | 1 |
| Doolan, DM; Froelicher, ES | 1 |
| Garvey, AJ; Kinnunen, T; Korhonen, T | 1 |
| Amodei, N; Lamb, RJ | 2 |
| Fulton, EK; Kelemen, WL | 1 |
| Brendryen, H; Drozd, F; Kraft, P | 1 |
| Guichenez, P; Guillaume, S; Pujol, JL; Quantin, X; Stoebner-Delbarre, A | 1 |
| Peiffer, G | 1 |
| Dima, E; Gratziou, C; Michailidou, M; Nikoloutsou, I; Roussos, C; Rovina, N | 1 |
| Ericson, M; Löf, E; Söderpalm, B; Stomberg, R | 1 |
| Ekpanyaskul, C; Hattapornsawan, Y; Rungruanghiranya, S; Tundulawessa, Y | 1 |
| Etter, JF; Stapleton, J | 1 |
| Miller, CL; Sedivy, V | 1 |
| Ferguson, SG; Shiffman, S; Strahs, KR | 1 |
| Chang, Y; Dale, LC; Gonzales, D; Lawrence, D; Rigotti, NA | 1 |
| Glautier, S; Kalamboka, N; Remington, B | 1 |
| Lessov-Schlaggar, CN; Swan, GE | 1 |
| Baker, A; Castle, D; Filia, S; Kay-Lambkin, F; Kulkarni, J; Lewin, TJ; Richmond, R; Sakrouge, R | 1 |
| McEwen, A; West, R | 1 |
| Hajek, P; Jarvis, M; Lancaster, T; Stead, LF; West, R | 1 |
| Aveyard, P; Hajek, P; Inglis, J; Parsons, AC; Shraim, M | 1 |
| Einarson, A; Riordan, S | 1 |
| Benowitz, NL; Hukkanen, J; Jacob, P | 1 |
| Brody, AL; Sharma, A | 1 |
| Pogun, S; Yararbas, G | 2 |
| Goyarzu, P; Malin, DH | 1 |
| Buchhalter, AR; Buchman, AC; Fant, RV; Henningfield, JE | 1 |
| Ashwin, C; Watts, K | 1 |
| Jarosz, M; Wierzejska, R | 1 |
| Florek, E; Piekoszewski, W | 3 |
| Brandys, J; Panas, M | 1 |
| Aubin, HJ | 2 |
| Dent, LA; Harris, KJ; Noonan, CW | 1 |
| Brenner, H; Mann, K; Merkel, S; Reinhard, I; Salize, HJ; Twardella, D | 1 |
| Barnhart, WC; Bogen, DL; Colborn, K; Davies, ED; Lucero, CA; Moss, DR | 1 |
| Bernhard, G; Groman, E; Kroat, A; Kroat, U; Riemerth, A; Steiner-Ringl, A; Veitsmeier, I | 1 |
| Groman, E; Homeier, I; Lichtenschopf, A; Mulzer, KH | 1 |
| Groman, E; Kunze, U; Riemerth, A | 1 |
| Cahill, K; Lancaster, T; Stead, L | 2 |
| Arora, G; Jain, M; Talwar, A | 1 |
| Briski, J; Fonte, C; Lerman, C; Perkins, KA; Scott, J | 1 |
| Bredesen, H; Lous, J | 1 |
| Aveyard, P; Johnstone, EC; Munafò, MR; Murphy, MF | 1 |
| Ebbert, JO | 1 |
| Ahluwalia, JS; Al Koudsi, N; Benowitz, NL; Ho, MK; Mwenifumbo, JC; Okuyemi, KS; Tyndale, RF | 1 |
| Costa, F; Soares, R | 1 |
| Adami, J; Gilljam, H; Lindström, D; Nåsell, H; Sadr Azodi, O; Tønnesen, H; Wladis, A | 1 |
| Simpson, D | 1 |
| Coppola, S; Harrison, EL; McKee, SA | 1 |
| Bertrand, D; D'hoedt, D | 1 |
| Alterman, A; Gariti, P; Kampman, K; Lynch, K; Varillo, K; Xie, H | 1 |
| Aveyard, P; Barton, P; Connock, M; Fry-Smith, A; Moore, D; Wang, D | 4 |
| Dawkins, L; Pickering, A; Powell, J; Powell, JH; West, R | 2 |
| Campbell, E; Freund, M; Girgis, A; Jones, T; Knight, J; Lecathelinais, C; Nagle, A; Paul, C; Sakrouge, R; Walsh, RA; Wiggers, J | 1 |
| Bárkai, Z; Hornyak, M; Jaehne, A; Loessl, B; Riemann, D | 1 |
| Burgess, C; Caldwell, B; Crane, J; Dickson, S; Mala, S; Parkes, A; Siebers, R | 1 |
| Ahluwalia, JS; Cox, LS; Cupertino, AP; Ellerbeck, EF; Greiner, KA; Mahnken, JD; Mussulman, LM; Nazir, N; Resnicow, K; Shireman, TI | 1 |
| Bover, MT; Carson, JL; Foulds, J; Greenhaus, S; Hoover, DR; Schmelzer, AC; Steinberg, MB | 1 |
| Burke, MV; Ebbert, JO; Hays, JT; Hurt, RD | 1 |
| Fish, LJ; Lyna, P; Myers, ER; Namenek Brouwer, RJ; Oncken, CA; Peterson, BL; Pletsch, PK; Pollak, KI; Swamy, GK | 1 |
| Badger, GJ; Bradstreet, MP; Higgins, ST; Thomas, CS; Yoon, JH | 1 |
| Hall, SM; Humfleet, GL; Muñoz, RF; Prochaska, JJ; Reus, VI; Robbins, JA | 1 |
| Carmody, TP; Duncan, C; Huggins, J; Simon, JA; Solkowitz, S | 1 |
| Cryan, JF; Flynn, RA; Glynn, DA; Kennedy, MP; Kent, P | 1 |
| Siegel, M | 1 |
| Gilbert, DG; Huggenvik, JI; Needham, R; Rabinovich, NE; Riise, H; Zuo, Y | 1 |
| Kirchner, TR; Shiffman, S | 1 |
| Donaldson, LF; Melichar, JK; Mullings, EL; Munafò, MR | 1 |
| Boogerd, EA; Engels, RC; Van Zundert, RM; Vermulst, AA | 1 |
| Brands, B; Elkader, AK; Selby, P; Sproule, BA | 1 |
| Laniado-Laborín, R | 2 |
| Besada, NA; Cuadrado, AR; Garcia, AG; Guerrero, AC; Jiménez-Ruiz, CA; Ulibarri, MM | 1 |
| Donny, EC; Jones, M | 1 |
| George, TP; Lising-Enriquez, K | 1 |
| Bullen, C; Hajek, P; Laugesen, M; Lin, RB; McRobbie, H; Senior, H; Thornley, S; Whittaker, R | 2 |
| Chen, DF; Di, XL; Guo, S; Jiang, ZN; Kosten, TR; Liu, Y; Lu, L; Sun, HQ; Yang, FD; Zhang, XY | 1 |
| Bau, CH; Bizarro, L; Dobler, CJ; Kortmann, GL | 1 |
| Batis, J; Bois, F; Cosgrove, KP; Esterlis, I; Kloczynski, T; Krishnan-Sarin, S; Maciejewski, PK; O'Malley, S; Perry, E; Seibyl, JP; Staley, JK; Stiklus, S; Tamagnan, G | 1 |
| Heimlich, L; Steinberg, ML; Williams, JM | 1 |
| Frishman, WH | 2 |
| Aubin, HJ; Benhaddi, H; Bolin, K; de Nigris, E; Marbaix, S; Mork, AC; Wilson, K | 1 |
| Martin, JW; Mousa, SA; Mousa, SS; Shaker, O | 1 |
| Escobar-Chávez, JJ; Ganem-Quintanar, A; López-Cervantes, M; Merino, V; Quintanar-Guerrero, D; Rodríguez-Cruz, IM | 1 |
| Wu, J | 2 |
| Deissenrieder, F; Groneberg, D; Kusma, B; Mache, S; Quarcoo, D; Welte, T | 1 |
| Cornuz, J; Etter, JF; Huguelet, P; Perneger, TV | 1 |
| Bardo, MT; Crooks, PA; Dwoskin, LP; Smith, AM; Wooters, TE; Zhang, Z | 1 |
| Campbell, W; Chan, G; Hatsukami, D; Kranzler, HR; Oncken, C | 1 |
| Kaelin, RM | 1 |
| Keiding, H | 1 |
| Audrain-McGovern, J; Bacher, I; George, TP; Morisano, D | 1 |
| de Dios, MA; Lloyd-Richardson, EE; Niaura, R; Papandonatos, GD; Stanton, CA | 1 |
| Clark, MM; Croghan, IT; Decker, PA; Ebbert, JO; Hathaway, J; Hurt, RD; Lewis, BA; Marcus, BH; Patten, CA; Ussher, M; Vickers, KS | 1 |
| Andreas, S; Hering, T; Mühlig, S; Nowak, D; Raupach, T; Worth, H | 1 |
| Carbone, M; Cohen, EH; Cooney, JL; Cooney, NL; Litt, MD; Oncken, CA; Perry, BL; Pilkey, DT; Sevarino, K; Steinberg, HR | 1 |
| Fidler, J; Kotz, D; West, R | 1 |
| Rigotti, NA; Thorndike, AN | 1 |
| Bencherif, M; Breining, SR; Grady, SR; Lester, HA; Marks, MJ; Wageman, CR; Whiteaker, P; Yohannes, D | 1 |
| Jennings, HR; Paciullo, CA; Short, MR; Steinke, DT | 1 |
| Behm, FM; Herskovic, JE; Rose, JE; Westman, EC | 1 |
| Kahler, CW; MacKillop, J | 1 |
| Connett, JE; Murray, RP; Zapawa, LM | 1 |
| Neuman, RJ; Pomerleau, CS; Pomerleau, OF; Ríos-Bedoya, CF | 1 |
| Araujo, RB; Castro, Mda G; Oliveira, Mda S; Pedroso, RS | 1 |
| Kapronczay, K | 1 |
| Loo, YK | 1 |
| Górecka, D | 2 |
| Demmel, V; Jin, Y; Koval, T; Mendes, P; Muhammad, R; Munjal, S; Roethig, HJ; Unverdorben, M | 1 |
| Kahler, CW; Leventhal, AM; Metrik, J; Monti, PM; Spillane, NS | 1 |
| Borland, R; Cummings, KM; Hammond, D; McNeill, A; Shahab, L; West, R | 1 |
| Rao, U; Schepis, TS | 1 |
| Ledgerwood, DM | 1 |
| Cornuz, J; Dobrinas, M; Eap, CB; Kohler Serra, M; Puhl, M | 1 |
| Sandlin-Leming, D | 1 |
| Goodfellow, LT; Waugh, JB | 1 |
| Gregg, EO; Lowe, FJ; McEwan, M | 1 |
| Batra, A; Friederich, HM; Lutz, U | 1 |
| Herman, AI; Mooney, M; Sofuoglu, M; Waters, AJ | 1 |
| Maritz, GS | 1 |
| Annemans, L; Bartsch, P; Marbaix, S; Nackaerts, K; Prignot, J | 1 |
| Kranzler, HR; Oncken, CA | 2 |
| Flanigan, T; Lloyd-Richardson, EE; Morrow, K; Neighbors, C; Niaura, R; Papandonatos, GD; Shadel, WG; Stanton, CA; Stein, M; Tashima, K | 1 |
| Kuehn, BM | 3 |
| Dubois, G | 2 |
| Bolliger, CT | 2 |
| Beckham, JC; Calhoun, PS; Dedert, EA; Hamlett-Berry, KW; Moore, SD; Wilson, SM | 1 |
| Bickel, WK; Burnett, CA; Kowal, BP; Landes, RD; Mueller, ET; Stitzer, ML; Yi, R | 1 |
| Mitchell, E; Mooney, M; Sofuoglu, M | 1 |
| Briski, JL; Fonte, CA; Lerman, C; Mercincavage, M; Perkins, KA | 1 |
| Asfar, T; Boyett, JM; Hudson, MM; Klesges, RC; Lando, H; Robison, LL; Sanford, SD; Sherrill-Mittleman, D; Somes, G | 1 |
| Kazmin, A; Koren, G; Osadchy, A | 1 |
| Covey, LS; Duan, N; LoDuca, C; Weissman, J | 1 |
| Berg, JZ; Boettcher, AJ; Hatsukami, DK; Mason, J; Murphy, SE | 1 |
| Bullen, C; McRobbie, H; Walker, N | 1 |
| Davies, C; Gunnell, D; Irvine, D; Martin, RM; Wise, L | 1 |
| Balaji, G; Dixon, H; Lewis, KE; Lewis, MJ; Syed, Y | 1 |
| Bergman, J; Gibson, LE; Johnson, K; Marshall, EC; Zvolensky, MJ | 1 |
| Berlin, I | 1 |
| Dalton, WT; Henderson, L; Johnson, KC; Klesges, LM; Robinson, L; Somes, G | 1 |
| Batra, A; Buchkremer, G; Collins, SE; Eck, S; Schröter, M; Torchalla, I | 1 |
| Ferguson, SG; Gitchell, JG; Sembower, MA; Shiffman, S | 1 |
| Briggs, A; Carmella, SG; Hatsukami, D; Hecht, SS; Hertsgaard, L; Lindgren, B; Stepanov, I | 1 |
| Hajek, P; May, S; McEwen, A; McRobbie, H; Vangeli, E; West, R | 1 |
| Mannino, DM | 1 |
| Burgess, DJ; Clothier, BA; Fu, SS; Noorbaloochi, S; Ricards, J; van Ryn, M; Widome, R | 1 |
| Croghan, IT; Danaher, BG; Ebbert, JO; Schroeder, DR; Severson, HH | 1 |
| Baker, TB; Fiore, MC; Fraser, D; Jorenby, DE; Piper, ME; Schlam, TR; Smith, SS | 1 |
| Ismailov, RM; Leatherdale, ST | 1 |
| Cupertino, AP; Ellerbeck, EF; Mussulman, L; Nazir, N; Richter, KP; Wick, JA | 1 |
| Batra, A; Friederich, HM | 1 |
| Cohen, LM; Cook, K; Cortez-Garland, M; Vanderveen, JW | 1 |
| Alberg, AJ; Hébert, JR | 1 |
| Coca, A; Coelho, OR; Ferreira-Melo, SE; Martins, LC; Moreira, MM; Moreno Júnior, H; Quinaglia, T; Sabha, M; Yugar-Toledo, JC | 1 |
| Hagimoto, A; Masui, S; Morita, T; Nakamura, M; Oshima, A | 1 |
| Courvoisier, DS; Etter, JF | 1 |
| Mattioli, L; Perfumi, M | 1 |
| Gustavsson, G; Kozak, JT; Kralikova, E; Le Houezec, J; Rasmussen, T | 1 |
| Dickinson, A; Duka, T; Hogarth, L | 1 |
| Hamajima, N; Hanioka, T; Matsuse, R; Naito, M; Ojima, M; Tanaka, H | 1 |
| Faulkner, G; Scerbo, F; Taylor, A; Thomas, S | 1 |
| Howick, J | 1 |
| Scharf, D | 1 |
| Barlow, D; Bullen, C; Fraser, T; McRobbie, H; Whittaker, R | 1 |
| Bernath, A; Ferris, D; Glass, M; Martinez, E; Reynolds, P; Schnoll, RA; Tatum, KL | 1 |
| Alpert, HR; Connolly, GN; Tomar, SL | 1 |
| Ciancio, G; Colina, M; De Leonardis, F; Govoni, M; La Corte, R; Lo Monaco, A; Trotta, F | 1 |
| Foldes, SS; Parker, ED; Solberg, LI; Walker, PF | 1 |
| Apelberg, BJ; Avila-Tang, E; Onicescu, G; Samet, JM | 1 |
| Nicholson, JA; Scott, MH; Smith, D | 1 |
| Coleman, T; Pilnick, A | 1 |
| Carpenter, MJ; Gray, KM | 1 |
| Corelli, RL; Hudmon, KS; Prokhorov, AV | 1 |
| Chan, PY; Davenport, PW | 1 |
| Balan, KV; Bhatti, B; Dehkordi, O; Jayam-Trouth, A; Millis, RM; Rose, JE | 1 |
| Bansal-Travers, M; Brown, A; Celestino, P; Cummings, KM; Hyland, A | 1 |
| Burgess, C; Caldwell, B; Crane, J | 1 |
| Jurberg, C | 1 |
| Allen, SS; Carmella, SG; Hatsukami, DK; Hecht, SS; Hertsgaard, LA; Jensen, JA; Kotlyar, M; Murphy, SE; Shields, PG; Stepanov, I; Zhang, Y | 1 |
| Glass, M; Kuzla, N; Langer, C; Leone, F; Martinez, E; Miyamoto, C; Ridge, JA; Schnoll, RA; Tatum, KL; Weber, DM; Wileyto, EP | 1 |
| Delucchi, KL; Hall, SM; Hendricks, PS | 1 |
| Baker, EA; Carey, MP; de Ybarra, DR; Reis, IM; Webb, MS | 1 |
| Baker, TB; Bittrich, AA; Brown, JL; Fiore, MC; Fleming, MF; Leitzke, CJ; Piper, ME; Schlam, TR; Smith, SS; Zehner, ME | 1 |
| Keating, GM; Lyseng-Williamson, KA | 1 |
| Conklin, CA; Giedgowd, GE; Karelitz, JL; Perkins, KA; Sayette, MA | 1 |
| Andreas, S; Eimer, S; Hasenfuss, G; Puls, M; Raupach, T; Shahab, L | 1 |
| Shibly, O | 1 |
| Eissenberg, T | 1 |
| Noda, K; Saku, K; Tsukahara, H | 1 |
| Berrendero, F; Maldonado, R; Martín-García, E; Robledo, P; Trigo, JM | 1 |
| Jackson, G; McRobbie, H; Sinclair, S; Smith, J; Thornley, S | 1 |
| Laugesen, M | 2 |
| Andreas, S; Cohrs, S; Feige, B; Hornyak, M; Jähne, A; Kloepfer, C; Loessl, B; Riemann, D; Rodenbeck, A | 1 |
| Cappella, JN; Leader, AE; Lerman, C | 1 |
| Berlin, I; Covey, LS; Hu, MC; Nunes, EV; Weissman, J; Winhusen, T | 1 |
| Aveyard, P; David, SP; Drgon, T; Johnson, C; Johnstone, EC; Munafò, MR; Murphy, M; Uhl, GR; Walther, D | 1 |
| Belizán, JM; Berghella, V; Bloch, MH; Dietz, PM; Goldenberg, RL; Lando, HA; Oncken, CA; Samet, JM; Tolosa, JE; Tong, VT | 1 |
| Quist-Paulsen, P | 1 |
| Jones, TE; Williams, J | 1 |
| Abe, K; Inoue, K; Kadota, K; Kohno, S; Mizuta, Y; Nakayama, S; Ozono, Y; Takamori, K; Takeshima, F; Yoshioka, S | 1 |
| Bühler, M; Fehr, C; Graf, C; Kobiella, A; Mann, K; Smolka, MN; Vollstädt-Klein, S | 1 |
| Baumgarten, D; Geimer, N; Kepner, JL; Mahoney, MC; Olson, CE | 1 |
| Costa, E; Davis, JM; Guidotti, A; Lajtha, A; Maloku, E; Sershen, H; Smith, RC; Zhubi, A | 1 |
| Benowitz, N; Jepson, C; Lerman, C; Mroziewicz, M; Patterson, F; Schnoll, R; Tyndale, RF; Wileyto, EP | 1 |
| Alberg, AJ; Carpenter, MJ; Gray, KM; Saladin, ME | 1 |
| Gottrup, F; James, T; Ladelund, S; Paddon, M; Rygaard, J; Sørensen, LT; Taylor, R; Toft, BG | 1 |
| Bates, JE; Behm, FM; Rose, JE; Salley, A; Westman, EC | 2 |
| Budsock, PD; Gandhi, KK; Steinberg, ML; Stipelman, B; Williams, JM; Ziedonis, DM; Zimmermann, MH | 1 |
| Bruin, JE; Gerstein, HC; Holloway, AC | 1 |
| Bauer, U; Celestino, P; Cummings, KM; Fix, BV; Hyland, A; Mahoney, M; Ossip, DJ | 1 |
| Henningfield, JE; Zaatari, GS | 1 |
| Bullen, C; Glover, M; Laugesen, M; Lin, R; McRobbie, H; Thornley, S | 1 |
| Beck, HN; Biazzo, LL; Campbell, SL; Froshaug, DB; Harwell, TS; Haugland, C; Helgerson, SD | 1 |
| Neisius, S | 1 |
| Ebbert, JO; Hays, JT; Hurt, RD | 1 |
| Amos, CI; Cinciripini, P; Spitz, MR | 1 |
| Breteler, MH; de Vries, H; Grol, RP; Hilberink, SR; Jacobs, JE | 1 |
| Bolt, DM; Cook, JW; Jorenby, DE; Loh, WY; Piper, ME; Schlam, TR; Smith, SS | 1 |
| Corrales, L; González-Moreno, O; Irigoyen, M; Martínez-García, E; Rouzaut, A; Salvo, E; Teijeira, A | 1 |
| Albert, DA; Andrews, JA; Crews, KM; Gordon, JS; Payne, TJ; Severson, HH | 1 |
| Hizue, M; Ishibashi, T; Nomura, S | 1 |
| Bhat, A; Crain, D | 1 |
| Chengappa, KN; Fonte, CA; Jain, A; Lerman, C; Mercincavage, M; Perkins, KA; Stitzer, ML | 1 |
| Banham, L; Gilbody, S | 1 |
| Amir, NA; Awaisu, A; Hashim, MI; Hassali, MA; Mohamad, MH; Omar, CG; Samsudin, S; Shafie, AA | 1 |
| Adler, LA; Brigham, GS; Covey, LS; Croghan, IT; Dorer, EM; Green, CA; Leimberger, JD; Lewis, DF; Liu, DS; Somoza, EC; Weiss, RD; Winhusen, TM | 1 |
| Ahluwalia, JS; Guo, H; Okuyemi, KS; Zheng, H | 1 |
| Botello-Harbaum, M; Collins, CC; Moolchan, ET; Schroeder, JR | 1 |
| Carpenter, MJ; Hughes, JR; Naud, S | 1 |
| Blough, BE; Carroll, FI; Damaj, MI; Eaton, JB; Huang, X; Lukas, RJ; Marxer-Miller, SK; Mascarella, SW; Muresan, AZ; Navarro, HA | 1 |
| Chutrthong, W; Tundulawessa, K; Tundulawessa, Y; Yongchaiyud, P | 1 |
| Ebbert, JO; Edmonds, A; Hatsukami, DK; Jensen, J; Luo, X | 1 |
| Bullen, C; Glover, M; Grigg, M; Howe, C; Laugesen, M; Lin, RB; McRobbie, H; Rodgers, A; Walker, N; Wallace-Bell, M; Whittaker, R | 1 |
| Coleman, T; Gibson, J; Huang, Y; Langley, TE; Lewis, S; McNeill, A; Szatkowski, L | 1 |
| Callas, PW; Hughes, JR; Livingston, AE; Peters, EN; Solomon, LJ | 1 |
| Beveridge, TJ; Li, L; Liu, Y; Zhang, Y; Zhou, W | 1 |
| Jatlow, P; Makuch, R; Meandzija, B; O'Malley, SS; Toll, BA; White, M; Wu, R | 1 |
| Cropsey, KL; Jackson, DO; McClure, LA; Stitzer, ML; Villalobos, GC; Weaver, MF | 1 |
| Hulse, GK; Khan, RJ; Siru, R; Tait, RJ | 1 |
| Amin, Z; Czarkowski, KA; Epperson, CN; Jatlow, P; Mazure, CM; O'Malley, SS; Toll, B; Wu, R | 1 |
| Burns, EK; Levinson, AH; Tong, S | 1 |
| Abarca, M; Cornuz, J; Gonseth, S; Madrid, C | 1 |
| Leeman, RF; McKee, SA; O'Malley, SS; White, MA | 1 |
| Bauer, B; Croghan, IT; Ebbert, JO; Prasad, K; Schroeder, DR; Sood, A | 1 |
| Chang, Y; Di, X; Huang, X; Liang, Y; Liu, C; Tao, R; Yan, J; Zhang, H; Zhang, J; Zhang, L; Zhao, B; Zhao, Y | 1 |
| Bailey, SR; Bryson, SW; Fong, DM; Fortmann, SP; Killen, JD | 1 |
| Ioannides-Demos, LL; McNeil, JJ; Piccenna, L | 1 |
| Lund, KE; McNeill, A; Scheffels, J | 1 |
| Herman, AI; Sofuoglu, M | 1 |
| Talbot, P; Trtchounian, A; Williams, M | 1 |
| Currie, E; Daley, V; Richardson, A | 1 |
| Feenstra, TL; Hoogenveen, RT; Kaper, J; Rutten-van Mölken, MP; van Schayck, CP; Vemer, P | 1 |
| Batis, JC; Bois, F; Carson, RE; Cosgrove, KP; Esterlis, I; Perkins, E; Seibyl, JP; Staley, JK; Stiklus, SM | 1 |
| Miller, MC | 1 |
| Curtin, JJ; Hogle, JM; Kaye, JT | 1 |
| Andrews, JA; Crews, KM; Gordon, JS; Lichtenstein, E; Payne, TJ; Severson, HH | 1 |
| Brandon, T; Bursac, Z; Sheffer, CE; Stitzer, M | 1 |
| Zellweger, JP | 3 |
| Ruff, P | 1 |
| Meyer, A; Stolz, D | 1 |
| Zeller, A | 1 |
| von Garnier, C | 1 |
| Abdullah, AS; Chan, SS; Ho, SY; Kok, WM; Lam, TH; Leung, DY; Lo, SS; Yip, AW | 1 |
| Beels, L; De Ruyck, K; De Volder, A; Meysman, M; Nackaerts, K; Salhi, B; Thierens, H; Van Meerbeeck, J; Werbrouck, J | 1 |
| McNeill, A; Murray, R; Raw, M | 1 |
| Ames, GE; Ames, SC; Hanson, AC; Lange, LJ; Patten, CA; Schroeder, DR; Werch, CE | 1 |
| Bize, R; Chiolero, A; Cornuz, J; Locatelli, I; Payot, S; Stoianov, R; Willi, C | 1 |
| Harrison, EL; Lavery, M; McKee, SA; Sinha, R; Sofuoglu, M; Wanzer, J; Weinberger, AH | 1 |
| Benowitz, NL; Corbridge, S; Fitzgerald, GA; Hahn, E; Heath, J; Howard, G; Pechacek, TF; Piano, MR | 1 |
| de Ruiter, MB; Goudriaan, AE; Oosterlaan, J; van den Brink, W; Veltman, DJ | 1 |
| Appleton, S; Fisher, M; Fox, K; Frost-Pineda, K; Gaworski, CL | 1 |
| Hooten, WM; Mantilla, CB; Shi, Y; Warner, DO; Weingarten, TN | 2 |
| Chen, S; Hamlett-Berry, K; Siroka, AM; Smith, MW | 1 |
| Ashley, DL; Backinger, CL; Benowitz, NL; Hatsukami, DK; Henningfield, JE; Lesage, MG; Perkins, KA; Zeller, M | 1 |
| Duale, C; Dubray, C; Lusson, JR; Morand, D; Motreff, P; Pereira, B; Perriot, J; Roux, A | 1 |
| Aveyard, P; Johnstone, E; Lycett, D; Munafò, M; Murphy, M | 1 |
| Dresler, C; Steliga, MA | 1 |
| Arnold, S; Gandhi, D; Joshi, A; Khanna, N; Sadaphal, S; Stewart, D | 1 |
| Bover, MT; Foulds, J; Richardson, DL; Schmelzer, AC; Steinberg, MB; Williams, JM | 1 |
| Baker, TB; Cook, JW; Jorenby, DE; Piper, ME; Schlam, TR | 1 |
| Alstat, V; Clark, K; Forinash, AB; Pitlick, JM | 1 |
| Batis, JC; Bois, F; Cosgrove, KP; Esterlis, I; Kloczynski, T; McKee, S; Mitsis, EM; Perry, E; Picciotto, MR; Seibyl, JP; Staley, JK; Stiklus, SM | 1 |
| Flynn, M; Golding, JF; Gresty, MA; Prosyanikova, O | 1 |
| Johnson, TS | 1 |
| Froeliger, B; Kozink, RV; Lutz, AM; McClernon, FJ; Rose, JE | 1 |
| Gage, SH; Greene, NM; Munafò, MR; Taylor, EM | 1 |
| Chamberlain, C; Coleman, T; Cooper, S; Leonardi-Bee, J | 1 |
| Reynaert, C; Tordeurs, D; Zdanowicz, N | 1 |
| Aveyard, P; Lindson, N | 2 |
| Baker, TB; Curtin, JJ; Gloria, R; Japuntich, SJ; Piper, ME; Schlam, TR | 1 |
| Armstrong, D; Aveyard, P; Crockett, RA; Hill, C; Hollands, GJ; Johnstone, EC; Kinmonth, AL; Marteau, TM; Munafò, MR; Prevost, AT; Sutton, S; Whitwell, S; Willis, TA; Wright, AJ | 1 |
| Carmella, SG; Hatsukami, DK; Hecht, SS; Hertsgaard, LA; Jensen, JA; Kotlyar, M; Lindgren, BR; Murphy, SE; Stepanov, I | 1 |
| Abrams, DB; Byron, MJ; Cobb, NK; Shields, PG | 1 |
| Alexopoulos, N; Stefanadis, C; Vlachopoulos, C | 1 |
| Burgess, DJ; Clothier, B; Fu, SS; Joseph, AM; Noorbaloochi, S; Rhodes, K; Ricards, JJ; Su, J; van Ryn, M; Widome, R | 1 |
| George, TP; Sacco, KA; Wing, VC | 1 |
| Aveyard, P; Beard, E; Fidler, J; McNeill, A; Michie, S; West, R | 1 |
| Blendy, JA; Castellano, LM; Turner, JR | 1 |
| Busch, AM; Kahler, CW; Leventhal, AM; Spillane, NS | 1 |
| DiFranza, JR; Soteriades, ES; Spanoudis, G; Talias, MA; Warren, CW | 1 |
| Cesario, A; Galetta, D; Granone, P; Greenberg, DS; Margaritora, S; Russo, P; Rutella, S; Spaggiari, L; Veronesi, G | 1 |
| Brender, E; Glass, RM; Lynm, C | 1 |
| Balmford, J; Borland, R; Cummings, KM; Hammond, D | 1 |
| Costello, MJ; Leatherdale, ST; Selby, P; Sproule, B; Victor, JC; Zawertailo, L | 1 |
| Abu-Huwaij, R; Al-Hiari, Y; Obaidat, RM; Sweidan, K | 1 |
| Gross, NJ | 1 |
| Ferguson, SG; Garvey, AJ; Gitchell, JG; Rohay, JM; Shiffman, S | 1 |
| Salis Gross, C; Schaub, M; Schnoz, D; Schwappach, DL | 1 |
| Behm, FM; McClernon, FJ; Murugesan, T; Rose, JE | 1 |
| Levin, ED; Petro, A; Rose, JE; Slade, S; Wells, C | 1 |
| Bauld, L; Boyd, KA; Briggs, AH; Chesterman, J; Ferguson, J; Hiscock, R; Judge, K | 1 |
| Stapleton, JA; Sutherland, G | 1 |
| Berlin, I; Coudert, M; Jacob, N; Perriot, J; Rodon, N; Schultz, L | 1 |
| Chen, W; Chen, WQ; Crump, C; David, SP; Ding, P; He, YH; Liu, T; Tyndale, RF; Wang, H; Wen, XZ; Yu, XQ; Zhou, Q | 1 |
| Abdullah, AS; Chan, SS; Hedley, AJ; Lam, TH; Leung, DY; Wong, VT | 1 |
| Bullen, C; Glover, M; Grigg, M; Howe, C; Laugesen, M; McRobbie, H; Vander Hoorn, S; Walker, NK; Whittaker, R | 1 |
| Martinasek, MP; Martini, L; McDermott, RJ | 1 |
| Adam, E; Allen, MH; Damsa, C; Debanné, M; Dickinson, LM; Lazignac, C | 1 |
| Benowitz, NL; Polosa, R | 1 |
| Huh, BY; Jeon, YJ; Kim, Y; Lee, EH; Myung, SK; Park, CH; Seo, HG | 1 |
| Weinsier, ST | 1 |
| Baker, TB; Bolt, DM; Japuntich, SJ; Leventhal, AM; Piper, ME | 1 |
| Dinter, C; Hermann, D; Kiefer, F; Loeber, S; Rockenbach, C; Schneider, S; Vollstädt-Klein, S; von der Goltz, C; Wagner, M; Wilden, S; Winterer, G | 1 |
| Ahluwalia, JS; Benowitz, NL; Bronars, CA; Choi, WS; Cox, LS; Faseru, B; Krebill, R; Mayo, MS; Nollen, NL; Okuyemi, KS; Salzman, GA; Snow, TS; Tyndale, RF | 1 |
| Akhavain, RC; Fahim, RE; Glover, ED; Gonzales, D; Hatsukami, DK; Jorenby, DE; Kalnik, MW; Kessler, PD; Niknian, M; Oncken, CA; Rennard, SI; Reus, VI; Rigotti, NA; Tashkin, DP | 1 |
| Bilello, K; Murin, S; Rafii, R | 1 |
| Al Rubaiy, SA; Bloom, SA; Guendisch, D; Papke, RL; Trocmé-Thibierge, C | 1 |
| Gross, H | 1 |
| Danielson, K; Kivell, BM; Truman, P | 1 |
| Eissenberg, T; Ibrahim, I; Khalil, R; Maziak, W; Rastam, S; Ward, KD | 1 |
| McEwen, A; Shahab, L; West, R | 1 |
| Blough, BE; Carroll, FI; Damaj, MI; Eaton, JB; Huang, X; Lukas, RJ; Mascarella, SW; Muresan, AZ; Navarro, HA | 1 |
| Chandra, S; Scharf, D; Shiffman, S | 1 |
| Calapai, G; Caputi, AP; Mannucci, C; Navarra, M; Pieratti, A; Russo, GA | 1 |
| Dawkins, L; Powell, J | 1 |
| Aveyard, P; Churchman, M; David, SP; Johnstone, EC; Munafò, MR; Murphy, MF | 1 |
| Baker, TB; Bolt, DM; Fiore, MC; Japuntich, SJ; Leventhal, AM; Piper, ME; Roberts, LJ | 1 |
| Acıcan, T; Akkoca Yıldız, O; Eriş Gülbay, B; Karabıyıkoğlu, G; Onen, ZP; Oztürk, A; Saryal, S; Sen, E | 1 |
| Eissenberg, T; Jennings, JM; Kleykamp, BA | 1 |
| Frost-Pineda, K; Hayden, AD; Liang, Q; Muhammad-Kah, RS; Sarkar, M | 1 |
| Glantz, SA; Ling, PM | 1 |
| Saint, DA; Sjoberg, N | 1 |
| Domino, EF; Jutkiewicz, EM; Ohmura, Y | 1 |
| Burki, T | 1 |
| Grief, SN | 1 |
| Fałdyga, J; Religa, L; Szyszka, A | 1 |
| Kaleta, D | 1 |
| Kobus, A | 1 |
| Bullen, C; Chen, MH; Glover, M; Grigg, M; Howe, C; Jiang, J; Laugesen, M; McRobbie, H; Rodgers, A; Walker, N; Whittaker, R | 1 |
| Allen, J; Ferguson, SG; Gitchell, JG; Rohay, JM; Sembower, MA; Shiffman, S | 1 |
| Diaz, PT; Rahmanian, SD; Wewers, ME | 1 |
| Britton, J; Le Houezec, J; McNeill, A | 1 |
| Díaz Cerezo, S; Martí Sánchez, B; Navarro Artieda, R; Sanz De Burgoa, V; Sicras Mainar, A | 1 |
| Baldwin, D; Benowitz, N; Bergen, AW; Falcone, M; Jepson, C; Lerman, C; Pinto, A; Ray, R; Tyndale, RF; Wileyto, EP | 1 |
| Coleman, T; Huang, Y; Langley, TE; Lewis, S; McNeill, A; Szatkowski, L | 2 |
| Ayers, JW; Brownstein, JS; Ribisl, KM | 1 |
| Siegel, MB; Tanwar, KL; Wood, KS | 1 |
| Bullen, C; Eissenberg, T; Etter, JF; Flouris, AD; Laugesen, M | 1 |
| Baker, TB; Bolt, DM; Cook, JW; Hefner, KR; Kaye, JT; Kim, SY; Loh, WY; Piper, ME; Schlam, TR; Sheffer, MA; Smith, SS | 1 |
| Beck, F; Khlat, M; Legleye, S; Peretti-Watel, P | 1 |
| Arrabal-Fernandes, FL; Bussacos, MA; Lombardi, EM; Prado, GF; Santos, Ude P; Terra-Filho, M | 1 |
| Curvall, M; Lunell, E | 1 |
| Douaihy, A; Fabian, T; Fichter-DeSando, C; Scharf, D | 1 |
| Inoue, K; Kadota, K; Nagaura, Y; Nakamichi, S; Nakao, K; Ozono, Y; Takeshima, F; Tatsuta, Y; Yoda, A; Yoshioka, S | 1 |
| Hughes, JR; Naud, S; Peters, EN | 1 |
| Schechter, MA | 1 |
| Fraser, T; Glover, M; Laugesen, M; McCormick, R; Scott, J | 1 |
| Raupach, T; van Schayck, CP | 1 |
| Edwards, AC; Kendler, KS | 1 |
| Bartholomew, JB; Ciccolo, JT; Dunsiger, SI; Jennings, EG; Kraemer, WJ; Marcus, BH; Ussher, MH; Williams, DM | 1 |
| Gur, RC; Lerman, C; Loughead, J; O'Donnell, GP; Ray, R; Ruparel, K; Senecal, N; Siegel, S; Wileyto, EP | 1 |
| Herz, L; Kahler, CW; Kalman, D; Monti, P; Mooney, M; O'Connor, K; Rodrigues, S | 1 |
| Allen, S; Anderson, A; Broadbent, B; Hatsukami, DK; Jensen, J; Severson, H; Zhang, Y | 1 |
| Simon, JA | 1 |
| Aubin, HJ; Karila, L; Reynaud, M | 1 |
| Boissoneault, J; Gilbertson, R; Nixon, SJ; Prather, R | 2 |
| Frolov, AV; Sidorenko, GI | 1 |
| Knudsen, HK; Studts, JL | 1 |
| Langer, C; Leone, F; Martinez, E; Miyamoto, C; Schnoll, RA | 1 |
| Ball, D; O'Gara, C; Spirling, LI; Stapleton, JA; Sutherland, G | 1 |
| Agboola, S; Coleman, T; Leonardi-Bee, J; McNeill, A; Taylor, M | 1 |
| Javitz, HS; Lerman, C; Swan, GE | 1 |
| Coleman, T; Lewis, S; McNeill, A; Szatkowski, L | 1 |
| Advani, M; Cabezas, C; Martin, C; Puente, D; Rodriguez-Blanco, T | 1 |
| McQueen, A; Sumner, W; Tower, S | 1 |
| Hoch, E; Klotsche, J; Muehlig, S; Wittchen, HU | 1 |
| Cinciripini, PM; Cofta-Woerpel, L; Li, Y; McClure, JB; Urbauer, D; Wetter, DW | 1 |
| Abrams, D; Evatt, DP; Greenberg, BD; Haber, S; Leventhal, AM; Niaura, R; Strong, DR | 1 |
| Hajek, P; McRobbie, H; West, O | 1 |
| Domínguez-Delgado, CL; Escobar-Chávez, JJ; Rodríguez-Cruz, IM | 1 |
| Barrett, SP; Wagner, E | 1 |
| Beard, E; Fidler, J; West, R | 1 |
| Evins, AE; Fava, M; Janes, AC; Jensen, JE; Kaufman, MJ; Mashhoon, Y; Pachas, G; Prescot, AP; Renshaw, PF | 1 |
| Audrain-McGovern, J; Benowitz, NL | 1 |
| Cauley, M; Johnson, JE; Levin, ED; Petro, A; Rose, JE; Slade, S; Wells, C | 1 |
| Kanit, L; Mola, G; Nesil, T; Pogun, S; Yararbas, G | 1 |
| Foulds, J; Gandhi, KK; Steinberg, MB; Steinberg, ML; Ulpe, R; Williams, JM | 1 |
| An, LC; Greenseid, L; Kavanaugh, A; Lien, R; Luxenberg, M; Saul, JE; Schillo, B; Wendling, A | 1 |
| Mendelsohn, C | 1 |
| Glantz, SA; Grana, RA; Ling, PM | 1 |
| Belcon, AL | 1 |
| Ricketti, AJ; Unkle, DW | 1 |
| Kelly, TH; Lee, DC; Perkins, KA; Robbins, G; Zimmerman, E | 1 |
| Marti, J | 1 |
| Babuscio, TA; Brewer, JA; Byrne, SA; Carroll, KM; Deleone, CM; Johnson, HE; Kober, H; Mallik, S; Minnix-Cotton, CA; Nich, C; Rounsaville, BJ; Weinstein, AJ | 1 |
| Ackerman, W; Mahvan, T; Namdar, R; Smith, PC; Voorhees, K | 1 |
| Balerio, GN; Calvo, M; Moutinho, LM; Varani, AP | 1 |
| Bastida, G; Beltrán, B | 1 |
| Bullen, C; Fernandes, K; Walker, N; Williman, J | 1 |
| Sandoval, DA; Seeley, RJ | 1 |
| Acheson, S; Beckham, JC; Calhoun, PS; Dedert, EA; Hamlett-Berry, KW; Lee, S; Moore, SD; Straits-Troster, K; Wilson, SM; Zaborowski, DE | 1 |
| Shoaib, M; Wing, VC | 2 |
| Abrams, K; Bresslour, M; Jalan, A; Leger, K; Merrill, A; Schlosser, L | 1 |
| De Biasi, M; Paolini, M | 1 |
| Kirchner, TR; Shiffman, S; Wileyto, EP | 1 |
| Berg, A; Foulds, J; Veldheer, S | 1 |
| Burroughs, D; Cornish, KE; Earley, C; Harris, AC; Keyler, DE; LeSage, MG; Pentel, PR | 1 |
| Auer, R; Cornuz, J; Prod'hom, S; Rodondi, N | 1 |
| Chapman, S | 4 |
| Dorner, TE; Groman, E; Tröstl, A; Womastek, I | 1 |
| Elger, BS; Etter, JF; Huynh, CK; Ritter, C | 1 |
| Hansson, A; Kraiczi, H; Perfekt, R | 1 |
| Carter, BL; Cinciripini, PM; Lam, CY; Robinson, JD; Wetter, DW | 2 |
| Barton, B; Carandang, RA; Ogilvy, CS; Rordorf, GA; Sims, JR | 1 |
| Bachmann, MF; Jennings, GT | 1 |
| Kadokura, Y; Kano, M; Kushihashi, Y; Saito, H; Shino, M; Suzaki, H; Suzuki, M; Takiguchi, S; Yamada, Y | 1 |
| Herman, AI; McKee, SA; Sofuoglu, M; Waters, AJ | 1 |
| Borland, R | 1 |
| Campagna, D; Caponnetto, P; Morjaria, JB; Papale, G; Polosa, R; Russo, C | 1 |
| Baker, TB; Fiore, MC | 1 |
| Zok, C | 1 |
| Caggiula, AR; Donny, EC; Levin, ME; Palmatier, MI; Sved, AF; Weaver, MT | 1 |
| Domino, EF; Jutkiewicz, EM; Ohmura, Y; Yoshioka, M | 1 |
| Adinoff, B; Brigham, G; Ghitza, U; Green, C; Kropp, F; Lindblad, R; Sharma, G; Somoza, E; Stitzer, M; Winhusen, T; Woody, G | 1 |
| Ansermot, N; Choong, E; Cornuz, J; Dobrinas, M; Eap, CB; Noetzli, M | 1 |
| Arrazola, R; Dube, SR; Promoff, G; Regan, AK | 1 |
| Carney, KK | 1 |
| Carter, BL; Cinciripini, PM; Cui, Y; Lam, CY; Minnix, JA; Robinson, JD; Versace, F; Wetter, DW | 1 |
| Furberg, CD; Glenmullen, J; Maltsberger, JT; Moore, TJ; Singh, S | 1 |
| Barnes, J; Bullen, C; Glover, M; Howe, C; McRobbie, H; Nosa, V; Parag, V; Veale, R; Walker, N; Williman, J | 1 |
| de Hoyos, A; DeCamp, MM; Southard, C | 1 |
| Hua, M; Talbot, P; Yip, H | 1 |
| Liebman, AK; Lockhart, AC; Regan, S; Reyen, M; Richards, AE; Rigotti, NA | 1 |
| Alberg, AJ; Carpenter, MJ; Gray, KM; Hughes, JR; Saladin, ME; Wahlquist, AE | 1 |
| van den Brink, W | 1 |
| Jee, SH; Kimm, H; Lee, S; Yun, JE | 1 |
| Aveyard, P; Colavita, G; Donegan, T; Egawhary, M; Hurley, M; Johnstone, EC; Munafò, MR; Murphy, MF; Spruell, T | 1 |
| Alexander, JC; Bishnoi, M; Bruijnzeel, AW; Ford, J; Ji, Y; Rogers, JA; Scheick, S | 1 |
| Fahim, RE; Fuller, SA; Kalnik, MW; Kessler, PD | 1 |
| Stapleton, JA; West, R | 1 |
| Alpert, HR; Biener, L; Connolly, GN | 1 |
| Lerman, C; Schnoll, RA; Wileyto, EP | 1 |
| Ammerman, S; Bailey, SR; Crew, EE; Killen, JD; Riske, EC; Robinson, TN | 1 |
| Aveyard, P; Farley, AC; Hajek, P; Lycett, D | 1 |
| Hood, N; Levinson, AH; Mahajan, R; Russ, R | 1 |
| Craig, L; Fong, GT; McNeill, A; Willemsen, MC | 1 |
| Ferguson, SG; Gitchell, JG; Shiffman, S | 1 |
| Campagna, D; Caponnetto, P; Papale, G; Polosa, R; Russo, C | 1 |
| Brown, ML; Johnson, JE; Kellar, KJ; Levin, ED; McDowell, BE; Paige, MA; Petro, A; Rezvani, AH; Sexton, H; Slade, S; Wells, C; Xiao, Y | 1 |
| Kahler, CW; Leventhal, AM; Monterosso, JR; Munafò, M; Sun, P; Sussman, S; Tidey, JW | 1 |
| Batra, A; Lauri, H; Mann, K; Perfekt, R; Tønnesen, P | 1 |
| Schuurmans, MM; Zellweger, JP | 1 |
| Henriksen, TB; Jensen, MS; Milidou, I; Olsen, J; Søndergaard, C | 1 |
| Bois, F; Cosgrove, KP; Esterlis, I; Kirk, K; Krishnan-Sarin, S; Lee, D; McKee, SA; O'Malley, SS; Seibyl, JP; Staley, JK; Stiklus, SM | 1 |
| Berlin, I; Covey, LS; Hu, MC; Winhusen, T | 1 |
| Conti, D; Cubells, JF; Gold, AB; Lerman, C; Lori, A; Wileyto, EP | 1 |
| Assayag, Y; Bernstein, A; Steeves, D; Stewart, SS; Zvolensky, MJ | 1 |
| Britton, J; Coleman, T; Cooper, S; Grainge, MJ; Lewis, S; Thornton, JG; Watts, K | 1 |
| Ataian, N; Goettsch, B; Libao, P; Nelson, R; Sami, M; Timberlake, DS; Vassile, E | 1 |
| Caldwell, B; Crane, J; Sumner, W | 1 |
| Baili, P; Bennett, K; Boshuizen, HC; Fernández, E; Kulik, MC; Lhachimi, SK; Mackenbach, JP; Nusselder, WJ; Smit, HA | 1 |
| Murphy, RS; Parrott, AC | 1 |
| Huestis, MA; Scheidweiler, KB; Shakleya, DM | 1 |
| Caponnetto, P; Polosa, R; Russo, C | 1 |
| Azar, MR; Cohen, A; Fox, BS; George, O; Goeders, NE; Koob, GF | 1 |
| George, J | 1 |
| Hosmer, D; Markin, C; McCauley, L | 1 |
| Dubin, JA; Hammond, D; Lane, NE; Leatherdale, ST | 1 |
| Brunzell, DH | 1 |
| Benowitz, NL; Bergen, AW; Conti, DV; Lee, W; Lerman, C; Ray, R; Swan, GE; Thomas, P; Tyndale, RF | 1 |
| Dawkins, L; Hasna, S; Soar, K; Turner, J | 1 |
| Beard, E; West, R | 1 |
| Isahak, M; Koh, D; Moy, FM; Retneswari, M; Yasin, SM | 1 |
| Armstrong, D; Aveyard, P; Hill, C; Hollands, GJ; Johnstone, E; Kinmonth, AL; Marteau, TM; Munafò, MR; Prevost, AT; Sutton, S | 1 |
| Emami, H; Hessami, Z; Kharaghani, R; Masjedi, MR; Sharifi, H | 1 |
| Etter, JF; Schneider, NG | 1 |
| Cloatre, E; Dingwall, R; Rooke, C | 1 |
| Bächi, B | 1 |
| Martinet, Y; Wirth, N | 1 |
| de Chazeron, I; Doly-Kuchcik, L; Le Houezec, J; Peiffer, G; Perriot, J; Samalin, L; Schmitt, A; Underner, M | 1 |
| Bordia, T; Chin, M; Hrachova, M; McIntosh, JM; Quik, M | 1 |
| Gallagher, T; Haseler, CA; Rucktooa, P; Sixma, TK; Smit, AB; van Elk, R | 1 |
| Ly, J; McIntosh, JM; Perez, XA; Quik, M | 1 |
| Carroll, FI; Damaj, MI; Grabus, SD | 1 |
| Browning, KK; Diaz, P; Ferketich, AK; Koletar, SL; Lu, B; Reynolds, NR; Wewers, ME | 1 |
| Bullen, C; Glover, M; Grigg, M; Howe, C; Laugesen, M; McRobbie, H; Parag, V; Walker, N; Whittaker, R | 1 |
| Caponnetto, P; Polosa, R; Sands, MF | 1 |
| LeSage, MG; Sofuoglu, M | 1 |
| Beard, E; Black, A; Brown, J; Fidler, J; West, R | 1 |
| Baker, TB; Bolt, D; Cook, JW; Loh, WY; Piper, ME; Schlam, TR; Smith, SS | 1 |
| Baker, TB; Japuntich, SJ; Jorenby, DE; Leventhal, AM; Piper, ME; Schlam, TR | 1 |
| Blendy, JA; Hayes, MR; Hopkins, TJ; Rupprecht, LE; Schmidt, HD | 1 |
| Ashare, RL; Blair, IA; Leone, F; Mesaros, AC; Strasser, AA; Tang, KZ | 1 |
| Cao, Y; Chen, D; Di, X; Guo, S; Kosten, T; Lu, L; Sun, H; Yang, F; Zhang, XY; Zou, Y | 1 |
| Herman, AI; Li, Y; Sofuoglu, M; Waters, AJ | 1 |
| Binkert, CA; Graf, N; Gutzeit, A; Hergan, K; Mutschler, J; Rössler, W; Spanaus, KS | 1 |
| Chen, HK; Lan, TH; Wu, BJ | 1 |
| Crystal, RG; Davisson, RL; De, BP; Hackett, NR; Hicks, MJ; Janda, KD; Kaminsky, SM; Pagovich, OE; Qiu, JP; Rosenberg, JB; Worgall, S; Young, CN | 1 |
| El-Mohandes, AA; Gantz, MG; Kiely, M; Perry, DC; Tan, S; Windsor, R | 1 |
| Farhang, S; Farnam, A; Ghiasi, F; Safikhanlou, S | 1 |
| Boeckelmann, I; D'Alessandro, A; Goette, A; Hammwhöner, M | 1 |
| Harrington, M | 1 |
| Brandstein, K; Chaplin, E; Cummins, S; Gamst, A; Kirby, C; Klonoff-Cohen, H; Lee, J; Morris, T; Seymann, G; Zhu, SH | 1 |
| Phillips, JJ | 1 |
| Leventhal, AM; Pitts, SR | 1 |
| Baker, TB; Cook, JW; Fiore, MC; Piper, ME; Schlam, TR | 1 |
| Breivogel, C; Jamerson, B | 1 |
| Al Ali, R; Asfar, T; Eissenberg, T; Maziak, W; Rastam, S; Ward, KD; Weg, MW | 1 |
| Conklin, CA; Fonte, CA; Parzynski, CS; Perkins, KA; Salkeld, RP | 1 |
| Islam, N; Rahman, S | 1 |
| Hatsukami, DK; Hecht, SS; Knezevich, A; Muzic, J; Stepanov, I | 1 |
| Bentley, GD; Bullmore, ET; Croft, RJ; Davies, CH; Dodds, CM; Jones, GA; Laruelle, M; Lawrence, P; Lund, J; Maruff, P; Nathan, PJ; O'Neill, BV; Peters, G; Robertson, J; Swirski, B; Watson, J; Watson, S | 1 |
| Heffner, JL; Lewis, DF; Winhusen, TM | 1 |
| Buffalari, DM; Donny, EC; Joel, D; LeSage, MG; Levin, M; Sved, AF; Taylor, TG | 1 |
| Holloway, AC; Nicholson, CJ; Raha, S; Woynillowicz, AK | 1 |
| Koren, G | 1 |
| Azar, MR; Janda, KD; Koob, GF; Moreno, AY | 1 |
| Hendricks, PS | 1 |
| Picciotto, MR; Zoli, M | 1 |
| Garvey, AJ; Gitchell, JG; Rohay, JM; Sembower, MA; Shiffman, S | 1 |
| Aveyard, P; Johnstone, EC; Marteau, T; Munafò, MR | 1 |
| Baker, TB; Bush, T; Fiore, MC; Fraser, DL; Keller, PA; Kobinsky, KH; Magnusson, B; McAfee, TA; Smith, SS; Zbikowski, SM | 1 |
| Einecke, D | 1 |
| Mikkelsen, K; Tønnesen, P | 1 |
| Montagne, M; Morgan, M | 1 |
| Bruno, CM; Caponnetto, P; Keller, E; Polosa, R | 1 |
| Grasman, J; Grasman, RP; van der Maas, HL | 1 |
| Agombar, H; Bains, M; Clarke, E; Patel, R | 1 |
| Bondy, ML; Gatus, LA; Hammond, SK; Hudmon, KS; Koehly, LM; Marani, SK; Prokhorov, AV; Spitz, MR; Wilkinson, AV | 1 |
| Ferketich, AK; Hood, NE; Klein, EG; Pirie, P; Wewers, ME | 1 |
| Benowitz, NL; Donny, E; Hatsukami, DK; Henningfield, J; Zeller, M | 1 |
| Anthony, JC; Behm, FM; Eaton, WW; Fisher, C; Ialongo, N; Musci, R; Rose, JE; Storr, CL; Uhl, GR; Walther, D | 1 |
| Arnott, D; McNeill, A; Rooke, C | 1 |
| Kenny, PJ; Picciotto, MR | 1 |
| Allen, JA; Gritz, ER; Haglund, M; Heck, J; Kralikova, E; Niaura, R; Rubenstein, R; Vallone, DM; Xiao, H | 1 |
| Bullen, C; Cahill, K; Hartmann-Boyce, J; Lancaster, T; Mant, D; Perera, R; Stead, LF | 1 |
| Al'absi, M; Allen, AM; Allen, SS; Hatsukami, D; Kotlyar, M; Lunos, S | 1 |
| Dušková, M; Hill, M; Hruškovičová, H; Králíková, E; Pospíšilová, H; Rácz, B; Simůnková, K; Stárka, L; Vondra, K | 1 |
| Denlinger, RL; Donny, E; Hatsukami, DK; Heishman, SJ; Jensen, J; Mackowick, KM; Murphy, SE; Roper-Batker, AN; Thomas, BF; Vogel, RI | 1 |
| Cheah, NP; Chong, NW; Morsed, FA; Tan, J; Yee, SK | 1 |
| Bracken, BK; Frederick, BD; Lindsey, KP; Lukas, SE; Maclean, RR; Ryan, ET | 1 |
| Almgren, MM; Clark, KJ; Stroman, RT; Wynn, WP | 1 |
| Antal, M; Barabás, K; Forster, A; Nagy, K; Ramseier, CA; Zalai, Z | 1 |
| Baker, TB; Benowitz, NL; Bergen, AW; Conti, DV; Edlund, CK; Hall, S; Javitz, HS; Krasnow, R; Kwok, PY; Lee, W; Lerman, C; Liu, J; Michel, M; Nishita, D; Swan, GE; Tyndale, RF | 1 |
| Camfield, DA; Kras, M; Kure, C; Pipingas, A; Scholey, AB; Silberstein, RB; Stough, C; Zangara, A | 1 |
| Aveyard, P; Hankins, M; Hollands, GJ; Marteau, TM; McDermott, MS | 1 |
| Conrad, M; King, AC; Kuhns, L; Matthews, AK; Vargas, M | 1 |
| De Cremer, K; Van Loco, J; Van Overmeire, I | 1 |
| Blendy, JA; Gold, A; Schnoll, R; Turner, JR | 1 |
| Crowe, E; Dawkins, L; Turner, J | 1 |
| Bonawitz, SC; Christensen, J; Coon, D; Tuffaha, S | 1 |
| Jorenby, D | 1 |
| Sutherland, G | 2 |
| Hu, TW; Keeler, TE; Keith, A; Manning, R; Marciniak, MD; Ong, M; Sung, HY | 1 |
| Cabanac, M; Frankham, P | 1 |
| Gulliver, SB; Hitsman, B; McChargue, DE | 1 |
| Lancaster, T; Stead, LF | 5 |
| Gatt, ME; Heyman, SN | 1 |
| Campbell, IA; Cannings, R; Edwards, S; Hand, S | 1 |
| DeGraff, AC | 1 |
| Cornuz, J; Wirthner, D; Zellweger, JP | 1 |
| Atkinson, ER; Gilbert, AL; Hotham, ED | 3 |
| Dobos, GJ; Konietzko, N; Michalsen, A; Reichardt, H; Reichart, H; Richarz, B; Spahn, G | 1 |
| Baker, TB; Fiore, MC; McCarthy, DE; Piasecki, TM | 2 |
| Carton, S; Jouvent, R; Lagrue, G; Le Houezec, J | 1 |
| Gilpin, EA; Pierce, JP | 2 |
| Grandt, D; Häuser, W | 1 |
| Aubin, HJ; Lagrue, G; Le Foll, B | 1 |
| Budenholzer, B | 1 |
| Lillington, GA; Sarinas, PS; Vaszar, LT | 1 |
| Fagerström, K | 1 |
| Fortmann, SP; Killen, JD; Kraemer, HC; Varady, A | 1 |
| Aveyard, PN; Barton, PM; Forbes, CA; Hyde, CJ; Jones, L; Mather, LC; Raftery, JP; Song, FJ; Sowden, AJ; Woolacott, NF | 1 |
| Fiore, MC; Sims, TH | 1 |
| Etter, JF; Laszlo, E; Perneger, TV; Perrot, C; Zellweger, JP | 1 |
| Frosch, D; Jarvik, ME; Ling, W; Nahom, D; Rawson, RA; Rotheram-Fuller, E; Shoptaw, S; Yang, X | 1 |
| Burns, DM | 1 |
| Gérard, S; Le Louarn, A | 1 |
| Croghan, IT; Hurt, RD; Moyer, TP; Offord, KP; Ogburn, PL; Ramin, KD; Schroeder, DR | 2 |
| Anderson, N; Fales, D; McAfee, T; Ringen, K; Zbikowski, SM | 1 |
| Hall, W | 1 |
| Cormier, S; Dupont, P; Lagrue, G; Mautrait, C | 1 |
| Bye, A; Milleri, S; Squassante, L; Teneggi, V; Tiffany, ST; Ziviani, L | 2 |
| Cerny, EH; Cerny, T; Henzelin-Nkubana, C; Lévy, R; Mauel, J; Mpandi, M; Mutter, M; Patiny, L; Tuchscherer, G | 1 |
| Cornuz, J | 2 |
| Aouina, H; Azzabi, S; Baccar, MA; Bouacha, H; el Gharbi, L; Khirouni, S | 1 |
| Coward, PY; Palmer, RM; Scott, DA; Stapleton, JA; Sutherland, G; Wilson, RF | 1 |
| Bar, JL; Eisen, SA; Faraone, SV; Goldberg, J; Kremen, WS; Lyons, MJ; Toomey, R; Tsuang, M | 1 |
| Breland, AB; Buchhalter, AR; Eissenberg, T; Evans, SE | 1 |
| Abram, L; Kriven, S; Miller, C; Rowley, D | 1 |
| Jonsdottir, D; Jonsdottir, H | 1 |
| Delnevo, CD; Hrywna, M; Steinberg, MB | 1 |
| Baxter, LR; Bota, RG; Brody, AL; Childress, AR; Ho, ML; Jarvik, ME; Lee, GS; London, ED; Madsen, D; Mandelkern, MA; Saxena, S | 1 |
| Alterman, A; Chychula, N; Dhopesh, V; Gariti, P; Mechanic, K; Mulvaney, F; Sacks, D; Yu, E | 1 |
| Cadore, JM | 1 |
| Davis, RM; Fiore, MC; Hatsukami, DK; Raw, M; Stead, LF; West, R | 1 |
| Antonuccio, DO | 1 |
| Franzon, M; Gustavsson, G; Korberly, BH | 1 |
| Frosch, DL; Nahom, D; Shoptaw, S | 1 |
| Martin, N | 1 |
| Fowler, G; Lancaster, T; Mant, D; Silagy, C; Stead, L | 3 |
| Cerullo, CC; Franzon, M; Glover, ED; Glover, PN; Hobbs, GR; Howell, RM; Keyes, GG; Nilsson, F; Sullivan, CR | 1 |
| Anderson, JR; Daughton, DM; Floreani, AA; Manouilova, LS; Millatmal, T; Patil, KD; Rennard, SI; Romberger, DJ; Ullrich, FA; Umino, T | 1 |
| Gorodetzky, CW; Gorsline, J; Shiffman, S | 1 |
| Stolerman, I | 1 |
| Fagerström, KO; Hughes, JR | 1 |
| Callas, PW; Fagerström, KO; Hughes, JR | 1 |
| Busto, UE; Cárdenas, L; Corrigall, WA; MacDonald, A | 1 |
| Gold, PB; Harvey, RT; Rubey, RN | 1 |
| Borgne, A; Grangé, G | 1 |
| Ferguson, CL; Jorenby, DE; Khayrallah, MA; Niaura, R; Ryan, CF; Shadel, WG; Shiffman, S | 1 |
| Monaghan, N | 1 |
| Addo, F; Croghan, IT; Hurt, RD; Kardinal, CG; Knost, JA; Krook, JE; Loprinzi, CL; Michalak, JC; Morton, RF; Novotny, PJ; Porter, PA; Schaefer, PL; Sloan, JA; Stella, PJ; Tirona, MT | 1 |
| Le Foll, B; Schwartz, JC; Sokoloff, P | 1 |
| Callas, P; Hughes, JR; Shiffman, S; Zhang, J | 1 |
| Ussher, M; West, R | 2 |
| Henningfield, JE; Houtsmuller, EJ; Stitzer, ML | 1 |
| Fortmann, SP; Hayward, C; Killen, JD; Schatzberg, A; Varady, A | 1 |
| Marks, JL; Mehringer, AM; Namenek Brouwer, RJ; Pomerleau, CS; Pomerleau, OF; Saules, KK; Snedecor, SM | 1 |
| Abrams, DB; Albrecht, AE; Bock, B; Hogan, J; King, TK; Lewis, BA; Marcus, BH; Parisi, AF | 1 |
| Chimonas, E; Diamantopoulos, I; Giannakoulas, G; Katramados, A; Melas, N | 1 |
| Baker, TB; Fiore, MC; Jorenby, DE; Piasecki, TM; Smith, SS | 3 |
| Kane, JK; Konu, O; Li, MD | 1 |
| Avenet, P; Bergis, OE; Besnard, F; Biton, B; Caille, D; Cohen, C; Coste, A; Curet, O; Galli, F; Gardes, A; George, P; Graham, D; Jegham, S; Leonardon, J; Lochead, AW; Oblin, A; Perrault, G; Scatton, B; Sgard, F; Soubrie, P; Voltz, C | 1 |
| van Schayck, CP; Wagena, EJ; Wouters, EF; Zeegers, MP | 1 |
| Dake, JA; Price, JH; Telljohann, SK; Yingling, F | 1 |
| Batra, V; Khurana, S; Leone, FT; Patkar, AA | 1 |
| Glavas, D; Rumboldt, M; Rumboldt, Z | 1 |
| Baile, WF; Blalock, JA; Carter, BL; Cinciripini, LG; Cinciripini, PM; Fouladi, RT; Wetter, DW | 1 |
| Calapai, G; Caputi, AP; Catania, MA; Crupi, A; Firenzuoli, F; Mannucci, C | 1 |
| DiFranza, JR; Nicolaou, M; Savageau, JA; Soteriades, ES | 1 |
| Aldrich, TK; Appel, DW | 1 |
| Worsnop, CJ | 1 |
| Brockway, K; Graham, S; MacLean, D; McSweeney, B; Parsons, A; Richards, D; Sutherland, M; Toop, L | 1 |
| Carpenter, MJ; Hughes, JR; Keely, JP | 1 |
| Barrett, S; Coleman, T; Wilson, A; Wynn, A | 1 |
| Cook, MR; Gerkovich, MM; Graham, C; Hoffman, SJ; Peterson, RC | 1 |
| Croghan, GA; Croghan, IT; DeKrey, WL; Ebbert, LP; Hurt, RD; Johnson, PA; Levitt, R; Loprinzi, C; Mailliard, JA; Novotny, P; Sloan, JA; Stella, P; Swan, DK; Tschetter, LK; Walsh, DJ; Wiesenfeld, M | 1 |
| Badger, GJ; Heil, SH; Higgins, ST; Holmes, HW; Tidey, JW | 1 |
| Leischow, SJ; Muramoto, ML; Ranger-Moore, J | 1 |
| Chaloupka, FJ; Tauras, JA | 1 |
| Eisen, SA; Lyons, MJ; Madden, PA; Scherrer, JF; True, WR; Tsuang, M; Xian, H | 2 |
| Swan, GE | 1 |
| Allen, SS; Christianson, D; Hatsukami, DK | 1 |
| Ahluwalia, JS; Catley, D; Nazir, N; Resnicow, K | 1 |
| Bohadana, A; Martinet, Y; Nilsson, F; Rasmussen, T | 2 |
| Baker, TB; Fiore, MC; Jamerson, B; Johnston, JA; Jorenby, DE; Leischow, SJ; Nides, MA; Rennard, SI; Smith, SS | 1 |
| Benowitz, N; Jepson, C; Kaufmann, V; Kucharski, S; Lerman, C; Patterson, F; Shields, P; Wileyto, P | 1 |
| Carmody, TP; Hudes, ES; Murray, J; Simon, JA; Snyder, E | 1 |
| Cornuz, J; Gilbert, A; Paccaud, F; Pinget, C | 1 |
| Ahluwalia, JS; Jolicoeur, DG; Mosier, MC; Resnicow, K; Richter, KP | 1 |
| Balfour, DJ | 4 |
| Sumner, W | 1 |
| Glasgow, H; Grigg, M | 1 |
| Henningfield, JE; Moolchan, ET; Zeller, M | 1 |
| Campbell, I | 1 |
| Anderton, A; Antoniak, M; Brackenridge, A; Britton, J; Leivers, U; Lewis, S; McNeill, A; Molyneux, A; Moxham, J; Nilsson, F; West, R | 1 |
| Diefenbacher, LJ; Lindbloom, E; Nashelsky, J; Smith, PO | 1 |
| Johnson, KC; Klesges, LM; Robinson, L; Somes, G; Zbikowski, S | 1 |
| Cummings, KM; Mahoney, MC; Murphy, JM; Repetto, PM; Shelley, D | 1 |
| Batra, A; Goliasch, T; Ladiges, O; Müller, C; Pfeiffer, H; Slotty, C | 1 |
| Ahmadi, J; Ahmadi, M; Ahmadi, N; Ashkani, H | 1 |
| Jørgensen, T; Sørensen, LT | 1 |
| Etter, JF; Landfeldt, B; le Houezec, J | 1 |
| Hey, K; Murphy, M; Roberts, S; Walton, R; Welch, S; Yudkin, P | 1 |
| Clemente Jiménez, ML; Herrero Labarga, I; Marrón Tundidor, R; Pérez-Trullén, A; Rubio Aranda, E | 1 |
| Corwin, EJ; Klein, LC | 1 |
| Hider, A; Hjalmarson, A; Lebargy, F; Sweet, R; Tonstad, S; Townsend, J; Tønnesen, P; Van Spiegel, PI | 1 |
| Dobos, GJ; Michalsen, A; Richarz, B | 1 |
| Fagerstrom, KO; Hasford, J; Haustein, KO | 1 |
| Waring, WS | 1 |
| Hegaard, HK; Kjaergaard, H; Møller, LF; Ottesen, B; Wachmann, H | 1 |
| Buisson, B | 1 |
| Burton, SL; Hughes, JR; Pillitteri, JL; Shiffman, S | 1 |
| Azen, S; Chen, X; Gallaher, P; Gong, J; Liu, C; Ph D, AJ; Shakib, S; Shan, J; Spruijt-Metz, D; Stacy, A; Unger, J; Zheng, H | 1 |
| Allen, S; Hanson, K; Hatsukami, D; Jensen, S | 1 |
| Baer, JS; Davis, TM; Fitzgibbons, K; Kivlahan, DR; Malte, CA; Saxon, AJ; Sloan, KL | 1 |
| Slama, K | 1 |
| Le Houezec, J | 4 |
| Khazaal, Y; Krenz, S; Zullino, DF | 1 |
| Domino, EF; Fedewa, KS; Kadoya, C; Matsuoka, S; Ni, L | 1 |
| Adams, IM; Arnaldi, VC; Charles, MA; Macleod, ZR | 1 |
| Bradbury, AW; Hobbs, SD | 1 |
| Danielsson, T; Landfeldt, B; Tønnesen, P; Wennike, P; Westin, A | 1 |
| Bradley, BP; Mogg, K; Shiffman, S; Waters, AJ | 1 |
| Biberman, R; Gerber, Y; Katzir, I; Neumann, R | 1 |
| Kaufmann, V; Lerman, C | 1 |
| Darwin, C; Hajek, P; McRobbie, H | 1 |
| Gilmore, A; McKee, M; Novotny, T | 1 |
| de Haes, JC; Legemate, DA; Peters, RJ; Smets, EM; Wiggers, LC | 1 |
| Foulds, J; Hajek, P; May, S; Meadow, A; Nilsson, F; West, R | 1 |
| Choi, JH; Dresler, CM; Norton, MR; Strahs, KR | 1 |
| Heishman, SJ; Moolchan, ET; Singleton, EG | 1 |
| Caggiula, A; Conklin, C; Perkins, K; Sayette, M | 1 |
| Burnier, M; Fallab Stubi, CL; Huynh-Ba, M; Iorillo, D; Schneider, MP; Uldry, C; van Melle, G; Zellweger, JP | 1 |
| Eissenberg, T; Klein, LC | 1 |
| Percival, J | 2 |
| Maeda, J; Semba, J; Suhara, T; Wakuta, M | 1 |
| Gillison, F; Hajek, P; McRobbie, H | 3 |
| Doran, C; Gates, J; Mattick, RP; Shakeshaft, A; Shanahan, M | 1 |
| Burroughs, CC; Lee, RW; Long, MA; Swanson, NA | 1 |
| Miyata, H | 1 |
| Cope, GF; Holder, R; Nayyar, P | 1 |
| Audrain-McGovern, J; Jepson, C; Kaufmann, V; Kucharski, S; Lerman, C; Patterson, F; Rukstalis, M | 1 |
| Audrain-McGovern, J; Jepson, C; Kaufmann, V; Lerman, C; Perkins, K; Rukstalis, M | 1 |
| Bailie, RS; Burns, CB; D'Abbs, PH; Farrington, M; Ivers, RG; Richmond, RL; Tipiloura, E | 1 |
| Girgis, A; Paul, CL; Walsh, RA | 1 |
| Di Marino, ME; Hughes, JR; Shiffman, S; Sweeney, CT | 1 |
| Marlow, SP; Stoller, JK | 1 |
| Hasford, J; Haustein, KO; Mulzer, K | 1 |
| Birek, C; Lavelle, C; Scott, DA | 1 |
| Hackett, LP; Hale, TW; Ilett, KF; Kohan, R; Kristensen, JH; Page-Sharp, M | 1 |
| Bradley, BP; Field, M; Mogg, K | 1 |
| Chorost, M; Curry, S; Dacey, S; Jack, LM; Javitz, H; McAfee, T; Swan, GE | 1 |
| Britt, DM; Burkholder, GJ; David, SP; Day, A; Griffiths, SE; Hutchison, K; Johnstone, E; Murphy, M; Niaura, R; Papandonatos, GD; Shadel, WG; Stumpff, J; Walton, RT | 1 |
| Babb, D; Hatsukami, DK; Sofuoglu, M | 1 |
| Jain, A | 1 |
| Kawane, H | 1 |
| Kino, H | 1 |
| Dresler, CM; Rohay, JM; Shiffman, S | 1 |
| Cryan, JF; Gasparini, F; Markou, A; van Heeke, G | 1 |
| Fekkes, D; Spijkerman, R; Van Den Eijnden, R | 1 |
| Noé, S | 1 |
| Benowitz, NL; Froelicher, ES; Hartley, C; Sohn, M | 1 |
| Bittoun, R | 1 |
| Hajek, P; McRobbie, H | 2 |
| Plans-Rubió, P | 1 |
| Joseph, AM; Nelson, DB; Nugent, SM; Willenbring, ML | 1 |
| George, TP; O'Malley, SS | 1 |
| Battersby, N; Cope, GF | 1 |
| García Thuring, L; Iruela Cuadrado, L; Martínez Vigo, M | 1 |
| Djordjevic, MV; Leischow, SJ | 1 |
| Krishnan-Sarin, S; Meandzija, B; O'Malley, S | 1 |
| Byers, TE; Espinoza, P; Flores, ET; Levinson, AH; Pérez-Stable, EJ | 1 |
| Colgrove, J; Fairchild, A | 1 |
| James-Enger, K | 1 |
| Hatsukami, DK; Lemmonds, C; Tomar, SL | 1 |
| Ivers, RG | 1 |
| Chen, R; Chou, KR; Ku, CH; Lee, JF; Lu, RB | 1 |
| Molyneux, A | 1 |
| Callahan, R; Callas, PW; Hughes, JR; Kenny, M; Pillitteri, JL | 1 |
| Lee, EM; Malson, JL; Moolchan, ET; Pickworth, WB | 1 |
| Roddy, E | 2 |
| Angrill Paxeras, J; Sampablo Lauro, I | 1 |
| Bölcskei, PL | 1 |
| Bergmann, L; Herschel, M; Warncke, W | 1 |
| Griffiths, RR; Sigmon, SC; Sobel, BF | 1 |
| Baska, T; Basková, M; Mad'ar, R; Straka, S | 1 |
| Kubota, T; Morozumi, T; Okuda, K; Sato, T; Yoshie, H | 1 |
| Baker, TB; Fiore, MC; Guiliani, TA; Jackson, TC; Jorenby, DE; McCarthy, DE; Mielke, M; Smith, SS; Zehner, ME | 1 |
| Audrain-McGovern, J; Benowitz, N; Kaufmann, V; Lerman, C; Patterson, F; Perkins, K; Rukstalis, M | 1 |
| Griffiths, S; Hey, K; Johnstone, E; Munafò, M; Murphy, M; Roberts, S; Walton, R; Welch, S; Yudkin, P | 1 |
| Cagle, BB | 1 |
| Ayers, JT; Crooks, PA; Deaciuc, AG; Dwoskin, LP; Sumithran, SP; Zhu, J | 1 |
| Albuquerque, EX; Almeida, LE; Camara, AL; Maelicke, A; Pereira, EF | 1 |
| Bednarek, M; Goljan-Geremek, A; Górecka, D; Nowiński, A; Puścińska, E; Zieliński, J | 1 |
| Alvarez, F; Botella-Carretero, JI; Cantarero, M; Escobar-Morreale, HF; García, G; Martín, I; Valero, AM; Varela, C | 1 |
| Mustonen, T | 1 |
| Fakhfakh, R; Lagrue, G | 1 |
| Griffiths, SE; Hey, K; Johnstone, EC; Murphy, MF; Roberts, SJ; Walton, RT; Welch, SJ; Yudkin, PL | 1 |
| Bolliger, CT; Diacon, AH; Schuurmans, MM; van Biljon, X | 1 |
| Fernández Pinilla, MC; Fernández-Cruz, A; Filozof, C | 1 |
| Johnston, JA; Tonstad, S | 1 |
| Davies, GM; James, DL; Morgan, MJ; Willner, P | 1 |
| Blakely, T; Crane, J; Hill, S | 1 |
| Achour, N; Aouina, H; Bouacha, H; Fakhfakh, R; Gharbi, L; Hsairi, M | 1 |
| Baron, JA; Crawford, L; Morgan, TM; Stoller, A; Toth, D; Yeo, KT | 1 |
| Hatsukami, D; Mooney, M; White, T | 1 |
| Chatkin, JM; Fritscher, CC; Haggsträm, FM; Mariante de Abreu, C; Wagner, MB | 1 |
| Bilgin, L; Demir, T; Koç, N; Tutluoğlu, B | 1 |
| Giarelli, E; Ledbetter, N; Mahon, S; McElwain, D | 1 |
| Burke, M; Foulds, J; Steinberg, M; Williams, JM; Ziedonis, DM | 1 |
| Ikinci, G; Senel, S; Sumnu, M; Wilson, CG | 1 |
| Maglione, MA; Mojica, WA; Morton, SC; Rhodes, SL; Roth, EA; Shekelle, PG; Sherman, SE; Suttorp, MJ | 1 |
| Bennett, K; Feely, J; Heery, A; Williams, D | 1 |
| Carmella, SG; Hatsukami, DK; Hecht, SS; Le, C; Lemmonds, C; Murphy, SE; Zhang, Y | 1 |
| Els, C | 1 |
| Hajek, P; West, R | 2 |
| Cort, N; Haustein, H; Haustein, KO; Krause, J; Rasmussen, T | 1 |
| Bickel, WK; Johnson, MW; Kirshenbaum, AP | 1 |
| Coddington, S; Fonte, C; Keenan, J; Lerman, C; Perkins, KA | 1 |
| Behm, FM; Rose, JE | 2 |
| Hébert Eb, R | 1 |
| Cinciripini, L; Cinciripini, P; De Moor, C; Minna, J; Tomlinson, G; Tsoh, J; Wetter, D | 1 |
| Asgaard, G; Botros, N; Gilbert, D; Huggenvik, J; McClernon, J; Plath, L; Rabinovich, N; Sugai, C; Zuo, Y | 1 |
| Connett, J; Hughes, J; Lindgren, P; Nides, M | 1 |
| Farrelly, M; Haviland, ML; Hersey, J; Messeri, P; Mowery, P; Nimsch, C; Nonnemaker, J | 1 |
| Cadet, JL; Gallo, J; Gorelick, D; Henningfield, J; Moolchan, E; Radzius, A; Uhl, G | 1 |
| Brown, K; Drury, M; Johnstone, E; Murphy, M; Roberts, K; Saunders, C; Walton, R | 1 |
| Gaffney, C; Melvin, C | 1 |
| Benowitz, N; Dempsey, D | 1 |
| Brandon, TH; Westmaas, JL | 1 |
| Fowler, G | 3 |
| Bayram, NG; Kadakal, F; Karşidağ, C; Uysal, MA; Uysal, O; Yilmaz, V | 1 |
| Martin, J; Wain, AA | 1 |
| Villanueva, EV; Zavarsek, S | 1 |
| Bagnall, AM; McIntosh, HM; Woolacott, NF | 1 |
| Muñoz, LR; Stevens, KR | 1 |
| Camarelles Guillem, F; de Miguel Díez, J; Sanz Pozo, B | 1 |
| Corominas, J; Godás, T; Marcos, T | 1 |
| Domino, EF; Guthrie, SK; Ni, L; Teter, CJ; Zubieta, JK | 1 |
| Callas, PW; Carpenter, MJ; Hughes, JR; Solomon, LJ | 1 |
| Clow, A; Evans, P; Hucklebridge, F; McEwen, A; Steptoe, A; Ussher, M; West, R | 1 |
| Hasman, A; Holm, S | 1 |
| Cepeda-Benito, A; Erath, S; Reynoso, JT | 1 |
| Ammerman, S; Green, S; Hayward, C; Killen, JD; Levin, SK; Robinson, TN; Rogers, J; Samuels, D; Schatzberg, AF; Stone, C | 1 |
| Dawkins, L; Pickering, AD; Powell, JF; Powell, JH; West, R | 1 |
| Foulds, J; Williams, JM; Ziedonis, DM | 1 |
| Carmody, TP; Duncan, C; Hudes, ES; Simon, JA | 1 |
| Lamberg, L | 1 |
| Gilbert, D; Shiffman, S; West, R | 1 |
| Khan, N; Wardman, AE | 1 |
| Drobes, D; Klein, LC | 1 |
| Cooper, TV; DeBon, MW; Jennings, LC; Johnson, KC; Klesges, RC; Sherrill-Mittleman, D; Steenbergh, TA; Stockton, M | 1 |
| Bensley, J; Corrigan, N; Harding, R | 1 |
| McClure, JB; Swan, GE; Zbikowski, SM | 1 |
| Levin, TT; Paperwalla, KN; Saravay, SM; Weiner, J | 1 |
| Jain, M; Talwar, A; Vijayan, VK | 1 |
| Fiore, MC; Kenford, SL | 1 |
| Feinsilver, SH; Greenberg, H; Htoo, A; Talwar, A | 1 |
| Halpern-Felsher, BL; Kropp, RY | 1 |
| Carmella, SG; Hatsukami, DK; Hecht, SS; Jensen, J; Le, C; Link, CA; Losey, L; Murphy, SE; Puumala, SS | 1 |
| Baker, KM; Bonn-Miller, MO; Brown, RA; Feldner, MT; Leen-Feldner, E; Zvolensky, MJ | 1 |
| Eisendrath, SJ; Hall, SM; Humfleet, GL; Meisner, MR; Prochaska, JJ; Redding, CA; Rosen, AB; Rossi, JS; Tsoh, JY | 1 |
| McEwen, A; Owen, L; West, R | 2 |
| Cullen, J; Hall, SM; Humfleet, GL; Muñoz, RF; Reus, VI | 1 |
| Antoniak, M; Britton, J; Coleman, T; Lewis, S; Thornton, J; Watts, K | 1 |
| Gottrup, F; Kharazmi, A; Nielsen, HB; Sørensen, LT | 1 |
| Alberg, AJ; Avey, A; Burke, A; Ernst, PA; Hoffman, SC; Kline, JA; Rasch, KA; Stashefsky Margalit, R; Stewart, N | 1 |
| Flynn, BS; Howe, KD; Marcy, TW; Reinier, K; Skelly, JM; Solomon, LJ | 1 |
| Lerman, C; Patterson, F; Pickworth, WB; Strasser, AA | 1 |
| Ahluwalia, JS; Choi, WS; Harris, KJ; McCool, RM; Richter, KP | 1 |
| Gill, P; Hall, SM; Prochaska, JJ | 1 |
| Fryer, GE; Kick, S; Miyoshi, T; Prochazka, AV; Steinbrunn, C | 1 |
| Favreau, M; Ingrand, P; Meurice, JC; Mura, P; Underner, M | 1 |
| Dietz, UA; Kauczok, J; Reith, HB; Schmidt, K; Ziegler, UE | 1 |
| Markou, A; Paterson, NE; Semenova, S | 1 |
| Kosten, TR; Sofuoglu, M | 1 |
| Audrain-McGovern, J; Jepson, C; Kaufmann, V; Lerman, C; Perkins, KA; Pickworth, WB; Rukstalis, M; Strasser, AA; Wileyto, EP | 1 |
| Clemens, LH; Cooper, TV; Debon, MW; Johnson, KC; Klesges, RC; Zbikowski, SM | 1 |
| Dale, LC; Offord, KP; Sarr, MG; Warner, DO | 1 |
| Barrueco Ferrero, M; Jiménez Ruiz, C; Palomo Cobos, L; Riesco Miranda, JA; Romero Palacios, P; Torrecilla García, M | 1 |
| Eule, B; Hudmon, KS; Schroeder, SA; Sullivan, MK | 1 |
| Patja, K; Rouhos, A | 1 |
| Akiba, Y; Arita, E; Hashiguchi, M; Hatsugaya, M; Mochizuki, M; Rokujoh, E; Shimizu, N; Takeuchi, M; Yamamoto, N | 1 |
| Cahall, EJ | 1 |
| García-Vera, MP | 1 |
| Balabanis, MH; Gwaltney, CJ; Paty, JA; Sayette, MA; Shiffman, S; Waters, AJ | 1 |
| Kordella, T | 1 |
| Bialous, SA; Sarna, L | 1 |
| Andrews, JO; Graham-Garcia, J; Heath, J | 1 |
| Himmerová, V; Králíková, E; Molyneux, A | 1 |
| Buchanan, LM; El-Banna, M; Moses, S; Siedlik, C; White, A; Wood, M | 1 |
| Campbell, E; Kerridge, R; Knight, J; Moore, K; Rissel, C; Spigelman, AD; Wiggers, J; Wolfenden, L | 1 |
| Heavner, DL; Morgan, WT; Ogden, MW; Richardson, JD | 1 |
| Hawkshaw, BA; Zuo, Y | 1 |
| Ramseier, CA | 1 |
| Hajek, P; Jarvis, M; Stead, LF; West, R | 1 |
| Jepson, C; Lerman, C; Lynch, KG; Patterson, F; Perkins, K; Rukstalis, M; Strasser, A | 1 |
| Ahijevych, K; Groner, J; Wewers, ME; Wood, T | 1 |
| Benowitz, N; Hatsukami, D; Hughes, JR; Mermelstein, RJ; Shiffman, S | 1 |
| Henningfield, JE; McLellan, AT | 1 |
| Di Marino, ME; Pillitteri, JL; Shiffman, S | 1 |
| Fu, SS; Geraci, MC; Hamlett-Berry, KW; Jonk, YC; Joseph, AM; Sherman, SE | 1 |
| McEwen, A; Owen, L; Raw, M; West, R | 1 |
| Shoptaw, S; Yang, X | 1 |
| Adams, EH; Franzon, MA; Guary, J; Hughes, JR; Maguire, MK | 1 |
| Berkowitz, AB; Best, D; Brooks, K; Curry, S; Geller, A; Lando, HA; Muramoto, M; Pbert, L; Prokhorov, AV; Tanski, SE; Thomson, C; Weitzman, M; Winickoff, JP | 1 |
| Meier, BM | 1 |
| Chaloupka, FJ; Emery, S; Tauras, JA | 1 |
| McLoughlin, C | 1 |
| Cummings, KM; Hyland, A | 1 |
| Barrueco, M; Jiménez Ruiz, C; Palomo, L; Riesco, JA; Romero, P; Torrecilla, M | 1 |
| Andrus, MR; Roth, MT; Westman, EC | 1 |
| Lewis, K | 1 |
| Alberg, AJ; Comstock, GW; Gitchell, J; Helzlsouer, KJ; Hoffman, SC; May, JW; Patnaik, JL | 1 |
| Byars, JA; Frost-Pineda, K; Gold, MS; Jacobs, WS | 1 |
| Berlin, I; Heishman, SJ; Notides, C; Singleton, EG; Vorspan, F; Warot, D | 1 |
| Rajska-Neumann, A; Saran, A; Wieczorowska-Tobis, K | 1 |
| Dar, R; Etter, JF; Stronguin, F | 1 |
| Bansal, MA; Cummings, KM; Giovino, GA; Hyland, A | 2 |
| Borland, R; Cummings, KM; Elton-Marshall, T; Fong, GT; Hammond, D; King, B; McNeill, A; Yong, HH | 1 |
| Bansal, MA; Bauer, JE; Cummings, KM; Giovino, GA; Hastrup, JL; Hyland, A | 1 |
| Borland, R; Cummings, KM; Fong, GT; Hammond, D; Laux, FL; Ross, H; Zanna, MP | 1 |
| Connolly, GN; Hamilton, WL; Kling, R; Norton, Gd; Ouellette, TK; Rhodes, WM | 1 |
| Bauer, JE; Cummings, KM; Giovino, GA; Hyland, A; Li, Q; Steger, C | 1 |
| Alder, S; Higbee, C; Murphy-Hoefer, R | 1 |
| Gibson, G; Slovic, P; Weinstein, ND | 1 |
| Kawahara, S; Kawai, H; Shibayama, T; Soda, R; Tada, A; Takahashi, K | 1 |
| Colrain, IM; Swan, GE; Trinder, J | 1 |
| Hughes, JR; Keely, JP | 1 |
| Clark, L; Conklin, CA; Jacobs, L; Perkins, KA; Sayette, M; Wilson, A | 1 |
| An, LC; Joseph, AM; Lando, H; Mohiuddin, A; Rice, K | 1 |
| DiFranza, JR; Wellman, RJ | 1 |
| Mehringer, AM; Ninowski, R; Pomerleau, CS; Pomerleau, OF; Sen, A; Snedecor, SM | 1 |
| Dresler, CM; Shiffman, S; Sweeney, CT | 2 |
| Bremann, L; Hvidberg, S; Nilsson, F; Pisinger, C; Thomsen, C; Tønnesen, P; Wennike, P; Westin, A | 1 |
| Cadet, JL; Ernst, M; Heishman, SJ; Moolchan, ET; Pickworth, WB; Robinson, ML; Schroeder, JR | 1 |
| Klein, JD; McMillen, RC; Rigotti, NA; Tanski, SE; Weitzman, M; Winickoff, JP | 1 |
| Cooke, CA; Sketris, IS; Whelan, AM | 1 |
| Cosnes, J; Johnson, GJ; Mansfield, JC | 1 |
| Ahmed, SN; Quigley, D; Siddiqi, ZA | 1 |
| Jollis, JG; Meine, TJ; Pappas, PA; Patel, MR; Washam, JB | 1 |
| Blumenthal, D; Pederson, LL | 1 |
| Bazar, KA; Daniel, SM; Gerber, A; Lee, PY; Yun, AJ | 1 |
| Bruggmann, P; Fritsch, K; Jacot, ML; Klarer, A; Krause, M; Thurnheer, R; Wick, F | 1 |
| Gill, GV; MacFarlane, IA; Morgan, C | 1 |
| Lee, HJ; Lee, JH | 1 |
| Shiffman, S; Strecher, VJ; West, R | 2 |
| de Haes, JC; Dijkstra, A; Legemate, DA; Oort, FJ; Smets, EM; Wiggers, LC | 1 |
| Eid, NC; Fant, RV; Moolchan, ET; Pickworth, WB | 1 |
| Langsam, K; Westmaas, JL | 1 |
| Berlin, J; Bunin, G; Colilla, S; DeMichele, A; Jepson, C; Lerman, C; Rebbeck, TR; Rukstalis, M; Shields, PG; Strom, BL | 1 |
| Halcomb, KA | 1 |
| Glantz, SA; Ong, MK | 1 |
| Kerker, BD; Metzger, KB; Mostashari, F | 1 |
| Benowitz, NL; Boyle, P; Connolly, GN; Dresler, C; Fagerstrom, K; Gray, N; Henningfield, JE; Jarvis, MJ | 1 |
| DiMarino, ME; Gitchell, J; McNeill, A; West, R | 1 |
| Ahluwalia, JS; Catley, D; Davies, G; Hall, M; Nollen, NL | 1 |
| McMillan, DE; Williams, DK; Wiseman, EJ | 1 |
| Bellia, V; Bonsignore, MR; Catalano, F; Soresi, S; Spatafora, M | 1 |
| Cummings, KM; Hyland, AJ; Lawvere, S; Mahoney, MC; Murphy, JM | 1 |
| Coppel, E; Delarue, A; Demazières, A; Fleury, C; Gilles, C; Lagrue, G; Laur, C; Luthringer, R; Roegel, JC | 1 |
| Secko, D | 1 |
| Ang, R; Manji, H; Sharma, P; Wroe, S | 1 |
| Copeland, L; Elton, R; Robertson, R | 1 |
| Adler, M; Dautzenberg, E; Garelik, D; Nguyen, P | 1 |
| Fontaine, B | 1 |
| McNee, W; Metcalfe, S; Moodie, P | 1 |
| Culligan, K; Kosten, T; Mouratidis, M; Sofuoglu, M; Yoo, S | 1 |
| Camarelles Guillem, F | 1 |
| Eisenberg, MJ; Ludvig, J; Miner, B | 1 |
| Tsuda, K | 1 |
| Granger, RH | 1 |
| Barlow, DH; Gulliver, SB; Morissette, SB; Palfai, TP; Spiegel, DA | 1 |
| Allen, SS; Bade, T; Brintnell, DM; Hatsukami, D | 1 |
| Brown, RA; Kahler, CW; Lejuez, CW; Strong, DR; Zvolensky, MJ | 1 |
| Caron, L; Karkazis, K; Koenig, BA; Raffin, TA; Swan, G | 1 |
| Warner, DO | 2 |
| Brody, A; Cohen, MS; Domier, CP; Ernst, M; Jarvik, M; London, ED; Mendrek, A; Monterosso, J; Olmstead, R; Rodriguez, P; Simon, SL; Xu, J | 1 |
| Schroeder, SA | 1 |
| Barrett, S; Britton, J; Coleman, T; Coupland, C; Hippisley-Cox, J; Wilson, A | 1 |
| Berrettini, WH; Lerman, CE | 1 |
| Barrueco, M; Jiménez-Ruiz, C; Otero, MJ; Palomo, L; Riesco, JA; Romero, P; Torrecilla, M | 1 |
| Cullen, J; Hall, SM; Humfleet, GL; Mengis, M; Muñoz, R; Prochaska, JJ; Reus, V | 1 |
| Britton, J; Coleman, T; Herbert, R | 1 |
| Bauer, JE; Giovino, G; Hyland, A; Michael Cummings, K; Rezaishiraz, H | 1 |
| Babb, D; Hatsukami, D; Jensen, J; Mooney, M | 1 |
| Shoaib, M; Warner, C | 1 |
| Graul, AI; Prous, JR | 1 |
| Butterfield, RM; Emmons, KM; Gritz, ER; Li, FP; Mertens, A; Park, E; Puleo, E; Weeks, JC | 1 |
| Corbridge, SJ; Wilken, L | 1 |
| Berrettini, W; Epstein, LH; Hawk, L; Jepson, C; Kaufmann, V; Lerman, C; Niaura, R; Patterson, F; Restine, S; Rukstalis, M; Wileyto, EP | 1 |
| Hua, M; Perusco, A; Poder, N | 1 |
| Cortner, C; Koury, MA; Olmstead, RE; Patel, S; Pendergrass, R; Schneider, NG; Terrace, S; Vaghaiwalla, B | 1 |
| Bernath, A; Clark, MM; Croghan, GA; Croghan, IT; Dakhil, SR; Ebbert, LP; Garneau, S; Hurt, RD; Loprinzi, CL; Morton, RF; Novotny, P; Patten, CA; Rowland, KM; Sloan, JA; Stella, PJ; Thomas, SP; Tschetter, LK; Wender, DB; Wos, EJ | 1 |
| Britt, H; Doran, CM; Mattick, RP; Robinson, M; Valenti, L | 1 |
| Batra, A; Buchkremer, G; Collins, SE; Frittrang, T; Schröter, M | 1 |
| Ait-Daoud, N; Bienkowski, P; Johnson, BA; Lesch, OM; Li, MD; Pfützer, RH; Singer, MV; Wiesbeck, GA | 1 |
| Lerman, C; Perkins, KA; Stitzer, M | 1 |
| Harréus, UA; Kleinsasser, NH; Richter, E; Sassen, AW; Semmler, MP; Staudenmaier, R | 1 |
| Anderson, CM; Burns, DM; Reed, MB; Vaughn, JW | 1 |
| Baker, L; Quibell, R | 1 |
| Avasarala, S; Griffiths, AN; Roy, M; Wiener, JJ; Woolley, JL | 1 |
| Di Marino, ME; Shiffman, S; Sweeney, CT | 1 |
| Al-Delaimy, WK; Gilpin, EA; Pierce, JP | 1 |
| Cather, C; Culhane, MA; Deckersbach, T; Evins, AE; Freudenreich, O; Goff, DC; Green, MF; Henderson, DC; Rigotti, NA; Schoenfeld, DA | 1 |
| Cooney, NL; McKee, SA; O'Malley, SS; Toll, BA | 1 |
| Hughes, JR; Kalman, D | 1 |
| Goldberg, SR; Le Foll, B | 1 |
| Barnfather, KD; Chapple, IL; Cope, GF | 1 |
| Warner, KE | 2 |
| Coleman, T | 2 |
| Huang, CL | 1 |
| Abrams, K; Feldner, MT; Gibson, LE; Gregor, K; Leen-Feldner, EW; Zvolensky, MJ | 1 |
| Croghan, IT; Decker, PA; Hays, JT; Hurt, RD; Morris, RA; Offord, KP; Patten, CA | 1 |
| de Vries, H; Hoving, EF; Mudde, AN | 1 |
| Balabanis, MH; Ferguson, SG; Gwaltney, CJ; Shadel, WG; Shiffman, S | 1 |
| Borel, ML; Guevel-Jointret, AL; Mansourati, J; Munier, S | 1 |
| Berlin, I; Heilbronner, C | 1 |
| Glover, ED; Koslo, R; Niaura, R; Nides, M; Robbins, B; Sayette, M; Shadel, W; Shelanski, M; Shiffman, S; Sorrentino, J | 1 |
| Ferguson, SG; Gwaltney, CJ; Shiffman, S | 2 |
| Irie, S; Kikkawa, H; Sekiguchi, K; Sobue, S | 1 |
| Buchhalter, AR; Fant, RV; Gitchell, JG; Henningfield, JE; Shiffman, S | 1 |
| Bardo, MT; Dwoskin, LP; Rauhut, AS | 1 |
| Evans, M; Rashid, M; Ussher, M; West, R | 1 |
| Barenboim, E; Goldstein, L; Grossman, A; Landau, DA | 1 |
| Britton, J; Farrington, P; Godfrey, C; Hubbard, R; Lewis, S; Smeeth, L; Smith, C | 1 |
| Bulik, CM; Furberg, H; Lerman, C; Lichtenstein, P; Pedersen, NL; Sullivan, PF | 1 |
| de Vos, A; Fiore, M; Hatsukami, DK; Horwith, G; Jorenby, D; Koopmeiners, J; Pentel, PR; Rennard, S | 1 |
| Choi, JH; Dresler, CM; Gamble, ML; Marsh, HS; Strahs, KR; Targett, DA | 1 |
| Coelho, OR; Consolin Colombo, FM; Ferreira-Melo, SE; Irigoyen, MC; Moreno, H; Nogueira, EA; Sabha, M; Yugar-Toledo, JC | 1 |
| Steptoe, A; Ussher, M | 1 |
| Batra, A; Danielsson, T; Friederich, HM; Klingler, K; Landfeldt, B; Westin, A | 1 |
| Errard-Lalande, G | 1 |
| Anderson, C; Baile, W; Cinciripini, L; Cinciripini, PM; de Moor, C; Lam, C; Minna, JD; Tsoh, JY; Wetter, DW | 1 |
| Ahluwalia, JS; Catley, D; Hall, M; McCool, RM; Richter, KP | 1 |
| Bradford, D; Gitchell, J; Hyland, A | 1 |
| Kwatra, G; Maseeh, A | 1 |
| Burke, MV; Foulds, J; Richardson, DL; Shah, P; Steinberg, MB | 1 |
| Mahon, SM | 1 |
| Benowitz, NL; Jepson, C; Lerman, C; Malaiyandi, V; Patterson, F; Tyndale, RF | 1 |
| Ota, A; Takahashi, Y | 1 |
| Butler, PE; Chan, LK; Withey, S | 1 |
| Kosten, T; Mouratidis, M; Poling, J; Sofuoglu, M | 1 |
| Epstein, DH; Franken, FH; Moolchan, ET; Pickworth, WB | 1 |
| Le Faou, AL; Scemama, O | 1 |
| al'Absi, M | 1 |
| Johnson, NW; Lowe, JC; Warnakulasuriya, KA | 1 |
| McMurry, TB | 1 |
| Parker, DR | 1 |
| Alpar, S; Kurt, B; Orsel, O; Orsel, S; Sipit, T; Uçar, N | 1 |
| Aubin, HJ; Dupont, C; Lagrue, G; Luthringer, R; Staner, L | 1 |
| Salin-Pascual, RJ | 1 |
| Henningfield, JE; Zeller, M | 1 |
| Parrott, AC | 2 |
| Ceballos, NA; Lawton-Craddock, A; Nixond, SJ; Tivis, R | 1 |
| Foulds, J; Steinberg, MB; Williams, JM; Ziedonis, DM | 1 |
| Elliot, KM; Johnstone, EC; Lerman, C; Munafò, MR; Shields, PG; Wileyto, EP | 1 |
| Cormier, S; Diviné, C; Lagrue, G; Mautrait, C | 1 |
| Bouloukaki, I; Mitrouska, I; Siafakas, NM | 1 |
| Behm, FM; Kukovich, P; Rose, JE; Westman, EC | 1 |
| Domino, EF; Hatazawa, J; Kanno, I; Matsuoka, S; Nagata, K; Sato, M; Shinohara, T; Yokoyama, E | 1 |
| Burkett, JS | 1 |
| dePinho, MM; Esteves, GA; Otero, UB; Perez, Cde A; Szklo, AS; Szklo, M; Turci, SR | 1 |
| de Haes, HC; Legemate, DA; Oort, FJ; Peters, RJ; Smets, EM; Storm-Versloot, MN; van Loenen, LB; Vermeulen, H; Wiggers, LC | 1 |
| Bachmann, MF; Maurer, P | 2 |
| McNeil, C | 1 |
| Kjellberg, J; Møller, AM; Pedersen, T | 1 |
| Heasman, L; Heasman, PA; Nasry, HA; Preshaw, PM; Stacey, F; Swan, M | 1 |
| Bolin, K; Lindgren, B; Willers, S | 1 |
| Corelli, RL; Hudmon, KS | 2 |
| Anderson, BJ; Anthony, JL; Herman, DS; Niaura, R; Stein, MD; Weinstock, MC | 1 |
| Al-Delaimy, WK; Pierce, JP; White, MM | 1 |
| Durkin, S; Spittal, M; Wakefield, M | 1 |
| Blakeslee, A; Cooney, JL; Cooney, NL; Dubin, JA; Jatlow, P; Krishnan-Sarin, S; Makuch, R; McKee, SA; Meandzija, B; O'Malley, SS; Romano-Dahlgard, D; Wu, R | 1 |
| Matsuzaki, H; Nemoto, Y; Nishimura, T; Oda, H; Okawa, A; Tokuhasi, Y; Uematu, Y | 1 |
| Munafò, MR | 1 |
| Buffels, J; Decramer, M; Degryse, J; Heyrman, J | 1 |
| Adson, DE; al'absi, M; Brauer, LH; Bronars, CA; Candell, S; Finocchi, ME; Harris, J; Hatsukami, DK; Kotlyar, M; Robiner, W; Thuras, P | 1 |
| Keyler, DE; LeSage, MG; Pentel, PR | 1 |
| Ikinci, G; Senel, S; Sumnu, M; Tokgözoğlu, L; Wilson, CG | 1 |
| McClure, JB; Swan, GE | 1 |
| Dietz, A | 1 |
| Sachs, DP | 1 |
| Andreachi, M; Appel, D; Banauch, GI; Bars, MP; Kelly, KJ; Mouren, P; Prezant, DJ | 1 |
| Aytemur Solak, Z; Başoğlu, OK; Erdinç, E | 1 |
| Garvey, AJ; Kahler, CW; Kalman, D; Monti, PM | 1 |
| Butterfield, RM; Emmons, KM; Gritz, ER; Li, FP; Mertens, AC; Park, ER; Puleo, E; Zorn, M | 1 |
| Davidson, P | 1 |
| Dempsey, DA; Stewart, SL | 1 |
| Djulus, J; Einarson, A; Koren, G; Sarkar, M | 1 |
| Benowitz, NL; Le Houezec, J | 1 |
| Clark, DB; Dang, Q; Gwaltney, CJ; Paton, SM; Scharf, DM; Shadel, WG; Shiffman, S | 1 |
| Harada, H; Kanetaka, K; Nakai, S; Nakaide, K; Nakamura, Y; Suzuki, J | 1 |
| Ahluwalia, JS; Choi, WS; Kaur, H; Mayo, MS; Nollen, N; Okuyemi, K; Pulvers, K | 1 |
| Ebrahim, S; Lawlor, DA; Montaner, D; Schroeder, K | 1 |
| Durrant, R; Wakefield, M | 1 |
| Isse, T; Kagawa, N; Kawamoto, T; Kono, K; Oyama, T; Ozaki, S; Sugio, K; Uramoto, H; Yasumoto, K | 1 |
| Cornuz, J; Gilbert, A; McDonald, P; Paccaud, F; Pinget, C; Salto, E; Slama, K | 1 |
| Cummings, KM; Giovino, GA; Kozlowski, LT; O'Connor, RJ; Pauly, J; Whetzel, CA | 1 |
| Britton, J; Currie, GP; Srivastava, P | 1 |
| Buades-Sánchez, MR; Bustamante-Navarro, R; Castillo-Aguilar, C; Contreras-Santos, C; De la Cruz-Amorós, E; Pascual-Lledó, JF | 1 |
| Benowitz, N; Lerman, C; Patterson, F; Pinto, A; Shields, PG; Tyndale, R; Wileyto, EP | 1 |
| Cooney, J; Feinn, R; Kranzler, HR; Lando, H; Oncken, C | 1 |
| Aubin, HJ; Demazières, A; Dupont, C; Lagrue, G; Luthringer, R | 1 |
| Dautzenberg, B; Dureuil, B; Masquelet, AC | 1 |
| Carmody, TP; Simon, JA; Tong, EK | 1 |
| Chapman, S; Chiang, PP | 1 |
| Baile, WF; Carter, BL; Cinciripini, PM; de Moor, CA; Lam, C; Robinson, JD; Wetter, DW; Wu, X | 1 |
| Hatsukami, DK; Leventhal, AM; Mooney, ME | 1 |
| Moolchan, ET; Robinson, ML; Schroeder, JR | 1 |
| van Biljon, X | 1 |
| Ahluwalia, JS; Choi, WS; Kaur, H; Mayo, MS; Nollen, NL; Okuyemi, KS; Sanderson Cox, L | 1 |
| Anderson, BJ; Niaura, R; Stein, MD | 2 |
| Barbeau, EM; Davis, RB; Kawachi, I; Rigotti, NA; Shiffman, S; Tindle, HA | 1 |
| Cinciripini, PM; Lam, CY; Minnix, JA; Robinson, JD | 1 |
| Jaszyna-Gasior, M; Moolchan, ET; Schroeder, JR | 1 |
| Stalnikowicz, R | 1 |
| Meurice, JC; Paquereau, J; Underner, M | 1 |
| Borrayo, EA; Espinoza, P; Flores, ET; Levinson, AH; Pérez-Stable, EJ | 1 |
| Bauer, U; Carlin-Menter, S; Celestino, P; Cummings, KM; Fix, B; Frieden, TR; Hyland, A; Miller, N | 1 |
| Dake, JA; Jordan, TR; Price, JH | 2 |
| Mooney, ME; Sofuoglu, M | 1 |
| Boyce-Smith, G; Halpin, HA; McMenamin, SB; Rideout, J | 1 |
| Carter, BL; Cinciripini, PM; Lam, CY; Robinson, JD; Tiffany, ST; Wetter, DW | 1 |
| Chaud, MV; do Prado, JF; Ferreira-Melo, SE; Hyslop, S; Martins, LC; Moreno, H; Paganelli, MO; Sabha, M; Tanus-Santos, JE | 1 |
| Lea, RA; Lewis, A; Miller, JH | 1 |
| Upadhyaya, HP | 1 |
| Ferguson, SG; Hellebusch, SJ; Shiffman, S | 1 |
| Allen, TM; Easton, CJ; George, TP; McKee, SA; Reutenauer, EL; Sacco, KA; Termine, A; Vessicchio, JC; Weinberger, AH | 1 |
| Etter, JF; Stapleton, JA | 1 |
| An, LC; Joseph, AM; Kavanaugh, AM; Lachter, RB; Luxenberg, MG; Schillo, BA; Wendling, AH | 1 |
| Kotz, D; Wagena, EJ; Wesseling, G | 1 |
| Chaya, C; Cortner, C; Hartman, N; Kim, A; Kleinman, L; Koury, MA; Leaf, D; Olmstead, RE; Schneider, NG | 1 |
| Pbert, L | 1 |
| Bremann, L; Mikkelsen, K; Tønnesen, P | 1 |
| Cofta-Woerpel, L; Wetter, DW; Wright, KL | 2 |
| Malone, RE; Yerger, VB | 1 |
| Britton, J; Coleman, T; Godfrey, C; Lewis, S; Madeley, R; McNeill, A; Molyneux, A | 1 |
| Fish, LJ; Lipkus, IM; Lyna, P; Myers, ER; Namenek Brouwer, RJ; Oncken, CA; Peterson, BL; Pletsch, PK; Pollak, KI; Swamy, GK | 1 |
| Danielsson, T; Daughton, DM; Franzon, M; Glover, ED; Glover, PN; Landfeldt, B; Leischow, S; Muramoto, M; Rennard, SI; Westin, A | 1 |
| Snyder, M | 1 |
| Nehrling, C | 1 |
| Chang, CJ; Cho, YH; Kim, MS; Lee, KJ; Lee, MH | 1 |
| Berrettini, WH; Jepson, C; Lerman, C; Lynch, KG; O'Malley, S; Patterson, F; Perkins, K; Ray, R; Rukstalis, M; Strasser, A | 1 |
| An, LC; Fu, SS; Joseph, AM; Nelson, DB; Nugent, S; Partin, MR; Snyder, A; Willenbring, ML | 1 |
| Etter, JF; Etter, M | 1 |
| Britton, J; Challenger, A; Lewis, S; Roddy, E; Romilly, N | 1 |
| Gilpin, EA; Messer, K; Pierce, JP | 1 |
| Krishnan-Sarin, S; Mase, T; McKee, SA; O'Malley, SS; Shi, J | 1 |
| Benowitz, N; Cargill, A; Day, I; Hinks, L; Jacob, R; Johnstone, E; Murphy, M; Walton, R | 1 |
| Smith, SD | 2 |
| de la Blanchardière, A; Depieds, D; Gueyffier, F | 1 |
| Adelman, WP | 1 |
| Feldman, HR; Levin, RF; Singleton, JK; Truglio-Londrigan, M | 1 |
| Cummings, KM; Mahoney, M | 1 |
| Bleich, S; Kornhuber, J; Lunkenheimer, B; Lunkenheimer, J; Schlabeck, M; Sperling, W; Thuerauf, N; Wiltfang, J | 1 |
| Dicpinigaitis, PV; Sakalauskas, R; Sitkauskiene, B; Stravinskaite, K | 1 |
| Béguinot, E; Bohadana, A; Martinet, Y; Spinosa, A; Wirth, N | 1 |
| Green, C; Hatsukami, D; Mooney, M | 1 |
| Shanahan, M; Shearer, J | 1 |
| Adams, CE; Leonard, S | 1 |
| Baker, A; Carr, VJ; Haile, M; Jansons, S; Lewin, TJ; Richmond, R; Taylor, RL; Wilhelm, K | 1 |
| Brody, AL; Cohen, MS; Ernst, M; Jarvik, M; London, ED; Mendrek, A; Monterosso, J; Rodriguez, P; Simon, S; Xu, J | 1 |
| Kang, HY; Kim, YH; Seo, NS | 1 |
| Cnattingius, S; George, L; Granath, F; Johansson, AL | 1 |
| Coggins, CR; Lee, PN; Werley, MS | 1 |
| Baldi, JC; Borrie, K; Cameron, L; Grove, JR; Harper, T; Prapavessis, H; Robinson, S | 1 |
| Burstein, AH; Clark, DJ; Faessel, HM; Gibbs, MA; Rohrbacher, K; Stolar, M | 1 |
| Li, J; Shoptaw, S; Wu, Y; Yang, X | 1 |
| Axelsson, A; Bolliger, CT; van Biljon, X | 1 |
| Kosten, T; Mouratidis, M; Sofuoglu, M; Yoo, S | 1 |
| Hill, A | 1 |
| Houtsmuller, EJ; Juliano, LM; Stitzer, ML | 1 |
| Diehl, A; Mann, K | 1 |
| Cedzynska, M; Tutka, P; West, R; Zatonski, W | 1 |
| Breland, AB; Eissenberg, T; Kleykamp, BA | 1 |
| Boscia, J; Chow, MY; Frampton, MW; Hyde, RW; O'Mara, RE; Perillo, I; Pietropaoli, A; Smith, CJ; Stewart, JC; Torres, A; Utell, MJ | 1 |
| Kumar, A; Kumar, JC; Mallya, KB | 1 |
| de Haes, HC; Legemate, DA; Oort, FJ; Peters, RJ; Smets, EM; Storm-Versloot, MN; Vermeulen, H; Wiggers, LC | 1 |
| Bisaga, A; Garawi, F; Haney, M; Padilla, M; Sullivan, MA | 1 |
| Fava, JL; Friedman, RH; Gulliver, SB; Keller, S; Prochaska, JO; Ramelson, H; Sun, X; Velicer, WF | 1 |
| Dimoulas, P; Mills, EJ; Wilson, K; Wu, P | 1 |
| Chambers, LK; Coe, JW; Glowa, J; Hurst, RS; Lebel, LA; Lu, Y; Mansbach, RS; Mather, RJ; Rollema, H; Rovetti, CC; Sands, SB; Schaeffer, E; Schulz, DW; Tingley, FD; Williams, KE | 1 |
| Carmella, SG; Hatsukami, DK; Hecht, SS; Joseph, AM; Le, CT; Mooney, ME; Zhang, Y | 1 |
| Górecka, D; Grzelewska-Rzymowska, I; Jankowska, R; Jassem, E; Kozielski, J; Milanowski, J; Nizankowska-Mogilnicka, E; Słomiński, JM; Zieliński, J | 1 |
| Burgess, D; Fu, SS; Hatsukami, DK; Joseph, AM; Solomon, J; van Ryn, M | 1 |
| Lerman, C; Munafò, M | 1 |
| Chen, TT; Cinciripini, PM; Lam, CY; Minna, JD; Minnix, JA; Robinson, JD; Tomlinson, GE; Wetter, DW | 1 |
| Batra, A; Croissant, B; Diehl, A; Mann, K; Nakovics, H; Smolka, MN | 1 |
| Horton, K; Lawrence, S; Levin, ED; Petro, A; Seidler, FJ; Slotkin, TA | 1 |
| Britton, J; Coleman, T; Coughtrie, MW; Godfrey, C; Lewis, S; Mannion, C; Marlow, N; Thornton, J; Watts, K | 1 |
| Siu, EC; Tyndale, RF | 1 |
| Donny, EC; Houtsmuller, E; Stitzer, ML | 1 |
| Ho, MK; Tyndale, RF | 1 |
| Elliot, KM; Johnstone, EC; Munafò, MR; Murphy, MF; Walton, RT | 1 |
| Andrews, JO; Ellen Wewers, M; Felton, G; Tingen, M; Waller, J | 1 |
| Beamonte, A; Gargallo, P; Jiménez-Muro, A; Marqueta, A; Nerín, I | 1 |
| Bergström, E; de Vries, H; Panday, S; Reddy, SP; Ruiter, RA | 1 |
| Duquet, N | 1 |
| Ball, D; Breen, G; Guindalini, C; Neale, B; O'Gara, C; Stapleton, J; Sutherland, G | 1 |
| Babb, D; Hatsukami, D; Hecht, S; LeSage, M; Mooney, M; Murphy, S | 1 |
| Foulds, J; Williams, JM | 1 |
| Hanke, W; Ligocka, D; Lowe, J; Polańska, K; Sobala, W | 1 |
| Czogała, J; Goniewicz, ML; Koszowski, B; Zymełka, A | 1 |
| Kurpas, D; Steciwko, A | 1 |
| Baker, A; Carr, VJ; Constable, PM; Haile, M; Jansons, S; Lewin, TJ; Moeller-Saxone, K; Richmond, R; Taylor, RL; Wilhelm, K | 1 |
| Bernath, A; Croghan, GA; Croghan, IT; Dakhil, SR; Ebbert, LP; Flynn, KA; Garneau, SC; Hurt, RD; Le-Lindqwister, NA; Loots, ML; Loprinzi, CL; Novotny, PJ; Rowland, KM; Sloan, JA; Tschetter, LK; Wender, DB | 1 |
| Creeden, CL; George, TP; Jatlow, PI; Sacco, KA; Vessicchio, JC; Weinberger, AH | 1 |
| Chandra, S; Dang, Q; Scharf, DM; Shadel, WG; Shiffman, S | 1 |
| Ahluwalia, JS; Cox, LS; Etter, JF; Kaur, H; Mayo, MS; Nazir, N; Okuyemi, KS; Pulvers, KM; Thomas, JL | 1 |
| Nagai, A; Tsuji, T | 1 |
| Krishnan-Sarin, S; McKee, SA; O'Malley, SS; Schepis, TS; Toll, BA | 1 |
| Gracia, MC | 1 |
| Carreras Castellet, JM; Fletes Dóniga, I; Quesada Laborda, M; Sánchez Agudo, L; Sánchez Torrecilla, B | 1 |
| Houfflin-Debarge, V | 1 |
| Flammino, F; Palamar, J; Raghavan, S; Reid, MS | 1 |
| Campbell, JL; Moody, RC; White, AR | 1 |
| Augustson, EM; Benowitz, NL; Mabry, PL; Malcolm, RJ; Moser, RP; Tooze, JA | 1 |
| Ames, SC; Echols, JD; Fredrickson, PA; Hurt, RD; Patten, CA; Pennebaker, JW; Schroeder, DR; Stevens, SR; Werch, CE | 1 |
| David, SP; Johnstone, EC; Munafò, MR; Murphy, MF; Walton, RT | 1 |
| Froeliger, B; Gilbert, DG; McClernon, FJ; Rabinovich, NE; Sugai, C; Zuo, Y | 1 |
| Calderón-Ezquerro, C; Drucker-Colín, R; Moreno-Coutiño, A | 1 |
| Ait-Daoud, N; Breland, AB; Johnson, BA; Lynch, WJ; Marzani-Nissen, GR; Penberthy, JK | 1 |
| Alonso Díaz, A; Barrueco Ferrero, M; Hernández Mezquita, MA; Jiménez Ruiz, CA; Morales Sánchez, A; Plaza Martín, D; Torrecilla García, M | 1 |
| David, SP; Johnstone, EC; Munafò, MR; Murphy, MF; Proctor, M; Walton, RT | 1 |
| Astray Mochales, J; Dale, LC; de Granda Orive, I; Guirao García, A; Jiménez-Ruiz, CA; Velázquez Buendía, L | 1 |
| Kollins, SH; Kozink, RV; Lutz, AM; McClernon, FJ; Pettiford, J; Rose, JE | 1 |
| Barnett, BC; Feuer, RM; Hatsukami, DK; Kotlyar, M; Li, ZZ; Mendoza-Baumgart, MI; Pentel, PR; Smith, EA | 1 |
| Oberpichler-Schwenk, H | 1 |
| Etter, JF; Laszlo, E | 1 |
| Anderson, BJ; Anthony, JL; Stein, MD; Weinstock, MC | 1 |
| Heishman, SJ; Moolchan, ET; Myers, CS; Taylor, RC | 1 |
| Damaj, MI; Kota, D; Martin, BR; Robinson, SE | 1 |
| Berlin, I; Gasior, MJ; Moolchan, ET | 1 |
| Khan, N; Quantz, D; Tootoosis, J; Wardman, D | 1 |
| Jatlow, P; Martin, DJ; McKee, SA; O'Malley, SS; Toll, BA | 1 |
| Dallery, J; Glenn, IM | 1 |
| Guthmiller, JM; Johnson, GK | 1 |
| Crane, R | 1 |
| Alexander, A; Aveyard, P; Brown, K; Johnstone, E; Munafò, MR; Murphy, M; Saunders, C | 1 |
| Garg, S; Kumar, G | 1 |
| Edwards, R; Grigg, M; Li, J; Sertsou, G; Thomson, G; Wilson, N | 1 |
| Burri, M; Etter, JF; Stapleton, J | 1 |
| Beckman, M | 1 |
| Christen, AG; Glover, ED; Glover, PN; Laflin, MT; Nides, M; Schuh, KJ; Schuh, LM; Strnad, JV | 1 |
| Goletiani, N; Mello, NK; Mendelson, JH; Sholar, MB; Siegel, AJ | 1 |
| Chiang, CY; Enarson, DA; Slama, K | 1 |
| Bayram, N; Dikensoy, O; Ekinci, E; Elbek, O; Filiz, A; Herken, H; Topcu, A; Uyar, M | 1 |
| Hill, KP; Mooney, M; Sofuoglu, M; Yoo, S | 1 |
| Carpenter, MJ; LaRowe, SD; Saladin, ME; Upadhyaya, HP | 1 |
| Garelik, D | 1 |
| David, SP; Elliot, KM; Johnstone, EC; Munafò, MR; Murphy, MF; Walton, RT | 1 |
| Benowitz, N; Jepson, C; Lee, AM; Lerman, C; Shields, PG; Tyndale, RF | 1 |
| Ismail, H | 1 |
| Fraser, R; Lubman, DI; Olivier, D | 1 |
| Borrelli, B; Novak, SP | 1 |
| Krishnan-Sarin, S; McKee, SA; O'Malley, SS; Salovey, P; Toll, BA | 1 |
| Paul, CL; Turner, R; Tzelepis, F; Walsh, RA | 1 |
| MacDonald, S; Moore, L; Rothwell, H | 1 |
| West, R; Zhou, X | 1 |
| Behm, FM; Hiott, FB; Liu, J; McClernon, FJ; Rose, JE; Salley, AN | 1 |
| Katulak, NA; O'Malley, S; Toll, BA; Williams-Piehota, P | 1 |
| Ahluwalia, JS; Choi, WS; Mayo, MS; Nollen, N; Okuyemi, KS; Resnicow, K; Richter, K | 1 |
| Lerman, C; Ray, R; Schnoll, RA | 1 |
| Harada, H; Kanetaka, K; Nakai, S; Nakaide, K; Nakamura, Y; Suzuki, J; Tsuji, M | 1 |
| Garwood, CL; Potts, LA | 1 |
| Aveyard, P; West, R | 1 |
| Fucito, LM; Juliano, LM | 1 |
| Birnbaum, A; Cather, C; Culhane, MA; Evins, AE; Freudenreich, O; Goff, DC; Henderson, DC; Horowitz, J; Hsieh, E; Rigotti, NA; Schoenfeld, DA | 1 |
| Ho, SW; Murphy, SE; Villalta, P; von Weymarn, LB | 1 |
| Bertram, MY; Lim, SS; Vos, T; Wallace, AL | 1 |
| Freedman, R | 1 |
| Arabi, Z | 1 |
| Evatt, DP; Greenstein, JE; Kassel, JD; Veilleux, JC; Wardle, MC; Yates, MC | 1 |
| Choudhury, SR; Croucher, R | 1 |
| Chouaid, C; Trosini-Desert, V | 1 |
| Bovbjerg, DH; Erblich, J; Tong, C | 1 |
| Delnevo, CD; Steinberg, MB | 1 |
| Enderby, B; Lenney, W | 1 |
| Allen, DL; Benowitz, NL; Bryan, A; Filbey, FM; Haughey, HM; Hutchison, KE; Jepson, C; Lerman, C; McGeary, J; Stitzel, J | 1 |
| Benowitz, NL; Dresler, CM; Etter, JF; Lukas, RJ; West, R | 1 |
| Croghan, E | 1 |
| Mooney, M; Sofuoglu, M; Waters, AJ | 1 |
| Barnett, P; Biemans, R; Gallagher, T; Mettens, P; Monteyne, P; Oliver, JL; Palmantier, R; Pashmi, G; Ramaya, S; Wonnacott, S | 1 |
| Brouwer, RJ; Fish, L; Heine, RP; Lipkus, IM; Lyna, P; Myers, ER; Oncken, CA; Peterson, BL; Pletsch, PK; Pollak, KI; Swamy, GK | 1 |
| Agrawal, S; Grant, KM; Kelley, SS; Meyer, JR; Romberger, DJ; Smith, LM | 1 |
| Felix, DH; Naudi, KB | 1 |
| Foerster, V; Murtagh, J | 1 |
| Boysun, MJ; Dent, C; Dilley, JA; Maher, JE; Pickle, KE; Pizacani, B; Rohde, K; Stark, MJ; Thompson, JR; Yepassis-Zembrou, P | 1 |
| Barry, MB; Li, Q; Pauly, J | 1 |
| Lechi, A; Lugoboni, F; Mezzelani, P; Pajusco, B; Quaglio, G | 1 |
| Johnson, TA; Lerman, C; Schnoll, RA | 1 |
| Britton, J; Edwards, R | 1 |
| Shiffman, S; Sweeney, CT | 1 |
| Lerman, C; Patterson, F; Schnoll, RA | 1 |
| Arfken, C; Brady, R; Burgess, C; Fallon, B; Flammino, F; Giordano, L; Jiang, H; Kourniotis, E; Lima, J; Nunes, EV; Pihlgren, E; Reid, MS; Robinson, J; Rotrosen, J; Sonne, S; Starosta, A | 1 |
| Cummings, KM; Hyland, A; Mahoney, MC; O'Connor, RJ; Rezaishiraz, H | 1 |
| Berrettini, W; Dahl, JP; Jepson, C; Lerman, C; Patterson, F; Pinto, A; Ray, R; Rukstalis, M; Wileyto, EP | 1 |
| Pauly, JR | 1 |
| Hotta, K; Imai, A; Kinumi, K; Kobayashi, M; Kuroki, K; Miura, H; Naito, K; Ogura, T; Ohnishi, M; Sakane, H; Takahashi, Y; Tobe, K | 1 |
| Borchers, AT; Gershwin, ME; Keen, CL | 1 |
| Doggrell, SA | 1 |
| Bristow, ZM; Ortiz, M; Rodriguez, JC; Sias, JJ; Urquidi, UJ | 1 |
| Benowitz, NL; Dempsey, D; Hall, SM; Jacob, P; Stewart, S; Wilson, M | 1 |
| Gulick, EE; Kim, SH; Kim, SS; Seo, HG | 1 |
| Hoogendoorn, M; Rutten-van Mölken, MP; Welsing, P | 1 |
| Lerman, CE; Munafò, MR; Schnoll, RA | 1 |
| Milbrandt, A; Ratcliffe, M; Smith, R; Spirling, LI; Stapleton, JA; Sutherland, G; Watson, L | 1 |
| Hwang, SS; Myung, SK; Oh, SW; Park, SH; Park, SK; Seo, HG; Yoo, KY | 1 |
| Andreas, S; Felten, D; Hasenfuss, G; Neubert, K; Raupach, T; Shahab, L | 1 |
| Novotny, TE; Schneider, NK | 1 |
| Fitzgerald, DP; Kollins, SH; Lutz, AM; McClernon, FJ; Murray, DW; Redman, C; Rose, JE | 1 |
| Biener, L; Levy, DE; Rigotti, NA; Thorndike, AN | 1 |
| Lindström, M | 1 |
| Lichtenstein, E | 1 |
| Haskins, AE; Woods, SS | 1 |
| An, LC; Christenson, M; Lachter, R; Luxenberg, MG; Saul, J; Schillo, BA; Wendling, A | 1 |
| Sweeney, CT; Tinkelman, D; Willett, J; Wilson, SM | 1 |
| Fellows, JL; Hollis, JF; McAfee, TA; Riedlinger, K; Stark, M; Zbikowski, SM | 1 |
| Bush, T; Dickerson, J; Fellows, JL; McAfee, T | 1 |
| Difranza, JR | 2 |
| Hatsukami, DK; Hecht, SS; Jensen, J; Le, C; Mendoza-Baumgart, MI; Murphy, S; Tulunay, OE; Zhang, Y | 1 |
| Cohen, AF; Dubois, EA; van Bronswijk, H; Zitman, FG | 1 |
| Cropsey, KL; Heckman, CJ; Ingersoll, KS | 1 |
| Belluzzi, JD; Fallon, JH; Gehricke, JG; Jamner, LD; Leslie, FM; Loughlin, SE; Potkin, SG; Whalen, CK | 1 |
| Andrews, JO; Bennett, SM; Heath, JH | 1 |
| Spangler, JG | 1 |
| Baker, CL; Bushmakin, AG; Cappelleri, JC; West, R | 1 |
| Allen, TM; Creeden, CL; Dudas, MM; Feingold, A; George, TP; Jatlow, PI; Potenza, MN; Sacco, KA; Vessicchio, JC; Weinberger, AH | 1 |
| Kim, DJ; Kim, JA; Kim, MY; Kim, Y; Lee, DH; Myung, SK; Nam, MH; Oh, SW; Park, S; Seo, HG; Seong, MW | 1 |
| Amor, C; Cortner, C; Gould, JL; Hartman, N; Justice, M; Kleinman, L; Olmstead, RE; Schneider, NG | 1 |
| de Vos, A; Horwith, G; van Schayck, CP; Wagena, EJ | 1 |
| David, SP; Johnstone, EC; Munafò, MR; Welton, NJ | 1 |
| Boyle, KJ; De Civita, P; Neumann, JE; Parmeter, CF; Paterson, RW | 1 |
| Otero, UB; Szklo, AS | 1 |
| Al-Omran, M | 1 |
| Aalto-Setälä, V; Alaranta, A | 1 |
| Cooley, ME; Murphy, M; Sarna, L; Sipples, RL | 1 |
| Ahluwalia, JS; Cox, LS; Cupertino, PA; Ellerbeck, EF; Greiner, AK; Nazir, N; Richter, KP | 1 |
| Chang, Y; Park, ER; Regan, S; Rigotti, NA | 1 |
| Allen, S; Hanson, K; Hatsukami, DK; Li, Z; Zylla, E | 1 |
| Bullen, C; Lancaster, T; Mant, D; Perera, R; Stead, LF | 1 |
| Aubin, HJ; Billing, CB; Bobak, A; Britton, JR; Gong, J; Oncken, C; Reeves, KR; Williams, KE | 1 |
| Argyropoulou, P; Boutou, AK; Kontou, PK; Pataka, A; Pitsiou, GG; Tsiata, EA | 1 |
| Doran, CM; Hall, WD; Lutsenko, H | 1 |
| Brendryen, H; Kraft, P | 1 |
| Macara, AW | 1 |
| Battista, V; Fanua, SP; Shaw Wilgis, EF | 1 |
| Blalock, JA; Cinciripini, PM; Robinson, JD; Schreindorfer, LS; Wetter, DW | 1 |
| Froelicher, ES; Malone, RE; McGruder, C; Wertz, M; Yerger, VB | 1 |
| Burns, EK; Levinson, AH | 1 |
| Childress, AR; Ehrman, R; Franklin, TR; Harper, D; Lynch, KG; O'Brien, CP; Sciortino, N | 1 |
| Carpenter, MJ; Larowe, SD; Leinbach, AS; Saladin, ME; Upadhyaya, HP | 1 |
| Huang, CL; Lin, HH; Wang, HH | 1 |
| Gvinianidze, K; Hammond, K; Novotny, T; Schick, S; Tsereteli, D | 1 |
| Blank, MD; Eissenberg, T; Sams, C; Weaver, MF | 1 |
| Ahluwalia, JS; Clothier, BA; Fu, SS; Joseph, AM; Nelson, DB; Okuyemi, KS; Partin, MR | 1 |
| Gorecki, JA; Hall, SM; Humfleet, GL; Muñoz, RF; Prochaska, JJ; Reus, VI | 1 |
| Kerrin, K; Lerman, C; Patterson, F; Wileyto, EP | 1 |
| Campbell, LA; Kisely, S | 1 |
| Naughton, F; Prevost, AT; Sutton, S | 1 |
| Nides, M | 1 |
| Guessous, I; Gwinn, M; Khoury, M | 1 |
| Bevins, RA; Sanderson, SD; Wilkinson, JL | 1 |
| Heavner, KK; Phillips, CV | 1 |
| Wonnacott, S | 1 |
| Burke, MV; Ebbert, JO; Hays, JT | 1 |
| Benowitz, N; Epstein, LH; Hawk, LW; Lerman, C; Patterson, F; Pinto, A; Schnoll, RA; Shields, PG; Tyndale, RF; Wileyto, EP | 1 |
| Briski, JL; Chengappa, KN; Fonte, CA; Lerman, C; Perkins, KA; Scott, JA; Stitzer, M | 1 |
| Brown, RA; Gifford, EV; Hayes, SC; Kahler, CW; Lejuez, CW; Palm, KM; Strong, DR; Wilson, KG; Zvolensky, MJ | 1 |
| Marris, E | 1 |
| Harvey, I; Lilford, R; Song, F | 1 |
| Bielska, D; Kurpas, D; Litwiejko, A; Trofimiuk, E | 1 |
| Balkissoon, RC; Dickinson, WP; Glasgow, RE; Hammond, SK; Rankin, AE; Szefler, SJ; Wamboldt, FS | 1 |
| Bedford, K; Carroll, T; Hua, M; Maunsell, T; Rissel, C; Wallace, C | 1 |
| Althabe, F; Belizán, JM; Buekens, P; Colomar, M; Gibbons, L | 1 |
| Garvey, AJ; Hartley, HL; Kinnunen, T; Korhonen, T; Leeman, RF; Quiles, ZN; Terwal, DM | 1 |
| Barrueco Ferrero, M; De Granda Orive, JI; Fagerström, KO; Grávalos Guzmán, J; Jiménez-Ruiz, CA; Pérez Trullén, A; Ramos Casado, L; Ramos Pinedo, A; Riesco Miranda, JA; Solano Reina, S | 1 |
| Cortner, C; Gould, JL; Koury, MA; Olmstead, RE; Schneider, NG | 1 |
| David, SP; Munafò, MR | 1 |
| Aveyard, P; Fillingham, S; Johnson, C; Murphy, M; Parsons, A | 1 |
| Botello-Harbaum, M; Covey, LS; Fried, J; Glassman, AH; LoDuca, C; Masmela, J; Salzman, V | 1 |
| Cerny, EH; Cerny, T | 1 |
| Alda, M; Andrés, E; Crucelaegui, A; García Campayo, J; Magallón, R; Mas, A; Sanz, B; Sobradiel, N | 1 |
| Crawford, JT; Goldenberg, RL; Tolosa, JE | 1 |
| Brees, DJ; Cai, JH; Elwell, MR; Finkelstein, MB; Jakowski, AB; Sands, SB; Shen, AC; Tingley, FD | 1 |
| Bülow, J; Gottrup, F; Hemmingsen, U; Jørgensen, S; Loft, S; Petersen, LJ; Sørensen, LT | 1 |
| Gan, Q; Hammond, SK; Hu, TW; Jiang, Y; Yang, Y | 1 |
| Aubin, HJ; Forget, B; Goldberg, SR; Le Foll, B | 1 |
| Seijas, D; Tamblay, N | 1 |
| Derr, D; Hollm, R; Ibrahim, J; Zanis, DA | 1 |
| Baker, C; Boler, A; Howard, P; Knight, C | 1 |
| al'Absi, M; Shaw, D | 1 |
| Alanko, J; Mucha, I; Parviainen, M; Riutta, A; Saareks, V; Vapaatalo, H | 1 |
| Foulds, J; Ghodse, AH | 1 |
| Baker, TB; Croghan, IT; Fiore, MC; Hays, JT; Hurt, RD; Jorenby, DE; Lewis, SF; Offord, KP; Smith, SS | 1 |
| Croghan, IT; Dale, LC; Hurt, RD; Lawson, GM; Offord, KP; Schroeder, DR | 1 |
| Henningfield, JE | 3 |
| Jarvis, MJ | 1 |
| Pomerleau, CS; Pomerleau, OF | 1 |
| Henningfield, JE; Woodson, PP | 1 |
| Bobo, JK; Hoffman, AL; Slade, J | 1 |
| Fagerström, KO; Leischow, SJ; Lunell, E; Molander, L | 1 |
| Cinciripini, PM; Kitchens, K; Lapitsky, L; Seay, S; Van Vunakis, H; Wallfisch, A | 1 |
| Fortmann, SP; Killen, JD | 2 |
| Howard, TS; Hughes, JR | 1 |
| Hein, H; Jugert, C; Kirsten, D; Magnussen, H | 1 |
| Gross, TM; Jarvik, ME; Rosenblatt, MR; Stein, RE | 1 |
| Sudan, BJ | 1 |
| Fagerström, KO; Franco, R; Herrera, L; Herrera, N; Partidas, A; Rolando, R | 1 |
| Forbes, A; Gourlay, SG; Marriner, T; McNeil, JJ; Pethica, D | 2 |
| Rosenberg, A | 2 |
| Heberlein, I; Vieregge, P | 1 |
| Mizuno, A; Nagashima, S; Nakamura, M; Oshima, A; Uematsu, T | 1 |
| Crowley, TJ; Macdonald, MJ; Walter, MI | 1 |
| Lauger, G; McGhan, WF; Smith, MD | 1 |
| Benowitz, NL; Fitzgerald, GA; Wilson, M; Zhang, Q | 1 |
| Bailey, D; Butschky, MF; Henningfield, JE; Pickworth, WB | 1 |
| Pérez Trullén, A | 1 |
| Kottke, TE; Solberg, LI | 1 |
| Farkas, AJ; Gilpin, E; Pierce, JP | 1 |
| Steele, C | 1 |
| White, DR | 1 |
| Gilbert, DG; Jensen, RA; Martinko, JM; Meliska, CJ; Stunkard, ME | 1 |
| Jarvis, MJ; Stolerman, IP | 1 |
| Asmussen, I | 1 |
| Enright, PL; Fagerström, KO; Hurt, RD; Lauger, GG; Marusić, Z; Offord, KP; Scanlon, PD | 1 |
| Foulds, J; Toone, B | 1 |
| Boutsen, M; Dramaix, M; Gustavsson, G; Kornitzer, M; Thijs, J | 1 |
| Prignot, J | 1 |
| Haxby, DG | 1 |
| Baluch, WM | 1 |
| Gauen, SE; Lee, NL | 1 |
| Behm, FM; Rose, JE; Westman, EC | 2 |
| Fagerström, KO; Kunze, M; Schoberberger, R | 1 |
| Fagerström, KO; Tönnesen, P | 1 |
| Burling, TA; Gaither, DE; Seidner, AL | 1 |
| Lumley, MA; Pomerleau, CS; Pomerleau, OF; Tate, JC | 1 |
| de Vries, AG; Festen, JM; Ottervanger, JP; Stricker, BH | 1 |
| Brunton, SA | 1 |
| Audrain, JE; Klesges, LM; Klesges, RC | 1 |
| Balabanova, S; Krupienski, M | 1 |
| Wallbank, IW | 1 |
| Fernö, O | 1 |
| Glover, ED | 2 |
| McKenna, JP | 1 |
| Swartz, SH | 1 |
| Haxby, D; Toffler, WL | 1 |
| Benowitz, NL; Faix, D; Hellerstein, MK; Hoh, R; LaBua, A; Neese, RA; Pun, K | 1 |
| Gross, TM; Jarvik, ME; Rosenblatt, MR | 1 |
| Bucher, H; Gutzwiller, F | 1 |
| Nørregaard, J; Petersen, L; Tønnesen, P | 2 |
| Bickel, WK; Higgins, ST; Hughes, JR | 2 |
| Buist, AS; Hess, DL; Istvan, JA; Voelker, H | 1 |
| Saenghirunvattan, S | 1 |
| Cogswell, BE | 1 |
| Rosen, RJ | 1 |
| Martin, PD; Robinson, GM | 1 |
| Anderson, J; Tejwani, GA; Wewers, ME | 1 |
| Goldstein, AO; Ives, TJ | 1 |
| Galí, N; Gayta, R; Navas, E; Plans, P; Rodríguez, G; Salleras, L; Taberner, JL; Tarín, A | 1 |
| Fagerström, KO; Lunell, E; Schneider, NG | 1 |
| Arnall, C; Warburton, DM | 1 |
| Richardson, GS | 1 |
| Feyerabend, C; Gustavsson, G; Russell, MA; Sawe, U; Stapleton, JA; Wiseman, D; Wiseman, SM | 1 |
| Abrams, DB; Emmons, KM; Hammond, SK | 1 |
| Hall, SM; Muñoz, RF; Reus, VI; Sees, KL | 1 |
| Fowler, G; Lodge, M; Mant, D; Silagy, C | 2 |
| Frances, RJ; Glazer, WM; Kosten, TR; Ziedonis, DM | 1 |
| Schmitz, JM; Tate, JC | 1 |
| Taylor, SA | 1 |
| Cormier, S; Lagrue, G; Mainguy, M; Roullet-Volmi, MC | 1 |
| Biernbaum, RM; Cummings, KM; Deloughry, T; Jaén, CR; Zevon, MA | 1 |
| Connett, J; Dolce, J; Murray, R; Nides, M; O'Hara, P; Rand, C; Voelker, H | 1 |
| Ringbeck, DM | 1 |
| Franzon, M; Hjalmarson, A; Westin, A; Wiklund, O | 1 |
| Crews, KM; Johnson, L; Nichols, M | 1 |
| Lahad, A | 1 |
| Austoker, J; Fowler, G; Sanders, D | 1 |
| Delcore, MG; Hilleman, DE; Mohiuddin, SM | 1 |
| Odd, RW | 1 |
| West, R | 3 |
| Baker, PJ | 1 |
| Schwartz, K | 1 |
| de Almeida Neto, A; Harris, K; Richmond, RL | 1 |
| Behm, FM; Levin, ED; Ripka, GV; Rose, JE; Stein, RM; Westman, EC | 1 |
| Heatherton, T; Kozlowski, LT; Orleans, CT; Pope, MA; Porter, CQ | 1 |
| Chaisson, RE | 1 |
| Allen, SS; Gorsline, J; Hatsukami, D | 1 |
| Goldberg, RJ; Hebert, JR; Kalan, K; Kristeller, J; Landon, J; Luippold, R; Ockene, JK; Pbert, L | 1 |
| Downey, K; Lumley, MA; Pomerleau, OF; Stettner, L; Wehmer, F | 1 |
| Alegría, E; Aparici, M; Fernández González, AL | 1 |
| Flórez, S; Jiménez Ruiz, CA; Ramos, A; Ramos, L; Solano Reina, S | 1 |
| Gagné, M; Gervais, A; Juneau, M; Laforte, R; Lemoine, C; Ostiguy, G; Perreault, D; Robitaille, M; Taillefer, J; Xhignesse, M | 1 |
| Benazzi, F; Mazzoli, M | 1 |
| Costello, J; Feyerabend, C; Fleming, T; Foulds, J; Hayward, M; Russell, MA; Stapleton, J | 1 |
| Cerisier, A; Dacosta, A; Denis, L; Gonthier, R; Guy, JM; Lamaud, M; Tardy, B; Verneyre, H | 1 |
| Hatterer, J; Pine, DS | 1 |
| Paradiso-Hardy, F | 1 |
| Fabregat, A; Monsó, E; Morera, J; Pujol, E; Rosell, A; Ruiz, J | 1 |
| Behm, FM; Carnahan, E; Herman, S; Levin, ED; Rose, JE; Sanchez, M; Stein, RM; Westman, EC | 1 |
| Alsagoff, F; Lee, HP | 1 |
| Alberisio, A; Fowler, G; Hirsch, A; Lagrue, G; Malvezzi, I; Manley, M; Molimard, R; Slama, K; Tonnesen, P | 1 |
| Li Wan Po, A | 1 |
| Warburton, DM | 1 |
| Richmond, R | 2 |
| Spilich, GJ | 1 |
| Parrott, A | 1 |
| Eiff, MP; Haxby, D; McQueen, MH; Sinclair, A; Toffler, WL | 1 |
| Brigham, J; Felch, LJ; Gross, J; Stitzer, ML | 1 |
| Law, M; Tang, JL; Wald, N | 1 |
| Antonuccio, D | 1 |
| Ferentz, KS; Valente, CM | 1 |
| Pomerleau, CS; Pomerleau, OF; Tate, JC | 1 |
| Ehrlich, E; Flessland, KA; Marks, JL; Pomerleau, CS; Pomerleau, OF; Tate, JC | 1 |
| Clarke, PB | 1 |
| Pierce, JR | 1 |
| Mendelsohn, C; Richmond, R | 1 |
| Ockene, JK; Orleans, CT | 1 |
| Battaglia, C; Bobrie, G; Loufrani, E; Ménard, J | 1 |
| Jenkusky, SM | 1 |
| Levin, ED; Rose, JE; Westman, EC | 1 |
| Behm, F; Carnahan, E; LeClair, R; Levin, ED; Rose, JE; Shipley, R | 1 |
| Huber, T; Keller-Stanislawski, B; Merz, PG; Rietbrock, N; Woodcock, BG | 1 |
| Slade, J | 1 |
| Cooper, TB; Covey, LS; Dalack, GW; Fleiss, J; Glassman, AH; Rivelli, SK; Stetner, F | 1 |
| Färm, G | 1 |
| Gourlay, S | 1 |
| Baker, TB; Fiore, MC; Jorenby, DE; Kenford, SL; Smith, SS; Wetter, D | 1 |
| Caldwell, CC; Dale, LC; Fredrickson, PA; Hurt, RD; Lauger, GG; Lee, GA; Lundberg, TG; Marŭsić, Z; Neese, LW; Offord, KP | 1 |
| Brown, TV; Keintz, MK; Noll, E; Orleans, CT; Resch, N; Rimer, BK; Snedden, TM | 1 |
| Knutson, D; Lickteig, S; Remington, PL; Yoast, R | 1 |
| Baker, TB; Fiore, MC; Jorenby, DE; Kenford, SL; Smith, SS; Wetter, DW | 2 |
| Hughes, JR; Oliveto, AH | 1 |
| Petty, TL | 1 |
| Spiers, AS | 1 |
| Goldstein, A | 1 |
| Kehoe, L; Richmond, RL; Webster, IW | 1 |
| Gora, ML | 1 |
| Gilbert, DD | 1 |
| McKay, F | 1 |
| Jerrett, W | 1 |
| Cocores, JA; Miller, NS | 1 |
| Cirone, M; Cusano, F; Guarrera, M; Tosti, A; Vincenzi, C | 1 |
| Gorsline, J; Prather, RD; Rolf, CN; Tu, TG | 1 |
| Ahijevych, K; Wewers, ME | 1 |
| Randolph, JF; Timmreck, TC | 1 |
| Carmelli, D; Robinette, D; Swan, GE | 1 |
| Fortmann, SP; Jarvik, M; Killen, JD; Varady, A | 1 |
| Jonsson, GG | 1 |
| Kjessler, B | 1 |
| Ivarsson, L | 1 |
| Behm, FM; Levin, ED; Rose, JE; Schur, C; Tashkin, DP | 1 |
| Bendayan, R; Frecker, RC; Kennedy, G; Sellers, EM | 1 |
| Jørgensen, S; Mikkelsen, K; Nilsson, F; Nørregaard, J; Tønnesen, P | 1 |
| Rose, KD | 1 |
| Coen, P; Gorsline, J; Gupta, SK; Okerholm, RA; Prather, RD | 1 |
| Apfelbaum, JL; Lichtor, JL; Zacny, JP; Zaragoza, JG | 1 |
| Nett, LM; Obrigewitch, R | 1 |
| Klomps, HC; Ottervanger, JP; Stricker, BH | 1 |
| McAfee, T | 1 |
| Hahn, L; Hjalmarson, A | 1 |
| Frank, SH; Jaén, CR | 1 |
| Glassman, AH | 1 |
| Nørregaard, J; Säwe, U; Simonsen, K; Tønnesen, P | 3 |
| Paoletti, P; Rodriguez-Roisin, R; Tonnesen, P | 2 |
| Mizuno, A; Nakamura, M; Nakashima, M; Oshima, A; Uematsu, T | 1 |
| Andreski, P; Breslau, N | 1 |
| Stolz, RE | 1 |
| Feyerabend, C; Russell, MA; Stapleton, JA; Sutherland, G | 1 |
| Campbell, IA | 2 |
| Connor, P; Feyerabend, C; Gustavsson, G; Russell, MA; Sawe, U; Stapleton, JA; Wiseman, SM | 1 |
| Croghan, IT; Dale, LC; Gomez-Dahl, L; Hays, JT; Hurt, RD; Offord, KP | 1 |
| Dozois, DN; Farrow, JA; Miser, A | 1 |
| Weiss, RD | 1 |
| Doan, K; Franzon, M; Jarvik, ME; Mody, FV; Olmstead, R; Schneider, NG; Steinberg, C | 1 |
| Causey, D; Gorsline, J; Gupta, SK; Hwang, SS; Rolf, CN | 1 |
| Smith, TM; Winters, FD | 1 |
| Batra, A; Buchkremer, G | 1 |
| Robinson, L | 1 |
| Nightingale, SL | 3 |
| Fiscella, K; Franks, P | 1 |
| Voelker, R | 1 |
| Colditz, GA; Delea, TE; Huse, DM; Oster, G; Regan, MM | 1 |
| Stapleton, J | 3 |
| Bailey, WC; Bjornson, WM; Connett, JE; Daniels, K; Kiley, JP; Kurnow, K; Murray, RP; Nides, MA | 1 |
| Hou, X; Lee, TS | 1 |
| Benhammou, K; Bignon, J; Branellec, A; Brée, F; Lagrue, G; Lebargy, F; Morin, D; Urien, S; Zini, R | 1 |
| Jacob, RF; Salinas, TJ | 1 |
| Breslau, N; Peterson, EL | 1 |
| Escudero Bueno, C; Flórez, S; García Hidalgo, A; González de Vega, JM; Jiménez Ruiz, CA; Pérez Trullén, A; Solano, S | 1 |
| Rose, JE; Westman, EC | 1 |
| Kleiger, RE; Rottman, JN; Stein, PK | 1 |
| Melrose, RJ | 1 |
| Garabrant, DH; Homa, DM; Mankani, SK | 1 |
| Ciruela, J; Gascon, P; Pardell, H; Salleras, L; Salto, E; Tresserras, R | 1 |
| Clark, D | 1 |
| Nardini, S | 1 |
| Ahluwalia, JS; McNagny, SE | 1 |
| Cathala, B; Ducassé, JL; Jorda, MF; Lapeyre-Mestre, M; Martinet, O; Rougé, P; Sanchez, P | 1 |
| Stevermer, J | 1 |
| Jork, K | 1 |
| McGhan, WF; Smith, MD | 1 |
| Benowitz, NL; Sachs, DP | 1 |
| Carrozzi, L; Corlando, A; Fornai, E; Giuntini, C; Gustavsson, G; Maggiorelli, F; Paoletti, P; Puntoni, R; Säwe, U; Viegi, G | 1 |
| Fowler, GH; Jones, L; Lancaster, T; Yudkin, PL | 1 |
| Martin, JE; Patten, CA | 1 |
| Bock, BC; Goldstein, MG; Marcus, BH | 1 |
| Croghan, IT; Fredrickson, PA; Gomez-Dahl, L; Hurt, RD; Lauger, G; Lee, GM; Offord, KP; Wingender, L | 1 |
| Boyko, EJ; Curry, SJ; Ellsworth, AJ; Swartz, SH | 1 |
| Doherty, K; Garvey, AJ; Kinnunen, T; Militello, FS | 2 |
| Benowitz, NL; Gourlay, SG | 2 |
| Groudine, SB; Morley, JN | 1 |
| Barchas, JD; Docherty, JP; Marzuk, PM | 1 |
| Anderson, R; Eells, TD; Head, M; Lippmann, S; Mount, R; Ryabik, B; Velasco, J | 1 |
| Cinciripini, LG; Cinciripini, PM; Gray, CL | 1 |
| Lunell, E; Seppälä, T; Sievi, E; Vanakoski, J | 1 |
| Comans, P; Gavish, A; Keren, A; Khoury, Z; Lerer, T; Tzivoni, D | 1 |
| Schlede, CM | 1 |
| Doan, K; Franzon, M; Mody, FV; Nilsson, F; Olmstead, R; Schneider, NG | 1 |
| Lucas, P; Scurlock, H | 1 |
| Campbell, IA; Prescott, RJ; Tjeder-Burton, SM | 1 |
| Jørgensen, S; Mikkelsen, K; Nørregaard, J; Tønnesen, P | 1 |
| Chase, SL | 1 |
| Conrad, K; Foerster, EH; Hillis, LD; Keeley, EC; Landau, C; Lange, RA; Pirwitz, MJ; Willard, JE | 1 |
| Borlongan, CV; McGartland, M; Polgar, S; Sanberg, PR; Shytle, RD | 1 |
| Colligan, RC; Croghan, IT; Gauvin, TR; Gomez-Dahl, LC; House, RF; Hurt, RD; Offord, KP; Smith, TA | 1 |
| Kupecz, D; Prochazka, A | 1 |
| Cinciripini, P; Gritz, E; Prokhorov, A; Skaar, K; Tsoh, J; Wetter, D | 1 |
| Gnys, M; Hickcox, M; Kassel, JD; Paty, JA; Richards, TJ; Shiffman, S | 1 |
| Duncan, C; Hall, SM; Hartz, DT; Humfleet, GL; Muñoz, RF; Reus, VI; Sees, KL | 1 |
| Davis, L; Fortmann, SP; Killen, JD; Kraemer, HC; Newman, B; Varady, AN | 1 |
| Bindra, RS; Kochar, MS | 1 |
| Allen, SS; Christianson, D; Hatsukami, D; Nelson, D | 1 |
| Risser, NL | 1 |
| Brown, HV; Daims, RM; Olmstead, RE; Schneider, NG; Sloan, K; Steinberg, C | 1 |
| Antonnucio, DO; Antonuccio, DO; Cleveland, M; Ferry, LH; Hartman, N; Joseph, AM; McGovern, PG; Norman, SM; Prochazka, AV; Sherman, SE; Steele, BG; Westman, EC | 1 |
| Caggiula, A; Fonte, C; Grobe, JE; Perkins, KA; Weiss, D | 1 |
| Allen, S; Baker, TB; Fiore, MC; Hatsukami, DK; Jensen, J; Jorenby, DE; Smith, SS | 1 |
| Gillespie, AM; Lowe, JB; Stanton, WR | 1 |
| Dalack, GW; Meador-Woodruff, JH | 2 |
| Schrand, JR | 1 |
| Balfour, DJ; Fagerström, KO | 1 |
| Morgan, RC | 1 |
| Brown, LS; Lin, MM; Meyer, TJ | 1 |
| Celi, A; Fornai, E; Giuntini, C; Paoletti, P; Petruzzelli, S; Pulerà, N; Puntoni, R; Säwe, U | 1 |
| Covey, LS; Glassman, AH; Stetner, F | 2 |
| Meillier, L; Olsen, J; Overvad, K; Sabroe, S; Sønderskov, J | 1 |
| Monsó, E | 1 |
| Flórez, S; Forniés, E; Jímenez Ruiz, CA; Ramos, A; Ramos, L; Solano, S | 1 |
| Benowitz, NL; Jacob, P; Zevin, S | 2 |
| Bell, N; Foulds, J; Jarvis, MJ; Russell, MA; Stapleton, JA; Swettenham, J | 1 |
| Danis, PG; Seaton, TL | 1 |
| Kunze, U; Schmeiser-Rieder, A; Schoberberger, R | 1 |
| Alterman, AI; Gariti, P; Lifrak, P; McKay, J; O'Brien, C; Sparkman, T; Volpicelli, J | 1 |
| Dankwa, E | 1 |
| Bättig, K; Hasenfratz, M; Kos, J | 1 |
| Sela, BA | 1 |
| Jack, LM; Swan, GE; Ward, MM | 1 |
| Henningfield, JE; Schuh, KJ; Schuh, LM; Stitzer, ML | 1 |
| Ananth, C; Hartmann, K; Kuller, JA; Shrewsbury, RP; Thorp, JM; Wright, LN | 1 |
| Aungst, W; Cummings, KM; Jaén, CR; Shah, D | 1 |
| Ford, SE; Ropchan, GV; Sanfilippo, AJ | 1 |
| Hickner, JM; Kreher, NE; Sesney, JW; Webb, S | 1 |
| Stillman, FA | 1 |
| Benowitz, NL; Bloom, MF; Byrd, WG; Mahmarian, JJ; Moyé, LA; Nagueh, SF; Nasser, GA; Pratt, CM; Verani, MS | 1 |
| Kottke, TE | 1 |
| Butschky, MF; Fant, RV; Goffman, AL; Henningfield, JE; Pickworth, WB | 1 |
| DiNardo, LJ; Oliver, DS; Vander Ark, W | 1 |
| Balfour, DJ; Benowitz, NL; Hatsukami, DK; Heishman, SJ; Lindstrom, JM; Ockene, JK | 1 |
| Eliasson, B; Lönnroth, P; Smith, U | 1 |
| Blöndal, T; Franzon, M; Westin, A | 1 |
| Faue, M; Folen, RA; James, LC; Needels, T | 1 |
| Aickin, M; Cook, G; Hill, AL; Holden, T; Kligman, E; Leischow, SJ; Otte, PS; Valente, SN | 1 |
| Davis, L; Fortmann, SP; Killen, JD; Varady, A | 1 |
| Akrawi, W; Benumof, JL | 1 |
| Ishikawa, T; Mizuno, A; Nakashima, M; Uematsu, T; Yoshimine, N | 1 |
| Daughton, D; Lassi, K; Millatmal, T; Rennard, S; Robbins, RA | 1 |
| Hawkins, JW | 1 |
| Sheahan, SL; Wilson, SM | 1 |
| Barinaga, M | 1 |
| Bachman, DS | 1 |
| Brahimi, N; Callais, F; Labrousse, F; Lequang, NT; Momas, I; Roche, D; Roussel, G | 1 |
| Croghan, IT; Dale, LC; Glover, ED; Glover, PN; Hurt, RD; Johnston, JA; Khayrallah, MA; Offord, KP; Sachs, DP; Schroeder, DR; Sullivan, CR; Sullivan, PM | 1 |
| Lous, J | 2 |
| Cherney, L; Klevan, D; Lando, HA; Lauger, G; Rolnick, S; Roski, J | 1 |
| Woolf, AD | 1 |
| Owens, GR | 1 |
| Croghan, IT; Dale, LC; Hurt, RD; Offord, KP; Olsen, DA; Patten, CA; Schroeder, DR; Wolter, TD | 1 |
| Amedee, R; Belafsky, PC; Kissinger, P | 1 |
| Bradley, N | 1 |
| Mitchell, A | 1 |
| Fowler, GH; John, JH; Murphy, M; Yudkin, P; Ziebland, S | 1 |
| Clemente Jiménez, ML; Córdoba García, R | 1 |
| Burrows, C; Haddock, J | 1 |
| Wiseman, EJ | 1 |
| Biron, CR | 1 |
| Audrain, J; Bowman, ED; Boyd, NR; Caporaso, N; Lerman, C; Main, D; Shields, PG | 1 |
| Ahluwalia, JS; Clark, WS; McNagny, SE | 1 |
| Croghan, IT; Dale, LC; Hurt, RD; Offord, KP; Schroeder, DR; Wolter, TD | 1 |
| de Almeida Neto, AC; Kehoe, L; Richmond, RL | 1 |
| Croghan, GA; Croghan, IT; Dale, LC; Gomez-Dahl, LC; Hurt, RD; Offord, KP | 1 |
| Boccoli, E; Federici, A; Melani, AS; Trianni, GL | 1 |
| Haydel, KF; Killen, JD; Robinson, TN; Rojas, NL | 1 |
| el-Guebaly, N; Ismail, Z | 1 |
| Hatsukami, DK; Hughes, JR | 1 |
| Johnson, MD; Setter, SM | 1 |
| Allen, SS; Goldman, A; Hatsukami, D; Jensen, J; Nelson, D; Pentel, PR; Rafael, D | 1 |
| Kozak, JT; Kralikova, E | 1 |
| Mattana, DJ; Stone, C | 1 |
| Gold, MS; Herkov, MJ | 1 |
| Klech, HH | 1 |
| Fagerström, KO; Jiménez-Ruiz, C; Kunze, M | 1 |
| West, R; Willis, N | 1 |
| Goldstein, MG | 2 |
| Garrett, SD; Montalto, NJ | 1 |
| Russell, MA; Stapleton, JA; Sutherland, G | 1 |
| Greenland, S; Lanes, SF; Satterfield, MH | 1 |
| Cook, IA; Holschneider, DP; Jarvik, MM; Lindholm, JE; Newton, TF; Rosenblatt, MR | 1 |
| Burton, SL; Gitchell, J; Kemper, KE; Lara, EA; Pinney, JM; Shiffman, S | 1 |
| Fagerström, KO; Lunell, E; Tejding, R; Westin, A | 1 |
| Cummings, KM; Hyland, A; Hymowitz, N; Manley, M; Ockene, JK | 1 |
| Groman, E; Kunze, M; Kunze, U; Schmeiser-Rieder, A; Schoberberger, R | 3 |
| Croghan, IT; Hurt, RD; Lewis, DA; Miller, VM; Offord, KP; Rud, KS | 1 |
| Baker, TB; Fiore, MC; Jorenby, DE | 1 |
| Baker, TB; Fiore, MC; Piasecki, TM | 1 |
| Fant, RV; Friedman, A; Gnjidic, M; Pickworth, WB; Stanton, JP | 1 |
| Hecht, SS | 1 |
| Fant, RV; Pickworth, WB | 1 |
| García Ortega, P; Navarro Sanz, JJ | 1 |
| Day, J; Schmitz, J; Spiga, R | 1 |
| Croghan, IT; Dale, LC; Hurt, RD; Jiang, NS; Lawson, GM; Offord, KP; Schroeder, DR | 2 |
| Goldberg, ME; Kozlowski, LT; Pillitteri, JL; Sweeney, CT; White, EL; Yost, BA | 1 |
| Kratzer, AM; Wolfgang, SA | 1 |
| Addington, J | 1 |
| Jones, RL; Man, SF; Nguyen, A | 1 |
| Diament, J; Forti, N; Giannini, SD; Issa, JS | 1 |
| Bandettini, PA; Bloom, AS; Cho, JK; Fuller, SA; Harsch, HH; Hawkins, M; Hoffmann, RG; Pankiewicz, J; Rao, SM; Stein, EA | 1 |
| Fant, RV; Henningfield, JE; Nelson, RA; Pickworth, WB | 1 |
| Ikeda, N; Nakamura, M; Saito, T; Sengoku, Y; Shirasaka, T | 1 |
| Baer, GA; Laippala, P; Puura, AI; Rorarius, MG | 1 |
| Armario, P; Hernández, R; Pardell, H; Saltó, E; Tresserras, R | 1 |
| Carpenter, CR | 1 |
| Goldman, A; Hatsukami, D; Lexau, B; Nelson, D; Pentel, PR; Sofuoglu, M | 1 |
| Feyerabend, C; Green, JT; Mani, V; Ragunath, K; Rhodes, J; Russell, MA; Thomas, GA; Williams, GT | 1 |
| Chen, YM; Chiang, SJ; Hsieh, WC; Lu, CC; Perng, RP | 1 |
| Fulcher, SM; Holden, M; Koman, LA; Smith, BP; Smith, TL | 1 |
| Brouwer, AJ; Feyerabend, C; Hop, WC; Meijssen, MA; van Bergeijk, JD; van Dijk, AP; Wilson, JH; Zijlstra, FJ | 1 |
| Oyewumi, LK | 1 |
| Schatz, BS | 1 |
| Crocker, H; Jones, TE; Ruffin, RE | 1 |
| Fryer, GE; Keller, RT; Licari, PA; Lofaso, D; Prochazka, AV; Weaver, MJ | 1 |
| Helmers, KF; Young, SN | 1 |
| Brunel, P; Keren, A; Khoury, Z; Lerer, T; Meyler, S; Tzivoni, D | 1 |
| Hunter, DA; Thompson, GH | 1 |
| Bruun, NH; Kyvik, KO; Leboeuf-Yde, C | 1 |
| Fowler, G; Smeeth, L | 1 |
| Meehan, H | 1 |
| Ernst, E; Resch, KL; White, AR | 1 |
| Benowitz, NL; Davis, RM; Deitchman, SD; Henningfield, JE; Houston, TP; Slade, J | 1 |
| Bende, M; Burian, P; Danielsson, GP; Kruse, E; Millqvist, E; Säwe, U | 1 |
| Dale, LC; Hays, JT; Hurt, RD | 1 |
| Broitman, M; Caperton-Brown, H; Day, JD; Elk, R; Schmitz, JM; Spiga, R | 1 |
| Burton, D; Dent, CW; Flay, BR; Nezami, E; Stacy, AW; Sussman, S | 1 |
| Wickelgren, I | 1 |
| Iwamoto-Schaap, PN; Jarvik, ME; Olmstead, RE; Rosenblatt, MR | 1 |
| Castellanos, E; Nebot, M | 1 |
| Coleman, T; Lakhani, M; Wilson, A | 1 |
| Cartagena, M; Pristach, CA; Smith, CM | 1 |
| Goldstein, MG; Hughes, JR; Hurt, RD; Shiffman, S | 1 |
| Anderson, R; Croghan, IT; Dale, LC; Hurt, RD; Ji, AJ; Lawson, GM | 1 |
| Gorell, JM; Johnson, CC; Peterson, EL; Rybicki, BA | 1 |
| Blondal, T; Gudmundsson, LJ; Gustavsson, G; Olafsdottir, I; Westin, A | 1 |
| Feyerabend, C; Foulds, J; Jarvis, MJ; Russell, MA | 1 |
| Ahluwalia, JS; Clark, WS; Resnicow, K | 1 |
| Carmella, SG; Chen, M; Dor Koch, JF; Hatsukami, DK; Hecht, SS; Jensen, JA; Miller, AT; Murphy, SE; Zimmerman, CL | 1 |
| Meillier, L; Olsen, J; Overvad, OK; Sabroe, S; Sønderskov, J | 1 |
| Farnam, CR | 1 |
| Fagerström, KO | 2 |
| Abu Hijleh, N; Abu Jbara, M; Al-Kayed, A; Gharaibeh, M; Salhab, A; Shubair, K; Shubair, M; Suliman, N; Zmeili, S | 1 |
| Daughton, DM; Fortmann, SP; Glover, ED; Hatsukami, DK; Heatley, SA; Killen, JD; Lichtenstein, E; Millatmal, T; Nowak, RT; Patil, KD; Rennard, SI; Repsher, L; Ullrich, F | 1 |
| Baker, TB; Daughton, DM; Doan, K; Fiore, MC; Hughes, AR; Johnston, JA; Jorenby, DE; Leischow, SJ; Muramoto, ML; Nides, MA; Rennard, SI; Smith, SS | 1 |
| Anthonisen, NR; Murray, RP | 1 |
| Gulsvik, A; Gustavsson, G; Paoletti, P; Rijcken, B; Russell, MA; Saracci, R; Sawe, U; Tønnesen, P | 1 |
| Alterman, AI; Cnaan, A; Cook, TG; Gariti, P | 1 |
| Haustein, KO | 4 |
| Baker, TB; Fiore, MC; Lawrence, WF; Smith, SS | 1 |
| Nett, LM | 1 |
| Basler, HD; Brinkmeier, U; Buser, K; Gluth, G | 1 |
| Fleszar, GJ; Joslin, KA; Malone, NT; Owens, SK | 1 |
| Curry, S; Dacey, S; McAfee, T; Sofian, N; Wagener, B; Wilson, J | 1 |
| Levan, S; McAfee, T; Sofian, NS; Wilson, J | 1 |
| Merriam, P; Ockene, J; Zapka, JG | 1 |
| Cherney, L; Klevan, D; Lando, HA; Rolnick, SJ | 1 |
| Christianson, M; Girolami, S; Sidorov, J; Wydra, C | 1 |
| Westman, EC | 1 |
| Cohen, SB | 1 |
| Clover, K; Hazell, T; Sanson-Fisher, R; Stanbridge, V | 1 |
| Alterman, AI; Barber, W; Bedi, N; Cnaan, A; Gariti, P; Luck, G | 1 |
| Lee, TH | 1 |
| Dahl, R; Frederiksen, R; Jensen, EJ; Pedersen, B | 1 |
| Assali, AR; Beigel, Y; Fainaru, M; Schreibman, R; Shafer, Z | 1 |
| Dey, P; Foy, R; Fullard, B; Gibbs, A; Woodman, M | 1 |
| Cresswell, J | 1 |
| Crauthers, DM; Gilbert, DG; Jensen, RA; McClernon, FJ; Mooney, DK | 1 |
| Henningfield, JE; Peck, CC; Slade, J; Warner, KE; Woosley, RL | 1 |
| Henningfield, JE; Slade, J | 1 |
| Goldman, J; Sanberg, PR; Shytle, RD | 1 |
| Paola, F | 1 |
| Bernabei, R; Gambassi, G | 1 |
| Birmingham, K | 1 |
| Dafoe, WA; Pipe, A; Reid, RD | 1 |
| Ellis, MR; Kane, KY | 1 |
| Akerberg, O; Boëthius, G; Bolinder, G; Post, A; Ribohn, M | 1 |
| Forbes, A; Gourlay, SG; Marriner, T; McNeil, JJ | 1 |
| Marron Tundidor, R; Pérez Trullén, A | 1 |
| MacKenzie, TD | 1 |
| Lowin, A; Russell, MA; Stapleton, JA | 1 |
| Becks, L; Dalack, GW; Hill, E; Meador-Woodruff, JH; Pomerleau, OF | 1 |
| Heufelder, AE; Schworm, HD | 1 |
| Fant, RV; Henningfield, JE; Owen, LL | 1 |
| Blöndal, T; Franzon, M; Gudmundsson, TV; Lúdvíksdóttir, D; Säwe, U | 1 |
| Danielsson, T; Rössner, S; Westin, A | 1 |
| Démolis, JL; Funck-Brentano, C; Jaillon, P; Michaud, P; Moryusef, A; Ragueneau, I | 1 |
| Davis, L; Fortmann, SP; Killen, JD; Strausberg, L; Varady, A | 1 |
| Carlson, MG; Goffaux, J; Oeser, A; Snead, W | 1 |
| Haddock, CK; Klesges, RC; Lando, H; Talcott, GW | 1 |
| Lyon, ER | 1 |
| Sweanor, DT | 1 |
| Burrows, S; Foulds, J; Hajek, P; Meadow, A; Nilsson, F; West, R | 1 |
| Antonnucio, DO; Antonuccio, DO; Joseph, AM | 1 |
| Fornitz, GG; Winther, K | 1 |
| Croghan, IT; Davidson, M; Hays, JT; Hurt, RD; Nides, MA; Offord, KP; Schroeder, DR; Wolter, TD | 1 |
| Lagrue, G | 2 |
| Cormier, S; Lagrue, G; Mautrait, C | 1 |
| Hirsch, JM; Nilsson, F; Sand, L; Wallström, M | 1 |
| Arnsten, JH; McKool, KM; Pasternak, RC; Rigotti, NA; Singer, DE; Wood-Reid, KM | 1 |
| Hildebrand, BE; Svensson, TH | 1 |
| Dibb, WD; Estes, SL; Gehlbach, BA; Gilbert, DG; Hiyane, S; Jensen, RA; McClernon, FJ; Meliska, CJ; Plath, LC; Rabinovich, NE | 1 |
| Jamner, LD; Jarvik, ME; Shapiro, D | 1 |
| Hackman, R; Kapur, B; Koren, G | 1 |
| Bodo, M; Debrier, F; Eerdekens, M; Kaufman, L; Pethica, D; Primo, C; Razavi, D; Vandecasteele, H; Verbist, H | 1 |
| Croghan, GA; Croghan, IT; Hurt, RD; Offord, KP; Wolter, TD; Wong, GY | 1 |
| Croghan, IT; Fiore, MC; Hays, JT; Hurt, RD; Jorenby, DE; Offord, KP; Patten, CA; Schroeder, DR | 1 |
| Sloan, WW | 1 |
| Beede, SD; Croghan, GA; Croghan, IT; Hurt, RD; Patten, CA; Wolter, TD | 1 |
| DeVeaugh-Geiss, J; Elash, CA; Evoniuk, G; Gnys, M; Gwaltney, CJ; Johnston, JA; Khayrallah, M; Paty, JA; Shiffman, S | 1 |
| Kmietowicz, Z | 1 |
| Balfour, D; Benowitz, N; Fagerström, K; Keil, U; Kunze, M | 1 |
| Fiore, MC; Nielsen, K | 1 |
| Goldstein, MG; Niaura, R | 1 |
| Hilsden, RJ; Hodgins, DC; Sutherland, LR; Timmer, A | 1 |
| Barrueco Ferrero, M; Flórez Martín, S; Hernández-Mezquita, MA; Jiménez Ruiz, CA; Lorza, JJ; Ramos Pineda, A; Solano Reina, S | 1 |
| Boyd, NR; Crosette, L; Glassman, B; Noll, E; Orleans, CT | 1 |
| Hall, SM; Hartz, DT; Humfleet, GL; Muñoz, RF; Reus, VI; Tsoh, JY | 1 |
| Bjornsdottir, US; Blondal, T; Gudmundsson, LJ; Hilmarsdottir, H; Jonsdottir, D; Kristjansson, F; Nilsson, F; Tomasson, K | 1 |
| Ahluwalia, JS; Harris, KJ; Okuyemi, KS | 1 |
| Seidman, DS | 1 |
| Clem, JR | 1 |
| Leonard, CT; Lillington, GA; Sachs, DP | 1 |
| Grass, JA; Hughes, JR; Pillitteri, JL | 1 |
| Prochazka, AV | 1 |
| Cox, LS; Elash, CA; Tiffany, ST | 1 |
| Barruero Ferrero, M; Cisneros, C; Hernández Mezquita, MA; Jiménez Ruiz, CA; Perelló Bosch, O; Solano Reina, S | 1 |
| Fowler, G; Lancaster, T; Mant, D; Silagy, C | 2 |
| Burkley, AR; Wewers, ME | 1 |
| Hurrell, D | 1 |
| Bickel, WK; Odum, AL; Shahan, TA | 1 |
| Chevretton, EB; Pracy, JP | 1 |
| Marzilli, TS; Shea, JB | 1 |
| Andrews, K; Baker, T; Englund, E; Fiore, MC; Korberly, B; Lawrence, DL; Schensky, AE; Thompson, SA; Welsch, S; Ziarnik, M | 1 |
| Di Marino, ME; Gitchell, J; Paty, JA; Rohay, JM; Shiffman, S | 1 |
| Eiden, P | 1 |
| Lebargy, F | 1 |
| Gylys, J | 1 |
| Gunawardana, RH | 1 |
| Flynn, BS; Scharoun, GM; Secker-Walker, RH; Sepinwall, D; Solomon, LJ | 1 |
| Benowitz, NL; Elins, JL; Iwamoto-Schaap, PN; Jarvik, ME; Madsen, DC; Olmstead, RE | 1 |
| King, AC; Meyer, PJ | 1 |
| Branchek, TA; Calligaro, DO; Czachura, JF; Dreshfield-Ahmad, LJ; Evans, DC; Hemrick-Luecke, SK; Kallman, MJ; Kendrick, WT; Leander, JD; Nelson, DL; Overshiner, CD; Rasmussen, K; Wainscott, DB; Wolff, MC; Wong, DT; Xu, YC; Zgombick, JM | 1 |
| Ahluwalia, JS; Gibson, C; Harris, KJ; Jolicoeur, DG; Moranetz, CA; Mosier, M; Richter, KP | 1 |
| Ockene, JK; Oncken, CA; Pbert, L; Stoddard, A; Zapka, J | 1 |
| Bolliger, CT; Danielsson, T; Perruchoud, AP; Robidou, A; Säwe, U; van Biljon, X; Westin, A; Zellweger, JP | 1 |
| Lancaster, T; Silagy, C; Sowden, A; Stead, L | 1 |
| Burton, SL; Gitchell, JG; Shiffman, S | 1 |
| Schultz, S | 1 |
| Baird, A; Quattrocki, E; Yurgelun-Todd, D | 1 |
| Brown, RA; Davis, RL; Larkin, JC | 1 |
| Callas, PW; Fagerström, KO; Hughes, JR; Rasmussen, T | 1 |
| Bates, C | 1 |
| Anderson, CM; Byrd, M; Gutiérrez-Terrell, E; Johnson, CE; Rosbrook, B; Tedeschi, G; Zhu, SH | 1 |
| Chestnutt, IG; Kinane, DF | 1 |
| Brock, G; Chapple, I; Cope, G; Holder, R; Nayyar, P | 1 |
| Jain, AK; Jaiswal, J; Panchagnula, R; Pillai, O | 1 |
| Albuquerque, EX; Alkondon, M; Almeida, LE; Fawcett, WP; Pereira, EF; Randall, WR | 1 |
| Feingold, A; George, TP; Kosten, TR; Pepper, WT; Rounsaville, BJ; Satterburg, CA; Winkel, J; Ziedonis, DM | 1 |
| Gamble, E; Kava, T; Partridge, MR; Taylor, J | 1 |
| Bootsma, GP; Heijdra, YF; van den Berkmortel, FW; van Spiegel, PI; Wollersheim, H | 1 |
| Fortmann, SP; Hayward, C; Killen, JD; Rothman, M; Schatzberg, AF; Strausberg, L; Sussman, L; Varady, A | 1 |
| Edwards, N; Hartmann, K; Henningfield, J; Oncken, C; Windsor, R | 1 |
| Broughton, JO; Fortmann, SP; Hatsukami, DK; Heatley, SA; Hughes, JR; Jorenby, DE; Leischow, SJ; Lesmes, GR; Lichtenstein, E; McKenna, JP; Rennard, SI; Richmond, RL; Wadland, WC | 1 |
| Abrams, DB; Borrelli, B; Britt, DM; Goldstein, MG; Niaura, R; Shadel, WG | 1 |
| Garvey, AJ; Kinnunen, T; Nordstrom, BL; Utman, CH | 1 |
| Schmitz, JM | 1 |
| Fant, RV; Henningfield, JE; Nelson, RA; Pickworth, WB; Rohrer, MS | 1 |
| Ameen, V; D'Angelo, A; Goldsmith, LJ; Kirby, SL; Prakash, S; Wright, RA | 1 |
| Doherty, K; Garvey, AJ; Kinnunen, T; Nordstrom, BL; Rosner, B; Utman, CH; Vokonas, PS | 1 |
| Marks, JL; Pomerleau, CS; Pomerleau, OF | 1 |
| Johnson, NW; Warnakulasuriya, KA; Watt, RG | 1 |
| Allen, SS; Brown, S; Christianson, D; Hatsukami, D | 1 |
| Hill, AL; Leischow, SJ; Muramoto, MM; Roe, DJ; Taren, DL | 1 |
| Callas, PW; Hughes, JR; Rose, GL | 1 |
| McNeill, A; Raw, M; West, R | 1 |
| Henriksen, TB; Jespersen, LB; Secher, NJ; Wisborg, K | 1 |
| Hirsch, JM; Nilsson, F; Wallström, M | 1 |
| Caskey, NH; Eisenberger, NI; Elins, JL; Iwamoto-Schaap, PN; Jarvik, ME; Madsen, DC; Olmstead, RE; Wirshing, WC | 1 |
| Clark, DB; Di Marino, ME; Elash, CA; Gwaltney, CJ; Liu, KS; Paton, SM; Paty, JA; Shiffman, S | 1 |
| Kaji, R; Kimura, J; Kohar, N; Matumoto, S; Murase, N; Sakamoto, T; Shibasaki, H; Shimazu, H | 1 |
| Denelsky, GY; Helge, TD | 1 |
| Mikkelsen, KL; Tønnesen, P | 1 |
| Meier, G; Solèr, M | 1 |
| Woodside, JR | 1 |
| Behm, FM; Johnson, M; Rose, JE; Westman, EC | 1 |
| Piotrovskaya, VR; Zhdanova, IV | 1 |
| Dale, LC; Ebbert, JO; Hays, JT; Hurt, RD | 1 |
| Arrazola, A; Cortada, JM; Grandes, G | 1 |
| DeVries, H; Kok, GJ; Mudde, AN; Pieterse, ME; Seydel, ER | 1 |
| Clark, CP; Drummond, S; Gillin, JC; Golshan, S; Kelsoe, J; Patten, CA; Rapaport, M; Sutton, LD; Thorsteinsson, HS | 1 |
| Alanko, J; Mucha, I; Parviainen, M; Riutta, A; Saareks, V; Sievi, E; Vapaatalo, H; Ylitalo, P | 1 |
| Celi, A; Fornai, E; Giuntini, C; Petruzzelli, S; Pulerà, N; Puntoni, R; Tavanti, LM | 1 |
| Khayrallah, M; Nowak, R; Shiffman, S | 1 |
| Foulds, J; Hajek, P; May, S; Meadows, A; Nilsson, F; West, R | 1 |
| Frey, O | 1 |
| Gerstenkorn, A | 1 |
| Henderson, S; Malcolm, R; McCormick, K; Myrick, H | 1 |
| Boykan, R; Lasner, H; Mazure, B; McFee, RB | 1 |
| Rustin, TA | 1 |
| Etter, JF; Perneger, TV | 1 |
| Abrams, DB; Brown, R; Cargill, B; Emmons, KM; Goldstein, MG; Millman, R; Roberts, M; Sherman, CB | 1 |
| Abrams, DB; Goldstein, MG; Hutchinson, KE; Niaura, R; Shadel, WG | 1 |
| Downey, KK; Schuh, KJ; Schuh, LM; Stamat, HM | 1 |
| Brouwer, RJ; Pomerleau, CS; Pomerleau, OF | 1 |
| Hser, YI; McCarthy, WJ; Zhou, Y | 1 |
| Al-Delaimy, W; Fraser, T; Woodward, A | 1 |
| Berlin, JA; Carson, JL; Jaskowiak, J; Kimmel, SE; Miles, C; Strom, BL | 1 |
| Hepburn, MJ; Longfield, JN | 1 |
| Abourjaily, HM; Ho, K | 1 |
| Benowitz, NL; Dempsey, DA | 1 |
| Barrueco, M; Hernández Mezquita, M; Jiménez Ruiz, C; Maderuelo, J; Plaza, M; Torrecilla, M | 1 |
| Angel Hernández Mezquita, M; Angel Maderuelo, J; Barrueco, M; Dolores Plaza, M; Jiménez Ruiz, C; Torrecilla, M | 1 |
| Coleman, T; West, R | 1 |
| Craven, R | 1 |
| Gattone, M | 1 |
| Giambanco, V; Lantz, MS | 1 |
| Bryan, J | 1 |
| Alanko, J; Mucha, I; Riutta, A; Saareks, V; Ylitalo, P | 1 |
| Campbell, J; Gustavsson, G; Monsó, E; Morera, J; Tønnesen, P | 1 |
| Boyce-Smith, G; Kamil, J; McMenamin, S; Olson, K; Rideout, JA; Schauffler, HH | 1 |
| Dautzenberg, B; Lagrue, G | 1 |
| Donahue, R; Fiore, MC; Garrett, P; Jamerson, BD; Johnston, JA; Jorenby, DE; Leischow, SJ; Nides, M; Rennard, SI | 1 |
| Shiffman, S; West, R | 1 |
| Buchhalter, AR; Eissenberg, T; Schrinel, L | 1 |
| Cousins, MS; de Wit, H; Stamat, HM | 1 |
| Conroy, JL; de Moor, CA; Hudmon, KS; Kelder, SH; Ordway, N; Prokhorov, AV | 1 |
| Pahlm, O; Stahl, MM; Wohlfart, B | 1 |
| Avino, S; Carrozzi, L; Desideri, M; Fornai, E; Giuntini, C; Gustavsson, G; Pistelli, F; Puntoni, R; Säwe, U; Viegi, G | 1 |
| Netter, P; Reuter, M | 1 |
| Houlihan, M; Pritchard, W; Robinson, J | 1 |
| Miguel Barrueco, D | 1 |
| Barrueco Ferrero, M; Hernández Mezquita, M; Jiménez Ruiz, C; Maderuelo Fernández, J; Plaza Martín, M; Torrecilla García, M | 1 |
| Buck, D; Morgan, A | 1 |
| Ward, T | 1 |
| Barnard, M; Johnson, KC; Klesges, LM; Ward, KD | 1 |
| Emmons, KM; Evans, JL; Fava, JL; Hammond, SK; Monroe, AD; Velicer, WF | 1 |
| Coons, SJ; Foster, SA; Hays, RD; Leischow, SJ; Shaw, JW | 1 |
| Bye, A; Gomeni, R; Iavarone, L; Squassante, L; Teneggi, V | 1 |
| Lancaster, T; Munafò, M; Murphy, M; Rigotti, N; Stead, L | 1 |
| Cittadino, M; Moreno, H; Rocha, JC; Sabha, M; Tanus-Santos, JE; Toledo, JC | 1 |
| Di Marino, ME; Gitchell, JG; Paty, JA; Rohay, JM; Shiffman, S | 1 |
| Alesci, NL; Boyle, RG; Davidson, G; Link Carlson, C; Magnan, S; Solberg, LI | 1 |
| Anderson, JE; Baker, TB; Beach, KE; Fiore, MC; Jorenby, DE; Mielke, MM; Piasecki, TM; Smith, SS | 1 |
| Bandlamudi, GR; Colenda, CC; D'Mello, DA | 1 |
| Delfino, RJ; Jamner, LD; Whalen, CK | 1 |
| Eliasson, B; Hjalmarson, A; Kruse, E; Landfeldt, B | 1 |
| Chiang, CN; Vocci, FJ | 1 |
| Binter, E; Brath, H; Buchhäusl, I; Kästenbauer, T; Lasar, D | 1 |
| Huibers, MJ; van Schayck, CP; Wagena, EJ | 1 |
| Hashimoto, E; Ikeda, N; Saito, T; Sakaguchi, S; Shiga, M; Toki, S | 1 |
| Ernst, M; Heishman, SJ; London, ED; Spurgeon, L | 1 |
| Fagerstrom, KO; Fant, RV; Henningfield, JE; McGovern, JF; Sweeney, CT | 1 |
| Herity, NA; Mathew, TP | 1 |
| Broge, M; Fonte, C; Gerlach, D; Perkins, KA; Wilson, A | 1 |
| Erickson, PA; Giovino, GA; Kozlowski, LT; Strasser, AA; Terza, JV | 1 |
| Badger, GJ; Bickel, WK; Giordano, LA; Shahan, TA | 1 |
| Jorenby, DE | 1 |
| Alterman, AI; Gariti, P; Mulvaney, F | 1 |
| Broge, M; Cherry, C; Fonte, C; Gerlach, D; Grobe, J; Jacob, R; Perkins, KA; Sanders, M; Wilson, A | 1 |
| Vainio, H; Weiderpass, E | 1 |
| Perkins, CE; Rose, JE; Tomlin, KF; Westman, EC | 1 |
| Behm, FM; Ramsey, C; Ritchie, JC; Rose, JE | 1 |
| Berman, JA; Glassman, AH; Laje, RP | 1 |
| Ahluwalia, JS; Okuyemi, KS; Wadland, WC | 1 |
| Lyman, AE; Raebal, MA | 1 |
| Baska, T; Kavcova, E; Madar, R; Straka, S | 1 |
| Lancaster, T; Silagy, CA; Stead, LF | 1 |
| Cruse, SM; Forster, NJ; Sys, L; Thurgood, G | 1 |
| Tanur, E | 1 |
| McKee, M | 1 |
| Bickel, WK | 1 |
| Hurt, RD | 1 |
| Bates, C; Foulds, J; McNeill, A | 1 |
| Benowitz, NL; Herrera, B; Jacob, P; Pérez-Stable, EJ | 1 |
| Mamiya, T; Masui, S; Nakamura, M; Terazawa, T | 1 |
| Møller, AM; Pedersen, T; Tønnesen, H; Villebro, N | 1 |
| Akita, H; Nosaka, H; Ohbayashi, H; Yamase, H | 1 |
| Rimón, R; Tuunainen, A | 1 |
| Hocking, B; Kee, P; Meadows, G; Moeller-Saxone, K; Stanton, J; Strasser, K | 1 |
| Obe, GF | 1 |
| Cheng, YH; Davis, SS; Faraj, NF; Hinchcliffe, M; Hotchkiss, R; Illum, L; Nankervis, R; Smith, A; Watts, P | 1 |
| Jones, DL; Mobley, CC | 1 |
| Biener, L; Rigotti, NA; Thorndike, AN | 1 |
| Bertrand, D; Buisson, B | 1 |
| Donovan, KA | 1 |
| Maharaj, K; Ternullo, S | 1 |
| Dybing, E; Sanner, T | 1 |
| Dupont, P; Fakhfakh, R; Lagrue, G; Lormier, S; Mautrait, C | 1 |
| Karnath, B | 1 |
| Christensen, HR; Døssing, M; Pedersen, ST | 1 |
| Gallinat, J; Hellweg, R; Jockers-Scherübl, mC; Kuhn, S; Lang, UE | 1 |
| Lie, MA | 1 |
| Andrews, J; Forbes, M; Harrell, L; Heath, J | 1 |
| Cummings, D; Doescher, MP; Goo, A; Huntington, J; Saver, BG; Whinston, MA | 1 |
| Cowan, TM; DePue, J; Goldstein, MG; Swartz, SH | 1 |
| Munday, DL; Park, CR | 1 |
| Slagle, M | 1 |
| Johnstone, EC; Walton, RT; York, EE | 1 |
| Gorman, C | 1 |
| Howell, F | 1 |
| Atchley, P; Fields, LM; Grobe, J | 1 |
| Jacobsen, CD | 1 |
| Chiang, YK; Di Marino, ME; Gorodetzky, CW; Gorsline, J; Hellebusch, SJ; Rolf, CN; Schleusener, DS; Shiffman, S | 1 |
| Dresler, CM; Gilburt, SJ; Hajek, P; Shiffman, S; Strahs, KR; Targett, DA | 1 |
| Glennon, RA; Young, R | 1 |
| Lancaster, T; Shepperd, S; Stead, L | 1 |
| Ferry, LH | 1 |
| Morgan, LC; Peters, MJ | 1 |
| Adams, A; Farris, K; Ryan, M; Yeager, B; Zillich, AJ | 1 |
| Roth, MT; Westman, EC | 1 |
| Taeron, C | 1 |
| Hutcherson, AB; Marzilli, TS | 1 |
| Henriksen, TB; Wisborg, K | 1 |
| Broge, M; Cherry, C; Gerlach, D; Grobe, JE; Perkins, KA; Sanders, M; Wilson, AS | 1 |
| DeBusk, RF; Houston Miller, N; Reilly, KR; Smith, PM; Taylor, CB | 1 |
| Cameron, OG; Garcia, AW; Pomerleau, CS; Pomerleau, OF | 1 |
| Caixeta, M | 1 |
| Bruce, BK; Dale, LC; Eberman, KM; Hurt, RD; Lauger, GG; McClain, FL; Offord, KP | 1 |
| Bostrom, AG; Hansen, MD; Leischow, SJ; Sachs, DP | 1 |
| Houston, TP | 1 |
| Belcher, M; Feyerabend, C; Hajek, P; Jarvis, MJ; Russell, MA; Stapleton, JA; Sutherland, G | 1 |
| Pomerleau, OF | 1 |
| Buckley, MM; Faulds, D; Palmer, KJ | 1 |
| Fortmann, SP; Killen, JD; Kraemer, HC; Newman, B; Varady, A | 1 |
| Ferno, O; Feyerabend, C; Russell, MA; Stapleton, J; Sutherland, G | 1 |
| Daughton, DM; Grimm, RH; Heim, C; Nett, L; Petty, TL; Prochazka, AV; Rennard, SI; Sachs, DP; Silvers, GW | 1 |
| Cruser, K; Fenwick, JW; Flynn, BS; Gulliver, SB; Hughes, JR; Pepper, S; Shea, P; Solomon, LJ; Valliere, WA | 1 |
| Olsen, J | 1 |
| Hopkins, PJ; Walsh, RA | 1 |
| Goldberg, RJ; Hebert, JR; Kalan, K; Kristeller, J; Landon, J; Luippold, R; Ockene, JK | 1 |
| Dalack, GW; Glassman, AH | 1 |
| Benhamou, S; Clavel-Chapelon, F; Paoletti, C | 1 |
| Glauser, F; Listello, D | 1 |
| Baker, TB; Brandon, TH; Jorenby, DE; Zelman, DC | 1 |
| Abelin, T; Gutzwiller, F; Keil, U; Kruse, W; Kunze, M; Matthys, H; Schoberberger, R | 1 |
| Holdcroft, C | 1 |
| Weatherall, M | 1 |
| Greeley, J; Redding, CA; Richmond, RL; Swift, W; Velicer, WF | 1 |
| Allen, S; Hatsukami, D; Hellerstedt, W; Jeffery, RW; Lando, H; McBride, CM; Pirie, PL | 1 |
| Glasgow, RE; Lichtenstein, E | 1 |
| Franklin, RA | 1 |
| Nørregaard, J; Petersen, L; Säwe, U; Simonsen, K; Tønnesen, P | 1 |
| Schneider, NG | 1 |
| Labbate, LA | 1 |
| Harmon, K; Jameson, M | 1 |
| Jones, RT | 1 |
| Slade, J; Warner, KE | 1 |
| Bennett, RH; Cherek, DR | 1 |
| Seidman, DS; Stevenson, DK | 1 |
| Andreski, P; Breslau, N; Kilbey, MM | 1 |
| Säwe, U | 1 |
| Gritsch, S; Günther, V; Meise, U | 1 |
| Schreiden, L | 1 |
| Feyerabend, C; Foulds, J; Jarvis, M; Russell, MA; Stapleton, J; Vesey, C | 1 |
| Lando, HA; McGovern, PG | 1 |
| Fincham, JE | 1 |
| Brigham, J; Felch, LJ; Stitzer, ML | 1 |
| Cox, JL; McKenna, JP | 1 |
| Corral, C; Pascual, M | 1 |
| Ginsberg, D; Hall, SM; Rosinski, M | 1 |
| Buchkremer, G; Minneker-Hügel, E; Unland, H | 1 |
| Persico, AM | 1 |
| Coomber, JA; Craig, D; Parrott, A | 1 |
| Airaksinen, MM; Kolonen, S; Puustinen, P; Tuomisto, J | 1 |
| McEntee, M; Millard, RW; Waranch, HR | 1 |
| Hollis, JF; Johnson, RE; Stevens, VJ; Woodson, GT | 1 |
| Varma, JR | 1 |
| Morgan, GD; Villagra, VG | 1 |
| Brown, NS; Makin, GS; Power, L | 1 |
| Dahl, R; Jensen, EJ; Pedersen, B; Schmidt, E | 2 |
| Leischow, SJ; Sachs, DP | 1 |
| Agustí, A; Bartlett, A; Estopá, R; González, J; Guerra, D; Marín, D; Roig, P; Salvador, T; Sánchez, L; Sobradillo, V | 1 |
| Smirnov, VK | 1 |
| Belcher, M; Hajek, P | 1 |
| Holmes, E; Mateczun, JM; Pentzien, RJ | 1 |
| Ahijevych, K; Page, JA; Wewers, ME | 1 |
| Hatsukami, DK; Huber, M; Hughes, J; Skoog, K | 1 |
| Moochhala, SM; Shahi, GS | 1 |
| Crowley, TJ; MacDonald, MJ; Petty, TL; Zerbe, GO | 1 |
| Drewnowski, A; Garcia, AW; Pomerleau, CS; Pomerleau, OF | 1 |
| Little, SJ; Stevens, VJ | 1 |
| Hatsukami, D; Hellerstedt, W; Lando, H; McBride, C; Pirie, P | 1 |
| Audrain, J; DePue, K; Klesges, LM; Klesges, RC; Meyers, AW | 1 |
| Behm, FM; Lee, YK; Levin, ED; Rose, JE | 1 |
| Collins, RL; Emmons, KM; Emont, SL; Weidner, G | 1 |
| Amble, P; Fletcher, L; Hatsukami, D; Keenan, R; Morgan, S | 1 |
| Majchrzak, MJ; Pomerleau, CS; Pomerleau, OF | 1 |
| Estruch Riba, J; Granero Fernández, EJ; Hernando Arizaleta, L; Quílez García, C; Rubio Díaz, A; Vila Coll, MA | 1 |
738 review(s) available for nicotine and Smoking Cessation
| Article | Year |
|---|---|
Nicotine Metabolism Predicted by CYP2A6 Genotypes in Relation to Smoking Cessation: A Systematic Review.
Topics: Cytochrome P-450 CYP2A6; Genotype; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2022 |
A review of the evidence on cigarettes with reduced addictiveness potential.
Topics: Adolescent; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Products | 2022 |
Implementing a Nicotine-Free Policy in the United States Military.
Topics: Electronic Nicotine Delivery Systems; Humans; Military Personnel; Nicotiana; Nicotine; Policy; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices; United States | 2022 |
Interventions for preventing weight gain after smoking cessation.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Weight Gain | 2021 |
[Diversification of smoking cessation programmes-the role of e-cigarettes].
Topics: Electronic Nicotine Delivery Systems; Germany; Humans; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2021 |
Nicotine Use Disorder in Older Adults.
Topics: Adult; Aged; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder | 2022 |
Tobacco Use Disorder.
Topics: Behavior, Addictive; Bupropion; Combined Modality Therapy; Counseling; Drug Therapy; Electronic Nicotine Delivery Systems; Humans; Morbidity; Neurobiology; Nicotine; Nicotinic Agonists; Phenotype; Prevalence; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline | 2022 |
Neurological repercussions of neonatal nicotine exposure: A review.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fetus; Humans; Infant; Infant, Newborn; Nicotine; Pregnancy; Prenatal Exposure Delayed Effects; Smoking Cessation; Sudden Infant Death; Tobacco Use Cessation Devices | 2022 |
[Central neural mechanism of increased pain sensitivity induced by nicotine abstinence].
Topics: Animals; Humans; Nicotine; Pain; Pain Threshold; Smoking Cessation; Tobacco Use Disorder | 2021 |
The Promise of Polygenic Risk Prediction in Smoking Cessation: Evidence From Two Treatment Trials.
Topics: Genome-Wide Association Study; Humans; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2022 |
Bridging: Accelerating Regulatory Acceptance of Reduced-Risk Tobacco and Nicotine Products.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotiana; Nicotine; Smoking Cessation; Tobacco Products; Vaping | 2022 |
The Role of TRP Channels in Nicotinic Provoked Pain and Irritation from the Oral Cavity and Throat: Translating Animal Data to Humans.
Topics: Animals; Humans; Mouth; Nicotine; Nicotinic Agonists; Pain; Pharynx; Smoking Cessation; Tobacco Use Cessation Devices; Transient Receptor Potential Channels | 2022 |
Moving targets: how the rapidly changing tobacco and nicotine landscape creates advertising and promotion policy challenges.
Topics: Advertising; Electronic Nicotine Delivery Systems; Humans; Marketing; Nicotiana; Nicotine; Public Policy; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices | 2022 |
Extended Duration Treatment of Tobacco Dependence: A Systematic Review and Meta-Analysis.
Topics: Humans; Nicotine; Nicotinic Agonists; Quality of Life; Recurrence; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2022 |
E-cigarettes and nicotine abstinence: a meta-analysis of randomised controlled trials.
Topics: Adult; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Cessation Devices; Vaping | 2022 |
Tobacco and nicotine use.
Topics: Humans; Nicotiana; Nicotine; Quality of Life; Smoking Cessation; Tobacco Products; Tobacco Use; Tobacco Use Cessation Devices | 2022 |
The Effect of Tobacco Control Mass Media Campaigns on Smoking-Related Behavior Among People With Mental Illness: A Systematic Literature Review.
Topics: Adult; Humans; Mass Media; Mental Disorders; Nicotiana; Nicotine; Smoking; Smoking Cessation; Smoking Prevention | 2022 |
[Tobacco dependence, anxiety, and depression].
Topics: Adolescent; Anxiety; Depression; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2022 |
Mindfulness for smoking cessation.
Topics: Adult; Electronic Nicotine Delivery Systems; Female; Humans; Mindfulness; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices | 2022 |
Oral side effects of locally delivered nicotine replacement therapy: A meta-analysis of randomized controlled trials.
Topics: Humans; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Cessation Devices | 2023 |
Effects of very low nicotine content cigarettes on smoking across vulnerable populations.
Topics: Adolescent; Female; Humans; Nicotiana; Nicotine; Pregnancy; Smoking Cessation; Smoking Reduction; Tobacco Products; Vulnerable Populations; Young Adult | 2022 |
Pathophysiology of nicotine, place of nicotine substitutes and electronic cigarettes in plastic surgery: A review of the literature.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Surgery, Plastic; Tobacco Use Cessation Devices | 2022 |
The Impact of Smoking on the Development and Severity of Chronic Pain.
Topics: Chronic Pain; Humans; Nicotine; Recurrence; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2022 |
[Influence of smoking on the gastrointestinal tract : Range of findings].
Topics: Gastrointestinal Tract; Nicotine; Quality of Life; Smoking; Smoking Cessation | 2022 |
A systematic review and meta-analysis of interventions to induce attempts to quit tobacco among adults not ready to quit.
Topics: Adult; Bupropion; Humans; Nicotiana; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices | 2023 |
Is There a Smoking Gun for Nicotine? A Review of the Role of Nicotine in Dermatologic Surgery.
Topics: Dermatologic Surgical Procedures; Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices | 2022 |
Electronic Cigarettes: A Pro-Con Review of the Current Literature.
Topics: Adolescent; Electronic Nicotine Delivery Systems; Humans; Nicotine; Public Health; Smokers; Smoking Cessation; Young Adult | 2022 |
Longer-term use of electronic cigarettes when provided as a stop smoking aid: Systematic review with meta-analyses.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Smoking | 2022 |
A systematic review of genetic variation within nicotinic acetylcholine receptor genes and cigarette smoking cessation.
Topics: Bupropion; Genetic Variation; Humans; Nicotine; Polymorphism, Single Nucleotide; Receptors, Nicotinic; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices | 2022 |
Effect of menthol on nicotine reduction: Pooled results from two double-blind randomized controlled trials.
Topics: Carbon Monoxide; Cotinine; Humans; Menthol; Nicotine; Randomized Controlled Trials as Topic; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder | 2022 |
Nicotine Addiction: A Burning Issue in Addiction Psychiatry.
Topics: Addiction Medicine; Humans; Nicotine; Smoking Cessation; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2022 |
Consensus statement on smoking cessation in patients with pain.
Topics: Activities of Daily Living; Chronic Pain; Humans; Nicotine; Smoking; Smoking Cessation | 2022 |
E-Cigarettes Reexamined: Product Toxicity.
Topics: Adolescent; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation | 2022 |
The Effect of Smoking Cessation on Body Weight and Other Metabolic Parameters with Focus on People with Type 2 Diabetes Mellitus.
Topics: Body Weight; Diabetes Mellitus, Type 2; Humans; Nicotine; Smoking; Smoking Cessation; Weight Gain | 2022 |
Toward an ontology of identity-related constructs in addiction, with examples from nicotine and tobacco research.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotiana; Nicotine; Smokers; Smoking Cessation; Tobacco Products; Vaping | 2023 |
An exploration of flavours in studies of e-cigarettes for smoking cessation: secondary analyses of a systematic review with meta-analyses.
Topics: Electronic Nicotine Delivery Systems; Flavoring Agents; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices | 2023 |
A systematic review with meta-analysis of the effects of smoking cessation strategies in patients with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2022 |
Smoking Cessation after Cancer Diagnosis and Enhanced Therapy Response: Mechanisms and Significance.
Topics: Humans; Neoplasms; Nicotine; Quality of Life; Smoking; Smoking Cessation; Tobacco Smoke Pollution | 2022 |
Safety of Nicotine Replacement Therapy during Pregnancy: A Narrative Review.
Topics: Adult; Female; Humans; Nicotine; Pregnancy; Pregnant Women; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2022 |
Developing a taxonomy to describe offspring outcomes in studies involving pregnant mammals' exposure to non-tobacco nicotine: A systematic scoping review.
Topics: Animals; Electronic Nicotine Delivery Systems; Female; Mammals; Nicotine; Pregnancy; Smoking Cessation; Tobacco Use Cessation Devices | 2023 |
Electronic cigarettes and health outcomes: umbrella and systematic review of the global evidence.
Topics: Adolescent; Child; Electronic Nicotine Delivery Systems; Humans; Nicotine; Prospective Studies; Smoking; Smoking Cessation; Young Adult | 2023 |
Common adverse events of electronic cigarettes compared with traditional nicotine replacement therapies: A systematic review and meta-analysis.
Topics: Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices | 2023 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Bupropion; Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2023 |
Efficacy and Safety of E-Cigarette Use for Smoking Cessation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Cessation Devices; Vaping | 2023 |
Epigenetic and long-term effects of nicotine on biology, behavior, and health.
Topics: Biology; Epigenesis, Genetic; Nicotine; Smoking; Smoking Cessation | 2023 |
Smoking Cessation Interventions and Abstinence Outcomes for People Living in Rural, Regional, and Remote Areas of Three High-Income Countries: A Systematic Review.
Topics: Behavior Therapy; Cognitive Behavioral Therapy; Developed Countries; Humans; Nicotine; Smoking Cessation | 2023 |
Addiction to Tobacco Smoking and Vaping.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Smoking; Vaping | 2023 |
[Medical support of cessation for pregnant smokers].
Topics: Alcoholism; Child; Female; Humans; Infant, Newborn; Nicotine; Pregnancy; Smokers; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2023 |
Cytisine for smoking cessation: A systematic review and meta-analysis.
Topics: Adult; Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Smoking Cessation; Varenicline | 2023 |
Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses.
Topics: Adult; Bupropion; Electronic Nicotine Delivery Systems; Female; Humans; Network Meta-Analysis; Nicotine; Nortriptyline; Pregnancy; Smoking Cessation; Varenicline | 2023 |
Respiratory health effects of e-cigarette substitution for tobacco cigarettes: a systematic review.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotiana; Nicotine; Smoking Cessation; Tobacco Products | 2023 |
Electronic cigarettes and cardiovascular health: what do we know so far?
Topics: Administration, Inhalation; Age Factors; Animals; Cardiovascular Diseases; Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Treatment Outcome; Vaping | 2019 |
Smoking reduction interventions for smoking cessation.
Topics: Bupropion; Humans; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Reduction; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2019 |
Biochemical Verification of Tobacco Use and Abstinence: 2019 Update.
Topics: Biomarkers; Carbon Monoxide; Cigarette Smoking; Cotinine; Humans; Nicotine; Smoking Cessation; Tobacco Products; United States | 2020 |
E-Cigarettes and Cancer Risk.
Topics: Administration, Inhalation; Disease Progression; Electronic Nicotine Delivery Systems; Heating; Humans; Neoplasms; Nicotine; Risk Factors; Smoking; Smoking Cessation; Sympathoadrenal System; Tobacco Products | 2020 |
Nicotine Use Disorders in Adolescents.
Topics: Adolescent; Adolescent Behavior; Ganglionic Stimulants; Humans; Nicotine; North America; Psychology, Adolescent; Smoking Cessation; Substance-Related Disorders; Tobacco Use Disorder; Vaping | 2019 |
Impact of Nicotine Replacement and Electronic Nicotine Delivery Systems on Fetal Brain Development.
Topics: Animals; Behavior Therapy; Brain; Electronic Nicotine Delivery Systems; Female; Fetal Development; Fetus; Humans; Nicotine; Pregnancy; Pregnant Women; Prenatal Care; Smoking Cessation; Smoking Cessation Agents; Tobacco Smoking; Tobacco Use Cessation Devices | 2019 |
Reducing tobacco use among women of childbearing age: Contributions of tobacco regulatory science and tobacco control.
Topics: Adult; Electronic Nicotine Delivery Systems; Female; Humans; Nicotine; Pregnancy; Smoking Cessation; Tobacco Smoking | 2020 |
Behavioral and Subjective Effects of Reducing Nicotine in Cigarettes: A Cessation Commentary.
Topics: Humans; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Products | 2019 |
The Importance of Estimating Causal Effects for Evaluating a Nicotine Standard for Cigarettes.
Topics: Causality; Humans; Nicotine; Randomized Controlled Trials as Topic; Smokers; Smoking; Smoking Cessation; Tobacco Products | 2019 |
Nicotine Reduction in Cigarettes: Literature Review and Gap Analysis.
Topics: Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Disorder | 2019 |
Genotoxic and Carcinogenic Potential of Compounds Associated with Electronic Cigarettes: A Systematic Review.
Topics: Carcinogenesis; Carcinogens; DNA Damage; Electronic Nicotine Delivery Systems; Humans; Mutagens; Nicotine; Smoking Cessation; Tobacco Products | 2019 |
The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions.
Topics: Biomarkers; Cost-Benefit Analysis; Cotinine; Cytochrome P-450 CYP2A6; Electronic Nicotine Delivery Systems; Genetic Testing; Genetic Variation; Humans; Implementation Science; Metabolic Clearance Rate; Neoplasms; Nicotine; Precision Medicine; Prevalence; Smokers; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2020 |
E-cigarettes and their impact on health: from pharmacology to clinical implications.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation | 2020 |
Exposure to Tobacco, Environmental Tobacco Smoke and Nicotine in Pregnancy: A Pragmatic Overview of Reviews of Maternal and Child Outcomes, Effectiveness of Interventions and Barriers and Facilitators to Quitting.
Topics: Child; Electronic Nicotine Delivery Systems; Female; Humans; Nicotiana; Nicotine; Pregnancy; Smoking Cessation; Tobacco Smoke Pollution; Tobacco Use Cessation Devices | 2020 |
More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder.
Topics: Animals; Clinical Trials, Phase III as Topic; Humans; Nicotine; Nicotinic Antagonists; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder | 2020 |
Nicotine Effects, Body Weight Concerns and Smoking: A Literature Review.
Topics: Animals; Electronic Nicotine Delivery Systems; Nicotine; Rats; Smoking; Smoking Cessation; Vaping | 2020 |
A case report of oral nicotine-associated keratosis and a review of oral mucosal changes in tobacco and similar products.
Topics: Administration, Cutaneous; Dentists; Humans; Keratosis; Nicotiana; Nicotine; Nicotinic Agonists; Professional Role; Smoking Cessation; Smoking Prevention; Tobacco Use; Tobacco Use Cessation Devices | 2020 |
E-cigarettes, nicotine, the lung and the brain: multi-level cascading pathophysiology.
Topics: Brain; Electronic Nicotine Delivery Systems; Humans; Lung; Nicotine; Smoking Cessation | 2020 |
Inequalities, harm reduction and non-combustible nicotine products: a meta-ethnography of qualitative evidence.
Topics: Adult; Aged; Aged, 80 and over; Anthropology, Cultural; Electronic Nicotine Delivery Systems; Europe; Female; Harm Reduction; Health Behavior; Humans; Male; Middle Aged; Nicotine; Qualitative Research; Smokers; Smoking Cessation; Smoking Prevention; Social Class; Socioeconomic Factors; Tobacco Smoking; Tobacco Use Cessation Devices | 2020 |
The two-way relationship between nicotine and cortical activity: a systematic review of neurobiological and treatment aspects.
Topics: Cerebral Cortex; Humans; Neuronal Plasticity; Nicotine; Smoking; Smoking Cessation | 2021 |
Apps for smoking cessation through Cognitive Behavioural Therapy. A review.
Topics: Cognitive Behavioral Therapy; Humans; Mobile Applications; Motivation; Nicotine; Smoking Cessation | 2021 |
Health effects of electronic cigarette (e‑cigarette) use on organ systems and its implications for public health.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Public Health; Smoking Cessation; Vaping | 2021 |
Early Life Exposure to Nicotine: Postnatal Metabolic, Neurobehavioral and Respiratory Outcomes and the Development of Childhood Cancers.
Topics: Animals; Child; Electronic Nicotine Delivery Systems; Female; Humans; Infant, Newborn; Neoplasms; Nicotine; Pregnancy; Prenatal Exposure Delayed Effects; Smoking Cessation; Tobacco Use Cessation Devices | 2020 |
Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Humans; Network Meta-Analysis; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Varenicline | 2020 |
Applying the Population Health Standard to the Regulation of Electronic Nicotine Delivery Systems.
Topics: Consumer Product Safety; Electronic Nicotine Delivery Systems; Flavoring Agents; Health Policy; Humans; Nicotine; Population Health; Prospective Studies; Public Health; Smoking; Smoking Cessation; Social Control, Formal; Tobacco Products; Vaping | 2021 |
Administration of Exogenous Hormones and the Implications for Cigarette Smoking-Related Behaviors.
Topics: Cigarette Smoking; Humans; Nicotine; Progesterone; Smoking; Smoking Cessation | 2020 |
Smoking and Nicotine Effects on Surgery: Is Nicotine Replacement Therapy (NRT) a Safe Option?
Topics: Humans; Nicotine; Smoking; Smoking Cessation; Surgical Procedures, Operative; Tobacco Use Cessation Devices | 2021 |
Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism.
Topics: Humans; Nicotine; Pharmacogenetics; Precision Medicine; Smoking Cessation; Tobacco Use Disorder | 2021 |
Efficacy of Electronic Cigarettes for Smoking Cessation: A Systematic Review and Meta-Analysis.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices | 2021 |
Pharmacological strategies for smoking cessation in patients with chronic obstructive pulmonary disease: a pragmatic review.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2021 |
[Smoking cessation in asthmatic patients and its impact].
Topics: Asthma; Child; Electronic Nicotine Delivery Systems; Humans; Nicotine; Quality of Life; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2021 |
[Relation between tobacco smoking and pain: A narrative review of the scientific literature].
Topics: Humans; Nicotine; Pain; Smoking; Smoking Cessation; Tobacco Smoking | 2021 |
Rodent models for nicotine withdrawal.
Topics: Animals; Disease Models, Animal; Electronic Nicotine Delivery Systems; Humans; Mice; Nicotine; Rats; Sex Factors; Smoking Cessation; Smoking Cessation Agents; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2021 |
Effects of transdermal nicotine delivery on cognitive outcomes: A meta-analysis.
Topics: Administration, Cutaneous; Adult; Brain; Cognition; Humans; Male; Nicotine; Smoking Cessation; Young Adult | 2021 |
Nicotine Replacement Therapy during Pregnancy and Child Health Outcomes: A Systematic Review.
Topics: Child; Child Health; Female; Humans; Nicotine; Pregnancy; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2021 |
Regulatory Approaches and Implementation of Minimally Addictive Combusted Products.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices | 2022 |
Skeletal System Biology and Smoke Damage: From Basic Science to Medical Clinic.
Topics: Animals; Bone and Bones; Fracture Healing; Fractures, Bone; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation | 2021 |
[Combinations of pharmacological treatments in smoking cessation. A systematic review].
Topics: Bupropion; Humans; Nicotine; Smoking; Smoking Cessation; Varenicline | 2021 |
Multifactorial Etiology of Adolescent Nicotine Addiction: A Review of the Neurobiology of Nicotine Addiction and Its Implications for Smoking Cessation Pharmacotherapy.
Topics: Adolescent; Behavior, Addictive; Humans; Neurobiology; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2021 |
Tobacco and diabetes: clinical relevance and approach to smoking cessation in diabetic smokers.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Diabetic Angiopathies; DNA Methylation; Drug Interactions; Humans; Insulin; Meta-Analysis as Topic; Neurotransmitter Agents; Nicotine; Risk Factors; Smoking; Smoking Cessation; Telomere Homeostasis; Tobacco Use Cessation Devices; Tobacco Use Disorder; Weight Gain | 2017 |
Tobacco Harms, Nicotine Pharmacology, and Pharmacologic Tobacco Cessation Interventions for Women.
Topics: Bupropion; Female; Fetus; Humans; Lactation; Nicotiana; Nicotine; Pregnancy; Pregnant Women; Smoking; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2017 |
Neural Correlates of Depressive Symptoms in Smokers - A Systematic Review of Imaging Studies.
Topics: Brain; Correlation of Data; Depressive Disorder; Dopamine; Humans; Magnetic Resonance Imaging; Monoamine Oxidase; Nicotine; Smokers; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2017 |
Impact of Electronic Cigarettes on the Cardiovascular System.
Topics: Animals; Cardiovascular Diseases; Cardiovascular System; Consumer Product Safety; Electronic Nicotine Delivery Systems; Humans; Inhalation Exposure; Nicotine; Nicotinic Agonists; Risk Assessment; Risk Factors; Smoking Cessation; Vaping | 2017 |
The influence of smoking and cessation on the human reproductive hormonal balance.
Topics: Androgens; Estrogens; Female; Humans; Male; Nicotine; Reproduction; Smoking; Smoking Cessation | 2017 |
Key issues surrounding the health impacts of electronic nicotine delivery systems (ENDS) and other sources of nicotine.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; United States | 2017 |
Smokers' Understandings of Addiction to Nicotine and Tobacco: A Systematic Review and Interpretive Synthesis of Quantitative and Qualitative Research.
Topics: Adolescent; Adult; Behavior, Addictive; Comprehension; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotiana; Nicotine; Qualitative Research; Smokers; Smoking Cessation; Smoking Prevention; Tobacco Smoking; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2018 |
[The fight against smoking. The need to consider behavioral dependence].
Topics: Cognitive Behavioral Therapy; France; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder | 2017 |
E-Cigarette Toxicity?
Topics: Aerosols; Electronic Nicotine Delivery Systems; Ganglionic Stimulants; Humans; Nicotine; Risk; Smoking Cessation; Tobacco Use; Tobacco Use Cessation | 2018 |
Safety Assessment of Electronic Cigarettes and Their Relationship with Cardiovascular Disease.
Topics: Atherosclerosis; Electronic Nicotine Delivery Systems; Humans; Nicotine; Nitrosamines; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Volatile Organic Compounds | 2018 |
Vaping
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Products; Vaping | 2018 |
[Interventions for smoking cessation in 2018].
Topics: Bupropion; History, 21st Century; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2018 |
Electronic cigarette substitution in the experimental tobacco marketplace: A review.
Topics: Commerce; Consumer Behavior; Economics, Behavioral; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation; Taxes; Tobacco Products | 2018 |
[Smoking cessation: Pharmacological strategies different from standard treatments].
Topics: Bupropion; Humans; Nicotine; Smoking; Smoking Cessation; Smoking Cessation Agents; Standard of Care; Tobacco Use Cessation Devices; Varenicline | 2018 |
Nicotine replacement therapy versus control for smoking cessation.
Topics: Administration, Cutaneous; Administration, Inhalation; Chewing Gum; Female; Humans; Male; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Prevention; Tablets; Time Factors; Tobacco Use Cessation Devices | 2018 |
Smoking in Schizophrenia: an Updated Review.
Topics: Humans; Nicotine; Schizophrenia; Smoking; Smoking Cessation; Tobacco Use Disorder | 2018 |
From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation.
Topics: Cytochrome P-450 CYP2A6; Genetic Variation; Humans; Nerve Tissue Proteins; Nicotine; Pharmacogenetics; Receptors, Nicotinic; Smoking; Smoking Cessation; Tobacco Use Disorder | 2018 |
The Use of Electronic Cigarettes in Pregnancy: A Review of the Literature.
Topics: Electronic Nicotine Delivery Systems; Female; Humans; Nicotine; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Smoking; Smoking Cessation | 2018 |
Are electronic cigarettes a healthier alternative to conventional tobacco smoking?
Topics: Electronic Nicotine Delivery Systems; Equipment Design; Humans; Nicotine; Smoking; Smoking Cessation | 2019 |
Use of polygenic risk scores of nicotine metabolism in predicting smoking behaviors.
Topics: Adult; Biomarkers; Female; Genome-Wide Association Study; Humans; Male; Middle Aged; Multifactorial Inheritance; Nicotine; Risk; Smoking; Smoking Cessation; Tobacco Use Disorder | 2018 |
Electronic cigarettes: a brief update.
Topics: Electronic Nicotine Delivery Systems; European Union; Humans; Nicotine; Smoking Cessation; Smoking Cessation Agents; United Kingdom; Vaping | 2018 |
Print-based self-help interventions for smoking cessation.
Topics: Behavior Therapy; Chewing Gum; Humans; Nicotine; Pamphlets; Patient Education as Topic; Polymethacrylic Acids; Polyvinyls; Randomized Controlled Trials as Topic; Self Care; Smoking Cessation; Smoking Prevention; Temperance; Tobacco Use Cessation Devices | 2019 |
Tobacco Use During Pregnancy.
Topics: Cigarette Smoking; Electronic Nicotine Delivery Systems; Female; Global Health; Humans; Nicotine; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Prevalence; Smoking Cessation; Tobacco Use Cessation Devices; United States | 2019 |
Nicotinic Acetylcholine Receptor Signaling in the Hypothalamus: Mechanisms Related to Nicotine's Effects on Food Intake.
Topics: Animals; Eating; Humans; Hypothalamus; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Signal Transduction; Smoking Cessation; Tobacco Smoking; Tobacco Use Cessation Devices | 2020 |
Relapse prevention interventions for smoking cessation.
Topics: Behavior Therapy; Bupropion; Chewing Gum; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pregnancy; Randomized Controlled Trials as Topic; Secondary Prevention; Smoking Cessation; Smoking Cessation Agents; Smoking Prevention; Varenicline | 2019 |
Electronic cigarettes and nicotine harm-reduction.
Topics: Adolescent; Cigarette Smoking; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2019 |
E-cigarettes and Atherosclerotic Cardiovascular Disease: What Clinicians and Researchers Need to Know.
Topics: Adult; Atherosclerosis; Electronic Nicotine Delivery Systems; Humans; Nicotine; Oxidants; Polycyclic Aromatic Hydrocarbons; Smoking; Smoking Cessation; Tobacco Smoke Pollution; Vaping | 2019 |
[Smoking, alcohol and diabetes (Update 2019)].
Topics: Alcohol Drinking; Benzazepines; Bupropion; Diabetes Mellitus; Humans; Nicotine; Practice Guidelines as Topic; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2019 |
Non-pharmacological Considerations in Human Research of Nicotine and Tobacco Effects: A Review.
Topics: Behavior, Addictive; Humans; Motivation; Nicotiana; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder | 2020 |
Smoking in schizophrenia: recent findings about an old problem.
Topics: Antipsychotic Agents; Epigenesis, Genetic; Humans; Nicotine; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Tobacco Use Disorder | 2019 |
Effect of nicotine on human gingival, periodontal ligament and oral epithelial cells. A systematic review of the literature.
Topics: Electronic Nicotine Delivery Systems; Epithelial Cells; Humans; Nicotine; Periodontal Ligament; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2019 |
[Stopping and reducing smoking in patients with schizophrenia].
Topics: Bupropion; Cognitive Behavioral Therapy; Electronic Nicotine Delivery Systems; Humans; Nicotine; Reinforcement, Psychology; Schizophrenia; Smoking Cessation; Tobacco Smoking; Tobacco Use Cessation Devices; Varenicline | 2019 |
[Smoking cessation: How can we involve patients better in treatment choice?]
Topics: Bupropion; Choice Behavior; Counseling; Decision Making, Shared; Humans; Nicotine; Patient Participation; Patient Selection; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2019 |
The Effects of Smoking Cessation on Diabetes Mellitus Patients.
Topics: Diabetes Mellitus, Type 2; Disease Progression; Humans; Nicotine; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Smoking Cessation | 2020 |
Electronic nicotine delivery systems and pregnancy: Recent research on perceptions, cessation, and toxicant delivery.
Topics: Cigarette Smoking; Electronic Nicotine Delivery Systems; Female; Humans; Nicotine; Pregnancy; Prenatal Exposure Delayed Effects; Smoking Cessation; Vaping | 2019 |
Expanded table: some drugs for smoking cessation.
Topics: Bupropion; Chewing Gum; Humans; Nicotine; Smoking Cessation; Smoking Cessation Agents; Statistics as Topic; Tobacco Use Cessation Devices | 2019 |
Efficacy of cytisine in helping smokers quit: systematic review and meta-analysis.
Topics: Alkaloids; Azocines; Humans; Nicotine; Public Health; Quinolizines; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2013 |
[Drugs used to treat nicotine addiction].
Topics: Adult; Age Distribution; Alkaloids; Azocines; Benzazepines; Bupropion; Causality; Comorbidity; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Poland; Quinolizines; Quinoxalines; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline; Young Adult | 2012 |
Interventions for smoking cessation and reduction in individuals with schizophrenia.
Topics: Adult; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline | 2013 |
Smoking cessation and COPD.
Topics: Benzazepines; Bupropion; Counseling; Humans; Nicotine; Nicotinic Agonists; Prevalence; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Risk Factors; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Cigarette smoking in methadone maintained patients: an up-to-date review.
Topics: Behavior, Addictive; Drug Interactions; Humans; Methadone; Narcotics; Nicotine; Nicotinic Agonists; Opioid-Related Disorders; Prevalence; Smoking; Smoking Cessation; Treatment Outcome; United States | 2013 |
[Tobacco use and illicit substance use disorders: what should we have to do?].
Topics: Behavior, Addictive; Cocaine-Related Disorders; Combined Modality Therapy; Comorbidity; Disease Susceptibility; Dopamine; Global Health; Humans; Illicit Drugs; Marijuana Abuse; Nicotine; Opioid-Related Disorders; Receptors, Dopamine D2; Receptors, Nicotinic; Reinforcement, Psychology; Reward; Smoking; Smoking Cessation; Substance-Related Disorders; Tobacco Use Disorder | 2013 |
Reducing the nicotine content to make cigarettes less addictive.
Topics: Crime; Health Promotion; Humans; Nicotine; Patient Education as Topic; Smoking Cessation; Smoking Prevention; Tobacco Industry; Tobacco Products; Tobacco Use Disorder | 2013 |
The impact of smoking cessation on schizophrenia and major depression.
Topics: Depressive Disorder, Major; Humans; Nicotine; Recurrence; Schizophrenia; Smoking Cessation; Substance Withdrawal Syndrome | 2013 |
[Problems of tobacco smoke and positive effects of quit-smoking on human health].
Topics: Humans; Japan; Nicotine; Public Health; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Tobacco Use Disorder | 2013 |
[Psychiatric and psychological features of nicotine dependence].
Topics: Humans; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2013 |
[Nicotine replacement therapy].
Topics: Humans; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation; Tobacco Use Disorder | 2013 |
Molecules and circuits involved in nicotine addiction: The many faces of smoking.
Topics: Animals; Appetite; Brain; Disease Models, Animal; Humans; Mood Disorders; Nicotine; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder | 2014 |
The "stop" and "go" of nicotine dependence: role of GABA and glutamate.
Topics: Animals; Behavior, Animal; Brain; Conditioning, Psychological; Dopamine; Excitatory Amino Acid Antagonists; GABA Agonists; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Limbic System; Nicotine; Nicotinic Antagonists; Receptors, Glutamate; Reinforcement, Psychology; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2013 |
Electronic cigarette: a possible substitute for cigarette dependence.
Topics: Drug Delivery Systems; Electrical Equipment and Supplies; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices | 2013 |
Smoking cessation treatment for COPD smokers: the role of pharmacological interventions.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2013 |
Relapse prevention interventions for smoking cessation.
Topics: Behavior Therapy; Benzazepines; Chewing Gum; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pregnancy; Quinoxalines; Randomized Controlled Trials as Topic; Secondary Prevention; Smoking Cessation; Smoking Prevention; Varenicline | 2013 |
Electronic cigarettes: a short review.
Topics: Aerosols; Electrical Equipment and Supplies; Humans; Nebulizers and Vaporizers; Nicotine; Nicotinic Agonists; Propylene Glycol; Smoking; Smoking Cessation | 2013 |
Novel delivery systems for nicotine replacement therapy as an aid to smoking cessation and for harm reduction: rationale, and evidence for advantages over existing systems.
Topics: Drug Delivery Systems; Harm Reduction; Humans; Nicotine; Smoking; Smoking Cessation | 2013 |
[Recent progress in vaccines against nicotine addiction].
Topics: Clinical Trials as Topic; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder; Vaccination; Vaccines | 2013 |
Nicotine yesterday, today, and tomorrow: a global review.
Topics: Advertising; Global Health; Health Promotion; Humans; Nicotine; Product Labeling; Smoking; Smoking Cessation; Taxes; Tobacco Industry; Tobacco Products; Workplace | 2014 |
Electronic nicotine delivery system (electronic cigarette) awareness, use, reactions and beliefs: a systematic review.
Topics: Attitude; Electronic Nicotine Delivery Systems; Electronics; Humans; Motivation; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Products | 2014 |
Is nicotine still the bad guy? Summary of the effects of smoking on patients with head and neck cancer in the postoperative period and the uses of nicotine replacement therapy in these patients.
Topics: Antioxidants; Free Tissue Flaps; Head and Neck Neoplasms; Humans; Nicotine; Postoperative Complications; Reactive Oxygen Species; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Wound Healing | 2014 |
Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.
Topics: Adult; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking; Smoking Cessation; Varenicline | 2014 |
E-cigarettes and cardiovascular risk: beyond science and mysticism.
Topics: Administration, Inhalation; Arrhythmias, Cardiac; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco, Smokeless; Volatile Organic Compounds | 2014 |
Pharmacogenetics of nicotine addiction: role of dopamine.
Topics: Dopamine; Genetic Variation; Humans; Nicotine; Pharmacogenetics; Precision Medicine; Smoking Cessation; Tobacco Use Disorder; White People | 2014 |
New directions in nicotine vaccine design and use.
Topics: Adjuvants, Immunologic; Animals; Clinical Trials as Topic; Drug Design; Humans; Immunity, Cellular; Nicotine; Smoking; Smoking Cessation; Vaccines | 2014 |
Smoking cessation.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2014 |
Electronic cigarettes. Potential harms and benefits.
Topics: Drug Delivery Systems; Harm Reduction; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder | 2014 |
'Hubble-bubble leads to trouble'--waterpipe smoking and oral health.
Topics: Attitude to Health; Carbon Monoxide; Humans; Nicotine; Oral Health; Smoking; Smoking Cessation; Tobacco Use; Tobacco Use Cessation | 2013 |
Interventions for preoperative smoking cessation.
Topics: Benzazepines; Humans; Nicotine; Nicotinic Agonists; Postoperative Complications; Preoperative Care; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2014 |
High-dose transdermal nicotine replacement for tobacco cessation.
Topics: Administration, Cutaneous; Dose-Response Relationship, Drug; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices | 2014 |
Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal.
Topics: Cognition; Humans; Nicotine; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder; Translational Research, Biomedical | 2014 |
[Research development of the use of electronic cigarettes in smoking cessation].
Topics: Consumer Product Safety; Equipment and Supplies; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2014 |
Analysis of comments in a petition defending electronic cigarettes.
Topics: Consumer Behavior; Electronic Nicotine Delivery Systems; Humans; Internet; Nicotine; Recurrence; Smoking; Smoking Cessation; United States | 2014 |
Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapies.
Topics: Humans; Nicotine; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome | 2014 |
Symptoms of nicotine toxicity in subjects achieving high cotinine levels during nicotine replacement therapy.
Topics: Administration, Cutaneous; Administration, Inhalation; Cotinine; Double-Blind Method; Humans; Nicotine; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2014 |
Print-based self-help interventions for smoking cessation.
Topics: Behavior Therapy; Chewing Gum; Humans; Nicotine; Pamphlets; Patient Education as Topic; Polymethacrylic Acids; Polyvinyls; Randomized Controlled Trials as Topic; Self Care; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2014 |
A call for an urgent ban on E-cigarettes in India--a race against time.
Topics: Electronic Nicotine Delivery Systems; Emergencies; Global Health; Harm Reduction; Health Services Needs and Demand; Humans; India; Nicotine; Smoking; Smoking Cessation; Tobacco Industry | 2015 |
Reduced nicotine product standards for combustible tobacco: building an empirical basis for effective regulation.
Topics: Government Regulation; Humans; Mental Disorders; Nicotiana; Nicotine; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Tobacco Industry; Tobacco Products; United States; United States Food and Drug Administration | 2014 |
Efficacy of electronic cigarettes for smoking cessation.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2014 |
Smoking addiction in chronic obstructive pulmonary disease: Integrating neurobiology and phenomenology through a review of the literature.
Topics: Behavior, Addictive; Brain; Humans; Neurobiology; Nicotine; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Tobacco Use Disorder | 2014 |
The effects of beliefs regarding drug assignment in experimental and field studies of nicotine delivery devices: a review.
Topics: Animals; Behavior, Addictive; Humans; Nicotine; Nicotinic Agonists; Placebo Effect; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2014 |
[Health consequences of smoking electronic cigarettes are poorly described].
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Vaping | 2014 |
Electronic cigarettes for smoking cessation.
Topics: Electronic Nicotine Delivery Systems; Evidence-Based Practice; Health Knowledge, Attitudes, Practice; Humans; Nicotine; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Cessation Devices | 2014 |
Is impulsivity a symptom of initial tobacco withdrawal? A meta-analysis and qualitative systematic review.
Topics: Adult; Female; Humans; Impulsive Behavior; Male; Nicotiana; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2015 |
Are e-cigarettes effective in smoking cessation?
Topics: Electronic Nicotine Delivery Systems; Evidence-Based Medicine; Female; Humans; Longitudinal Studies; Male; Nicotine; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome | 2015 |
The electronic cigarette: the new cigarette of the 21st century?
Topics: Adolescent; Adult; Electronic Nicotine Delivery Systems; Female; Harm Reduction; Humans; Male; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Young Adult | 2014 |
Smoking and plastic surgery, part I. Pathophysiological aspects: update and proposed recommendations.
Topics: Ganglionic Stimulants; Humans; Hypoxia; Ischemia; Nicotine; Plastic Surgery Procedures; Postoperative Complications; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Wound Healing | 2015 |
Electronic cigarettes for smoking cessation and reduction.
Topics: Cohort Studies; Electronic Nicotine Delivery Systems; Humans; Middle Aged; Nicotine; Nicotinic Agonists; Publication Bias; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2014 |
Neurobiological Bases of Cue- and Nicotine-induced Reinstatement of Nicotine Seeking: Implications for the Development of Smoking Cessation Medications.
Topics: Animals; Behavior, Addictive; Behavior, Animal; Cues; Nicotine; Smoking Cessation | 2015 |
Electronic Cigarettes—A Narrative Review for Clinicians.
Topics: Adult; Attitude of Health Personnel; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Narration; Needs Assessment; Nicotine; Practice Patterns, Physicians'; Risk Factors; Safety Management; Smoking; Smoking Cessation; Tobacco Industry; United States | 2015 |
Targeting the noradrenergic system for gender-sensitive medication development for tobacco dependence.
Topics: Female; Gender Identity; Humans; Male; Nicotine; Receptors, Androgen; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2015 |
E-cigarettes and smoking cessation: evidence from a systematic review and meta-analysis.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Outcome Assessment, Health Care; Smoking Cessation | 2015 |
[Electronic Cigarettes: Lifestyle Gadget or Smoking Cessation Aid?].
Topics: Adolescent; Adult; Aged; Electronic Nicotine Delivery Systems; Female; Humans; Life Style; Male; Middle Aged; Nicotine; Smoking Cessation; Switzerland; Utilization Review; Young Adult | 2015 |
[E-Cigarettes – Friend or Foe?].
Topics: Electronic Nicotine Delivery Systems; Equipment Design; Harm Reduction; Humans; Nicotine; Smoking Cessation; Switzerland; Tobacco Use Disorder | 2015 |
The electronic cigarette: a wolf in sheep's clothing.
Topics: Adolescent; Adult; Austria; Child; Deception; Electronic Nicotine Delivery Systems; Flavoring Agents; Humans; Intention; Nicotine; Particulate Matter; Smoking; Smoking Cessation; Social Marketing; Solvents; Tobacco Industry; Young Adult | 2015 |
Smoking Cessation in Chronic Obstructive Pulmonary Disease.
Topics: Combined Modality Therapy; Counseling; Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Secondary Prevention; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2015 |
Effect of Smoking Reduction Therapy on Smoking Cessation for Smokers without an Intention to Quit: An Updated Systematic Review and Meta-Analysis of Randomized Controlled.
Topics: Adult; Aged; Benzazepines; Bupropion; Female; Humans; Intention; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline | 2015 |
The Past, Present, and Future of Nicotine Addiction Therapy.
Topics: Alkaloids; Azocines; Bupropion; Directive Counseling; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Health Policy; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Smoking Cessation; Social Media; Text Messaging; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
[Nicotine dependence].
Topics: Animals; Brain; Humans; Nicotine; Receptors, Nicotinic; Reward; Smoking Cessation; Tobacco Use Disorder | 2015 |
A Review of E-Cigarettes and Related Health Issues.
Topics: Drug Delivery Systems; Electronic Nicotine Delivery Systems; Humans; Nicotine; Safety; Smoking Cessation; Tobacco Use Cessation Devices; United States | 2015 |
Association between catechol-O-methyltransferase (COMT) Val/Met genotype and smoking cessation treatment with nicotine: a meta-analysis.
Topics: Catechol O-Methyltransferase; Genetic Association Studies; Genotype; Humans; Methionine; Nicotine; Smoking; Smoking Cessation; Treatment Outcome; Valine | 2015 |
Nicotine-Targeting Nano-Vaccines for Smoking Cessation.
Topics: Animals; Drug Delivery Systems; Humans; Nanotechnology; Nicotine; Smoking Cessation; Tobacco Use Disorder; Vaccines | 2016 |
Is there a role for e-cigarettes in smoking cessation?
Topics: Administration, Inhalation; Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2016 |
To quit or not: Vulnerability of women to smoking tobacco.
Topics: Behavior, Addictive; Epigenesis, Genetic; Female; Genetic Predisposition to Disease; Hormones; Humans; Male; Menthol; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Socioeconomic Factors | 2016 |
E-cigarettes and smoking cessation. Similar efficacy to other nicotine delivery devices, but many uncertainties.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2015 |
Effectiveness of Interventions to Reduce Tobacco Smoke Pollution in Homes: A Systematic Review and Meta-Analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Air Pollution, Indoor; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Nicotine; Parents; Particulate Matter; Smoking Cessation; Tobacco Smoke Pollution; Young Adult | 2015 |
Neuroscience of nicotine for addiction medicine: novel targets for smoking cessation medications.
Topics: Animals; Behavior, Addictive; Brain; Humans; Nicotine; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder | 2016 |
The efficacy and short-term effects of electronic cigarettes as a method for smoking cessation: a systematic review and a meta-analysis.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2016 |
Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio.
Topics: Humans; Nicotine; Precision Medicine; Reproducibility of Results; Smoking Cessation; Tobacco Use Disorder | 2016 |
Medications to Assist in Tobacco Cessation for Dental Patients.
Topics: Administration, Cutaneous; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation | 2016 |
How can we Improve on Modeling Nicotine Addiction to Develop Better Smoking Cessation Treatments?
Topics: Animals; Disease Models, Animal; Humans; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Self Administration; Smoking Cessation; Tobacco Use Disorder | 2016 |
Cardiovascular toxicity of nicotine: Implications for electronic cigarette use.
Topics: Administration, Inhalation; Animals; Cardiovascular Diseases; Cardiovascular System; Consumer Product Safety; Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Vaping | 2016 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azepines; Azocines; Benzazepines; Bupropion; Counseling; Heterocyclic Compounds, 4 or More Rings; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2016 |
Pathways to precision medicine in smoking cessation treatments.
Topics: Gene-Environment Interaction; Genetic Markers; Humans; Nicotine; Pharmacogenetics; Precision Medicine; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder | 2018 |
[Safety of long-term nicotine use: An ongoing debate].
Topics: Cardiovascular Diseases; Humans; Long Term Adverse Effects; Neoplasms; Nicotine; Nitrosation; Risk Assessment; Smoking Cessation; Time Factors; Tobacco Use Disorder | 2016 |
An update on the pharmacotherapeutic interventions for smoking cessation.
Topics: Benzazepines; Bupropion; Drug Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2016 |
[Summary of the existing knowledge about electronic cigarettes].
Topics: Electronic Nicotine Delivery Systems; Evidence-Based Medicine; Humans; Nicotine; Nicotinic Agonists; Public Health; Smoking; Smoking Cessation | 2016 |
A decade of e-cigarettes: Limited research & unresolved safety concerns.
Topics: Air Pollutants; Consumer Product Safety; Electronic Nicotine Delivery Systems; Environmental Exposure; Humans; Nicotine; Public Health; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Products; Tobacco Use Disorder; Vulnerable Populations | 2016 |
Smoking and Cognition.
Topics: Attention; Brain; Cognition; Humans; Learning; Memory; Nicotine; Receptors, Nicotinic; Smoking; Smoking Cessation; Tobacco Use Disorder | 2016 |
Nicotine and Tobacco Use Prevention among Youth and Families.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Humans; Male; Middle Aged; Nicotine; Oncology Nursing; Parents; Smoking Cessation; Tobacco Use; Tobacco Use Disorder; Young Adult | 2016 |
Smoking cessation for people with chronic obstructive pulmonary disease.
Topics: Adult; Behavior Therapy; Bupropion; Combined Modality Therapy; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Smoking Cessation; Varenicline | 2016 |
[Efficacy and security of electronic cigarette for tobacco harm reduction: Systematic review and meta-analysis].
Topics: Electronic Nicotine Delivery Systems; Evaluation Studies as Topic; France; Humans; Nicotine; Patient Safety; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2016 |
Sex Differences in Smoking Cessation Pharmacotherapy Comparative Efficacy: A Network Meta-analysis.
Topics: Adult; Female; Humans; Male; Nicotine; Nicotinic Agonists; Sex Distribution; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2017 |
Pharmacogenetic Optimization of Smoking Cessation Treatment.
Topics: Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Genetic Variation; Humans; Nicotine; Organic Cation Transport Proteins; Organic Cation Transporter 2; Pharmacogenetics; Polymorphism, Single Nucleotide; Receptors, Dopamine D4; Receptors, Nicotinic; Smoking Cessation | 2017 |
Interventions to reduce harm from continued tobacco use.
Topics: Biomarkers; Bupropion; Carbon Monoxide; Cotinine; Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2016 |
Could Vaping be a New Weapon in the Battle of the Bulge?
Topics: Electronic Nicotine Delivery Systems; Flavoring Agents; Humans; Nicotine; Obesity; Smoking; Smoking Cessation; Smoking Prevention; Vaping; Weight Gain; Weight Loss | 2017 |
Selection criteria limit generalizability of smoking pharmacotherapy studies differentially across clinical trials and laboratory studies: A systematic review on varenicline.
Topics: Adult; Bupropion; Clinical Trials as Topic; Female; Humans; Laboratories; Middle Aged; Nicotine; Nicotinic Agonists; Patient Selection; Smoking; Smoking Cessation; Varenicline | 2016 |
Overview of Electronic Nicotine Delivery Systems: A Systematic Review.
Topics: Biomarkers; Cognition; Commerce; Electronic Nicotine Delivery Systems; Humans; Marketing; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Vaping | 2017 |
Neuropeptide systems and new treatments for nicotine addiction.
Topics: Animals; Anxiety; Corticotropin-Releasing Hormone; Humans; Neuropeptides; Nicotine; Receptors, Opioid, kappa; Self Administration; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2017 |
E-cigarettes and Urologic Health: A Collaborative Review of Toxicology, Epidemiology, and Potential Risks.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Animals; Child; Consumer Product Safety; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Prevalence; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Urologic Diseases; Vaping; Young Adult | 2017 |
Effect of tobacco and electronic cigarette use on cough reflex sensitivity.
Topics: Animals; Cats; Cough; Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Reflex; Smoking; Smoking Cessation; Time Factors | 2017 |
Endogenous opioid system: a promising target for future smoking cessation medications.
Topics: Analgesics, Opioid; Animals; Drug Delivery Systems; Forecasting; Humans; Nicotine; Opioid Peptides; Receptors, Opioid; Reward; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2017 |
[Nicotine in plastic surgery : a review].
Topics: Abdominal Wall; Female; Humans; Mammaplasty; Nicotine; Patient Selection; Plastic Surgery Procedures; Postoperative Complications; Pregnancy; Rhytidoplasty; Smoking; Smoking Cessation; Treatment Outcome; Wound Healing | 2008 |
[The ABC of smoking cessation].
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Humans; Hypnosis; Motivation; Nicotiana; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2008 |
Maternal tobacco smoking, nicotine replacement and neurobehavioural development.
Topics: Attention Deficit Disorder with Hyperactivity; Brain; Female; Ganglionic Stimulants; Humans; Infant, Newborn; Mothers; Nicotine; Perinatal Care; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Risk Factors; Smoking; Smoking Cessation; Sudden Infant Death; Time Factors | 2008 |
Tobacco addiction.
Topics: Counseling; Female; Humans; Male; Nicotine; Nicotinic Agonists; Physician's Role; Prevalence; Smoking; Smoking Cessation; Tobacco Use Disorder | 2008 |
A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.
Topics: Black or African American; Bupropion; Hispanic or Latino; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2008 |
Smoking and smoking cessation -- the relationship between cardiovascular disease and lipoprotein metabolism: a review.
Topics: Carbon Monoxide; Cardiovascular Diseases; Dose-Response Relationship, Drug; Female; Humans; Lipids; Lipoproteins; Male; Nicotine; Risk Factors; Smoking; Smoking Cessation | 2008 |
Smoking care provision in hospitals: a review of prevalence.
Topics: Hospitals; Humans; Meta-Analysis as Topic; Nicotine; Patient Education as Topic; Physician's Role; Prevalence; Smoking Cessation; Tobacco Use Disorder | 2008 |
Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research.
Topics: Animals; Genetic Predisposition to Disease; Humans; Mice; Mice, Knockout; Nicotine; Receptors, Nicotinic; Smoking; Smoking Cessation; Tobacco Use Disorder | 2008 |
A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report.
Topics: Counseling; Humans; Meta-Analysis as Topic; Motivation; Nicotine; Practice Guidelines as Topic; Smoking Cessation; Tobacco Use Disorder; United States; United States Agency for Healthcare Research and Quality; United States Public Health Service | 2008 |
Which drug to be used in smoking cessation?
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline | 2008 |
Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Benzazepines; Bupropion; Chewing Gum; Female; Follow-Up Studies; Humans; Male; Multivariate Analysis; Nicotine; Nicotinic Agonists; Patient Compliance; Probability; Quebec; Quinoxalines; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Sex differences in long-term smoking cessation rates due to nicotine patch.
Topics: Administration, Cutaneous; Adult; Confidence Intervals; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Odds Ratio; Sex Distribution; Sex Factors; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2008 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline | 2008 |
Genetic and environmental influences on therapeutic and toxicity outcomes: studies with CYP2A6.
Topics: Alleles; Aryl Hydrocarbon Hydroxylases; Cadmium; Cytochrome P-450 CYP2A6; Environment; Humans; Nicotine; Polymorphism, Genetic; Smoking; Smoking Cessation | 2006 |
Over-the-counter nicotine replacement therapy: a methodological review of the evidence supporting its effectiveness.
Topics: Administration, Cutaneous; Chewing Gum; Humans; Nicotine; Nicotinic Agonists; Nonprescription Drugs; Self Administration; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2008 |
[Treatment of smoking cessation during pregnancy].
Topics: Adult; Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Chewing Gum; Combined Modality Therapy; Female; Humans; Nicotine; Pregnancy; Smoking; Smoking Cessation | 2008 |
The relevance and treatment of cue-induced cravings in tobacco dependence.
Topics: Adaptation, Psychological; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Cues; Extinction, Psychological; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2009 |
Drugs for tobacco dependence.
Topics: Adrenergic alpha-Agonists; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2008 |
Modelling the health benefits of smoking cessation in Japan.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Female; Forecasting; Ganglionic Stimulants; Health Promotion; Humans; Japan; Lung Neoplasms; Male; Middle Aged; Models, Statistical; Nicotine; Nicotinic Antagonists; Prevalence; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2009 |
Serotonin receptors as potential targets for modulation of nicotine use and dependence.
Topics: Animals; Behavior; Brain; Humans; Nicotine; Nicotinic Agonists; Protein Isoforms; Receptors, Serotonin; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
Multimodal techniques for smoking cessation: a review of their efficacy and utilisation and clinical practice guidelines.
Topics: Benzazepines; Combined Modality Therapy; Complementary Therapies; Drug Therapy, Combination; Humans; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Psychotherapy; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Developing human laboratory models of smoking lapse behavior for medication screening.
Topics: Alcohol Drinking; Arousal; Bupropion; Cues; Drug Evaluation, Preclinical; Humans; Models, Psychological; Motivation; Naltrexone; Nicotine; Psychotropic Drugs; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Social Environment; Social Facilitation; Tobacco Use Disorder | 2009 |
Women's use of nicotine replacement therapy in pregnancy-a structured review of the literature.
Topics: Female; Ganglionic Stimulants; Health Services Needs and Demand; Humans; Nicotine; Nurse Midwives; Patient Acceptance of Health Care; Patient Education as Topic; Pregnancy; Pregnancy Complications; Research Design; Smoking; Smoking Cessation; Smoking Prevention; Social Support | 2010 |
Effectiveness of smoking cessation interventions among adults: a systematic review of reviews.
Topics: Adult; Algorithms; Antidepressive Agents; Behavior Therapy; Bupropion; Counseling; Humans; Nicotine; Physician-Patient Relations; Psychotherapy, Group; Self Medication; Smoking Cessation; Treatment Outcome | 2008 |
[Modern medical support for smoking cessation].
Topics: Benzazepines; Bupropion; Humans; Nicotine; Practice Patterns, Physicians'; Quinoxalines; Smoking Cessation; Smoking Prevention; Varenicline | 2009 |
[Not smoking, essential for healthy lungs].
Topics: Administration, Cutaneous; Benzazepines; Bupropion; Chewing Gum; Health; Humans; Lung; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tablets; Varenicline | 2008 |
Smoking cessation in pregnancy.
Topics: Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; Smoking Cessation; Varenicline | 2008 |
Varenicline for tobacco dependence.
Topics: Benzazepines; Brain; Coronary Artery Disease; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2008 |
Disrupting nicotine reinforcement: from cigarette to brain.
Topics: Animals; Brain; Cardiovascular System; Cats; Clinical Trials as Topic; Humans; Immunotherapy, Active; Neurotransmitter Agents; Nicotiana; Nicotine; Nicotinic Antagonists; Receptors, Nicotinic; Reinforcement, Psychology; Respiratory System; Reward; Sensation; Smoke; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
Sex differences in nicotine reinforcement and reward: influences on the persistence of tobacco smoking.
Topics: Administration, Intranasal; Association Learning; Cues; Dose-Response Relationship, Drug; Female; Humans; Male; Motivation; Nicotine; Reinforcement, Psychology; Reward; Self Administration; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2009 |
New findings on nicotine addiction and treatment.
Topics: Animals; Benzazepines; Bupropion; Humans; Mecamylamine; Motivation; Nicotine; Nicotinic Antagonists; Quinoxalines; Reward; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline | 2009 |
Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases.
Topics: Chronic Disease; Dopamine; Genotype; Humans; Nicotine; Pharmacogenetics; Serotonin; Smoking Cessation; Tobacco Use Disorder | 2009 |
Smoking cessation interventions and older adults.
Topics: Age Distribution; Age Factors; Aged; Aged, 80 and over; Cardiovascular Diseases; Cause of Death; Evidence-Based Medicine; Female; Humans; Male; Nicotine; Nicotinic Agonists; Nurse's Role; Nursing Assessment; Patient Education as Topic; Prevalence; Research Design; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; United States | 2008 |
Over-the-counter nicotine replacement therapy: can its impact on smoking cessation be enhanced?
Topics: Attitude to Health; Cross-Sectional Studies; Culture; Humans; Nicotine; Nonprescription Drugs; Self Administration; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2008 |
Tobacco addiction and pharmacogenetics of nicotine metabolism.
Topics: Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2A6; Environment; Genetic Association Studies; Humans; Nicotine; Pharmacogenetics; Smoking; Smoking Cessation; Tobacco Use Disorder; Twin Studies as Topic; United States | 2009 |
Relapse prevention interventions for smoking cessation.
Topics: Behavior Therapy; Chewing Gum; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pregnancy; Randomized Controlled Trials as Topic; Secondary Prevention; Smoking Cessation; Smoking Prevention | 2009 |
Interventions for preventing weight gain after smoking cessation.
Topics: Antidepressive Agents; Benzazepines; Exercise; Female; Humans; Male; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Varenicline; Weight Gain | 2009 |
Smoking in pregnancy and lactation: a review of risks and cessation strategies.
Topics: Adult; Alkaloids; Antidepressive Agents; Azocines; Benzazepines; Breast Feeding; Bromocriptine; Cognitive Behavioral Therapy; Female; Humans; Lactation; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinolizines; Quinoxalines; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Vaccines; Varenicline; Young Adult | 2009 |
Nicotine chemistry, metabolism, kinetics and biomarkers.
Topics: Biomarkers; Cotinine; Humans; Nicotiana; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tissue Distribution; Tobacco Use Disorder | 2009 |
In vivo brain imaging of human exposure to nicotine and tobacco.
Topics: Animals; Brain; Cognition; Dopamine; Humans; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Smoking; Smoking Cessation; Tobacco Use Disorder | 2009 |
Sex differences in nicotine action.
Topics: Animals; Cognition; Female; Humans; Male; Motor Activity; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Reward; Rodentia; Sex Factors; Smoking; Smoking Cessation; Tobacco Use Disorder | 2009 |
Rodent models of nicotine withdrawal syndrome.
Topics: Animals; Disease Models, Animal; Gene Expression; Mice; Nicotine; Nicotinic Agonists; Rats; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Validation Studies as Topic | 2009 |
Pharmacotherapy for tobacco dependence.
Topics: Adrenergic alpha-Agonists; Animals; Cannabinoid Receptor Antagonists; Dopamine Antagonists; Humans; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2009 |
[Is tobacco smoking an effective means of body weight control--review of literature].
Topics: Abdominal Fat; Appetite; Body Weight; Causality; Comorbidity; Diabetes Mellitus, Type 2; Energy Metabolism; Female; Heart Diseases; Humans; Male; Nicotine; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Weight Loss | 2008 |
[Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs].
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2008 |
[Preparation of a programme entitled "The role of pharmacists in providing support for nicotine replacement therapy in public pharmacies].
Topics: Education, Pharmacy, Continuing; Health Promotion; Humans; Nicotine; Pharmacies; Pharmacists; Poland; Program Development; Smoking Cessation; Smoking Prevention | 2008 |
[Smoking cessation with nicotine replacement therapy (NRT) - a scientific update].
Topics: Administration, Intranasal; Chewing Gum; Clinical Trials as Topic; Compliance; Female; Humans; Male; Nicotine; Odds Ratio; Smoking Cessation; Smoking Prevention; Tablets; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2009 |
A preliminary benefit-risk assessment of varenicline in smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Recurrence; Risk Assessment; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2009 |
Emerging drugs for the treatment of tobacco dependence.
Topics: Animals; Benzazepines; Clinical Trials as Topic; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2009 |
Nicotine: a pro-angiogenic factor.
Topics: Angiogenesis Inducing Agents; Animals; Humans; Neovascularization, Physiologic; Nicotine; Signal Transduction; Smoking Cessation | 2009 |
Nicotinic acetylcholine receptors: an overview on drug discovery.
Topics: Allosteric Regulation; Analgesics; Bridged Bicyclo Compounds, Heterocyclic; Cardiovascular Diseases; Drug Discovery; Hearing; Humans; Myasthenia Gravis; Neurodegenerative Diseases; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pain; Protein Subunits; Psoriasis; Pyridines; Receptors, Nicotinic; Schizophrenia; Smoking; Smoking Cessation; Tobacco Use Disorder | 2009 |
Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis.
Topics: Behavior Therapy; Combined Modality Therapy; Female; Humans; Male; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Recurrence; Smoking Cessation; Treatment Outcome | 2009 |
Effects of nicotine on sleep during consumption, withdrawal and replacement therapy.
Topics: Animals; Humans; Nicotine; Sleep; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2009 |
Update on smoking cessation therapies.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cost of Illness; Drug Approval; Global Health; Humans; Morbidity; Nicotine; Nicotinic Agonists; Quinoxalines; Safety; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; United States; Varenicline | 2009 |
Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century.
Topics: Benzazepines; Bupropion; Combined Modality Therapy; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2009 |
Pharmacogenetics of smoking cessation therapy.
Topics: Benzazepines; Bupropion; Clonidine; Genome-Wide Association Study; Humans; Nicotine; Nortriptyline; Pharmacogenetics; Quinoxalines; Smoking Cessation; Varenicline | 2010 |
Tobacco use among individuals with intellectual or developmental disabilities: a brief review.
Topics: Adult; Benzazepines; Bupropion; Counseling; Cross-Sectional Studies; Disabled Persons; Health Policy; Humans; Nicotine; Persons with Mental Disabilities; Quinoxalines; Smoking; Smoking Cessation; Tobacco Smoke Pollution; Tobacco Use Disorder; United States; Varenicline | 2009 |
Smoking cessation pharmacotherapy.
Topics: Cardiovascular Diseases; Drugs, Investigational; Humans; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2009 |
The multiple faces of nicotine and its implications in tissue and wound repair.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Apoptosis; Atherosclerosis; Cell Hypoxia; Cell Transformation, Neoplastic; Cocarcinogenesis; Diabetes Mellitus, Experimental; Endothelial Cells; Humans; Ischemia; Mice; Neoplasms, Experimental; Neovascularization, Pathologic; Neovascularization, Physiologic; Nicotine; Rats; Receptors, Nicotinic; Smoking; Smoking Cessation; Wound Healing | 2009 |
The use of iontophoresis in the administration of nicotine and new non-nicotine drugs through the skin for smoking cessation.
Topics: Administration, Cutaneous; Animals; Bupropion; Dosage Forms; Drugs, Investigational; Humans; Iontophoresis; Models, Biological; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder | 2009 |
Nicotinic receptor-based therapeutics and candidates for smoking cessation.
Topics: Animals; Drug Partial Agonism; Humans; Neurotransmitter Agents; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Smoking; Smoking Cessation; Tobacco Use Disorder | 2009 |
Mechanisms underlying the comorbidity of tobacco use in mental health and addictive disorders.
Topics: Brain; Comorbidity; Cross-Sectional Studies; Diseases in Twins; Genetic Predisposition to Disease; Humans; Mental Disorders; Neurotransmitter Agents; Nicotine; Receptors, Neurotransmitter; Risk Factors; Smoking; Smoking Cessation; Substance-Related Disorders; Treatment Outcome; Twin Studies as Topic | 2009 |
A tragic triad: coronary artery disease, nicotine addiction, and depression.
Topics: Coronary Artery Disease; Depression; Humans; Nicotine; Prevalence; Risk Factors; Smoking Cessation; Substance Withdrawal Syndrome; Syndrome; Tobacco Use Disorder; United States | 2009 |
[Smoking cessation in patients with chronic obstructive pulmonary disease].
Topics: Health Education; Health Knowledge, Attitudes, Practice; Humans; Nicotine; Nicotinic Agonists; Patient Education as Topic; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Social Support | 2009 |
Smoking cessation for adolescents: a review of pharmacological and psychosocial treatments.
Topics: Adolescent; Adult; Behavior Therapy; Bupropion; Cognitive Behavioral Therapy; Humans; Motivation; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2008 |
Contingency management for smoking cessation: where do we go from here?
Topics: Adolescent; Adult; Animals; Chewing Gum; Combined Modality Therapy; Conditioning, Operant; Female; Humans; Male; Nicotine; Outcome and Process Assessment, Health Care; Pregnancy; Smoking Cessation; Tobacco Use Disorder; Token Economy; Young Adult | 2008 |
Tobacco treatment and prevention: what works and why.
Topics: Central Nervous System Stimulants; Health Promotion; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Respiratory Therapy; Smoking Cessation; Social Control, Formal | 2009 |
[Treatment of tobacco dependence: a responsibility of psychiatry and addiction medicine].
Topics: Combined Modality Therapy; Germany; Humans; Nicotine; Psychiatry; Psychotherapy; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2009 |
Are nicotine replacement therapy, varenicline or bupropion options for pregnant mothers to quit smoking? Effects on the respiratory system of the offspring.
Topics: Animals; Antioxidants; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Maternal-Fetal Exchange; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; Respiratory System; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline | 2009 |
What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy?
Topics: Animals; Benzazepines; Bupropion; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Nicotine; Pregnancy; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline | 2009 |
Reduced-nicotine content cigarettes: Is there potential to aid smoking cessation?
Topics: Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder | 2009 |
Therapeutic strategies to optimize the efficacy of nicotine replacement therapies.
Topics: Administration, Cutaneous; Administration, Oral; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Combined Modality Therapy; Humans; Nicotine; Nortriptyline; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2009 |
Why won't our patients stop smoking? The power of nicotine addiction.
Topics: Adolescent; Adult; Age Distribution; Aged; Cardiovascular Diseases; Humans; Lung Neoplasms; Middle Aged; Neoplasms; Nicotine; Smoking; Smoking Cessation; Substance-Related Disorders; Young Adult | 2009 |
Current approaches to pharmacotherapy for smoking cessation.
Topics: Adolescent; Adult; Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pregnancy; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; United States; Varenicline | 2010 |
Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cost-Benefit Analysis; Delayed-Action Preparations; Health Care Costs; Humans; Models, Statistical; Nicotine; Nicotinic Agonists; Prevalence; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system.
Topics: Animals; Behavior, Addictive; Humans; Motivation; Naltrexone; Neurotransmitter Agents; Nicotine; Opioid Peptides; Receptors, Nicotinic; Reinforcement, Psychology; Reward; Smoking Cessation; Tobacco Use Disorder | 2010 |
[Nicotine. Influence on sleep and its relevance for psychiatry and psychotherapy].
Topics: Humans; Mental Disorders; Nicotine; Sleep Initiation and Maintenance Disorders; Smoking Cessation | 2010 |
Smoking cessation intervention: an evidence-based approach.
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Directive Counseling; Drug Therapy, Combination; Evidence-Based Medicine; Global Health; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2010 |
Prenatal tobacco prevention and cessation interventions for women in low- and middle-income countries.
Topics: Adolescent; Advertising; Behavior Therapy; Biomedical Research; Developing Countries; Female; Health Priorities; Humans; Mass Media; Maternal Exposure; Nicotine; Nicotinic Agonists; Pregnancy; Product Packaging; Public Health; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Taxes; Tobacco Smoke Pollution | 2010 |
Cessation in the use of tobacco - pharmacologic and non-pharmacologic routines in patients.
Topics: Coronary Disease; Cost-Benefit Analysis; Directive Counseling; Humans; Nicotine; Nicotinic Agonists; Patient Education as Topic; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Time Factors | 2008 |
Long-term consequences of fetal and neonatal nicotine exposure: a critical review.
Topics: Animals; Animals, Newborn; Diabetes Mellitus, Type 2; Female; Fertility; Fetal Hypoxia; Fetus; Humans; Hypertension; Lung; Neoplasms; Nicotine; Obesity; Pregnancy; Prenatal Exposure Delayed Effects; Smoking Cessation | 2010 |
Combination pharmacotherapy for stopping smoking: what advantages does it offer?
Topics: Animals; Bupropion; Drug Therapy, Combination; Humans; Nicotine; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation | 2010 |
[Pharmacological profile and clinical findings on varenicline tartrate (Champix tablets)].
Topics: Animals; Benzazepines; Clinical Trials, Phase III as Topic; Corpus Striatum; Dopamine; Humans; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Smoking cessation in severe mental illness: what works?
Topics: Adult; Behavior Therapy; Body Weight; Bupropion; Dopamine Uptake Inhibitors; Female; Healthcare Disparities; Humans; Male; Mental Disorders; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Schizophrenic Psychology; Smoking; Smoking Cessation; Time Factors; Tobacco Use Disorder | 2010 |
Do point prevalence and prolonged abstinence measures produce similar results in smoking cessation studies? A systematic review.
Topics: Clinical Trials as Topic; Follow-Up Studies; Humans; Nicotine; Nicotinic Agonists; Odds Ratio; Outcome Assessment, Health Care; Predictive Value of Tests; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2010 |
Pre-cessation nicotine replacement therapy: pragmatic randomized trial.
Topics: Administration, Cutaneous; Adult; Algorithms; Chewing Gum; Female; Hotlines; Humans; Male; Native Hawaiian or Other Pacific Islander; New Zealand; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Smoking; Smoking Cessation; Smoking Prevention; Statistics as Topic; Substance Withdrawal Syndrome; Treatment Outcome | 2010 |
Interventions for smoking cessation and reduction in individuals with schizophrenia.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Humans; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Smoking Prevention | 2010 |
Smoking cessation-recent advances.
Topics: Australia; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Humans; Immunotherapy, Active; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Transdermal Patch; Treatment Outcome; United Kingdom; United States; Varenicline | 2010 |
Interventions for preoperative smoking cessation.
Topics: Humans; Nicotine; Nicotinic Agonists; Postoperative Complications; Preoperative Care; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation | 2010 |
Comparison of available treatments for tobacco addiction.
Topics: Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nortriptyline; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2010 |
[Why do not all smokers stop smoking?].
Topics: Health Knowledge, Attitudes, Practice; Humans; Lung Neoplasms; Nicotine; Physician-Patient Relations; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Switzerland; Tobacco Industry; Tobacco Use Disorder | 2010 |
[Preventive relapse treatment for tobacco cessation - is it worthwhile?].
Topics: Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Secondary Prevention; Smoking Cessation; Treatment Outcome; Varenicline | 2010 |
Does dual use jeopardize the potential role of smokeless tobacco in harm reduction?
Topics: Attitude to Health; Europe; Harm Reduction; Health Behavior; Humans; Nicotine; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Tobacco, Smokeless; United States | 2010 |
Smoking and pain: pathophysiology and clinical implications.
Topics: Analgesics; Analgesics, Opioid; Animals; Chronic Disease; Depression; Female; Humans; Ligands; Male; Nicotine; Nicotinic Agonists; Pain; Pain, Postoperative; Receptors, Nicotinic; Risk Factors; Smoking; Smoking Cessation; Treatment Outcome | 2010 |
Nicotine reduction revisited: science and future directions.
Topics: Animals; Government Regulation; Health Policy; Humans; Nicotiana; Nicotine; Smoking; Smoking Cessation; Tobacco Industry; Tobacco Use Disorder; United States | 2010 |
Nicotine replacement therapy effect on pregnancy outcomes.
Topics: Animals; Female; Fetus; Humans; Infant, Newborn; Maternal Exposure; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Risk Factors; Smoking Cessation; Smoking Prevention | 2010 |
A brief review of pharmacotherapeutic treatment options in smoking cessation: bupropion versus varenicline.
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; Varenicline | 2010 |
Efficacy and safety of nicotine replacement therapy for smoking cessation in pregnancy: systematic review and meta-analysis.
Topics: Adolescent; Behavior Therapy; Combined Modality Therapy; Female; Fetal Mortality; Humans; Nicotine; Nicotinic Agonists; Patient Compliance; Pregnancy; Pregnancy Complications; Premature Birth; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2011 |
An updated meta-analysis of nicotine preloading for smoking cessation: investigating mediators of the effect.
Topics: Databases, Factual; Humans; Models, Biological; Nicotine; Nicotinic Agonists; Odds Ratio; Outcome Assessment, Health Care; Reward; Smoking Cessation; Tobacco Use Disorder | 2011 |
Impact of genetic variability in nicotinic acetylcholine receptors on nicotine addiction and smoking cessation treatment.
Topics: Benzazepines; Bupropion; Genetic Variation; Humans; Nicotine; Protein Subunits; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2011 |
Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2010 |
Treatment of nicotine addiction: present therapeutic options and pipeline developments.
Topics: Drug Design; Humans; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Vaccines | 2011 |
Effectiveness of pharmacologic therapy for smoking cessation in adolescent smokers: Meta-analysis of randomized controlled trials.
Topics: Adolescent; Adolescent Behavior; Bupropion; Humans; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder | 2011 |
Smoking and smoking cessation in pregnancy.
Topics: Attention Deficit Disorder with Hyperactivity; Cognition Disorders; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infertility, Female; Maternal-Fetal Exchange; Nervous System Physiological Phenomena; Nicotine; Overweight; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Respiratory Tract Diseases; Risk Factors; Smoking; Smoking Cessation; Sudden Infant Death; United States | 2011 |
The effects of nicotine and cigarette smoke on the monoamine transporters.
Topics: Animals; Brain; Gene Expression Regulation; Humans; Neurotransmitter Transport Proteins; Nicotine; Nicotinic Agonists; Rats; Receptors, Nicotinic; Smoking; Smoking Cessation | 2011 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2011 |
Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials.
Topics: Genotype; Humans; Nicotine; Pharmacogenetics; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation | 2011 |
Nicotine dependence: health consequences, smoking cessation therapies, and pharmacotherapy.
Topics: Administration, Cutaneous; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Heart Diseases; Humans; Neoplasms; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; Varenicline | 2011 |
[Recommendations of the World Health Organization Tobacco Control Research Team regarding electronic nicotine delivery devices].
Topics: Administration, Inhalation; Electronics; Health Promotion; Humans; Information Dissemination; Nebulizers and Vaporizers; Nicotine; Risk Reduction Behavior; Smoking Cessation; World Health Organization | 2010 |
[Simple therapeutic options in counteracting tobacco smoking].
Topics: Alkaloids; Azocines; Humans; Nicotine; Quinolizines; Smoking; Smoking Cessation; Tobacco Use Disorder | 2010 |
Tobacco use and cessation among women: research and treatment-related issues.
Topics: Causality; Disease Susceptibility; Female; Humans; Life Style; Lung Neoplasms; Male; Nicotine; Prevalence; Pulmonary Disease, Chronic Obstructive; Risk Factors; Sex Distribution; Sex Factors; Smoking; Smoking Cessation | 2011 |
Tobacco, nicotine and harm reduction.
Topics: Animals; Harm Reduction; Health Policy; Humans; Nicotiana; Nicotine; Smoking; Smoking Cessation; Tobacco Industry; Tobacco Use Disorder; Tobacco, Smokeless | 2011 |
Effectiveness of over-the-counter nicotine replacement therapy: a qualitative review of nonrandomized trials.
Topics: Humans; Nicotine; Nonprescription Drugs; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2011 |
Pharmacotherapy for smoking cessation: current advances and research topics.
Topics: Administration, Topical; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2011 |
Pharmacotherapy for smoking cessation: present and future.
Topics: Adolescent; Animals; Benzazepines; Bupropion; Delayed-Action Preparations; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline | 2011 |
Systematic review of the relationship between the 3-hydroxycotinine/cotinine ratio and cigarette dependence.
Topics: Cotinine; Humans; Nicotine; Reproducibility of Results; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2011 |
Targeting nicotine addiction: the possibility of a therapeutic vaccine.
Topics: Animals; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder; Vaccines | 2011 |
Cigarette smoking, nicotine, and body weight.
Topics: Body Weight; Health Status; Humans; Nicotine; Nicotinic Agonists; Obesity; Smoking; Smoking Cessation; Weight Gain | 2011 |
Varenicline for tobacco dependence: panacea or plight?
Topics: Animals; Benzazepines; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline | 2011 |
Women who smoke - A review of the evidence.
Topics: Female; Health Promotion; Humans; Lactation; Nicotine; Pregnancy; Sex Factors; Smoking; Smoking Cessation; Smoking Prevention; Weight Gain; Women's Health | 2011 |
Clinical Inquiry: which smoking cessation interventions work best?
Topics: Behavior Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2011 |
Ulcerative colitis in smokers, non-smokers and ex-smokers.
Topics: Clinical Trials as Topic; Colitis, Ulcerative; Disease Progression; Female; Humans; Male; Nicotine; Nicotinic Agonists; Risk Factors; Smoking; Smoking Cessation | 2011 |
Mechanistic insights into nicotine withdrawal.
Topics: Animals; Brain; Disease Models, Animal; Dopamine; Humans; Nicotine; Receptors, Nicotinic; Reinforcement, Psychology; Smoking Cessation; Substance Withdrawal Syndrome | 2011 |
Therapeutic vaccines for chronic diseases: successes and technical challenges.
Topics: Angiotensin II; Animals; Antibodies; Antibody Formation; Antihypertensive Agents; Chronic Disease; Diabetes Mellitus, Type 2; Humans; Hypertension; Interleukin-1beta; Mice; Nicotine; Risk Factors; Smoking; Smoking Cessation; Vaccination; Vaccines; Vaccines, Virus-Like Particle | 2011 |
Smokeless tobacco as a nicotine delivery device: harm or harm reduction?
Topics: Cardiovascular Diseases; Drug Delivery Systems; Harm Reduction; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Disorder; Tobacco, Smokeless | 2011 |
Clinical practice. Treating smokers in the health care setting.
Topics: Benzazepines; Bupropion; Cholinergic Agents; Counseling; Dopamine Uptake Inhibitors; Evidence-Based Medicine; Female; Humans; Middle Aged; Motivation; Nicotine; Patient Compliance; Physician-Patient Relations; Practice Guidelines as Topic; Quinoxalines; Smoking; Smoking Cessation; United States; Varenicline | 2011 |
Perioperative smoking cessation.
Topics: Counseling; Elective Surgical Procedures; Humans; Nicotine; Preoperative Period; Smoking Cessation | 2012 |
Evidence-based pharmacological treatment of substance use disorders and pathological gambling.
Topics: Alcohol Deterrents; Alcoholism; Cocaine-Related Disorders; Evidence-Based Medicine; Gambling; Humans; Marijuana Abuse; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Opiate Substitution Treatment; Opioid-Related Disorders; Receptors, Nicotinic; Smoking Cessation; Substance-Related Disorders; Tobacco Use Disorder; Vaccination | 2012 |
Nicotine vaccines.
Topics: Animals; Clinical Trials as Topic; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder; Vaccines | 2011 |
Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
Topics: Adolescent; Benzazepines; Bupropion; Clinical Trials as Topic; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Patient Compliance; Prescription Drugs; Quinoxalines; Randomized Controlled Trials as Topic; Safety; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2012 |
Interventions for preventing weight gain after smoking cessation.
Topics: Antidepressive Agents; Benzazepines; Exercise; Female; Humans; Male; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Weight Gain | 2012 |
Tobacco control in Europe: a deadly lack of progress.
Topics: Environmental Pollutants; Europe; Humans; Nicotiana; Nicotine; Smoking; Smoking Cessation; Smoking Prevention | 2012 |
The emerging phenomenon of electronic cigarettes.
Topics: Administration, Inhalation; Drug Delivery Systems; Electronics; Equipment Design; Health Behavior; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2012 |
[Smoking cessation in medical practice--new possibilities?].
Topics: Benzazepines; Bupropion; Complementary Therapies; Drugs, Investigational; General Practitioners; Humans; Nicotine; Nicotinic Agonists; Professional Practice; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2012 |
A systematic review of nicotine by inhalation: is there a role for the inhaled route?
Topics: Administration, Inhalation; Adult; Female; Humans; Lung; Male; Metered Dose Inhalers; Nicotine; Smoking; Smoking Cessation; Tobacco Products | 2012 |
Smoking cessation: present status and future perspectives.
Topics: Animals; Behavior Therapy; Drugs, Investigational; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Vaccines | 2012 |
Preclinical evidence that activation of mesolimbic alpha 6 subunit containing nicotinic acetylcholine receptors supports nicotine addiction phenotype.
Topics: Animals; Dopamine; Humans; Limbic System; Nicotine; Receptors, Nicotinic; Reinforcement, Psychology; Rodentia; Smoking Cessation; Tobacco Use Disorder; Ventral Tegmental Area | 2012 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azepines; Azocines; Benzazepines; Bupropion; Counseling; Heterocyclic Compounds, 4 or More Rings; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2012 |
[Helping the "hard-core" smokers].
Topics: Algorithms; Helping Behavior; Humans; Motivation; Nicotine; Practice Guidelines as Topic; Smoking; Smoking Cessation; Tobacco Use Disorder | 2012 |
The reinforcement threshold for nicotine as a target for tobacco control.
Topics: Adolescent; Animals; Humans; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Smoking; Smoking Cessation; Tobacco Use Disorder | 2012 |
Nicotine, cigarette smoking and cardiac arrhythmia: an overview.
Topics: Animals; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Heart Conduction System; Humans; Nicotine; Nicotinic Agonists; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Smoke Pollution | 2012 |
Improved treatment of nicotine addiction and emerging pulmonary drug delivery.
Topics: Drug Delivery Systems; Humans; Lung; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2012 |
Impact of tobacco regulation on animal research: new perspectives and opportunities.
Topics: Animal Experimentation; Animals; Comorbidity; Disease Models, Animal; Dose-Response Relationship, Drug; Government Regulation; Humans; Nicotiana; Nicotine; Rodentia; Schizophrenia; Self Administration; Smoking Cessation; Tobacco Industry; Tobacco Products; Tobacco Use Disorder; United States | 2012 |
Nicotinic regulation of energy homeostasis.
Topics: Adipose Tissue; Animals; Autonomic Nervous System; Body Weight; Energy Metabolism; Enteric Nervous System; Food; Homeostasis; Humans; Neurons; Nicotine; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder | 2012 |
Nicotine reduction: strategic research plan.
Topics: Animals; Biomarkers; Humans; Nicotine; Racial Groups; Research; Smoking Cessation; Smoking Prevention; Tobacco Products; United States | 2013 |
Molecular mechanisms underlying behaviors related to nicotine addiction.
Topics: Animals; Brain; Humans; Ligand-Gated Ion Channels; Mice; Nerve Tissue Proteins; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Reinforcement, Psychology; Smoking Cessation; Tobacco Use Disorder | 2013 |
Nicotine replacement therapy for smoking cessation.
Topics: Administration, Cutaneous; Administration, Inhalation; Chewing Gum; Humans; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Prevention; Tablets; Tobacco Use Cessation Devices | 2012 |
The pharmacist "toolbox" for smoking cessation: a review of methods, medicines, and novel means to help patients along the path of smoking reduction to smoking cessation.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Education, Pharmacy, Continuing; Humans; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Pharmacists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline | 2012 |
Translational research in nicotine dependence.
Topics: Acetylcholine; Animals; Cholinergic Antagonists; Cholinesterase Inhibitors; Humans; Mice; Nicotine; Nicotinic Agonists; Polymorphism, Genetic; Receptors, Nicotinic; Rodentia; Smoking; Smoking Cessation; Tobacco Use Disorder; Translational Research, Biomedical | 2013 |
Clinical efficacy of bupropion in the management of smoking cessation.
Topics: Body Weight; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Drug Administration Schedule; Female; Humans; Male; Nicotine; Practice Guidelines as Topic; Secondary Prevention; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2002 |
Tolerability and safety of sustained-release bupropion in the management of smoking cessation.
Topics: Bupropion; Clinical Trials as Topic; Consumer Product Safety; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Humans; Nicotine; Seizures; Sleep Initiation and Maintenance Disorders; Smoking Cessation; Tobacco Use Disorder; Xerostomia | 2002 |
Current approaches to the management of smoking cessation.
Topics: Bupropion; Delayed-Action Preparations; Hotlines; Humans; Nicotine; Practice Guidelines as Topic; Psychotherapy, Group; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2002 |
Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment?
Topics: Drug Interactions; Ganglionic Stimulants; Humans; Nicotine; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2002 |
Self-help interventions for smoking cessation.
Topics: Behavior Therapy; Chewing Gum; Humans; Nicotine; Patient Education as Topic; Polymethacrylic Acids; Polyvinyls; Randomized Controlled Trials as Topic; Self Care; Smoking Cessation; Smoking Prevention | 2002 |
Have we lost our way? The need for dynamic formulations of smoking relapse proneness.
Topics: Administration, Cutaneous; Fatigue; Forecasting; Humans; Motivation; Nicotine; Risk Factors; Secondary Prevention; Smoking Cessation; Smoking Prevention; Stress, Psychological | 2002 |
[Tobacco associated gastrointestinal disorders: smoking cessation therapy - a task for gastroenterologists].
Topics: Cognitive Behavioral Therapy; Combined Modality Therapy; Gastroenterology; Gastrointestinal Diseases; Humans; Nicotine; Patient Care Team; Psychotherapy, Group; Smoking; Smoking Cessation | 2002 |
[Behavioral and cognitive therapy to break the smoking habit. Review of the literature].
Topics: Cognitive Behavioral Therapy; Diet; Ganglionic Stimulants; Humans; Nicotine; Relaxation Therapy; Smoking Cessation; Social Support; Tobacco Use Disorder | 2002 |
Achieving tobacco cessation: current status, current problems, future possibilities.
Topics: Administration, Cutaneous; Administration, Inhalation; Antidepressive Agents, Second-Generation; Bupropion; Chewing Gum; Forecasting; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder; Treatment Failure | 2002 |
The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation.
Topics: Bupropion; Cost-Benefit Analysis; Dopamine Uptake Inhibitors; Ganglionic Stimulants; Humans; Nicotine; Smoking Cessation; Treatment Outcome | 2002 |
Pharmacotherapy for treating tobacco dependence: what is the ideal duration of therapy?
Topics: Bupropion; Clinical Trials as Topic; Drug Administration Schedule; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2002 |
The prospects for immunotherapy in smoking cessation.
Topics: Adolescent; Adult; Antibodies; Blood-Brain Barrier; Disease Models, Animal; Health Education; Humans; Needs Assessment; Nicotine; Patient Compliance; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Vaccination | 2002 |
Smoking cessation intervention in clinical practice.
Topics: Behavior Therapy; Bupropion; Humans; Nicotine; Patient Education as Topic; Primary Health Care; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2002 |
Nicotine replacement therapy for smoking cessation.
Topics: Administration, Cutaneous; Administration, Inhalation; Chewing Gum; Humans; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Prevention; Tablets | 2002 |
Chronic tolerance to nicotine in humans and its relationship to tobacco dependence.
Topics: Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Tolerance; Heart Rate; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2002 |
Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: a review.
Topics: Humans; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2002 |
A meta-analysis of the efficacy of over-the-counter nicotine replacement.
Topics: Drug Prescriptions; Humans; Nicotine; Nonprescription Drugs; Odds Ratio; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2003 |
Nicotine, body weight and potential implications in the treatment of obesity.
Topics: Animals; Body Weight; Humans; Nicotine; Obesity; Smoking Cessation | 2003 |
Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease.
Topics: Administration, Buccal; Administration, Intranasal; Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Risk Assessment; Smoking Cessation; Tobacco Use Disorder | 2003 |
Twenty-first century tobacco use: it is not just a risk factor anymore.
Topics: Administration, Cutaneous; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Risk Factors; Smoking; Smoking Cessation; Tobacco Use Disorder | 2003 |
Smoking: can we really make a difference?
Topics: Family Practice; Health Policy; Humans; Myocardial Ischemia; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Primary Health Care; Prognosis; Secondary Prevention; Smoking Cessation; Smoking Prevention; Social Support; State Medicine; United Kingdom | 2003 |
Smoking cessation in the elderly.
Topics: Administration, Cutaneous; Aged; Behavior Therapy; Clonidine; Counseling; Habits; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2003 |
Effects of the nicotine patch on performance during the first week of smoking cessation.
Topics: Administration, Cutaneous; Adult; Aged; Cognition; Double-Blind Method; Female; Humans; Linguistics; Male; Mathematics; Memory; Middle Aged; Nicotine; Nicotinic Agonists; Problem Solving; Reaction Time; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Visual Perception | 2003 |
Neuroplasticity within the mesoaccumbens dopamine system and its role in tobacco dependence.
Topics: Animals; Dopamine; Humans; Limbic System; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2002 |
Regulatory strategies to reduce tobacco addiction in youth.
Topics: Adolescent; Adolescent Behavior; Adult; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder; Tobacco, Smokeless; Toxins, Biological; United States | 2003 |
Clinical inquiries. What is the most effective nicotine replacement therapy?
Topics: Administration, Cutaneous; Administration, Inhalation; Chewing Gum; Evidence-Based Medicine; Ganglionic Stimulants; Humans; Nicotine; Primary Health Care; Severity of Illness Index; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2003 |
Pharmacotherapies to enhance smoking cessation during pregnancy.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Intranasal; Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Chewing Gum; Delayed-Action Preparations; Female; Humans; Nicotine; Pregnancy; Smoking; Smoking Cessation; Smoking Prevention | 2003 |
The role of pharmacotherapy in assisting smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Dosage Forms; Drug Administration Routes; Drug Therapy, Combination; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2003 |
Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review.
Topics: Affect; Cognition; Ganglionic Stimulants; Humans; Nicotine; Reinforcement, Psychology; Smoking; Smoking Cessation; Social Behavior; Tobacco Use Disorder; Treatment Outcome | 2003 |
Smoking cessation strategies in patients with peripheral arterial disease: an evidence-based approach.
Topics: Arteriosclerosis; Bupropion; Counseling; Humans; Nicotine; Peripheral Vascular Diseases; Smoking Cessation | 2003 |
Smoking cessation interventions in cardiovascular patients.
Topics: Behavior Therapy; Cardiovascular Diseases; Counseling; Humans; Nicotine; Patient Education as Topic; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2003 |
Placebo effects of tobacco smoking and other nicotine intake.
Topics: Clinical Trials as Topic; Environment; Ganglionic Stimulants; Humans; Nicotine; Placebo Effect; Research Design; Smoking; Smoking Cessation | 2003 |
[Nicotine-related mental disorders].
Topics: Animals; Behavior Therapy; Central Nervous System; Child Behavior Disorders; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Maternal Exposure; Maternal-Fetal Exchange; Neonatal Abstinence Syndrome; Nicotine; Pregnancy; Smoking; Smoking Cessation; Tobacco Smoke Pollution; Tobacco Use Disorder | 2003 |
Smoking cessation.
Topics: Adult; Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Humans; Nicotine; Prevalence; Respiratory Therapy; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; United States | 2003 |
Are nicotine replacement strategies to facilitate smoking cessation safe?
Topics: Animals; Canada; Contraindications; Drug Interactions; Humans; Nicotine; Nicotinic Agonists; Risk Factors; Safety; Smoking Cessation; Tobacco Use Disorder | 2003 |
Treating nicotine addiction.
Topics: Acupuncture Therapy; Administration, Cutaneous; Anti-Anxiety Agents; Bupropion; Counseling; Dopamine Uptake Inhibitors; Exercise Therapy; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2003 |
[Prevention of chronic obstructive pulmonary disease (primary prevention and secondary prevention)].
Topics: Adolescent; Behavior Therapy; Disease Progression; Health Education; Humans; Nicotine; Primary Prevention; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Tobacco Smoke Pollution; Tobacco Use Disorder | 2003 |
[New drug therapy of chronic obstructive pulmonary disease].
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Antidepressive Agents; Antioxidants; Bronchodilator Agents; Bupropion; Cholinergic Antagonists; Disease Progression; Drug Design; Humans; Nicotine; Protease Inhibitors; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Theophylline | 2003 |
Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion.
Topics: Animals; Bupropion; Disease Models, Animal; Extinction, Psychological; Humans; Nicotine; Reinforcement Schedule; Smoking Cessation; Tobacco Use Disorder | 2003 |
[New therapeutic options for smoking cessation. Nicotine polacrilex tablets for tobacco cessation].
Topics: Central Nervous System Stimulants; Clinical Trials as Topic; Humans; Nicotine; Patient Compliance; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Tobacco Use Cessation Devices | 2003 |
Tobacco use and dependence.
Topics: Health Education; Humans; Nicotine; Nursing Methodology Research; Oncology Nursing; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; United States | 2003 |
The four Ds deconstructed.
Topics: Australia; Female; Humans; Male; Nicotine; Smoking Cessation | 2003 |
Current pharmacological treatments for nicotine dependence.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Drug Therapy; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2004 |
Smokeless tobacco use: harm reduction or induction approach?
Topics: Humans; Mouth Neoplasms; Nicotine; Smoking; Smoking Cessation; Tobacco, Smokeless | 2004 |
Nicotine replacement therapy.
Topics: Administration, Cutaneous; Administration, Oral; Breast Feeding; Cardiovascular Diseases; Chewing Gum; Contraindications; Female; Ganglionic Stimulants; Humans; Nicotine; Pregnancy; Pregnancy Complications; Safety; Smoking Cessation; Smoking Prevention | 2004 |
Bupropion and other non-nicotine pharmacotherapies.
Topics: Administration, Inhalation; Adrenergic alpha-Agonists; Antidepressive Agents, Second-Generation; Bupropion; Clonidine; Dopamine Uptake Inhibitors; Drug Interactions; Humans; Mecamylamine; Nicotine; Nicotinic Antagonists; Smoking Cessation | 2004 |
[Update on the treatment of tobacco dependence].
Topics: Behavior Therapy; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation | 2004 |
[Withdrawal of tobacco: a critical appraisal and future chances of cure].
Topics: Humans; Nicotine; Reproducibility of Results; Smoking Cessation | 2004 |
Economic rewarding of smoking cessation-facilitating drugs--a comparison of over-the-counter and prescribed nicotine replacement therapy.
Topics: Bupropion; Clinical Trials as Topic; Dopamine Uptake Inhibitors; Dosage Forms; Drug Prescriptions; Humans; Nicotine; Nonprescription Drugs; Smoking Cessation | 2004 |
Kicking butt. A review of smoking cessation strategies.
Topics: Aftercare; Antidepressive Agents; Complementary Therapies; Humans; Hypnosis; Information Services; Internet; Nicotine; Nurse Practitioners; Nurse's Role; Patient Education as Topic; Patient-Centered Care; Primary Health Care; Recurrence; Smoking Cessation; Treatment Outcome | 2004 |
[The neurobiology of nicotine addiction].
Topics: Adaptation, Physiological; Dopamine; Humans; Neurobiology; Neurotransmitter Agents; Nicotine; Receptors, Cholinergic; Risk Factors; Sensitivity and Specificity; Smoking; Smoking Cessation; Tobacco Use Disorder | 2004 |
Smoking cessation and weight gain.
Topics: Body Composition; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Female; Humans; Insulin Resistance; Nicotine; Obesity; Randomized Controlled Trials as Topic; Risk Factors; Smoking Cessation; Weight Gain | 2004 |
Does bupropion have advantages over other medical therapies in the cessation of smoking?
Topics: Administration, Cutaneous; Aged; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder; Weight Gain | 2004 |
[Treatment of tobacco dependence: brief and intensive clinical intervention].
Topics: Anxiety; Bupropion; Cognitive Behavioral Therapy; Depression; Dopamine Uptake Inhibitors; Ganglionic Stimulants; Health Personnel; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2004 |
The blind spot in the nicotine replacement therapy literature: assessment of the double-blind in clinical trials.
Topics: Controlled Clinical Trials as Topic; Double-Blind Method; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation | 2004 |
"Not lighting up": a case study of a woman who quit smoking.
Topics: Adolescent; Adult; Behavior, Addictive; Cause of Death; Child; Female; Humans; Incidence; Lung Neoplasms; Male; Mass Media; Middle Aged; Nicotine; Oncology Nursing; Patient Advocacy; Peer Group; Periodontal Diseases; Prevalence; Reinforcement, Social; Risk Assessment; Self Concept; Smoking; Smoking Cessation; Smoking Prevention; Survival Rate; United States; Women's Health | 2004 |
Smoking-cessation interventions by type of provider: a meta-analysis.
Topics: Counseling; Humans; Nicotine; Nicotinic Agonists; Nurse's Role; Outcome and Process Assessment, Health Care; Physician's Role; Psychology; Smoking Cessation | 2004 |
Treating nicotine use and dependence of pregnant and parenting smokers: an update.
Topics: Adult; Counseling; Female; Humans; Infant; Infant Welfare; Infant, Newborn; Nicotine; Parent-Child Relations; Practice Guidelines as Topic; Pregnancy; Smoking Cessation; Tobacco Smoke Pollution; Tobacco Use Disorder | 2004 |
Pharmacotherapy for smoking cessation during pregnancy.
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Female; Ganglionic Stimulants; Humans; Nicotine; Pregnancy; Pregnancy Complications; Risk Factors; Smoking; Smoking Cessation; Tobacco Use Disorder | 2004 |
Reducing risk in smokers.
Topics: Bupropion; Chewing Gum; Counseling; Dopamine Uptake Inhibitors; Humans; Lung Neoplasms; Nicotine; Risk Reduction Behavior; Smoking; Smoking Cessation; Tobacco Use Disorder | 2004 |
Can transdermal nicotine patch cause acute intoxication in a child? A case report and review of literature.
Topics: Administration, Cutaneous; Child; Drug Overdose; Humans; Male; Nicotine; Nicotinic Agonists; Smoking Cessation | 2004 |
Cigarette smoking: Evidence to guide measurement.
Topics: Adolescent; Adolescent Behavior; Biomarkers; Carbon Monoxide; Cotinine; Female; Half-Life; Humans; Male; Nicotine; Nursing Research; Smoking; Smoking Cessation | 2004 |
Nicotine replacement therapy for smoking cessation.
Topics: Administration, Cutaneous; Administration, Inhalation; Chewing Gum; Humans; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Prevention; Tablets | 2004 |
[Tobacco dishabituation: therapeutic attitude in patients in preparation phase].
Topics: Counseling; Habituation, Psychophysiologic; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2004 |
Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women.
Topics: Adult; Double-Blind Method; Female; Humans; Male; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder | 2004 |
Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials.
Topics: Clinical Trials as Topic; Data Collection; Endpoint Determination; Ganglionic Stimulants; Humans; Nicotine; Patient Dropouts; Recurrence; Research Design; Smoking Cessation; Substance Withdrawal Syndrome; Terminology as Topic; Tobacco Use Disorder | 2004 |
Cigarette smoking and nicotine dependence.
Topics: Adult; Behavior Therapy; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder | 2004 |
Smoking and depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Depression; Humans; Nicotine; Nicotinic Agonists; Risk Factors; Smoking; Smoking Cessation | 2004 |
Pharmacotherapy of tobacco dependence.
Topics: Adrenergic alpha-Agonists; Adult; Antidepressive Agents, Second-Generation; Bupropion; Clonidine; Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder; United States | 2004 |
Promoting tobacco cessation and relapse prevention.
Topics: Adult; Antidepressive Agents; Behavior Therapy; Humans; Motivation; Nicotine; Nicotinic Agonists; Patient Education as Topic; Secondary Prevention; Smoking Cessation; Tobacco Use Disorder | 2004 |
Smoking and sleep disorders.
Topics: Humans; Nicotine; Nicotinic Agonists; Sleep; Sleep Wake Disorders; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2004 |
[Methods and cost effectiveness of nicotine abstinence].
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cost-Benefit Analysis; Humans; Nicotine; Poland; Smoking Cessation; Tobacco Use Disorder | 2004 |
Does extended proactive telephone support increase smoking cessation among low-income women using nicotine patches?
Topics: Administration, Cutaneous; Adolescent; Adult; Female; Follow-Up Studies; Humans; Logistic Models; Middle Aged; Nicotine; Nicotinic Agonists; Outcome and Process Assessment, Health Care; Patient Compliance; Poverty; Smoking Cessation; Social Support; Telemedicine; Treatment Outcome | 2005 |
Pharmacologic management of relapse prevention in addictive disorders.
Topics: Administration, Cutaneous; Administration, Oral; Alcohol Deterrents; Alcoholism; Behavior, Addictive; Disulfiram; Humans; Naltrexone; Narcotics; Nicotine; Smoking Cessation; Smoking Prevention; Substance-Related Disorders | 2004 |
[Smoking cessation].
Topics: Female; Finland; Health Services Needs and Demand; Humans; Male; Nicotine; Risk Assessment; Smoking Cessation; Tobacco Use Disorder | 2004 |
Assisting with tobacco cessation.
Topics: Algorithms; Attitude to Health; Behavior Therapy; Cost of Illness; Cost-Benefit Analysis; Counseling; Decision Trees; Helping Behavior; Humans; Motivation; Nicotine; Nurse's Role; Nursing Assessment; Patient Education as Topic; Practice Guidelines as Topic; Prevalence; Quality of Life; Recurrence; Smoking Cessation; Social Support; Tobacco Use Disorder; United States | 2004 |
Sparing a few minutes for tobacco cessation: if only half of all nurses helped one patient per month quit smoking, more than 12 million smokers would overcome their addictions every year.
Topics: Adult; Female; Humans; Male; Nicotine; Nurse's Role; Smoking; Smoking Cessation; United States | 2004 |
Management of tobacco dependence in older adults: using evidence-based strategies.
Topics: Aftercare; Aged; Algorithms; Attitude to Health; Counseling; Decision Trees; Evidence-Based Medicine; Geriatric Nursing; Health Knowledge, Attitudes, Practice; Humans; Models, Psychological; Motivation; Nicotine; Nurse's Role; Nursing Assessment; Patient Education as Topic; Risk Factors; Smoking Cessation; Tobacco Use Disorder | 2004 |
Relapse prevention interventions for smoking cessation.
Topics: Behavior Therapy; Chewing Gum; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pregnancy; Randomized Controlled Trials as Topic; Secondary Prevention; Smoking Cessation; Smoking Prevention | 2005 |
State-of-the-art interventions for office-based parental tobacco control.
Topics: Counseling; Health Education; Humans; Nicotine; Parents; Pediatrics; Smoking; Smoking Cessation; Tobacco Smoke Pollution; Tobacco Use Disorder | 2005 |
Impact of nicotine replacement therapy on smoking behavior.
Topics: Chemistry, Pharmaceutical; Community Health Planning; Drug Approval; Drug Costs; Drug Utilization; Evidence-Based Medicine; Humans; Licensure, Pharmacy; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Public Health; Safety; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; United States; United States Food and Drug Administration | 2005 |
Helping patients to quit smoking.
Topics: Behavior Therapy; Counseling; Family Practice; Humans; Nicotine; Nicotinic Agonists; Patient Education as Topic; Practice Guidelines as Topic; Smoking Cessation; Smoking Prevention | 2005 |
[Nicotine replacement therapy--method for smoking cessation].
Topics: Administration, Cutaneous; Administration, Intranasal; Clinical Trials as Topic; Humans; Nicotine; Nonprescription Drugs; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2004 |
The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens [corrected].
Topics: Conditioning, Classical; Dopamine; Drug Administration Routes; Humans; Neurons; Nicotine; Nucleus Accumbens; Psychological Theory; Smoking Cessation; Synapses; Tobacco Use Disorder | 2004 |
The impact of smoking cessation on objective and subjective markers of sleep: review, synthesis, and recommendations.
Topics: Administration, Cutaneous; Arousal; Brain; Bupropion; Circadian Rhythm; Dopamine Uptake Inhibitors; Drug Administration Routes; Electroencephalography; Ganglionic Stimulants; Heart Rate; Humans; Nicotine; Sleep Deprivation; Sleep, REM; Smoking Cessation; Sympathetic Nervous System; Tobacco Use Disorder; Vagus Nerve | 2004 |
A sensitization-homeostasis model of nicotine craving, withdrawal, and tolerance: integrating the clinical and basic science literature.
Topics: Adolescent; Behavior, Addictive; Humans; Models, Neurological; Nicotine; Receptors, Cholinergic; Receptors, Muscarinic; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2005 |
Review article: smoking cessation as primary therapy to modify the course of Crohn's disease.
Topics: Behavior Therapy; Bupropion; Cohort Studies; Colitis, Ulcerative; Counseling; Crohn Disease; Dopamine Uptake Inhibitors; Genetic Predisposition to Disease; Humans; Nicotine; Nicotinic Agonists; Patient Compliance; Recurrence; Remote Consultation; Sex Factors; Smoking; Smoking Cessation; Telephone | 2005 |
Smoking cessation: what works in primary care settings.
Topics: Bupropion; Counseling; Education, Medical, Continuing; Evidence-Based Medicine; Guideline Adherence; Humans; Internet; Nicotine; Practice Guidelines as Topic; Primary Health Care; Smoking; Smoking Cessation; Smoking Prevention; United States | 2005 |
Smoke-free nurses: leading by example.
Topics: Cardiovascular Diseases; Gastrointestinal Diseases; Humans; Lung Diseases; Neoplasms; Nicotine; Nicotinic Agonists; Nurses; Smoking; Smoking Cessation | 2005 |
Toward a comprehensive long term nicotine policy.
Topics: Health Policy; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Tobacco, Smokeless | 2005 |
Nicotine replacement therapy and ischaemic stroke.
Topics: Administration, Cutaneous; Adult; Aged; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation | 2005 |
[What smoking cessation interventions are effective in pregnant women?].
Topics: Breast Feeding; Female; Fetus; Humans; Infant, Newborn; Nicotine; Pregnancy; Smoking; Smoking Cessation | 2005 |
[Cessation of smoking: implementation of effective techniques. Prenatal and hospital pregnancy consultations with smoking women and/or smoking couples].
Topics: Biomarkers; Clinical Protocols; Female; Humans; Male; Nicotine; Pregnancy; Prenatal Care; Psychological Tests; Smoking; Smoking Cessation | 2005 |
Smoking cessation in patients with coronary artery disease.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Atherosclerosis; Behavior Therapy; Bupropion; Carbon Monoxide; Coronary Disease; Double-Blind Method; Hemodynamics; Humans; Hypoxia; Nicotine; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Thrombophilia; Tobacco Use Disorder; Vasoconstriction | 2005 |
[Recommendation of smoking cessation for diabetic patients].
Topics: Arteriosclerosis; Counseling; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Humans; Insulin; Insulin Resistance; Insulin Secretion; Myocardial Infarction; Nicotine; Physician's Role; Risk Factors; Smoking; Smoking Cessation; Stroke | 2005 |
Distress tolerance and early smoking lapse.
Topics: Adaptation, Psychological; Affective Symptoms; Combined Modality Therapy; Humans; Nicotine; Personality Assessment; Psychotherapy, Group; Recurrence; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2005 |
Self-help interventions for smoking cessation.
Topics: Behavior Therapy; Chewing Gum; Humans; Nicotine; Patient Education as Topic; Polymethacrylic Acids; Polyvinyls; Randomized Controlled Trials as Topic; Self Care; Smoking Cessation; Smoking Prevention | 2005 |
Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking.
Topics: Behavior, Addictive; Ethics, Research; Humans; Neurosciences; Nicotine; Pharmacogenetics; Primary Prevention; Public Policy; Research Design; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2005 |
Helping surgical patients quit smoking: why, when, and how.
Topics: Anesthesia; Humans; Nicotine; Nicotinic Agonists; Preoperative Care; Smoking Cessation; Surgical Procedures, Operative; Treatment Outcome | 2005 |
Pharmacotherapy and pharmacogenetics of nicotine dependence.
Topics: Administration, Cutaneous; Administration, Intranasal; Animals; Animals, Genetically Modified; Bupropion; Clinical Trials as Topic; Disease Models, Animal; Drug Design; Genetic Predisposition to Disease; Genotype; Humans; Nicotine; Pharmacogenetics; Phenotype; Smoking Cessation; Tobacco Use Disorder; United States | 2005 |
Adverse effects of pharmacological therapy for nicotine addiction in smokers following a smoking cessation program.
Topics: Bupropion; Female; Humans; Longitudinal Studies; Male; Nicotine; Prospective Studies; Smoking Cessation; Tobacco Use Disorder | 2005 |
How does bupropion work as a smoking cessation aid?
Topics: Administration, Cutaneous; Bupropion; Dopamine; Dopamine Uptake Inhibitors; Double-Blind Method; Humans; Nicotine; Norepinephrine; Receptors, Nicotinic; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2005 |
Executive summary: nicotine addiction.
Topics: Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2005 |
Smoking cessation--part III: Pharmacotherapy of smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Humans; Nicotine; Smoking; Smoking Cessation | 2005 |
Medication screening for smoking cessation: a proposal for new methodologies.
Topics: Administration, Cutaneous; Administration, Oral; Antidepressive Agents, Second-Generation; Bupropion; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Motivation; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2006 |
Do smokers with alcohol problems have more difficulty quitting?
Topics: Alcoholism; Humans; Nicotine; Smoking; Smoking Cessation; Substance-Related Disorders; Temperance | 2006 |
Will the next generation of "safer" cigarettes be safer?
Topics: Consumer Product Safety; Harm Reduction; Humans; Nicotiana; Nicotine; Smoking Cessation; Smoking Prevention; Tars | 2005 |
[Medications in smoking cessation].
Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Bupropion; Cannabinoid Receptor Antagonists; Cannabinoids; Central Nervous System Stimulants; Chewing Gum; Child; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Piperidines; Polymethacrylic Acids; Polyvinyls; Pyrazoles; Rimonabant; Smoking Cessation; Surveys and Questionnaires; Time Factors; Tobacco Use Cessation Devices | 2005 |
Nicotine delivery systems.
Topics: Area Under Curve; Drug Delivery Systems; Humans; Metabolic Clearance Rate; Nicotine; Smoking Cessation | 2005 |
Smoking cessation therapy and the return of aviators to flying duty.
Topics: Aerospace Medicine; Antidepressive Agents; Humans; Nicotine; Nicotinic Agonists; Psychomotor Performance; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2005 |
[Assisting smoking cessation].
Topics: Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Surveys and Questionnaires | 2005 |
Nicotine and nonnicotine factors in cigarette addiction.
Topics: Association Learning; Cues; Humans; Infusions, Intravenous; Injections, Intravenous; Nicotine; Perception; Sensation; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2006 |
A review of smoking cessation interventions.
Topics: Clinical Trials as Topic; Humans; Nicotine; Practice Guidelines as Topic; Prognosis; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2005 |
Perioperative abstinence from cigarettes: physiologic and clinical consequences.
Topics: Animals; Cardiovascular Physiological Phenomena; Humans; Nervous System Physiological Phenomena; Nicotine; Nicotinic Agonists; Perioperative Care; Respiratory Physiological Phenomena; Risk; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Wound Healing | 2006 |
Nicotine psychopharmacology research contributions to United States and global tobacco regulation: a look back and a look forward.
Topics: Animals; Brain; Forecasting; Health Policy; Humans; Nicotine; Research; Smoking; Smoking Cessation; Tobacco Industry; Tobacco Use Disorder; United States; United States Food and Drug Administration | 2006 |
Nicotine psychobiology: how chronic-dose prospective studies can illuminate some of the theoretical issues from acute-dose research.
Topics: Adolescent; Adult; Attention; Awareness; Chronic Disease; Cognitive Dissonance; Depression; Humans; Models, Psychological; Nicotine; Prospective Studies; Self Medication; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Developments in pharmacotherapy for tobacco dependence: past, present and future.
Topics: Adolescent; Adult; Bupropion; Clinical Trials as Topic; Clonidine; Drug Administration Routes; Female; Humans; Male; Nicotine; Nicotinic Agonists; Nortriptyline; Pregnancy; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2006 |
Pharmacological approaches to smoking cessation.
Topics: Bupropion; Dopamine Uptake Inhibitors; Drug Therapy; Humans; Models, Psychological; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder | 2007 |
The use of the nicotine inhaler in smoking cessation.
Topics: Administration, Inhalation; Behavior Therapy; Clinical Trials as Topic; Combined Modality Therapy; Counseling; Equipment Design; Humans; Nebulizers and Vaporizers; Nicotine; Nicotinic Agonists; Nurse Practitioners; Nurse's Role; Patient Education as Topic; Patient Selection; Practice Guidelines as Topic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2006 |
Therapeutic vaccines for nicotine dependence.
Topics: Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder; Vaccines | 2006 |
Pharmacologic interventions for smoking cessation.
Topics: Administration, Cutaneous; Administration, Inhalation; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Critical Care; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Nurse's Role; Patient Education as Topic; Patient Selection; Phytotherapy; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Smoking Prevention; United States; United States Food and Drug Administration; Varenicline | 2006 |
Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies.
Topics: Animals; Antibodies; Humans; Immunization; Immunotherapy; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2006 |
Tailoring nicotine replacement therapy: rationale and potential approaches.
Topics: Animals; Drug Delivery Systems; Drug Eruptions; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder | 2006 |
Smoking cessation.
Topics: Behavior Therapy; Counseling; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Social Support | 2006 |
Bupropion for smoking cessation: a review.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Nicotine; Secondary Prevention; Smoking; Smoking Cessation | 2006 |
A brief review of pharmacotherapies for smoking cessation.
Topics: Antidepressive Agents; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention | 2006 |
[Cigarette smoking and sleep disturbance].
Topics: Arousal; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Sleep; Sleep Wake Disorders; Smoking; Smoking Cessation | 2006 |
Bupropion for the treatment of nicotine withdrawal and craving.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Nicotine; Practice Patterns, Physicians'; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2006 |
Monoamine oxidase and tobacco dependence.
Topics: Animals; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nicotine; Nicotinic Agonists; Polymorphism, Genetic; Smoking Cessation; Tobacco Use Disorder | 2007 |
Nicotine replacement therapy for long-term smoking cessation: a meta-analysis.
Topics: Administration, Cutaneous; Administration, Inhalation; Adult; Chewing Gum; Follow-Up Studies; Humans; Middle Aged; Nicotine; Nicotinic Agonists; Nonprescription Drugs; Odds Ratio; Patient Compliance; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Time Factors | 2006 |
Smoking cessation 1: pharmacological treatments.
Topics: Bupropion; Clonidine; Female; Humans; Male; Nicotine; Smoking Cessation | 2006 |
Melanin and nicotine: A review of the literature.
Topics: Animals; Autoradiography; Carcinogens; Humans; Melanins; Melanosis; Melanosomes; Mice; Nicotiana; Nicotine; Smoking Cessation | 2006 |
Serious mental illness and smoking cessation.
Topics: Combined Modality Therapy; Humans; Mental Disorders; Motivation; Nicotine; Selective Serotonin Reuptake Inhibitors; Smoking Cessation; Tobacco Use Disorder | 2006 |
Tobacco use cessation for adolescents.
Topics: Adolescent; Algorithms; Animals; Antidepressive Agents; Behavior Therapy; Bupropion; Evidence-Based Medicine; Humans; Medical History Taking; Nicotine; Practice Guidelines as Topic; Psychology, Adolescent; Rats; Smoking Cessation | 2006 |
Evidence for smoking cessation: Implications for gender-specific strategies.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Counseling; Evidence-Based Medicine; Female; Humans; Male; Nicotine; Sex Factors; Smoking Cessation | 2005 |
Current and emerging treatment approaches for tobacco dependence.
Topics: Community Health Planning; Counseling; Health Personnel; Humans; Nicotine; Pharmaceutical Preparations; Smoking Cessation; Tobacco Use Disorder | 2006 |
Cost effectiveness analysis of smoking cessation interventions.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cost-Benefit Analysis; Counseling; Health Promotion; Humans; New South Wales; Nicotine; Nicotinic Agonists; Program Evaluation; Smoking Cessation | 2006 |
Possible effects on smokers of cigarette mentholation: a review of the evidence relating to key research questions.
Topics: Adult; Black or African American; Blood Pressure; Carbon Monoxide; Cotinine; Female; Health Behavior; Heart Rate; Humans; Lung Neoplasms; Male; Menthol; Nicotine; Prevalence; Respiratory Mechanics; Risk Factors; Sex Factors; Smoking; Smoking Cessation; Tars | 2007 |
A cost-effectiveness evaluation of single and combined smoking cessation interventions in Texas.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Bupropion; Clonidine; Cost-Benefit Analysis; Decision Trees; Drug Therapy, Combination; Health Care Costs; Humans; Nicotine; Nortriptyline; Smoking; Smoking Cessation; Texas; Tobacco Use Disorder; Treatment Outcome | 2006 |
[Pharmacological relapse prevention in alcohol and tobacco dependence].
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Clinical Trials as Topic; Combined Modality Therapy; Disulfiram; Humans; Naltrexone; Nicotine; Psychotherapy; Secondary Prevention; Smoking Cessation; Substance Withdrawal Syndrome; Taurine; Tobacco Use Disorder | 2007 |
Effectiveness of smoking cessation therapies: a systematic review and meta-analysis.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline | 2006 |
[Diagnosis and treatment of tobacco dependence].
Topics: Asthma; Comorbidity; Humans; Lung Diseases, Obstructive; Lung Neoplasms; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Poland; Prevalence; Public Health; Risk Factors; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2005 |
Non-nicotinic therapies for smoking cessation.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Drugs, Investigational; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
Overview of the pharmacogenomics of cigarette smoking.
Topics: Aryl Hydrocarbon Hydroxylases; Behavior, Addictive; Cytochrome P-450 CYP2A6; Dopamine; Dopamine Plasma Membrane Transport Proteins; Gene Expression Regulation, Enzymologic; Genetic Linkage; Genetic Predisposition to Disease; Genotype; Humans; Mixed Function Oxygenases; Nicotine; Patient Selection; Polymorphism, Single Nucleotide; Receptors, Cholinergic; Receptors, Dopamine; Research Design; Serotonin; Serotonin Plasma Membrane Transport Proteins; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Tryptophan Hydroxylase | 2007 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azocines; Benzazepines; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Varenicline | 2007 |
[Quit smoking is not just a matter or will].
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Humans; Nicotine; Nortriptyline; Smoking Cessation; Tobacco Use Disorder | 2006 |
[Alternative method of smoking cessation--reduce to stop].
Topics: Administration, Cutaneous; Administration, Inhalation; Chewing Gum; Female; Humans; Male; Motivation; Nicotine; Nicotinic Agonists; Program Evaluation; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Tobacco Smoke Pollution | 2006 |
[New prospects of nicotine dependence treatment--vaccines].
Topics: Antibodies; Humans; Nicotine; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Tobacco Use Disorder; Vaccination; Vaccines, Synthetic | 2006 |
[European experiences concerning schedules of the fight against the tobacco addiction].
Topics: Behavior, Addictive; Ethnicity; Government Programs; Humans; Motivation; Nicotine; Nicotinic Agonists; Patient Education as Topic; Smoking; Smoking Cessation; Tobacco Use Disorder; White People | 2006 |
Smoking cessation 3: multicomponent interventions.
Topics: Behavior Therapy; Bupropion; Clonidine; Combined Modality Therapy; Humans; Motivation; Nicotine; Nortriptyline; Psychotherapy, Brief; Smoking Cessation; Tobacco Use Disorder | 2007 |
Effects of abstinence from tobacco: valid symptoms and time course.
Topics: Female; Humans; Male; Mental Disorders; Meta-Analysis as Topic; Nicotine; Psychomotor Agitation; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
Effects of abstinence from tobacco: etiology, animal models, epidemiology, and significance: a subjective review.
Topics: Animals; Disease Models, Animal; Humans; Mental Disorders; Nicotine; Randomized Controlled Trials as Topic; Research Design; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
Treating smoking dependence in depressed alcoholics.
Topics: Alcoholism; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Depressive Disorder; Fructose; Humans; Nicotine; Psychotherapy, Group; Smoking Cessation; Topiramate | 2006 |
Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations.
Topics: Administration, Cutaneous; Administration, Inhalation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Coronary Artery Disease; Humans; Monoamine Oxidase Inhibitors; Nicotine; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Selective Serotonin Reuptake Inhibitors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline | 2007 |
The impact of cigarette smoking on periodontal disease and treatment.
Topics: Bacteria; Dental Implants; Humans; Nicotine; Nicotinic Agonists; Periodontal Diseases; Periodontium; Risk Factors; Smoking; Smoking Cessation; Tobacco Smoke Pollution | 2007 |
The most addictive drug, the most deadly substance: smoking cessation tactics for the busy clinician.
Topics: Age Factors; Benzazepines; Bupropion; Complementary Therapies; Dopamine Uptake Inhibitors; Dosage Forms; Humans; Nicotine; Nicotinic Agonists; Physician's Role; Primary Health Care; Quinoxalines; Referral and Consultation; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
The impact of pharmaceutical company funding on results of randomized trials of nicotine replacement therapy for smoking cessation: a meta-analysis.
Topics: Drug Industry; Humans; Nicotine; Nicotinic Agonists; Polymethacrylic Acids; Polyvinyls; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2007 |
Tobacco smoking within psychiatric inpatient settings: biopsychosocial perspective.
Topics: Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Drug Interactions; Humans; Interpersonal Relations; Mental Disorders; Nicotine; Patient Compliance; Psychiatric Department, Hospital; Psychotropic Drugs; Reinforcement, Psychology; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
Measurement of the effects of abstinence from tobacco: a qualitative review.
Topics: Anxiety; Humans; Nicotine; Predictive Value of Tests; Qualitative Research; Randomized Controlled Trials as Topic; Research Design; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
Pharmacogenetics and smoking cessation with nicotine replacement therapy.
Topics: Humans; Nicotine; Nicotinic Agonists; Pharmacogenetics; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention | 2007 |
Varenicline: the newest agent for smoking cessation.
Topics: Animals; Benzazepines; Clinical Trials, Phase III as Topic; Drug Interactions; Humans; Nicotine; Quinoxalines; Receptors, Cholinergic; Smoking Cessation; Varenicline | 2007 |
Managing smoking cessation.
Topics: Antidepressive Agents; Behavior Therapy; Counseling; Family Practice; Humans; Nicotine; Nicotinic Agonists; Patient Education as Topic; Physician-Patient Relations; Secondary Prevention; Smoking Cessation; Smoking Prevention | 2007 |
Interventions to reduce harm from continued tobacco use.
Topics: Biomarkers; Bupropion; Carbon Monoxide; Cotinine; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention | 2007 |
Metabolic and cardiovascular effects of smokeless tobacco.
Topics: Adult; Blood Pressure; Body Weight; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Heart Rate; Humans; Hypertension; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction; Nicotine; Nicotinic Agonists; Obesity; Risk Assessment; Risk Factors; Smoking Cessation; Stroke; Tobacco, Smokeless | 2006 |
Smoking cessation interventions in clinical practice.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Counseling; Humans; Motivation; Nicotine; Nicotinic Agonists; Physician-Patient Relations; Secondary Prevention; Smoking; Smoking Cessation; Tobacco Use Disorder | 2007 |
"Blowing in the wind": a review of teenage smoking.
Topics: Adolescent; Adolescent Behavior; Advertising; Culture; Family Relations; Global Health; Government Regulation; Humans; Mass Media; Nicotine; Nicotinic Agonists; Religion; Smoking; Smoking Cessation; Tobacco Use Disorder | 2008 |
Cytisine for smoking cessation: a research agenda.
Topics: Alkaloids; Animals; Azocines; Clinical Trials as Topic; Drug Overdose; Humans; Nicotine; Quinolizines; Smoking Cessation; Substance-Related Disorders | 2008 |
Optimizing on smoke free legislation making the most of the opportunity.
Topics: Benzazepines; Bupropion; Decision Trees; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Health Services Needs and Demand; Humans; Nicotine; Nicotinic Agonists; Nurse's Role; Patient Care Planning; Patient Education as Topic; Practice Guidelines as Topic; Public Facilities; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Social Support; United Kingdom; Varenicline | 2007 |
Genetics and smoking behavior.
Topics: Alleles; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2A6; Genetic Predisposition to Disease; Genetic Research; Humans; Mixed Function Oxygenases; Nicotine; Pharmacogenetics; Phenotype; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2007 |
Tobacco smoking, harm reduction, and nicotine product regulation.
Topics: Adult; Health Promotion; Humans; Mouth Neoplasms; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Industry; Tobacco, Smokeless; United Kingdom | 2008 |
Ten years after the Rx-to-OTC switch of nicotine replacement therapy: what have we learned about the benefits and risks of non-prescription availability?
Topics: Drug Prescriptions; Humans; Nicotine; Nonprescription Drugs; Smoking Cessation; Tobacco Use Disorder; United States | 2008 |
Treating tobacco dependence in women.
Topics: Benzazepines; Bupropion; Counseling; Dopamine Uptake Inhibitors; Female; Humans; Lung Neoplasms; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; United States; Varenicline; Women's Health | 2007 |
Vaccination against nicotine: an emerging therapy for tobacco dependence.
Topics: Animals; Carrier Proteins; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder; Vaccination; Vaccines | 2007 |
Gender differences in tobacco smoking dynamics and the neuropharmacological actions of nicotine.
Topics: Dopamine; Female; Hormones; Humans; Male; Menstrual Cycle; Nicotine; Pregnancy; Receptors, Nicotinic; Sex Factors; Smoking; Smoking Cessation; Substance-Related Disorders; Tobacco Use Disorder; Treatment Outcome | 2008 |
Smoking cessation: significance and implications for children.
Topics: Adult; Antidepressive Agents; Child; Female; Genetic Predisposition to Disease; Humans; Male; Nicotine; Receptors, Nicotinic; Sex Factors; Smoking; Smoking Cessation; Weight Gain | 2008 |
Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
Topics: Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Dopamine Uptake Inhibitors; Drug Administration Routes; Drug Partial Agonism; Drug Therapy, Combination; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Time Factors; Treatment Outcome; Varenicline | 2007 |
Genetics and smoking cessation improving outcomes in smokers at risk.
Topics: Bupropion; Controlled Clinical Trials as Topic; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Pharmacogenetics; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2007 |
Meta-analysis of studies investigating one-year effectiveness of transdermal nicotine patches for smoking cessation.
Topics: Administration, Cutaneous; Humans; Nicotine; Odds Ratio; Placebos; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2007 |
Hooked from the first cigarette.
Topics: Adolescent; Adolescent Behavior; Female; Humans; Nicotine; Patient Education as Topic; Smoking; Smoking Cessation; Smoking Prevention | 2007 |
Smoking to self-medicate attentional and emotional dysfunctions.
Topics: Affective Symptoms; Attention Deficit Disorder with Hyperactivity; Humans; Interpersonal Relations; Nicotine; Smoking; Smoking Cessation | 2007 |
Breaking the ties of nicotine dependence.
Topics: Algorithms; Benzazepines; Bupropion; Decision Trees; Dopamine Uptake Inhibitors; Drug Costs; Evidence-Based Medicine; Global Health; Humans; Nicotine; Nicotinic Agonists; Nurse Practitioners; Nurse's Role; Nursing Assessment; Patient Acceptance of Health Care; Patient Care Planning; Patient Education as Topic; Practice Guidelines as Topic; Prevalence; Primary Health Care; Quinoxalines; Risk Factors; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
An update on therapeutics for tobacco dependence.
Topics: Alkaloids; Anti-Anxiety Agents; Azocines; Benzazepines; Bupropion; Clinical Trials as Topic; Databases, Bibliographic; Humans; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinolizines; Quinoxalines; Review Literature as Topic; Rimonabant; Smoking; Smoking Cessation; Varenicline | 2008 |
Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.
Topics: Adolescent; Adult; Affect; Aged; Benzazepines; Bupropion; Clinical Trials, Phase III as Topic; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Follow-Up Studies; Humans; Middle Aged; Motivation; Multicenter Studies as Topic; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline | 2008 |
'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.
Topics: Adult; Age Factors; Aged; Costs and Cost Analysis; Decision Support Techniques; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quality of Life; Randomized Controlled Trials as Topic; Sex Factors; Smoking; Smoking Cessation | 2008 |
Smoking cessation and lung cancer: oncology nurses can make a difference.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Information Services; Lung Neoplasms; Nicotine; Oncology Nursing; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2008 |
Nicotine replacement therapy for smoking cessation.
Topics: Administration, Cutaneous; Administration, Inhalation; Chewing Gum; Humans; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Prevention; Tablets | 2008 |
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American; Bupropion; Cotinine; Cues; Cytochrome P-450 CYP2A6; Drug Tolerance; Genetic Predisposition to Disease; Harm Reduction; Humans; Menthol; Mixed Function Oxygenases; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Reinforcement, Psychology; Smoking; Smoking Cessation; Tobacco Use Disorder; United States; Varenicline; White People | 2008 |
Use of smoking cessation therapies in individuals with psychiatric illness : an update for prescribers.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cognitive Behavioral Therapy; Dopamine Uptake Inhibitors; Drug Prescriptions; Humans; Mental Disorders; Nicotine; Nortriptyline; Smoking Cessation; Tobacco Use Disorder | 2008 |
Nicotine patch therapy prior to quitting smoking: a meta-analysis.
Topics: Administration, Cutaneous; Humans; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking Cessation; Substance Withdrawal Syndrome | 2008 |
Self-help smoking cessation interventions in pregnancy: a systematic review and meta-analysis.
Topics: Adolescent; Adult; Behavior Therapy; Female; Humans; Nicotine; Nicotinic Agonists; Patient Education as Topic; Pregnancy; Randomized Controlled Trials as Topic; Self Care; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2008 |
Update on pharmacologic options for smoking cessation treatment.
Topics: Antidepressive Agents; Drug Administration Routes; Humans; Nicotine; Smoking Cessation; Smoking Prevention | 2008 |
Neurobiology of nicotine addiction: implications for smoking cessation treatment.
Topics: Humans; Neurobiology; Nicotine; Receptors, Nicotinic; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2008 |
Treatment of tobacco dependence.
Topics: Drug Administration Routes; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2008 |
Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bias; Bupropion; Data Interpretation, Statistical; Drug Therapy; Fluoxetine; Haloperidol; Humans; Imipramine; Meta-Analysis as Topic; Nicotine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Smoking Cessation; Treatment Outcome | 2008 |
Anti-nicotine abuse vaccines in the pipeline: an update.
Topics: Antibody Formation; Clinical Trials as Topic; Humans; Immunotherapy, Active; Nicotine; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Vaccines, Synthetic | 2008 |
Smoking cessation in pregnancy: why, how, and what next...
Topics: Behavior Therapy; Benzazepines; Bupropion; Counseling; Female; Humans; Nicotine; Pregnancy; Pregnancy Outcome; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2008 |
Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies.
Topics: Animals; Brain; Cannabinoid Receptor Modulators; Clinical Trials as Topic; Drug Evaluation, Preclinical; Emotions; Humans; Motivation; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Secondary Prevention; Smoking Cessation; Tobacco Use Disorder | 2008 |
Nicotine medications for smoking cessation.
Topics: Adolescent; Contraindications; Drug Interactions; Humans; Nicotine; Smoking Cessation; Substance-Related Disorders | 1995 |
Smoking cessation: time for action.
Topics: Adult; Family Practice; Forced Expiratory Volume; Hospitalization; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Nicotine; Smoking Cessation | 1995 |
Dose-related actions of nicotine on behavior and physiology: review and implications for replacement therapy for nicotine dependence.
Topics: Animals; Appetitive Behavior; Arousal; Brain; Chewing Gum; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Humans; Nicotine; Smoking; Smoking Cessation | 1989 |
Reduction of tobacco health hazards in continuing users: individual behavioral and public health approaches.
Topics: Attitude to Health; Coronary Disease; Dose-Response Relationship, Drug; Health Behavior; Health Education; Humans; Nicotine; Plants, Toxic; Public Health; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Smoke Pollution; Tobacco, Smokeless | 1989 |
Nicotine replacement therapy. What has been accomplished--can we do better?
Topics: Behavior Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
Smoking cessation programs.
Topics: Humans; Nebulizers and Vaporizers; Nicotine; Smoking Cessation; Weight Gain | 1995 |
The scientific case that nicotine is addictive.
Topics: Animals; Humans; Nicotine; Smoking; Smoking Cessation; Substance-Related Disorders | 1995 |
[Nicotine substitution as an aid in smoking cessation. Mechanisms of action, methods and evaluation of the results].
Topics: Administration, Cutaneous; Chewing Gum; Evaluation Studies as Topic; Humans; Nicotine; Receptors, Dopamine; Smoking Cessation; Substance Withdrawal Syndrome | 1995 |
Treatment of nicotine dependence.
Topics: Adult; Chewing Gum; Female; Humans; Male; Nicotine; Polymethacrylic Acids; Polyvinyls; Prevalence; Risk-Taking; Smoking; Smoking Cessation; Substance-Related Disorders; Tobacco Use Cessation Devices; United States | 1995 |
Nicotine chewing gum and nicotine patch.
Topics: Administration, Cutaneous; Chewing Gum; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Long-Term Care; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1995 |
Neural mechanisms underlying nicotine dependence.
Topics: Animals; Brain; Dopamine; Drug Tolerance; Humans; Nicotine; Receptors, Nicotinic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1994 |
Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities.
Topics: Animals; Arousal; Female; Humans; Infant, Newborn; Neonatal Abstinence Syndrome; Neurologic Examination; Nicotine; Pregnancy; Recurrence; Risk Factors; Smoking Cessation; Substance Withdrawal Syndrome | 1994 |
Treatments for smokers.
Topics: Behavior Therapy; Combined Modality Therapy; Humans; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 1994 |
Nicotine withdrawal symptoms. A review for primary care practitioners.
Topics: Adult; Depression; Humans; Nicotine; Primary Health Care; Recurrence; Smoking Cessation; Substance Withdrawal Syndrome | 1995 |
Nicotine, negative affect, and depression.
Topics: Combined Modality Therapy; Depression; Humans; Neurotransmitter Agents; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1993 |
Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Intranasal; Chewing Gum; Humans; Nicotine; Smoking Cessation | 1994 |
Nicotine dependence and schizophrenia.
Topics: Adult; Antipsychotic Agents; Comorbidity; Female; Humans; Male; Middle Aged; Nicotine; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1994 |
Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital. A placebo-controlled trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Affective Disorders, Psychotic; Aged; Blood Pressure; Body Weight; Combined Modality Therapy; Dosage Forms; England; Female; Follow-Up Studies; Heart Rate; Hospitals, General; Humans; Male; Middle Aged; Nicotine; Outpatient Clinics, Hospital; Smoking Cessation; Social Support; Substance Withdrawal Syndrome; Treatment Outcome | 1993 |
Nicotine-replacement products in smoking cessation: a review.
Topics: Administration, Cutaneous; Aerosols; Chewing Gum; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Ion Exchange Resins; Male; Nebulizers and Vaporizers; Nicotine; Placebos; Polymethacrylic Acids; Polyvinyls; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 1993 |
Transdermal nicotine in smoking cessation. A meta-analysis.
Topics: Administration, Cutaneous; Adult; Aged; Female; Humans; Male; Middle Aged; Nicotine; Recurrence; Smoking Cessation; Weight Gain | 1993 |
How effective is nicotine replacement therapy in helping people to stop smoking?
Topics: Administration, Cutaneous; Chewing Gum; Drug Administration Schedule; Humans; Nicotine; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance-Related Disorders | 1994 |
An algorithm for smoking cessation.
Topics: Administration, Cutaneous; Algorithms; Behavior Therapy; Clinical Protocols; Humans; Nicotine; Smoking Cessation | 1994 |
Nicotine dependence--mechanisms and therapeutic strategies.
Topics: Animals; Humans; Nicotine; Receptors, Nicotinic; Smoking; Smoking Cessation; Substance-Related Disorders | 1993 |
[Drug aid to tobacco withdrawal].
Topics: Humans; Mecamylamine; Nicotine; Smoking Cessation; Tobacco Use Disorder | 1993 |
Pharmacotherapy for smoking cessation: unvalidated assumptions, anomalies, and suggestions for future research.
Topics: Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Male; Motivation; Nicotine; Psychotherapy; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
Meta-analytical review of the efficacy of nicotine chewing gum in smoking treatment programs.
Topics: Chewing Gum; Clinical Trials as Topic; Humans; Nicotine; Smoking Cessation; Treatment Outcome | 1993 |
Nicotine patches.
Topics: Administration, Cutaneous; Humans; Nicotine; Smoking Cessation | 1993 |
The pros and cons of transdermal nicotine therapy.
Topics: Administration, Cutaneous; Cost-Benefit Analysis; Humans; Nicotine; Smoking Cessation; Treatment Outcome | 1994 |
The effectiveness of nicotine replacement therapies in smoking cessation.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Intranasal; Chewing Gum; Female; Humans; Male; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation; Treatment Outcome | 1994 |
Nicotine transdermal systems.
Topics: Administration, Cutaneous; Choice Behavior; Drug Interactions; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors | 1993 |
Chemical analyses as validators in smoking cessation programs.
Topics: Biomarkers; Biotransformation; Breath Tests; Carbon Monoxide; Cotinine; Follow-Up Studies; Humans; Metabolic Clearance Rate; Nicotine; Smoking Cessation; Thiocyanates | 1993 |
Nicotine dependence: diagnosis, chemistry, and pharmacologic treatments.
Topics: Acetates; Acetic Acid; Administration, Cutaneous; Adolescent; Chewing Gum; Clonidine; Female; Humans; Male; Nicotine; Plants, Toxic; Polymethacrylic Acids; Polyvinyls; Prevalence; Risk Factors; Scopolamine; Smoking; Smoking Cessation; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco, Smokeless | 1993 |
Smoking cessation: clinical steps to improve compliance.
Topics: Aftercare; Aged; Alcoholism; Comorbidity; Depressive Disorder; Female; Geriatrics; Humans; Male; Middle Aged; Motivation; Nicotine; Patient Compliance; Patient Education as Topic; Psychological Tests; Smoking Cessation; Stress, Psychological; Teaching Materials | 1993 |
Office evaluation and treatment of the dependent smoker.
Topics: Combined Modality Therapy; Family Practice; Humans; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
Cigarette smoking: implications for psychiatric illness.
Topics: Adolescent; Brain Chemistry; Comorbidity; Depressive Disorder; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotine; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Smoking Prevention; Substance-Related Disorders | 1993 |
Possible effects of smoke-free inpatient units on psychiatric diagnosis and treatment.
Topics: Ambulatory Care; Hospitalization; Humans; Mental Disorders; Nicotine; Psychiatric Department, Hospital; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 1993 |
Risk-benefit assessment of nicotine preparations in smoking cessation.
Topics: Humans; Nicotine; Risk Factors; Smoking Cessation | 1993 |
Smoking cessation leads to reduced stress, but why?
Topics: Adaptation, Psychological; Affect; Arousal; Follow-Up Studies; Humans; Longitudinal Studies; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1995 |
[Smoking cessation with the nicotine patch].
Topics: Administration, Cutaneous; Behavior Therapy; Clinical Trials as Topic; Combined Modality Therapy; Follow-Up Studies; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1995 |
The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline.
Topics: Counseling; Delivery of Health Care; Humans; Nicotine; Primary Health Care; Smoking Cessation; Social Support; United States; United States Agency for Healthcare Research and Quality | 1996 |
Prescribing nicotine substitutes for tobacco cessation: considerations and contraindications.
Topics: Administration, Cutaneous; Behavior Therapy; Chewing Gum; Contraindications; Dentists; Humans; Nicotine; Patient Selection; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 1994 |
Pharmacological interventions for smoking cessation.
Topics: Cotinine; Humans; Nicotine; Smoking; Smoking Cessation | 1996 |
Nicotine addiction and treatment.
Topics: Humans; Nicotine; Psychotropic Drugs; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome | 1996 |
Measuring tobacco withdrawal: a review of self-report questionnaires.
Topics: Arousal; Humans; Neurologic Examination; Nicotine; Personality Inventory; Psychometrics; Reproducibility of Results; Smoking Cessation; Substance Withdrawal Syndrome | 1996 |
The benefits of stopping smoking and the role of nicotine replacement therapy in older patients.
Topics: Administration, Cutaneous; Aged; Aging; Cardiovascular Diseases; Ganglionic Stimulants; Humans; Lung Neoplasms; Nicotine; Risk Factors; Smoking; Smoking Cessation | 1996 |
Practice guideline for the treatment of patients with nicotine dependence. American Psychiatric Association.
Topics: Adolescent; Adult; Aged; Chewing Gum; Female; Humans; Male; Middle Aged; Nicotine; Patient Education as Topic; Polymethacrylic Acids; Polyvinyls; Psychotherapy; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder | 1996 |
Smoking cessation.
Topics: Administration, Cutaneous; Adult; Behavior Therapy; Central Nervous System Stimulants; Chewing Gum; Health Behavior; Humans; Motivation; Nicotine; Recurrence; Smoking Cessation | 1996 |
Current approaches in smoking cessation.
Topics: Antidepressive Agents; Behavior Therapy; Ganglionic Stimulants; Humans; Nicotine; Practice Guidelines as Topic; Smoking Cessation; Tobacco Use Disorder; United States; United States Agency for Healthcare Research and Quality | 1996 |
The additive effects of smoking and hypertension. More reasons to help your patients kick the habit.
Topics: Antihypertensive Agents; Cardiovascular System; Humans; Hypertension; Nicotine; Risk Factors; Smoking; Smoking Cessation | 1996 |
Prevention of lung cancer: the key is to stop smoking.
Topics: Behavior Therapy; Humans; Lung Neoplasms; Mass Screening; Nicotine; Nicotinic Agonists; Primary Prevention; Smoking; Smoking Cessation; Smoking Prevention | 1996 |
Smoking, smoking withdrawal and schizophrenia: case reports and a review of the literature.
Topics: Adult; Arousal; Chronic Disease; Dopamine; Humans; Male; Nicotine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation | 1996 |
Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders.
Topics: Alzheimer Disease; Animals; Behavior, Animal; Clinical Trials as Topic; Drug Carriers; Humans; Nicotine; Nicotinic Agonists; Parkinson Disease; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders | 1996 |
Helping your patients to quit smoking.
Topics: Humans; Motivation; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder | 1997 |
Subgroups of smokers with different success rates after use of transdermal nicotine.
Topics: Administration, Cutaneous; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Randomized Controlled Trials as Topic; Recurrence; Smoking Cessation; Smoking Prevention; Survival Analysis; Treatment Outcome | 1997 |
Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy.
Topics: Administration, Cutaneous; Arteriosclerosis; Blood Platelets; Cardiovascular Diseases; Cardiovascular System; Hemodynamics; Humans; Nicotine; Smoking; Smoking Cessation | 1997 |
A pathophysiological basis for informed preoperative smoking cessation counseling.
Topics: Carbon Monoxide; Counseling; Humans; Nicotine; Nitric Oxide; Smoke; Smoking; Smoking Cessation; Tars | 1997 |
[Support and guidelines, nicotine substitutes and clonidine have positive effects on smoking cessation. Five Cochrane meta-analyses on agents used in smoking cessation].
Topics: Adrenergic alpha-Agonists; Clonidine; Counseling; Denmark; Humans; Meta-Analysis as Topic; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation; Social Support | 1997 |
Smoking and nicotine addiction: a pediatric epidemic with sequelae in adulthood.
Topics: Adolescent; Adolescent Behavior; Adult; Child; Comorbidity; Female; Humans; Nicotine; Pregnancy; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Smoke Pollution; Tobacco Use Disorder; United States | 1997 |
Nicotine addiction and smoking cessation.
Topics: Adult; Female; Humans; Louisiana; Male; Nicotine; Prevalence; Prognosis; Smoking; Smoking Cessation; Survival Rate; Tobacco Smoke Pollution; Tobacco Use Disorder | 1997 |
Nicotine and endogenous opioids: toward specific pharmacotherapy.
Topics: Animals; Brain; Clinical Trials as Topic; Humans; Narcotic Antagonists; Nicotine; Opioid Peptides; Receptors, Opioid; Smoking; Smoking Cessation | 1998 |
Transdermal nicotine replacement smoking cessation therapy.
Topics: Administration, Cutaneous; Heart Diseases; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation | 1998 |
The role of the dental team in helping patients stop using tobacco.
Topics: Central Nervous System Stimulants; Chewing Gum; Dental Staff; Humans; Medical History Taking; Nicotine; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 1996 |
Tobacco smoking and nicotine dependence: biological basis for pharmacotherapy from nicotine to treatments that prevent relapse.
Topics: Central Nervous System Stimulants; Dopamine; Humans; Nicotine; Nucleus Accumbens; Polymethacrylic Acids; Polyvinyls; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Failure | 1998 |
Cigarette smoking and major depression.
Topics: Administration, Cutaneous; Adult; Aged; Comorbidity; Depressive Disorder; Female; Humans; Male; Middle Aged; Nicotine; Prevalence; Recurrence; Risk Factors; Severity of Illness Index; Smoking; Smoking Cessation; Smoking Prevention | 1998 |
Reduced smoking--an acceptable goal for the hopeless heavy smoker?
Topics: Humans; Nicotine; Smoking Cessation | 1998 |
Nicotine replacement: a new approach to reducing tobacco-related harm.
Topics: Gingiva; Humans; Nicotine; Plants, Toxic; Smoking Cessation; Tobacco, Smokeless | 1998 |
Bupropion sustained release and smoking cessation.
Topics: Administration, Cutaneous; Adult; Ambulatory Care; Bupropion; Clinical Trials as Topic; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Male; Mood Disorders; Nicotine; Practice Guidelines as Topic; Self Medication; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 1998 |
A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch.
Topics: Administration, Cutaneous; Cardiovascular Diseases; Dermatitis, Contact; Drug Delivery Systems; Female; Humans; Male; Nausea; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Regression Analysis; Respiration; Risk Assessment; Sleep Wake Disorders; Smoking Cessation; Tobacco Use Disorder; Vomiting | 1998 |
Tobacco and cancer: approaches using carcinogen biomarkers and chemoprevention.
Topics: Adult; Animals; Anticarcinogenic Agents; Biomarkers; Carcinogens; Chemoprevention; Humans; Isothiocyanates; Lung Neoplasms; Male; Neoplasms; Nicotiana; Nicotine; Nitrosamines; Plants, Toxic; Risk Factors; Smoke; Smoking; Smoking Cessation; Smoking Prevention; Substance-Related Disorders | 1997 |
Endocrine effects of nicotine administration, tobacco and other drug withdrawal in humans.
Topics: Animals; Endocrine Glands; Humans; Hypothalamo-Hypophyseal System; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1998 |
Cigarette smoking prevalence, cessation and relapse.
Topics: Adolescent; Adult; Aged; Female; Humans; Logistic Models; Male; Middle Aged; Nicotine; Odds Ratio; Prevalence; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; United Kingdom | 1998 |
Group treatment for smoking cessation among persons with schizophrenia.
Topics: Behavior Therapy; Cholinergic Agents; Humans; Motivation; Nicotine; Ontario; Outcome Assessment, Health Care; Program Evaluation; Psychotherapy, Group; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Tobacco Use Disorder; United States | 1998 |
[Use of nicotine containing products in weaning from tobacco].
Topics: Administration, Cutaneous; Administration, Intranasal; Contraindications; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Tablets; Tobacco Use Disorder | 1998 |
Management of the hypertensive patient who smokes.
Topics: Adolescent; Adult; Antihypertensive Agents; Humans; Hypertension; Middle Aged; Nicotine; Smoking; Smoking Cessation | 1998 |
Nicotine replacement products: implications for the breastfeeding mother.
Topics: Administration, Cutaneous; Adult; Breast Feeding; Chewing Gum; Female; Humans; Infant; Lactation; Nicotine; Nicotinic Agonists; Smoking Cessation | 1998 |
Nicotine replacement therapy.
Topics: Administration, Cutaneous; Animals; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation | 1998 |
Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association.
Topics: Behavior, Addictive; Health Promotion; Humans; Nicotine; Recurrence; Smoking; Smoking Cessation | 1998 |
Drug therapy to aid in smoking cessation. Tips on maximizing patients' chances for success.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Intranasal; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Smoking Cessation | 1998 |
[Pregnancy and smoking: significance of the problem and health-service based prevention].
Topics: Female; Health Services; Humans; Nicotine; Pregnancy; Pregnancy Complications; Smoking; Smoking Cessation; Smoking Prevention | 1998 |
Recent advances in the pharmacotherapy of smoking.
Topics: Administration, Inhalation; Administration, Intranasal; Administration, Topical; Behavior Therapy; Bupropion; Chewing Gum; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Self-Help Groups; Smoking; Smoking Cessation | 1999 |
Smoking tobacco, microcirculatory changes and the role of nicotine.
Topics: Cardiovascular Diseases; Cardiovascular System; Ganglionic Stimulants; Humans; Nicotine; Receptors, Adrenergic; Smoking; Smoking Cessation | 1999 |
[Smoking, cardiovascular diseases and possibilities for treating nicotine dependence].
Topics: Cardiovascular Diseases; Humans; Nicotine; Smoking Cessation; Treatment Outcome | 1999 |
[Nicotine preparations and other preparations for smoking cessation].
Topics: Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Smoking Cessation | 1999 |
[Nicotine replacement always better than further smoking or using snuff].
Topics: Guidelines as Topic; Health Education; Humans; Nicotine; Patient Education as Topic; Smoking Cessation | 1999 |
[Exophthalmos--what now?].
Topics: Anti-Inflammatory Agents; Combined Modality Therapy; Diagnosis, Differential; Exophthalmos; Graves Disease; Humans; Hyperthyroidism; Methylprednisolone; Nicotine; Ophthalmologic Surgical Procedures; Smoking Cessation | 1999 |
Nicotine replacement therapy.
Topics: Administration, Cutaneous; Administration, Intranasal; Administration, Oral; Drug Delivery Systems; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pregnancy; Smoking Cessation; Tobacco Use Disorder | 1999 |
A review of the effects of nicotine on schizophrenia and antipsychotic medications.
Topics: Antipsychotic Agents; Auditory Perception; Chlorpromazine; Chronic Disease; Clozapine; Databases as Topic; Dopamine; Dose-Response Relationship, Drug; Frontal Lobe; Humans; Nicotine; Nucleus Accumbens; Prefrontal Cortex; Schizophrenia; Severity of Illness Index; Smoking Cessation | 1999 |
Policy options to reduce tobacco-caused mortality.
Topics: Health Policy; Health Promotion; Humans; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 1999 |
Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials.
Topics: Administration, Cutaneous; Adult; Carbon Monoxide; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nonprescription Drugs; Research Design; Smoking Cessation; Treatment Outcome | 1999 |
[New possibilities in pharmacological treatment of nicotine dependence].
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Humans; Nicotine; Rats; Receptors, Dopamine; Receptors, Serotonin; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1999 |
Hypothesis for temporal displacement of metabolic and neuronal accommodation in smoking addiction.
Topics: Behavior, Addictive; Homeostasis; Humans; Neurons; Neurotransmitter Agents; Nicotine; Receptors, Cholinergic; Recurrence; Smoking; Smoking Cessation; Time Factors; Tobacco Use Disorder | 1999 |
Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report.
Topics: Administration, Cutaneous; Cardiology; Humans; Nicotine; Practice Guidelines as Topic; Smoking Cessation; Tobacco Use Disorder | 2000 |
Methods to enhance smoking cessation after myocardial infarction.
Topics: Behavior Therapy; Bupropion; Combined Modality Therapy; Humans; Myocardial Infarction; Nicotine; Recurrence; Risk Factors; Smoking; Smoking Cessation | 2000 |
Helping patients with Crohn's disease quit smoking.
Topics: Administration, Cutaneous; Behavior, Addictive; Bupropion; Counseling; Crohn Disease; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention | 2000 |
Nicotine replacement to aid smoking cessation.
Topics: Humans; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation | 1999 |
Smoking cessation: nicotine replacement, gums and patches.
Topics: Administration, Cutaneous; Administration, Inhalation; Antidepressive Agents; Bupropion; Chewing Gum; Humans; Nicotine; Smoking Cessation | 1999 |
Pharmacotherapy of smoking cessation.
Topics: Administration, Cutaneous; Administration, Inhalation; Antidepressive Agents, Second-Generation; Bupropion; Drug Therapy, Combination; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Smoking; Smoking Cessation; United States | 2000 |
Smoking cessation. Techniques and benefits.
Topics: Behavior Therapy; Humans; Nicotine; Nicotinic Antagonists; Smoking Cessation; Substance Withdrawal Syndrome | 2000 |
New developments in smoking cessation.
Topics: Administration, Cutaneous; Antidepressive Agents; Behavior Therapy; Bupropion; Counseling; Humans; Lung Neoplasms; Nicotine; Pamphlets; Smoking; Smoking Cessation; United States | 2000 |
Nicotine replacement therapy for smoking cessation.
Topics: Administration, Cutaneous; Humans; Nicotine; Smoking Cessation; Smoking Prevention | 2000 |
Mecamylamine (a nicotine antagonist) for smoking cessation.
Topics: Administration, Cutaneous; Drug Therapy, Combination; Humans; Mecamylamine; Nicotine; Nicotinic Antagonists; Smoking Cessation; Smoking Prevention | 2000 |
Self-help interventions for smoking cessation.
Topics: Behavior Therapy; Chewing Gum; Humans; Nicotine; Patient Education as Topic; Polymethacrylic Acids; Polyvinyls; Self Care; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2000 |
Kicking the habit: aids to giving up smoking.
Topics: Administration, Cutaneous; Administration, Oral; Attitude to Health; Humans; Information Services; Nicotine; Nicotinic Agonists; Smoking Cessation | 1999 |
The whys and wherefores of getting patients to give up smoking.
Topics: Costs and Cost Analysis; Health Education; Health Expenditures; Humans; Motivation; Nicotine; Nicotinic Agonists; Prognosis; Risk Factors; Smoking; Smoking Cessation | 2000 |
A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives.
Topics: Cost-Benefit Analysis; Counseling; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Social Support; Tobacco Use Disorder | 2000 |
[Nicotine dependence].
Topics: Animals; Brain; Dopamine; Humans; Nicotine; Receptors, Nicotinic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders | 2000 |
Cigarette smoking and anaesthesia.
Topics: Anesthetics; Cardiovascular Physiological Phenomena; Cotinine; Drug Synergism; Humans; Nicotine; Nicotinic Agonists; Preoperative Care; Respiratory Physiological Phenomena; Smoking; Smoking Cessation; Time Factors | 1999 |
Nicotine replacement therapy for smoking cessation.
Topics: Administration, Cutaneous; Humans; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Prevention | 2000 |
Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library.
Topics: Behavior Therapy; Clinical Trials as Topic; Health Promotion; Humans; Nicotine; Self Care; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2000 |
Smoking cessation.
Topics: Administration, Cutaneous; Adult; Bupropion; Combined Modality Therapy; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Humans; Middle Aged; Nicotine; Nicotinic Agonists; Psychotherapy; Randomized Controlled Trials as Topic; Smoking Cessation | 2000 |
Biological aspects of the link between smoking and depression.
Topics: Affect; Brain; Cognition; Depression; Humans; Monoamine Oxidase; Neurotransmitter Agents; Nicotine; Receptors, Nicotinic; Reinforcement, Psychology; Smoking; Smoking Cessation; Smoking Prevention | 2000 |
Current concepts in the management of smoking cessation: a review.
Topics: Behavior Therapy; Bupropion; Dosage Forms; Drug Interactions; Education, Continuing; Humans; Nicotine; Patient Education as Topic; Practice Guidelines as Topic; Smoking Cessation | 2000 |
Smoking and periodontal disease.
Topics: Bone Regeneration; Cytokines; Dental Plaque; Dose-Response Relationship, Drug; Humans; Nicotine; Nicotinic Agonists; Periodontal Diseases; Periodontium; Risk Assessment; Smoking; Smoking Cessation; Vasoconstrictor Agents; Wound Healing | 2000 |
Nicotine transdermal systems: pharmaceutical and clinical aspects.
Topics: Administration, Cutaneous; Animals; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation | 2000 |
Treatment of nicotine dependence.
Topics: Adaptation, Psychological; Antidepressive Agents; Behavior Therapy; Combined Modality Therapy; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2000 |
Techniques for smoking cessation: what really works?
Topics: Bupropion; Drug Therapy, Combination; Family Practice; Humans; Motivation; Nicotine; Smoking; Smoking Cessation | 2001 |
Pharmacological aids for smoking cessation.
Topics: Administration, Cutaneous; Administration, Intranasal; Bupropion; Central Nervous System Stimulants; Chewing Gum; Dopamine Uptake Inhibitors; Feedback; Humans; Nebulizers and Vaporizers; Nicotine; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2001 |
Risks and benefits of nicotine to aid smoking cessation in pregnancy.
Topics: Animals; Disease Models, Animal; Female; Fetus; Humans; Nicotine; Pregnancy; Pregnancy Complications; Rats; Risk Assessment; Smoking Cessation | 2001 |
[Pharmacologic therapy for smoking cessation].
Topics: Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation | 2001 |
Effect of oral nicotine dosing forms on cigarette withdrawal symptoms and craving: a systematic review.
Topics: Administration, Oral; Animals; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome | 2001 |
Smoking cessation: integrating recent advances into clinical practice.
Topics: Administration, Cutaneous; Antidepressive Agents; Bupropion; Ganglionic Stimulants; Health Education; Health Policy; Humans; Motivation; Nicotine; Nortriptyline; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; United Kingdom | 2001 |
Smoking cessation in pregnant women.
Topics: Female; Fetus; Humans; Internet; Nicotine; Pregnancy; Smoking Cessation | 2001 |
Interventions for smoking cessation in hospitalised patients: a systematic review.
Topics: Adult; Hospitalization; Humans; Middle Aged; Nicotine; Nicotinic Agonists; Odds Ratio; Randomized Controlled Trials as Topic; Smoking Cessation; Treatment Outcome | 2001 |
Glucose for smoking cessation: does it have a role?
Topics: Glucose; Humans; Hunger; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2001 |
Vaccines against nicotine: how effective are they likely to be in preventing smoking?
Topics: Animals; Humans; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Vaccines | 2001 |
[Therapies for smoking cessation (antidepressants, nicotine-replacement and counseling) and implications for the treatment of patients with chronic obstructive pulmonary disease].
Topics: Administration, Cutaneous; Antidepressive Agents; Combined Modality Therapy; Counseling; Humans; Lung Diseases, Obstructive; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention | 2001 |
Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability.
Topics: Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation | 2001 |
Nicotine replacement therapy for smoking cessation.
Topics: Administration, Cutaneous; Humans; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Prevention | 2001 |
Depression and nicotine: preclinical and clinical evidence for common mechanisms.
Topics: Antidepressive Agents; Comorbidity; Depressive Disorder, Major; Humans; Nicotine; Receptors, Cholinergic; Receptors, Nicotinic; Smoking; Smoking Cessation | 2001 |
The evaluation and treatment of tobacco use disorder.
Topics: Algorithms; Bupropion; Combined Modality Therapy; Decision Trees; Dopamine Uptake Inhibitors; Drug Costs; Evidence-Based Medicine; Family Practice; Hotlines; Humans; Information Services; Internet; Nicotine; Nicotinic Agonists; Office Visits; Patient Education as Topic; Practice Guidelines as Topic; Primary Health Care; Prognosis; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2001 |
Pharmacotherapy in smoking cessation.
Topics: Bupropion; Humans; Nicotine; Smoking Cessation | 2001 |
Effects of smoking on the prevalence and severity of periodontal disease.
Topics: Disease Progression; Fibroblasts; Gingiva; Humans; Neutrophils; Nicotine; Periodontal Diseases; Regional Blood Flow; Smoking; Smoking Cessation | 2001 |
Nicotine self-administration.
Topics: Animals; Cues; Humans; Nicotine; Research; Self Administration; Smoking; Smoking Cessation; Tobacco Use Disorder | 1999 |
New medications for nicotine dependence treatment.
Topics: Administration, Cutaneous; Administration, Inhalation; Bupropion; Chewing Gum; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Mecamylamine; Nicotine; Nicotinic Antagonists; Smoking; Smoking Cessation; Tobacco Use Disorder | 1999 |
Nicotine replacement therapy in patients with cardiovascular disease: guidelines for health professionals.
Topics: Cardiovascular Diseases; Humans; Nicotine; Nicotinic Agonists; Patient Selection; Practice Guidelines as Topic; Smoking Cessation | 2001 |
Regulation of nicotine replacement therapies (NRT): a critique of current practice.
Topics: Adolescent; Adult; Cardiovascular Diseases; Drug and Narcotic Control; Drug Delivery Systems; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pregnancy; Public Health; Risk Assessment; Smoking Cessation; United Kingdom | 2001 |
[Diagnostics and therapy of nicotine dependence].
Topics: Drug Interactions; Humans; Nicotine; Psychotropic Drugs; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1999 |
Clinical practice. Treatment of tobacco use and dependence.
Topics: Aged; Counseling; Female; Humans; Nicotine; Practice Guidelines as Topic; Smoking Cessation; Tobacco Use Disorder; Weight Gain | 2002 |
The neurobiology of tobacco dependence: a commentary.
Topics: Bupropion; Dopamine; Dopamine Uptake Inhibitors; Female; Humans; Male; Neurobiology; Nicotine; Nucleus Accumbens; Sensitivity and Specificity; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2002 |
Helping patients to stop smoking.
Topics: Bupropion; Controlled Clinical Trials as Topic; Dopamine Uptake Inhibitors; Humans; Motivation; Nicotine; Nicotinic Agonists; Smoking Cessation; Treatment Outcome | 2002 |
Nicotine addiction: the possible role of functional upregulation.
Topics: Animals; Binding Sites; Brain; Cells, Cultured; Humans; Neurons; Nicotine; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Up-Regulation | 2002 |
Smoking cessation programs for adolescents.
Topics: Adolescent; Computer-Assisted Instruction; Female; Humans; Male; Nicotine; Pregnancy; Pregnancy Complications; School Nursing; Self-Help Groups; Smoking Cessation; Social Support | 2000 |
Using nicotine replacement therapy in treating nicotine addiction in adolescents.
Topics: Adolescent; Adolescent Behavior; Bupropion; Central Nervous System Stimulants; Dopamine Uptake Inhibitors; Humans; Nicotine; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Time Factors; Tobacco Use Cessation Devices | 2001 |
[Nicotine dependence--medico-biological aspects].
Topics: Brain; Dopamine; Humans; Nicotine; Receptors, Dopamine; Receptors, Nicotinic; Reward; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2002 |
Medications for smoking cessation.
Topics: Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation | 2002 |
[Nicotine substitution therapy: 10 years later].
Topics: Administration, Cutaneous; Chewing Gum; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Follow-Up Studies; Humans; Motivation; Nicotine; Placebos; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Cessation Devices | 2002 |
Smoking cessation.
Topics: Aged; Chewing Gum; Drug Therapy; Female; Humans; Male; Nicotine; Physician's Role; Prevalence; Risk Factors; Smoking; Smoking Cessation; United States | 2002 |
[Treatment of nicotine addiction. Drug therapy for smoking cessation].
Topics: Administration, Inhalation; Administration, Intranasal; Antidepressive Agents, Second-Generation; Bupropion; Chewing Gum; Delayed-Action Preparations; Drug Interactions; Female; Humans; Male; Nicotine; Pregnancy; Smoking Cessation; Tablets; Tobacco Use Disorder | 2002 |
[Smoking as a risk factor for periodontitis].
Topics: Dental Plaque; Humans; Nicotine; Nicotinic Agonists; Periodontal Pocket; Periodontitis; Risk Factors; Smoking; Smoking Cessation | 1999 |
Meeting national tobacco challenges: recommendations for smoking cessation groups.
Topics: Behavior Therapy; Evidence-Based Medicine; Ganglionic Stimulants; Guideline Adherence; Health Policy; Humans; Marketing of Health Services; Nicotine; Practice Guidelines as Topic; Self-Help Groups; Smoking; Smoking Cessation | 2000 |
Medication update.
Topics: Bupropion; Central Nervous System Stimulants; Dopamine Uptake Inhibitors; Humans; Nicotine; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Tobacco Use Cessation Devices | 2002 |
Genetic testing: the future of smoking cessation therapy?
Topics: Genetic Testing; Haplotypes; Humans; Microsatellite Repeats; Neurotransmitter Agents; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2002 |
Helping parents to stop smoking: which interventions are effective?
Topics: Adult; Antidepressive Agents; Behavior Therapy; Child; Environmental Exposure; Evidence-Based Medicine; Female; Humans; Male; Nicotine; Parents; Patient Education as Topic; Pregnancy; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Smoke Pollution | 2001 |
The pharmacotherapy of smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Chewing Gum; Contraindications; Female; Humans; Mental Disorders; Nicotine; Pregnancy; Smoking Cessation | 2002 |
Nicotine and the central nervous system: biobehavioral effects of cigarette smoking.
Topics: Behavior; Behavior Therapy; Catecholamines; Central Nervous System; Dose-Response Relationship, Drug; Humans; Neurosecretory Systems; Neurotransmitter Agents; Nicotine; Pituitary Hormones; Smoking; Smoking Cessation; Substance-Related Disorders | 1992 |
Transdermal Nicotine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation.
Topics: Administration, Cutaneous; Drug Delivery Systems; Humans; Nicotine; Smoking Cessation | 1992 |
A clinical approach to help psychiatric patients with smoking cessation.
Topics: Adult; Ambulatory Care; Behavior, Addictive; Cognitive Behavioral Therapy; Female; Humans; Male; Mental Disorders; Nicotine; Psychiatric Status Rating Scales; Smoking Cessation; Tobacco Use Disorder | 1992 |
COPD: primary care management with drug and oxygen therapies.
Topics: Aged; Anti-Bacterial Agents; Bronchodilator Agents; Clinical Protocols; Geriatrics; Humans; Lung Diseases, Obstructive; Nicotine; Oxygen Inhalation Therapy; Prognosis; Smoking Cessation; Theophylline | 1992 |
Efficacy of transdermal nicotine patches for nicotine replacement and smoking cessation.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Drug Costs; Drug Interactions; Humans; Nicotine; Smoking Cessation | 1992 |
Smoking cessation: what have we learned over the past decade?
Topics: Administration, Cutaneous; Behavior Therapy; Combined Modality Therapy; Humans; Motivation; Nicotine; Patient Care Team; Smoking; Smoking Cessation | 1992 |
Smoking.
Topics: Costs and Cost Analysis; Humans; Lung Neoplasms; Nicotine; Primary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Substance-Related Disorders | 1992 |
Nicotine therapy in smoking cessation. Pharmacokinetic considerations.
Topics: Humans; Nicotine; Smoking Cessation | 1992 |
What have we learned from nicotine, cocaine, and marijuana about addiction?
Topics: Brain; Cannabinoids; Cocaine; Humans; Marijuana Abuse; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders | 1992 |
Cigarette smoking and nicotine addiction.
Topics: Animals; Brain; Humans; Nicotine; Receptors, Nicotinic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1992 |
Metabolic effects of cigarette smoking.
Topics: Animals; Basal Metabolism; Body Weight; Energy Metabolism; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation; Weight Gain | 1992 |
Transdermal nicotine replacement and smoking cessation.
Topics: Administration, Cutaneous; Behavior Therapy; Chewing Gum; Clinical Trials as Topic; Humans; Nicotine; Smoking; Smoking Cessation; Smoking Prevention | 1992 |
Pharmacologic approaches to smoking cessation.
Topics: Clonidine; Doxepin; Humans; Nicotine; Smoking; Smoking Cessation; Weight Gain | 1991 |
Smoking and Parkinson's disease--a new perspective.
Topics: Age Factors; Animals; Diagnosis, Differential; Dopamine; Humans; Mice; Nicotine; Parkinson Disease; Personality; Smoking; Smoking Cessation | 1991 |
Dental hygiene's role in reducing tobacco use. A literature review and recommendations for action.
Topics: Chewing Gum; Counseling; Dental Hygienists; Humans; Nicotine; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Tobacco Use Cessation Devices | 1991 |
Combined psychological and nicotine gum treatment for smoking: a critical review.
Topics: Adult; Chewing Gum; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Nicotine; Outcome and Process Assessment, Health Care; Psychotherapy; Smoking Cessation | 1991 |
Nicotine replacement therapy during pregnancy.
Topics: Cardiovascular System; Contraindications; Female; Humans; Nicotine; Pregnancy; Pregnancy Complications; Risk Factors; Smoking Cessation; Smoking Prevention | 1991 |
Nicotine dependence and the Fagerström Tolerance Questionnaire: a brief review.
Topics: Chewing Gum; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Nicotine; Personality Tests; Psychometrics; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1989 |
1041 trial(s) available for nicotine and Smoking Cessation
| Article | Year |
|---|---|
Daily use of nicotine replacement medications is related to daily smoking status: An ecological momentary assessment study.
Topics: Administration, Cutaneous; Ecological Momentary Assessment; Female; Humans; Middle Aged; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2021 |
Effect of Electronic Nicotine Delivery Systems on Cigarette Abstinence in Smokers With No Plans to Quit: Exploratory Analysis of a Randomized Placebo-Controlled Trial.
Topics: Adult; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smokers; Smoking Cessation; Tobacco Products; United States | 2022 |
Predicting Non-Adherence With Very Low Nicotine Content Cigarettes Among Adults With Serious Mental Illness Who Smoke.
Topics: Adult; Humans; Mental Disorders; Nicotine; Prevalence; Smoking; Smoking Cessation; Tobacco Products | 2022 |
Planning a Change Easily (PACE) for smokers who are not ready to quit: a telephone-based, randomized controlled trial.
Topics: Adult; Female; Humans; Male; Middle Aged; Motivational Interviewing; Nicotine; Smokers; Smoking Cessation; Telephone | 2022 |
Comparison of withdrawal symptom intensity between hypnosis and nicotine-replacement-therapies: A pilot study.
Topics: Adult; Humans; Hypnosis; Nicotine; Pilot Projects; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2022 |
"Push it!" or "Hold it!"? A comparison of nicotine-avoidance training and nicotine-inhibition training in smokers motivated to quit.
Topics: Humans; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Use Disorder | 2022 |
Educating the Public on the Health Risks of Very Low Nicotine Content Cigarettes: Results From a US-Based Convenience Sample.
Topics: Adult; Behavior, Addictive; Humans; Lung Neoplasms; Nicotine; Smoking Cessation; Tobacco Products | 2022 |
Nicotine Patch Alters Patterns of Cigarette Smoking-Induced Dopamine Release: Patterns Relate to Biomarkers Associated With Treatment Response.
Topics: Biomarkers; Cigarette Smoking; Dopamine; Female; Humans; Nicotiana; Nicotine; Raclopride; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2022 |
Visual Attention to Health Warning Labels on Waterpipe Venue Menus in Immersive Virtual Reality.
Topics: Humans; Nicotine; Product Labeling; Smoking Cessation; Virtual Reality; Water Pipe Smoking; Young Adult | 2022 |
The Impact of Cigarette Relighting on Nicotine Dependence and Smoking Cessation Treatment Outcome Measures Among Adults With Mood Disorders.
Topics: Adult; Humans; Mood Disorders; Nicotiana; Nicotine; Smoking Cessation; Tobacco Products; Tobacco Use Disorder; Treatment Outcome | 2022 |
Time-Varying Mediation of Pharmacological Smoking Cessation Treatments on Smoking Lapse via Craving, Cessation Fatigue, and Negative Mood.
Topics: Craving; Fatigue; Humans; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Smoking; Varenicline | 2022 |
Hispanic/Latinx Ethnic Subgroup Differences in Sociodemographic, Sociocultural, and Smoking Characteristics in a Cessation Trial: An Exploratory Study.
Topics: Female; Hispanic or Latino; Humans; Male; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder; United States | 2022 |
A pilot randomised controlled trial of abrupt versus gradual smoking cessation in combination with vaporised nicotine products for people receiving alcohol and other drug treatment.
Topics: Electronic Nicotine Delivery Systems; Ethanol; Humans; Nicotine; Pilot Projects; Smoking Cessation; Tobacco Use Cessation Devices | 2022 |
Electronic cigarettes versus nicotine patches for smoking cessation in pregnancy: a randomized controlled trial.
Topics: Electronic Nicotine Delivery Systems; Female; Humans; Nicotine; Pregnancy; Smoking Cessation; Tobacco Use Cessation Devices | 2022 |
Effects of Very Low Nicotine Content Cigarette use on Cigarette Reinforcement among Smokers with Serious Mental Illness.
Topics: Humans; Mental Disorders; Nicotine; Smokers; Smoking Cessation; Tobacco Products | 2022 |
Progesterone Increases Nicotine Withdrawal and Anxiety in Male but Not Female Smokers During Brief Abstinence.
Topics: Anxiety; Cross-Over Studies; Female; Humans; Male; Nicotine; Progesterone; Smokers; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2022 |
Analyzing Trajectories of Acute Cigarette Reduction Post-Introduction of an E-Cigarette Using Ecological Momentary Assessment Data.
Topics: Adult; Ecological Momentary Assessment; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Products | 2022 |
Changes in Nicotine Dependence Among Smokers Using Electronic Cigarettes to Reduce Cigarette Smoking in a Randomized Controlled Trial.
Topics: Adult; Cigarette Smoking; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotiana; Nicotine; Smokers; Smoking Cessation; Tobacco Products; Tobacco Use Disorder | 2023 |
A Randomized Trial of Telephone-Based Smoking Cessation Treatment in the Lung Cancer Screening Setting.
Topics: Counseling; Early Detection of Cancer; Humans; Lung Neoplasms; Nicotine; Smoking Cessation; Telephone; Tobacco Use Cessation Devices | 2022 |
Cost-Effectiveness of a Telephone-Based Smoking Cessation Randomized Trial in the Lung Cancer Screening Setting.
Topics: Cost-Benefit Analysis; Early Detection of Cancer; Humans; Lung Neoplasms; Nicotine; Nicotinic Agonists; Smoking Cessation; Telephone; Tobacco Use Cessation Devices | 2022 |
Smoking abstinence and cessation-related outcomes one month after an immediate versus gradual reduction in nicotine content of cigarettes.
Topics: Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Disorder; United States | 2022 |
Pilot randomized controlled trial evaluating the effect of random nicotine delivery on cigarettes per day and smoke exposure.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Pilot Projects; Smoke; Smoking Cessation; Tobacco Products | 2022 |
Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening Trial.
Topics: Alkaloids; Azocines; Early Detection of Cancer; Humans; Lung; Lung Neoplasms; Nicotine; Quinolizines; Smoking Cessation; Varenicline | 2022 |
Effectiveness of Varenicline and Cytisine for Alcohol Use Reduction Among People With HIV and Substance Use: A Randomized Clinical Trial.
Topics: Adult; Alcoholism; Alkaloids; Azocines; Benzazepines; Female; HIV Infections; Humans; Male; Nicotine; Nicotinic Agonists; Quinolizines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2022 |
Medium- and longer-term cardiovascular effects of e-cigarettes in adults making a stop-smoking attempt: a randomized controlled trial.
Topics: Adult; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Smoking; Tobacco Use Cessation Devices | 2022 |
Leveraging the cigarette purchase task to understand relationships between cumulative vulnerabilities, the relative reinforcing effects of smoking, and response to reduced nicotine content cigarettes.
Topics: Adult; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Products; Tobacco Smoking | 2022 |
Preoperative smoking cessation program in patients undergoing intermediate to high-risk surgery: a randomized, single-blinded, controlled, superiority trial.
Topics: Delivery of Health Care; Humans; Nicotine; Quality of Life; Smoking; Smoking Cessation | 2022 |
Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial.
Topics: Alcoholism; Australia; Cost-Benefit Analysis; Humans; Nicotiana; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation; Social Class; Tobacco Use Cessation Devices; Treatment Outcome | 2022 |
Reactions to Pictorial and Text Cigarette Pack Warning Labels among Chinese Smokers.
Topics: Adult; Humans; Nicotine; Product Labeling; Smokers; Smoking Cessation; Smoking Prevention; Tobacco Products | 2022 |
Effect of very low nicotine content cigarettes on alcohol drinking and smoking among adult smokers who are at-risk alcohol drinkers.
Topics: Adult; Alcohol Drinking; Cross-Over Studies; Double-Blind Method; Ethanol; Humans; Nicotiana; Nicotine; Smoke; Smokers; Smoking; Smoking Cessation; Tobacco Products | 2023 |
The effect of three-part breathing exercise on smoking cessation: A 6-month cluster-randomized clinical trial.
Topics: Breathing Exercises; Cotinine; Humans; Nicotine; Quality of Life; Smoking Cessation; Substance Withdrawal Syndrome; Thailand | 2022 |
Potential effects of nicotine content in cigarettes on use of other substances.
Topics: Dronabinol; Female; Humans; Nicotiana; Nicotine; Smokers; Smoking Cessation; Tobacco Products | 2022 |
Efficacy and safety evaluation of adjuvant auricular acupuncture for smoking cessation: A study protocol of randomized, assessor-blinded, pragmatic pilot trial.
Topics: Acupuncture, Ear; Humans; Nicotine; Nicotinic Agonists; Pilot Projects; Quality of Life; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2022 |
Cigarette filter ventilation, smoking topography, and subjective effects: A mediational analysis.
Topics: Humans; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Products | 2022 |
Nicotine-Free E-Cigarettes Might Promote Tobacco Smoking Reduction Better Than Nicotine Delivery Devices: Results of a Double-Blind Randomized Controlled Trial at 1 Year.
Topics: Electronic Nicotine Delivery Systems; Female; Humans; Nicotiana; Nicotine; Smoking Cessation; Smoking Reduction | 2022 |
Daily adherence to nicotine replacement therapy in low-income smokers: The role of gender, negative mood, motivation, and self-efficacy.
Topics: Female; Humans; Male; Middle Aged; Motivation; Nicotine; Self Efficacy; Smokers; Smoking Cessation; Tobacco Use Cessation Devices | 2023 |
The Impact of Reducing Nicotine Content on Adolescent Cigarette Smoking and Nicotine Exposure: Results From a Randomized Controlled Trial.
Topics: Adolescent; Adult; Cigarette Smoking; Humans; Nicotine; Smokers; Smoking Cessation; Tobacco Products; Young Adult | 2023 |
Subjective experiences, contexts, and risk perceptions of very low nicotine content cigarettes and electronic cigarettes among people with depression and anxiety disorders who smoke.
Topics: Anxiety Disorders; Depression; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Products; Vaping | 2023 |
Acceptance and Commitment Therapy-Based Smartphone Applications for Cessation of Tobacco Use among Adults with High Nicotine Dependence: Results from the iCanQuit Randomized Trial.
Topics: Acceptance and Commitment Therapy; Adult; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smartphone; Smoking Cessation; Tobacco Use; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2023 |
Behavioral activation for smoking cessation and the prevention of smoking cessation-related weight gain: A randomized trial.
Topics: Adult; Counseling; Female; Health Behavior; Humans; Male; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Weight Gain | 2023 |
Influence of CYP2A6 Genetic Variation, Nicotine Dependence Severity, and Treatment on Smoking Cessation Success.
Topics: Adult; Cytochrome P-450 CYP2A6; Female; Genetic Variation; Humans; Male; Nicotine; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2023 |
Study protocol for approach bias retraining for nicotine addiction among dual combustible and electronic cigarette users.
Topics: Adult; Electronic Nicotine Delivery Systems; Evaluation Studies as Topic; Humans; Nicotine; Smokers; Smoking Cessation; Tobacco Use Disorder | 2023 |
Impact of reduced nicotine content on behavioral economic measures of cigarette reinforcement in adolescents who smoke cigarettes.
Topics: Adolescent; Cigarette Smoking; Economics, Behavioral; Humans; Nicotine; Smoking Cessation; Tobacco Products | 2023 |
Coordinating smoking cessation treatment with menstrual cycle phase to improve quit outcomes (MC-NRT): study protocol for a randomized controlled trial.
Topics: Female; Humans; Male; Menstrual Cycle; Nicotine; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2023 |
Comparing the Effectiveness, Tolerability, and Acceptability of Heated Tobacco Products and Refillable Electronic Cigarettes for Cigarette Substitution (CEASEFIRE): Randomized Controlled Trial.
Topics: Electronic Nicotine Delivery Systems; Health Behavior; Humans; Nicotine; Smoking Cessation; Tobacco Products | 2023 |
Glucagon-like peptide-1 analogues: a new way to quit smoking? (SKIP)-a structured summary of a study protocol for a randomized controlled study.
Topics: Double-Blind Method; Glucagon-Like Peptide 1; Humans; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline; Weight Gain | 2023 |
Effect of perioperative high-dose transdermal nicotine patch on pain sensitivity among male abstinent tobacco smokers undergoing abdominal surgery: A randomized controlled pilot study.
Topics: Analgesics; China; Humans; Male; Nicotine; Pain Threshold; Pain, Postoperative; Pilot Projects; Smokers; Smoking Cessation; Tobacco Use Cessation Devices | 2023 |
Long-term follow-up of tobacco cessation intervention in a dental setting: A randomized trial.
Topics: Adult; Chronic Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Cessation Devices | 2023 |
Predicting smoking cessation, reduction and relapse six months after using the Stop-Tabac app for smartphones: a machine learning analysis.
Topics: Electronic Nicotine Delivery Systems; Humans; Mobile Applications; Nicotine; Recurrence; Smartphone; Smoking Cessation | 2023 |
Reengagement for Long-Term Smoking-Cessation In Military Personnel, Retirees, Family Members (TRICARE): A Randomized Trial.
Topics: Family; Humans; Military Personnel; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Reduction; Tobacco Use Cessation Devices | 2023 |
Cytisine Versus Varenicline for Smoking Cessation in a Primary Care Setting: A Randomized Non-inferiority Trial.
Topics: Alkaloids; Azocines; Benzazepines; Humans; Nicotine; Nicotinic Agonists; Primary Health Care; Quinolizines; Smoking Cessation; Treatment Outcome; Varenicline | 2023 |
Exenatide as an adjunct to nicotine patch for smoking cessation and prevention of postcessation weight gain among treatment-seeking smokers with pre-diabetes and/or overweight: study protocol for a randomised, placebo-controlled clinical trial.
Topics: Exenatide; Humans; Nicotine; Obesity; Overweight; Prediabetic State; Randomized Controlled Trials as Topic; Smokers; Smoking Cessation; Tobacco Use Cessation Devices; Weight Gain | 2023 |
Multiple Pharmacotherapy Adaptations for Smoking Cessation Based on Treatment Response in Black Adults Who Smoke: A Randomized Clinical Trial.
Topics: Adult; Bupropion; Ethnicity; Female; Humans; Male; Middle Aged; Minority Groups; Nicotine; Smoking; Smoking Cessation; Varenicline | 2023 |
Feasibility, Acceptability, and Potential Impact of a Novel mHealth App for Smokers Ambivalent About Quitting: Randomized Pilot Study.
Topics: Adult; Feasibility Studies; Female; Humans; Mobile Applications; Nicotine; Pilot Projects; Smokers; Smoking Cessation; Telemedicine; Tobacco Use Cessation Devices | 2023 |
Cytisinicline for Smoking Cessation: A Randomized Clinical Trial.
Topics: Alkaloids; Azocines; Cigarette Smoking; Double-Blind Method; Duration of Therapy; Female; Humans; Male; Middle Aged; Nicotine; Quinolizidine Alkaloids; Quinolizines; Receptors, Nicotinic; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome | 2023 |
Effect of Postal-Mailed Nicotine Patches on Tobacco Cessation Among Smokers in Rural Canada: A Randomized Clinical Trial.
Topics: Humans; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Use Cessation | 2023 |
Randomized clinical trial examining financial incentives for smoking cessation among mothers of young children and possible impacts on child secondhand smoke exposure.
Topics: Child, Preschool; Female; Humans; Motivation; Nicotine; Smoking Cessation; Tobacco Smoke Pollution; Tobacco Use Cessation Devices | 2023 |
Adaptive Smoking Cessation Using Precessation Varenicline or Nicotine Patch: A Randomized Clinical Trial.
Topics: Bupropion; COVID-19; Female; Humans; Male; Middle Aged; Nicotine; Pandemics; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2023 |
Effectiveness of nicotine salt vapes, cytisine, and a combination of these products, for smoking cessation in New Zealand: protocol for a three-arm, pragmatic, community-based randomised controlled trial.
Topics: Electronic Nicotine Delivery Systems; Humans; New Zealand; Nicotine; Quality of Life; Randomized Controlled Trials as Topic; Smoking Cessation; Sodium Chloride, Dietary; Tobacco Use Cessation Devices; Vaping; Varenicline | 2023 |
Reaching adults who smoke cigarettes in rural Appalachia: Rationale, design & analysis plan for a mixed-methods study disseminating pharmacy-delivered cessation treatment.
Topics: Adult; Cigarette Smoking; Humans; Nicotine; Pharmacy; Smoking Cessation; Tobacco Use Cessation Devices | 2023 |
The impact of blunt use on smoking abstinence among Black adults: Secondary analysis from randomized controlled smoking cessation clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Black or African American; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Varenicline; Young Adult | 2024 |
Helping pregnant smokers quit: a multi-centre randomised controlled trial of electronic cigarettes versus nicotine replacement therapy.
Topics: Alcoholism; Bayes Theorem; Birth Weight; Electronic Nicotine Delivery Systems; Female; Humans; Infant; Nicotine; Pregnancy; Smokers; Smoking Cessation; Tobacco Use Cessation Devices | 2023 |
Preloaded combination nicotine replacement therapy for smoking cessation in Kazakhstan: A randomized controlled trial study protocol.
Topics: Alcoholism; Humans; Kazakhstan; Nicotine; Quality of Life; Randomized Controlled Trials as Topic; Single-Blind Method; Smoking Cessation; Tobacco Use Cessation Devices | 2023 |
Delivery of a Nicotine Replacement Therapy Sample at Outdoor Smoking Hotspots for Promoting Quit Attempts: A Pilot Randomized Controlled Trial.
Topics: Adult; Behavior Therapy; Female; Health Behavior; Hong Kong; Humans; Male; Nicotine; Pilot Projects; Single-Blind Method; Smokers; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2020 |
A Pilot Study of a Standardized Smoking Cessation Intervention for Patients with Vascular Disease.
Topics: Aneurysm; Cardiovascular Agents; Cholinergic Agents; Connecticut; Endovascular Procedures; Female; Humans; Male; Middle Aged; Nicotine; Patient Education as Topic; Peripheral Arterial Disease; Pilot Projects; Risk Factors; Risk Reduction Behavior; Smokers; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Transdermal Patch; Treatment Outcome; Vascular Surgical Procedures | 2019 |
Randomized Trial of Low-Nicotine Cigarettes and Transdermal Nicotine.
Topics: Adult; Cigarette Smoking; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Outcome Assessment, Health Care; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices | 2019 |
Smoking Topography Characteristics During a 6-Week Trial of Very Low Nicotine Content Cigarettes in Smokers With Serious Mental Illness.
Topics: Adolescent; Adult; Aged; Behavior, Addictive; Double-Blind Method; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Products; Young Adult | 2020 |
Very Low Nicotine Content Cigarettes Disrupt the Feedback Loop of Affective States and Smoking Behavior.
Topics: Adolescent; Adult; Case-Control Studies; Cigarette Smoking; Double-Blind Method; Emotions; Feedback; Female; Humans; Male; Motivation; Nicotine; Reinforcement, Psychology; Smokers; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Disorder; United States; Young Adult | 2020 |
Predictors of adherence to nicotine replacement therapy: Machine learning evidence that perceived need predicts medication use.
Topics: Adult; Behavior Therapy; Counseling; Female; Humans; Machine Learning; Male; Medication Adherence; Middle Aged; Motivation; Needs Assessment; Nicotine; Smokers; Smoking Cessation; Tobacco Smoking; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2019 |
Short halt in vaping modifies cardiorespiratory parameters and urine metabolome: a randomized trial.
Topics: Adult; Biomarkers; Blood Pressure; Diffusion; Discriminant Analysis; Heart; Heart Rate; Hemodynamics; Hemoglobins; Humans; Least-Squares Analysis; Lung Injury; Metabolome; Microcirculation; Nicotine; Oximetry; Oxygen; Partial Pressure; Regional Blood Flow; Respiration; Respiratory Function Tests; Skin; Smoking Cessation; Vaping | 2020 |
Pain characteristics and nicotine deprivation as predictors of performance during a laboratory paradigm of smoking cessation.
Topics: Adult; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Pain; Psychomotor Performance; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2020 |
Effect of nicotine 6 mg gum on urges to smoke, a randomized clinical trial.
Topics: Adult; Cross-Over Studies; Female; Humans; Male; Middle Aged; Nicotine; Nicotine Chewing Gum; Smoking Cessation; Young Adult | 2019 |
Benefits of e-cigarettes in smoking reduction and in pulmonary health among chronic smokers undergoing a lung cancer screening program at 6 months.
Topics: Aged; Double-Blind Method; Early Detection of Cancer; Electronic Nicotine Delivery Systems; Female; Health Status; Humans; Lung Diseases; Male; Middle Aged; Motivation; Nicotine; Smoking Cessation; Smoking Reduction; Time Factors; Tobacco Use Cessation Devices | 2020 |
Increasing Quit Attempts by Transitioning to Very Low Nicotine Content Cigarettes Versus Reducing Number of Cigarettes Per Day: A Secondary Analysis of an Exploratory Randomized Trial.
Topics: Humans; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Products | 2019 |
Effects of 6-Week Use of Very Low Nicotine Content Cigarettes in Smokers With Serious Mental Illness.
Topics: Adult; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotine; Smoking; Smoking Cessation; Tobacco Products | 2019 |
The Impact of Gradual and Immediate Nicotine Reduction on Subjective Cigarette Ratings.
Topics: Humans; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Products | 2019 |
Examining Age as a Potential Moderator of Response to Reduced Nicotine Content Cigarettes in Vulnerable Populations.
Topics: Adolescent; Adult; Age Factors; Female; Humans; Male; Mental Disorders; Nicotine; Poverty; Smokers; Smoking; Smoking Cessation; Tobacco Products; Vulnerable Populations; Young Adult | 2019 |
Effects of a Nicotine Fact Sheet on Perceived Risk of Nicotine and E-Cigarettes and Intentions to Seek Information About and Use E-Cigarettes.
Topics: Adolescent; Adult; Electronic Nicotine Delivery Systems; Female; Health Promotion; Humans; Information Seeking Behavior; Intention; Male; Middle Aged; Nicotine; Risk; Smoking Cessation; Smoking Prevention; Young Adult | 2019 |
Nicotine patch for cannabis withdrawal symptom relief: a randomized controlled trial.
Topics: Adolescent; Adult; Female; Hallucinogens; Humans; Male; Marijuana Abuse; Marijuana Smoking; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Young Adult | 2020 |
The Impact of Exclusive Use of Very Low Nicotine Cigarettes on Compensatory Smoking: An Inpatient Crossover Clinical Trial.
Topics: Adult; Cigarette Smoking; Cross-Over Studies; Female; Humans; Male; Middle Aged; Nicotine; Smokers; Smoking Cessation; Tobacco Products | 2020 |
Heterogeneous treatment effects of a text messaging smoking cessation intervention among university students.
Topics: Adult; Bayes Theorem; Behavior Therapy; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation; Students; Sweden; Text Messaging; Tobacco Smoking; Tobacco, Smokeless; Universities; Young Adult | 2020 |
Five-Year Follow-up of a Randomized Clinical Trial Testing Mailed Nicotine Patches to Promote Tobacco Cessation.
Topics: Adult; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome | 2020 |
Transcranial Direct Current Stimulation Applied to the Dorsolateral and Ventromedial Prefrontal Cortices in Smokers Modifies Cognitive Circuits Implicated in the Nicotine Withdrawal Syndrome.
Topics: Cognition; Cross-Over Studies; Female; Humans; Nicotine; Prefrontal Cortex; Smokers; Smoking Cessation; Tobacco Use Cessation Devices; Transcranial Direct Current Stimulation | 2020 |
Evaluation of nicotine patch adherence measurement using self-report and saliva cotinine among abstainers in a smoking cessation trial.
Topics: Adult; Cotinine; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotine; ROC Curve; Saliva; Self Report; Smoking Cessation; Tobacco Smoking; Tobacco Use Cessation Devices | 2020 |
Effectiveness of nicotine gum in preventing lapses in the face of temptation to smoke among non-daily smokers: a secondary analysis.
Topics: Adult; Bayes Theorem; Ecological Momentary Assessment; Female; Humans; Male; Motivation; Nicotine; Nicotine Chewing Gum; Pennsylvania; Smoking; Smoking Cessation; Smoking Cessation Agents | 2020 |
Electronically Monitored Nicotine Gum Use Before and After Smoking Lapses: Relationship With Lapse and Relapse.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Behavior Therapy; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Recurrence; Smokers; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2020 |
Personalized dosing of nicotine replacement therapy versus standard dosing for the treatment of individuals with tobacco dependence: study protocol for a randomized placebo-controlled trial.
Topics: Administration, Cutaneous; Clinical Trials, Phase III as Topic; Humans; Multicenter Studies as Topic; Nicotine; Nicotinic Agonists; Ontario; Pragmatic Clinical Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2020 |
Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo-Controlled Trial.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Missouri; Nerve Tissue Proteins; Nicotine; Nicotinic Agonists; Pharmacogenetics; Pharmacogenomic Variants; Prospective Studies; Race Factors; Receptors, Nicotinic; Smokers; Smoking Cessation; Smoking Cessation Agents; Time Factors; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2020 |
Both reducing cigarettes per day and transitioning to very low-nicotine-content cigarettes decreases demand for usual-brand cigarettes.
Topics: Behavior, Addictive; Humans; Nicotine; Smoking Cessation; Tobacco Products; Tobacco Use Disorder | 2021 |
Opposite effects of smoking and nicotine intake on cognition.
Topics: Adult; Cognition; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Photic Stimulation; Pilot Projects; Psychomotor Performance; Smoking; Smoking Cessation; Tobacco Smoking; Tobacco Use Disorder; Young Adult | 2020 |
Comparison between Gradual Reduced Nicotine Content and Usual Nicotine Content Groups on Subjective Cigarette Ratings in a Randomized Double-Blind Trial.
Topics: Consumer Behavior; Double-Blind Method; Humans; Nicotine; Smokers; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Products; United States | 2020 |
Treating tobacco dependence to aid re-employment among job-seekers: A randomized controlled trial.
Topics: Employment; Female; Humans; Male; Nicotine; San Francisco; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2020 |
Facilitating smoking cessation using reduced nicotine cigarettes: Intervention development and RCT study design.
Topics: Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices | 2020 |
Changes in Cigarette Consumption With Reduced Nicotine Content Cigarettes Among Smokers With Psychiatric Conditions or Socioeconomic Disadvantage: 3 Randomized Clinical Trials.
Topics: Adult; Behavior, Addictive; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotine; Outcome Assessment, Health Care; Smoking; Smoking Cessation; Smoking Reduction; Tobacco Use Disorder; Young Adult | 2020 |
A Parental Smoking Cessation Intervention in the Pediatric Emergency Setting: A Randomized Trial.
Topics: Adult; Child; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Female; Humans; Male; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices | 2020 |
An Evaluation of Potential Unintended Consequences of a Nicotine Product Standard: A Focus on Drinking History and Outcomes.
Topics: Adult; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Products; Tobacco Smoking; United States | 2021 |
Switching to Progressively Reduced Nicotine Content Cigarettes in Smokers With Low Socioeconomic Status: A Double-Blind Randomized Clinical Trial.
Topics: Adult; Female; Humans; Male; Nicotine; Smokers; Smoking Cessation; Social Class; Tobacco Products; Tobacco Use Disorder | 2021 |
Support for a nicotine reduction policy among participants enrolled in a 20-week trial of very low nicotine content cigarettes.
Topics: Adolescent; Adult; Female; Humans; Male; Nicotine; Policy; Smoking; Smoking Cessation; Tobacco Products; Young Adult | 2021 |
Nicotine gum enhances visual processing in healthy nonsmokers.
Topics: Bayes Theorem; Double-Blind Method; Humans; Magnetic Resonance Imaging; Nicotine; Non-Smokers; Smoking Cessation; Visual Perception | 2021 |
Correlates of the nicotine metabolite ratio in Alaska Native people who smoke cigarettes.
Topics: Adult; Alaskan Natives; Binge Drinking; Cigarette Smoking; Electronic Nicotine Delivery Systems; Female; Humans; Male; Menthol; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Products; Tobacco Use Disorder | 2022 |
Effect of an electronic nicotine delivery system with 0, 8, or 36 mg/mL liquid nicotine versus a cigarette substitute on tobacco-related toxicant exposure: a four-arm, parallel-group, randomised, controlled trial.
Topics: Adult; Carcinogens; Double-Blind Method; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Nitrosamines; Smoking Cessation | 2021 |
Effects of advertising features on smokers' and non-smokers' perceptions of a reduced nicotine cigarette modified risk tobacco product.
Topics: Adult; Advertising; Female; Humans; Male; Nicotiana; Nicotine; Non-Smokers; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Disorder | 2023 |
Pharmacokinetic Characterization of a Prototype Mini Nicotine Lozenge.
Topics: Cross-Over Studies; Humans; Nicotine; Smoking Cessation; Therapeutic Equivalency; Tobacco Use Cessation Devices | 2021 |
E-cigarettes versus nicotine replacement treatment as harm reduction interventions for smokers who find quitting difficult: randomized controlled trial.
Topics: Adult; Electronic Nicotine Delivery Systems; Female; Harm Reduction; Humans; Male; Nicotine; Smokers; Smoking Cessation; Tobacco Use Cessation Devices | 2022 |
Nicotine acutely alters temporal properties of resting brain states.
Topics: Brain; Brain Mapping; Cross-Over Studies; Female; Humans; Magnetic Resonance Imaging; Male; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices | 2021 |
Cumulative vulnerabilities as a potential moderator of response to reduced nicotine content cigarettes.
Topics: Humans; Nicotine; Smokers; Smoking Cessation; Tobacco Products; Tobacco Use Disorder | 2021 |
Effects of Reduced Nicotine Content Cigarettes on Fractional Exhaled Nitric Oxide and Self-Reported Respiratory Health Outcomes Among Smokers With Psychiatric Conditions or Socioeconomic Disadvantage.
Topics: Adult; Fractional Exhaled Nitric Oxide Testing; Humans; Nicotine; Outcome Assessment, Health Care; Respiratory System; Self Report; Smokers; Smoking Cessation; Socioeconomic Factors; Tobacco Products | 2022 |
Effect of brief nicotine corrective messaging on nicotine beliefs in persons who use opioids.
Topics: Adolescent; Adult; Analgesics, Opioid; Electronic Nicotine Delivery Systems; Humans; Nicotine; Opioid-Related Disorders; Pilot Projects; Smoking Cessation; Tobacco Use Cessation Devices | 2022 |
The effect of nicotine dependence and withdrawal symptoms on use of nicotine replacement therapy: Secondary analysis of a randomized controlled trial in primary care.
Topics: Humans; Nicotine; Nicotinic Agonists; Primary Health Care; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2022 |
Smokers making a quit attempt using e-cigarettes with or without nicotine or prescription nicotine replacement therapy: Impact on cardiovascular function (ISME-NRT) - a study protocol.
Topics: Cardiovascular Diseases; Electronic Nicotine Delivery Systems; England; Female; Hemodynamics; Humans; Male; Nicotine; Research Design; Single-Blind Method; Smoking Cessation | 2017 |
Effectiveness of mass distribution of nicotine patches to promote tobacco control in rural versus urban settings.
Topics: Adult; Canada; Follow-Up Studies; Humans; Middle Aged; Nicotine; Outcome and Process Assessment, Health Care; Rural Population; Smoking; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Cessation Devices | 2017 |
Neural Signatures of Cognitive Flexibility and Reward Sensitivity Following Nicotinic Receptor Stimulation in Dependent Smokers: A Randomized Trial.
Topics: Adult; Cerebral Cortex; Cross-Over Studies; Double-Blind Method; Executive Function; Female; Humans; Impulsive Behavior; Limbic System; Male; Motivation; Nicotine; Receptors, Nicotinic; Reversal Learning; Reward; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2017 |
Anhedonia: Its Dynamic Relations With Craving, Negative Affect, and Treatment During a Quit Smoking Attempt.
Topics: Adult; Anhedonia; Bupropion; Craving; Female; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2017 |
Nicotine deprivation attenuates panic reactivity in smokers: Findings from a placebo-controlled nicotine patch study.
Topics: Administration, Cutaneous; Adult; Arousal; Culture; Double-Blind Method; Fear; Female; Humans; Male; Middle Aged; Nicotine; Panic Disorder; Prospective Studies; Risk Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2017 |
Does menthol cigarette use moderate the effect of nicotine metabolism on short-term smoking cessation?
Topics: Adult; Female; Humans; Logistic Models; Male; Menthol; Middle Aged; Nicotine; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Products; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2017 |
Effects of varenicline versus transdermal nicotine replacement therapy on cigarette demand on quit day in individuals with substance use disorders.
Topics: Administration, Cutaneous; Adult; Craving; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Reinforcement, Psychology; Smoking; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; Treatment Outcome; Varenicline | 2017 |
Reduced nicotine content cigarettes in smokers of low socioeconomic status: study protocol for a randomized control trial.
Topics: Adolescent; Adult; Aged; District of Columbia; Double-Blind Method; Female; Harm Reduction; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Pennsylvania; Research Design; Smokers; Smoking; Smoking Cessation; Social Class; Time Factors; Tobacco Products; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2017 |
Impact of large-scale distribution and subsequent use of free nicotine patches on primary care physician interaction.
Topics: Adult; Cost-Benefit Analysis; Female; Health Promotion; Humans; Male; Middle Aged; Nicotine; Patient Acceptance of Health Care; Physicians, Primary Care; Postal Service; Practice Patterns, Physicians'; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2017 |
Long-term effectiveness of mailed nicotine replacement therapy: study protocol of a randomized controlled trial 5-year follow-up.
Topics: Adult; Costs and Cost Analysis; Female; Follow-Up Studies; Humans; Male; Nicotine; Postal Service; Research Design; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2017 |
Addiction Potential of Cigarettes With Reduced Nicotine Content in Populations With Psychiatric Disorders and Other Vulnerabilities to Tobacco Addiction.
Topics: Adult; Behavior, Addictive; Female; Humans; Male; Mental Disorders; Nicotine; Outcome Assessment, Health Care; Smoking Cessation; Smoking Prevention; Tobacco Products; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2017 |
Ovarian Hormones and Transdermal Nicotine Administration Independently and Synergistically Suppress Tobacco Withdrawal Symptoms and Smoking Reinstatement in the Human Laboratory.
Topics: Administration, Cutaneous; Adult; Cigarette Smoking; Estradiol; Female; Humans; Nicotine; Ovary; Progesterone; Saliva; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2018 |
Nicotine Metabolism-informed Care for Smoking Cessation: A Pilot Precision RCT.
Topics: Adult; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Pilot Projects; Precision Medicine; Smoking Cessation; Smoking Cessation Agents; Tobacco Smoking; Tobacco Use Cessation Devices; Varenicline | 2018 |
Pilot Study of a Tailored Smoking Cessation Intervention for Individuals in Treatment for Opioid Dependence.
Topics: Adult; Analgesics, Opioid; Behavior Therapy; Female; Humans; Male; Methadone; Middle Aged; Nicotine; Opiate Substitution Treatment; Opioid-Related Disorders; Pilot Projects; Smokers; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2018 |
A Naturalistic, Randomized Pilot Trial of E-Cigarettes: Uptake, Exposure, and Behavioral Effects.
Topics: Adult; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Pilot Projects; Prospective Studies; Smoking Cessation; Tobacco Use Cessation Devices | 2017 |
[Smoking abstinence rate and its associated factors between abrupt and gradual smoking cessation].
Topics: China; Humans; Nicotine; Prevalence; Prospective Studies; Smoking; Smoking Cessation; Time Factors; Treatment Outcome | 2017 |
Evaluation of the safety profile of an electronic vapour product used for two years by smokers in a real-life setting.
Topics: Adult; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotiana; Nicotine; Smoke; Smokers; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Products; Tobacco Use Disorder | 2018 |
Preliminary validity of the modified Cigarette Evaluation Questionnaire in predicting the reinforcing effects of cigarettes that vary in nicotine content.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Nicotine; Nicotinic Agonists; Outcome Assessment, Health Care; Personal Satisfaction; Predictive Value of Tests; Reinforcement, Psychology; Reproducibility of Results; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Products | 2017 |
Pharmacokinetic characterization of three novel 4-mg nicotine lozenges
.
Topics: Adult; Area Under Curve; Cross-Over Studies; Drug Liberation; Half-Life; Humans; India; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Therapeutic Equivalency; Tobacco Use Cessation Devices; Young Adult | 2018 |
Randomized Trial to Compare Smoking Cessation Rates of Snus, With and Without Smokeless Tobacco Health-Related Information, and a Nicotine Lozenge.
Topics: Adult; Aged; Counseling; Female; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco, Smokeless; Young Adult | 2019 |
Factors associated with nicotine replacement therapy use among hospitalised smokers.
Topics: Adult; Aged; Female; Hospitalization; Humans; Inpatients; Male; Middle Aged; Nicotine; Smokers; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2018 |
Lack of effects of simvastatin on smoking cessation in humans: A double-blind, randomized, placebo-controlled clinical study.
Topics: Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Proof of Concept Study; Simvastatin; Smoking; Smoking Cessation; Tobacco Smoking; Tobacco Use Disorder; Treatment Outcome | 2018 |
Effects of reduced nicotine content cigarettes on individual withdrawal symptoms over time and during abstinence.
Topics: Adult; Cigarette Smoking; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Self Report; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Weight Gain | 2018 |
A randomized clinical trial to evaluate the efficacy of contingency management for treatment of waterpipe tobacco addiction.
Topics: Adult; Behavior Therapy; Behavior, Addictive; Cotinine; Female; Humans; Indicators and Reagents; Male; Middle Aged; Nicotine; Reward; Saliva; Smoking Cessation; Substance Abuse Detection; Tobacco, Waterpipe; Treatment Outcome; Water Pipe Smoking | 2018 |
Motivation and readiness for tobacco cessation among nicotine dependent postmenopausal females: A pilot study.
Topics: Cigarette Smoking; Female; Humans; Middle Aged; Motivation; Motivational Interviewing; Nicotine; Pilot Projects; Postmenopause; Smokers; Smoking Cessation; Symptom Assessment; Tobacco Use Disorder; Treatment Outcome | 2018 |
E-cigarettes May Support Smokers With High Smoking-Related Risk Awareness to Stop Smoking in the Short Run: Preliminary Results by Randomized Controlled Trial.
Topics: Counseling; Double-Blind Method; Early Detection of Cancer; Electronic Nicotine Delivery Systems; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Humans; Lung Neoplasms; Male; Middle Aged; Nicotine; Smokers; Smoking Cessation; Smoking Prevention; Tobacco Smoking | 2019 |
How do electronic cigarettes affect cravings to smoke or vape? Parsing the influences of nicotine and expectancies using the balanced-placebo design.
Topics: Adolescent; Adult; Aged; Craving; Double-Blind Method; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder; Vaping; Young Adult | 2018 |
Can we increase smokers' adherence to nicotine replacement therapy and does this help them quit?
Topics: Adult; Counseling; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Nicotine Chewing Gum; Recurrence; Smokers; Smoking Cessation; Smoking Cessation Agents; Telephone; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2018 |
Age Moderates Smokers' Subjective Response to Very-Low Nicotine Content Cigarettes: Evidence from a Randomized Controlled Trial.
Topics: Adolescent; Age Factors; Cigarette Smoking; Double-Blind Method; Female; Humans; Male; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices; Young Adult | 2019 |
Adolescent smokers' response to reducing the nicotine content of cigarettes: Acute effects on withdrawal symptoms and subjective evaluations.
Topics: Adolescent; Affect; Breath Tests; Carbon Monoxide; Craving; Dose-Response Relationship, Drug; Female; Humans; Male; Nicotiana; Nicotine; Smokers; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Products; Young Adult | 2018 |
A randomized clinical trial of counseling and nicotine replacement therapy for treatment of African American non-daily smokers: Design, accrual, and baseline characteristics.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Black or African American; Combined Modality Therapy; Counseling; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Kansas; Male; Middle Aged; Nicotine; Research Design; Smoking; Smoking Cessation; Smoking Cessation Agents; Treatment Outcome; Young Adult | 2018 |
Nicotine metabolite ratio and smoking outcomes using nicotine replacement therapy and varenicline among smokers with and without psychiatric illness.
Topics: Female; Humans; Male; Mental Disorders; Middle Aged; Nicotine; Smoking; Smoking Cessation; Smoking Cessation Agents; Time Factors; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2018 |
Nondaily Smokers' Changes in Cigarette Consumption With Very Low-Nicotine-Content Cigarettes: A Randomized Double-blind Clinical Trial.
Topics: Adult; Cigarette Smoking; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Outcome Assessment, Health Care; Smoking Cessation; Tobacco Products; Young Adult | 2018 |
Changes in Biomarkers of Exposure on Switching From a Conventional Cigarette to Tobacco Heating Products: A Randomized, Controlled Study in Healthy Japanese Subjects.
Topics: Adult; Biomarkers; Cigarette Smoking; Electronic Nicotine Delivery Systems; Female; Heating; Humans; Japan; Male; Middle Aged; Nicotine; Smoking Cessation; Tobacco Products | 2019 |
A randomized controlled trial of distress tolerance treatment for smoking cessation.
Topics: Adult; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Stress, Psychological; Tobacco Use Cessation Devices; Treatment Outcome | 2018 |
Predicting smoking abstinence with biological and self-report measures of adherence to varenicline: Impact on pharmacogenetic trial outcomes.
Topics: Adult; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Nicotinic Agonists; Pharmacogenetics; Predictive Value of Tests; Self Report; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2018 |
Effects of nicotine deprivation on current pain intensity among daily cigarette smokers.
Topics: Adult; Carbon Monoxide; Chronic Pain; Cigarette Smoking; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Nicotine; Patient Outcome Assessment; Smoking Cessation; Substance Withdrawal Syndrome | 2018 |
Mediators of the effect of nicotine pre-treatment on quitting smoking.
Topics: Adult; Behavior Therapy; Bupropion; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Premedication; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline | 2018 |
Electronic nicotine devices to aid smoking cessation by alcohol- and drug-dependent clients: protocol for a pilot randomised controlled trial.
Topics: Administration, Inhalation; Alcoholics; Alcoholism; Clinical Trials, Phase II as Topic; Counseling; Drug Users; Electronic Nicotine Delivery Systems; Feasibility Studies; Humans; Nicotine; Nicotinic Agonists; Pilot Projects; Pragmatic Clinical Trials as Topic; Recurrence; Smoking; Smoking Cessation; Substance-Related Disorders; Time Factors; Tobacco Use Disorder; Treatment Outcome; Vaping; Victoria | 2018 |
Nicotine preloading for smoking cessation: the Preloading RCT.
Topics: Adult; Aged; Cost-Benefit Analysis; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Smoking Cessation Agents; State Medicine; United Kingdom; Varenicline | 2018 |
Pregnancy-Induced Increases in the Nicotine Metabolite Ratio: Examining Changes During Antepartum and Postpartum.
Topics: Cotinine; Female; Humans; Nicotine; Postpartum Period; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Third; Smoking; Smoking Cessation | 2019 |
Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial.
Topics: Acetylcysteine; Adult; Area Under Curve; Biomarkers; Breath Tests; Carbon Monoxide; Creatinine; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotiana; Nicotine; Phenanthrenes; Smoke; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Products; Tobacco Use Disorder | 2018 |
Biomarkers of Tobacco Exposure Decrease After Smokers Switch to an E-Cigarette or Nicotine Gum.
Topics: Adult; Biomarkers; Cigarette Smoking; Electronic Nicotine Delivery Systems; Female; Hazardous Substances; Humans; Male; Middle Aged; Nicotine; Nicotine Chewing Gum; Smokers; Smoking Cessation; Vaping | 2019 |
Do non-daily smokers compensate for reduced cigarette consumption when smoking very-low-nicotine-content cigarettes?
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Products; Young Adult | 2018 |
Correlates of support for a nicotine-reduction policy in smokers with 6-week exposure to very low nicotine cigarettes.
Topics: Cigarette Smoking; Double-Blind Method; Female; Humans; Male; Nicotine; Public Health; Public Policy; Smokers; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices | 2019 |
Efficacy and Safety of a Nicotine Mouth Spray for Smoking Cessation: A Randomized, Multicenter, Controlled Study in a Naturalistic Setting.
Topics: Carbon Monoxide; Counseling; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome | 2020 |
The Network Structure of Tobacco Withdrawal in a Community Sample of Smokers Treated With Nicotine Patch and Behavioral Counseling.
Topics: Adolescent; Adult; Behavior Therapy; Combined Modality Therapy; Community Networks; Counseling; Female; Humans; Male; Middle Aged; Minnesota; Nicotine; Smokers; Smoking Cessation; Social Networking; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2020 |
Efficacy of Mobile Phone-Delivered Smoking Cessation Interventions for Socioeconomically Disadvantaged Individuals: A Randomized Clinical Trial.
Topics: Adult; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Texas; Text Messaging; Tobacco Use Cessation Devices; Treatment Outcome; Vulnerable Populations; Young Adult | 2019 |
Effect of Long-term Nicotine Replacement Therapy vs Standard Smoking Cessation for Smokers With Chronic Lung Disease: A Randomized Clinical Trial.
Topics: Adult; Aged; Carbon Monoxide; Chronic Disease; Counseling; Female; Humans; Lung Diseases; Male; Middle Aged; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices | 2018 |
A randomized controlled trial of 24 weeks of varenicline for tobacco use among cancer patients: Efficacy, safety, and adherence.
Topics: Adult; Benzazepines; Counseling; Female; Humans; Male; Medication Adherence; Middle Aged; Neoplasms; Nicotine; Smoking; Smoking Cessation; Smoking Cessation Agents; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline | 2019 |
A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy.
Topics: Adult; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Vaping | 2019 |
Self-initiated gradual smoking reduction among community correction smokers.
Topics: Adult; Age of Onset; Black or African American; Bupropion; Cigar Smoking; Cigarette Smoking; Counseling; Criminal Law; Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Cessation Agents; Smoking Reduction; Substance Withdrawal Syndrome; White People | 2019 |
Very-low-nicotine-content cigarettes and dependence among non-daily smokers.
Topics: Adult; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Disorder; United States; United States Food and Drug Administration; Young Adult | 2019 |
Smoking abstinence symptoms across 67 days compared with randomized controls-Moderation by nicotine replacement therapy, bupropion, and negative-affect traits.
Topics: Administration, Cutaneous; Adult; Anxiety; Behavior Therapy; Bupropion; Cigarette Smoking; Craving; Female; Humans; Male; Nicotine; Smoking Cessation; Smoking Cessation Agents; Substance Withdrawal Syndrome | 2019 |
e-Cigarettes for smoking cessation: Do they deliver?
Topics: Adult; Aged; Electronic Nicotine Delivery Systems; Flavoring Agents; Humans; Middle Aged; Nicotine; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Young Adult | 2019 |
Anxiety Sensitivity and Distress Tolerance in Smokers: Relations With Tobacco Dependence, Withdrawal, and Quitting Success†.
Topics: Adolescent; Adult; Anxiety Disorders; Child; Ecological Momentary Assessment; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Smokers; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Varenicline; Young Adult | 2020 |
Opioid Use and Rate of Nicotine Metabolism Among Pregnant Smokers.
Topics: Adult; Analgesics, Opioid; Biomarkers; Case-Control Studies; Female; Humans; Nicotine; Non-Smokers; Opioid-Related Disorders; Pregnancy; Smokers; Smoking; Smoking Cessation; Young Adult | 2020 |
A Pilot Study of E-Cigarette Naïve Cigarette Smokers and the Effects on Craving After Acute Exposure to E-Cigarettes in the Laboratory.
Topics: Adult; Carbon Monoxide; Cigarette Smoking; Craving; Double-Blind Method; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pilot Projects; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Vaping | 2019 |
The Relationship of Varenicline Agonism of α4β2 Nicotinic Acetylcholine Receptors and Nicotine-Induced Dopamine Release in Nicotine-Dependent Humans.
Topics: Adolescent; Adult; Brain; Dopamine; Double-Blind Method; Female; Humans; Male; Maryland; Middle Aged; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline; Young Adult | 2020 |
Effectiveness of switching to very low nicotine content cigarettes plus nicotine patch versus reducing daily cigarette consumption plus nicotine patch to decrease dependence: an exploratory randomized trial.
Topics: Adult; Cigarette Smoking; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Reduction; Tobacco Products; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2019 |
Is the apparently protective effect of maternal nicotine replacement therapy (NRT) used in pregnancy on infant development explained by smoking cessation?: secondary analyses of a randomised controlled trial.
Topics: Adult; Child Development; England; Female; Humans; Infant; Infant, Newborn; Logistic Models; Nicotine; Outcome Assessment, Health Care; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Smoking; Smoking Cessation; Smoking Prevention; Time; Tobacco Use Cessation Devices; Young Adult | 2019 |
Effect of a nicotine vaccine on nicotine binding to β2*-nicotinic acetylcholine receptors in vivo in human tobacco smokers.
Topics: Adult; Azetidines; Brain; Female; Functional Neuroimaging; Humans; Iodine Radioisotopes; Male; Nicotine; Pyridines; Receptors, Nicotinic; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Tomography, Emission-Computed, Single-Photon; Vaccination; Vaccines | 2013 |
Adherence to and consumption of nicotine replacement therapy and the relationship with abstinence within a smoking cessation trial in primary care.
Topics: Female; Humans; Male; Nicotine; Primary Health Care; Smoking Cessation | 2013 |
A randomized clinical trial of the efficacy of extended smoking cessation treatment for adolescent smokers.
Topics: Adolescent; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2013 |
Niccine®, a nicotine vaccine, for relapse prevention: a phase II, randomized, placebo-controlled, multicenter clinical trial.
Topics: Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Vaccines | 2013 |
Symptoms of depression and smoking behaviors following treatment with transdermal nicotine patch.
Topics: Adolescent; Adult; Affect; Anhedonia; Depression; Humans; Linear Models; Logistic Models; Middle Aged; Nicotine; Predictive Value of Tests; Psychiatric Status Rating Scales; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Treatment Outcome; Young Adult | 2013 |
Public education about the relative harm of tobacco products: an intervention for tobacco control professionals.
Topics: Awareness; Carcinogens; Comprehension; Education, Professional; Health Knowledge, Attitudes, Practice; Humans; Nicotiana; Nicotine; Nitrosamines; Smoking Cessation; Surveys and Questionnaires; Tobacco Products; Tobacco Use; Tobacco, Smokeless | 2014 |
Down-regulation of amygdala and insula functional circuits by varenicline and nicotine in abstinent cigarette smokers.
Topics: Adolescent; Adult; Amygdala; Benzazepines; Brain Mapping; Cerebral Cortex; Double-Blind Method; Down-Regulation; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Rest; Smoking Cessation; Varenicline; Young Adult | 2013 |
Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.
Topics: Adolescent; Adult; Affect; Aged; Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Delayed-Action Preparations; Depression; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline; Young Adult | 2013 |
Effects of nicotine withdrawal on panic-like response to breath holding: a placebo-controlled, double-blind, crossover patch study.
Topics: Administration, Cutaneous; Adolescent; Adult; Blood Pressure; Breath Holding; Cross-Over Studies; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Panic; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Young Adult | 2013 |
Effects of nicotine withdrawal on cognition in a clinical trial setting.
Topics: Adult; Cognition; Humans; Male; Middle Aged; Nicotine; Reaction Time; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Young Adult | 2013 |
Reduced nicotine content cigarettes and nicotine patch.
Topics: Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Prognosis; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2013 |
Do atypical antipsychotics really enhance smoking reduction more than typical ones?: the effects of antipsychotics on smoking reduction in patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Bupropion; Dose-Response Relationship, Drug; Female; Humans; Linear Models; Male; Middle Aged; Nicotine; Schizophrenia; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2013 |
Cigarette craving and withdrawal symptoms during temporary abstinence and the effect of nicotine gum.
Topics: Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Cessation Devices; Treatment Outcome; Young Adult | 2013 |
Effect of varenicline on individual nicotine withdrawal symptoms: a combined analysis of eight randomized, placebo-controlled trials.
Topics: Adult; Aged; Benzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Varenicline | 2013 |
Effectiveness of a telephone delivered and a face-to-face delivered counseling intervention for smoking cessation in patients with coronary heart disease: a 6-month follow-up.
Topics: Combined Modality Therapy; Coronary Disease; Counseling; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Telephone | 2014 |
A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIV.
Topics: Adult; Alabama; Ambulatory Care; Analysis of Variance; Counseling; Female; HIV Infections; Humans; Intention to Treat Analysis; Male; Mass Screening; Models, Psychological; Motivation; Nicotine; Nicotinic Agonists; Outcome Assessment, Health Care; Patient Acceptance of Health Care; Pilot Projects; Referral and Consultation; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2013 |
Implementation of a parental tobacco control intervention in pediatric practice.
Topics: Adolescent; Adult; Child; Child, Preschool; Combined Modality Therapy; Evidence-Based Medicine; Female; Health Plan Implementation; Humans; Infant; Male; Middle Aged; Motivational Interviewing; Nicotine; Parents; Referral and Consultation; Smoking Cessation; Tobacco Smoke Pollution; Young Adult | 2013 |
The effectiveness of a perioperative smoking cessation program: a randomized clinical trial.
Topics: Administration, Cutaneous; Adult; Canada; Carbon Dioxide; Confidence Intervals; Critical Care; Female; Follow-Up Studies; Humans; Length of Stay; Male; Middle Aged; Nicotine; Nicotinic Agonists; Ontario; Perioperative Care; Postoperative Care; Postoperative Complications; Smoking; Smoking Cessation; Treatment Outcome | 2013 |
A randomized phase II clinical trial of high-dose nicotine patch therapy for smokeless tobacco users.
Topics: Adolescent; Adult; Behavior Therapy; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder; Tobacco, Smokeless; Treatment Outcome; Weight Gain; Young Adult | 2013 |
Development and preliminary randomized controlled trial of a distress tolerance treatment for smokers with a history of early lapse.
Topics: Adolescent; Adult; Affect; Aged; Behavior Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2013 |
Knowing quitters predicts smoking cessation in a homeless population.
Topics: Adult; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Ill-Housed Persons; Male; Middle Aged; Motivational Interviewing; Nicotine; Smoking Cessation; Social Conformity; Tobacco Use Disorder | 2013 |
Electronic cigarettes for smoking cessation: a randomised controlled trial.
Topics: Adult; Breath Tests; Carbon Monoxide; Counseling; Female; Humans; Male; Middle Aged; New Zealand; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2013 |
Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).
Topics: Adult; Base Sequence; Bupropion; Cytochrome P-450 CYP2A6; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Molecular Sequence Data; Nerve Tissue Proteins; Nicotine; Proportional Hazards Models; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome | 2014 |
Multicentric cohort study on the long-term efficacy and safety of electronic cigarettes: study design and methodology.
Topics: Adult; Aged; Clinical Trials as Topic; Cohort Studies; Electronic Nicotine Delivery Systems; Female; Humans; Italy; Male; Middle Aged; Nicotine; Prospective Studies; Research Design; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires | 2013 |
A randomized controlled trial of two different lengths of nicotine replacement therapy for smoking cessation.
Topics: Adolescent; Adult; Aged; China; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome | 2013 |
Factors associated with smoking cessation in early and late pregnancy in the smoking, nicotine, and pregnancy trial: a trial of nicotine replacement therapy.
Topics: Adult; Cotinine; Female; Humans; Logistic Models; Nicotine; Pregnancy; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Young Adult | 2014 |
Commitment contracts and team incentives: a randomized controlled trial for smoking cessation in Thailand.
Topics: Adult; Aged; Benzazepines; Contracts; Cost-Benefit Analysis; Counseling; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Quinoxalines; Rural Population; Smoking Cessation; Thailand; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Pilot investigation of changes in readiness and confidence to quit smoking after E-cigarette experimentation and 1 week of use.
Topics: Adult; Electronics; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Products | 2014 |
Tobacco cessation among low-income smokers: motivational enhancement and nicotine patch treatment.
Topics: Adult; Counseling; Female; Health Promotion; Humans; Male; Middle Aged; Motivation; Nicotine; Poverty; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States | 2014 |
Effect of nicotine patch on energy intake and weight gain in postmenopausal women during smoking cessation.
Topics: Body Mass Index; Double-Blind Method; Energy Intake; Female; Follow-Up Studies; Humans; Middle Aged; Nicotine; Postmenopause; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; Weight Gain | 2013 |
Motivational interviewing versus brief advice for cigarette smokers in residential alcohol treatment.
Topics: Alcoholism; Female; Humans; Male; Middle Aged; Motivational Interviewing; Nicotine; Sample Size; Smoking Cessation; Tobacco Use Disorder | 2014 |
Overcoming limitations in previous research on exercise as a smoking cessation treatment: rationale and design of the "Quit for Health" trial.
Topics: Combined Modality Therapy; Exercise Therapy; Female; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2014 |
The effects of acute exercise on tobacco cravings and withdrawal symptoms in temporary abstinent pregnant smokers.
Topics: Adult; Exercise; Exercise Therapy; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Young Adult | 2014 |
Semipermeable membrane dressings can be used with the nicotine transdermal system and do not interfere with nicotine absorption.
Topics: Administration, Cutaneous; Adult; Aged; Bandages; Cell Membrane Permeability; Cotinine; Cross-Over Studies; Drug Carriers; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Skin Absorption; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2013 |
Effect of high-dose nicotine patch on craving and negative affect leading up to lapse episodes.
Topics: Administration, Cutaneous; Adult; Affect; Craving; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2014 |
An exploratory examination of the mechanisms through which pre-quit patch use aids smoking cessation.
Topics: Administration, Cutaneous; Adult; Computers, Handheld; Craving; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Personal Satisfaction; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2014 |
Behavioral effects of modafinil and nicotine, alone and in combination, in tobacco-deprived young adult smokers.
Topics: Adolescent; Benzhydryl Compounds; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Modafinil; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Wakefulness-Promoting Agents; Young Adult | 2014 |
Constructing a trial as a personal lifestyle change project: participants' experiences in a clinical study for nicotine vaccination.
Topics: Adult; Double-Blind Method; Female; Follow-Up Studies; Humans; Life Style; Male; Middle Aged; Netherlands; Nicotine; Qualitative Research; Research Subjects; Smoking; Smoking Cessation; Smoking Prevention; Vaccination; Volunteers | 2014 |
Adolescents' use of nicotine replacement therapy for smoking cessation: predictors of compliance trajectories.
Topics: Administration, Cutaneous; Adolescent; Double-Blind Method; Female; Humans; Male; Netherlands; Nicotine; Nicotinic Agonists; Patient Compliance; Personality; Regression Analysis; Smoking; Smoking Cessation; Socioeconomic Factors; Surveys and Questionnaires; Time Factors; Tobacco Use Cessation Devices; Treatment Outcome | 2014 |
Evaluating the effect of access to free medication to quit smoking: a clinical trial testing the role of motivation.
Topics: Adult; Female; Health Behavior; Hotlines; Humans; Male; Middle Aged; Motivation; Nicotine; Smoking; Smoking Cessation; South Carolina; Telephone; Tobacco Use Disorder | 2014 |
Comparison of cotinine levels in pregnant women while smoking and when using nicotine replacement therapy.
Topics: Administration, Cutaneous; Adult; Cotinine; Female; Humans; Nicotine; Pregnancy; Saliva; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Young Adult | 2014 |
Smoking cessation and reduction in schizophrenia (SCARIS) with e-cigarette: study protocol for a randomized control trial.
Topics: Administration, Inhalation; Analysis of Variance; Chi-Square Distribution; Clinical Protocols; Cognition; Electronics; Equipment Design; Humans; Italy; Nicotine; Nicotinic Agonists; Patient Satisfaction; Perception; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Research Design; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Volatilization | 2014 |
S-PC: an e-treatment application for management of smoke-quitting patients.
Topics: Adult; Cell Phone; Communication; Female; Humans; Internet; Male; Middle Aged; Models, Statistical; Nicotine; Professional-Patient Relations; Psychotherapy; Recurrence; Reminder Systems; Risk Factors; Smoking; Smoking Cessation; Telemedicine; User-Computer Interface | 2014 |
Sex differences in response to reduced nicotine content cigarettes.
Topics: Adult; Female; Humans; Male; Middle Aged; Nicotine; Sex Factors; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices; Treatment Outcome | 2014 |
Long-term efficacy of nicotine replacement therapy for smoking cessation in adolescents: a randomized controlled trial.
Topics: Administration, Cutaneous; Adolescent; Child; Double-Blind Method; Female; Humans; Male; Nicotine; Nicotinic Agonists; Patient Compliance; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome | 2014 |
Smoking cessation is followed by increases in serum bilirubin, an endogenous antioxidant associated with lower risk of lung cancer and cardiovascular disease.
Topics: Administration, Cutaneous; Adult; Antioxidants; Bilirubin; Cardiovascular Diseases; Counseling; Double-Blind Method; Female; Humans; Lung Neoplasms; Male; Middle Aged; Naltrexone; Nicotine; Risk Factors; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome | 2014 |
E-cigarette versus nicotine inhaler: comparing the perceptions and experiences of inhaled nicotine devices.
Topics: Adult; Aged; Attitude to Health; Cross-Over Studies; Electronic Nicotine Delivery Systems; Female; Follow-Up Studies; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Nebulizers and Vaporizers; New Jersey; Nicotine; Patient Satisfaction; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Young Adult | 2014 |
Combination rapid-acting nicotine mouth spray and nicotine patch therapy in smoking cessation.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; New Zealand; Nicotine; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Young Adult | 2014 |
Comparison of consumption patterns, biomarkers of exposure, and subjective effects in cigarette smokers who switched to dissolvable tobacco (Camel Orbs), dual use, or tobacco abstinence.
Topics: Adult; Animals; Biomarkers; Carboxyhemoglobin; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2014 |
A pragmatic, randomized, controlled study evaluating the impact of access to smoking cessation pharmacotherapy coverage on the proportion of successful quitters in a Canadian population of smokers motivated to quit (ACCESSATION).
Topics: Benzazepines; Bupropion; Canada; Female; Health Services Accessibility; Humans; Insurance, Health; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Effects of advertisements on smokers' interest in trying e-cigarettes: the roles of product comparison and visual cues.
Topics: Adult; Advertising; Cues; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Tobacco Products; United States | 2014 |
Smoking cessation in smokers who smoke menthol and non-menthol cigarettes.
Topics: Administration, Cutaneous; Adult; Bupropion; Combined Modality Therapy; Counseling; Double-Blind Method; Drug Therapy, Combination; History, 15th Century; Humans; Longitudinal Studies; Male; Menthol; Nicotine; Sex Factors; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices; Treatment Failure; Treatment Outcome | 2014 |
Randomized trial comparing mindfulness training for smokers to a matched control.
Topics: Adult; Cognitive Behavioral Therapy; Female; Humans; Male; Meditation; Middle Aged; Mindfulness; Nicotine; Nicotinic Agonists; Patient Compliance; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2014 |
Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes.
Topics: Administration, Inhalation; Adult; Blood Pressure; Echocardiography, Doppler; Electronic Nicotine Delivery Systems; Female; Heart Rate; Humans; Male; Mitral Valve; Nicotine; Nicotinic Agonists; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Ventricular Function, Left | 2014 |
Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
Topics: Adult; Benzazepines; Breath Tests; Carbon Monoxide; Cholinergic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers.
Topics: Cotinine; Cytochrome P-450 CYP2A6; Female; Genotype; Humans; Linear Models; Male; Middle Aged; Nicotine; Predictive Value of Tests; Smoking; Smoking Cessation; Tobacco Use Disorder | 2014 |
Is smoking cessation associated with worse comorbid substance use outcomes among homeless adults?
Topics: Administration, Topical; Adult; Alcoholism; Comorbidity; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Ill-Housed Persons; Illicit Drugs; Male; Motivational Interviewing; Nicotine; Outcome Assessment, Health Care; Smoking; Smoking Cessation; Substance-Related Disorders | 2014 |
Evaluation of a novel nicotine inhaler device: part 2--effect on craving and smoking urges.
Topics: Administration, Inhalation; Adolescent; Adult; Area Under Curve; Craving; Female; Humans; Lung; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Smoking; Smoking Cessation | 2015 |
Cognitive effects of very low nicotine content cigarettes, with and without nicotine replacement, in smokers with schizophrenia and controls.
Topics: Adult; Cognition; Female; Humans; Male; Memory, Short-Term; Middle Aged; Nicotiana; Nicotine; Schizophrenia; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2015 |
Pharmacokinetic-pharmacodynamic modeling of the effect of varenicline on nicotine craving in adult smokers.
Topics: Adolescent; Adult; Benzazepines; Craving; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Surveys and Questionnaires; Varenicline | 2015 |
The SNAP trial: a randomised placebo-controlled trial of nicotine replacement therapy in pregnancy--clinical effectiveness and safety until 2 years after delivery, with economic evaluation.
Topics: Administration, Cutaneous; Adult; Child, Preschool; Cost-Benefit Analysis; Double-Blind Method; England; Female; Humans; Infant; Infant, Newborn; Nicotine; Outcome Assessment, Health Care; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Smoking; Smoking Cessation; Smoking Prevention; Time; Tobacco Use Cessation Devices | 2014 |
Greater reductions in nicotine exposure while smoking very low nicotine content cigarettes predict smoking cessation.
Topics: Adult; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Products; Tobacco Use Cessation Devices; Treatment Outcome | 2015 |
Combining varenicline and nicotine patches: a randomized controlled trial study in smoking cessation.
Topics: Administration, Cutaneous; Adolescent; Adult; Benzazepines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
[Smoking cessation: varenicline/nicotine patch combination more effective than varenicline alone].
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Benzazepines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult | 2014 |
Impact of cigarette smoking cessation on high-density lipoprotein functionality.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Administration, Cutaneous; Adult; Apolipoprotein A-I; Benzazepines; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholinergic Agonists; Female; Humans; Inflammation; Lipid Peroxidation; Lipids; Lipoproteins, HDL; Macrophages; Male; Malondialdehyde; Middle Aged; Nicotine; Oxidation-Reduction; Quinoxalines; Receptors, Nicotinic; Risk Factors; Smoking; Smoking Cessation; Varenicline | 2014 |
A mechanistic test of nicotine replacement therapy sampling for smoking cessation induction.
Topics: Adult; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Self Efficacy; Smoking; Smoking Cessation; Treatment Outcome | 2015 |
The moderating role of experiential avoidance in the relationships between internal distress and smoking behavior during a quit attempt.
Topics: Adult; Depression; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2015 |
Effectiveness of the electronic cigarette: An eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints.
Topics: Adult; Belgium; Biomarkers; Carbon Dioxide; Cotinine; Craving; Electronic Nicotine Delivery Systems; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Saliva; Smoking Cessation; Substance Withdrawal Syndrome | 2014 |
Success rates with nicotine personal vaporizers: a prospective 6-month pilot study of smokers not intending to quit.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Electronic Nicotine Delivery Systems; Female; Health Behavior; Humans; Male; Middle Aged; Nicotine; Pilot Projects; Prospective Studies; Smoking Cessation | 2014 |
Anhedonia as a component of the tobacco withdrawal syndrome.
Topics: Adult; Anhedonia; Double-Blind Method; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2015 |
Evaluation of a novel nicotine inhaler device: part 1--arterial and venous pharmacokinetics.
Topics: Administration, Inhalation; Adolescent; Adult; Female; Humans; Lung; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Smoking; Smoking Cessation; United Kingdom | 2015 |
Randomised trial of two nicotine patch protocols distributed through a state quitline.
Topics: Administration, Cutaneous; Adolescent; Adult; Cost-Benefit Analysis; Drug Costs; Female; Government Regulation; Humans; Local Government; Male; Middle Aged; Nicotine; Nicotinic Agonists; Preventive Health Services; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Transdermal Patch; Treatment Outcome; Young Adult | 2016 |
Cost-Effectiveness of Nicotine Patches for Smoking Cessation in Pregnancy: A Placebo Randomized Controlled Trial (SNAP).
Topics: Adult; Behavior Therapy; Cost-Benefit Analysis; Costs and Cost Analysis; Female; Health Promotion; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Transdermal Patch; Treatment Outcome; United Kingdom; Young Adult | 2015 |
Differential Efficacy of Nicotine Replacement Among Overweight and Obese Women Smokers.
Topics: Administration, Cutaneous; Adult; Body Mass Index; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Obesity; Overweight; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome | 2015 |
Cytisine versus nicotine for smoking cessation.
Topics: Adult; Alkaloids; Azocines; Female; Humans; Male; Middle Aged; Nausea; Nicotine; Quinolizines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2014 |
Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial.
Topics: Adult; Biomarkers; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2015 |
The Nicotine Metabolite Ratio in Pregnancy Measured by trans-3'-Hydroxycotinine to Cotinine Ratio: Characteristics and Relationship With Smoking Cessation.
Topics: Administration, Cutaneous; Adolescent; Adult; Cotinine; Female; Humans; Middle Aged; Nicotine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Second; Smoking; Smoking Cessation; Tobacco Use Disorder; Young Adult | 2015 |
The comparative efficacy of first- versus second-generation electronic cigarettes in reducing symptoms of nicotine withdrawal.
Topics: Adult; Analysis of Variance; Cross-Over Studies; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2015 |
Preliminary effects of progressive muscle relaxation on cigarette craving and withdrawal symptoms in experienced smokers in acute cigarette abstinence: a randomized controlled trial.
Topics: Adolescent; Adult; Craving; Female; Humans; Hypertension; Male; Middle Aged; Nicotine; Relaxation Therapy; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2015 |
Cluster-Randomized Trial of Clinical Pharmacist Tobacco Cessation Counseling Among Patients with Cardiovascular Disease.
Topics: Aged; Cardiac Rehabilitation; Cardiovascular Diseases; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Pharmacists; Prospective Studies; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder | 2015 |
Long-term quit rates after a perioperative smoking cessation randomized controlled trial.
Topics: Administration, Cutaneous; Adult; Counseling; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Humans; Logistic Models; Male; Middle Aged; Motivation; Multivariate Analysis; Nicotine; Nicotinic Agonists; Odds Ratio; Ontario; Pamphlets; Patient Education as Topic; Perioperative Care; Recurrence; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Telephone; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Transdermal Patch; Treatment Outcome | 2015 |
The effect of acute exercise on cigarette cravings while using a nicotine lozenge.
Topics: Adolescent; Adult; Aged; Craving; Exercise; Female; Heart Rate; Humans; Male; Middle Aged; Motor Activity; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tablets; Tobacco Products; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2015 |
Long-term nicotine replacement therapy: a randomized clinical trial.
Topics: Administration, Cutaneous; Adult; Aged; Directive Counseling; Female; Humans; Male; Middle Aged; Nicotine; Recurrence; Self Report; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome | 2015 |
Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking Smokers.
Topics: Adult; Biomarkers; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Patient Acceptance of Health Care; Reproducibility of Results; Retrospective Studies; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2015 |
Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy.
Topics: Adolescent; Adult; Benzazepines; Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Nicotine; Nicotinic Agonists; Progesterone; Quinoxalines; Smoking Cessation; Transdermal Patch; Treatment Outcome; Varenicline; Women's Health | 2015 |
Gender differences in responses to cues presented in the natural environment of cigarette smokers.
Topics: Adult; Cues; Female; Gender Identity; Humans; Male; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Social Environment; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2015 |
Gender differences in a randomized controlled trial treating tobacco use among adolescents and young adults with mental health concerns.
Topics: Adolescent; Adolescent Health Services; Female; Gender Identity; Humans; Male; Mental Disorders; Mental Health Services; Nicotine; San Francisco; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Transdermal Patch; Young Adult | 2015 |
Paths to tobacco abstinence: A repeated-measures latent class analysis.
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2015 |
Does smoking reduction worsen mental health? A comparison of two observational approaches.
Topics: Adult; Emotions; Female; Humans; Male; Mental Health; Middle Aged; Mood Disorders; Nicotiana; Nicotine; Nicotinic Agonists; Prospective Studies; Research Design; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching.
Topics: Administration, Oral; Adult; Biomarkers; Chewing Gum; Consumer Behavior; Cotinine; Female; Glucuronides; Humans; Male; Middle Aged; Minnesota; Nicotine; Nicotinic Agonists; Nitrosamines; Oregon; Pyridines; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Tobacco, Smokeless; Treatment Outcome; Urinalysis | 2016 |
Measuring the detriment of treatment: number needed to harm.
Topics: Administration, Cutaneous; Adult; Birth Weight; Drug-Related Side Effects and Adverse Reactions; Female; Health Services Needs and Demand; Humans; Infant, Newborn; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome | 2015 |
Evaluating Nicotine Craving, Withdrawal, and Substance Use as Mediators of Smoking Cessation in Cocaine- and Methamphetamine-Dependent Patients.
Topics: Adult; Amphetamine-Related Disorders; Cocaine-Related Disorders; Craving; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2016 |
The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite Ratio.
Topics: Adult; Female; Humans; Male; Middle Aged; Nicotine; Prospective Studies; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up.
Topics: Adult; Breath Tests; Carbon Monoxide; Cotinine; Female; Humans; Male; Nicotiana; Nicotine; Nicotinic Agonists; Smoke; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Disorder | 2015 |
Does smoking abstinence influence distress tolerance? An experimental study comparing the response to a breath-holding test of smokers under tobacco withdrawal and under nicotine replacement therapy.
Topics: Adult; Blood Pressure; Breath Holding; Cross-Over Studies; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Stress, Physiological; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Young Adult | 2015 |
Challenges in Enforcing Home Smoking Rules in a Low-Income Population: Implications for Measurement and Intervention Design.
Topics: Adult; Environmental Monitoring; Family Characteristics; Female; Georgia; Humans; Male; Middle Aged; Nicotine; Poverty; Smoking Cessation; Smoking Prevention; Tobacco Smoke Pollution | 2016 |
Experimental study on the effects of anxiety sensitivity and somatosensory amplification on the response to the 35% CO₂ challenge in abstinent smokers.
Topics: Administration, Cutaneous; Adolescent; Adult; Anxiety; Case-Control Studies; Double-Blind Method; Fear; Female; Humans; Male; Nicotine; Panic; Smoking; Smoking Cessation; Young Adult | 2015 |
Electronic cigarette nicotine delivery can exceed that of combustible cigarettes: a preliminary report.
Topics: Administration, Inhalation; Adult; Aerosols; Double-Blind Method; Drug Administration Schedule; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Products; Tobacco Use Disorder; Vaping; Young Adult | 2016 |
Perceived Health Risks of Snus and Medicinal Nicotine Products.
Topics: Aged; Behavior, Addictive; Bronchitis; Emphysema; Female; Harm Reduction; Humans; Lung Neoplasms; Male; Middle Aged; Nicotine; Patient Compliance; Patient Dropouts; Patient Satisfaction; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Tobacco, Smokeless | 2016 |
Nicotine delivery, tolerability and reduction of smoking urge in smokers following short-term use of one brand of electronic cigarettes.
Topics: Adult; Cough; Craving; Cross-Over Studies; Dizziness; Electronic Nicotine Delivery Systems; Female; Headache; Humans; Male; Menthol; Middle Aged; Nicotiana; Nicotine; Pharyngitis; Single-Blind Method; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Products; Tobacco Use Disorder | 2015 |
Protocol for a randomised pragmatic policy trial of nicotine products for quitting or long-term substitution in smokers.
Topics: Australia; Electronic Nicotine Delivery Systems; Humans; New Zealand; Nicotine; Policy; Research Design; Sample Size; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Cessation Devices | 2015 |
The coupling of nicotine and stimulant craving during treatment for stimulant dependence.
Topics: Adult; Amphetamine-Related Disorders; Cocaine-Related Disorders; Craving; Humans; Methamphetamine; Models, Psychological; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Disorder; Treatment Outcome | 2016 |
Dopaminergic genetic variation moderates the effect of nicotine on cigarette reward.
Topics: Adolescent; Adult; Aged; Dopamine; Double-Blind Method; Female; Genetic Variation; Genotype; Humans; Male; Middle Aged; Minisatellite Repeats; Nicotine; Polymorphism, Single Nucleotide; Receptors, Dopamine D4; Reward; Smoking; Smoking Cessation; Tobacco Products; Young Adult | 2016 |
A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part A: Pharmacokinetics.
Topics: Administration, Inhalation; Adult; Aged; Area Under Curve; Cross-Over Studies; Electronic Nicotine Delivery Systems; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nebulizers and Vaporizers; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Volatilization; Wales; Young Adult | 2016 |
A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part B: Safety and subjective effects.
Topics: Administration, Inhalation; Adult; Aged; Breath Tests; Carbon Monoxide; Consumer Product Safety; Cross-Over Studies; Electronic Nicotine Delivery Systems; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Nicotinic Agonists; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder; Volatilization; Wales; Young Adult | 2016 |
A Randomized Trial Comparing the Effect of Nicotine Versus Placebo Electronic Cigarettes on Smoking Reduction Among Young Adult Smokers.
Topics: Adult; Double-Blind Method; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; Young Adult | 2016 |
Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
Topics: Adult; Carbon Monoxide; Counseling; Female; Humans; Intention to Treat Analysis; Male; Medication Adherence; Middle Aged; Nicotine; Nicotinic Agonists; Outcome Assessment, Health Care; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Cessation Devices; Varenicline | 2016 |
Evaluation of Biomarkers of Exposure in Smokers Switching to a Carbon-Heated Tobacco Product: A Controlled, Randomized, Open-Label 5-Day Exposure Study.
Topics: Adult; Biomarkers; Carboxyhemoglobin; Electronic Nicotine Delivery Systems; Female; Harm Reduction; Humans; Male; Middle Aged; Nicotine; Poland; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Young Adult | 2016 |
Approach bias modification in inpatient psychiatric smokers.
Topics: Adult; Analysis of Variance; Avoidance Learning; Behavior Therapy; Bias; Cues; Female; Humans; Inpatients; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2016 |
Correlates of nicotine withdrawal severity in smokers during a smoke-free psychiatric hospitalization.
Topics: Adult; California; Ethnicity; Female; Hospitalization; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Nicotine; Sex Factors; Smoke-Free Policy; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders | 2016 |
The Impact of Smoking Very Low Nicotine Content Cigarettes on Alcohol Use.
Topics: Adult; Alcohol Drinking; Binge Drinking; Double-Blind Method; Humans; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Products; Tobacco Use Cessation Devices | 2016 |
Smoking Topography Characteristics of Very Low Nicotine Content Cigarettes, With and Without Nicotine Replacement, in Smokers With Schizophrenia and Controls.
Topics: Adult; Behavior, Addictive; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Schizophrenia; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2016 |
Supplemental nicotine preloading for smoking cessation in posttraumatic stress disorder: Results from a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Craving; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Stress Disorders, Post-Traumatic; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2016 |
Predictors of nicotine withdrawal symptoms: findings from the first randomized smoking cessation trial in a low-income country setting.
Topics: Adolescent; Adult; Aged; Behavior Therapy; Counseling; Developing Countries; Female; Humans; Male; Middle Aged; Nicotine; Poverty; Smoking Cessation; Substance Withdrawal Syndrome; Syria; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2016 |
Nicotine withdrawal alters neural responses to psychosocial stress.
Topics: Adult; Brain; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome | 2016 |
Combination Nicotine Metered Dose Inhaler and Nicotine Patch for Smoking Cessation: A Randomized Controlled Trial.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Metered Dose Inhalers; Middle Aged; New Zealand; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; Young Adult | 2016 |
Is the Effect of Anhedonia on Smoking Cessation Greater for Women Versus Men?
Topics: Adult; Anhedonia; Black or African American; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Odds Ratio; Patient Compliance; Psychiatric Status Rating Scales; Risk Factors; Sex Factors; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2017 |
Longitudinal changes in smoking abstinence symptoms and alternative reinforcers predict long-term smoking cessation outcomes.
Topics: Administration, Cutaneous; Adult; Anxiety; Counseling; Craving; Depression; Female; Humans; Longitudinal Studies; Male; Nicotine; Predictive Value of Tests; Prospective Studies; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Treatment Outcome; Young Adult | 2016 |
Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes.
Topics: Adult; Biomarkers; Craving; Electronic Nicotine Delivery Systems; Exhalation; Female; Follow-Up Studies; Hazardous Substances; Humans; Male; Nicotine; Smoking; Smoking Cessation; Tobacco Products | 2016 |
Motivating smokers at outdoor public smoking hotspots to have a quit attempt with a nicotine replacement therapy sample: study protocol for a randomized controlled trial.
Topics: Counseling; Health Behavior; Health Knowledge, Attitudes, Practice; Hong Kong; Humans; Motivation; Nicotine; Nicotinic Agonists; Research Design; Smokers; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Cessation Devices; Treatment Outcome | 2016 |
Intra-individual changes in Stroop-related activations linked to cigarette abstinence in adolescent tobacco smokers: Preliminary findings.
Topics: Adolescent; Brain; Cerebral Cortex; Female; Humans; Individuality; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Nicotine; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Young Adult | 2016 |
Evaluation of a reduced nicotine product standard: Moderating effects of and impact on cannabis use.
Topics: Adult; Biomarkers; Female; Humans; Male; Marijuana Smoking; Middle Aged; Motivation; Nicotine; Prevalence; Public Health; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2016 |
Gender differences in snus versus nicotine gum for cigarette avoidance among a sample of US smokers.
Topics: Adult; Female; Harm Reduction; Humans; Male; Middle Aged; Nicotine; Sex Factors; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2016 |
The Association Between Treatment Adherence to Nicotine Patches and Smoking Cessation in Pregnancy: A Secondary Analysis of a Randomized Controlled Trial.
Topics: Adult; Female; Humans; Nicotine; Patient Compliance; Pregnancy; Pregnancy Complications; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; Young Adult | 2016 |
Effects of 6-Week Use of Reduced-Nicotine Content Cigarettes in Smokers With and Without Elevated Depressive Symptoms.
Topics: Adult; Depression; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Psychiatric Status Rating Scales; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Products; Tobacco Use Disorder; Young Adult | 2017 |
Combination Extended Smoking Cessation Treatment Plus Home Visits for Smokers With Schizophrenia: A Randomized Controlled Trial.
Topics: Adult; Aged; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Diagnosis, Dual (Psychiatry); House Calls; Humans; Male; Middle Aged; Nicotine; Schizophrenic Psychology; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2017 |
Reduced Exposure to Harmful and Potentially Harmful Smoke Constituents With the Tobacco Heating System 2.1.
Topics: Adult; Aged; Biomarkers; Electronic Nicotine Delivery Systems; Equipment Design; Harm Reduction; Hot Temperature; Humans; Male; Middle Aged; Nicotiana; Nicotine; Pyrenes; Risk Assessment; Smoke; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Young Adult | 2017 |
Can brain games help smokers quit?: Results of a randomized clinical trial.
Topics: Adult; Attention; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Reaction Time; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Treatment Outcome | 2016 |
A randomised, parallel group study to evaluate the safety profile of an electronic vapour product over 12 weeks.
Topics: Administration, Inhalation; Adult; Biomarkers; Consumer Product Safety; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder; United Kingdom; Volatilization; Young Adult | 2016 |
Daily nicotine patch wear time predicts smoking abstinence in socioeconomically disadvantaged adults: An analysis of ecological momentary assessment data.
Topics: Adult; Ecological Momentary Assessment; Female; Humans; Male; Middle Aged; Nicotine; Prevalence; Safety-net Providers; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Vulnerable Populations | 2016 |
Quit Intentions Moderate Subjective and Physiological Responses to Acute Nicotine Replacement Therapy Administration in Dependent Smokers.
Topics: Adult; Craving; Health Behavior; Heart Rate; Humans; Intention; Motivation; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2017 |
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Bupropion; Cohort Studies; Comorbidity; Double-Blind Method; Female; Humans; Male; Middle Aged; Mood Disorders; Nicotine; Smoking Cessation; Varenicline; Young Adult | 2016 |
Toward precision smoking cessation treatment II: Proximal effects of smoking cessation intervention components on putative mechanisms of action.
Topics: Adult; Counseling; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Precision Medicine; Self Efficacy; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome | 2017 |
Toward precision smoking cessation treatment I: Moderator results from a factorial experiment.
Topics: Adult; Biomedical Research; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Precision Medicine; Smoking; Smoking Cessation; Telephone; Tobacco Use Cessation Devices; Treatment Outcome | 2017 |
A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
Topics: Adult; Anxiety Disorders; Biomarkers; Carbon Monoxide; Clinical Protocols; Cotinine; Double-Blind Method; Female; Humans; Male; Massachusetts; Mood Disorders; Nicotiana; Nicotine; Nicotinic Agonists; Nitrosamines; Oxidative Stress; Pennsylvania; Pyrenes; Pyridines; Smoke; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Disorder; United States; United States Food and Drug Administration; Young Adult | 2017 |
Factor structure of the Smoking Cessation Self-Efficacy Questionnaire among smokers with and without a psychiatric diagnosis.
Topics: Adult; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Outcome Assessment, Health Care; Self Efficacy; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Cessation Devices; Varenicline | 2017 |
The Importance of Conditioned Stimuli in Cigarette and E-Cigarette Craving Reduction by E-Cigarettes.
Topics: Adolescent; Adult; Aged; Craving; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Tobacco Products; Vaping; Young Adult | 2017 |
Timing of nicotine lozenge administration to minimize trigger induced craving and withdrawal symptoms.
Topics: Craving; Cross-Over Studies; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tablets; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2017 |
Reduction of smoking urges with intranasal insulin: a randomized, crossover, placebo-controlled clinical trial.
Topics: Administration, Intranasal; Adult; Craving; Cross-Over Studies; Female; Humans; Insulin; Male; Middle Aged; Nicotine; Nicotinic Agonists; Placebos; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Smoking; Tobacco Use Disorder | 2017 |
Molecular genetics of successful smoking cessation: convergent genome-wide association study results.
Topics: Adult; Alleles; Antidepressive Agents, Second-Generation; Bupropion; Chromosome Mapping; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Genetic Markers; Genetic Predisposition to Disease; Genetic Variation; Genome; Humans; Male; Monte Carlo Method; Nicotine; Nicotinic Agonists; Polymorphism, Single Nucleotide; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2008 |
Olanzapine reduces urge to smoke and nicotine withdrawal symptoms in community smokers.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cross-Over Studies; Cues; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Individuality; Male; Middle Aged; Nicotine; Nicotinic Agonists; Olanzapine; Patient Compliance; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2008 |
A placebo-controlled trial of modafinil for nicotine dependence.
Topics: Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Double-Blind Method; Female; Humans; Male; Middle Aged; Modafinil; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
The impact of depressive symptoms on the efficacy of naltrexone in smoking cessation.
Topics: Administration, Cutaneous; Adult; Combined Modality Therapy; Counseling; Depression; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Personality Inventory; Smoking Cessation; Treatment Outcome | 2008 |
Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.
Topics: Administration, Cutaneous; Adult; Alleles; Female; Follow-Up Studies; Gene Frequency; Genotype; Humans; Male; Meta-Analysis as Topic; Middle Aged; Nicotine; Pharmacogenetics; Polymorphism, Single Nucleotide; Serotonin Plasma Membrane Transport Proteins; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome; Tryptophan Hydroxylase | 2008 |
Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette.
Topics: Adult; Affect; Aged; Anxiety; Basal Ganglia; Brain Mapping; Dopamine; Dopamine Antagonists; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Positron-Emission Tomography; Raclopride; Smoking; Smoking Cessation; Young Adult | 2009 |
Hypnosis for smoking cessation: a randomized trial.
Topics: Administration, Cutaneous; Adult; Behavior Therapy; Combined Modality Therapy; Female; Ganglionic Stimulants; Humans; Hypnosis; Logistic Models; Male; Middle Aged; Nicotine; Prevalence; Risk; San Francisco; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2008 |
A vaccine against nicotine for smoking cessation: a randomized controlled trial.
Topics: Adult; Antibody Formation; Double-Blind Method; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Nicotine; Placebos; Smoking Cessation; Vaccines | 2008 |
Nicotine decreases attentional bias to negative-affect-related Stroop words among smokers.
Topics: Adult; Affect; Attention; Brain; Cognition; Cues; Double-Blind Method; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Psychomotor Performance; Reading; Smoking; Smoking Cessation; Visual Perception | 2008 |
Comparing the tolerability and effectiveness of two treatment regimens in a smoking clinic.
Topics: Administration, Cutaneous; Ambulatory Care Facilities; Bupropion; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Treatment Outcome; Veterans | 2008 |
Nicotine patches and uninsured quitline callers. A randomized trial of two versus eight weeks.
Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Cost-Benefit Analysis; Counseling; Female; Hotlines; Humans; Male; Medically Uninsured; Middle Aged; Nicotine; Oregon; Smoking Cessation; Time Factors; Treatment Outcome | 2008 |
Nicotine does not compromise resting myocardial blood flow autoregulation in smokers at high cardiovascular risk.
Topics: Administration, Oral; Coronary Circulation; Coronary Disease; Female; Homeostasis; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Tablets; Tobacco Use Disorder | 2008 |
A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.
Topics: Administration, Cutaneous; Administration, Inhalation; Adult; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2008 |
Smoking cessation intervention for female prisoners: addressing an urgent public health need.
Topics: Adaptation, Psychological; Administration, Cutaneous; Adult; Analysis of Variance; Cross-Over Studies; Female; Follow-Up Studies; Health Services Needs and Demand; Humans; Nicotine; Nicotinic Agonists; Patient Dropouts; Patient Education as Topic; Prisoners; Program Evaluation; Psychotherapy, Group; Public Health; Regression Analysis; Self Care; Smoking Cessation; Southeastern United States; Waiting Lists; Women | 2008 |
Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette.
Topics: Adult; Brain; Brain Mapping; Dose-Response Relationship, Drug; Female; Humans; Magnetic Resonance Imaging; Male; Nicotine; Positron-Emission Tomography; Pyridines; Receptors, Nicotinic; Smoking; Smoking Cessation; Statistics as Topic; Substance Withdrawal Syndrome; Time Factors; Tissue Distribution; Tobacco Use Disorder | 2009 |
A randomized trial of nicotine nasal spray in adolescent smokers.
Topics: Administration, Intranasal; Adolescent; Air; Breath Tests; California; Carbon Monoxide; Cotinine; Counseling; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Incidence; Male; Nicotine; Nicotinic Agonists; Retrospective Studies; Saliva; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2008 |
A comparison of the nicotine lozenge and nicotine gum: an effectiveness randomized controlled trial.
Topics: Adult; Chewing Gum; Female; Humans; Logistic Models; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2008 |
Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2008 |
Nicotine dependence, psychological distress and personality traits as possible predictors of smoking cessation. Results of a double-blind study with nicotine patch.
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Female; Humans; Male; Mental Disorders; Middle Aged; Neurotic Disorders; Nicotine; Nicotinic Agonists; Psychotic Disorders; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Stress, Psychological; Tobacco Use Disorder; Young Adult | 2009 |
Nicotine gum for pregnant smokers: a randomized controlled trial.
Topics: Birth Weight; Chewing Gum; Cotinine; Counseling; Double-Blind Method; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Outcome; Prospective Studies; Smoking Cessation | 2008 |
Addressing heavy drinking in smoking cessation treatment: a randomized clinical trial.
Topics: Administration, Cutaneous; Adult; Alcoholism; Combined Modality Therapy; Feasibility Studies; Female; Follow-Up Studies; Humans; Intention; Male; Middle Aged; Nicotine; Outcome and Process Assessment, Health Care; Patient Compliance; Smoking Cessation; Temperance | 2008 |
Extended cognitive behavior therapy for cigarette smoking cessation.
Topics: Adult; Bupropion; Carbon Monoxide; Cognitive Behavioral Therapy; Counseling; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Smoking Cessation; Substance Withdrawal Syndrome | 2008 |
Age at menarche and weight concerns in relation to smoking trajectory and dependence among adolescent girls enrolled in a smoking cessation trial.
Topics: Adolescent; Body Weight; Child; Feeding and Eating Disorders; Female; Humans; Menarche; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder | 2009 |
Reduced-nicotine cigarettes increase platelet activation in smokers in vivo: a dilemma in harm reduction.
Topics: Adult; Analysis of Variance; Environmental Monitoring; Female; Flow Cytometry; Ganglionic Stimulants; Harm Reduction; Humans; Male; Nicotine; Platelet Activation; Smoke; Smoking Cessation; Tobacco Smoke Pollution | 2008 |
A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.
Topics: Administration, Cutaneous; Adult; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Dropouts; Psychiatric Status Rating Scales; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2008 |
Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
Topics: Administration, Oral; Adult; Affect; Attention; Cognition; Cross-Over Studies; Dosage Forms; Double-Blind Method; Female; Humans; Male; Memory; Middle Aged; Nicotine; Nicotinic Agonists; Psychomotor Performance; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2008 |
Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers.
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Female; Humans; Male; Medication Adherence; Nicotine; Nicotinic Agonists; Nonprescription Drugs; Smoking Cessation; Socioeconomic Factors | 2008 |
Role of nicotine gum and pretreatment depressive symptoms in smoking cessation: twelve-month results of a randomized placebo controlled trial.
Topics: Adult; Chewing Gum; Comorbidity; Depression; Educational Status; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Marital Status; Nicotine; Placebos; Psychiatric Status Rating Scales; Smoking; Smoking Cessation; Smoking Prevention; Survival Analysis; Treatment Outcome | 2008 |
Cigarette abstinence impairs memory and metacognition despite administration of 2 mg nicotine gum.
Topics: Adolescent; Adult; Attention; Chewing Gum; Cognition Disorders; Female; Humans; Male; Memory Disorders; Mental Recall; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Task Performance and Analysis; Tobacco Use Disorder; Young Adult | 2008 |
A digital smoking cessation program delivered through internet and cell phone without nicotine replacement (happy ending): randomized controlled trial.
Topics: Adolescent; Behavior Therapy; Cell Phone; Electronic Mail; Happiness; Humans; Internet; Multimedia; Nicotine; Pamphlets; Patient Selection; Smoking; Smoking Cessation; Therapy, Computer-Assisted; Treatment Outcome; User-Computer Interface; Young Adult | 2008 |
Effect of nicotine polyestex gum on smoking cessation and quality of life.
Topics: Adult; Chewing Gum; Double-Blind Method; Health Status Indicators; Health Surveys; Humans; Male; Middle Aged; Nicotine; Prospective Studies; Quality of Life; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Young Adult | 2008 |
Using a quitline plus low-cost nicotine replacement therapy to help disadvantaged smokers to quit.
Topics: Adult; Combined Modality Therapy; Counseling; Drug Costs; Female; Hotlines; Humans; Male; Middle Aged; Nicotine; Patient Satisfaction; Pilot Projects; Smoking Cessation; Smoking Prevention; Socioeconomic Factors; Tobacco Use Disorder; Treatment Outcome; Vulnerable Populations | 2009 |
Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial.
Topics: Adult; Chewing Gum; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Socioeconomic Factors; Tobacco Use Disorder | 2009 |
A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Counseling; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Odds Ratio; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Weight Gain; Young Adult | 2009 |
Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation.
Topics: Bupropion; Community Pharmacy Services; Cotinine; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2009 |
Cost-effective primary care-based strategies to improve smoking cessation: more value for money.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Cost-Benefit Analysis; Germany; Humans; Middle Aged; Nicotine; Nicotinic Agonists; Physicians, Family; Primary Health Care; Reimbursement, Incentive; Smoking Cessation | 2009 |
Severity of tobacco abstinence symptoms varies by time of day.
Topics: Administration, Cutaneous; Adult; Carbon Monoxide; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Humans; Male; Nicotine; Nicotinic Agonists; Periodicity; Severity of Illness Index; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome; Wakefulness | 2009 |
Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial.
Topics: Adult; Aged; Alleles; Female; Humans; Male; Middle Aged; Nicotine; Placebos; Polymorphism, Genetic; Receptors, Dopamine D2; Sex Factors; Smoking; Smoking Cessation; Tobacco Use Disorder; Young Adult | 2009 |
Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers.
Topics: Adult; Aged; Aryl Hydrocarbon Hydroxylases; Black or African American; Body Mass Index; Cotinine; Cytochrome P-450 CYP2A6; Double-Blind Method; Female; Genotype; Humans; Male; Middle Aged; Nicotine; Polymorphism, Genetic; Smoking Cessation | 2009 |
The efficacy of a smoking cessation programme in patients undergoing elective surgery: a randomised clinical trial.
Topics: Adolescent; Adult; Aged; Counseling; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; Nicotine; Perioperative Care; Postoperative Complications; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2009 |
Comparing smoking treatment programs for lighter smokers with and without a history of heavier smoking.
Topics: Adult; Black or African American; Bupropion; Combined Modality Therapy; Directive Counseling; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Nicotinic Agonists; Prospective Studies; Smoking Cessation; Tobacco Use Disorder | 2009 |
A pilot study of nicotine delivery to smokers from a metered-dose inhaler.
Topics: Adult; Blood Pressure; Female; Heart Rate; Humans; Male; Metered Dose Inhalers; Middle Aged; Nicotine; Nicotinic Agonists; Patient Satisfaction; Pilot Projects; Smoking Cessation; Tobacco Use Disorder; Young Adult | 2009 |
Effect of varying levels of disease management on smoking cessation: a randomized trial.
Topics: Administration, Cutaneous; Adult; Bupropion; Combined Modality Therapy; Counseling; Disease Management; Female; Humans; Male; Middle Aged; Nicotine; Primary Health Care; Single-Blind Method; Smoking Cessation; Social Support; Tobacco Use Disorder; Young Adult | 2009 |
Triple-combination pharmacotherapy for medically ill smokers: a randomized trial.
Topics: Administration, Cutaneous; Administration, Inhalation; Adolescent; Adult; Aged; Anxiety; Bupropion; Comorbidity; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Odds Ratio; Recurrence; Sleep Initiation and Maintenance Disorders; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2009 |
Changes in the relative reinforcing effects of cigarette smoking as a function of initial abstinence.
Topics: Adolescent; Adult; Carbon Dioxide; Choice Behavior; Cotinine; Female; Humans; Male; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Pain Measurement; Reinforcement Schedule; Reinforcement, Psychology; Smoking; Smoking Cessation; Time Factors; Tobacco Use Disorder; Young Adult | 2009 |
Extended treatment of older cigarette smokers.
Topics: Aged; Aged, 80 and over; Bupropion; Cognitive Behavioral Therapy; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotine; Program Evaluation; Smoking Cessation; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2009 |
Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Delayed-Action Preparations; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2009 |
Neurotransmission-related genetic polymorphisms, negative affectivity traits, and gender predict tobacco abstinence symptoms across 44 days with and without nicotine patch.
Topics: Adult; Affect; Alleles; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Polymorphism, Genetic; Receptors, Dopamine D2; Risk Assessment; Serotonin Plasma Membrane Transport Proteins; Sex Factors; Smoking; Smoking Cessation; Smoking Prevention; Synaptic Transmission; Time Factors; Treatment Outcome; Young Adult | 2009 |
Cigarette-by-cigarette satisfaction during ad libitum smoking.
Topics: Adult; Aged; Black or African American; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Pennsylvania; Personal Satisfaction; Reinforcement, Psychology; Sex Factors; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Young Adult | 2009 |
Effects of acute abstinence and nicotine administration on taste perception in cigarette smokers.
Topics: Adult; Affect; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Sodium Chloride, Dietary; Sucrose; Taste Perception; Taste Threshold; Young Adult | 2010 |
Methadone-nicotine interactions in methadone maintenance treatment patients.
Topics: Adult; Double-Blind Method; Drug Interactions; Female; Humans; Male; Methadone; Middle Aged; Narcotics; Nicotine; Nicotinic Agonists; Opioid-Related Disorders; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2009 |
Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine.
Topics: Administration, Cutaneous; Adolescent; Adult; Affect; Aged; Carbon Monoxide; Double-Blind Method; Extinction, Psychological; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Reinforcement, Psychology; Self Administration; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Young Adult | 2009 |
A single-blind, randomized, crossover trial of the effects of a nicotine pouch on the relief of tobacco withdrawal symptoms and user satisfaction.
Topics: Administration, Buccal; Administration, Cutaneous; Adult; Chewing Gum; Dose-Response Relationship, Drug; Female; Humans; Male; Nicotine; Patient Satisfaction; Single-Blind Method; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 2009 |
Family support and employment as predictors of smoking cessation success: a randomized, double-blind, placebo-controlled trial of nicotine sublingual tablets in chinese smokers.
Topics: Administration, Sublingual; Adult; Carbon Monoxide; China; Cotinine; Double-Blind Method; Family Relations; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Social Support; Workplace | 2009 |
Nicotine gum treatment before smoking cessation: a randomized trial.
Topics: Bupropion; Chewing Gum; Humans; Nicotine; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Tobacco Use Cessation Devices; Weight Gain | 2009 |
Effects of nicotine patch or nasal spray on nicotine and cotinine concentrations in pregnant smokers.
Topics: Adult; Cotinine; Female; Ganglionic Stimulants; Heart Rate, Fetal; Humans; Nicotine; Pregnancy; Smoking Cessation; Young Adult | 2009 |
Mediators of the relationship between nicotine replacement therapy and smoking abstinence among people living with HIV/AIDS.
Topics: Administration, Cutaneous; Cultural Characteristics; Female; HIV Infections; Humans; Internet; Male; Motivation; Nicotine; Nicotinic Agonists; Racial Groups; Self Efficacy; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome | 2009 |
Feasibility of an exercise counseling intervention for depressed women smokers.
Topics: Adolescent; Adult; Aged; Counseling; Depression; Exercise; Feasibility Studies; Female; Humans; Middle Aged; Nicotine; Patient Compliance; Smoking; Smoking Cessation; Young Adult | 2009 |
Smoking cessation during alcohol treatment: a randomized trial of combination nicotine patch plus nicotine gum.
Topics: Adult; Alcoholism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Placebos; Secondary Prevention; Smoking; Smoking Cessation; Treatment Outcome | 2009 |
Delayed reward discounting predicts treatment response for heavy drinkers receiving smoking cessation treatment.
Topics: Adult; Alcohol Drinking; Counseling; Female; Humans; Male; Models, Psychological; Nicotine; Reward; Risk-Taking; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2009 |
Coping strategies for craving management in nicotine dependent patients.
Topics: Adaptation, Psychological; Adolescent; Adult; Analysis of Variance; Behavior, Addictive; Brazil; Cognition; Female; Humans; Male; Middle Aged; Nicotine; Recurrence; Self Efficacy; Smoking; Smoking Cessation; Statistics, Nonparametric; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors; Young Adult | 2009 |
Heart rate variability increases with reductions in cigarette smoke exposure after 3 days.
Topics: Adult; Autonomic Nervous System; Cross-Over Studies; Electrocardiography, Ambulatory; Heart; Heart Rate; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Prospective Studies; Signal Processing, Computer-Assisted; Smoking; Smoking Cessation; Time Factors | 2009 |
Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans.
Topics: Adult; Affect; Benzazepines; Blood Pressure; Cognition Disorders; Cotinine; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Quinoxalines; Severity of Illness Index; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
Motivation and patch treatment for HIV+ smokers: a randomized controlled trial.
Topics: Administration, Cutaneous; Adult; Black or African American; Counseling; Female; Hispanic or Latino; HIV Seropositivity; Humans; Male; Motivation; New England; Nicotine; Program Evaluation; Smoking; Smoking Cessation; Treatment Outcome; White People | 2009 |
Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers.
Topics: Adult; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estradiol; Female; Heart Rate; Humans; Injections, Intravenous; Male; Nicotine; Nicotinic Agonists; Progesterone; Progestins; Sex Factors; Smoking; Smoking Cessation; Surveys and Questionnaires | 2009 |
Trial design: The St. Jude Children's Research Hospital Cancer Survivors Tobacco Quit Line study.
Topics: Adult; Behavior Therapy; Child; Counseling; Female; Ganglionic Stimulants; Hotlines; Humans; Male; Neoplasms; Nicotine; Patient Selection; Research Design; Smoking Cessation; Survivors; Young Adult | 2010 |
Influence of smoking abstinence and nicotine replacement therapy on heart rate and QT time-series.
Topics: Adult; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Nonlinear Dynamics; Prospective Studies; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2010 |
A cluster-randomized effectiveness trial of smoking cessation modified for at-risk smoker subgroups.
Topics: Adult; Behavior Therapy; Chi-Square Distribution; Depression; Female; Health Behavior; Humans; Intention to Treat Analysis; Male; Middle Aged; Nicotine; Patient Compliance; Psychotherapy, Group; Risk-Taking; Smoking; Smoking Cessation; Social Support; Statistics, Nonparametric; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2010 |
A randomised trial of glucose tablets to aid smoking cessation.
Topics: Administration, Oral; Adult; Bupropion; Combined Modality Therapy; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Interactions; Female; Follow-Up Studies; Glucose; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Psychotherapy, Group; Smoking Cessation; Tablets; Tobacco Use Disorder | 2010 |
A randomized clinical trial of nicotine lozenge for smokeless tobacco use.
Topics: Administration, Oral; Adult; Affect; Attention; Dosage Forms; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2009 |
A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies.
Topics: Administration, Cutaneous; Adult; Bupropion; Counseling; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Placebos; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Tablets; Treatment Outcome | 2009 |
The role of nicotine replacement therapy in early quitting success.
Topics: Adult; Female; Humans; Logistic Models; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Treatment Outcome | 2010 |
Acute effects of pharmacotherapies in blood pressure in normotensive moderate smokers.
Topics: Adult; Blood Pressure; Bupropion; Cross-Over Studies; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Single-Blind Method; Smoking; Smoking Cessation; Time Factors; Treatment Outcome | 2009 |
Smoking cessation or reduction with nicotine replacement therapy: a placebo-controlled double blind trial with nicotine gum and inhaler.
Topics: Adult; Aged; Breath Tests; Carbon Monoxide; Chewing Gum; Cotinine; Double-Blind Method; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Smoking Cessation; Treatment Outcome; Young Adult | 2009 |
Intensive smoking-cessation intervention in the dental setting.
Topics: Administration, Cutaneous; Adult; Counseling; Dental Care; Dental Health Services; Dental Hygienists; Dentist-Patient Relations; Dentists; Humans; Intention to Treat Analysis; Nicotine; Nicotinic Agonists; Outcome and Process Assessment, Health Care; Practice Patterns, Dentists'; Program Evaluation; Single-Blind Method; Smoking Cessation; Tobacco Use Disorder | 2010 |
Effects of exercise on cravings to smoke: the role of exercise intensity and cortisol.
Topics: Adult; Cross-Over Studies; Exercise; Exercise Therapy; Female; Heart Rate; Humans; Hydrocortisone; Male; Nicotine; Physical Exertion; Running; Saliva; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Walking; Young Adult | 2010 |
Nicotine patch vs. nicotine lozenge for smoking cessation: an effectiveness trial coordinated by the Community Clinical Oncology Program.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Breath Tests; Carbon Monoxide; Cognition; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Nicotine; Nicotinic Agonists; Philadelphia; Smoking Cessation; Stress, Psychological; Tobacco Use Disorder; Treatment Outcome | 2010 |
Nicotine-patch therapy on mucocutaneous lesions of Behcet's disease: a case series.
Topics: Adult; Behcet Syndrome; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nicotine; Recurrence; Skin Diseases, Vascular; Smoking; Smoking Cessation; Transdermal Patch; Treatment Outcome | 2010 |
A pilot randomized study of smokeless tobacco use among smokers not interested in quitting: changes in smoking behavior and readiness to quit.
Topics: Adult; Behavior, Addictive; Dose-Response Relationship, Drug; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Nicotine; Pilot Projects; Self Efficacy; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tobacco, Smokeless | 2010 |
The role of nicotine on respiratory sensory gating measured by respiratory-related evoked potentials.
Topics: Administration, Oral; Anxiety; Cerebral Cortex; Chewing Gum; Electroencephalography; Electrooculography; Evoked Potentials; Female; Humans; Male; Mechanotransduction, Cellular; Nicotine; Nicotinic Agonists; Perception; Reaction Time; Respiration; Respiratory Function Tests; Sensory Gating; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Young Adult | 2010 |
Educating smokers about their cigarettes and nicotine medications.
Topics: Health Education; Health Knowledge, Attitudes, Practice; Humans; Nicotine; Smoking; Smoking Cessation | 2010 |
Randomized crossover trial of the acceptability of snus, nicotine gum, and Zonnic therapy for smoking reduction in heavy smokers.
Topics: Administration, Buccal; Administration, Cutaneous; Adult; Chewing Gum; Cross-Over Studies; Female; Humans; Male; Middle Aged; New Zealand; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2010 |
Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation.
Topics: Adolescent; Adult; Aged; Behavior, Addictive; Biomarkers; Female; Humans; Male; Middle Aged; Minnesota; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder; Young Adult | 2010 |
A bupropion smoking cessation clinical trial for cancer patients.
Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Bupropion; Depression; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasms; Nicotine; Nicotinic Agonists; Prevalence; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome | 2010 |
Mechanisms of change in extended cognitive behavioral treatment for tobacco dependence.
Topics: Adult; Affect; Bupropion; Chewing Gum; Cognitive Behavioral Therapy; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Psychometrics; Secondary Prevention; Self Efficacy; Smoking Cessation; Social Support; Stress, Psychological; Tobacco Use Disorder; Treatment Outcome | 2010 |
Cognitive-behavioral therapy to promote smoking cessation among African American smokers: a randomized clinical trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Black or African American; Chi-Square Distribution; Cognitive Behavioral Therapy; Female; Health Education; Humans; Intention to Treat Analysis; Male; Middle Aged; Nicotine; Odds Ratio; Psychotherapy, Group; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome | 2010 |
Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation.
Topics: Adult; Anxiety Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Mood Disorders; Motivation; Nicotine; Patient Selection; Psychiatric Status Rating Scales; Regression Analysis; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome | 2010 |
Acute negative affect relief from smoking depends on the affect situation and measure but not on nicotine.
Topics: Adult; Affect; Anxiety; Executive Function; Female; Humans; Male; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Reward; Smoking; Smoking Cessation; Social Environment; Stress, Psychological; Substance Withdrawal Syndrome | 2010 |
Increasing the use of nicotine replacement therapy by a simple intervention: an exploratory trial.
Topics: Adolescent; Adult; Aged; Cohort Studies; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Patient Education as Topic; Pilot Projects; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2010 |
Electronic nicotine delivery devices: ineffective nicotine delivery and craving suppression after acute administration.
Topics: Administration, Inhalation; Adult; Female; Heart Rate; Humans; Male; Nebulizers and Vaporizers; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Young Adult | 2010 |
A randomized controlled open comparative trial of varenicline vs nicotine patch in adult smokers: efficacy, safety and withdrawal symptoms (the VN-SEESAW study).
Topics: Administration, Cutaneous; Adult; Benzazepines; Emotions; Endpoint Determination; Female; Humans; Incidence; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline | 2010 |
Evaluating oral noncombustible potential-reduced exposure products for smokers.
Topics: Administration, Oral; Adolescent; Adult; Carbon Monoxide; Female; Humans; Male; Middle Aged; Nicotine; Nitrosamines; Smoking Cessation; Tobacco, Smokeless; Young Adult | 2010 |
OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differences.
Topics: Administration, Cutaneous; Adult; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Drug Therapy, Combination; Ethnicity; Female; Forecasting; Humans; Male; Methylphenidate; Nicotine; Nicotinic Agonists; Psychiatric Status Rating Scales; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 2010 |
Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement.
Topics: Administration, Cutaneous; Alleles; Family Practice; Gene Frequency; Genome-Wide Association Study; Humans; Nicotine; Oligonucleotide Array Sequence Analysis; Pharmacogenetics; Polymorphism, Single Nucleotide; Principal Component Analysis; Smoking; Smoking Cessation; Treatment Outcome; United Kingdom | 2010 |
Craving control using nicotine replacement therapy in a teaching hospital.
Topics: Administration, Cutaneous; Administration, Inhalation; Cough; Dreams; Female; Health Promotion; Hospitals, Teaching; Humans; Inpatients; Male; Middle Aged; Motivation; Nicotine; Personal Satisfaction; Pruritus; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2012 |
Use of a liquid nicotine delivery product to promote smoking cessation.
Topics: Adult; Carbon Monoxide; Female; Humans; Male; Middle Aged; Nicotine; Pharmaceutical Solutions; Smoking; Smoking Cessation; Young Adult | 2010 |
Validity of the 12-item French version of the Tobacco Craving Questionnaire in treatment-seeking smokers.
Topics: Adult; Factor Analysis, Statistical; Female; Humans; Logistic Models; Male; Middle Aged; Nicotine; Smoking Cessation; Surveys and Questionnaires; Young Adult | 2010 |
Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy.
Topics: Administration, Cutaneous; Adult; Aryl Hydrocarbon Hydroxylases; Cohort Studies; Cytochrome P-450 CYP2A6; Delayed-Action Preparations; Drug Administration Schedule; Female; Follow-Up Studies; Genetic Variation; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Predictive Value of Tests; Smoking; Smoking Cessation; Treatment Outcome | 2010 |
Motivating the unmotivated for health behavior change: a randomized trial of cessation induction for smokers.
Topics: Health Behavior; Humans; Nicotine; Nicotinic Agonists; Research Design; Smoking Cessation; Telephone | 2010 |
Effect of smoking, smoking cessation, and nicotine patch on wound dimension, vitamin C, and systemic markers of collagen metabolism.
Topics: Administration, Cutaneous; Adult; Ascorbic Acid; Biomarkers; Collagen; Double-Blind Method; Female; Humans; Male; Matrix Metalloproteinase 8; Matrix Metalloproteinase 9; Neutrophils; Nicotine; Peptide Fragments; Procollagen; Smoking; Smoking Cessation; Wound Healing | 2010 |
Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder.
Topics: Administration, Cutaneous; Adult; Behavior Therapy; Combined Modality Therapy; Directive Counseling; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Psychotic Disorders; Schizophrenia; Secondary Prevention; Smoking Cessation; Time Factors; Tobacco Use Disorder | 2010 |
Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial.
Topics: Administration, Inhalation; Adult; Consumer Behavior; Cross-Over Studies; Data Interpretation, Statistical; Drug Delivery Systems; Electrons; Female; Humans; Irritants; Male; Middle Aged; Multivariate Analysis; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 2010 |
General practice counseling for patients with chronic obstructive pulmonary disease to quit smoking: impact after 1 year of two complex interventions.
Topics: Adult; Aged; Attitude to Health; Counseling; Female; General Practice; General Practitioners; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Outcome and Process Assessment, Health Care; Prevalence; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Time Factors | 2011 |
Tobacco cessation via public dental clinics: results of a randomized trial.
Topics: Adult; Community Dentistry; Dental Clinics; Female; Humans; Male; Middle Aged; Mississippi; New York; Nicotine; Nicotinic Agonists; Oregon; Patient Education as Topic; Smoking Cessation | 2010 |
Cross-validation of a new procedure for early screening of smoking cessation medications in humans.
Topics: Administration, Cutaneous; Adult; Benzazepines; Cross-Over Studies; Data Interpretation, Statistical; Double-Blind Method; Drug Evaluation, Preclinical; Female; Humans; Male; Motivation; Nicotine; Nicotinic Agonists; Quinoxalines; Reproducibility of Results; Research Design; Smoking; Smoking Cessation; Surveys and Questionnaires; Varenicline | 2010 |
A randomized trial of the effects of two novel nicotine replacement therapies on tobacco withdrawal symptoms and user satisfaction.
Topics: Administration, Buccal; Adolescent; Adult; Aged; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Satisfaction; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2010 |
Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial.
Topics: Administration, Oral; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Combined Modality Therapy; Counseling; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Methylphenidate; Middle Aged; Nicotine; Smoking; Smoking Cessation; Treatment Outcome | 2010 |
Predictors of adherence to nicotine gum and counseling among African-American light smokers.
Topics: Adult; Behavior Therapy; Black or African American; Body Mass Index; Chewing Gum; Double-Blind Method; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Nicotinic Agonists; Odds Ratio; Placebos; Smoking; Smoking Cessation; Smoking Prevention; Treatment Failure | 2010 |
The bioequivalent and effect of nicotine formulation gum on smoking cessation.
Topics: Adult; Chewing Gum; Chromatography, High Pressure Liquid; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Polymethacrylic Acids; Polyvinyls; Smoking; Smoking Cessation; Smoking Prevention; Therapeutic Equivalency; Tobacco Use Cessation Devices | 2010 |
Smokeless tobacco reduction with the nicotine lozenge and behavioral intervention.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Tobacco, Smokeless; Young Adult | 2010 |
Pre-cessation nicotine replacement therapy: pragmatic randomized trial.
Topics: Administration, Cutaneous; Adult; Algorithms; Chewing Gum; Female; Hotlines; Humans; Male; Native Hawaiian or Other Pacific Islander; New Zealand; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Smoking; Smoking Cessation; Smoking Prevention; Statistics as Topic; Substance Withdrawal Syndrome; Treatment Outcome | 2010 |
A randomized, controlled trial of NRT-aided gradual vs. abrupt cessation in smokers actively trying to quit.
Topics: Adult; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Self Efficacy; Smoking Cessation; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2010 |
Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial.
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Naltrexone; Nicotine; Prospective Studies; Smoking; Smoking Cessation; Weight Gain | 2010 |
The impact of quitting smoking on weight among women prisoners participating in a smoking cessation intervention.
Topics: Adult; Affect; Analysis of Variance; Behavior Therapy; Cross-Over Studies; Female; Follow-Up Studies; Health Education; Humans; Nicotine; Nicotinic Agonists; Prevalence; Prisoners; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Southeastern United States; Treatment Outcome; Weight Gain; Women | 2010 |
Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Body Weight; Female; Humans; Interviews as Topic; Male; Medication Adherence; Menstrual Cycle; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Sex Characteristics; Smoking Cessation; Treatment Outcome; Young Adult | 2010 |
Reduced NRT supplies through a quitline: smoking cessation differences.
Topics: Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Smoking Prevention; Young Adult | 2010 |
A pilot study combining individual-based smoking cessation counseling, pharmacotherapy, and dental hygiene intervention.
Topics: Adult; Attitude to Health; Bupropion; Counseling; Dental Care; Feasibility Studies; Female; Humans; Male; Nicotine; Patient Satisfaction; Periodontal Diseases; Periodontics; Pilot Projects; Smoking Cessation; Surveys and Questionnaires; Switzerland; Tobacco Use Disorder | 2010 |
Nicotine and food deprivation decrease the ability to resist smoking.
Topics: Adult; Female; Food Deprivation; Ganglionic Stimulants; Humans; Male; Nicotine; Reinforcement, Psychology; Self Administration; Smoking; Smoking Cessation; Young Adult | 2010 |
A randomized clinical trial of St. John's wort for smoking cessation.
Topics: Adolescent; Adult; Aged; Carbon Monoxide; Female; Flowers; Humans; Hypericum; Intention to Treat Analysis; Male; Middle Aged; Nicotine; Phytotherapy; Plant Extracts; Single-Blind Method; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2010 |
The cessation and detoxification effect of tea filters on cigarette smoke.
Topics: Adolescent; Adult; Animals; Behavior, Animal; Case-Control Studies; Female; Filtration; Glutamates; Humans; Lung Diseases; Male; Mice; Nicotine; Smoking Cessation; Tea; Tobacco Smoke Pollution; Tobacco Use Disorder | 2010 |
Perceived drug assignment and treatment outcome in smokers given nicotine patch therapy.
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Treatment Outcome | 2010 |
Effect of high-dose nicotine patch on the characteristics of lapse episodes.
Topics: Administration, Cutaneous; Adult; Aged; Behavior, Addictive; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2010 |
If you try to stop smoking, should we pay for it? The cost-utility of reimbursing smoking cessation support in the Netherlands.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bupropion; Cost-Benefit Analysis; Counseling; Data Interpretation, Statistical; Dopamine Uptake Inhibitors; Female; Health Care Costs; Humans; Male; Middle Aged; National Health Programs; Netherlands; Nicotine; Nicotinic Agonists; Quality-Adjusted Life Years; Reimbursement Mechanisms; Smoking; Smoking Cessation; Statistics as Topic; Time Factors; Treatment Outcome; Young Adult | 2010 |
Do faxed quitline referrals add value to dental office-based tobacco-use cessation interventions?
Topics: Adult; Attitude to Health; Central Nervous System Stimulants; Counseling; Dental Offices; Dentist-Patient Relations; Female; Follow-Up Studies; Health Behavior; Hotlines; Humans; Male; Nicotine; Nicotinic Agonists; Oral Health; Referral and Consultation; Smoking Cessation; Telefacsimile; Tobacco Use Cessation; Tobacco, Smokeless; Treatment Outcome; Young Adult | 2010 |
Smoking-cessation and adherence intervention among Chinese patients with erectile dysfunction.
Topics: Adult; Asian People; China; Combined Modality Therapy; Directive Counseling; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Nicotinic Agonists; Single-Blind Method; Smoking; Smoking Cessation; Smoking Prevention | 2010 |
Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Catechol O-Methyltransferase; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Nicotine; Polymorphism, Genetic; Receptors, Dopamine D2; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Transdermal Patch; Treatment Outcome; Young Adult | 2010 |
Integrated smoking cessation and binge drinking intervention for young adults: a pilot investigation.
Topics: Adolescent; Adult; Alcoholism; Behavior Therapy; Combined Modality Therapy; Female; Humans; Intention to Treat Analysis; Male; Nicotine; Patient Satisfaction; Pilot Projects; Smoking; Smoking Cessation; Treatment Outcome | 2010 |
Participation in a population-based physical activity programme as an aid for smoking cessation: a randomised trial.
Topics: Adult; Carbon Monoxide; Combined Modality Therapy; Counseling; Exercise; Female; Health Education; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Weight Gain | 2010 |
Stress decreases the ability to resist smoking and potentiates smoking intensity and reward.
Topics: Adrenocorticotropic Hormone; Adult; Behavior, Addictive; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Imagery, Psychotherapy; Male; Middle Aged; Motivation; Nicotine; Pituitary-Adrenal System; Reinforcement, Psychology; Reward; Smoking; Smoking Cessation; Stress, Psychological; Young Adult | 2011 |
Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment.
Topics: Adolescent; Anxiety Disorders; Bupropion; Counseling; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Humans; Interview, Psychological; Logistic Models; Male; Nicotine; Nicotinic Agonists; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2011 |
Brain β2*-nicotinic acetylcholine receptor occupancy after use of a nicotine inhaler.
Topics: Administration, Inhalation; Adult; Behavior, Addictive; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Young Adult | 2011 |
Cognitive conflict following appetitive versus negative cues and smoking cessation failure.
Topics: Adult; Appetitive Behavior; Cognition Disorders; Conflict, Psychological; Cues; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Photic Stimulation; Reaction Time; Smoking; Smoking Cessation; Tobacco Use Disorder; Transdermal Patch | 2011 |
Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence.
Topics: Adult; Communication; England; Ganglionic Stimulants; Genotype; Humans; Molecular Targeted Therapy; Nicotine; Patient Compliance; Receptors, Opioid, mu; Research Design; Smoking; Smoking Cessation; State Medicine; Surveys and Questionnaires | 2010 |
Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study.
Topics: Adolescent; Adult; Aged; Carbon Monoxide; Cotinine; Feasibility Studies; Humans; Middle Aged; Nicotine; Nitrosamines; Pyridines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco, Smokeless; Young Adult | 2011 |
Time-varying smoking abstinence predicts lower depressive symptoms following smoking cessation treatment.
Topics: Adult; Depression; Female; Follow-Up Studies; Humans; Male; Multilevel Analysis; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2011 |
Effectiveness of pharmacist counseling combined with nicotine replacement therapy: a pragmatic randomized trial with 6,987 smokers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Behavior Therapy; Combined Modality Therapy; Directive Counseling; Female; Follow-Up Studies; Health Promotion; Humans; Male; Middle Aged; Nicotine; Pharmacists; Prevalence; Smoking; Smoking Cessation; Treatment Outcome; Young Adult | 2011 |
Effect of compliance with nicotine gum dosing on weight gained during a quit attempt.
Topics: Adult; Chewing Gum; Dose-Response Relationship, Drug; Female; Humans; Male; Nicotine; Nicotinic Agonists; Patient Compliance; Placebos; Smoking; Smoking Cessation; Weight Gain; Young Adult | 2011 |
Silver acetate interactions with nicotine and non-nicotine smoke components.
Topics: Acetates; Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotiana; Nicotine; Nicotinic Agonists; Silver Compounds; Smoking Cessation; Smoking Prevention; Taste | 2010 |
Treating heavy smokers in primary care with the nicotine nasal spray: randomized placebo-controlled trial.
Topics: Administration, Intranasal; Adult; Breath Tests; Carbon Monoxide; Cotinine; Double-Blind Method; England; Family Practice; Female; Humans; Logistic Models; Male; Middle Aged; Nasal Sprays; Nicotine; Nicotinic Agonists; Odds Ratio; Patient Education as Topic; Recurrence; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2011 |
Adjustment of nicotine replacement therapies according to saliva cotinine concentration: the ADONIS* trial-a randomized study in smokers with medical comorbidities.
Topics: Administration, Buccal; Cardiovascular Diseases; Comorbidity; Cotinine; Counseling; Diabetes Mellitus; Female; France; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Outcome Assessment, Health Care; Pulmonary Disease, Chronic Obstructive; Recurrence; Saliva; Smoking; Smoking Cessation; Socioeconomic Factors; Statistics as Topic; Transdermal Patch | 2011 |
A randomized controlled trial of a smoking reduction plus nicotine replacement therapy intervention for smokers not willing to quit smoking.
Topics: Adult; Combined Modality Therapy; Counseling; Female; Hong Kong; Humans; Intention to Treat Analysis; Male; Medication Adherence; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Treatment Refusal | 2011 |
Study protocol for a randomised trial of nicotine-free cigarettes as an adjunct to usual NRT-based cessation practice, in people who wish to stop smoking.
Topics: Clinical Protocols; Female; Hotlines; Humans; Male; New Zealand; Nicotine; Research Design; Single-Blind Method; Smoking; Smoking Cessation; Smoking Prevention; Socioeconomic Factors; Substance Withdrawal Syndrome; Substance-Related Disorders; Surveys and Questionnaires; Treatment Outcome | 2011 |
Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Nicotine; Psychiatric Department, Hospital; Psychiatric Status Rating Scales; Psychomotor Agitation; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Transdermal Patch; Violence; Young Adult | 2011 |
Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Black or African American; Bupropion; Cotinine; Counseling; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Female; Genotype; Health Behavior; Health Knowledge, Attitudes, Practice; Humans; Kansas; Male; Middle Aged; Motivation; Nicotine; Oxidoreductases, N-Demethylating; Patient Education as Topic; Patient Selection; Phenotype; Recurrence; Saliva; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2011 |
Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic.
Topics: Adult; Antibodies; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Vaccines; Vaccines, Conjugate | 2011 |
Comparative analysis of waterpipe and cigarette suppression of abstinence and craving symptoms.
Topics: Adult; Behavior, Addictive; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Syria; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2011 |
Acceptability and effectiveness for withdrawal symptom relief of a novel oral nicotine delivery device: a randomised crossover trial.
Topics: Administration, Inhalation; Adolescent; Adult; Cross-Over Studies; Drug Delivery Systems; Female; Humans; Male; Nicotine; Nicotinic Agonists; Patient Satisfaction; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2011 |
Within-day temporal patterns of smoking, withdrawal symptoms, and craving.
Topics: Adult; Behavior, Addictive; Circadian Rhythm; Cross-Sectional Studies; Female; Health Records, Personal; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Placebos; Prospective Studies; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2011 |
Effects of nicotine and alcohol on affective responses to emotionally toned film clips.
Topics: Adolescent; Adult; Affect; Dopamine; Emotions; Ethanol; Female; Happiness; Humans; Male; Motion Pictures; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Smoking; Smoking Cessation; Young Adult | 2011 |
Smoker characteristics and smoking-cessation milestones.
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Recurrence; Sex Factors; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Tobacco Use Disorder; Treatment Failure | 2011 |
Effects of transdermal nicotine and concurrent smoking on cognitive performance in tobacco-abstinent smokers.
Topics: Administration, Cutaneous; Adult; Attention; Double-Blind Method; Female; Humans; Male; Memory, Short-Term; Middle Aged; Nicotine; Psychomotor Performance; Smoking; Smoking Cessation; Tobacco Use Disorder; Young Adult | 2011 |
A single 4 mg dose of nicotine decreases heart rate variability in healthy nonsmokers: implications for smoking cessation programs.
Topics: Adolescent; Adult; Cross-Over Studies; Female; Heart Rate; Humans; Male; Nicotine; Placebos; Smoking Cessation; Sympatholytics; Young Adult | 2011 |
Does improved access and greater choice of nicotine replacement therapy affect smoking cessation success? Findings from a randomized controlled trial.
Topics: Adult; Choice Behavior; Drug Administration Routes; Female; Health Services Accessibility; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Native Hawaiian or Other Pacific Islander; New Zealand; Nicotine; Nicotinic Agonists; Patient Preference; Recurrence; Smoking; Smoking Cessation; Socioeconomic Factors; Treatment Outcome | 2011 |
Tobacco withdrawal components and their relations with cessation success.
Topics: Adult; Affect; Bupropion; Double-Blind Method; Humans; Multivariate Analysis; Nicotine; Nicotinic Agonists; Recurrence; Regression Analysis; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2011 |
Nicotine delivery and subjective effects of Swedish portion snus compared with 4 mg nicotine polacrilex chewing gum.
Topics: Adult; Area Under Curve; Chewing Gum; Cross-Over Studies; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Polymethacrylic Acids; Polyvinyls; Salivation; Self Report; Smoking; Smoking Cessation; Sweden; Tobacco Use Cessation Devices; Tobacco, Smokeless; Young Adult | 2011 |
Resistance training as an aid to standard smoking cessation treatment: a pilot study.
Topics: Adipose Tissue; Adolescent; Adult; Aged; Exercise; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Pilot Projects; Resistance Training; Smoking; Smoking Cessation; Smoking Prevention; Weight Lifting; Young Adult | 2011 |
Brain activity and emotional processing in smokers treated with varenicline.
Topics: Adolescent; Adult; Affect; Aged; Amygdala; Analysis of Variance; Benzazepines; Brain; Cross-Over Studies; Double-Blind Method; Emotions; Facial Expression; Female; Functional Neuroimaging; Humans; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Nicotinic Agonists; Oxygen; Photic Stimulation; Placebos; Quinoxalines; Reaction Time; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline; Young Adult | 2013 |
Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study.
Topics: Adult; Aged; Bupropion; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2011 |
Oral tobacco products: preference and effects among smokers.
Topics: Adult; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco, Smokeless | 2011 |
Nicotine effects on immediate and delayed verbal memory after substance use detoxification.
Topics: Administration, Cutaneous; Adult; Attention; Double-Blind Method; Female; Humans; Male; Mass Screening; Memory; Middle Aged; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance-Related Disorders; Tobacco Use Disorder; Verbal Learning | 2011 |
Predictors of smoking cessation among cancer patients enrolled in a smoking cessation program.
Topics: Behavior Therapy; Bupropion; Female; Humans; Male; Middle Aged; Neoplasms; Nicotine; Placebos; Prognosis; Smoking; Smoking Cessation; Treatment Outcome | 2011 |
The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy.
Topics: Administration, Intranasal; Black People; Body Mass Index; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Linear Models; Logistic Models; Male; Middle Aged; Nicotine; Nicotinic Agonists; Placebos; Recurrence; Self Report; Severity of Illness Index; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Transdermal Patch; White People | 2011 |
Effectiveness of a stepped primary care smoking cessation intervention: cluster randomized clinical trial (ISTAPS study).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Breath Tests; Bupropion; Carbon Monoxide; Chewing Gum; Cluster Analysis; Counseling; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Primary Health Care; Program Evaluation; Psychological Theory; Smoking; Smoking Cessation; Social Class; Spain; Spouses; Time Factors; Transdermal Patch; Treatment Outcome; Young Adult | 2011 |
Smoking cessation in primary care - a randomized controlled trial of bupropione, nicotine replacements, CBT and a minimal intervention.
Topics: Adult; Bupropion; Cognitive Behavioral Therapy; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Primary Health Care; Psychiatric Status Rating Scales; Smoking; Smoking Cessation; Treatment Outcome | 2011 |
Early cessation success or failure among women attempting to quit smoking: trajectories and volatility of urge and negative mood during the first postcessation week.
Topics: Administration, Cutaneous; Adult; Affect; Female; Humans; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Cessation Devices; Treatment Outcome | 2011 |
A comparison between quick-release nicotine lozenges and Swedish-style snus for the acute management of craving.
Topics: Double-Blind Method; Female; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tablets; Tobacco Use Disorder; Tobacco, Smokeless | 2011 |
Effects of 24 hours of tobacco withdrawal and subsequent tobacco smoking among low and high sensation seekers.
Topics: Adolescent; Adult; Affect; Blood Pressure; Carbon Monoxide; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Nicotiana; Nicotine; Sensation; Smoking; Smoking Cessation; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder; Young Adult | 2011 |
Mindfulness training for smoking cessation: results from a randomized controlled trial.
Topics: Adult; Carbon Monoxide; Female; Follow-Up Studies; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2011 |
Nicotine withdrawal exacerbates fear reactivity to CO₂-induced bodily sensations among smokers.
Topics: Adult; Carbon Dioxide; Fear; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Panic Disorder; Regression Analysis; Sensation; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Young Adult | 2011 |
Relapse dynamics during smoking cessation: recurrent abstinence violation effects and lapse-relapse progression.
Topics: Adult; Aged; Cognitive Behavioral Therapy; Double-Blind Method; Female; Guilt; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Recurrence; Self Efficacy; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Young Adult | 2012 |
Single-dose pharmacokinetics of nicotine when given with a novel mouth spray for nicotine replacement therapy.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Biological Availability; Confidence Intervals; Cross-Over Studies; Female; Humans; Male; Middle Aged; Mouth; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Young Adult | 2011 |
Contrasting behavioral effects of acute nicotine and chronic smoking in detoxified alcoholics.
Topics: Administration, Cutaneous; Adult; Alcoholism; Attention; Case-Control Studies; Chronic Disease; Double-Blind Method; Female; Florida; Humans; Kentucky; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2011 |
Is delaying a quit attempt associated with less success?
Topics: Achievement; Counseling; Follow-Up Studies; Humans; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Recurrence; Self Efficacy; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2011 |
Effects of pregabalin on smoking behavior, withdrawal symptoms, and cognitive performance in smokers.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Female; gamma-Aminobutyric Acid; Humans; Male; Nicotine; Outpatients; Pregabalin; Psychomotor Performance; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2012 |
Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study.
Topics: Adult; Cohort Studies; Electrical Equipment and Supplies; Female; Follow-Up Studies; Humans; Italy; Male; Middle Aged; Nicotine; Pilot Projects; Prospective Studies; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Tobacco Use Cessation Devices; Treatment Outcome | 2011 |
Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Central Nervous System Stimulants; Drug Therapy, Combination; Follow-Up Studies; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance-Related Disorders; Tobacco Use Disorder; Treatment Outcome | 2012 |
Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking.
Topics: Adult; Alkaloids; Azocines; Clinical Protocols; Humans; Motivation; New Zealand; Nicotine; Quinolizines; Sample Size; Single-Blind Method; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome | 2011 |
Nicotine therapy sampling to induce quit attempts among smokers unmotivated to quit: a randomized clinical trial.
Topics: Adult; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices | 2011 |
Association between nicotinic acetylcholine receptor single nucleotide polymorphisms and smoking cessation.
Topics: Adult; alpha7 Nicotinic Acetylcholine Receptor; Cohort Studies; Female; Genetic Predisposition to Disease; Humans; Logistic Models; Male; Middle Aged; Nicotine; Polymorphism, Single Nucleotide; Receptors, Nicotinic; Smoking; Smoking Cessation; Tobacco Use Disorder; United Kingdom | 2012 |
Extended duration therapy with transdermal nicotine may attenuate weight gain following smoking cessation.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Anti-Obesity Agents; Drug Administration Schedule; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Weight Gain; Young Adult | 2012 |
Continuing to wear nicotine patches after smoking lapses promotes recovery of abstinence.
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Female; Humans; Male; Nicotine; Secondary Prevention; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome | 2012 |
Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial.
Topics: Administration, Inhalation; Adult; Breath Tests; Carbon Monoxide; Counseling; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Treatment Outcome | 2012 |
Attention-deficit/hyperactivity disorder (ADHD) symptoms, craving to smoke, and tobacco withdrawal symptoms in adult smokers with ADHD.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Behavior, Addictive; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2012 |
Pharmacogenetic association of the galanin receptor (GALR1) SNP rs2717162 with smoking cessation.
Topics: Adult; Alleles; Bupropion; Female; Genetic Association Studies; Humans; Male; Middle Aged; Nicotine; Polymorphism, Single Nucleotide; Receptors, Galanin; Retrospective Studies; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2012 |
Nature and role of change in anxiety sensitivity during NRT-aided cognitive-behavioral smoking cessation treatment.
Topics: Anxiety; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Nicotine; Recurrence; Smoking; Smoking Cessation | 2012 |
A randomized trial of nicotine-replacement therapy patches in pregnancy.
Topics: Administration, Cutaneous; Adult; Behavior Therapy; Cesarean Section; Double-Blind Method; Female; Follow-Up Studies; Humans; Medication Adherence; Nicotine; Pregnancy; Pregnancy Complications; Smoking Cessation; Tobacco Use Cessation Devices | 2012 |
The electronic-cigarette: effects on desire to smoke, withdrawal symptoms and cognition.
Topics: Adolescent; Adult; Attention; Cognition; Female; Humans; Male; Memory; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2012 |
Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial.
Topics: Adult; Female; Genotype; Humans; Male; Middle Aged; Nicotine; Receptors, Opioid, mu; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2012 |
Safety of varenicline among smokers enrolled in the lung HIV study.
Topics: Adult; Benzazepines; Female; HIV Infections; Humans; Male; Middle Aged; Nicotine; Prospective Studies; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline | 2013 |
The combined effect of very low nicotine content cigarettes, used as an adjunct to usual Quitline care (nicotine replacement therapy and behavioural support), on smoking cessation: a randomized controlled trial.
Topics: Adult; Behavior Therapy; Combined Modality Therapy; Female; Humans; Kaplan-Meier Estimate; Male; Nicotine; Nicotinic Agonists; Recurrence; Single-Blind Method; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices; Treatment Outcome; Young Adult | 2012 |
Isolating the role of psychological dysfunction in smoking cessation: relations of personality and psychopathology to attaining cessation milestones.
Topics: Adult; Bupropion; Counseling; Defense Mechanisms; Female; Humans; Male; Mental Disorders; Nicotine; Personality; Psychiatric Status Rating Scales; Recurrence; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome | 2012 |
Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers.
Topics: Adult; alpha7 Nicotinic Acetylcholine Receptor; Behavior, Addictive; Benzazepines; Biomarkers; Cotinine; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Pennsylvania; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Varenicline; Young Adult | 2012 |
Association of functional COMT Val108/Met polymorphism with smoking cessation in a nicotine replacement therapy.
Topics: Administration, Sublingual; Adult; Aged; Catechol O-Methyltransferase; Double-Blind Method; Female; Genotype; Humans; Male; Middle Aged; Nicotine; Pharmacogenetics; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Reverse Transcriptase Polymerase Chain Reaction; Smoking Cessation; Tobacco Use Cessation Devices; Young Adult | 2012 |
Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report.
Topics: Behavior, Addictive; Blood Pressure; Cholinesterase Inhibitors; Cognition; Connecticut; Cross-Over Studies; Double-Blind Method; Female; Galantamine; Heart Rate; Humans; Infusions, Intravenous; Logistic Models; Male; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Pilot Projects; Severity of Illness Index; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Task Performance and Analysis; Time Factors; Tobacco Use Disorder | 2012 |
A double-blind randomized clinical trial of different doses of transdermal nicotine patch for smoking reduction and cessation in long-term hospitalized schizophrenic patients.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome | 2013 |
A randomized clinical trial of trans-dermal nicotine replacement in pregnant African-American smokers.
Topics: Administration, Cutaneous; Adult; Black or African American; Carbon Monoxide; Cognitive Behavioral Therapy; Female; Gestational Age; Humans; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Saliva; Smoking; Smoking Cessation; Socioeconomic Factors; Tobacco Use Cessation Devices; Treatment Outcome; United States | 2013 |
The short term effect of nicotine abstinence on visuospatial working memory in smoking patients with schizophrenia.
Topics: Adult; Ganglionic Stimulants; Humans; Male; Memory, Short-Term; Nicotine; Schizophrenia; Smoking; Smoking Cessation; Space Perception; Tobacco Use Cessation Devices; Visual Perception; Young Adult | 2013 |
Nicotine patches and quitline counseling to help hospitalized smokers stay quit: study protocol for a randomized controlled trial.
Topics: Administration, Cutaneous; Aftercare; California; Cost-Benefit Analysis; Counseling; Drug Costs; Hospital Costs; Hotlines; Humans; Inpatients; Nicotine; Nicotinic Agonists; Patient Discharge; Recurrence; Research Design; Smoking; Smoking Cessation; Smoking Prevention; Telephone; Time Factors; Tobacco Use Cessation Devices; Transdermal Patch; Treatment Outcome | 2012 |
Randomized trial of the effectiveness of combined behavioral/pharmacological smoking cessation treatment in Syrian primary care clinics.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Ambulatory Care Facilities; Behavior, Addictive; Carbon Monoxide; Counseling; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Primary Health Care; Program Evaluation; Self Report; Smoking Cessation; Smoking Prevention; Syria; Tobacco Use Cessation Devices; Treatment Outcome; Young Adult | 2013 |
The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction.
Topics: Adult; Allosteric Regulation; Behavior, Addictive; Benzimidazoles; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Humans; Male; Memory, Episodic; Middle Aged; Nicotine; Receptor, Muscarinic M1; Smoking; Smoking Cessation; Young Adult | 2013 |
Assigning dose of nicotine gum by time to first cigarette.
Topics: Algorithms; Chewing Gum; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Nicotine; Placebos; Smoking Cessation | 2013 |
Enhancing tobacco quitline effectiveness: identifying a superior pharmacotherapy adjuvant.
Topics: Adult; Chewing Gum; Cost-Benefit Analysis; Counseling; Female; Hotlines; Humans; Male; Middle Aged; Nicotiana; Nicotine; Patient Compliance; Smoking; Smoking Cessation; Telephone; Time Factors; Tobacco Use Cessation Devices; Treatment Outcome; Wisconsin | 2013 |
Varenicline to stop long-term nicotine replacement use: a double-blind, randomized, placebo-controlled trial.
Topics: Benzazepines; Body Weight; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Antagonists; Placebos; Quinoxalines; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Varenicline | 2013 |
Eliminating second-hand smoke from Mexican-American households: outcomes from Project Clean Air-Safe Air (CASA).
Topics: Adult; Air; Child; Family; Female; Humans; Inhalation Exposure; Male; Mexican Americans; Middle Aged; Nicotine; Patient Education as Topic; Residence Characteristics; Smoke-Free Policy; Smoking; Smoking Cessation; Tobacco Smoke Pollution; Treatment Outcome; United States | 2013 |
Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances.
Topics: Adolescent; Benzazepines; Bupropion; Case-Control Studies; Cohort Studies; Dose-Response Relationship, Drug; Female; Genotype; Humans; Male; Nicotine; Outcome Assessment, Health Care; Polymorphism, Single Nucleotide; Quinoxalines; Reproducibility of Results; Risk Factors; Smoking Cessation; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult | 2014 |
Menstrual phase and depressive symptoms differences in physiological response to nicotine following acute smoking abstinence.
Topics: Adolescent; Adult; Cross-Over Studies; Depression; Female; Follicular Phase; Humans; Luteal Phase; Menstrual Cycle; Nicotine; Recurrence; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Young Adult | 2013 |
Dose-response effects of spectrum research cigarettes.
Topics: Adolescent; Adult; Behavior; Blood Pressure; Cotinine; Demography; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Pilot Projects; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Products; Tobacco Use Cessation Devices; Young Adult | 2013 |
Nicotinic acetylcholine receptor variation and response to smoking cessation therapies.
Topics: Adult; Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Female; Genotype; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Polymorphism, Single Nucleotide; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Varenicline | 2013 |
The neurocognitive effects of Hypericum perforatum Special Extract (Ze 117) during smoking cessation.
Topics: Adolescent; Adult; Drug Therapy, Combination; Humans; Hypericum; Memory, Short-Term; Middle Aged; Nicotine; Plant Extracts; Reaction Time; Reproducibility of Results; Smoking Cessation; Substance Withdrawal Syndrome; Young Adult | 2013 |
Change in anxiety following successful and unsuccessful attempts at smoking cessation: cohort study.
Topics: Adaptation, Psychological; Anxiety; Cohort Studies; England; Female; Health Knowledge, Attitudes, Practice; Humans; Linear Models; Male; Mental Disorders; Nicotine; Recurrence; Smoking; Smoking Cessation; State Medicine; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Treatment Outcome | 2013 |
Evidence that transient nicotine lowers the body weight set point.
Topics: Administration, Cutaneous; Adult; Appetite; Blood Pressure; Body Weight; Heart Rate; Humans; Male; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Taste | 2002 |
Controlled trial of three weeks nicotine replacement treatment in hospital patients also given advice and support.
Topics: Administration, Cutaneous; Administration, Inhalation; Adult; Aged; Breath Tests; Carbon Monoxide; Counseling; Female; Hospitalization; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Smoking Cessation; Smoking Prevention | 2002 |
Pharmacologic therapy for nicotine addiction.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Double-Blind Method; Humans; Male; Middle Aged; Nicotine; Nortriptyline; Smoking; Smoking Cessation; Tobacco Use Disorder | 2002 |
[Smoking cessation for hospital staff. A controlled intervention study].
Topics: Adult; Female; Germany; Humans; Male; Nicotine; Personnel, Hospital; Prevalence; Smoking; Smoking Cessation; Stress, Physiological; Treatment Outcome | 2002 |
Do men outperform women in smoking cessation trials? Maybe, but not by much.
Topics: Administration, Cutaneous; Adult; Body Mass Index; Clinical Trials as Topic; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotine; Nicotinic Agonists; Odds Ratio; Sex Characteristics; Smoking; Smoking Cessation | 2002 |
Nicotine replacement to reduce cigarette consumption in smokers who are unwilling to quit: a randomized trial.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Adult; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder; Treatment Failure | 2002 |
Smoking cessation in methadone maintenance.
Topics: Adolescent; Adult; Aged; Female; Humans; Male; Methadone; Middle Aged; Narcotics; Nicotine; Smoking; Smoking Cessation; Substance-Related Disorders; Tobacco Use Disorder | 2002 |
Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Carbon Monoxide; Cotinine; Cross-Over Studies; Double-Blind Method; Female; Heart Rate; Humans; Hydrocortisone; Male; Nicotine; Random Allocation; Saliva; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2002 |
Brain metabolic changes during cigarette craving.
Topics: Adult; Arousal; Attention; Blood Glucose; Brain Mapping; Cerebral Cortex; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Motivation; Nicotine; Radionuclide Imaging; Smoking Cessation; Substance Withdrawal Syndrome | 2002 |
A comparison of a nicotine sublingual tablet and placebo for smoking cessation.
Topics: Administration, Sublingual; Adult; Double-Blind Method; Female; Humans; Hyperplasia; Leukoplakia, Oral; Male; Mouth Mucosa; Nicotine; Smoking Cessation; Smoking Prevention | 2002 |
Efficacy of over-the-counter nicotine patch.
Topics: Administration, Topical; Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Smoking Prevention | 2002 |
Long-term effects of the Eclipse cigarette substitute and the nicotine inhaler in smokers not interested in quitting.
Topics: Administration, Inhalation; Adult; Aged; Cross-Over Studies; Humans; Middle Aged; Nicotine; Smoking Cessation; Smoking Prevention; Time; Tobacco Use Disorder | 2002 |
Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Carbon Monoxide; Cotinine; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Pilot Projects; Psychotropic Drugs; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2002 |
Naturalistic, self-assignment comparative trial of bupropion SR, a nicotine patch, or both for smoking cessation treatment in primary care.
Topics: Administration, Cutaneous; Aged; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Primary Health Care; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2002 |
Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving.
Topics: Adult; Analysis of Variance; Chewing Gum; Cues; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2003 |
Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2003 |
Subjective effects of the nicotine lozenge: assessment of abuse liability.
Topics: Adolescent; Adult; Behavior, Addictive; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Tablets; Tobacco Use Disorder | 2003 |
Onset of major depression during treatment for nicotine dependence.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Paroxetine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2003 |
Prolonged nicotine patch use in quitters with past abstinence-induced depressed mood.
Topics: Administration, Cutaneous; Adult; Depressive Disorder; Drug Administration Schedule; Female; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2003 |
Rationale, design, and baseline data for Commit to Quit II: an evaluation of the efficacy of moderate-intensity physical activity as an aid to smoking cessation in women.
Topics: Administration, Cutaneous; Adolescent; Adult; Affect; Aged; Anxiety; Behavior Therapy; Body Weight; Combined Modality Therapy; Exercise; Female; Health Behavior; Humans; Life Style; Middle Aged; Motor Activity; Nicotine; Research Design; Smoking; Smoking Cessation; Treatment Outcome | 2003 |
Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers.
Topics: Administration, Cutaneous; Double-Blind Method; Humans; Nicotine; Recurrence; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2003 |
Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations.
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotine; Recurrence; Severity of Illness Index; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2003 |
Smoking cessation with nicotine replacement therapy among health care workers: randomized double-blind study.
Topics: Administration, Cutaneous; Adult; Croatia; Double-Blind Method; Female; Health Personnel; Humans; Male; Nicotine; Prevalence; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2003 |
The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy.
Topics: Adaptation, Psychological; Administration, Cutaneous; Adult; Aged; Behavior Therapy; Depression; Female; Humans; Male; Middle Aged; Nicotine; Self Efficacy; Smoking; Smoking Cessation; Smoking Prevention; Time Factors | 2003 |
Effect of smoking reduction on later cessation: a pilot experimental study.
Topics: Administration, Cutaneous; Adult; Behavior Therapy; Female; Follow-Up Studies; Humans; Incidence; Male; Motivation; Nicotine; Nicotinic Agonists; Pilot Projects; Smoking; Smoking Cessation; Smoking Prevention; Time Factors | 2003 |
Effects of the nicotine patch on performance during the first week of smoking cessation.
Topics: Administration, Cutaneous; Adult; Aged; Cognition; Double-Blind Method; Female; Humans; Linguistics; Male; Mathematics; Memory; Middle Aged; Nicotine; Nicotinic Agonists; Problem Solving; Reaction Time; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Visual Perception | 2003 |
Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting.
Topics: Administration, Cutaneous; Administration, Intranasal; Adult; Ambulatory Care; Combined Modality Therapy; Female; Humans; Incidence; Male; Nicotine; Nicotinic Agonists; Prevalence; Smoking; Smoking Cessation; Time Factors | 2003 |
A contingent payment model of smoking cessation: effects on abstinence and withdrawal.
Topics: Adolescent; Adult; Carbon Monoxide; Female; Humans; Incidence; Male; Nicotine; Nicotinic Agonists; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2003 |
Efficacy of oral transmucosal nicotine lozenge for suppression of withdrawal symptoms in smoking abstinence.
Topics: Administration, Oral; Adult; Female; Humans; Male; Nicotine; Nicotinic Agonists; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2003 |
Depressive symptoms and smoking cessation among inner-city African Americans using the nicotine patch.
Topics: Administration, Cutaneous; Adult; Black or African American; Depression; Female; Follow-Up Studies; Humans; Male; Nicotine; Smoking Cessation; Urban Population | 2003 |
Gender differences in quit rates following smoking cessation with combination nicotine therapy: influence of baseline smoking behavior.
Topics: Administration, Inhalation; Adult; Carbon Monoxide; Female; Humans; Male; Nicotine; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires | 2003 |
Targeting smokers at increased risk for relapse: treating women and those with a history of depression.
Topics: Administration, Cutaneous; Bupropion; Depression; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Recurrence; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention | 2003 |
Intensive smoking cessation counseling versus minimal counseling among hospitalized smokers treated with transdermal nicotine replacement: a randomized trial.
Topics: Administration, Cutaneous; Adult; Aged; Cognitive Behavioral Therapy; Counseling; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Outcome Assessment, Health Care; Smoking Cessation; Tobacco Use Disorder | 2003 |
Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients.
Topics: Administration, Intranasal; Administration, Oral; Adolescent; Adult; Aged; Combined Modality Therapy; Counseling; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quality of Life; Smoking Cessation; Smoking Prevention; Tablets | 2003 |
Twenty-four week maintenance treatment of cigarette smoking with nicotine gum, clonidine and naltrexone.
Topics: Adult; Antihypertensive Agents; Chewing Gum; Clonidine; Double-Blind Method; Humans; Iran; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Prospective Studies; Smoking; Smoking Cessation; Smoking Prevention; Time Factors | 2003 |
Short-term pre-operative smoking cessation intervention does not affect postoperative complications in colorectal surgery: a randomized clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Colectomy; Digestive System Surgical Procedures; Female; Humans; Male; Middle Aged; Nicotine; Postoperative Complications; Smoking Cessation; Time Factors; Wound Healing | 2003 |
Impact of messages on concomitant use of nicotine replacement therapy and cigarettes: a randomized trial on the Internet.
Topics: Adolescent; Adult; Aged; Female; Humans; Internet; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Patient Education as Topic; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder | 2003 |
Abstinence from smoking eight years after participation in randomised controlled trial of nicotine patch.
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Follow-Up Studies; Humans; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Smoking Cessation; Statistics as Topic | 2003 |
A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.
Topics: Adult; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Weight Gain | 2003 |
[Nicotine withdrawal in hospital coworkers: opportunities instead of prohibitions].
Topics: Central Nervous System Stimulants; Chewing Gum; Combined Modality Therapy; Germany; Humans; Nicotine; Nurse's Role; Nursing Staff, Hospital; Outcome and Process Assessment, Health Care; Polymethacrylic Acids; Polyvinyls; Relaxation Therapy; Secondary Prevention; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2003 |
Multimodal intervention raises smoking cessation rate during pregnancy.
Topics: Adult; Cotinine; Counseling; Female; Humans; Nicotine; Odds Ratio; Pregnancy; Pregnancy Complications; Prenatal Care; Prospective Studies; Saliva; Smoking; Smoking Cessation; Surveys and Questionnaires; Treatment Outcome | 2003 |
Treatment of adolescent smokers with the nicotine patch.
Topics: Administration, Cutaneous; Adolescent; Adolescent Behavior; Adult; Cognitive Behavioral Therapy; Double-Blind Method; Female; Ganglionic Stimulants; Humans; Male; Nicotine; Patient Compliance; Placebos; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2003 |
Smoking cessation treatment among dually diagnosed individuals: preliminary evaluation of different pharmacotherapies.
Topics: Adult; Bupropion; Counseling; Diagnosis, Dual (Psychiatry); Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Ganglionic Stimulants; Humans; Male; Mental Disorders; Middle Aged; Nicotine; Psychotherapy, Group; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2003 |
Telephone counselling as an adjunct to nicotine patches in smoking cessation: a randomised controlled trial.
Topics: Administration, Cutaneous; Adult; Counseling; Female; Humans; Male; Nicotine; Nicotinic Agonists; Recurrence; Smoking Cessation; Smoking Prevention; Telephone; Treatment Outcome | 2003 |
Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up.
Topics: Adult; Attitude to Health; Chewing Gum; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention | 2003 |
Attentional shifts to smoking cues in smokers.
Topics: Adult; Attention; Cues; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2003 |
A randomized controlled trial of oral selegiline plus nicotine skin patch compared with placebo plus nicotine skin patch for smoking cessation.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Nicotine; Selegiline; Smoking Cessation | 2003 |
The use of videos to inform smokers about different nicotine replacement products.
Topics: Adult; Attitude to Health; Feasibility Studies; Female; Ganglionic Stimulants; Humans; London; Male; Middle Aged; Nicotine; Patient Education as Topic; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Teaching Materials; Videotape Recording | 2003 |
Pharmacokinetics of a nicotine polacrilex lozenge.
Topics: Administration, Oral; Adult; Area Under Curve; Central Nervous System Stimulants; Chewing Gum; Cross-Over Studies; Female; Humans; Ion Exchange Resins; Male; Nicotine; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2003 |
Tobacco Craving Questionnaire: reliability and validity of a new multifactorial instrument.
Topics: Adult; Affect; Female; Ganglionic Stimulants; Humans; Male; Nicotine; Reproducibility of Results; Sensitivity and Specificity; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder | 2003 |
Electronic monitoring of long-term use of the nicotine nasal spray and predictors of success in a smoking cessation program.
Topics: Administration, Inhalation; Adult; Aged; Automation; Drug Administration Schedule; Electronics; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Monitoring, Physiologic; Motivation; Nicotine; Patient Compliance; Predictive Value of Tests; Prospective Studies; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2003 |
Pharmacologic and sensorimotor components of satiation in cigarette smoking.
Topics: Adolescent; Adult; Arousal; Carbon Monoxide; Cross-Over Studies; Female; Humans; Injections, Intravenous; Male; Middle Aged; Nicotine; Nicotinic Agonists; Satiation; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2003 |
Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity.
Topics: Administration, Cutaneous; Bupropion; Chi-Square Distribution; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotine; Nicotinic Agonists; Predictive Value of Tests; Psychiatric Status Rating Scales; Recurrence; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2003 |
Controlled trial for smoking cessation in a Navy shipboard population using nicotine patch, sustained-release buproprion, or both.
Topics: Bupropion; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Military Personnel; Naval Medicine; Nicotine; Smoking Cessation | 2003 |
Feedback from a point-of-care test for nicotine intake to reduce smoking during pregnancy.
Topics: Counseling; Female; Follow-Up Studies; Humans; Nicotine; Patient Education as Topic; Point-of-Care Systems; Pregnancy; Pregnancy Outcome; Pregnant Women; Prenatal Care; Smoking; Smoking Cessation | 2003 |
Predictors of attendance in a randomized clinical trial of nicotine replacement therapy with behavioral counseling.
Topics: Administration, Cutaneous; Administration, Intranasal; Behavior Therapy; Body Mass Index; Counseling; Depression; Female; Follow-Up Studies; Humans; Male; Nicotine; Patient Compliance; Prospective Studies; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Tobacco Use Disorder | 2003 |
Subjective effects of an initial dose of nicotine nasal spray predict treatment outcome.
Topics: Administration, Intranasal; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Treatment Outcome | 2004 |
Use of nicotine patches in breast-feeding mothers: transfer of nicotine and cotinine into human milk.
Topics: Administration, Cutaneous; Adult; Breast Feeding; Chromatography, High Pressure Liquid; Cotinine; Female; Humans; Infant, Newborn; Male; Milk, Human; Nicotine; Nicotinic Agonists; Pregnancy; Smoking; Smoking Cessation | 2003 |
Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome.
Topics: Adult; Bupropion; Counseling; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Prognosis; Risk Factors; Smoking Cessation | 2003 |
Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Ganglionic Stimulants; Genotype; Humans; Male; Middle Aged; Nicotine; Placebos; Polymorphism, Genetic; Receptors, Dopamine D2; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2003 |
Labetalol treatment enhances the attenuation of tobacco withdrawal symptoms by nicotine in abstinent smokers.
Topics: Adrenergic alpha-Antagonists; Adult; Cross-Over Studies; Double-Blind Method; Female; Ganglionic Stimulants; Heart Rate; Humans; Infusions, Intravenous; Labetalol; Male; Nicotine; Placebos; Smoking Cessation; Substance Withdrawal Syndrome | 2003 |
Successful treatment with a nicotine lozenge of smokers with prior failure in pharmacological therapy.
Topics: Double-Blind Method; Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Tablets; Treatment Failure | 2004 |
Effect of glucose on tobacco withdrawal symptoms in recent quitters using bupropion or nicotine replacement.
Topics: Adult; Bupropion; Double-Blind Method; Female; Glucose; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2004 |
Timing of alcohol and smoking cessation (TASC): smoking among substance use patients screened and enrolled in a clinical trial.
Topics: Administration, Cutaneous; Adult; Alcohol-Related Disorders; Behavior Therapy; Female; Humans; Male; Minnesota; Nicotine; Smoking Cessation; Substance Abuse Treatment Centers; Time Factors; Tobacco Use Disorder | 2003 |
Naltrexone and nicotine patch smoking cessation: a preliminary study.
Topics: Administration, Cutaneous; Adult; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Placebos; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2003 |
The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia.
Topics: Administration, Cutaneous; Adult; Carbon Monoxide; Female; Ganglionic Stimulants; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Patient Compliance; Prevalence; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome | 2004 |
[Bupropion SR for weaning from smoking in relapsed smokers: results of an open multicentre trial in Germany].
Topics: Adult; Age of Onset; Antidepressive Agents, Second-Generation; Bupropion; Female; Humans; Male; Nicotine; Smoking Cessation; Substance-Related Disorders | 2004 |
Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusers.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Caffeine; Central Nervous System Stimulants; Cocaine-Related Disorders; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Surveys and Questionnaires | 2004 |
Integrating smoking cessation treatment into primary care: an effectiveness study.
Topics: Administration, Cutaneous; Adult; Directive Counseling; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Primary Health Care; Smoking Cessation; Treatment Outcome | 2004 |
Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial.
Topics: Administration, Cutaneous; Administration, Intranasal; Adult; Behavior Therapy; Cotinine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Obesity; Smoking Cessation; Socioeconomic Factors; Tobacco Use Disorder; Treatment Outcome | 2004 |
Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial.
Topics: Administration, Cutaneous; Female; Genotype; Humans; Male; Nicotine; Nicotinic Agonists; Receptors, Dopamine D2; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2004 |
[Effect of treatment for nicotine dependence in patients with COPD].
Topics: Administration, Cutaneous; Adult; Aged; Attitude to Health; Bupropion; Delayed-Action Preparations; Disease Progression; Dopamine Uptake Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Poland; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking; Smoking Cessation; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2003 |
Weight gain and cardiovascular risk factors during smoking cessation with bupropion or nicotine.
Topics: Administration, Cutaneous; Adult; Aging; Blood Pressure; Bupropion; Cardiovascular Diseases; Diastole; Female; Humans; Insulin Resistance; Lipids; Male; Middle Aged; Nicotine; Nicotinic Agonists; Obesity; Risk Factors; Selective Serotonin Reuptake Inhibitors; Smoking Cessation; Thinness; Weight Gain | 2004 |
Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch.
Topics: Adult; Aged; Dopamine beta-Hydroxylase; Female; Genetic Variation; Genotype; Humans; Male; Middle Aged; Nicotine; Odds Ratio; Receptors, Dopamine D2; Signal Transduction; Smoking Cessation | 2004 |
Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Female; Humans; Male; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 2004 |
Influence of nicotine gum on acute cravings for cigarettes.
Topics: Affect; Chewing Gum; Cues; Double-Blind Method; Female; Humans; Male; Nicotine; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Cessation Devices; Treatment Outcome | 2004 |
Acute effects of nicotine on serum glucose insulin growth hormone and cortisol in healthy smokers.
Topics: Administration, Cutaneous; Adolescent; Adult; Blood Glucose; Cross-Over Studies; Double-Blind Method; Female; Glucose Tolerance Test; Human Growth Hormone; Humans; Hydrocortisone; Insulin; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation | 2004 |
Abstinence rates and predictors of outcome for smoking cessation: do Brazilian smokers need special strategies?
Topics: Adolescent; Adult; Aged; Brazil; Bupropion; Counseling; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotine; Patient Acceptance of Health Care; Prospective Studies; Risk Factors; Smoking Cessation; Treatment Outcome | 2004 |
[One-year follow up results of Smoking Cessation Outpatient Clinic].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Ambulatory Care Facilities; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Patient Education as Topic; Retrospective Studies; Smoking Cessation; Treatment Outcome; Turkey | 2004 |
Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products.
Topics: Administration, Cutaneous; Adult; Biomarkers; Carbon Monoxide; Carcinogens; Humans; Inhalation Exposure; Male; Middle Aged; Nicotine; Nitrosamines; Pyrenes; Research Design; Smoking; Smoking Cessation; Tobacco, Smokeless | 2004 |
Changes in hemorheological and biochemical parameters following short-term and long-term smoking cessation induced by nicotine replacement therapy (NRT).
Topics: Administration, Cutaneous; Administration, Oral; Adult; Blood Viscosity; Carbon Monoxide; Cotinine; Erythrocyte Deformability; Fibrinogen; Gingiva; Humans; Leukocytes; Male; Middle Aged; Nicotine; Smoking Cessation; Thiocyanates | 2004 |
Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers.
Topics: Administration, Cutaneous; Administration, Intranasal; Adult; Blood Pressure; Drug Administration Schedule; Female; Ganglionic Stimulants; Heart Rate; Humans; Male; Nicotine; Placebos; Reinforcement Schedule; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2004 |
Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments.
Topics: Administration, Cutaneous; Adult; Behavior Therapy; Extinction, Psychological; Female; Ganglionic Stimulants; Humans; Male; Mecamylamine; Menthol; Middle Aged; Nicotine; Nicotinic Antagonists; Reinforcement, Psychology; Smoking; Smoking Cessation; Tobacco Use Disorder | 2004 |
The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood.
Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Counseling; Cyclohexanols; Double-Blind Method; Female; Ganglionic Stimulants; Genotype; Humans; Male; Middle Aged; Nicotine; Placebos; Polymorphism, Genetic; Receptors, Dopamine D2; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Smoking reduction in the Lung Health Study.
Topics: Administration, Oral; Adult; Bronchodilator Agents; Counseling; Female; Ganglionic Stimulants; Humans; Ipratropium; Lung Diseases; Male; Middle Aged; Nicotine; Placebos; Smoking Cessation; Treatment Outcome | 2004 |
Changes in craving for a cigarette and arterial nicotine plasma concentrations in abstinent smokers.
Topics: Adolescent; Adult; Affect; Area Under Curve; Cues; Female; Hemodynamics; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tomography, Emission-Computed | 2004 |
Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit.
Topics: Administration, Oral; Adult; Chewing Gum; Counseling; Female; Ganglionic Stimulants; Humans; Incidence; Male; Motivation; Nicotine; Smoking; Smoking Cessation; Time Factors | 2004 |
Acute reduction in secretory immunoglobulin A following smoking cessation.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Female; Humans; Immunoglobulin A, Secretory; Male; Middle Aged; Nicotine; Nicotinic Agonists; Saliva; Smoking; Smoking Cessation | 2004 |
Adherence to nicotine replacement therapy versus quitting smoking among Chinese smokers: a preliminary investigation.
Topics: Adult; Age Factors; Education; Female; Follow-Up Studies; Hong Kong; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Regression Analysis; Risk Factors; Smoking; Smoking Cessation; Socioeconomic Factors; Surveys and Questionnaires | 2005 |
Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers.
Topics: Administration, Cutaneous; Adolescent; Bupropion; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2004 |
Cognitive and psychological correlates of smoking abstinence, and predictors of successful cessation.
Topics: Adult; Analysis of Variance; Brain; Cognition; Dopamine; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Prospective Studies; Signal Transduction; Smoking Cessation | 2004 |
Bupropion for smoking cessation: a randomized trial.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Double-Blind Method; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nicotine; Placebo Effect; Risk; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome | 2004 |
The relationship between smoking cessation and mouth ulcers.
Topics: Adult; Female; Ganglionic Stimulants; Humans; Incidence; Male; Middle Aged; Nicotine; Oral Ulcer; Severity of Illness Index; Smoking; Smoking Cessation; Time Factors; Treatment Outcome | 2004 |
Correlates of adherence with transdermal nicotine.
Topics: Administration, Cutaneous; Adolescent; Adult; Age Factors; Aged; Female; Humans; Income; Logistic Models; Male; Middle Aged; Nicotine; Patient Compliance; Sex Factors; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2004 |
A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers.
Topics: Adult; Alkaloids; Biomarkers; Carcinogens; Endpoint Determination; Environmental Exposure; Female; Ganglionic Stimulants; Humans; Male; Nicotine; Nitrosamines; Polycyclic Aromatic Hydrocarbons; Pyridines; Reproducibility of Results; Smoking; Smoking Cessation; Urinalysis | 2004 |
Depressed smokers and stage of change: implications for treatment interventions.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Comorbidity; Depression; Female; Humans; Internal-External Control; Male; Middle Aged; Motivation; Nicotine; Personal Construct Theory; Personality Assessment; Smoking; Smoking Cessation; Treatment Outcome | 2004 |
Extended nortriptyline and psychological treatment for cigarette smoking.
Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Tricyclic; Behavior Therapy; Combined Modality Therapy; Counseling; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Nicotine; Nortriptyline; Placebos; Psychotherapy, Group; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2004 |
Effect of smoking and abstention on oxidative burst and reactivity of neutrophils and monocytes.
Topics: Administration, Cutaneous; Adult; Humans; Monocytes; Neutrophils; Nicotine; Reference Values; Respiratory Burst; Smoking; Smoking Cessation; Time Factors | 2004 |
Does extended proactive telephone support increase smoking cessation among low-income women using nicotine patches?
Topics: Administration, Cutaneous; Adolescent; Adult; Female; Follow-Up Studies; Humans; Logistic Models; Middle Aged; Nicotine; Nicotinic Agonists; Outcome and Process Assessment, Health Care; Patient Compliance; Poverty; Smoking Cessation; Social Support; Telemedicine; Treatment Outcome | 2005 |
Smoking topography predicts abstinence following treatment with nicotine replacement therapy.
Topics: Adult; Aged; Carbon Monoxide; Female; Humans; Logistic Models; Male; Middle Aged; Nicotine; Predictive Value of Tests; Smoking; Smoking Cessation; Treatment Outcome | 2004 |
A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Nortriptyline; Probability; Reference Values; Risk Assessment; Smoking; Smoking Cessation; Statistics, Nonparametric; Substance Withdrawal Syndrome; Treatment Outcome | 2004 |
Clinical correlation between the consumption of nicotine and cotinine concentrations in urine and serum by competitive enzyme-linked immunosorbent assay.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cotinine; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Reproducibility of Results; Smoking; Smoking Cessation | 2004 |
Effects of different nicotine replacement therapies on postcessation psychological responses.
Topics: Administration, Cutaneous; Administration, Intranasal; Adult; Affect; Aged; Female; Humans; Male; Middle Aged; Nicotine; Recurrence; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2005 |
A placebo controlled randomized trial of the effects of phenylpropanolamine and nicotine gum on cessation rates and postcessation weight gain in women.
Topics: Adult; Appetite Depressants; Chewing Gum; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Logistic Models; Middle Aged; Nicotine; Phenylpropanolamine; Smoking Cessation; Weight Gain | 2005 |
[Continuous and momentous tobacco abstinence with pharmacologic therapy in clinical practice].
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Female; Humans; Longitudinal Studies; Male; Nicotine; Patient Compliance; Prospective Studies; Smoking; Smoking Cessation; Time Factors | 2004 |
[Randomized controlled study on the effectiveness of community pharmacists' advice for smoking cessation by Nicorette--evaluation at three months after initiation].
Topics: Adult; Aged; Community Pharmacy Services; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Polymethacrylic Acids; Polyvinyls; Self Medication; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices | 2004 |
Clinical utility of the combination of cognitive-behavioral techniques with nicotine patches as a smoking-cessation treatment: five-year results of the "Ex-Moker" program.
Topics: Administration, Cutaneous; Adult; Carbon Monoxide; Cognitive Behavioral Therapy; Female; Follow-Up Studies; Humans; Interviews as Topic; Male; Nicotine; Patient Dropouts; Psychotherapy, Group; Smoking Cessation; Spain | 2004 |
Cue-provoked craving and nicotine replacement therapy in smoking cessation.
Topics: Administration, Cutaneous; Adult; Cues; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation | 2004 |
An exploratory study of multicomponent treatment intervention for tobacco dependency.
Topics: Adult; Aftercare; Attitude to Health; Behavior Therapy; Combined Modality Therapy; Counseling; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Midwestern United States; Motivation; Nicotine; Nurse Clinicians; Nursing Evaluation Research; Patient Education as Topic; Program Evaluation; Self Efficacy; Smoking Cessation; Social Support; Surveys and Questionnaires; Tobacco Use Disorder | 2004 |
A programme for reducing smoking in pre-operative surgical patients: randomised controlled trial.
Topics: Adult; Aged; Female; Health Care Costs; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Preoperative Care; Program Evaluation; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2005 |
Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm.
Topics: Adolescent; Adult; Aged; Bupropion; Choice Behavior; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Reinforcement, Psychology; Smoking Cessation; Tobacco Use Disorder | 2005 |
Nicotine lozenge efficacy in light smokers.
Topics: Administration, Oral; Adolescent; Adult; Aged; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2005 |
Naltrexone augments the effects of nicotine replacement therapy in female smokers.
Topics: Administration, Cutaneous; Administration, Topical; Adult; Combined Modality Therapy; Double-Blind Method; Female; Humans; Naltrexone; Narcotic Antagonists; Nicotine; Psychotherapy; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2005 |
The effect of a novel smoking system--Accord--on ongoing smoking and toxin exposure.
Topics: Adult; Carbon Monoxide; Female; Humans; Male; Nicotine; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2004 |
Instructions about nicotine dose influence acute responses to nasal spray.
Topics: Administration, Intranasal; Adult; Affect; Blood Pressure; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Impulsive Behavior; Male; Nicotine; Reinforcement, Psychology; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Teaching | 2004 |
Effects of smoking cessation and reduction in asthmatics.
Topics: Administration, Inhalation; Adult; Anti-Asthmatic Agents; Asthma; Carbon Monoxide; Chewing Gum; Chi-Square Distribution; Cotinine; Denmark; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Nicotinic Agonists; Prospective Studies; Quality of Life; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Thiocyanates; Time Factors | 2005 |
Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
Topics: Administration, Cutaneous; Adolescent; Chewing Gum; Double-Blind Method; Female; Humans; Logistic Models; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder | 2005 |
Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes.
Topics: Acute Disease; Administration, Cutaneous; Aged; Databases, Factual; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Myocardial Infarction; Nicotine; Prospective Studies; Smoking Cessation; Treatment Outcome | 2005 |
Effects of medicinal herb tea on the smoking cessation and reducing smoking withdrawal symptoms.
Topics: Adult; Antioxidants; Beverages; Cells, Cultured; Cotinine; Drugs, Chinese Herbal; Humans; Liver; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Taste; Treatment Outcome | 2005 |
Randomized controlled trial of a web-based computer-tailored smoking cessation program as a supplement to nicotine patch therapy.
Topics: Administration, Cutaneous; Adolescent; Adult; Combined Modality Therapy; England; Female; Humans; Internet; Ireland; Male; Nicotine; Nicotinic Agonists; Patient Compliance; Smoking Cessation; Therapy, Computer-Assisted | 2005 |
Cognitive changes in cardiovascular patients following a tailored behavioral smoking cessation intervention.
Topics: Adult; Age Factors; Ambulatory Care; Attitude to Health; Behavior Therapy; Cardiovascular Diseases; Cognition; Combined Modality Therapy; Counseling; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Netherlands; Nicotine; Reference Values; Risk Factors; Self Efficacy; Sex Factors; Smoking; Smoking Cessation; Treatment Outcome | 2005 |
Effectiveness of payment for reduced carbon monoxide levels and noncontingent payments on smoking behaviors in cocaine-abusing outpatients wearing nicotine or placebo patches.
Topics: Administration, Cutaneous; Adult; Aged; Carbon Monoxide; Cocaine-Related Disorders; Cross-Over Studies; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Treatment Outcome | 2005 |
A randomized trial to promote pharmacotherapy use and smoking cessation in a Medicaid population (United States).
Topics: Adolescent; Adult; Age Distribution; Chi-Square Distribution; Confidence Intervals; Cost-Benefit Analysis; Female; Health Care Costs; Health Promotion; Humans; Incidence; Male; Medicaid; Middle Aged; Nicotine; Odds Ratio; Patient Compliance; Pharmaceutical Preparations; Reference Values; Risk Assessment; Sex Distribution; Smoking Cessation; Treatment Outcome; United States | 2005 |
Ability of a new oral nicotine substitute to reduce smoking urge in moderate smokers.
Topics: Administration, Oral; Adult; Cross-Over Studies; Double-Blind Method; Female; Heart Rate; Humans; Male; Nicotine; Nicotinic Agonists; Psychomotor Performance; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2006 |
Case studies of three pregnant smokers and their use of nicotine replacement therapy.
Topics: Administration, Cutaneous; Adult; Female; Health Promotion; Humans; Infant, Newborn; Maternal Behavior; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Pregnant Women; Smoking Cessation; Smoking Prevention; South Australia; Surveys and Questionnaires; Time Factors | 2005 |
Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers.
Topics: Adult; Anticonvulsants; Arousal; Attention; Blood Pressure; Brain; Cross-Over Studies; Double-Blind Method; Female; gamma-Aminobutyric Acid; Heart Rate; Humans; Male; Neuropsychological Tests; Nicotine; Nipecotic Acids; Reward; Smoking Cessation; Substance Withdrawal Syndrome; Tiagabine | 2005 |
A randomised-controlled pilot study using nicotine patches with pregnant women.
Topics: Administration, Cutaneous; Adult; Carbon Monoxide; Cotinine; Feasibility Studies; Female; Humans; Nicotine; Nicotinic Agonists; Patient Compliance; Patient Dropouts; Pilot Projects; Pregnancy; Saliva; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2006 |
Effect of nicotine replacement therapy on post-cessation weight gain and nutrient intake: a randomized controlled trial of postmenopausal female smokers.
Topics: Adult; Aged; Analysis of Variance; Dietary Carbohydrates; Energy Intake; Estrogen Replacement Therapy; Feeding Behavior; Female; Humans; Middle Aged; Motor Activity; Nicotine; Postmenopause; Smoking Cessation; Tobacco Use Disorder; Weight Gain | 2005 |
Brain activity in cigarette smokers performing a working memory task: effect of smoking abstinence.
Topics: Adult; Brain Mapping; Female; Humans; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Nicotine; Nicotinic Agonists; Prefrontal Cortex; Reaction Time; Smoking; Smoking Cessation; Tobacco Use Disorder | 2005 |
Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Child; Female; Follow-Up Studies; Humans; Male; Nicotine; Recurrence; Smoking; Smoking Cessation; Treatment Failure | 2005 |
Interventions to increase use of nicotine gum: a randomized, controlled, single-blind trial.
Topics: Adult; Aged; Chewing Gum; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Psychotherapy, Brief; Single-Blind Method; Smoking; Smoking Cessation; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2005 |
Peer-delivered smoking counseling for childhood cancer survivors increases rate of cessation: the partnership for health study.
Topics: Adolescent; Adult; Age Distribution; Child; Child, Preschool; Counseling; Female; Follow-Up Studies; Humans; Male; Neoplasms; Nicotine; Patient Education as Topic; Predictive Value of Tests; Prevalence; Probability; Reference Values; Risk Factors; Self-Help Groups; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Survivors; United States | 2005 |
Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.
Topics: Administration, Intranasal; Adult; Alleles; Antidepressive Agents, Second-Generation; Bupropion; Double-Blind Method; Female; Genetic Variation; Genotype; Haplotypes; Humans; Logistic Models; Male; Middle Aged; Nicotine; Nicotinic Agonists; Receptors, Dopamine D2; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2006 |
Comparison of three nicotine treatments: initial reactions and preferences with guided use.
Topics: Adult; Analysis of Variance; Chewing Gum; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Routes; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Time Factors; Tobacco Use Disorder | 2005 |
The prevalence of weight concerns in a smoking abstinence clinical trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Body Image; Body Weight; Bupropion; Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Treatment Outcome; United States | 2006 |
Randomized controlled trial of relapse prevention and a standard behavioral intervention with adult smokers.
Topics: Adolescent; Adult; Aged; Behavior Therapy; Female; Germany; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Secondary Prevention; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2006 |
Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h.
Topics: Adult; Antidepressive Agents, Second-Generation; Appetite; Bupropion; Circadian Rhythm; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Nicotine; Pulmonary Gas Exchange; Saliva; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors | 2005 |
Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia.
Topics: Adult; Attention; Bupropion; Cognition Disorders; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Placebos; Psychomotor Performance; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2005 |
Do daily interactive voice response reports of smoking behavior correspond with retrospective reports?
Topics: Data Collection; Double-Blind Method; Female; Humans; Male; Mental Recall; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Patient Compliance; Self Disclosure; Sensitivity and Specificity; Smoking; Smoking Cessation; Telephone; Time Factors | 2005 |
Effect of incorporating a 10 minute point of care test for salivary nicotine metabolites into a general practice based smoking cessation programme: randomised controlled trial.
Topics: Biofeedback, Psychology; Dental Care; Humans; Nicotine; Point-of-Care Systems; Prospective Studies; Saliva; Smoking Cessation; Treatment Outcome | 2005 |
Predictors of smoking relapse in a sample of Dutch adult smokers; the roles of gender and action plans.
Topics: Antidepressive Agents, Second-Generation; Attitude to Health; Bupropion; Female; Humans; Intention; Male; Middle Aged; Netherlands; Nicotine; Nicotinic Agonists; Risk Factors; Secondary Prevention; Self Efficacy; Sex Factors; Smoking; Smoking Cessation; Smoking Prevention | 2006 |
Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy.
Topics: Administration, Cutaneous; Adult; Affect; Attention; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Comparative efficacy of rapid-release nicotine gum versus nicotine polacrilex gum in relieving smoking cue-provoked craving.
Topics: Adolescent; Adult; Aged; Chewing Gum; Cues; Female; Humans; Male; Middle Aged; Nicotine; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2005 |
Immediate hedonic response to smoking lapses: relationship to smoking relapse, and effects of nicotine replacement therapy.
Topics: Administration, Cutaneous; Adult; Affect; Attitude; Behavior Therapy; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Reinforcement, Psychology; Risk Assessment; Secondary Prevention; Set, Psychology; Smoking; Smoking Cessation | 2006 |
Effect of application sites and multiple doses on nicotine pharmacokinetics in healthy male Japanese smokers following application of the transdermal nicotine patch.
Topics: Abdomen; Administration, Cutaneous; Adult; Arm; Asian People; Back; Cross-Over Studies; Drug Administration Schedule; Humans; Male; Nicotine; Skin Absorption; Smoking; Smoking Cessation | 2005 |
Safety and immunogenicity of a nicotine conjugate vaccine in current smokers.
Topics: Adult; Antibodies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Haptens; Humans; Immunotherapy; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Survival Analysis; Tobacco Use Disorder; Vaccines | 2005 |
Safety profile of a nicotine lozenge compared with that of nicotine gum in adult smokers with underlying medical conditions: a 12-week, randomized, open-label study.
Topics: Algorithms; Central Nervous System Stimulants; Chewing Gum; Female; Gastrointestinal Diseases; Heart Diseases; Humans; Hypertension; Male; Middle Aged; Nervous System Diseases; Nicotine; Polymethacrylic Acids; Polyvinyls; Respiratory Tract Diseases; Smoking Cessation; Tablets; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States | 2005 |
Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study.
Topics: Administration, Oral; Adult; Breath Tests; Carbon Dioxide; Carbon Monoxide; Chewing Gum; Cotinine; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Smoking Cessation; Smoking Prevention; Thiocyanates; Time Factors; Treatment Outcome | 2005 |
Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.
Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Counseling; Cyclohexanols; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Nausea; Nicotine; Nicotinic Agonists; Patient Selection; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Dual pharmacotherapy and motivational interviewing for tobacco dependence among drug treatment patients.
Topics: Administration, Topical; Bupropion; Counseling; Dopamine Uptake Inhibitors; Follow-Up Studies; Humans; Interviews as Topic; Mental Health Services; Methadone; Motivation; Narcotics; Nicotine; Patient Compliance; Pilot Projects; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome | 2005 |
Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy.
Topics: Administration, Cutaneous; Administration, Inhalation; Adult; Analysis of Variance; Aryl Hydrocarbon Hydroxylases; Chi-Square Distribution; Cytochrome P-450 CYP2A6; Drug Administration Schedule; Follow-Up Studies; Humans; Middle Aged; Mixed Function Oxygenases; Nicotine; Reference Values; Smoking; Smoking Cessation; Statistics, Nonparametric; Tobacco Use Disorder; Treatment Outcome; White People | 2006 |
Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers.
Topics: Administration, Oral; Adult; Arousal; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fructose; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Neuropsychological Tests; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Topiramate | 2006 |
Smoking rates and topography predict adolescent smoking cessation following treatment with nicotine replacement therapy.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adolescent Behavior; Breath Tests; Chewing Gum; Cognitive Behavioral Therapy; Double-Blind Method; Female; Follow-Up Studies; Humans; Logistic Models; Male; Nicotine; Smoking; Smoking Cessation; Surveys and Questionnaires; Treatment Outcome | 2006 |
Sleep effects of a 24-h versus a 16-h nicotine patch: a polysomnographic study during smoking cessation.
Topics: Administration, Cutaneous; Administration, Topical; Adult; Cross-Over Studies; Drug Administration Schedule; Female; Ganglionic Stimulants; Humans; Male; Nicotine; Polysomnography; Sleep, REM; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Time Factors | 2006 |
Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial.
Topics: Administration, Cutaneous; Administration, Intranasal; Adult; Aged; Female; Genotype; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Polymorphism, Genetic; Serotonin Plasma Membrane Transport Proteins; Smoking; Smoking Cessation | 2006 |
Precessation treatment with nicotine skin patch facilitates smoking cessation.
Topics: Administration, Cutaneous; Adult; Carbon Dioxide; Combined Modality Therapy; Double-Blind Method; Female; Humans; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Saliva; Smoking Cessation; Smoking Prevention; Time Factors | 2006 |
[Randomized clinical trial: effectiveness of the cognitive-behavioral approach and the use of nicotine replacement transdermal patches for smoking cessation among adults in Rio de Janeiro, Brazil].
Topics: Administration, Cutaneous; Adult; Body Mass Index; Cognitive Behavioral Therapy; Counseling; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Socioeconomic Factors; Tobacco Use Disorder | 2006 |
[Health economic analysis of smoking cessation prior to surgery--based on a randomised trial].
Topics: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Cost-Benefit Analysis; Humans; Nicotine; Postoperative Complications; Preoperative Care; Reoperation; Risk Factors; Smoking Cessation; Surgical Wound Infection; Wound Healing | 2006 |
A smoking cessation intervention for the methadone-maintained.
Topics: Adult; Combined Modality Therapy; Female; Humans; Male; Methadone; Middle Aged; Nicotine; Opioid-Related Disorders; Psychotherapy, Brief; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2006 |
Looking for boomerang effects: a pre-post experimental study of the effects of exposure of youth to television advertising for nicotine replacement therapy and Zyban.
Topics: Adolescent; Advertising; Analysis of Variance; Attitude to Health; Bupropion; Dopamine Uptake Inhibitors; Female; Hotlines; Humans; Male; Motivation; Nicotine; Psychology, Adolescent; Risk Factors; Risk-Taking; Smoking; Smoking Cessation; Social Perception; Television | 2006 |
A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.
Topics: Administration, Cutaneous; Administration, Oral; Ambulatory Care; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Linear Models; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Treatment Outcome; Weight Gain | 2006 |
Spirometry and smoking cessation advice in general practice: a randomised clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Airway Obstruction; Belgium; Bupropion; Child; Counseling; Dopamine Uptake Inhibitors; Family Practice; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Practice Guidelines as Topic; Smoking Cessation; Spirometry | 2006 |
"Tobacco Free With FDNY": the New York City Fire Department World Trade Center Tobacco Cessation Study.
Topics: Bupropion; Directive Counseling; Dopamine Uptake Inhibitors; Fires; Follow-Up Studies; Humans; New York City; Nicotine; Nicotinic Agonists; Rescue Work; Smoking Cessation; Tobacco Use Disorder | 2006 |
High-dose nicotine patch therapy for smokers with a history of alcohol dependence: 36-week outcomes.
Topics: Administration, Cutaneous; Adult; Alcoholism; Cotinine; Data Interpretation, Statistical; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Odds Ratio; Predictive Value of Tests; Smoking; Smoking Cessation; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2006 |
A process evaluation of a telephone-based peer-delivered smoking cessation intervention for adult survivors of childhood cancer: the partnership for health study.
Topics: Adult; Counseling; Demography; Female; Humans; Least-Squares Analysis; Male; Neoplasms; Nicotine; Nicotinic Agonists; Outcome and Process Assessment, Health Care; Peer Group; Program Evaluation; Smoking Cessation; Smoking Prevention; Survivors; Telephone | 2006 |
Analyzing milestones in smoking cessation: illustration in a nicotine patch trial in adult smokers.
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation | 2006 |
The effects of nicotine gum and counseling among African American light smokers: a 2 x 2 factorial design.
Topics: Adult; Black or African American; Chewing Gum; Combined Modality Therapy; Counseling; Female; Health Education; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Smoking Prevention | 2006 |
Effects of exposure of youths at risk for smoking to television advertising for nicotine replacement therapy and Zyban: an experimental study.
Topics: Adolescent; Adolescent Behavior; Advertising; Bupropion; Child; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation; Television | 2006 |
Smoking cessation program and CYP2A6 polymorphism.
Topics: Administration, Cutaneous; Adult; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2A6; Female; Ganglionic Stimulants; Genotype; Humans; Male; Middle Aged; Mixed Function Oxygenases; Nicotine; Polymorphism, Genetic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2006 |
Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation.
Topics: Administration, Cutaneous; Administration, Inhalation; Cotinine; Female; Humans; Liver; Male; Middle Aged; Nicotine; Smoking Cessation; Treatment Outcome | 2006 |
Transdermal nicotine for smoking cessation in postmenopausal women.
Topics: Administration, Cutaneous; Bupropion; Chest Pain; Counseling; Double-Blind Method; Drug Eruptions; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Logistic Models; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Postmenopause; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Smoking Cessation; Treatment Outcome | 2007 |
Comparison of the effects of a 24-hour nicotine patch and a 16-hour nicotine patch on smoking urges and sleep.
Topics: Administration, Cutaneous; Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Polysomnography; Sleep; Smoking Cessation; Statistics, Nonparametric; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2006 |
The effects of smoking deprivation and nicotine administration on emotional reactivity.
Topics: Adult; Affect; Behavior, Addictive; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Reflex, Startle; Regression Analysis; Reinforcement, Psychology; Saliva; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2006 |
Attitudes and knowledge about nicotine and nicotine replacement therapy.
Topics: Adult; Analysis of Variance; Chewing Gum; Counseling; Female; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Nicotine; Reproducibility of Results; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires | 2006 |
Predictors of quitting among African American light smokers enrolled in a randomized, placebo-controlled trial.
Topics: Black People; Chewing Gum; Female; Humans; Male; Nicotine; Placebos; Predictive Value of Tests; Regression Analysis; Smoking Cessation; Social Support; Socioeconomic Factors; Stress, Psychological; Treatment Outcome; United States | 2006 |
Alcohol use and tobacco abstinence among adolescents in cessation treatment: preliminary findings.
Topics: Administration, Cutaneous; Adolescent; Alcohol Drinking; Chewing Gum; Female; Humans; Male; Nicotine; Regression Analysis; Smoking Cessation; Tobacco Use Disorder | 2007 |
The costs and effectiveness of different benefit designs for treating tobacco dependence: results from a randomized trial.
Topics: Adolescent; Adult; Behavior Therapy; Bupropion; Female; Humans; Insurance Coverage; Insurance, Health; Male; Middle Aged; Nicotine; Smoking Cessation; Socioeconomic Factors; Tobacco Use Disorder | 2006 |
Gender differences in affective response to acute nicotine administration and deprivation.
Topics: Administration, Inhalation; Adolescent; Adult; Affect; Analysis of Variance; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Psychiatric Status Rating Scales; Reflex, Startle; Saliva; Sex Factors; Smoking Cessation | 2007 |
Life before and after quitting smoking: an electronic diary study.
Topics: Administration, Cutaneous; Administration, Topical; Adolescent; Adult; Electronics; Female; Humans; Male; Medical Records; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Time Factors | 2006 |
Preferences among four combination nicotine treatments.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Adult; Chewing Gum; Cross-Over Studies; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Nicotinic Agonists; Patient Satisfaction; Research Design; Self Administration; Smoking Cessation; Tablets; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2006 |
Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support.
Topics: Administration, Sublingual; Behavior Control; Double-Blind Method; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quality of Life; Retrospective Studies; Smoking Cessation; Surveys and Questionnaires; Treatment Outcome | 2006 |
Efficacy of the nicotine inhaler in smoking reduction: A double-blind, randomized trial.
Topics: Administration, Inhalation; Adult; Carbon Monoxide; Double-Blind Method; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Quality of Life; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2006 |
Association of OPRM1 A118G variant with the relative reinforcing value of nicotine.
Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Polymorphism, Genetic; Receptors, Opioid, mu; Reinforcement, Psychology; Risk Factors; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2006 |
Randomized trial of an intervention to facilitate recycling for relapsed smokers.
Topics: Adult; Aged; Behavior Therapy; Bupropion; Female; Follow-Up Studies; Hospitals, Veterans; Humans; Male; Middle Aged; Nicotine; Outcome Assessment, Health Care; Patient Satisfaction; Retreatment; Secondary Prevention; Smoking Cessation; Tobacco Use Disorder; United States; Veterans | 2006 |
Use of nicotine replacement therapy in socioeconomically deprived young smokers: a community-based pilot randomised controlled trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Child; Counseling; Double-Blind Method; Female; Humans; Male; Nicotine; Pilot Projects; Poverty Areas; Smoking Cessation; United Kingdom | 2006 |
Modeling the effect of alcohol on smoking lapse behavior.
Topics: Adult; Alcohol Drinking; Behavior, Addictive; Central Nervous System Depressants; Ethanol; Female; Humans; Male; Middle Aged; Nicotine; Reinforcement, Psychology; Self Administration; Smoking; Smoking Cessation | 2006 |
Memantine fails to facilitate partial cigarette deprivation in smokers--no role of Memantine in the treatment of nicotine dependency?
Topics: Adult; Dopamine Agents; Double-Blind Method; Female; Humans; Male; Memantine; Nicotine; Nicotinic Agonists; Pilot Projects; Placebos; Reward; Smell; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Failure | 2007 |
Changes in cough reflex sensitivity after cessation and resumption of cigarette smoking.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Analgesics, Non-Narcotic; Breath Tests; Capsaicin; Carbon Monoxide; Clonidine; Cough; Female; Humans; Male; Middle Aged; Nicotine; Recurrence; Reflex; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors | 2007 |
A double-blind placebo controlled experimental study of nicotine: I--effects on incentive motivation.
Topics: Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Reward; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2006 |
Nicotine self-administration: cigarette versus nicotine gum diurnal topography.
Topics: Adolescent; Adult; Aged; Chewing Gum; Circadian Rhythm; Female; Humans; Individuality; Male; Middle Aged; Nicotine; Nicotinic Agonists; Self Administration; Sex Characteristics; Smoking; Smoking Cessation; Tobacco Use Disorder | 2006 |
A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder.
Topics: Adult; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Counseling; Female; Humans; Interviews as Topic; Male; Motivation; Nicotine; Psychotic Disorders; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2006 |
The effects of exercise and nicotine replacement therapy on smoking rates in women.
Topics: Administration, Cutaneous; Adolescent; Adult; Cognitive Behavioral Therapy; Exercise; Female; Humans; Incidence; Middle Aged; Nicotine; Prevalence; Smoking Cessation; Smoking Prevention | 2007 |
Multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy smokers.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Benzazepines; Cotinine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Half-Life; Headache; Humans; Hypotension, Orthostatic; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Nicotine; Patient Dropouts; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Smoking Prevention; Tablets; Varenicline; Vomiting | 2006 |
A nicotine mouth spray for smoking cessation: a pilot study of preference, safety and efficacy.
Topics: Administration, Inhalation; Administration, Topical; Adult; Female; Follow-Up Studies; Humans; Male; Mouth; Nicotine; Nicotinic Agonists; Pilot Projects; Smoking Cessation; Treatment Outcome | 2007 |
Adrenergic blocker carvedilol attenuates the cardiovascular and aversive effects of nicotine in abstinent smokers.
Topics: Adrenergic Antagonists; Adult; Blood Pressure; Carbazoles; Carvedilol; Cross-Over Studies; Double-Blind Method; Female; Ganglionic Stimulants; Heart Rate; Humans; Male; Nicotine; Propanolamines; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
A preliminary investigation of rapid smoking as a lapse-responsive treatment for tobacco dependence.
Topics: Adult; Attitude; Combined Modality Therapy; Counseling; Data Interpretation, Statistical; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Recurrence; Reinforcement, Psychology; Smoking; Smoking Cessation; Treatment Failure; Treatment Outcome | 2006 |
An uncontrolled trial of cytisine (Tabex) for smoking cessation.
Topics: Adult; Alkaloids; Azocines; Female; Humans; Male; Nicotine; Poland; Quinolizines; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2006 |
The effect of a minimal intervention strategy in addition to nicotine replacement therapy to support smoking cessation in cardiovascular outpatients: a randomized clinical trial.
Topics: Administration, Cutaneous; Cardiovascular Diseases; Female; Humans; Logistic Models; Male; Middle Aged; Nicotine; Smoking Cessation; Treatment Outcome | 2006 |
Evaluating nicotine replacement therapy and stage-based therapies in a population-based effectiveness trial.
Topics: Adult; Aged; Behavior Therapy; Combined Modality Therapy; Counseling; Expert Systems; Feedback, Psychological; Female; Humans; Male; Manuals as Topic; Middle Aged; Nicotine; Programmed Instructions as Topic; Recurrence; Retreatment; Smoking Cessation; Substance Withdrawal Syndrome; Telecommunications; Tobacco Use Disorder; Treatment Outcome; Veterans | 2006 |
Does reducing withdrawal severity mediate nicotine patch efficacy? A randomized clinical trial.
Topics: Adaptation, Psychological; Administration, Cutaneous; Adult; Affect; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Nicotine; Proportional Hazards Models; Recurrence; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2006 |
The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms.
Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Double-Blind Method; Female; Gene Frequency; Genotype; Homozygote; Humans; Linkage Disequilibrium; Male; Middle Aged; Nicotine; Nicotinic Agonists; Phenotype; Polymorphism, Genetic; Receptors, Dopamine D2; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Venlafaxine Hydrochloride | 2007 |
Galantamine reduces smoking in alcohol-dependent patients: a randomized, placebo-controlled trial.
Topics: Administration, Cutaneous; Adult; Alcoholism; Cholinesterase Inhibitors; Cotinine; Double-Blind Method; Female; Galantamine; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Sex Factors; Skin Diseases; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2006 |
Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days.
Topics: Adolescent; Adult; Affect; Aged; Female; Humans; Male; Middle Aged; Nicotine; Personal Satisfaction; Sleep; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2007 |
Association of the mu-opioid receptor gene with smoking cessation.
Topics: Administration, Cutaneous; Adult; Aged; Body Mass Index; Double-Blind Method; Female; Follow-Up Studies; Gene Frequency; Genotype; Humans; Logistic Models; Male; Middle Aged; Nicotine; Nicotinic Agonists; Odds Ratio; Receptors, Opioid, mu; Sex Factors; Smoking; Smoking Cessation; Time Factors; Treatment Outcome | 2007 |
The effect of a multi-component smoking cessation intervention in African American women residing in public housing.
Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Aged, 80 and over; Behavior Therapy; Black or African American; Community Health Nursing; Community Participation; Female; Georgia; Humans; Logistic Models; Middle Aged; Nicotine; Poverty; Self Efficacy; Smoking Cessation; Social Support; Spirituality | 2007 |
Dopamine transporter polymorphisms are associated with short-term response to smoking cessation treatment.
Topics: 3' Untranslated Regions; Adult; Bupropion; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Genotype; Humans; Male; Middle Aged; Minisatellite Repeats; Nicotine; Nicotinic Agonists; Polymorphism, Genetic; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2007 |
Characteristics of smokers with a psychotic disorder and implications for smoking interventions.
Topics: Adolescent; Adult; Age Factors; Alcoholism; Cognitive Behavioral Therapy; Comorbidity; Female; Humans; Longitudinal Studies; Male; Middle Aged; Motivation; New South Wales; Nicotine; Outcome and Process Assessment, Health Care; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Smoking; Smoking Cessation; Statistics as Topic; Tobacco Use Disorder; Victoria | 2007 |
Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.
Topics: Administration, Inhalation; Adult; Bupropion; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Nicotinic Agonists; Secondary Prevention; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2007 |
Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia.
Topics: Acute Disease; Adult; Cotinine; Demography; Depression; Female; Humans; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Prevalence; Psychotic Disorders; Receptors, Nicotinic; Recurrence; Schizophrenia; Severity of Illness Index; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
Daily smoking patterns, their determinants, and implications for quitting.
Topics: Administration, Cutaneous; Adolescent; Adult; Circadian Rhythm; Cluster Analysis; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Patient Dropouts; Self Disclosure; Self-Assessment; Smoking; Smoking Cessation; Tobacco Use Disorder | 2007 |
Subjective reactivity to the first cigarette of the day as a predictor of smoking relapse: a preliminary study.
Topics: Adolescent; Adult; Affect; Aged; Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Circadian Rhythm; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Outcome Assessment, Health Care; Prognosis; Secondary Prevention; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
Effects of topiramate on cue-induced cigarette craving and the response to a smoked cigarette in briefly abstinent smokers.
Topics: Adult; Behavior, Addictive; Blood Pressure; Cues; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fructose; Ganglionic Stimulants; Heart Rate; Humans; Male; Middle Aged; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Topiramate | 2007 |
Acupressure for smoking cessation--a pilot study.
Topics: Acupressure; Adult; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Patient Satisfaction; Pilot Projects; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 2007 |
Expressive writing as a smoking cessation treatment adjunct for young adult smokers.
Topics: Adult; Humans; Nicotine; Smoking; Smoking Cessation; Writing | 2007 |
The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial.
Topics: Adult; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotine; Polymorphism, Genetic; Serotonin Plasma Membrane Transport Proteins; Smoking; Smoking Cessation; Treatment Outcome | 2007 |
Brain indices of nicotine's effects on attentional bias to smoking and emotional pictures and to task-relevant targets.
Topics: Adult; Affect; Brain; Cues; Double-Blind Method; Electroencephalography; Female; Ganglionic Stimulants; Humans; Male; Nicotine; Reaction Time; Reinforcement, Psychology; Smoking; Smoking Cessation; Visual Perception | 2007 |
Smoking cessation patterns in methadone-maintained smokers.
Topics: Administration, Cutaneous; Adult; Combined Modality Therapy; Confidence Intervals; Female; Humans; Male; Methadone; Middle Aged; Multivariate Analysis; Nicotine; Nicotinic Agonists; Odds Ratio; Psychotherapy, Brief; Rhode Island; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2007 |
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch.
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Exons; Female; Follow-Up Studies; Gene Frequency; Genetic Predisposition to Disease; Humans; Logistic Models; Male; Middle Aged; Minisatellite Repeats; Nicotine; Nicotinic Agonists; Odds Ratio; Polymorphism, Genetic; Receptors, Dopamine D4; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Time Factors; Treatment Failure; Treatment Outcome; White People | 2008 |
Nicotine pharmacokinetics and subjective effects of three potential reduced exposure products, moist snuff and nicotine lozenge.
Topics: Adolescent; Adult; Aged; Cross-Over Studies; Harm Reduction; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Tablets; Tobacco, Smokeless | 2007 |
Postintervention effect of nicotine replacement therapy for smoking reduction: a randomized trial with a 5-year follow-up.
Topics: Administration, Cutaneous; Adult; Chewing Gum; Female; Follow-Up Studies; Ganglionic Stimulants; Humans; Male; Nebulizers and Vaporizers; Nicotine; Sex Factors; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Switzerland; Time Factors; Treatment Outcome; Weight Gain | 2007 |
Relationship of depression to smoking outcomes in a methadone-maintained population.
Topics: Administration, Cutaneous; Adolescent; Adult; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Mass Screening; Methadone; Motivation; Narcotics; Nicotine; Nicotinic Agonists; Opioid-Related Disorders; Prevalence; Severity of Illness Index; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Treatment Outcome | 2007 |
Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray.
Topics: Administration, Inhalation; Adult; Aerosols; Affect; Blood Pressure; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Male; Memory, Short-Term; Nicotine; Nicotinic Agonists; Psychomotor Performance; Sex Characteristics; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2008 |
Effects of internet-based voucher reinforcement and a transdermal nicotine patch on cigarette smoking.
Topics: Administration, Cutaneous; Adult; Behavior Therapy; Breath Tests; Carbon Monoxide; Computer Peripherals; Female; Humans; Internet; Male; Middle Aged; Monitoring, Ambulatory; Nicotine; Reinforcement, Psychology; Smoking Cessation; Therapy, Computer-Assisted; Tobacco Use Disorder; Token Economy; Video Recording | 2007 |
Weekly versus basic smoking cessation support in primary care: a randomised controlled trial.
Topics: Administration, Cutaneous; Adult; Aged; Behavior Therapy; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2007 |
Moderators and mediators of a web-based computer-tailored smoking cessation program among nicotine patch users.
Topics: Administration, Cutaneous; Adult; Behavior Therapy; Female; Humans; Internet; Ireland; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Patient Dropouts; Program Development; Self Care; Smoking Cessation; Surveys and Questionnaires; Therapy, Computer-Assisted; Tobacco Use Disorder; Treatment Outcome; United Kingdom | 2006 |
Use of more nicotine lozenges leads to better success in quitting smoking.
Topics: Adult; Chewing Gum; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Placebos; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome | 2007 |
A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine/mecamylamine in cigarette smokers.
Topics: Administration, Cutaneous; Adult; Aged; Double-Blind Method; Drug Administration Routes; Drug Hypersensitivity; Female; Humans; Male; Mecamylamine; Middle Aged; Nicotine; Nicotinic Antagonists; Safety; Smoking Cessation; Treatment Outcome | 2007 |
Effects of smoking successive low- and high-nicotine cigarettes on hypothalamic-pituitary-adrenal axis hormones and mood in men.
Topics: Adrenocorticotropic Hormone; Adult; Affect; Blood Pressure; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Heart Rate; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Nicotine; Nicotinic Agonists; Pain Measurement; Pituitary-Adrenal System; Smoking Cessation; Tobacco Use Disorder | 2008 |
A randomized trial of smoking cessation. Medication versus motivation.
Topics: Adult; Bupropion; Female; Humans; Male; Motivation; Nicotine; Prospective Studies; Smoking Cessation | 2007 |
Self-administration of intravenous nicotine in male and female cigarette smokers.
Topics: Adult; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Injections, Intraventricular; Male; Middle Aged; Nicotine; Nicotinic Agonists; Self Administration; Severity of Illness Index; Smoking Cessation; Tobacco Use Disorder | 2008 |
Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial.
Topics: Administration, Cutaneous; Adult; Catechol O-Methyltransferase; Double-Blind Method; Female; Genotype; Humans; Male; Nicotine; Nicotinic Agonists; Polymerase Chain Reaction; Polymorphism, Genetic; Sex Factors; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2007 |
Validation of a scale for the assessment of food cravings among smokers.
Topics: Administration, Cutaneous; Appetite; Dietary Fats; Dietary Sucrose; Female; Food Preferences; Humans; Male; Naltrexone; Nicotine; Placebos; Reproducibility of Results; Smoking; Smoking Cessation; Surveys and Questionnaires; Taste; Weight Gain | 2008 |
A randomized trial of targeted educational materials for smoking cessation in African Americans using transdermal nicotine.
Topics: Administration, Cutaneous; Adult; Black or African American; Chi-Square Distribution; Cultural Competency; Female; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Nicotine; Outcome and Process Assessment, Health Care; Reminder Systems; Single-Blind Method; Smoking Cessation; Southeastern United States; Teaching Materials; Urban Health; Video Recording | 2007 |
Effects of instructions on responses to the nicotine patch: a laboratory study.
Topics: Administration, Cutaneous; Adolescent; Adult; Affect; Algorithms; Analysis of Variance; Dose-Response Relationship, Drug; Female; Health Promotion; Humans; Male; Nicotine; Nicotinic Agonists; Patient Education as Topic; Proportional Hazards Models; Recurrence; Sex Factors; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2007 |
A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Carbon Monoxide; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Psychiatric Status Rating Scales; Sample Size; Schizophrenia; Schizophrenic Psychology; Smoking Cessation | 2007 |
Smoking-related videos for use in cue-induced craving paradigms.
Topics: Adult; Behavior, Addictive; Cues; Female; Humans; Male; Nicotine; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Video Recording | 2007 |
Modafinil and nicotine interactions in abstinent smokers.
Topics: Adult; Benzhydryl Compounds; Blood Pressure; Central Nervous System Stimulants; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Heart Rate; Humans; Male; Modafinil; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Pain Measurement; Severity of Illness Index; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2008 |
Nicotine replacement and behavioral therapy for smoking cessation in pregnancy.
Topics: Adult; Behavior Therapy; Female; Humans; Nicotine; Nicotinic Agonists; North Carolina; Pregnancy; Smoking Cessation; Tobacco Use Disorder | 2007 |
Bupropion and nicotine patch as smoking cessation aids in alcoholics.
Topics: Administration, Cutaneous; Adult; Alcoholism; Bupropion; Community Health Services; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Nebraska; Neurotransmitter Uptake Inhibitors; Nicotine; Nicotinic Agonists; Patient Compliance; Research Design; Smoking Cessation; Smoking Prevention; Substance Abuse Treatment Centers; Time Factors; Tobacco Use Disorder; Treatment Outcome; Veterans | 2007 |
Smoking cessation treatment in community-based substance abuse rehabilitation programs.
Topics: Adult; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Smoking Cessation; Substance-Related Disorders; Treatment Outcome | 2008 |
Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings?
Topics: Administration, Cutaneous; Adult; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2007 |
Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial.
Topics: Adult; Female; Genetic Variation; Genotype; Humans; Male; Middle Aged; Multivariate Analysis; Nicotine; Nicotinic Agonists; Receptors, Opioid, mu; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2007 |
Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study.
Topics: Adult; Affect; Arousal; Attention; Attention Deficit Disorder with Hyperactivity; Comorbidity; Cross-Sectional Studies; Cues; Female; Humans; Inhibition, Psychological; Male; Motivation; Neuropsychological Tests; Nicotine; Pattern Recognition, Visual; Psychomotor Performance; Reaction Time; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2008 |
The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline.
Topics: Adult; Combined Modality Therapy; Cost-Benefit Analysis; Counseling; Delivery of Health Care; Female; Health Care Costs; Hotlines; Humans; Male; Middle Aged; Nicotine; Oregon; Patient Selection; Single-Blind Method; Smoking Cessation; Smoking Prevention; Telephone; Tobacco Use Disorder | 2007 |
Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine.
Topics: Adult; Biomarkers; Carbon Monoxide; Central Nervous System Stimulants; Cotinine; Cross-Over Studies; Female; Harm Reduction; Humans; Male; Middle Aged; Nicotine; Nitrosamines; Pilot Projects; Polymethacrylic Acids; Polyvinyls; Research Design; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco, Smokeless | 2007 |
A test of motivational plus nicotine replacement interventions for HIV positive smokers.
Topics: Administration, Cutaneous; Adult; Follow-Up Studies; HIV Infections; Humans; Intention; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Patient Compliance; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2009 |
A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia.
Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Bupropion; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors | 2008 |
Sociodemographic and smoking behavioral predictors associated with smoking cessation according to follow-up periods: a randomized, double-blind, placebo-controlled trial of transdermal nicotine patches.
Topics: Administration, Cutaneous; Adult; Age Factors; Double-Blind Method; Follow-Up Studies; Humans; Logistic Models; Male; Nicotine; Smoking; Smoking Cessation | 2007 |
Preferences among five nicotine treatments based on information versus sampling.
Topics: Adult; Aged; Chewing Gum; Cross-Over Studies; Drug Administration Routes; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Patient Education as Topic; Patient Satisfaction; Research Design; Self Administration; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2008 |
The immunogenicity and safety of a nicotine vaccine in smokers and nonsmokers: results of a randomized, placebo-controlled phase 1/2 trial.
Topics: Adult; Antibodies; Antibody Formation; Double-Blind Method; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Vaccination; Vaccines, Synthetic | 2008 |
[Profile of smokers not searching for smoking cessation intervention in Rio de Janeiro, Brazil].
Topics: Administration, Cutaneous; Adolescent; Adult; Behavior Therapy; Brazil; Female; Health Promotion; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Patient Selection; Smoking; Smoking Cessation | 2008 |
Smoking cessation medication use among pregnant and postpartum smokers.
Topics: Adult; Bupropion; Counseling; Educational Status; Female; Health Care Costs; Humans; Marital Status; Nicotine; Obstetrics; Parity; Patient Education as Topic; Postpartum Period; Practice Patterns, Physicians'; Pregnancy; Prenatal Care; Smoking; Smoking Cessation | 2008 |
Cigarette reduction: an intervention for adolescent smokers.
Topics: Administration, Cutaneous; Adolescent; Chewing Gum; Female; Follow-Up Studies; Humans; Male; Nicotine; Smoking Cessation; Treatment Outcome | 2008 |
Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Benzazepines; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Quinoxalines; Reinforcement, Psychology; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline | 2008 |
Happy ending: a randomized controlled trial of a digital multi-media smoking cessation intervention.
Topics: Adult; Cell Phone; Combined Modality Therapy; Female; Humans; Internet; Male; Middle Aged; Multimedia; Nicotine; Patient Compliance; Self Efficacy; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2008 |
Nicotine withdrawal in smokers with current depressive disorders undergoing intensive smoking cessation treatment.
Topics: Adult; Counseling; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2008 |
Menstrual phase effects on smoking cessation: a pilot feasibility study.
Topics: Adult; Counseling; Feasibility Studies; Female; Follicular Phase; Humans; Luteal Phase; Menstrual Cycle; Nicotine; Pilot Projects; Smoking; Smoking Cessation; Treatment Outcome; Women's Health | 2008 |
Older versus younger treatment-seeking smokers: differences in smoking behavior, drug and alcohol use, and psychosocial and physical functioning.
Topics: Adult; Age Distribution; Alcohol Drinking; Antidepressive Agents; Behavior Therapy; Female; Health Behavior; Humans; Male; Middle Aged; Nicotine; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Social Environment; Socioeconomic Factors; Tobacco Use Disorder | 2008 |
Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Nicotine; Smoking Cessation; Treatment Outcome | 2008 |
Development of procedures for early screening of smoking cessation medications in humans.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Female; Humans; Male; Mass Screening; Motivation; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 2008 |
Exercise as an adjunct to nicotine gum in treating tobacco dependence among women.
Topics: Adult; Chewing Gum; Combined Modality Therapy; Exercise; Female; Humans; Logistic Models; Middle Aged; Nicotine; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Women's Health | 2008 |
Comparison of craving and withdrawal among four combination nicotine treatments.
Topics: Adult; Cross-Over Studies; Female; Humans; Male; Nicotine; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2008 |
Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Behavior Therapy; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Nortriptyline; Quality of Life; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome | 2008 |
Smokers' response to combination bupropion, nicotine patch, and counseling treatment by race/ethnicity.
Topics: Adult; Antidepressive Agents, Second-Generation; Black or African American; Bupropion; Counseling; Female; Hispanic or Latino; Humans; Male; Middle Aged; Nicotine; Polypharmacy; Smoking Cessation; Tobacco Use Disorder; White People | 2008 |
Effectiveness of topiramate for tobacco dependence in patients with depression; a randomised, controlled trial.
Topics: Adolescent; Adult; Aged; Depressive Disorder, Major; Female; Follow-Up Studies; Fructose; Humans; Male; Middle Aged; Neuroprotective Agents; Nicotine; Psychotherapy; Smoking Cessation; Tobacco Use Disorder; Topiramate | 2008 |
Varying nicotine patch dose and type of smoking cessation counseling.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Carbon Monoxide; Combined Modality Therapy; Cotinine; Counseling; Double-Blind Method; Female; Humans; Logistic Models; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1995 |
High-dose nicotine patch therapy. Percentage of replacement and smoking cessation.
Topics: Administration, Cutaneous; Adult; Cotinine; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1995 |
Environmental determinants of the reinforcing effects of nicotine in humans.
Topics: Adult; Arousal; Chewing Gum; Cross-Sectional Studies; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Motivation; Nicotine; Placebo Effect; Reinforcement Schedule; Reinforcement, Social; Self Administration; Set, Psychology; Smoking; Smoking Cessation; Smoking Prevention; Social Environment; Substance Withdrawal Syndrome | 1989 |
Effect of nicotine vapour inhalation on the relief of tobacco withdrawal symptoms.
Topics: Administration, Inhalation; Adult; Female; Humans; Male; Middle Aged; Nicotiana; Nicotine; Plants, Toxic; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors | 1995 |
The effects of smoking schedules on cessation outcome: can we improve on common methods of gradual and abrupt nicotine withdrawal?
Topics: Adult; Female; Humans; Male; Middle Aged; Nicotine; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome | 1995 |
Nicotine gum and self-help behavioral treatment for smoking relapse prevention: results from a trial using population-based recruitment.
Topics: Adult; Behavior Therapy; Chewing Gum; Female; Follow-Up Studies; Humans; Internal-External Control; Male; Middle Aged; Motivation; Nicotine; Recurrence; Self Care; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 1995 |
Enhanced lexical processing of smoking stimuli during smoking abstinence.
Topics: Adult; Humans; Middle Aged; Nicotine; Perception; Semantics; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 1995 |
Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program.
Topics: Adult; Behavior Therapy; Chewing Gum; Combined Modality Therapy; Cotinine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Nicotine; Saliva; Smoking Cessation; Substance-Related Disorders; Time Factors; Treatment Outcome | 1995 |
Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers.
Topics: Administration, Cutaneous; Adult; Counseling; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotine; Patient Compliance; Recurrence; Smoking Cessation; Treatment Outcome; Weight Gain | 1995 |
Behavioral anti-smoking trial in chronic obstructive pulmonary disease patients.
Topics: Behavior Therapy; Breath Tests; Carbon Monoxide; Chewing Gum; Follow-Up Studies; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Nicotine; Polymethacrylic Acids; Polyvinyls; Reinforcement, Psychology; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Cessation Devices; Treatment Outcome | 1995 |
Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Cutaneous; Adult; Aged; beta-Thromboglobulin; Blood Coagulation; Cell Adhesion Molecules; Coronary Disease; Eicosanoids; Factor VII; Fibrinogen; Humans; Leukocyte Count; Male; Middle Aged; Nicotine; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Factor 4; Platelet Membrane Glycoproteins; Risk Factors; Smoking; Smoking Cessation; Thromboxane A2; Thromboxane B2 | 1993 |
Smoking without nicotine delivery decreases withdrawal in 12-hour abstinent smokers.
Topics: Adult; Blood Pressure; Humans; Male; Nicotine; Pulse; Pupil; Skin Temperature; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1995 |
Immune function in cigarette smokers who quit smoking for 31 days.
Topics: Adult; Alcohol Drinking; Concanavalin A; Cotinine; Cytotoxicity, Immunologic; Humans; Hydrocortisone; Immunity; Killer Cells, Natural; Lymphocytes; Male; Nicotine; Patient Compliance; Phytohemagglutinins; Smoking; Smoking Cessation | 1995 |
Cessation of long-term nicotine gum use--a prospective, randomized trial.
Topics: Adult; Chewing Gum; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Long-Term Care; Male; Middle Aged; Motivation; Nicotine; Risk Factors; Smoking Cessation; Substance-Related Disorders | 1995 |
Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial.
Topics: Administration, Cutaneous; Adult; Aged; Chewing Gum; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Smoking Cessation | 1995 |
Airway sensory replacement combined with nicotine replacement for smoking cessation. A randomized, placebo-controlled trial using a citric acid inhaler.
Topics: Administration, Cutaneous; Administration, Inhalation; Adult; Citrates; Citric Acid; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Humans; Logistic Models; Middle Aged; Nebulizers and Vaporizers; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1995 |
Nicotine abstinence produces content-specific Stroop interference.
Topics: Adult; Breath Tests; Carbon Monoxide; Color Perception Tests; Humans; Male; Mental Processes; Nicotine; Saliva; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
[Causes of relapse during attempted smoking cessation using nicotine or placebo plasters].
Topics: Administration, Cutaneous; Adult; Female; Humans; Male; Middle Aged; Nicotine; Placebos; Prognosis; Recurrence; Smoking Cessation; Surveys and Questionnaires | 1994 |
Relationship of smoking cessation and nicotine gum use to salivary androstenedione and testosterone in middle-aged men.
Topics: Adult; Chewing Gum; Cross-Sectional Studies; Humans; Male; Middle Aged; Nicotine; Saliva; Smoking; Smoking Cessation; Testosterone | 1995 |
Trial of transdermal nicotine patch in smoking cessation.
Topics: Administration, Cutaneous; Adult; Humans; Middle Aged; Nicotine; Smoking Cessation | 1994 |
The safety, tolerability and efficacy of transdermal nicotine (Nicotinell TTS) in initially hospitalised patients.
Topics: Administration, Cutaneous; Adult; Aged; Female; Hospitalization; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Smoking Cessation; Tobacco Use Disorder | 1995 |
Plasma nicotine, plasma beta-endorphin and mood states during periods of chronic smoking, abstinence and nicotine replacement.
Topics: Adult; Affect; beta-Endorphin; Chronic Disease; Humans; Male; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires | 1994 |
Tobacco and drug use.
Topics: Chewing Gum; Humans; Marketing of Health Services; Nicotine; North Carolina; Smoking Cessation | 1994 |
Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms.
Topics: Administration, Cutaneous; Chewing Gum; Combined Modality Therapy; Cotinine; Double-Blind Method; Humans; Nicotine; Saliva; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
Improvements in performance without nicotine withdrawal.
Topics: Adolescent; Adult; Female; Humans; Male; Nicotine; Psychomotor Performance; Reaction Time; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1994 |
Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice.
Topics: Administration, Cutaneous; Adult; Affect; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Family Practice; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Treatment Outcome | 1995 |
Smoking at home: the impact of smoking cessation on nonsmokers' exposure to environmental tobacco smoke.
Topics: Case-Control Studies; Chi-Square Distribution; Environmental Monitoring; Family Health; Female; Humans; Male; Middle Aged; Nicotine; Occupational Exposure; Smoking Cessation; Surveys and Questionnaires; Tobacco Smoke Pollution | 1994 |
Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Intranasal; Chewing Gum; Humans; Nicotine; Smoking Cessation | 1994 |
Weight gain as a function of smoking cessation and 2-mg nicotine gum use among middle-aged smokers with mild lung impairment in the first 2 years of the Lung Health Study.
Topics: Adult; Cholinergic Agonists; Female; Follow-Up Studies; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Nicotine; Polymethacrylic Acids; Polyvinyls; Regression Analysis; Risk Factors; Sex Factors; Smoking Cessation; Tobacco Use Cessation Devices; Weight Gain | 1994 |
Effect of nicotine nasal spray on smoking cessation. A randomized, placebo-controlled, double-blind study.
Topics: Adult; Aerosols; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Placebos; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1994 |
Randomised trial of nicotine patches in general practice: results at one year. Imperial Cancer Research Fund General Practice Research Group.
Topics: Administration, Cutaneous; Family Practice; Humans; Nicotine; Recurrence; Smoking Cessation; Treatment Outcome | 1994 |
Comparison of fixed-dose transdermal nicotine, tapered-dose transdermal nicotine, and buspirone in smoking cessation.
Topics: Administration, Cutaneous; Adult; Behavior Therapy; Buspirone; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation | 1994 |
The transdermal nicotine patch: results of a randomised placebo-controlled trial.
Topics: Administration, Cutaneous; Adult; Age Factors; Attitude to Health; Behavior Therapy; Carbon Monoxide; Delayed-Action Preparations; Dermatitis, Irritant; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotine; Patient Compliance; Placebos; Sleep Wake Disorders; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome | 1994 |
Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone.
Topics: Administration, Cutaneous; Adult; Affect; Blood Pressure; Breath Tests; Carbon Monoxide; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Mecamylamine; Nicotine; Patient Compliance; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1994 |
Inhalation of vapor from black pepper extract reduces smoking withdrawal symptoms.
Topics: Administration, Inhalation; Adult; Conditioning, Classical; Humans; Male; Menthol; Middle Aged; Nicotine; Oils; Plant Extracts; Smoking Cessation; Spices; Substance Withdrawal Syndrome; Taste | 1994 |
Cholesterol changes in smoking cessation using the transdermal nicotine system. Transdermal Nicotine Study Group.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Triglycerides; Weight Gain | 1994 |
The physician-delivered smoking intervention project: can short-term interventions produce long-term effects for a general outpatient population?
Topics: Adolescent; Adult; Aged; Ambulatory Care; Chewing Gum; Cohort Studies; Counseling; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Patient Education as Topic; Physician-Patient Relations; Primary Health Care; Smoking Cessation; Treatment Outcome | 1994 |
[Clonidine in the treatment of tobacco withdrawal. A comparison with nicotine chewing gum].
Topics: Adult; Chewing Gum; Clonidine; Female; Humans; Male; Nicotine; Prospective Studies; Smoking Cessation; Spain; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1994 |
[The nicotine patch. Short-term results in a group of hospital workers].
Topics: Administration, Cutaneous; Adult; Aged; Female; Humans; Male; Middle Aged; Nicotine; Personnel, Hospital; Smoking Cessation; Spain; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 1994 |
Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital. A placebo-controlled trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Affective Disorders, Psychotic; Aged; Blood Pressure; Body Weight; Combined Modality Therapy; Dosage Forms; England; Female; Follow-Up Studies; Heart Rate; Hospitals, General; Humans; Male; Middle Aged; Nicotine; Outpatient Clinics, Hospital; Smoking Cessation; Social Support; Substance Withdrawal Syndrome; Treatment Outcome | 1993 |
Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking.
Topics: Administration, Cutaneous; Adult; Arousal; Breath Tests; Carbon Monoxide; Double-Blind Method; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1994 |
Effects of a restricted work-site smoking policy on employees who smoke.
Topics: Adult; Analysis of Variance; Behavior; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Occupational Health; Organizational Policy; Saliva; Smoking; Smoking Cessation; Smoking Prevention; Workplace | 1994 |
Nicotine replacement therapy for patients with coronary artery disease. Working Group for the Study of Transdermal Nicotine in Patients with Coronary artery disease.
Topics: Administration, Cutaneous; Analysis of Variance; Coronary Disease; Double-Blind Method; Electrocardiography, Ambulatory; Female; Humans; Logistic Models; Male; Middle Aged; Nicotine; Pilot Projects; Smoking; Smoking Cessation; Treatment Outcome | 1994 |
The nicotine patch in smoking cessation. A randomized trial with telephone counseling.
Topics: Administration, Cutaneous; Adult; Counseling; Delayed-Action Preparations; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotine; Patient Compliance; Self-Help Groups; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Telephone | 1993 |
Clinical trials using ascorbic acid aerosol to aid smoking cessation.
Topics: Adult; Aerosols; Ascorbic Acid; Equipment Design; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
Transdermal nicotine in smoking cessation and involvement of non-specific influences.
Topics: Administration, Cutaneous; Adult; Carboxyhemoglobin; Female; Humans; Male; Middle Aged; Nicotine; Single-Blind Method; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers.
Topics: Adolescent; Adult; Aged; Clonidine; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Placebos; Risk Factors; Sex Factors; Smoking; Smoking Cessation; Substance-Related Disorders | 1993 |
Predicting smoking cessation. Who will quit with and without the nicotine patch.
Topics: Administration, Cutaneous; Adult; Aged; Breath Tests; Carbon Monoxide; Confidence Intervals; Cotinine; Counseling; Double-Blind Method; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Nicotine; Odds Ratio; Smoking; Smoking Cessation; Treatment Outcome | 1994 |
Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.
Topics: Administration, Cutaneous; Adult; Aged; Breath Tests; Carbon Monoxide; Cotinine; Counseling; Double-Blind Method; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nicotine; Nurses; Physician's Role; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1994 |
Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments.
Topics: Administration, Cutaneous; Adult; Aged; Body Weight; Carbon Monoxide; Combined Modality Therapy; Cotinine; Counseling; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Placebos; Psychotherapy, Group; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome | 1994 |
Coffee and alcohol intake as predictors of smoking cessation and tobacco withdrawal.
Topics: Adult; Alcohol Drinking; Chewing Gum; Coffee; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neurologic Examination; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
Clinical evaluation of a citric acid inhaler for smoking cessation.
Topics: Adult; Aerosols; Affect; Behavior Therapy; Breath Tests; Carbon Monoxide; Citrates; Citric Acid; Double-Blind Method; Equipment Design; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
Lack of effect of cimetidine on cigarette smoking.
Topics: Carbon Monoxide; Cimetidine; Cotinine; Double-Blind Method; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation | 1993 |
A double-blind trial of a nicotine inhaler for smoking cessation.
Topics: Adult; Carbon Monoxide; Double-Blind Method; Female; Humans; Male; Nebulizers and Vaporizers; Nicotine; Smoking Cessation; Treatment Outcome | 1993 |
Single- and multiple-dose pharmacokinetics of Nicoderm (Nicotine Transdermal System).
Topics: Administration, Cutaneous; Adult; Blood Pressure; Cotinine; Heart Rate; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation | 1993 |
Effects of 5-hydroxytryptamine3 antagonist, ondansetron, on cigarette smoking, smoke exposure, and mood in humans.
Topics: Adult; Affect; Double-Blind Method; Female; Humans; Male; Nicotine; Ondansetron; Prospective Studies; Smoking; Smoking Cessation; Tobacco Smoke Pollution | 1993 |
Predictors and reasons for relapse in smoking cessation with nicotine and placebo patches.
Topics: Administration, Cutaneous; Adult; Aged; Chi-Square Distribution; Cotinine; Female; Follow-Up Studies; Forecasting; Humans; Male; Middle Aged; Motivation; Nicotine; Outcome and Process Assessment, Health Care; Patient Compliance; Placebos; Prospective Studies; Regression Analysis; Saliva; Self-Assessment; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Surveys and Questionnaires; Time Factors; Weight Gain | 1993 |
Recycling with nicotine patches in smoking cessation.
Topics: Administration, Cutaneous; Adult; Aged; Cotinine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Recurrence; Saliva; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
CEASE (Collaborative European Anti-Smoking Evaluation). A challenging multicenter trial organized by the European Respiratory Society.
Topics: Administration, Cutaneous; Data Collection; Double-Blind Method; Europe; Humans; Nicotine; Smoking Cessation; Time Factors | 1993 |
Effectiveness of a nicotine patch in helping people stop smoking: results of a randomised trial in general practice. Imperial Cancer Research Fund General Practice Research Group.
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Family Practice; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Skin Diseases; Sleep Wake Disorders; Smoking Cessation; Social Support; Substance Withdrawal Syndrome; Treatment Outcome | 1993 |
Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches.
Topics: Administration, Cutaneous; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Family Practice; Female; Health Education; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Smoking Cessation; Social Support; Substance Withdrawal Syndrome; Treatment Outcome | 1993 |
Nicotine patch therapy for smoking cessation in recovering alcoholics.
Topics: Administration, Cutaneous; Adult; Aged; Alcoholism; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Treatment Outcome | 1995 |
Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial.
Topics: Administration, Intranasal; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1995 |
Comparison of the nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) and half-hourly cigarette smoking.
Topics: Administration, Cutaneous; Adult; Cotinine; Cross-Over Studies; Humans; Male; Middle Aged; Nicotine; Skin Absorption; Smoking; Smoking Cessation; Time Factors | 1995 |
Smoking cessation: a clinical study of the transdermal nicotine patch.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Prognosis; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Failure | 1995 |
Cessation of long-term nicotine gum use.
Topics: Chewing Gum; Drug Administration Schedule; Humans; Long-Term Care; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1995 |
Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Lung Health Study Research Group.
Topics: Adult; Bronchodilator Agents; Cardiovascular Diseases; Chewing Gum; Female; Hospitalization; Humans; Ipratropium; Lung Diseases, Obstructive; Male; Middle Aged; Nicotine; Polymethacrylic Acids; Polyvinyls; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Cessation Devices | 1996 |
Importance of baseline cotinine plasma values in smoking cessation: results from a double-blind study with nicotine patch.
Topics: Adult; Cotinine; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder | 1996 |
Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial.
Topics: Administration, Cutaneous; Adult; Age Factors; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Odds Ratio; Retrospective Studies; Smoking Cessation; Time Factors | 1996 |
High dose transdermal nicotine therapy for heavy smokers: safety, tolerability and measurement of nicotine and cotinine levels.
Topics: Administration, Cutaneous; Adult; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Skin Diseases; Smoking; Smoking Cessation | 1995 |
Depression and smoking cessation: characteristics of depressed smokers and effects of nicotine replacement.
Topics: Adaptation, Psychological; Affect; Depressive Disorder; Female; Humans; Male; Nicotine; Smoking Cessation; Stress, Psychological | 1996 |
Nicotine gum dose and weight gain after smoking cessation.
Topics: Adult; Chewing Gum; Female; Humans; Male; Middle Aged; Nicotine; Plants, Toxic; Random Allocation; Smoking Cessation; Tobacco, Smokeless; Weight Gain | 1996 |
Exposure to high ambient temperature increases absorption and plasma concentrations of transdermal nicotine.
Topics: Administration, Cutaneous; Adult; Cross-Over Studies; Female; Hot Temperature; Humans; Male; Nicotine; Nicotinic Agonists; Norepinephrine; Smoking; Smoking Cessation; Steam Bath; Sympathomimetics; Thromboxane A2 | 1996 |
Effects of transdermal nicotine patches on ambulatory ECG monitoring findings: a double-blind study in healthy smokers.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Double-Blind Method; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1996 |
Randomised controlled trial of ondansetron in smoking cessation.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Ondansetron; Serotonin Antagonists; Smoking Cessation; Substance Withdrawal Syndrome | 1996 |
Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial.
Topics: Adult; Behavior Therapy; Combined Modality Therapy; Double-Blind Method; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Patient Acceptance of Health Care; Smoking Cessation; Treatment Outcome | 1996 |
Transdermal nicotine plus support in patients attending hospital with smoking-related diseases: a placebo-controlled study.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Odds Ratio; Respiration Disorders; Smoking Cessation; Smoking Prevention; Time Factors; Treatment Outcome | 1996 |
Recycling of hard-core smokers with nicotine nasal spray.
Topics: Administration, Intranasal; Chi-Square Distribution; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Treatment Outcome | 1996 |
Intranasal nicotine spray does not augment the adverse effects of cigarette smoking on myocardial oxygen demand or coronary arterial dimensions.
Topics: Administration, Intranasal; Adult; Cardiac Catheterization; Cineangiography; Coronary Angiography; Coronary Vessels; Female; Heart Rate; Humans; Male; Middle Aged; Myocardium; Nicotine; Oxygen Consumption; Smoking; Smoking Cessation; Vasoconstriction | 1996 |
Nicotine patch therapy in adolescent smokers.
Topics: Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Cotinine; Female; Follow-Up Studies; Humans; Male; Minnesota; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Urban Population | 1996 |
A comparison of nicotine delivery systems in a multimodality smoking cessation program.
Topics: Administration, Cutaneous; Adult; Age Factors; Aged; Female; Humans; Male; Middle Aged; Nicotine; Nurse Practitioners; Polymethacrylic Acids; Polyvinyls; Prospective Studies; Recurrence; Smoking Cessation; Tobacco Use Cessation Devices | 1996 |
Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study.
Topics: Adult; Affect; Aged; Chewing Gum; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Recurrence; Risk Factors; Self Concept; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1996 |
Interactive effects of depression symptoms, nicotine dependence, and weight change on late smoking relapse.
Topics: Algorithms; Behavior Therapy; Body Weight; Chewing Gum; Depression; Follow-Up Studies; Humans; Nicotine; Recurrence; Risk Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Survival Analysis; Treatment Outcome | 1996 |
Efficacy of buspirone in smoking cessation: a placebo-controlled trial.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Buspirone; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1996 |
The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Analysis of Variance; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Treatment Outcome | 1996 |
Nicotine preference in smokers as a function of smoking abstinence.
Topics: Adult; Aerosols; Affect; Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1996 |
Characterization of tobacco withdrawal symptoms: transdermal nicotine reduces hunger and weight gain.
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Erythema; Female; Headache; Humans; Hunger; Male; Minnesota; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Weight Gain; Wisconsin | 1996 |
Presence and persistence of serum anti-benzo[a]pyrene diolepoxide-DNA adduct antibodies in smokers: effects of smoking reduction and cessation.
Topics: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; Antibodies, Antinuclear; Biomarkers; DNA Adducts; DNA Damage; Humans; Nicotine; Single-Blind Method; Smoking; Smoking Cessation | 1997 |
Nicotine patches in smoking cessation: a randomized trial among over-the-counter customers in Denmark.
Topics: Administration, Cutaneous; Adolescent; Adult; Denmark; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Nonprescription Drugs; Smoking Cessation; Surveys and Questionnaires; Treatment Outcome; Treatment Refusal | 1997 |
Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking.
Topics: Administration, Cutaneous; Administration, Inhalation; Adult; Analysis of Variance; Biological Availability; Cotinine; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Regression Analysis; Smoking; Smoking Cessation | 1997 |
Mood and physiological effects of subcutaneous nicotine in smokers and never-smokers.
Topics: Adult; Affect; Arousal; Dose-Response Relationship, Drug; Double-Blind Method; Drug Tolerance; Female; Galvanic Skin Response; Heart Rate; Humans; Injections, Subcutaneous; Male; Nicotine; Pulse; Smoking; Smoking Cessation | 1997 |
Results of two levels of adjunctive treatment used with the nicotine patch.
Topics: Administration, Cutaneous; Adult; Aged; Cognitive Behavioral Therapy; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Education as Topic; Prospective Studies; Recurrence; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 1997 |
Nicotine nasal spray and vapor inhaler: abuse liability assessment.
Topics: Administration, Inhalation; Adult; Blood Pressure; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Stimulation, Chemical; Substance-Related Disorders; Tobacco Use Disorder | 1997 |
Evaluation of cranial electrostimulation therapy on short-term smoking cessation.
Topics: Adult; Brain; Carbon Monoxide; Double-Blind Method; Electric Stimulation Therapy; Female; Humans; Male; Middle Aged; Neurologic Examination; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1997 |
No acute effects of smoking and nicotine nasal spray on lipolysis measured by subcutaneous microdialysis.
Topics: Adipose Tissue; Administration, Intranasal; Adult; Fatty Acids, Nonesterified; Glucose Tolerance Test; Glycerol; Humans; Hyperlipidemias; Insulin; Insulin Resistance; Lactic Acid; Lipolysis; Male; Microdialysis; Middle Aged; Nicotine; Smoking; Smoking Cessation | 1997 |
A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation.
Topics: Administration, Intranasal; Adult; Aerosols; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Nicotine; Prospective Studies; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors | 1997 |
Effects of nicotine dose and administration method on withdrawal symptoms and side effects during short-term smoking abstinence.
Topics: Administration, Cutaneous; Adult; Affect; Blood Pressure; Carbon Monoxide; Central Nervous System Stimulants; Chewing Gum; Dose-Response Relationship, Drug; Female; Humans; Male; Nicotine; Nicotinic Agonists; Polymethacrylic Acids; Polyvinyls; Saliva; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 1997 |
Nicotine patch and self-help video for cigarette smoking cessation.
Topics: Administration, Cutaneous; Adult; Chi-Square Distribution; Female; Humans; Logistic Models; Male; Manuals as Topic; Middle Aged; Nicotine; Nicotinic Agonists; Proportional Hazards Models; Prospective Studies; Self Care; Smoking Cessation; Survival Analysis; Treatment Outcome; Video Recording | 1997 |
Clinical outcome of smoking-cessation trial of nicotine chewing gum evaluated by analysis of nicotine in hair.
Topics: Adult; Chewing Gum; Double-Blind Method; Drug Monitoring; Hair; Humans; Male; Middle Aged; Nicotine; Outcome Assessment, Health Care; Placebos; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Thiocyanates; Tobacco Use Cessation Devices | 1997 |
A comparison of sustained-release bupropion and placebo for smoking cessation.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Delayed-Action Preparations; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Weight Gain | 1997 |
Telephone support as an adjunct to transdermal nicotine in smoking cessation.
Topics: Administration, Cutaneous; Adult; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Outcome and Process Assessment, Health Care; Self-Help Groups; Smoking Cessation; Telephone | 1997 |
The role of the nurse in health promotion: an evaluation of a smoking cessation programme in surgical pre-admission clinics.
Topics: England; Female; Health Knowledge, Attitudes, Practice; Humans; Internal-External Control; Male; Middle Aged; Motivation; Nicotine; Nurse-Patient Relations; Nursing; Nursing Assessment; Patient Education as Topic; Patient Satisfaction; Preoperative Care; Program Evaluation; Smoking Cessation; Social Support | 1997 |
Smoking cessation among inner-city African Americans using the nicotine transdermal patch.
Topics: Administration, Cutaneous; Black or African American; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Outpatients; Patient Education as Topic; Retrospective Studies; Smoking Cessation; Social Class; Tobacco Use Disorder; Treatment Outcome; United States; Urban Population | 1998 |
Weight change after smoking cessation using variable doses of transdermal nicotine replacement.
Topics: Administration, Cutaneous; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Weight Gain | 1998 |
Three year continuous abstinence in a smoking cessation study using the nicotine transdermal patch.
Topics: Administration, Cutaneous; Behavior Therapy; Combined Modality Therapy; Drug Administration Schedule; Ganglionic Stimulants; Humans; Nicotine; Smoking Cessation; Time Factors | 1997 |
Nicotine nasal spray for smoking cessation: pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels.
Topics: Administration, Inhalation; Adult; Aged; Body Weight; Cotinine; Female; Humans; Linear Models; Male; Middle Aged; Nasal Mucosa; Nicotine; Nicotinic Agonists; Severity of Illness Index; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome | 1998 |
Effects of three doses of transdermal nicotine on post-cessation eating, hunger and weight.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Appetite; Diet; Dietary Carbohydrates; Dietary Fats; Dose-Response Relationship, Drug; Double-Blind Method; Energy Intake; Feeding Behavior; Female; Humans; Hunger; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Weight Gain | 1997 |
Cotinine: effects with and without nicotine.
Topics: Administration, Topical; Adult; Affect; Blood Pressure; Cotinine; Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome | 1998 |
[Is cardiovascular disease a contraindication for nicotine substitution?].
Topics: Cardiovascular Diseases; Contraindications; Humans; Nicotine; Smoking Cessation | 1998 |
Double-blind placebo controlled trial of dextrose tablets and nicotine patch in smoking cessation.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Glucose; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation | 1998 |
How much does relapse after one year erode effectiveness of smoking cessation treatments? Long-term follow up of randomised trial of nicotine nasal spray.
Topics: Administration, Inhalation; Follow-Up Studies; Humans; Nicotine; Recurrence; Smoking Cessation; Treatment Outcome | 1998 |
Quantitative EEG effects of nicotine replacement by cigarette smoking.
Topics: Adult; Carbon Monoxide; Electroencephalography; Functional Laterality; Humans; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation | 1998 |
Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker?
Topics: Adult; Carbon Monoxide; Cotinine; Cross-Over Studies; Female; Humans; Infant; Male; Middle Aged; Nicotiana; Nicotine; Plants, Toxic; Saliva; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 1997 |
Profiles in discouragement: two studies of variability in the time course of smoking withdrawal symptoms.
Topics: Administration, Cutaneous; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1998 |
Delayed auditory feedback during smoking cessation.
Topics: Adult; Auditory Perception; Feedback; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1998 |
Effects of nicotine on methadone self-administration in humans.
Topics: Adult; Analysis of Variance; Behavior, Addictive; Carbon Monoxide; Drug Interactions; Female; Heroin Dependence; Humans; Male; Methadone; Narcotics; Nicotine; Nicotinic Agonists; Self Administration; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1998 |
Application of serum nicotine and plasma cotinine concentrations to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy.
Topics: Administration, Cutaneous; Adult; Aged; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation | 1998 |
Application of urine nicotine and cotinine excretion rates to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy.
Topics: Administration, Cutaneous; Cotinine; Double-Blind Method; Humans; Metabolic Clearance Rate; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation | 1998 |
Nicotine and cotinine replacement when nicotine nasal spray is used to quit smoking.
Topics: Administration, Intranasal; Adult; Aerosols; Carbon Monoxide; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Respiratory Function Tests; Smoking Cessation | 1998 |
Effects of cigarette smoking through a partially occluded filter.
Topics: Adult; Carbon Monoxide; Cross-Over Studies; Double-Blind Method; Electroencephalography; Female; Filtration; Hemodynamics; Humans; Male; Nicotine; Smoking; Smoking Cessation | 1998 |
Does abstinence from smoking or a transdermal nicotine system influence atracurium-induced neuromuscular block?
Topics: Administration, Cutaneous; Adult; Anesthetics, Combined; Atracurium; Double-Blind Method; Electromyography; Female; Humans; Male; Middle Aged; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Nicotine; Prospective Studies; Smoking; Smoking Cessation; Time Factors | 1998 |
Effects of cotinine on cigarette self-administration.
Topics: Adult; Cotinine; Double-Blind Method; Extinction, Psychological; Female; Humans; Male; Middle Aged; Nicotine; Self Administration; Smoking; Smoking Cessation | 1998 |
Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy.
Topics: Adult; Affect; Behavior Therapy; Drug Therapy, Combination; Female; Humans; Male; Mecamylamine; Nicotine; Nicotinic Agonists; North Carolina; Smoking Cessation; Time Factors; Tobacco Use Disorder | 1998 |
Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation | 1998 |
The effect of transdermal nicotine on digital perfusion in reformed habitual smokers.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Body Temperature Regulation; Carbon Monoxide; Female; Fingers; Humans; Male; Microcirculation; Middle Aged; Nicotine; Patient Compliance; Quality of Life; Regional Blood Flow; Smoking Cessation | 1998 |
Transdermal nicotine inhibits interleukin 2 synthesis by mononuclear cells derived from healthy volunteers.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents; Cotinine; Dinoprostone; Female; Humans; Interferon-gamma; Interleukin-10; Interleukin-13; Interleukin-2; Interleukin-4; Leukocytes, Mononuclear; Leukotriene B4; Male; Middle Aged; Nicotine; Nicotinic Agonists; Phytohemagglutinins; Smoking Cessation; Thromboxane B2; Tumor Necrosis Factor-alpha | 1998 |
A randomized trial of nortriptyline for smoking cessation.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents, Tricyclic; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nortriptyline; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1998 |
The effect of sucrose on acute tobacco withdrawal in women.
Topics: Adult; Analysis of Variance; Anxiety; Demography; Double-Blind Method; Female; Food Preferences; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Sucrose | 1998 |
Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking.
Topics: Administration, Cutaneous; Adult; Aged; Blood Pressure; Coronary Disease; Double-Blind Method; Electrocardiography; Exercise Test; Heart Rate; Humans; Israel; Middle Aged; Monitoring, Ambulatory; Nicotine; Smoking Cessation; Switzerland | 1998 |
Randomized trial of acupuncture for nicotine withdrawal symptoms.
Topics: Adult; Electroacupuncture; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1998 |
Context modulates effects of nicotine abstinence on human cooperative responding.
Topics: Adolescent; Adult; Cooperative Behavior; Female; Humans; Male; Nicotine; Psychomotor Performance; Sex Factors; Smoking Cessation; Surveys and Questionnaires | 1998 |
Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine.
Topics: Administration, Cutaneous; Adult; Carbon Monoxide; Carboxyhemoglobin; Cross-Over Studies; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Single-Blind Method; Smoking; Smoking Cessation | 1998 |
A new gas chromatography-mass spectrometry method for simultaneous determination of total and free trans-3'-hydroxycotinine and cotinine in the urine of subjects receiving transdermal nicotine.
Topics: Administration, Cutaneous; Cotinine; Gas Chromatography-Mass Spectrometry; Humans; Nicotine; Nicotinic Agonists; Sensitivity and Specificity; Smoking; Smoking Cessation | 1999 |
Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up.
Topics: Administration, Cutaneous; Administration, Intranasal; Adult; Aged; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Treatment Outcome | 1999 |
Knowledge about smoking, reasons for smoking, and reasons for wishing to quit in inner-city African Americans.
Topics: Administration, Cutaneous; Black or African American; Data Interpretation, Statistical; Double-Blind Method; Female; Humans; Infant, Newborn; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Placebos; Poverty Areas; Smoking; Smoking Cessation; Smoking Prevention; Time Factors | 1998 |
[The effect of transdermal nicotine patches in smoking cessation. A randomized trial in pharmacy customers in Denmark].
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Denmark; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nonprescription Drugs; Smoking Cessation; Surveys and Questionnaires | 1999 |
Clinical evaluation of a new A.S. mouth wash 881010 as an antismoking agent: a placebo-controlled double-blind trial.
Topics: Adult; Chromatography, Gas; Cotinine; Double-Blind Method; Humans; Male; Middle Aged; Mouthwashes; Nicotine; Placebos; Silver Nitrate; Smoking Cessation | 1999 |
The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day.
Topics: Administration, Cutaneous; Adult; Behavior, Addictive; Chi-Square Distribution; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Recurrence; Smoking Cessation; Survival Analysis; Time Factors; Tobacco Use Disorder; Treatment Outcome; Weight Gain | 1999 |
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Bupropion; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Weight Gain | 1999 |
Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society.
Topics: Administration, Cutaneous; Adult; Aged; Body Weight; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Smoking Cessation; Treatment Outcome | 1999 |
Nicodermal patch adherence and its correlates.
Topics: Administration, Cutaneous; Adult; Cognitive Behavioral Therapy; Female; Humans; Male; Mental Disorders; Middle Aged; Multivariate Analysis; Nicotine; Nicotinic Agonists; Patient Compliance; Patient Dropouts; Prognosis; Severity of Illness Index; Smoking; Smoking Cessation; Time Factors; Tobacco Use Disorder; Treatment Outcome | 1999 |
Nicotine replacement therapy in a group model HMO.
Topics: Administration, Cutaneous; Health Maintenance Organizations; Hotlines; Humans; Midwestern United States; Models, Organizational; Nicotine; Patient Satisfaction; Program Evaluation; Smoking Cessation; Social Support; Tobacco Use Disorder | 1997 |
Cotinine replacement levels for a 21 mg/day transdermal nicotine patch in an outpatient treatment setting.
Topics: Administration, Cutaneous; Adult; Biomarkers; Chi-Square Distribution; Cholinergic Agents; Cotinine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Logistic Models; Male; Middle Aged; Nicotine; Sex Factors; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 1999 |
Should smoking cessation cost a packet? A pilot randomized controlled trial of the cost-effectiveness of distributing nicotine therapy free of charge.
Topics: Administration, Cutaneous; Adult; Cost-Benefit Analysis; Drug Costs; Family Practice; Female; Humans; Male; Middle Aged; Nicotine; Pilot Projects; Smoking Cessation | 1999 |
Effects of monetary contingencies on smoking relapse: influences of trait depression, personality, and habitual nicotine intake.
Topics: Depression; Humans; Male; Nicotine; Personality; Recurrence; Reward; Smoking; Smoking Cessation; Smoking Prevention | 1999 |
Is telephone counselling a useful addition to physician advice and nicotine replacement therapy in helping patients to stop smoking? A randomized controlled trial.
Topics: Adult; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Nurses; Ontario; Sex Factors; Smoking Cessation; Telephone; Time Factors | 1999 |
Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Cross-Over Studies; Double-Blind Method; Humans; Male; Middle Aged; Nicotine; Prevalence; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1999 |
Effects of nicotine nasal spray on atherogenic and thrombogenic factors during smoking cessation.
Topics: Administration, Inhalation; Administration, Intranasal; Adult; Aged; Arteriosclerosis; Cardiovascular Diseases; Cholesterol; Double-Blind Method; Erythrocyte Indices; Female; Fibrinogen; Hematocrit; Hemoglobins; Humans; Leukocyte Count; Male; Middle Aged; Nicotine; Nicotinic Agonists; Platelet Count; Prospective Studies; Risk Factors; Smoking Cessation; Thrombosis | 1999 |
Gender differences in smoking cessation.
Topics: Administration, Cutaneous; Adult; Aged; Female; Gender Identity; Humans; Male; Middle Aged; Nicotine; Personality Inventory; Smoking Cessation; Treatment Outcome | 1999 |
Open randomised trial of intermittent very low energy diet together with nicotine gum for stopping smoking in women who gained weight in previous attempts to quit.
Topics: Chewing Gum; Diet; Energy Intake; Female; Headache; Humans; Middle Aged; Nicotine; Patient Compliance; Rhinitis; Smoking Cessation; Treatment Outcome; Weight Gain | 1999 |
Effects of cigarette smoking on short-term variability of blood pressure in smoking and non smoking healthy volunteers.
Topics: Adult; Blood Pressure; Heart Rate; Humans; Male; Nicotine; Smoking; Smoking Cessation | 1999 |
Do heavy smokers benefit from higher dose nicotine patch therapy?
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Drug Tolerance; Female; Follow-Up Studies; Humans; Interviews as Topic; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Telephone | 1999 |
Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Intranasal; Adult; Chewing Gum; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Polymethacrylic Acids; Polyvinyls; Saliva; Smoking Cessation; Tobacco Use Cessation Devices | 1999 |
Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials.
Topics: Administration, Cutaneous; Adult; Carbon Monoxide; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nonprescription Drugs; Research Design; Smoking Cessation; Treatment Outcome | 1999 |
The use of nicotine-replacement therapy by hospitalized smokers.
Topics: Boston; Educational Status; Female; Hospitalization; Humans; Male; Middle Aged; Nicotine; Prevalence; Prospective Studies; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder | 1999 |
EEG, physiology, and task-related mood fail to resolve across 31 days of smoking abstinence: relations to depressive traits, nicotine exposure, and dependence.
Topics: Adult; Affect; Alpha Rhythm; Caffeine; Central Nervous System Stimulants; Cotinine; Depressive Disorder; Electroencephalography; Heart Rate; Humans; Hydrocortisone; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance-Related Disorders; Surveys and Questionnaires; Theta Rhythm | 1999 |
Nicotine reduces the frequency of anger reports in smokers and nonsmokers with high but not low hostility: an ambulatory study.
Topics: Administration, Cutaneous; Adult; Affect; Anger; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Hostility; Humans; Male; Nicotine; Nicotinic Agonists; Personality Tests; Sex Characteristics; Smoking; Smoking Cessation | 1999 |
Use of the nicotine patch by pregnant women.
Topics: Administration, Cutaneous; Cotinine; Female; Humans; Nicotine; Pilot Projects; Pregnancy; Saliva; Smoking; Smoking Cessation | 1999 |
Maintaining abstinence from cigarette smoking: effectiveness of group counselling and factors predicting outcome.
Topics: Adolescent; Adult; Aged; Body Mass Index; Counseling; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nicotine; Patient Compliance; Prognosis; Program Evaluation; Psychotherapy; Smoking Cessation; Smoking Prevention; Weight Gain | 1999 |
A randomized trial of naltrexone for smoking cessation.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Smoking Cessation | 1999 |
Response to nicotine dependence treatment in smokers with current and past alcohol problems.
Topics: Administration, Cutaneous; Adult; Alcoholism; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Multicenter Studies as Topic; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Severity of Illness Index; Smoking; Smoking Cessation; Time Factors; Tobacco Use Disorder; Treatment Outcome | 1999 |
Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels.
Topics: Administration, Cutaneous; Adolescent; Carbon Monoxide; Cotinine; Female; Follow-Up Studies; Humans; Male; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors | 2000 |
The effect of bupropion on nicotine craving and withdrawal.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Double-Blind Method; Female; Humans; Male; Nicotine; Patient Compliance; Psychiatric Status Rating Scales; Psychomotor Performance; Sleep; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome | 2000 |
[Nasal nicotine spray in smoking cessation. Results of a multicenter study].
Topics: Administration, Inhalation; Adult; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Time Factors | 1999 |
The effects of fluoxetine combined with nicotine inhalers in smoking cessation--a randomized trial.
Topics: Adult; Aged; Algorithms; Antidepressive Agents, Second-Generation; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Respiratory Therapy; Smoking Cessation | 1999 |
Practical experiences in smoking reduction and cessation.
Topics: Double-Blind Method; Female; Ganglionic Stimulants; Humans; Male; Nicotine; Smoking; Smoking Cessation | 2000 |
Effects of transdermal nicotine patches on abstinence-induced and cue-elicited craving in cigarette smokers.
Topics: Administration, Cutaneous; Adult; Arousal; Cues; Female; Humans; Male; Motivation; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 2000 |
[Individual treatment of smoking addiction. Results using 2 and 4 mg nicotine gum].
Topics: Adult; Chewing Gum; Counseling; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Time Factors | 2000 |
Nicotine gum as a substitute for cigarettes: a behavioral economic analysis.
Topics: Adult; Chewing Gum; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Reinforcement Schedule; Self Administration; Smoking; Smoking Cessation | 2000 |
The efficacy of computer-tailored smoking cessation material as a supplement to nicotine polacrilex gum therapy.
Topics: Adult; Behavior Therapy; Chewing Gum; Combined Modality Therapy; Follow-Up Studies; Humans; Interviews as Topic; Middle Aged; Nicotine; Patient Dropouts; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Telephone; Therapy, Computer-Assisted; Time Factors; Tobacco Use Cessation Devices | 2000 |
Free nicotine patches plus proactive telephone peer support to help low-income women stop smoking.
Topics: Administration, Cutaneous; Adolescent; Adult; Female; Follow-Up Studies; Humans; Logistic Models; Middle Aged; Monitoring, Physiologic; Nicotine; Patient Compliance; Poverty; Self-Help Groups; Smoking Cessation; Surveys and Questionnaires; Telephone | 2000 |
Nicotine blood levels and subjective craving for cigarettes.
Topics: Adult; Behavior, Addictive; Humans; Nicotine; Pilot Projects; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors | 2000 |
Naltrexone alteration of acute smoking response in nicotine-dependent subjects.
Topics: Adult; Affect; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2000 |
Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Double-Blind Method; Follow-Up Studies; Humans; Middle Aged; Nicotine; Patient Compliance; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2000 |
Randomised trial investigating effect of a novel nicotine delivery device (Eclipse) and a nicotine oral inhaler on smoking behaviour, nicotine and carbon monoxide exposure, and motivation to quit.
Topics: Administration, Inhalation; Adult; Aged; Carbon Monoxide; Female; Humans; Male; Middle Aged; Motivation; Nebulizers and Vaporizers; Nicotine; Smoking Cessation; Smoking Prevention | 2000 |
Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia.
Topics: Administration, Cutaneous; Adult; Antipsychotic Agents; Comorbidity; Female; Humans; Male; Nicotine; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2000 |
Nicotine patch and paroxetine for smoking cessation.
Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Paroxetine; Patient Compliance; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2000 |
Acute feasibility and safety of a smoking reduction strategy for smokers with schizophrenia.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Consumer Product Safety; Cross-Over Studies; Double-Blind Method; Humans; Nicotine; Schizophrenia; Smoking Cessation; Tobacco Use Disorder | 1999 |
Are higher doses of nicotine replacement more effective for smoking cessation?
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Regression Analysis; Smoking Cessation | 1999 |
Long-term effects of nicotine gum on weight gain after smoking cessation.
Topics: Adult; Cotinine; Double-Blind Method; Female; Ganglionic Stimulants; Gingiva; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Tobacco Use Disorder; Weight Gain | 1999 |
Transdermal nicotine patches do not cause clinically significant gastroesophageal reflux or esophageal motor disorders.
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Dyspepsia; Ganglionic Stimulants; Gastroesophageal Reflux; Gastrointestinal Motility; Heartburn; Humans; Nicotine; Smoking Cessation | 1999 |
Effects of nicotine gum dose by level of nicotine dependence.
Topics: Adult; Analysis of Variance; Chewing Gum; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Logistic Models; Male; Nicotine; Recurrence; Smoking Cessation; Statistics, Nonparametric; Substance Withdrawal Syndrome | 2000 |
Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial.
Topics: Administration, Inhalation; Administration, Topical; Adult; Combined Modality Therapy; Double-Blind Method; Female; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 2000 |
Effects of transdermal nicotine on craving, withdrawal and premenstrual symptomatology in short-term smoking abstinence during different phases of the menstrual cycle.
Topics: Administration, Cutaneous; Adult; Female; Humans; Menstrual Cycle; Nicotine; Premenstrual Syndrome; Smoking Cessation; Substance Withdrawal Syndrome; Weight Gain | 2000 |
Efficacy of transdermal nicotine in reducing post-cessation weight gain in a Hispanic sample.
Topics: Administration, Cutaneous; Adult; Female; Hispanic or Latino; Humans; Male; Middle Aged; Nicotine; Sex Factors; Smoking Cessation; Weight Gain | 2000 |
Do former smokers respond to nicotine differently from never smokers? A pilot study.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Nicotine; Pilot Projects; Reinforcement, Psychology; Smoking; Smoking Cessation | 2000 |
Nicotine patches for pregnant smokers: a randomized controlled study.
Topics: Administration, Cutaneous; Adult; Birth Weight; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant, Low Birth Weight; Infant, Newborn; Nicotine; Obstetric Labor, Premature; Pregnancy; Prenatal Care; Prospective Studies; Risk; Smoking Cessation | 2000 |
A randomized, double-blind, placebo-controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation.
Topics: Administration, Sublingual; Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Mouth Mucosa; Nicotine; Nicotinic Agonists; Smoking Cessation; Statistics, Nonparametric; Tablets; Time Factors; Treatment Outcome | 2000 |
Bromocriptine reduces cigarette smoking.
Topics: Adolescent; Adult; Analysis of Variance; Bromocriptine; Cotinine; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mood Disorders; Nausea; Nicotine; Self Disclosure; Smoking Cessation | 2000 |
Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Drug Administration Schedule; Female; Humans; Male; Microcomputers; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Statistics, Nonparametric; Substance Withdrawal Syndrome | 2000 |
Smoking cessation with four nicotine replacement regimes in a lung clinic.
Topics: Adult; Aged; Analysis of Variance; Carbon Monoxide; Central Nervous System Stimulants; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Polymethacrylic Acids; Polyvinyls; Proportional Hazards Models; Smoking Cessation; Spirometry; Statistics, Nonparametric; Surveys and Questionnaires; Tobacco Use Cessation Devices; Treatment Outcome | 2000 |
An evidence-based programme for smoking cessation: effectiveness in routine general practice.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Algorithms; Evidence-Based Medicine; Family Practice; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nicotine; Program Evaluation; Smoking Cessation; Socioeconomic Factors | 2000 |
Effectiveness of a minimal contact smoking cessation program for Dutch general practitioners: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Chewing Gum; Family Practice; Female; Humans; Logistic Models; Male; Middle Aged; Netherlands; Nicotine; Odds Ratio; Patient Education as Topic; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Tobacco Use Cessation Devices | 2001 |
The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression.
Topics: Administration, Cutaneous; Affect; Behavior; Depressive Disorder, Major; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 2001 |
[Antidepressive drug against nicotine. A method for smoking cessation].
Topics: Administration, Cutaneous; Bupropion; Chewing Gum; Delayed-Action Preparations; Drug Administration Schedule; Humans; Nicotine; Smoking Cessation; Weight Gain | 2000 |
Efficacy of the nicotine patch for relief of craving and withdrawal 7-10 weeks after cessation.
Topics: Administration, Cutaneous; Adult; Affect; Double-Blind Method; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Recurrence; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2000 |
Individual differences in preferences for and responses to four nicotine replacement products.
Topics: Administration, Cutaneous; Administration, Inhalation; Adult; Chewing Gum; Double-Blind Method; Female; Humans; Individuality; Male; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Time Factors | 2001 |
The use of nicotine replacement therapy during hospitalization.
Topics: Administration, Cutaneous; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Motivation; Nicotine; Smoking; Smoking Cessation; Smoking Prevention | 2000 |
Subjective and discriminative stimulus effects of two de-nicotinized cigarettes with different tar yields.
Topics: Adult; Blood Pressure; Female; Fluoxetine; Heart Rate; Humans; Male; Middle Aged; Nicotine; Selective Serotonin Reuptake Inhibitors; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder | 2001 |
Sociodemographic predictors of success in smoking intervention.
Topics: Administration, Cutaneous; Adult; Age Factors; Aged; Double-Blind Method; Europe; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nicotine; Residence Characteristics; Risk; Sex Factors; Smoking Cessation; Socioeconomic Factors | 2001 |
Variations in treatment benefits influence smoking cessation: results of a randomised controlled trial.
Topics: Adult; California; Cost Sharing; Follow-Up Studies; Health Benefit Plans, Employee; Health Care Costs; Health Maintenance Organizations; Humans; Independent Practice Associations; Insurance Coverage; Logistic Models; Nicotine; Odds Ratio; Self-Help Groups; Smoking Cessation | 2001 |
Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo.
Topics: Administration, Cutaneous; Adult; Bupropion; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Nicotine; Smoking Cessation; Tobacco Use Disorder; Treatment Failure; Treatment Outcome | 2001 |
Withdrawal-suppressing effects of a novel smoking system: comparison with own brand, not own brand, and de-nicotinized cigarettes.
Topics: Adolescent; Adult; Body Temperature; Choice Behavior; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2001 |
Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking.
Topics: Acute Disease; Adult; Affect; Baclofen; Dose-Response Relationship, Drug; Double-Blind Method; Female; GABA Agonists; Humans; Male; Nicotine; Self Disclosure; Severity of Illness Index; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2001 |
Tolerability of concurrent use of nicotine gum and smoking in healthy volunteers.
Topics: Adult; Blood Pressure; Carbon Monoxide; Chewing Gum; Cross-Over Studies; Drug Administration Schedule; Drug Tolerance; Female; Health Status; Heart Rate; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2001 |
The influence of personality on nicotine craving: a hierarchical multivariate statistical prediction model.
Topics: Adult; Arousal; Cross-Over Studies; Dopamine; Fluphenazine; Humans; Limbic System; Lisuride; Male; Mesencephalon; Motivation; Nicotine; Personality; Personality Inventory; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders | 2001 |
EEG effects of smoking: Is there tachyphylaxis?
Topics: Adult; Alpha Rhythm; Arousal; Beta Rhythm; Cerebral Cortex; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Humans; Male; Nicotine; Smoking; Smoking Cessation; Tachyphylaxis | 2001 |
[Tobacco detoxication at a primary care clinic: efficacy of medical counseling, minimal intervention and nicotine replacement therapy at the one-year follow-up].
Topics: Adult; Counseling; Female; Follow-Up Studies; Humans; Male; Nicotine; Nicotinic Agonists; Primary Health Care; Smoking Cessation; Time Factors | 2001 |
Using psychological insights to help people quit smoking.
Topics: Adult; Behavior Therapy; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Jamaica; Linear Models; Male; Nicotine; Psychological Theory; Self Efficacy; Smoking Cessation | 2001 |
A randomized trial to reduce passive smoke exposure in low-income households with young children.
Topics: Adult; Air; Analysis of Variance; Caregivers; Child, Preschool; Female; Follow-Up Studies; Health Promotion; Humans; Income; Infant; Male; Motivation; Nicotine; Pamphlets; Parents; Self-Help Groups; Smoking Cessation; Time Factors; Tobacco Smoke Pollution | 2001 |
Responsiveness of the Smoking Cessation Quality of Life (SCQoL) questionnaire.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quality of Life; Reproducibility of Results; Smoking Cessation; Surveys and Questionnaires | 2001 |
Population pharmacokinetic-pharmacodynamic model of craving in an enforced smoking cessation population: indirect response and probabilistic modeling.
Topics: Adult; Behavior, Addictive; Cross-Over Studies; Double-Blind Method; Female; Humans; Logistic Models; Male; Middle Aged; Models, Psychological; Models, Statistical; Nicotine; Nicotinic Agonists; Saliva; Smoking Cessation | 2001 |
Cardiovascular effects of transdermal nicotine in mildly hypertensive smokers.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Cross-Over Studies; Female; Heart Rate; Humans; Hypertension; Male; Nicotine; Nicotinic Agonists; Single-Blind Method; Smoking Cessation; Thromboxane A2 | 2001 |
The efficacy of computer-tailored smoking cessation material as a supplement to nicotine patch therapy.
Topics: Administration, Cutaneous; Adult; Behavior Therapy; Combined Modality Therapy; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Interviews as Topic; Logistic Models; Male; Middle Aged; Nicotine; Outcome Assessment, Health Care; Patient Compliance; Smoking Cessation; Time Factors; Treatment Outcome | 2001 |
Strike while the iron is hot: can stepped-care treatments resurrect relapsing smokers?
Topics: Administration, Cutaneous; Adult; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Psychotherapy, Brief; Psychotherapy, Group; Recurrence; Smoking Cessation | 2001 |
[Intensified smoking cessation for diabetic patients--preliminary results].
Topics: Adult; Ambulatory Care; Austria; Behavior Therapy; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Life Style; Male; Middle Aged; Nicotine; Patient Admission; Risk Factors; Smoking; Smoking Cessation; Treatment Outcome | 1999 |
Smoking history and nicotine effects on cognitive performance.
Topics: Administration, Cutaneous; Aged; Cognition; Double-Blind Method; Female; Hemodynamics; Humans; Male; Mental Processes; Nicotine; Nicotinic Agonists; Psychomotor Performance; Reaction Time; Smoking; Smoking Cessation | 2001 |
Reinforcing effects of nicotine as a function of smoking status.
Topics: Administration, Intranasal; Adult; Exploratory Behavior; Female; Hemodynamics; Humans; Individuality; Male; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Sex Characteristics; Smoking; Smoking Cessation | 2001 |
Short- and long-term smoking cessation for three levels of intensity of behavioral treatment.
Topics: Administration, Cutaneous; Adult; Behavior Therapy; Combined Modality Therapy; Cost-Benefit Analysis; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation | 2001 |
Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.
Topics: Administration, Cutaneous; Adult; Female; Humans; Male; Mecamylamine; Monoamine Oxidase; Neostigmine; Nicotine; Nicotinic Antagonists; Parasympathomimetics; Reproducibility of Results; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2001 |
[The effect of smoking cessation counseling at health checkup].
Topics: Adult; Counseling; Follow-Up Studies; Humans; Nicotine; Physical Examination; Smoking Cessation | 2001 |
Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Counseling; Denmark; Female; Ganglionic Stimulants; Humans; Length of Stay; Male; Middle Aged; Morbidity; Nicotine; Patient Education as Topic; Postoperative Complications; Preoperative Care; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Treatment Outcome | 2002 |
Real-world efficacy of prescription and over-the-counter nicotine replacement therapy.
Topics: Adult; Aged; Drug Prescriptions; Female; Humans; Male; Middle Aged; Nicotine; Nonprescription Drugs; Smoking Cessation; Tobacco Use Disorder | 2002 |
Efficacy of a nicotine lozenge for smoking cessation.
Topics: Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Tablets; Tobacco Use Cessation Devices | 2002 |
Effectiveness of a pharmacist-based smoking-cessation program and its impact on quality of life.
Topics: Administration, Topical; Adult; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pharmacists; Prospective Studies; Quality of Life; Smoking Cessation; Substance Withdrawal Syndrome | 2002 |
Nicotine deprivation effects on the dissociated components of simple reaction time.
Topics: Adult; Double-Blind Method; Electromyography; Humans; Male; Motivation; Nicotine; Psychomotor Performance; Reaction Time; Smoking Cessation; Substance Withdrawal Syndrome | 2002 |
Acute nicotine reinforcement, but not chronic tolerance, predicts withdrawal and relapse after quitting smoking.
Topics: Administration, Intranasal; Adult; Cognitive Behavioral Therapy; Dose-Response Relationship, Drug; Drug Tolerance; Female; Follow-Up Studies; Humans; Male; Motivation; Nicotine; Recurrence; Reinforcement, Psychology; Self Administration; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2002 |
Application of a nurse-managed inpatient smoking cessation program.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case Management; Counseling; Female; Ganglionic Stimulants; Humans; Inpatients; Male; Middle Aged; Nicotine; Nurse's Role; Patient Education as Topic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2002 |
Effects of differing nicotine-replacement doses on weight gain after smoking cessation.
Topics: Adult; Age Factors; Chewing Gum; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Tobacco Use Cessation Devices; Weight Gain | 1992 |
Randomised controlled trial of nasal nicotine spray in smoking cessation.
Topics: Administration, Intranasal; Adult; Breath Tests; Carbon Monoxide; Combined Modality Therapy; Cotinine; Double-Blind Method; Female; Humans; London; Male; Middle Aged; Nicotine; Occupations; Outpatient Clinics, Hospital; Psychotherapy, Group; Smoking; Smoking Cessation; Surveys and Questionnaires | 1992 |
Who will relapse? Symptoms of nicotine dependence predict long-term relapse after smoking cessation.
Topics: Adult; Behavior Therapy; Combined Modality Therapy; Female; Humans; Male; Nicotine; Recurrence; Risk Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1992 |
Nasal nicotine spray: a rapid nicotine delivery system.
Topics: Administration, Intranasal; Adult; Blood Pressure; Drug Delivery Systems; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Smoking Cessation | 1992 |
Transdermal clonidine reduced some withdrawal symptoms but did not increase smoking cessation.
Topics: Administration, Cutaneous; Adult; Anxiety; Behavior Therapy; Clonidine; Double-Blind Method; Female; Humans; Irritable Mood; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors | 1992 |
Patient characteristics and the effect of three physician-delivered smoking interventions.
Topics: Adult; Aged; Analysis of Variance; Chewing Gum; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Physician's Role; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Tobacco Use Cessation Devices | 1992 |
A randomised 2 x 2 factorial design to evaluate different smoking cessation methods.
Topics: Acupuncture Therapy; Adult; Chewing Gum; Female; Humans; Male; Nicotine; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Tobacco Use Cessation Devices | 1992 |
Measures of affect and nicotine dependence predict differential response to smoking cessation treatments.
Topics: Affect; Arousal; Aversive Therapy; Chewing Gum; Female; Follow-Up Studies; Humans; Male; Nicotine; Smoking; Smoking Cessation; Social Support; Substance Withdrawal Syndrome | 1992 |
Smoking cessation in women concerned about weight.
Topics: Adult; Behavior Therapy; Body Weight; Chewing Gum; Female; Humans; Middle Aged; Nicotine; Smoking Cessation | 1992 |
Long-term nicotine substitution after application of a 16-hour nicotine patch in smoking cessation.
Topics: Administration, Cutaneous; Adult; Aged; Cotinine; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Saliva; Smoking Cessation | 1992 |
Smoking cessation--gradual or sudden stopping?
Topics: Behavior Therapy; Follow-Up Studies; Humans; Nicotine; Recurrence; Smoking Cessation; Substance Withdrawal Syndrome | 1992 |
Effect of transdermal nicotine patches on cigarette smoking: a double blind crossover study.
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation | 1992 |
An assessment of nicotine gum as an adjunct to freedom from smoking cessation clinics.
Topics: Adult; Chewing Gum; Female; Follow-Up Studies; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1992 |
Partner support, psychological treatment, and nicotine gum in smoking treatment: an incremental study.
Topics: Adult; Attitude to Health; Chewing Gum; Chi-Square Distribution; Female; Humans; Male; Nicotine; Polymethacrylic Acids; Polyvinyls; Psychotherapy; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Surveys and Questionnaires; Tobacco Use Cessation Devices | 1992 |
Predictors of smoking cessation in a sample of Italian smokers.
Topics: Adaptation, Psychological; Affective Symptoms; Chewing Gum; Cross-Cultural Comparison; Double-Blind Method; Dreams; Female; Humans; Italy; Male; Nicotine; Patient Compliance; Prognosis; Sleep Stages; Smoking Cessation; Substance Withdrawal Syndrome | 1992 |
Transdermal nicotine patch for smoking cessation.
Topics: Administration, Cutaneous; Humans; Nicotine; Smoking Cessation | 1992 |
[A double-blind trial of nicotine patches in smoking cessation].
Topics: Administration, Cutaneous; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation | 1992 |
The effect of nicotine, silver acetate, and placebo chewing gum on the cessation of smoking. The influence of smoking type and nicotine dependence.
Topics: Acetates; Acetic Acid; Adult; Chewing Gum; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation | 1991 |
[A multicenter study of the breaking of the smoking habit with nicotine chewing gum in health personnel].
Topics: Adult; Chewing Gum; Humans; Medical Staff, Hospital; Nicotine; Prevalence; Smoking; Smoking Cessation; Smoking Prevention; Spain; Tobacco Use Disorder | 1991 |
[Results of clinical use of nicorette in the treatment of tobacco smokers].
Topics: Adult; Chewing Gum; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Polymethacrylic Acids; Polyvinyls; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 1991 |
Effect on smoking cessation of silver acetate, nicotine and ordinary chewing gum. Influence of smoking history.
Topics: Acetates; Acetic Acid; Adult; Chewing Gum; Female; Humans; Male; Middle Aged; Nicotine; Random Allocation; Recurrence; Smoking; Smoking Cessation | 1991 |
Signs and symptoms from nicotine gum abstinence.
Topics: Adult; Chewing Gum; Cotinine; Dose-Response Relationship, Drug; Female; Humans; Male; Nicotine; Saliva; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1991 |
Reinforcing breath carbon monoxide reductions in chronic obstructive pulmonary disease.
Topics: Breath Tests; Carbon Monoxide; Chewing Gum; Follow-Up Studies; Forced Expiratory Volume; Humans; Lung Diseases, Obstructive; Motivation; Nicotine; Saliva; Smoking Cessation; Thiocyanates; Token Economy | 1991 |
Effects of nicotine gum on prevalence and severity of withdrawal in female cigarette smokers.
Topics: Adult; Behavior Therapy; Chewing Gum; Combined Modality Therapy; Energy Intake; Female; Humans; Neurologic Examination; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1991 |
Metabolic effects of nicotine gum and cigarette smoking: potential implications for postcessation weight gain?
Topics: Adolescent; Adult; Chewing Gum; Energy Metabolism; Female; Humans; Nicotine; Smoking; Smoking Cessation; Weight Gain | 1991 |
Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. Transdermal Nicotine Study Group.
Topics: Administration, Cutaneous; Adult; Aged; Analysis of Variance; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Regression Analysis; Smoking Cessation | 1991 |
Utility of observer reports of smoking status.
Topics: Adult; Chewing Gum; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotine; Patient Compliance; Smoking Cessation; Social Environment | 1990 |
Relapse prevention versus broad spectrum treatment for smoking cessation: a comparison of efficacy.
Topics: Adult; Behavior Therapy; Carbon Monoxide; Chewing Gum; Cognitive Behavioral Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Recurrence; Saliva; Smoking; Smoking Cessation; Smoking Prevention; Thiocyanates; Treatment Outcome; Weight Gain | 1988 |
[Double-blind study of the efficacy of nicotine chewing gum for smoking cessation in the primary care setting].
Topics: Adult; Chewing Gum; Double-Blind Method; Female; Humans; Male; Nicotine; Primary Health Care; Smoking Cessation | 1989 |
1994 other study(ies) available for nicotine and Smoking Cessation
| Article | Year |
|---|---|
Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
Topics: Animals; Benzazepines; Cell Line; Cerebral Cortex; Humans; In Vitro Techniques; Nicotinic Agonists; Oocytes; Quinoxalines; Radioligand Assay; Rats; Receptors, Nicotinic; Smoking Cessation; Varenicline; Xenopus laevis | 2005 |
In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisine.
Topics: Alkaloids; Animals; Azocines; Carbon; Dopamine; Nicotinic Agonists; Nucleus Accumbens; Quinolizines; Rats; Receptors, Nicotinic; Smoking Cessation; Structure-Activity Relationship | 2005 |
3,5-Bicyclic aryl piperidines: a novel class of alpha4beta2 neuronal nicotinic receptor partial agonists for smoking cessation.
Topics: Animals; Cyclization; Molecular Structure; Piperidines; Rats; Receptors, Nicotinic; Smoking Cessation; Structure-Activity Relationship | 2005 |
Stability of Varenicline Concentration in Saliva Over 21 Days at Three Storage Temperatures.
Topics: Cotinine; Humans; Nicotine; Saliva; Smoking Cessation; Temperature; Varenicline | 2022 |
Public health impact of a US ban on menthol in cigarettes and cigars: a simulation study.
Topics: Electronic Nicotine Delivery Systems; Humans; Menthol; Nicotine; Public Health; Smoking; Smoking Cessation; Tobacco Products; Vaping | 2023 |
Topics: Animals; Dietary Supplements; Flavonoids; Ginkgo biloba; Mice; Microsomes, Liver; Nicotine; Quercetin; Smoking Cessation; Tobacco Use Cessation Devices | 2022 |
Barriers and facilitators to using vaporised nicotine products as smoking cessation aids among people receiving treatment for substance use disorder.
Topics: Australia; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Substance-Related Disorders; Tobacco Use Cessation Devices | 2022 |
Genetic predispositions moderate the effectiveness of tobacco excise taxes.
Topics: Databases, Factual; Genetic Predisposition to Disease; Humans; Nicotiana; Nicotine; Public Policy; Smoking; Smoking Cessation; Smoking Prevention; Taxes; Tobacco Industry; Tobacco Products; Tobacco Smoking; Tobacco Use; United States | 2021 |
Prevalence and characteristics of ever regular use of non-combustible nicotine for 1 year or more: a population survey in England.
Topics: Adult; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; England; Humans; Nicotine; Prevalence; Smoking Cessation; Tobacco Use Cessation Devices | 2021 |
Recommendations of the treatment-resistant depression expert center network for promoting tobacco smoking cessation based on the results from the real-world FACE-TRD national cohort.
Topics: Cohort Studies; Depressive Disorder, Treatment-Resistant; Female; Humans; Male; Middle Aged; Nicotine; Precision Medicine; Sex Factors; Smoking Cessation; Suicidal Ideation; Suicide, Attempted; Surveys and Questionnaires; Tobacco Smoking | 2022 |
Trajectories of Nicotine Use Leading to Dual and Cyclical Tobacco Product Use in Young Adults.
Topics: Adolescent; Adult; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Smoking Cessation; Tobacco Products; Tobacco Use Disorder; United States; Vaping; Young Adult | 2022 |
Associations Between Nicotine Knowledge and Smoking Cessation Behaviors Among US Adults Who Smoke.
Topics: Adult; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Vaping | 2022 |
Improving Spanish translations of tobacco dependence measures using cognitive interviewing.
Topics: Cognition; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder | 2022 |
[Nicotine, alcohol and opioids - three interacting substances].
Topics: Adolescent; Analgesics, Opioid; Humans; Nicotine; Smokers; Smoking Cessation; Tobacco Use Disorder | 2022 |
Not all smokers are alike: the hidden cost of sustained attention during nicotine abstinence.
Topics: Humans; Magnetic Resonance Imaging; Neuroimaging; Nicotine; Smokers; Smoking Cessation; Substance Withdrawal Syndrome | 2022 |
Effectiveness of e-cigarettes as aids for smoking cessation: evidence from the PATH Study cohort, 2017-2019.
Topics: Cohort Studies; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices | 2023 |
Nicotine pouch product awareness, interest and ever use among US adults who smoke, 2021.
Topics: Adult; Electronic Nicotine Delivery Systems; Humans; Nicotiana; Nicotine; Smoking; Smoking Cessation; Tobacco Products; Tobacco, Smokeless | 2023 |
Affective mechanisms of stress-induced cigarette craving: Considerations of gender and race/ethnicity.
Topics: Craving; Ethnicity; Female; Humans; Male; Nicotine; Smoking Cessation; Tobacco Products | 2022 |
Assessing combined effects of varenicline and N-acetylcysteine on reducing nicotine seeking in rats.
Topics: Acetylcysteine; Animals; Nicotine; Rats; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2022 |
Knowledge, Attitude, Practices, and Preparedness of Dental Professionals in Prescribing Nicotine Replacement Therapy.
Topics: Adult; Attitude of Health Personnel; Dentist-Patient Relations; Health Knowledge, Attitudes, Practice; Humans; India; Nicotine; Physician's Role; Primary Health Care; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2022 |
Preferences for different features of ENDS products by tobacco product use: a latent class analysis.
Topics: Adult; Electronic Nicotine Delivery Systems; Humans; Latent Class Analysis; Nicotine; Smoking Cessation; Tobacco Products; Tobacco Use; Tobacco Use Disorder | 2022 |
Assessment of the Exposure to Tobacco-Specific Nitrosamines and Minor Tobacco Alkaloids in Users of Various Tobacco/Nicotine Products.
Topics: Alkaloids; Biomarkers; Carcinogens; Electronic Nicotine Delivery Systems; Humans; Nicotiana; Nicotine; Nitrosamines; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices | 2022 |
Perceptions of Nicotine Reduction Policy in the United States: A Qualitative Study.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Policy; Smoking Cessation; Tobacco Products; United States; Young Adult | 2022 |
Do Smokers' Perceptions of the Harmfulness of Nicotine Replacement Therapy and Nicotine Vaping Products as Compared to Cigarettes Influence Their Use as an Aid for Smoking Cessation? Findings from the ITC Four Country Smoking and Vaping Surveys.
Topics: Acquired Immunodeficiency Syndrome; Alcoholism; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smokers; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices; United States; Vaping | 2022 |
The Effectiveness of E-Cigarettes for Smoking Cessation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bayes Theorem; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Humans; Middle Aged; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Young Adult | 2022 |
Beliefs and Characteristics Associated With Believing Nicotine Causes Cancer: A Descriptive Analysis to Inform Corrective Message Content and Priority Audiences.
Topics: Adult; Electronic Nicotine Delivery Systems; Humans; Neoplasms; Nicotiana; Nicotine; Smokers; Smoking Cessation; Tobacco Products | 2022 |
Effect of vaping on past-year smoking cessation success of Australians in 2019-evidence from a national survey.
Topics: Australia; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; United States; Vaping | 2022 |
Diversifying the Editorial Board of Nicotine & Tobacco Research.
Topics: Humans; Nicotiana; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2022 |
Tobacco-free Nicotine Pouch Use in Great Britain: A Representative Population Survey 2020-2021.
Topics: Adult; Aged; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices; United Kingdom | 2022 |
Effects of COVID-19-Related Disruptions on Service Use in a Large Smoking Cessation Program.
Topics: COVID-19; Humans; Nicotine; Ontario; Pandemics; Smoking Cessation; Tobacco Use Cessation Devices | 2022 |
Dual Orexin Receptor Antagonists (DORAs) as an Adjunct Treatment for Smoking Cessation.
Topics: Humans; Nicotine; Orexin Receptor Antagonists; Orexins; Sleep Initiation and Maintenance Disorders; Smoking Cessation; Tobacco Use Cessation Devices | 2022 |
Maternal nicotine exposure induces congenital heart defects in the offspring of mice.
Topics: Animals; Female; Heart Defects, Congenital; Humans; Male; Mice; Nicotine; Pregnancy; Prenatal Exposure Delayed Effects; Smoking Cessation; Tobacco Use Cessation Devices | 2022 |
Early Changes in Puffing Intensity When Exclusively Using Open-Label Very Low Nicotine Content Cigarettes.
Topics: Adult; Cigarette Smoking; Humans; Nicotine; Research; Smoking Cessation; Tobacco Products | 2022 |
Barriers and Facilitators for Smoking Cessation in Chinese Smokers with Chronic Obstructive Pulmonary Disease: A Qualitative Study.
Topics: Humans; Motivation; Nicotine; Pulmonary Disease, Chronic Obstructive; Recurrence; Smokers; Smoking Cessation | 2022 |
The youth e-cigarette epidemic: updates and review of devices, epidemiology and regulation.
Topics: Adolescent; Adult; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Products; United States; Vaping | 2022 |
Lucy-Novel Flavored Nicotine Gum, Lozenges, and Pouches: Are They Misleading Consumers?
Topics: Adolescent; Chewing Gum; Humans; Nicotine; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices | 2022 |
Estimating the public health impact had tobacco-free nicotine pouches been introduced into the US in 2000.
Topics: Adult; Aged; Aged, 80 and over; Humans; Middle Aged; Nicotine; Public Health; Smoking; Smoking Cessation; Tobacco Products | 2022 |
Characterising the use of varenicline: an analysis of the Australian dispensing claims data.
Topics: Aged; Australia; Benzazepines; Bupropion; Humans; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2022 |
The Impact of the Covid-19 Pandemic on Smoking Among Vulnerable Populations.
Topics: Adult; Cigarette Smoking; COVID-19; Humans; Nicotine; Pandemics; Smoking Cessation; Tobacco Products; Vulnerable Populations | 2023 |
Formulation and Characterization of Nicotine Microemulsion-Loaded Fast-Dissolving Films for Smoking Cessation.
Topics: Excipients; Nicotine; Smoking Cessation; Solubility; Solvents; Surface-Active Agents | 2022 |
Exploring Potential for a Personalized Medicine Approach to Smoking Cessation With an American Indian Tribe.
Topics: Adult; American Indian or Alaska Native; Humans; Nicotine; Precision Medicine; Smoking Cessation; Tobacco Use Cessation Devices | 2023 |
Predictors of Adherence Among Vulnerable Populations of Adults Assigned to Smoke Very Low Nicotine Content Cigarettes.
Topics: Adult; Analgesics, Opioid; Cotinine; Electronic Nicotine Delivery Systems; Female; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Disorder; Vulnerable Populations | 2022 |
Nanomicelles-in-coaxial nanofibers with exit channels as a transdermal delivery platform for smoking cessation.
Topics: Animals; Nanofibers; Nicotine; Rats; Smoking Cessation; Smoking Prevention; Tartrates; Tobacco Use Cessation Devices | 2022 |
[Therapeutic education in patients with coronary artery disease: impact on smoking cessation].
Topics: Coronary Artery Disease; Cross-Sectional Studies; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2022 |
Nicotine replacement gums dependence: A case report of a new potential addiction.
Topics: Alcoholism; Behavior, Addictive; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2023 |
Commentary: Smoking, nicotine and COVID-19 outcomes: unprecedented challenges to epidemiologists.
Topics: COVID-19; Epidemiologists; Humans; Nicotine; Smoking; Smoking Cessation | 2022 |
[Tobacco cessation treatment for people with schizophrenia].
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Schizophrenia; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Cessation Devices; Varenicline | 2022 |
FDA plans to reduce nicotine in cigarettes.
Topics: Humans; Nicotine; Smoking Cessation; Tobacco Products | 2022 |
Novel rapid-acting sublingual nicotine tablet as a cigarette substitution strategy.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotiana; Nicotine; Smoking Cessation; Tablets; Tobacco Products; Tobacco Use Cessation Devices | 2022 |
An update on vaping and nicotine prescribing.
Topics: Adult; Australia; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Vaping | 2022 |
Adult smokers' discussions about vaping with health professionals and subsequent behavior change: a cohort study.
Topics: Adult; Cohort Studies; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smokers; Smoking; Smoking Cessation; United States; Vaping | 2022 |
Reducing Misperceptions About Very Low Nicotine Content Cigarettes: Insights From Adults Who Smoke.
Topics: Adult; Female; Humans; Male; Nicotine; Qualitative Research; Smoking; Smoking Cessation; Tobacco Products | 2022 |
Predictors of electronic nicotine product quit attempts and cessation: Analysis of waves 3 and 4 of the PATH study.
Topics: Adult; Cigarette Smoking; Electronic Nicotine Delivery Systems; Health Behavior; Humans; Nicotine; Smoking Cessation | 2022 |
Understanding Hesitation to Use Nicotine Replacement Therapy: A Content Analysis of Posts in Online Tobacco-Cessation Support Groups.
Topics: Adult; Humans; Nicotiana; Nicotine; Self-Help Groups; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2023 |
Smoking cessation support strategies for Aboriginal and Torres Strait Islander women of reproductive age: findings from the Which Way? study.
Topics: Aged; Cross-Sectional Studies; Female; Health Services, Indigenous; Humans; Native Hawaiian or Other Pacific Islander; Nicotine; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder | 2022 |
Belief and Recall of Nicotine as Therapeutic for COVID-19 May Undermine E-Cigarette Quitting Behavior.
Topics: COVID-19; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Vaping; Young Adult | 2022 |
Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIV.
Topics: Feasibility Studies; Harm Reduction; HIV Infections; Humans; Nicotiana; Nicotine; Smoking Cessation; Vaping | 2023 |
Smoking habits, awareness and support needs for cessation among people with multiple sclerosis in Australia: findings from an online survey.
Topics: Adult; Australia; Humans; Multiple Sclerosis; Nicotine; Smoking; Smoking Cessation; Tobacco Smoke Pollution | 2022 |
Assessment of the exposure to polycyclic aromatic hydrocarbons in users of various tobacco/nicotine products by suitable urinary biomarkers.
Topics: Benzo(a)pyrene; Biomarkers; Carcinogens; Cotinine; Electronic Nicotine Delivery Systems; Fluorenes; Humans; Naphthalenes; Nicotiana; Nicotine; Oils; Phenanthrenes; Polycyclic Aromatic Hydrocarbons; Pyrenes; Smoking Cessation; Tobacco Products; Tobacco Smoke Pollution; Tobacco Use Cessation Devices | 2022 |
Tobacco/nicotine use among individuals using cannabis for therapeutic purposes.
Topics: Cannabis; Electronic Nicotine Delivery Systems; Female; Hallucinogens; Humans; Male; Medical Marijuana; Nicotiana; Nicotine; Smoking Cessation; Tobacco Products | 2022 |
Challenges and opportunities for tobacco control in Australia: a qualitative study.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotiana; Nicotine; Smoking Cessation; Tobacco Industry; Tobacco Products | 2022 |
Young adults' beliefs about modern oral nicotine products: Implications for uptake in nonvapers, dual use with e-cigarettes, and use to reduce/quit vaping.
Topics: Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Products; Vaping; Young Adult | 2023 |
An evaluation of a New Zealand "vape to quit smoking" programme.
Topics: Acquired Immunodeficiency Syndrome; Electronic Nicotine Delivery Systems; Humans; New Zealand; Nicotine; Retrospective Studies; Smoking; Smoking Cessation; Vaping | 2022 |
Nicotine Replacement Therapy Does Not Reduce Headaches Following Subarachnoid Hemorrhage: A Propensity Score-Matched Study.
Topics: Headache; Humans; Nicotine; Propensity Score; Retrospective Studies; Smoking Cessation; Subarachnoid Hemorrhage; Tobacco Use Cessation Devices | 2023 |
A Proposed Policy Agenda For Electronic Cigarettes In The US: Product, Price, Place, And Promotion.
Topics: Adolescent; Adult; Electronic Nicotine Delivery Systems; Humans; Nicotine; Policy; Smoking Cessation; Tobacco Products | 2022 |
Smoking Status, Nicotine Medication, Vaccination, and COVID-19 Hospital Outcomes: Findings from the COVID EHR Cohort at the University of Wisconsin (CEC-UW) Study.
Topics: Cohort Studies; COVID-19; COVID-19 Vaccines; Hospital Mortality; Hospitals; Humans; Nicotine; SARS-CoV-2; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Universities; Wisconsin | 2023 |
The Australia Smoking and Vaping Model: The Potential Impact of Increasing Access to Nicotine Vaping Products.
Topics: Australia; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation; Vaping | 2023 |
Nicotine Replacement Therapy for Smokers with Acute Aneurysmal Subarachnoid Hemorrhage: An International Survey.
Topics: Humans; Nicotine; Smokers; Smoking Cessation; Subarachnoid Hemorrhage; Surveys and Questionnaires; Tobacco Use Cessation Devices | 2022 |
Can electronic cigarettes help pregnant smokers quit, and are they as safe to use in pregnancy as nicotine replacement treatments?
Topics: Electronic Nicotine Delivery Systems; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Smokers; Smoking Cessation; Tobacco Use Cessation Devices | 2022 |
Time to Stop Using the Word "Smoker": Reflecting on the Role of Language in Advancing the Field of Nicotine and Tobacco Research.
Topics: Humans; Language; Nicotiana; Nicotine; Smoking Cessation; Tobacco Products | 2022 |
Comparison of urinary mercapturic acid excretions in users of various tobacco/nicotine products.
Topics: Acetylcysteine; Acrolein; Acrylamides; Biomarkers; Carcinogens; Electronic Nicotine Delivery Systems; Humans; Nicotiana; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices | 2023 |
Publicly subsidised smoking cessation medicines in times of COVID-19 in Australia: An interrupted time series analysis.
Topics: Bupropion; COVID-19; Humans; Interrupted Time Series Analysis; Nicotine; Nicotinic Agonists; Pandemics; Pharmaceutical Preparations; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2023 |
Factors influencing the practice of Smoking Cessation Assessment and Management among Primary Care Doctors (SCAAM-DOC) in three districts of Malaysia.
Topics: Cross-Sectional Studies; Humans; Malaysia; Nicotine; Nicotinic Agonists; Primary Health Care; Smoking Cessation; Tobacco Use Cessation Devices | 2022 |
Development of an Ultra-High Performance Liquid Chromatography method for the simultaneous mass detection of tobacco biomarkers in urine.
Topics: Anabasine; Biomarkers; Chromatography, High Pressure Liquid; Cotinine; Emulsions; Humans; Methylene Chloride; Nicotine; Reproducibility of Results; Smoking Cessation; Solvents; Tandem Mass Spectrometry; Tobacco Use; Tobacco Use Cessation Devices; Water | 2022 |
Immediate Switching to Reduced Nicotine Cigarettes in a U.S.-Based Sample: The Impact on Cannabis Use and Related Variables at 20 Weeks.
Topics: Biomarkers; Cannabis; Carcinogens; Humans; Nicotine; Smoking Cessation; Tobacco Products | 2023 |
FDA Gains Power to Regulate Synthetic Nicotine in e-Cigarettes.
Topics: Electronic Nicotine Delivery Systems; Nicotine; Smoking; Smoking Cessation | 2022 |
Public Health Practitioners' Knowledge towards Nicotine and Other Cigarette Components on Various Human Diseases in Pakistan: A Contribution to Smoking Cessation Policies.
Topics: Humans; Nicotiana; Nicotine; Pakistan; Policy; Public Health; Smoking Cessation; Tobacco Products | 2022 |
A dichotomy of smokers in the Philippines following sin tax reform: Distinguishing potential quitters from those unlikely to quit.
Topics: Adult; Commerce; Cross-Sectional Studies; Female; Humans; Nicotiana; Nicotine; Philippines; Smoking Cessation; Taxes; Tobacco Products; Tobacco Use Disorder | 2022 |
Assessment of Pharmaceutical Services for Smoking Cessation: An Effectiveness-Implementation Hybrid Study.
Topics: Antidepressive Agents; Nicotine; Pharmaceutical Services; Smoking Cessation; Tobacco Use Cessation Devices | 2022 |
Effects of Genetic Variants in the Nicotine Metabolism Pathway on Smoking Cessation.
Topics: Case-Control Studies; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2D6; Glucuronosyltransferase; Humans; Nicotine; Smoking Cessation | 2022 |
Concentrated Distribution of Nicotine Patches to a Town With High Smoking Rates-Any Evidence of Large Impacts on Tobacco Cessation?
Topics: Administration, Cutaneous; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Smoking; Tobacco Use Cessation | 2023 |
An Analysis of Arguments Advanced via Twitter in an Advocacy Campaign to Promote Electronic Nicotine Delivery Systems.
Topics: Child; Electronic Nicotine Delivery Systems; Humans; Nicotiana; Nicotine; Smoking Cessation; Social Media | 2023 |
Disparities in Nicotine Addictiveness and Cancer Harm Perceptions Among U.S. Adults: A Trend Analysis Using the Health Information National Trends Survey.
Topics: Adolescent; Adult; Electronic Nicotine Delivery Systems; Humans; Neoplasms; Nicotine; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2023 |
Nicotine dependence and intention to quit among electronic, conventional and dual cigarette users in Karachi.
Topics: Adolescent; Adult; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Electronics; Humans; Intention; Nicotine; Smoking Cessation; Tobacco Products; Tobacco Use Disorder; Young Adult | 2022 |
Electronic Nicotine Delivery Systems: An Updated Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology.
Topics: Adolescent; Adult; Electronic Nicotine Delivery Systems; Humans; Medical Oncology; Neoplasms; Nicotine; Policy; Smoking Cessation; United States | 2022 |
Antecedents of Self-Efficacy to Achieve Smoking-Behavior-Change Goals among Low-Income Parents Enrolled in an Evidence-Based Tobacco Intervention.
Topics: Child; Goals; Humans; Nicotiana; Nicotine; Self Efficacy; Smoking; Smoking Cessation; Tobacco Smoke Pollution; Tobacco Use Cessation Devices | 2022 |
Within-person decline in pregnancy smoking is observable prior to pregnancy awareness: Evidence across two independent observational cohorts.
Topics: Child; Female; Humans; Nicotine; Pregnancy; Smoking; Smoking Cessation; Tobacco Smoking; Tobacco Use Cessation Devices | 2022 |
Unintentional fatal toxicity due to nicotine chewing gum: A case report.
Topics: Adult; Chewing Gum; Electronic Nicotine Delivery Systems; Humans; Male; Nicotine; Nicotine Chewing Gum; Smoking Cessation; Tobacco Use Cessation Devices; Unconsciousness | 2022 |
Consumer experiences of long-term oral nicotine replacement therapy and related health information-seeking: A qualitative study.
Topics: Adolescent; Adult; Behavior Therapy; Humans; Information Seeking Behavior; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices | 2022 |
No controversy: e-cigarettes are not a treatment for tobacco/nicotine cessation.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotiana; Nicotine; Smoking Cessation; Tobacco Products; Tobacco Use Disorder | 2022 |
Confidence in nicotine for tobacco harm reduction-Bridging the policy-practice gap.
Topics: Electronic Nicotine Delivery Systems; Harm Reduction; Humans; Nicotiana; Nicotine; Professional Practice Gaps; Smoking Cessation; Tobacco Control; Tobacco Use Cessation Devices | 2023 |
Socializing with Smoker and Social Smoking Behavior among Chinese Male Smokers with Low Nicotine Dependence: The Mediating Roles of Belief of Smoking Rationalization and Smoker Identity.
Topics: Cross-Sectional Studies; Humans; Male; Nicotine; Rationalization; Smokers; Smoking; Smoking Cessation; Tobacco Use Disorder | 2022 |
Tobacco use and risk of COVID-19 infection in the Finnish general population.
Topics: COVID-19; Electronic Nicotine Delivery Systems; Finland; Humans; Nicotine; Smoking Cessation; Tobacco Use; Tobacco Use Cessation Devices | 2022 |
A Qualitative Analysis of the Experiences of People Who Resumed Smoking Following Exclusive Electronic Nicotine Delivery Systems Use.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotiana; Nicotine; Qualitative Research; Smoking; Smoking Cessation; Tobacco Products | 2023 |
E-cigarette Use Patterns, Flavors, and Device Characteristics Associated With Quitting Smoking Among a U.S. sample of Adults Using E-cigarettes in a Smoking Cessation Attempt.
Topics: Adult; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Products; United States; Vaping | 2023 |
Association of psychological distress with smoking cessation, duration of abstinence from smoking, and use of non-combustible nicotine-containing products: A cross-sectional population survey in Great Britain.
Topics: Adult; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Humans; Nicotine; Psychological Distress; Smoking; Smoking Cessation; United Kingdom | 2023 |
The Role of Emotion Differentiation in the Association Between Momentary Affect and Tobacco/Nicotine Craving in Young Adults.
Topics: Adolescent; Adult; Craving; Emotions; Female; Humans; Male; Nicotiana; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Young Adult | 2023 |
Trends in Over-the-Counter Nicotine Replacement Therapy Sales, U.S., 2017‒2020.
Topics: Commerce; Humans; Nicotiana; Nicotine; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices | 2023 |
Challenges and opportunities associated with e-cigarettes in Australia: A qualitative study.
Topics: Adolescent; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Smoking | 2023 |
Adequacy of nicotine replacement and success quitting tobacco in clinical populations: An observational study.
Topics: Humans; Nicotiana; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2023 |
E-Cigarette Quit Attempts and Experiences in a Convenience Sample of Adult Users.
Topics: Adult; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smokers; Smoking Cessation; Tobacco Use Disorder; Vaping | 2023 |
Public Perceptions on the Policy of Electronic Cigarettes as Medical Products on Twitter.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Public Opinion; Smoking; Smoking Cessation; Social Media; Vaping | 2023 |
Nicotine e-cigarettes as a tool for smoking cessation.
Topics: Electronic Nicotine Delivery Systems; Nicotine; Smoking Cessation | 2023 |
Development and Content Validation of a Questionnaire for Measuring Beliefs About Using Nicotine Replacement Therapy for Smoking Cessation in Pregnancy.
Topics: Female; Humans; Nicotine; Pregnancy; Pregnant Women; Self Report; Smoking Cessation; Tobacco Use Cessation Devices | 2023 |
Comparative effect of varenicline and nicotine patches on preventing repeat cardiovascular events.
Topics: Aftercare; Cardiovascular Diseases; Cohort Studies; Female; Humans; Male; Nicotine; Nicotinic Agonists; Patient Discharge; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2023 |
Increased Nicotine Consumption in Australia During the First Months of the COVID-19 Pandemic.
Topics: Australia; Communicable Disease Control; COVID-19; Humans; Nicotine; Pandemics; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2023 |
Vaporized nicotine use among patients in HIV care who smoke tobacco: perceived health effects and effectiveness as a smoking cessation tool.
Topics: Health Status; HIV Infections; Humans; Nicotiana; Nicotine; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2023 |
Youths' Perceptions of Nicotine Harm and Associations With Product Use.
Topics: Adolescent; Adult; Electronic Nicotine Delivery Systems; Humans; Longitudinal Studies; Neoplasms; Nicotine; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices | 2023 |
Recovery From Nicotine Addiction: A Diffusion Model Decomposition of Value-Based Decision-Making in Current Smokers and Ex-smokers.
Topics: Ex-Smokers; Humans; Nicotiana; Nicotine; Smokers; Smoking Cessation; Tobacco Use Disorder | 2023 |
Nicotine Dependence among College Students Uninterested in Smoking Cessation during the COVID-19 Pandemic: A Cross-Sectional Survey.
Topics: Adult; COVID-19; Cross-Sectional Studies; Humans; Nicotine; Nigeria; Pandemics; Smoking Cessation; Students; Surveys and Questionnaires; Tobacco Use Disorder; Young Adult | 2023 |
Electronic nicotine delivery systems: pragmatism or expectancy? - Authors' reply.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation | 2023 |
Smoking in women.
Topics: Female; Humans; Infant; Nicotine; Pregnancy; Smoking; Smoking Cessation | 1998 |
Genotyping, characterization, and imputation of known and novel CYP2A6 structural variants using SNP array data.
Topics: African People; Base Sequence; Black People; Cytochrome P-450 CYP2A6; European People; Genotype; Humans; Nicotine; Polymorphism, Single Nucleotide; Smoking Cessation; White People | 2023 |
Nicotine-Friend or Foe? The Complex Interplay Between Its Role in Dependence, Harm Reduction, and Risk Communication.
Topics: Communication; Harm Reduction; Humans; Nicotine; Smoking Cessation | 2023 |
Varenicline mitigates the increased risk of pseudarthrosis associated with nicotine.
Topics: Animals; Male; Nicotine; Pseudarthrosis; Rats; Rats, Sprague-Dawley; Smoking Cessation; Varenicline | 2023 |
[Smoking, heated tobacco products, alcohol and diabetes mellitus (update 2023)].
Topics: Benzazepines; Bupropion; Diabetes Mellitus; Electronic Nicotine Delivery Systems; Ethanol; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices | 2023 |
US Physicians' Self-reported Discussions About Tobacco-Free Nicotine Pouches During Clinical Encounters With Patients in 2021.
Topics: Humans; Nicotine; Physicians; Self Report; Smoking Cessation | 2023 |
Individual and Conjoint Factors Associated With Beliefs About the Harmfulness of Nicotine Replacement Therapies Relative to Combustible Cigarettes Among People Who Smoke: Findings From the 2020 ITC Four Country Smoking and Vaping Survey.
Topics: Adult; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Surveys and Questionnaires; Tobacco Products; Tobacco Use Cessation Devices; United States; Vaping | 2023 |
Can Treatment Support Mitigate Nicotine Metabolism-Based Disparities in Smoking Abstinence? Secondary Analysis of the Helping HAND 4 Trial.
Topics: Adult; Aftercare; Female; Humans; Male; Middle Aged; Nicotine; Patient Discharge; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices | 2023 |
How has Expenditure on Nicotine Products Changed in a Fast-Evolving Marketplace? A Representative Population Survey in England, 2018-2022.
Topics: Adult; Alcoholism; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; England; Health Expenditures; Humans; Nicotine; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices; Vaping | 2023 |
Chronotype, Social Jetlag, and Nicotine Use.
Topics: Chronotype; Circadian Rhythm; Disorders of Excessive Somnolence; Humans; Jet Lag Syndrome; Nicotine; Sleep; Smoking Cessation; Social Behavior; Surveys and Questionnaires; Tobacco Use Cessation Devices | 2023 |
Should Nicotine Replacement Therapy be Provided Free of Charge? A Cost-Utility Analysis in Sweden.
Topics: Cost-Benefit Analysis; Health Status Disparities; Humans; Nicotine; Smoking Cessation; Sweden; Tobacco Use Cessation Devices | 2023 |
Experiences of nicotine users motivated to quit during the COVID-19 pandemic: a secondary qualitative analysis.
Topics: British Columbia; COVID-19; Electronic Nicotine Delivery Systems; Humans; Nicotine; Pandemics; Smoking Cessation | 2023 |
How do smoking, vaping, and nicotine affect people with epilepsy and seizures? A scoping review protocol.
Topics: Epilepsy; Humans; Nicotine; Research Design; Review Literature as Topic; Seizures; Smoking; Smoking Cessation; Systematic Reviews as Topic; Tobacco Smoking; Tobacco Use Cessation Devices; Vaping | 2023 |
Associations between nicotine product use and craving among stable daily and non-daily users.
Topics: Craving; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Products; Tobacco Use Disorder | 2023 |
Smoking reduction using electronic nicotine delivery systems in combination with nicotine skin patches.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Smoking Reduction; Tobacco Use Cessation Devices | 2023 |
In Italy Banning Smoking Has Not Worked. How Crucial Are New Nicotine-Delivery Devices in Reducing Tobacco-Related Health Risk?
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotiana; Nicotine; Smoking; Smoking Cessation; Tobacco Smoking | 2023 |
Effect of the Nicotine Replacement Therapy on Biomarkers of Inflammation, Endothelial Dysfunction, Oxidative Stress, and Lipids in Smokers Who Quit Smoking.
Topics: Biomarkers; Humans; Inflammation; Lipids; Nicotine; Nicotinic Agonists; Oxidative Stress; Smokers; Smoking Cessation; Tobacco Use Cessation Devices | 2023 |
Protection of Children and Adolescents from Tobacco and Nicotine.
Topics: Adolescent; Child; Electronic Nicotine Delivery Systems; Humans; Nicotiana; Nicotine; Smoking Cessation; Tobacco Smoke Pollution | 2023 |
Applications of biomarkers of exposure and biological effects in users of new generation tobacco and nicotine products: Tentative proposals.
Topics: Biomarkers; Electronic Nicotine Delivery Systems; Humans; Nicotiana; Nicotine; Smoking; Smoking Cessation | 2023 |
Dental Hygienists Knowledge, Beliefs, and Intentions Regarding Asking Adolescents About Electronic Nicotine Delivery Systems Use.
Topics: Adolescent; Cross-Sectional Studies; Dental Hygienists; Electronic Nicotine Delivery Systems; Humans; Intention; Nicotine; Smoking Cessation | 2023 |
Perceptions, intentions, and actual use of a consumer nicotine gum.
Topics: Adolescent; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Humans; Intention; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Young Adult | 2023 |
Nicotine Receptor Partial Agonists for Smoking Cessation.
Topics: Humans; Nicotine; Smoking Cessation | 2023 |
Effects of reduced-risk nicotine-delivery products on smoking prevalence and cigarette sales: an observational study.
Topics: Adolescent; Bayes Theorem; Electronic Nicotine Delivery Systems; Humans; Nicotine; Prevalence; Smoking; Smoking Cessation; Tobacco Products; United States | 2023 |
Associations between smokers' knowledge of causes of smoking harm and related beliefs and behaviors: Findings from the International Tobacco Control (ITC) Four Country Smoking and Vaping Survey.
Topics: Attitude to Health; Electronic Nicotine Delivery Systems; Health Surveys; Humans; Nicotiana; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Control; United States; Vaping | 2023 |
How is nicotine vaping product (e-cigarette) use monitored in primary care electronic health records in the United Kingdom? An exploratory analysis of Clinical Practice Research Datalink (CPRD).
Topics: Electronic Health Records; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Primary Health Care; Smoking Cessation; United Kingdom; Vaping | 2023 |
Nicotine Use During Pregnancy: Cessation and Treatment Strategies.
Topics: Counseling; Female; Humans; Infant, Newborn; Nicotine; Pregnancy; Premature Birth; Smoking; Smoking Cessation | 2023 |
The smoking and vaping model, A user-friendly model for examining the country-specific impact of nicotine VAPING product use: application to Germany.
Topics: Adult; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Smoking; Vaping | 2023 |
Quantitation of Urine Nicotine, Cotinine, and 3-OH-Cotinine by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Topics: Chromatography, Liquid; Cotinine; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tandem Mass Spectrometry; Tobacco Use Cessation Devices | 2024 |
High Rates of Menthol Cigarette Use Among Pregnant Smokers: Preliminary Findings and Call for Future Research.
Topics: Adolescent; Adult; Ethnicity; Female; Humans; Menthol; Nicotine; Pregnancy; Prospective Studies; Smokers; Smoking; Smoking Cessation; Tobacco Use Disorder; United States; Young Adult | 2020 |
[Tobacco products and related: EU-CEG European Portal].
Topics: Cross-Sectional Studies; European Union; Humans; Nicotiana; Nicotine; Smoking; Smoking Cessation; Spain; Tobacco Products; Vaping | 2019 |
Distress intolerance and withdrawal severity among daily smokers: The role of smoking abstinence expectancies.
Topics: Adult; Attitude; Cigarette Smoking; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Patient Health Questionnaire; Psychological Distress; Severity of Illness Index; Smoking Cessation; Substance Withdrawal Syndrome | 2019 |
Nicotine addiction as a moral problem: Barriers to e-cigarette use for smoking cessation in two working-class areas in Northern England.
Topics: Adult; England; Female; Humans; Male; Morals; Nicotine; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Vaping | 2019 |
Response to nicotine following overnight smoking abstinence during short-term progesterone treatment in women.
Topics: Adolescent; Adult; Cross-Over Studies; Double-Blind Method; Female; Hormone Replacement Therapy; Humans; Nicotine; Progesterone; Smoking Cessation; Tobacco Use Cessation Devices; Young Adult | 2020 |
Lessons learned from animal models: adverse effects of electronic cigarettes.
Topics: Animals; Electronic Nicotine Delivery Systems; Nicotiana; Nicotine; Smoking Cessation; Tobacco Smoke Pollution | 2019 |
Examining effects of unit price on preference for reduced nicotine content cigarettes and smoking rate.
Topics: Adult; Aged; Aged, 80 and over; Consumer Behavior; Cost-Benefit Analysis; Economics, Behavioral; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Tobacco Smoking; United States; Vulnerable Populations | 2019 |
Nicotine without smoke: fighting the tobacco epidemic with harm reduction.
Topics: Electronic Nicotine Delivery Systems; Harm Reduction; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Vaping | 2019 |
[E-Cigarettes and Health - The Cons].
Topics: Adolescent; Electronic Nicotine Delivery Systems; Germany; Humans; Nicotine; Smoking; Smoking Cessation | 2019 |
E-cigarettes and dual nicotine replacement therapy for smoking cessation.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2020 |
Estimation of high-dimensional propensity scores with multiple exposure levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Bupropion; Cohort Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nicotine; Pharmacoepidemiology; Propensity Score; Proportional Hazards Models; Retrospective Studies; Smoking Cessation; United Kingdom; Varenicline; Young Adult | 2020 |
Electronic Nicotine Delivery Systems: Recommendations to Regulate Their Use.
Topics: Electronic Nicotine Delivery Systems; Nicotine; Smoking Cessation | 2019 |
Varenicline for cessation from nicotine-containing electronic cigarettes.
Topics: Behavior, Addictive; Humans; Male; Middle Aged; Nicotine; Severity of Illness Index; Smoking Cessation; Treatment Outcome; Vaping; Varenicline | 2019 |
Prevalence and correlates of long-term e-cigarette and nicotine replacement therapy use: a prospective study in England.
Topics: Adolescent; Adult; Correlation of Data; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; England; Female; Humans; Male; Middle Aged; Nicotine; Prevalence; Prospective Studies; Smoking; Smoking Cessation; Time Factors; Young Adult | 2019 |
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Pulmonary Medicine; Smoking Cessation; Tobacco Use Cessation Devices | 2019 |
Determining nicotine-related behavior changes in juvenile female rats through long-term maternal nicotine exposure.
Topics: Animals; Behavior, Animal; Body Weight; Female; Lactation; Maternal Behavior; Maternal Exposure; Nicotine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Smoking Cessation; Tobacco Use Cessation Devices | 2020 |
Are E-cigarettes more effective in supporting smoking cessation than nicotine-replacement therapy?
Topics: Alcoholism; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices | 2020 |
Linking nicotine addiction and T2DM.
Topics: Diabetes Mellitus, Type 2; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder; Transcription Factor 7-Like 2 Protein | 2020 |
Differences in mechanisms underlying reinstatement of cigarette smoke extract- and nicotine-seeking behavior in rats.
Topics: Animals; Behavior, Animal; Cues; Disease Models, Animal; Drug-Seeking Behavior; Extinction, Psychological; Male; Nicotiana; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Self Administration; Smoke; Smoking Cessation; Tobacco Products; Tobacco Use Disorder | 2020 |
Smokers' behavioral intentions in response to a low-nicotine cigarette policy.
Topics: Adult; Consumer Behavior; Electronic Nicotine Delivery Systems; Female; Humans; Intention; Male; Middle Aged; Nicotine; Policy; Smokers; Smoking; Smoking Cessation; Tobacco Products; Young Adult | 2019 |
Smokers with pain are more likely to report use of e-cigarettes and other nicotine products.
Topics: Adult; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Female; Humans; Longitudinal Studies; Male; Motivation; Nicotine; Pain; Smokers; Smoking Cessation | 2020 |
E-cigarette or Vaping product use Associated Lung Injury (EVALI): Health issues going beyond anaesthetic and surgical perioperative procedures.
Topics: Disease Outbreaks; Dronabinol; Electronic Nicotine Delivery Systems; Europe; Humans; Lung Injury; Nicotine; Risk Reduction Behavior; Smoking Cessation; United States; Vaping | 2019 |
A Forced-Choice Procedure to Assess the Acute Relative Reinforcing Effects of Nicotine Dose per se in Humans.
Topics: Adult; Behavior, Addictive; Choice Behavior; Female; Humans; Male; Nicotine; Reinforcement, Psychology; Smokers; Smoking; Smoking Cessation; Young Adult | 2020 |
Letter in Reply: Promoting accurate public health messages about electronic cigarettes: E-cigs contain carcinogens.
Topics: Carcinogens; Electronic Nicotine Delivery Systems; Humans; Nicotine; Public Health; Smoking Cessation | 2023 |
Reply to: "Promoting accurate public health messages about electronic cigarettes: E-cigs contain carcinogens".
Topics: Carcinogens; Electronic Nicotine Delivery Systems; Humans; Nicotine; Public Health; Smoking Cessation | 2023 |
The influence of nicotine metabolic rate on working memory over 6 hours of abstinence from nicotine.
Topics: Adult; Cigarette Smoking; Cognition; Female; Humans; Magnetic Resonance Spectroscopy; Male; Memory, Short-Term; Middle Aged; Nicotine; Prospective Studies; Reaction Time; Smoking Cessation; Time Factors; Young Adult | 2020 |
[Smoking cessation: Overcoming "nicotinophobia" in patients … and prescribers?]
Topics: Health Personnel; Heart Diseases; Humans; Medication Adherence; Nicotine; Nicotinic Agonists; Phobic Disorders; Smokers; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices | 2019 |
Long-term effectiveness and safety of varenicline and nicotine replacement therapy in people with neurodevelopmental disorders: A prospective cohort study.
Topics: Cohort Studies; Confidence Intervals; Female; Humans; Male; Neurodevelopmental Disorders; Nicotine; Propensity Score; Prospective Studies; Smoking Cessation; Varenicline | 2019 |
Effects of Very Low Nicotine Content Cigarettes on Smoking Behavior and Biomarkers of Exposure in Menthol and Non-menthol Smokers.
Topics: Biomarkers; Humans; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Products | 2019 |
Anticipated Effects of Nicotine Reduction on Youth Smoking Initiation and Maintenance.
Topics: Adolescent; Adult; Humans; Models, Statistical; Nicotine; Smokers; Smoking Cessation; Tobacco Products; Young Adult | 2019 |
Latent Classes of Nicotine Beliefs Correlate with Perceived Susceptibility and Severity of Nicotine and Tobacco Products in US young adults.
Topics: Adolescent; Adult; Cohort Studies; Health Knowledge, Attitudes, Practice; Humans; Nicotine; Smokers; Smoking Cessation; Young Adult | 2019 |
Interest in Illicit Purchase of Cigarettes Under a Very Low Nicotine Content Product Standard.
Topics: Adult; Humans; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Products; United States | 2019 |
Reducing the Nicotine Content of Cigarettes: Effects in Smokers With Mental Health Conditions and Socioeconomic Disadvantages.
Topics: Humans; Mental Disorders; Nicotine; Smokers; Smoking; Smoking Cessation; Socioeconomic Factors; Tobacco Products | 2019 |
Effects of Framing Nicotine Reduction in Cigarettes on Anticipated Tobacco Product Use Intentions and Risk Perceptions Among US Adult Smokers.
Topics: Adolescent; Adult; Craving; Cross-Sectional Studies; Health Knowledge, Attitudes, Practice; Humans; Nicotine; Risk; Smokers; Smoking Cessation; Tobacco Products; United States; Young Adult | 2019 |
Potential Moderating Effects of Psychiatric Diagnosis and Symptom Severity on Subjective and Behavioral Responses to Reduced Nicotine Content Cigarettes.
Topics: Anxiety; Depression; Humans; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Products | 2019 |
The Role of Compensation in Nicotine Reduction.
Topics: Humans; Nicotine; Smokers; Smoking Cessation | 2019 |
Marketing Influences on Perceptions of Reduced Nicotine Content Cigarettes.
Topics: Adolescent; Adult; Humans; Marketing; Nicotine; Product Packaging; Smokers; Smoking Cessation; Tobacco Products; Young Adult | 2019 |
Reducing Nicotine Without Misleading the Public: Descriptions of Cigarette Nicotine Level and Accuracy of Perceptions About Nicotine Content, Addictiveness, and Risk.
Topics: Adult; Behavior, Addictive; Health Knowledge, Attitudes, Practice; Humans; Nicotine; Smokers; Smoking Cessation; Tobacco Products | 2019 |
The American Heart Association Takes on Vaping.
Topics: Adolescent; American Heart Association; Cardiovascular Diseases; Electronic Nicotine Delivery Systems; Humans; Marketing; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Products; United States; United States Food and Drug Administration; Vaping | 2020 |
Smoking cessation, weight gain, and cardiovascular risk.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Nicotine; Risk Factors; Smoking; Smoking Cessation; Smoking Cessation Agents; Weight Gain | 2020 |
Health-care providers' concern regarding smoking cessation pharmacotherapies during pregnancy: Calls to a teratology information service.
Topics: Australia; Behavior Therapy; Bupropion; Call Centers; Female; Health Personnel; Humans; Information Services; Nicotine; Pregnancy; Smoking; Smoking Cessation; Teratology; Tobacco Use Cessation Devices; Varenicline | 2020 |
Nicotine dependence (trait) and acute nicotinic stimulation (state) modulate attention but not inhibitory control: converging fMRI evidence from Go-Nogo and Flanker tasks.
Topics: Adolescent; Adult; Attention; Brain; Brain Mapping; Cross-Over Studies; Double-Blind Method; Executive Function; Female; Humans; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder; Varenicline; Young Adult | 2020 |
Nicotine patches with e-cigarettes for smoking cessation: Twitter discussion from a respirology journal club.
Topics: Electronic Nicotine Delivery Systems; Nicotine; Smoking Cessation; Social Media; Tobacco Use Cessation Devices | 2020 |
Enforced smoking cessation programme prior to elective surgery.
Topics: Australia; Decision Making; Delivery of Health Care; Elective Surgical Procedures; Health Care Costs; Humans; Infections; New Zealand; Nicotine; Postoperative Complications; Preoperative Period; Smoking; Smoking Cessation; Wound Healing | 2020 |
Comparison of smoking cessation rates of Quitline users in Korea between smokers of ultra-low nicotine yield cigarettes and other types of cigarette: a prospective study.
Topics: Adult; Counseling; Humans; Male; Middle Aged; Nicotine; Prospective Studies; Republic of Korea; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Disorder; Young Adult | 2020 |
Unexpected loss of sensitivity to the nicotinic acetylcholine receptor antagonist activity of mecamylamine and dihydro-β-erythroidine in nicotine-tolerant mice.
Topics: Animals; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Drug Tolerance; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Smoking Cessation | 2020 |
Historical Perspective of Proactive and Reactive Regulations of E-cigarettes to Combat Nicotine Addiction.
Topics: Adolescent; Adult; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder | 2020 |
Nicotine patches with e-cigarettes for smoking cessation: Twitter discussion from a respirology journal club - Authors' reply.
Topics: Electronic Nicotine Delivery Systems; Nicotine; Smoking Cessation; Social Media; Tobacco Use Cessation Devices | 2020 |
Associations Between Nicotine Metabolite Ratio and Gender With Transitions in Cigarette Smoking Status and E-Cigarette Use: Findings Across Waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study.
Topics: Adolescent; Adult; Cigarette Smoking; Electronic Nicotine Delivery Systems; Female; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Research Design; Sex Factors; Smoking Cessation; Surveys and Questionnaires; United States; Vaping; Young Adult | 2020 |
Effectiveness of transdermal nicotine patch in premenopausal female smokers is moderated by within-subject severity of negative affect and physical symptoms.
Topics: Administration, Cutaneous; Adult; Affect; Cigarette Smoking; Female; Humans; Nicotine; Premenopause; Smokers; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome | 2020 |
Comprehensive Parent-Metabolite PBPK/PD Modeling Insights into Nicotine Replacement Therapy Strategies.
Topics: Cotinine; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices | 2020 |
Initial Information on a Novel Nicotine Product.
Topics: Adult; Cross-Sectional Studies; Female; Humans; Male; Nicotine; Nicotinic Agonists; North America; Risk Reduction Behavior; Smoking Cessation; Smoking Prevention; Tobacco Products; Tobacco Use Disorder | 2020 |
'Open-System' electronic cigarettes cannot be regulated effectively.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation | 2021 |
World No Tobacco Day: what's in it for us?
Topics: Humans; Nicotiana; Nicotine; Smoking Cessation | 2020 |
Subjective social status is indirectly associated with short-term smoking cessation through nicotine withdrawal symptoms.
Topics: Adult; Anxiety Disorders; Humans; Nicotine; Psychological Distance; Smoking Cessation; Substance Withdrawal Syndrome | 2021 |
Precision nicotine metabolism-informed care for smoking cessation in Crohn's disease: A pilot study.
Topics: Adult; Bupropion; Crohn Disease; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Pilot Projects; Prevalence; Randomized Controlled Trials as Topic; Severity of Illness Index; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2020 |
Does free nicotine replacement improve smoking cessation rates in cancer patients?
Topics: Aged; Humans; Middle Aged; Neoplasms; Nicotine; Pilot Projects; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome | 2020 |
Is nicotine damaging to oral tissues?
Topics: Electronic Nicotine Delivery Systems; Epithelial Cells; Humans; Nicotine; Periodontal Ligament; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2020 |
Differences in acute reinforcement across reduced nicotine content cigarettes.
Topics: Adult; Choice Behavior; Cigarette Smoking; Dose-Response Relationship, Drug; Female; Humans; Male; Nicotine; Reinforcement, Psychology; Smokers; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices | 2020 |
Pregnant Smokers Receiving Opioid Agonist Therapy Have an Elevated Nicotine Metabolite Ratio: A Replication Study.
Topics: Analgesics, Opioid; Bupropion; Cotinine; Female; Humans; Methadone; Nicotine; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Smoking; Smoking Cessation | 2020 |
The differential impact of nicotine replacement therapy sampling on cessation outcomes across established tobacco disparities groups.
Topics: Adult; Humans; Nicotiana; Nicotine; Smoking Cessation; South Carolina; Tobacco Use Cessation Devices | 2020 |
Beyond Smoking Cessation: Investigating Medicinal Nicotine to Prevent and Treat COVID-19.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Nicotine; Nicotinic Agonists; Pandemics; Pneumonia, Viral; SARS-CoV-2; Smoking Cessation | 2020 |
Novel microsimulation model of tobacco use behaviours and outcomes: calibration and validation in a US population.
Topics: Adult; Aged; Aged, 80 and over; Calibration; Cigarette Smoking; Computer Simulation; Female; Humans; Male; Middle Aged; Nicotine; Outcome Assessment, Health Care; Prevalence; Recurrence; Research Design; Smoking; Smoking Cessation; Tobacco Use; United States | 2020 |
Transitions in smoking and nicotine use from 2016 to 2017 among a UK cohort of adult smokers and ex-smokers.
Topics: Adult; Electronic Nicotine Delivery Systems; Ex-Smokers; Humans; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; United Kingdom | 2020 |
Commentary on a study of tobacco-related violence in a mental health setting.
Topics: Humans; Mental Health; Nicotiana; Nicotine; Smoking Cessation; Tobacco Use; Violence | 2020 |
Lack of Authoritative Measures to Support Abstinence From Nicotine.
Topics: Employment; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2020 |
Type of e-liquid vaped, poly-nicotine use and nicotine dependence symptoms in young adult e-cigarette users: a descriptive study.
Topics: Adolescent; Adolescent Health Services; Child; Cigarette Smoking; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Quebec; Smoking Cessation; Surveys and Questionnaires; Vaping; Young Adult | 2020 |
Acute effects of a very low nicotine content cigarette on laboratory smoking lapse: Impacts of nicotine metabolism and nicotine dependence.
Topics: Adult; Craving; Female; Humans; Male; Nicotine; Reinforcement, Psychology; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2021 |
Determination of anabasine, anatabine, and nicotine biomarkers in wastewater by enhanced direct injection LC-MS/MS and evaluation of their in-sewer stability.
Topics: Alkaloids; Anabasine; Australia; Biomarkers; Chromatography, Liquid; Cotinine; Electronic Nicotine Delivery Systems; Nicotine; Pyridines; Smoking Cessation; Tandem Mass Spectrometry; Tobacco Use Cessation Devices; Wastewater | 2020 |
The Public Health Gains Had Cigarette Companies Chosen to Sell Very Low Nicotine Cigarettes.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Nicotine; Prevalence; Public Health; Smoking Cessation; Tobacco Industry; Tobacco Smoking; United States | 2021 |
Tobacco and Nicotine Cessation During Pregnancy.
Topics: Female; Humans; Nicotiana; Nicotine; Pregnancy; Smoking Cessation; Tobacco Use Cessation Devices | 2020 |
A Time-to-Event Model Relating Integrated Craving to Risk of Smoking Relapse Across Different Nicotine Replacement Therapy Formulations.
Topics: Adult; Aged; Craving; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Recurrence; Retrospective Studies; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Young Adult | 2021 |
The Dilemma of Correcting Nicotine Misperceptions: Nicotine Replacement Therapy versus Electronic Cigarettes.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2021 |
Abuse liability of cigarettes with very low nicotine content in pregnant cigarette smokers.
Topics: Baltimore; Female; Humans; Nicotine; Pregnancy; Smokers; Smoking Cessation; Tobacco Products | 2020 |
Biocompatible SPME fibers for direct monitoring of nicotine and its metabolites at ultra trace concentration in rabbit plasma following the application of smoking cessation formulations.
Topics: Anabasine; Animals; Chromatography, High Pressure Liquid; Cotinine; Isotope Labeling; Limit of Detection; Nicotine; Rabbits; Reference Standards; Reproducibility of Results; Smoking Cessation; Solid Phase Microextraction; Tandem Mass Spectrometry; Time Factors | 2020 |
Dissecting the genetic overlap of smoking behaviors, lung cancer, and chronic obstructive pulmonary disease: A focus on nicotinic receptors and nicotine metabolizing enzyme.
Topics: Alleles; Cytochrome P-450 CYP2A6; Genome-Wide Association Study; Humans; Linkage Disequilibrium; Lung Neoplasms; Male; Middle Aged; Nerve Tissue Proteins; Nicotine; Polymorphism, Single Nucleotide; Pulmonary Disease, Chronic Obstructive; Receptors, Nicotinic; Risk Factors; Smoking; Smoking Cessation | 2020 |
Dual use of cigarettes and electronic nicotine delivery systems during pregnancy and the risk of small for gestational age neonates.
Topics: Adolescent; Adult; Cigarette Smoking; Cohort Studies; Electronic Nicotine Delivery Systems; Female; Humans; Infant, Newborn; Infant, Small for Gestational Age; Nicotine; Pregnancy; Premature Birth; Prenatal Exposure Delayed Effects; Smoking Cessation; Term Birth; Tobacco Products; Tobacco, Smokeless; United States; Young Adult | 2020 |
Nicotine Risk Misperception Among US Physicians.
Topics: Body Weight; Humans; Nicotine; Physicians; Smoking Cessation | 2021 |
Self-Perceived Oral Symptoms Associated with Nicotine Replacement Therapy.
Topics: Australia; Humans; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2020 |
Snus cessation patterns - a long-term follow-up of snus users in Sweden.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Sweden; Tobacco, Smokeless; Young Adult | 2020 |
Reported patterns of vaping to support long-term abstinence from smoking: a cross-sectional survey of a convenience sample of vapers.
Topics: Adult; Aged; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Smoking; Vaping | 2020 |
Smoking cessation increases levels of osteocalcin and uncarboxylated osteocalcin in human sera.
Topics: Adult; Animals; Bone Density; Cotinine; Female; Homeostasis; Humans; Male; Mice, Inbred C57BL; Middle Aged; Nicotine; Osteocalcin; Osteoclasts; Osteogenesis; Osteoporosis; Risk Factors; Smoking; Smoking Cessation; Tartrate-Resistant Acid Phosphatase | 2020 |
Respiratory illness linked with the use of electronic cigarettes: An alarming situation.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation | 2020 |
Can exercise alleviate sleep disturbances during acute nicotine withdrawal in cigarette smokers?
Topics: Female; Humans; Male; Nicotine; Sleep; Smokers; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Products; Tobacco Use Cessation Devices | 2022 |
E-cigarettes for smokers trying to quit.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smokers; Smoking Cessation; Tobacco Use Cessation Devices | 2020 |
Electronic cigarettes for smoking cessation: an opportunity to readdress smoking cessation treatment.
Topics: Behavior Therapy; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices | 2020 |
Social Determinants of Health and Smoking Cessation: A Challenge.
Topics: Diagnostic and Statistical Manual of Mental Disorders; Humans; Nicotine; Smoking Cessation; Social Determinants of Health; Tobacco Use Disorder; United States | 2020 |
Alignment of Medical and Psychosocial Sectors for Promotion of Tobacco Cessation among Residents of Public Housing: A Feasibility Study.
Topics: Adult; Baltimore; Feasibility Studies; Female; Humans; Male; Nicotine; Pilot Projects; Public Housing; Smoking Cessation; Social Support; Tobacco Use Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2020 |
Identifying factors that conjointly influence nicotine vaping product relative harm perception among smokers and recent ex-smokers: Findings from the 2016 ITC Four Country Smoking and Vaping Survey.
Topics: Adult; Australia; Canada; Electronic Nicotine Delivery Systems; England; Ex-Smokers; Female; Health Surveys; Humans; Male; Middle Aged; Nicotine; Perception; Smokers; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Smoking; Tobacco Use; Tobacco Use Cessation Devices; Vaping | 2021 |
Clearing the Haze: What Do We Still Need to Learn about Electronic Nicotine Delivery Systems?
Topics: Cardiovascular Diseases; Cigarette Smoking; Electronic Nicotine Delivery Systems; Humans; Neoplasms; Nicotine; Respiratory Tract Diseases; Smoking Cessation; Vaping | 2021 |
Attitudes towards a hypothetical 'clean nicotine' product and harm reduction among smokers.
Topics: Attitude; Australia; Electronic Nicotine Delivery Systems; Harm Reduction; Humans; Nicotine; Smokers; Smoking Cessation; Tobacco Use Cessation Devices | 2021 |
Household-smoking bans are associated with reduced nicotine exposure, increased smoking abstinence, and improved birth outcomes among pregnant women enrolled in smoking-cessation treatment.
Topics: Female; Humans; Nicotine; Pregnancy; Pregnant Women; Smoke-Free Policy; Smoking; Smoking Cessation | 2021 |
Temporal discounting and smoking cessation: choice consistency predicts nicotine abstinence in treatment-seeking smokers.
Topics: Adult; Bayes Theorem; Brain; Choice Behavior; Chronic Disease; Delay Discounting; Female; Humans; Magnetic Resonance Imaging; Male; Nicotine; Reward; Smokers; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder | 2021 |
Commentary on Taylor et al. : Nicotine replacement therapy in pregnancy-amalgamating and contextualising evidence from different study designs.
Topics: Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Prenatal Care; Smoking Cessation; Tobacco Use Cessation Devices | 2021 |
Medicaid coverage and use of nicotine replacement treatment.
Topics: Humans; Medicaid; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices; United States | 2021 |
Estimating the price elasticity of demand for JUUL E-cigarettes among teens.
Topics: Adolescent; Aged; Elasticity; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Public Health; Smokers; Smoking Cessation; Taxes; Tobacco Products | 2021 |
Young adults' intention to quit using JUUL.
Topics: Adolescent; Adult; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Female; Humans; Intention; Male; Marketing; Motivation; Nicotine; Smoking; Smoking Cessation; Students; Surveys and Questionnaires; Tobacco Products; Tobacco Use; Universities; Vaping; Young Adult | 2021 |
Relationship between the strength of craving as assessed by the Tobacco Craving Index and success of quitting smoking in Japanese smoking cessation therapy.
Topics: Adolescent; Adult; Aged; Craving; Female; Humans; Japan; Male; Middle Aged; Nicotiana; Nicotine; Regression Analysis; Risk Factors; Smokers; Smoking; Smoking Cessation; Tobacco Smoking; Tobacco Use; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2020 |
The Multi-Component Smoking Cessation Support Programme (McSCSP) is effective in patients with severe mental disorder without gender differences.
Topics: Female; Humans; Male; Nicotine; Nicotinic Agonists; Prospective Studies; Reproducibility of Results; Sex Factors; Smoking Cessation; Substance Withdrawal Syndrome | 2022 |
Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration.
Topics: Administration, Cutaneous; Administration, Oral; Humans; Nicotine; Retrospective Studies; Smokers; Smoking Cessation; Tobacco Use Cessation Devices | 2021 |
"I actually finally feel like the cigarettes aren't controlling me." - Interviews with participants smoking very low nicotine content cigarettes during a residential study.
Topics: Adult; Attitude; Cigarette Smoking; Emotions; Fatigue; Female; Humans; Male; Nicotine; Policy; Public Health; Qualitative Research; Smoking; Smoking Cessation; Tobacco Products; Tobacco Smoking | 2021 |
APOE genotype influences P3b amplitude and response to smoking abstinence in young adults.
Topics: Acoustic Stimulation; Adult; Apolipoprotein E3; Electroencephalography; Female; Genotype; Heterozygote; Humans; Male; Nicotine; Nicotinic Agonists; Parietal Lobe; Psychomotor Performance; Smoking; Smoking Cessation; Young Adult | 2021 |
Effectiveness of Non-Nicotinic E-Cigarettes to Reduce Cue- and Abstinence-Induced Cigarette Craving in Non-Treatment Seeking Daily Dependent Smokers.
Topics: Adult; Craving; Cues; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Smokers; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Products; Tobacco Use Cessation Devices; Young Adult | 2021 |
Acute subjective sensory perceptions predict relative reinforcing effects of smoked nicotine.
Topics: Adult; Humans; Nicotine; Perception; Smoke; Smoking Cessation; Tobacco Products | 2021 |
5-HT
Topics: Humans; Molecular Targeted Therapy; Nicotine; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Serotonin; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2021 |
Electronic cigarettes' withdrawal severity symptoms among users during intermittent fasting: a cross-sectional study.
Topics: Adolescent; Adult; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Fasting; Female; Humans; Islam; Jordan; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Young Adult | 2021 |
E-Cigarettes Versus Nicotine Replacement Therapy for Smoking Cessation : Hajek P, Phillips-waller A, Przulj D, et al. A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy. N Engl J Med. 2019;380(7):629-637.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2021 |
Use of additional nicotine replacement therapy by participants in a five-year follow-up of a tobacco cessation trial.
Topics: Follow-Up Studies; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Cessation Devices | 2021 |
Early life adversity and appetite hormones: The effects of smoking status, nicotine withdrawal, and relapse on ghrelin and peptide YY during smoking cessation.
Topics: Adverse Childhood Experiences; Appetite; Ghrelin; Humans; Nicotine; Peptide YY; Recurrence; Smoking; Smoking Cessation | 2021 |
Patterns of Non-Cigarette Tobacco and Nicotine Use Among Current Cigarette Smokers and Recent Quitters: Findings From the 2020 ITC Four Country Smoking and Vaping Survey.
Topics: Adult; Electronic Nicotine Delivery Systems; Humans; Nicotiana; Nicotine; Smokers; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Products; Tobacco Use Cessation Devices; United States; Vaping | 2021 |
A Single-Arm, Open-Label, Pilot, and Feasibility Study of a High Nicotine Strength E-Cigarette Intervention for Smoking Cessation or Reduction for People With Schizophrenia Spectrum Disorders Who Smoke Cigarettes.
Topics: Adult; Electronic Nicotine Delivery Systems; Feasibility Studies; Female; Humans; Male; Nicotine; Pilot Projects; Schizophrenia; Smoke; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices | 2021 |
An adapted smoking-cessation intervention for Turkish-speaking migrants in Switzerland: Predictors of smoking outcomes at one-year follow-up.
Topics: Adaptation, Physiological; Adult; Behavior Therapy; Cigarette Smoking; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Smoking Cessation; Switzerland; Tobacco Smoking; Tobacco Use Cessation Devices; Transients and Migrants; Turkey | 2021 |
Choice and Variety-Seeking of E-liquids and Flavor Categories by New Zealand Smokers Using an Electronic Cigarette: A Longitudinal Study.
Topics: Adolescent; Adult; Choice Behavior; Consumer Behavior; Electronic Nicotine Delivery Systems; Flavoring Agents; Humans; Longitudinal Studies; Male; Middle Aged; New Zealand; Nicotiana; Nicotine; Smokers; Smoking; Smoking Cessation; Taste; Tobacco Products; Tobacco Smoking; Tobacco Use; Vaping; Young Adult | 2021 |
Characteristics and changes over time of nicotine vaping products used by vapers in the 2016 and 2018 ITC Four Country Smoking and Vaping Surveys.
Topics: Adult; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smokers; Smoking; Smoking Cessation; Vaping | 2022 |
Responses to Gradual and Immediate Reduction of Nicotine in Cigarettes in Young Versus Older Adult Smokers.
Topics: Adolescent; Adult; Aged; Humans; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Products; United States; Young Adult | 2021 |
Electronic Cigarettes and Oral Health.
Topics: Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Nicotine; Oral Health; Smoking Cessation | 2021 |
Evaluation of long-term quitters: who stays smoke free forever?
Topics: Electronic Nicotine Delivery Systems; Female; Health Behavior; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; World Health Organization | 2021 |
Trends and Patterns of Tobacco and Nicotine Product Use Among Youth in Canada, England, and the United States From 2017 to 2019.
Topics: Adolescent; Canada; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Humans; Nicotiana; Nicotine; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices; United States | 2021 |
'It brings light to what you really put into your body': a focus group study of reactions to messages about nicotine reduction in cigarettes.
Topics: Electronic Nicotine Delivery Systems; Focus Groups; Humans; Nicotine; Smokers; Smoking Cessation; Tobacco Products | 2022 |
E-vaping and high-fat diet consumption: It's all a hazy memory.
Topics: Brain; Diet, High-Fat; Nicotine; Smoking Cessation; Vaping | 2021 |
Recognizing and Preventing Participant Deception in Online Nicotine and Tobacco Research Studies: Suggested Tactics and a Call to Action.
Topics: Deception; Humans; Nicotiana; Nicotine; Smoking; Smoking Cessation | 2021 |
Nicotine Induces Maternal and Fetal Inflammatory Responses Which Predispose Intrauterine Infection Risk in a Rat Model.
Topics: Amniotic Fluid; Animals; Female; Nicotine; Placenta; Pregnancy; Rats; Rats, Sprague-Dawley; Smoking Cessation; Tobacco Use Cessation Devices | 2021 |
Evaluating Nicotine Abstinence, Smoking Cessation, Reduction and its Relapsed Among Electronic Cigarettes Single and Dual Malaysian Users: A One Year Observational Study.
Topics: Adult; Electronic Nicotine Delivery Systems; Female; Humans; Malaysia; Male; Nicotine; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Products; Young Adult | 2021 |
A Comparison of Quit Outcomes for Men and Women in a Smoking Cessation Program Offering Personalized Nicotine Replacement Therapy and Counseling in Primary Care Clinics.
Topics: Counseling; Female; Humans; Male; Nicotine; Primary Health Care; Smoking Cessation; Tobacco Use Cessation Devices | 2021 |
Petition to ban nicotine pouches in Kenya.
Topics: Humans; Kenya; Nicotine; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2021 |
Wikipedia and Nicotine and Tobacco: Meeting People Where They Are.
Topics: Humans; Nicotiana; Nicotine; Smoking; Smoking Cessation; Tobacco Use | 2021 |
Reactions to reduced nicotine content cigarettes in a sample of young adult, low-frequency smokers.
Topics: Child, Preschool; Electronic Nicotine Delivery Systems; Female; Humans; Infant; Male; Nicotine; Pregnancy; Smokers; Smoking Cessation; Tobacco Products; Young Adult | 2021 |
The Effectiveness of Nicotine Replacement Therapy in Light Versus Heavier Smokers.
Topics: Humans; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2021 |
Differences in Switching Away From Smoking Among Adult Smokers Using JUUL Products in Regions With Different Maximum Nicotine Concentrations: North America and the United Kingdom.
Topics: Adult; Electronic Nicotine Delivery Systems; Humans; Longitudinal Studies; Nicotine; North America; Smokers; Smoking; Smoking Cessation; Tobacco Products; United Kingdom; United States; Vaping | 2021 |
Offering nicotine patches to all households in a community with high smoking rates: Pilot test of a population-based approach to promote tobacco cessation.
Topics: Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Cessation Devices | 2021 |
Characterizing symptoms of e-cigarette dependence: a qualitative study of young adults.
Topics: Adolescent; Adult; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder; Vaping; Young Adult | 2021 |
Chemical characterization of tobacco-free "modern" oral nicotine pouches and their position on the toxicant and risk continuums.
Topics: Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco, Smokeless | 2022 |
Topics of Nicotine-Related Discussions on Twitter: Infoveillance Study.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Social Media; Vaping | 2021 |
Influence of current and previous smoking on current phenotype in Parkinson's disease.
Topics: Aged; Humans; Middle Aged; Nicotine; Parkinson Disease; Phenotype; Smoking; Smoking Cessation | 2021 |
The feasibility, acceptability, and initial efficacy of a remotely delivered, financial-incentive intervention to initiate vaping abstinence in young adults.
Topics: Adolescent; Cotinine; Electronic Nicotine Delivery Systems; Feasibility Studies; Humans; Motivation; Nicotine; Smoking Cessation; Vaping; Young Adult | 2022 |
Views and preferences of people living with HIV about smoking, quitting and use of nicotine products.
Topics: Electronic Nicotine Delivery Systems; HIV Infections; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2021 |
Electronic Nicotine Product Cessation and Cigarette Smoking: Analysis of Waves 3 and 4 From the PATH Study.
Topics: Adult; Cigarette Smoking; Electronic Nicotine Delivery Systems; Electronics; Humans; Nicotiana; Nicotine; Smoking Cessation; Tobacco Products | 2022 |
Harm perceptions of nicotine-containing products and associated sources of information in UK adults with and without mental ill health: A cross-sectional survey.
Topics: Adult; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Humans; Nicotiana; Nicotine; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices; United Kingdom; Vaping | 2022 |
"Don't Know" Responses for Nicotine Vaping Product Features among Adult Vapers: Findings from the 2018 and 2020 ITC Four Country Smoking and Vaping Surveys.
Topics: Adult; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smokers; Smoking; Smoking Cessation; Vaping | 2021 |
Clinical Pharmacology of Electronic Nicotine Delivery Systems (ENDS): Implications for Benefits and Risks in the Promotion of the Combusted Tobacco Endgame.
Topics: Area Under Curve; Brain; Electronic Nicotine Delivery Systems; Humans; Metabolic Clearance Rate; Nicotiana; Nicotine; Prevalence; Smoking Cessation; Tobacco Use Disorder; United States; United States Food and Drug Administration | 2021 |
The Comparative Effectiveness of Varenicline and Nicotine Patches for Smoking Abstinence During Pregnancy: Evidence From a Population-based Cohort Study.
Topics: Australia; Cohort Studies; Female; Humans; Nicotine; Pregnancy; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2021 |
Comparison of saliva cotinine and exhaled carbon monoxide concentrations when smoking and after being offered dual nicotine replacement therapy in pregnancy.
Topics: Bayes Theorem; Carbon Monoxide; Cotinine; Female; Humans; Nicotine; Observational Studies as Topic; Pregnancy; Saliva; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2022 |
Ongoing Difficulty of Characterizing Nicotine Product Risks.
Topics: Electronic Nicotine Delivery Systems; Humans; Longitudinal Studies; Nicotine; Smoking Cessation | 2021 |
Tobacco, Nicotine and Health.
Topics: Adolescent; Electronic Nicotine Delivery Systems; Humans; Nicotiana; Nicotine; Smoking Cessation; Tobacco Products | 2021 |
The Cochrane review of electronic cigarettes for smoking cessation: remaining focused on the evidence.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Smoking Prevention | 2021 |
Self-control depletion and nicotine deprivation as precipitants of smoking cessation failure: A human laboratory model.
Topics: Adult; Behavior, Addictive; Craving; Delay Discounting; Humans; Models, Psychological; Nicotine; Self-Control; Smoking; Smoking Cessation | 2017 |
Estimating Demand and Cross-Price Elasticity for Very Low Nicotine Content (VLNC) Cigarettes Using a Simulated Demand Task.
Topics: Adolescent; Adult; Behavior, Addictive; Commerce; Female; Humans; Male; New Zealand; Nicotine; Smoking Cessation; Tobacco Products; Tobacco Smoking; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2018 |
The effect of varenicline and nicotine patch on smoking rate and satisfaction with smoking: an examination of the mechanism of action of two pre-quit pharmacotherapies.
Topics: Humans; Nicotine; Nicotinic Agonists; Personal Satisfaction; Research Design; Smartphone; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Smoking; Tobacco Use Cessation Devices; Varenicline | 2017 |
A system dynamics modelling approach to assess the impact of launching a new nicotine product on population health outcomes.
Topics: Electronic Nicotine Delivery Systems; Forecasting; Harm Reduction; Humans; Models, Theoretical; Nicotine; Smoking; Smoking Cessation; Tobacco Products | 2017 |
Electronic cigarette use is not associated with quitting of conventional cigarettes in youth smokers.
Topics: Adolescent; Electronic Nicotine Delivery Systems; Female; Follow-Up Studies; Hong Kong; Hotlines; Humans; Logistic Models; Longitudinal Studies; Male; Nicotine; Odds Ratio; Prevalence; Regression Analysis; Self Report; Smokers; Smoking; Smoking Cessation; Social Class; Surveys and Questionnaires; Tobacco Products; Tobacco Use Disorder; Young Adult | 2017 |
Nicotine Withdrawal Induces Neural Deficits in Reward Processing.
Topics: Adult; Brain; Electroencephalography; Female; Humans; Male; Middle Aged; Nicotine; Reward; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2017 |
Love Conquers all but Nicotine: Spousal Peer Effects on the Decision to Quit Smoking.
Topics: Adolescent; Adult; Algorithms; Decision Making; Female; Humans; Male; Netherlands; Nicotine; Smoking Cessation; Spouses; Surveys and Questionnaires; Young Adult | 2017 |
Nicotine Metabolite Ratio (NMR) Prospectively Predicts Smoking Relapse: Longitudinal Findings From ITC Surveys in Five Countries.
Topics: Cross-Sectional Studies; Humans; Mauritius; Mexico; Nicotine; Recurrence; Saliva; Smoking; Smoking Cessation; Thailand; Tobacco Use Disorder; United Kingdom; United States | 2017 |
Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophrenia.
Topics: Adult; Antipsychotic Agents; Cognition; Cognition Disorders; Female; Humans; Male; Models, Theoretical; Neuropsychological Tests; Nicotine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking; Smoking Cessation | 2018 |
Evaluation of Nicotine Pharmacokinetics and Subjective Effects following Use of a Novel Nicotine Delivery System.
Topics: Administration, Inhalation; Adult; Craving; Cross-Over Studies; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Smokers; Smoking Cessation; Surveys and Questionnaires; Tobacco Smoking; Young Adult | 2018 |
E-cigarettes and Weight Loss-Product Design Innovation Insights From Industry Patents.
Topics: Electronic Nicotine Delivery Systems; Equipment Design; Humans; Marketing; Nicotine; Patents as Topic; Smoking Cessation; Tobacco Industry; Tobacco Products; Vaping; Weight Loss | 2018 |
Using PICO Methodology to Answer Questions About Smoking in COPD Patients.
Topics: Biomarkers; Bupropion; Clinical Trials as Topic; Cost-Benefit Analysis; Counseling; Evidence-Based Medicine; Humans; Motivation; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Spirometry; Surveys and Questionnaires; Varenicline | 2017 |
Effects of Smoking and Smoking Cessation during Pregnancy on Adverse Birth Outcomes in Rhode Island, 2012-2014.
Topics: Adult; Female; Humans; Income; Logistic Models; Nicotine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Rhode Island; Risk Assessment; Smoking; Smoking Cessation; Young Adult | 2017 |
Perspectives of key stakeholders and smokers on a very low nicotine content cigarette-only policy: qualitative study.
Topics: Adolescent; Adult; Electronic Nicotine Delivery Systems; Female; Focus Groups; Humans; Male; Middle Aged; New Zealand; Nicotine; Qualitative Research; Smoking; Smoking Cessation; Tobacco Products; Young Adult | 2017 |
Vaporised nicotine and tobacco harm reduction for addressing smoking among people living with HIV: A cross-sectional survey of Australian HIV health practitioners' attitudes.
Topics: Attitude of Health Personnel; Australia; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Female; HIV Infections; Humans; Male; Nebulizers and Vaporizers; Nicotine; Smoking Cessation; Surveys and Questionnaires | 2017 |
Diverging effects of nicotine on motor learning performance: Improvement in deprived smokers and attenuation in non-smokers.
Topics: Adult; Female; Ganglionic Stimulants; Humans; Learning; Male; Motor Activity; Nicotine; Psychomotor Performance; Reaction Time; Smokers; Smoking Cessation; Young Adult | 2017 |
[Electronic nicotine release systems, the healthy evolution of smoking].
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Smoking Prevention | 2017 |
Effects of nicotine versus placebo e-cigarette use on symptom relief during initial tobacco abstinence.
Topics: Adolescent; Adult; Craving; Cross-Over Studies; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2017 |
Nicotine biomarkers and rate of nicotine metabolism among cigarette smokers taking buprenorphine for opioid dependency.
Topics: Biomarkers; Buprenorphine; Humans; Nicotine; Opioid-Related Disorders; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use | 2017 |
Tobacco Use Prevalence and Outcomes Among Perinatal Patients Assessed Through an "Opt-out" Cessation and Follow-Up Clinical Program.
Topics: Adult; Continuity of Patient Care; Counseling; Female; Follow-Up Studies; Health Care Surveys; Humans; Inpatients; Nicotine; Pregnancy; Prevalence; Smoking; Smoking Cessation; Telephone; Tobacco Use; Treatment Outcome | 2017 |
Effects of ceftriaxone on conditioned nicotine reward in rats.
Topics: Animals; Ceftriaxone; Conditioning, Classical; Conditioning, Psychological; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Reward; Smoking; Smoking Cessation; Tobacco Use Disorder | 2017 |
Online Vape Shop Customers Who Use E-Cigarettes Report Abstinence from Smoking and Improved Quality of Life, But a Substantial Minority Still Have Vaping-Related Health Concerns.
Topics: Adult; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Netherlands; Nicotine; Perception; Quality Improvement; Quality of Life; Smoking Cessation; Tobacco Smoking; Tobacco Use Disorder; Vaping | 2017 |
Selective and regulated trapping of nicotinic receptor weak base ligands and relevance to smoking cessation.
Topics: HEK293 Cells; Humans; Hydrogen-Ion Concentration; Ligands; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Smoking Cessation; Up-Regulation; Varenicline | 2017 |
Measures and predictors of varenicline adherence in the treatment of nicotine dependence.
Topics: Adult; Affect; Craving; Female; Humans; Logistic Models; Male; Medication Adherence; Middle Aged; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Saliva; Self Report; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline | 2017 |
Smoking relapse situations among a community-recruited sample of Spanish daily smokers.
Topics: Adult; Affect; Aged; Aged, 80 and over; Craving; Female; Habits; Humans; Life Change Events; Male; Middle Aged; Nicotine; Nicotinic Agonists; Recurrence; Smokers; Smoking; Smoking Cessation; Smoking Prevention; Spain; Substance Withdrawal Syndrome; Surveys and Questionnaires; Young Adult | 2017 |
Use of higher-nicotine/tar-yield (regular full-flavor) cigarettes is associated with nicotine dependence and smoking during pregnancy among U.S. women.
Topics: Adolescent; Adult; Cigarette Smoking; Female; Health Surveys; Humans; Nicotine; Pregnancy; Prevalence; Smokers; Smoking Cessation; Tobacco Use Disorder; United States | 2017 |
A Nicotine-Focused Framework for Public Health.
Topics: Government Regulation; Humans; Nicotine; Public Health; Smoking Cessation; Tobacco Products; Tobacco Use Disorder; United States; United States Food and Drug Administration | 2017 |
FDA's new plan to reduce the nicotine in cigarettes to sub-addictive levels could be a game-changer.
Topics: Behavior, Addictive; Cigarette Smoking; Consumer Product Safety; Government Regulation; Harm Reduction; Health Policy; Humans; Nicotine; Nicotinic Agonists; Policy Making; Risk Factors; Smoking Cessation; Tobacco Products; Tobacco Use Disorder; United States; United States Food and Drug Administration | 2016 |
Nicotine addiction, reduction, and smoking cessation.
Topics: Humans; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Products; Tobacco Use Disorder; United States; United States Food and Drug Administration | 2017 |
Evaluating the effect of smoking cessation treatment on a complex dynamical system.
Topics: Bupropion; Craving; Drug Therapy, Combination; Fatigue; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tablets; Tobacco Use Cessation Devices; Treatment Outcome | 2017 |
E-Cigarettes and Toxin Exposure.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation | 2017 |
E-Cigarettes and Toxin Exposure.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation | 2017 |
Unpacking smokers' beliefs about addiction and nicotine: A qualitative study.
Topics: Adolescent; Adult; Behavior, Addictive; Focus Groups; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Nicotine; Qualitative Research; Smokers; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; United States; Young Adult | 2017 |
Abstinence-induced withdrawal severity among adolescent smokers with and without ADHD: disentangling effects of nicotine and smoking reinstatement.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Female; Humans; Male; Nicotine; Smokers; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Smoking; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2018 |
Sex differences in tobacco withdrawal and responses to smoking reduced-nicotine cigarettes in young smokers.
Topics: Affect; Craving; Female; Humans; Male; Nicotine; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2018 |
[Smoking cessation and pregnancy].
Topics: Behavior Therapy; Breast Feeding; Electronic Nicotine Delivery Systems; Female; Fetal Development; Humans; Infant Health; Infant, Newborn; Maternal Health; Nicotine; Pregnancy; Pregnant Women; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2017 |
The effectiveness of varenicline versus nicotine replacement therapy on long-term smoking cessation in primary care: a prospective cohort study of electronic medical records.
Topics: Adult; Electronic Health Records; England; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nicotine; Primary Health Care; Propensity Score; Prospective Studies; Smoking Cessation; Social Class; Time Factors; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2017 |
Association of nicotine metabolism and sex with relapse following varenicline and nicotine replacement therapy.
Topics: Adult; Cotinine; Cytochrome P-450 CYP2A6; Female; Genotype; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Recurrence; Smoking; Smoking Cessation; Tobacco Products; Varenicline | 2017 |
Sex Differences in Subjective Responses To Moderate Versus Very Low Nicotine Content Cigarettes.
Topics: Adult; Cigarette Smoking; Female; Humans; Male; Middle Aged; Nicotine; Random Allocation; Sex Characteristics; Smoking Cessation; Tobacco Products; Young Adult | 2018 |
Reversal of Nicotine Withdrawal Signs Through Positive Allosteric Modulation of α4β2 Nicotinic Acetylcholine Receptors in Male Mice.
Topics: Allosteric Regulation; Animals; Hydrocarbons, Brominated; Indole Alkaloids; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred ICR; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2018 |
Anxiety Sensitivity and Nicotine Replacement Therapy Side Effects: Examining the Role of Emotion Dysregulation Among Treatment-Seeking Smokers.
Topics: Adult; Anxiety; Emotions; Female; Humans; Male; Middle Aged; Nicotine; Smokers; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2017 |
"They're thinking, well it's not as bad, I probably won't get addicted to that. But it's still got the nicotine in it, so…": Maturity, Control, and Socializing: Negotiating Identities in Relation to Smoking and Vaping-A Qualitative Study of Young Adults i
Topics: Adolescent; Adult; Behavior, Addictive; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Qualitative Research; Scotland; Smokers; Smoking Cessation; Tobacco Smoking; Vaping; Young Adult | 2019 |
Reduction of anxiety sensitivity in relation to nicotine withdrawal symptoms during smoking cessation: an examination among successful quitters.
Topics: Adult; Alcoholism; Anxiety; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Self Concept; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2018 |
Nicotine Intake in Pregnant Smokers and a General Population of Smokers.
Topics: Adult; Cotinine; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Nicotine; Pregnancy; Saliva; Smokers; Smoking; Smoking Cessation; Young Adult | 2018 |
Characterising the nicotine metabolite ratio and its association with treatment choice: A cross sectional analysis of Stop Smoking Services in England.
Topics: Adult; Cigarette Smoking; Cross-Sectional Studies; England; Female; Humans; Male; Middle Aged; Nicotine; Patient Selection; Smokers; Smoking Cessation; Tobacco Smoking; Tobacco Use Cessation Devices | 2017 |
AMB warns against the use of electronic nicotine delivery devices: Electronic and heated cigarettes.
Topics: Brazil; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Societies, Medical; Tobacco Products | 2017 |
Predicting Short-Term Uptake of Electronic Cigarettes: Effects of Nicotine, Subjective Effects, and Simulated Demand.
Topics: Adult; Cigarette Smoking; Craving; Electronic Nicotine Delivery Systems; Female; Forecasting; Humans; Male; Middle Aged; New Zealand; Nicotine; Smokers; Smoking Cessation; Substance Withdrawal Syndrome; Vaping | 2018 |
Protecting Young Children From Tobacco Smoke Exposure: A Pilot Study of Project Zero Exposure.
Topics: Air Pollution, Indoor; Biomarkers; Child; Environmental Exposure; Hair; Health Behavior; Health Education; Humans; Israel; Motivational Interviewing; Nicotine; Parents; Pilot Projects; Smoking Cessation; Tobacco Smoke Pollution; Tobacco Smoking | 2018 |
Differences between Dual Users and Switchers Center around Vaping Behavior and Its Experiences Rather than Beliefs and Attitudes.
Topics: Adult; Attitude; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Products; Tobacco Smoke Pollution; Vaping | 2017 |
Electronic cigarettes for adults with tobacco dependence enrolled in a tobacco treatment program: A pilot study.
Topics: Adult; Counseling; Electronic Nicotine Delivery Systems; Female; Harm Reduction; Humans; Male; Middle Aged; Nicotine; Patient Acceptance of Health Care; Pilot Projects; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; Transdermal Patch | 2018 |
Initial ratings of different types of e-cigarettes and relationships between product appeal and nicotine delivery.
Topics: Adult; Consumer Behavior; Craving; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Perception; Smoking Cessation; Smoking, Non-Tobacco Products; Vaping | 2018 |
An enzymatic advance in nicotine cessation therapy.
Topics: Albumins; Bacterial Proteins; Brain; Enzyme Stability; Half-Life; Humans; Nicotine; Pseudomonas putida; Smoking Cessation | 2018 |
Smoking cessation medications ineffective in US smokers.
Topics: Female; Humans; Male; Nicotine; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Failure; United States | 2018 |
E-Cigarettes: Use, Effects on Smoking, Risks, and Policy Implications.
Topics: Adolescent; Cigarette Smoking; Electronic Nicotine Delivery Systems; Humans; Nicotine; Policy; Smoking Cessation; Smoking Prevention | 2018 |
Public misperception that very low nicotine cigarettes are less carcinogenic.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Nicotine; Smokers; Smoking Cessation; Tobacco Products; Young Adult | 2018 |
Tobacco smoking, E-cigarettes, and nicotine harm.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotiana; Nicotine; Smoking Cessation; Tobacco Smoking; Tobacco Use Disorder | 2018 |
E-cigarettes Associated With Depressed Smoking Cessation: A Cross-sectional Study of 28 European Union Countries.
Topics: Adult; Aged; Cross-Sectional Studies; Datasets as Topic; Electronic Nicotine Delivery Systems; European Union; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Tobacco Products; United Kingdom | 2018 |
Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats.
Topics: Alcohol Drinking; Animals; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Ethanol; Female; Modafinil; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Receptors, Nicotinic; Self Administration; Smoking Cessation; Varenicline | 2018 |
Public Health England publishes e-cigarette review.
Topics: Consumer Product Safety; Electronic Nicotine Delivery Systems; England; Evidence-Based Medicine; Humans; Inhalation Exposure; Nicotine; Nicotinic Agonists; Public Health; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; State Medicine; Vaping | 2018 |
Effect of Permeation Enhancers on the Buccal Permeability of Nicotine: Ex vivo Transport Studies Complemented by MALDI MS Imaging.
Topics: Administration, Buccal; Animals; Cheek; Drug Compounding; Excipients; Models, Animal; Mouth Mucosa; Nicotine; Oral Mucosal Absorption; Permeability; Smoking Cessation; Smoking Cessation Agents; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sus scrofa | 2018 |
Vaping Topography and Reasons of Use among Adults in Klang Valley, Malaysia
Topics: Adult; Electronic Nicotine Delivery Systems; Female; Humans; Malaysia; Male; Nicotine; Smoking Cessation; Surveys and Questionnaires; Tobacco Products; Vaping | 2018 |
Reinforcement Enhancing Effects of Nicotine Via Patch and Nasal Spray.
Topics: Adult; Female; Humans; Male; Nasal Sprays; Nicotine; Reinforcement, Psychology; Reward; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2019 |
Nicotine Abstinence Influences the Calculation of Salience in Discrete Insular Circuits.
Topics: Adult; Brain Mapping; Cerebral Cortex; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Nicotine; Rest; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2018 |
Behavioral Economic Purchase Tasks to Estimate Demand for Novel Nicotine/tobacco Products and Prospectively Predict Future Use: Evidence From The Netherlands.
Topics: Adult; Economics, Behavioral; Female; Humans; Male; Netherlands; Nicotine; Prospective Studies; Smokers; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Products | 2019 |
Intolerance for smoking abstinence among nicotine-deprived, treatment-seeking smokers.
Topics: Adaptation, Psychological; Adult; Craving; Cues; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2018 |
E-cigarettes: from nicotine to cannabinoids, the French situation.
Topics: Cannabinoid Receptor Agonists; Dronabinol; Electronic Nicotine Delivery Systems; France; Humans; Nicotine; Smoking Cessation; Tobacco Use; Vaping | 2018 |
Smoking cessation treatment outcomes among people with and without mental and substance use disorders: An observational real-world study.
Topics: Adult; Brazil; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotine; Nortriptyline; Outcome and Process Assessment, Health Care; Psychotherapy, Group; Smoking; Smoking Cessation; Substance-Related Disorders; Treatment Outcome | 2018 |
[Clinical Practice Guidelines for Smoking Cessation].
Topics: Bupropion; Chile; Evidence-Based Medicine; Humans; Nicotine; Smoking Cessation; Varenicline | 2017 |
Examining Risk Perceptions Among Daily Smokers Naïve to Reduced Nicotine Content Cigarettes.
Topics: Adult; Cigarette Smoking; Female; Health Risk Behaviors; Humans; Male; Middle Aged; Nicotine; Smokers; Smoking Cessation; Surveys and Questionnaires; Tobacco Products; Tobacco Use Disorder; Young Adult | 2019 |
Cytisine for smoking cessation.
Topics: Alkaloids; Azocines; Humans; Meta-Analysis as Topic; Nicotine; Nicotinic Agonists; Quinolizines; Smoking Cessation; Systematic Reviews as Topic; Treatment Outcome | 2018 |
Targeting Nicotine Addiction.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Guidelines as Topic; Humans; Male; Middle Aged; Nicotine; Nurse's Role; Oncology Nursing; Smoking Cessation; Tobacco Use Disorder; Young Adult | 2018 |
Developing a laboratory model of smoking lapse targeting stress and brief nicotine deprivation.
Topics: Adult; Affect; Cigarette Smoking; Craving; Economics, Behavioral; Female; Humans; Imagery, Psychotherapy; Male; Middle Aged; Motivation; Nicotine; Random Allocation; Reinforcement, Psychology; Self Administration; Smoking Cessation; Stress, Psychological; Young Adult | 2018 |
Obesity Paradox and Smoking Gun: A Mystery of Statistical Confounding?
Topics: Body Mass Index; Body Weight; Cardiovascular Diseases; Humans; Insulin; Insulin Resistance; Lipogenesis; Lipolysis; Nicotine; Nicotinic Agonists; Non-Smokers; Obesity; Smokers; Smoking; Smoking Cessation; Thinness | 2018 |
Anthropometric and body composition changes in smokers vs abstainers following an exercise-aided pharmacotherapy smoking cessation trial for women.
Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Anthropometry; Body Composition; Body Fat Distribution; Exercise; Female; Humans; Intra-Abdominal Fat; Middle Aged; Nicotine; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Weight Gain | 2018 |
A retrospective analysis of the association between providing nicotine replacement therapy at admission and motivation to quit and nicotine withdrawal symptoms during an inpatient psychiatric hospitalization.
Topics: Adult; Anger; Anxiety; Attention; Craving; Depression; Female; Hospitalization; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Retrospective Studies; Sleep Initiation and Maintenance Disorders; Smoking Cessation; Substance Withdrawal Syndrome | 2018 |
Managing nicotine without smoke to save lives now: Evidence for harm minimization.
Topics: Electronic Nicotine Delivery Systems; Harm Reduction; Humans; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Products | 2018 |
Smoking Decisions: Altered Reinforcement Learning Signals Induced by Nicotine State.
Topics: Adolescent; Adult; Behavior, Addictive; Decision Making; Female; Humans; Male; Nicotine; Photic Stimulation; Reinforcement, Psychology; Smokers; Smoking Cessation; Tobacco Smoking; Tobacco Use Disorder; Young Adult | 2020 |
Characteristics of Adult Cigarette Smokers Who "Relight" and the Effects of Exposure to Tobacco Smoke Constituents.
Topics: Adult; Aged; Biomarkers; Cigarette Smoking; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Nicotine; Risk Factors; Smokers; Smoking; Smoking Cessation; Tobacco Products; Tobacco Smoke Pollution; Tobacco Use Disorder; Young Adult | 2019 |
Barriers to electronic cigarette use.
Topics: Adult; Electronic Nicotine Delivery Systems; Female; Health Behavior; Humans; Male; Nicotine; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Products; Young Adult | 2018 |
Denicotinised cigarettes.
Topics: Adolescent; Child; Humans; Nicotine; Smoke-Free Policy; Smoking; Smoking Cessation; Substance-Related Disorders; United States; United States Food and Drug Administration; Young Adult | 2018 |
Prevalence of withdrawal symptoms from electronic cigarette cessation: A cross-sectional analysis of the US Population Assessment of Tobacco and Health.
Topics: Adolescent; Adult; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Prevalence; Severity of Illness Index; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; United States; Vaping; Young Adult | 2019 |
Nicotine Dependence: Future Opportunities and Emerging Clinical Challenges.
Topics: Behavior, Addictive; Ganglionic Stimulants; Humans; Nicotine; Recurrence; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2018 |
Rapid nicotine tolerance and cross-tolerance to varenicline in rhesus monkeys: Drug discrimination.
Topics: Animals; Discrimination Learning; Dose-Response Relationship, Drug; Drug Tolerance; Female; Macaca mulatta; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2018 |
How Will Alcohol Research be Impacted by Future Reduction in Nicotine Content in Cigarettes?
Topics: Alcoholism; Animals; Central Nervous System Depressants; Comorbidity; Ethanol; Humans; Nicotine; Nicotinic Agonists; Research; Smoking; Smoking Cessation; Tobacco Products; United States; United States Food and Drug Administration | 2018 |
Paradox of PEGylation in fabricating hybrid nanoparticle-based nicotine vaccines.
Topics: Animals; Drug Delivery Systems; Female; Haptens; Humans; Liposomes; Mice; Mice, Inbred BALB C; Nanoparticles; Nicotine; Polyethylene Glycols; Smoking Cessation; Tobacco Use Disorder; Vaccines | 2018 |
Circulating orexin changes during withdrawal are associated with nicotine craving and risk for smoking relapse.
Topics: Adult; Case-Control Studies; Cigarette Smoking; Craving; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Orexins; Recurrence; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2019 |
Impact of early life adversity on the stress biobehavioral response during nicotine withdrawal.
Topics: Adrenocorticotropic Hormone; Adult; Adverse Childhood Experiences; Affect; Behavior, Addictive; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Nicotine; Pituitary-Adrenal System; Saliva; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2018 |
Qualitative and Sensitivity Analysis of the Effect of Electronic Cigarettes on Smoking Cessation.
Topics: Electronic Nicotine Delivery Systems; Humans; Models, Theoretical; Nicotine; Smoking; Smoking Cessation; Smoking Prevention | 2018 |
Influence of Gender and Age on the Willingness to Reduce Nicotine Consumption-Results of a Survey in Urological Cancer Patients (KRAUT Study).
Topics: Age Factors; Aged; Disease Progression; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nicotine; Patient Education as Topic; Patient Preference; Risk Factors; Sex Factors; Smoking; Smoking Cessation; Surveys and Questionnaires; Urologic Neoplasms | 2018 |
Development and validation of a new instrument to measure perceived risks associated with the use of tobacco and nicotine-containing products.
Topics: Adolescent; Adult; Female; Focus Groups; Humans; Intention; Male; Middle Aged; Nicotine; Perception; Psychometrics; Reproducibility of Results; Risk Assessment; Self Report; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Products; Young Adult | 2018 |
Effects of Nicotine Metabolic Rate on Withdrawal Symptoms and Response to Cigarette Smoking After Abstinence.
Topics: Adult; Cigarette Smoking; Female; Humans; Male; Middle Aged; Nicotine; Saliva; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2019 |
Are we guilty of errors of omission on the potential role of electronic nicotine delivery systems as less harmful substitutes for combusted tobacco use?
Topics: Electronic Nicotine Delivery Systems; Government Regulation; Harm Reduction; Health Policy; Humans; Nicotine; Public Health; Smoking; Smoking Cessation; Tobacco Products | 2018 |
Does the nicotine metabolite ratio moderate smoking cessation treatment outcomes in real-world settings? A prospective study.
Topics: Adult; England; Female; Humans; Male; Nicotine; Prospective Studies; Saliva; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Treatment Outcome | 2019 |
Beliefs and reality of e-cigarette smoking.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Chills; Depressive Disorder; Electronic Nicotine Delivery Systems; Health Knowledge, Attitudes, Practice; Humans; Male; Nausea; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tachycardia; Tobacco Use Disorder; Vaping | 2018 |
Cotton pillows: A novel field method for assessment of thirdhand smoke pollution.
Topics: Air Pollution, Indoor; Bedding and Linens; Environmental Monitoring; Nicotiana; Nicotine; Smoking; Smoking Cessation; Tobacco Smoke Pollution | 2019 |
Does cessation fatigue predict smoking-cessation milestones? A longitudinal study of current and former smokers.
Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Female; Health Behavior; Humans; Longitudinal Studies; Male; Middle Aged; Motivation; Nicotine; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2018 |
Editorial: 5
Topics: Behavior, Addictive; Electronic Nicotine Delivery Systems; Harm Reduction; Health Status Disparities; Humans; Nicotiana; Nicotine; Smoking; Smoking Cessation | 2018 |
Progressive nicotine patch dosing prior to quitting smoking: feasibility, safety and effects during the pre-quit and post-quit periods.
Topics: Adult; Feasibility Studies; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nicotine; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2019 |
Short-Term Safety of Nicotine Replacement in Smokers Hospitalized With Coronary Heart Disease.
Topics: Aged; Coronary Disease; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Nicotine; Retrospective Studies; Smokers; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Treatment Outcome | 2018 |
Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse.
Topics: Adult; Cigarette Smoking; Comorbidity; Dronabinol; Female; Humans; Male; Marijuana Abuse; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Cessation Agents; Substance Withdrawal Syndrome; Varenicline; Young Adult | 2019 |
Anti-inflammatory agents for smoking cessation? Focus on cognitive deficits associated with nicotine withdrawal in male mice.
Topics: Animals; Anti-Inflammatory Agents; Attention; Brain; Cannabidiol; Cognition; Cognition Disorders; Cognitive Dysfunction; Hippocampus; Male; Memory Disorders; Memory, Short-Term; Mice; Mice, Inbred C57BL; Microglia; Nicotine; Nicotinic Agonists; Prefrontal Cortex; Smoking; Smoking Cessation; Tobacco Use Disorder | 2019 |
Differential cross-tolerance to the effects of nicotinic acetylcholine receptor drugs in C57BL/6J mice following chronic varenicline.
Topics: Alkaloids; Animals; Azocines; Bridged Bicyclo Compounds, Heterocyclic; Cocaine; Conditioning, Operant; Drug Tolerance; Female; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pyridines; Quinolizines; Receptors, Nicotinic; Reinforcement, Psychology; Smoking Cessation; Varenicline | 2019 |
High-nicotine dependent smokers less likely to quit after screening.
Topics: Early Detection of Cancer; Humans; Lung Neoplasms; Nicotine; Smokers; Smoking Cessation; Tobacco Use Disorder | 2018 |
Letter to the Editor Regarding "Students' Cigarette Smoking and the Perceived Nicotine Content of Their E-cigarettes".
Topics: Cigarette Smoking; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Students | 2018 |
Impact of the Society for Research on Nicotine and Tobacco Health Disparities Network's Scholarship on Professional Development of Its Recipients.
Topics: Adult; Biomedical Research; Efficiency; Ethnicity; Fellowships and Scholarships; Female; Humans; Male; Nicotiana; Nicotine; Professional Competence; Publishing; Smoking Cessation; Societies, Scientific; Staff Development; Surveys and Questionnaires; Tobacco Use Disorder | 2020 |
E-cigarettes-new product, old tricks.
Topics: Administration, Inhalation; Consumer Product Safety; Direct-to-Consumer Advertising; Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Risk Assessment; Smoking; Smoking Cessation; Time Factors; Vaping | 2018 |
A modeling approach to gauging the effects of nicotine vaping product use on cessation from cigarettes: what do we know, what do we need to know?
Topics: Adult; Cohort Studies; Female; Follow-Up Studies; Health Surveys; Humans; Life Expectancy; Male; Middle Aged; Models, Statistical; Motivation; Nicotine; Risk Assessment; Smoking; Smoking Cessation; United States; Vaping | 2019 |
Early weight gain after stopping smoking: a predictor of overall large weight gain? A single-site retrospective cohort study.
Topics: Adult; Appetite; Body Mass Index; Czech Republic; Female; Humans; Male; Middle Aged; Nicotine; Overweight; Prognosis; Retrospective Studies; Smoking; Smoking Cessation; Smoking Cessation Agents; Weight Gain | 2018 |
The effect of body mass index on smoking behaviour and nicotine metabolism: a Mendelian randomization study.
Topics: Adult; Body Mass Index; Body Weight; Cohort Studies; DNA Methylation; Female; Genome-Wide Association Study; Humans; Longitudinal Studies; Male; Mendelian Randomization Analysis; Middle Aged; Nicotine; Polymorphism, Single Nucleotide; Risk Factors; Smoking; Smoking Cessation | 2019 |
Will the Debate Over e-Cigarettes Start Cooling Down?
Topics: Electronic Nicotine Delivery Systems; Hazardous Substances; Nicotine; Smoking Cessation; Tobacco Products | 2018 |
Effect of preoperative smoking cessation on postoperative pain outcomes in elderly patients with high nicotine dependence.
Topics: Aged; Analgesics, Opioid; Humans; Lung Neoplasms; Male; Middle Aged; Nicotine; Pain Measurement; Pain, Postoperative; Patient Satisfaction; Preoperative Period; Smoking Cessation; Sufentanil; Thoracoscopy; Tobacco Use Disorder | 2019 |
Increasing Smoking Cessation in the United States: Expanding the Availability of Over-the-Counter Medications.
Topics: Behavior Therapy; Bupropion; Humans; Nicotine; Nonprescription Drugs; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; United States; Varenicline | 2019 |
Menthol cigarette use and pain reporting among African American adults seeking treatment for smoking cessation.
Topics: Adult; Black or African American; Cigarette Smoking; Female; Humans; Male; Menthol; Middle Aged; Motivation; Nicotine; Pain; Smokers; Smoking Cessation; Tobacco Products | 2019 |
Pre-quit nicotine decreases nicotine self-administration and attenuates cue- and drug-induced reinstatement.
Topics: Animals; Behavior, Animal; Cues; Extinction, Psychological; Male; Nicotine; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2019 |
E-Cigarettes to Assist with Smoking Cessation.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2019 |
Clarifying the Role of the Rostral Interpeduncular Nucleus in Aversion to Nicotine.
Topics: Animals; Aversive Therapy; Humans; Interpeduncular Nucleus; Mice; Nerve Tissue Proteins; Nicotine; Receptors, Nicotinic; Smoking; Smoking Cessation | 2019 |
Vitexin as an active ingredient in passion flower with potential as an agent for nicotine cessation: vitexin antagonism of the expression of nicotine locomotor sensitization in rats.
Topics: Animals; Apigenin; Locomotion; Male; Nicotine; Nicotinic Antagonists; Passiflora; Plant Extracts; Rats; Rats, Wistar; Smoking Cessation; Tobacco Use Disorder | 2019 |
Barriers and facilitators to switching from smoking to vaping: Advice from vapers.
Topics: Adult; Aged; Australia; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Smokers; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Products; Tobacco Smoking; Vaping | 2019 |
E-cigarettes Best Other Cessation Tools.
Topics: Electronic Nicotine Delivery Systems; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices | 2019 |
When Less is More: Vaping Low-Nicotine vs. High-Nicotine E-Liquid is Compensated by Increased Wattage and Higher Liquid Consumption.
Topics: Belgium; Electronic Nicotine Delivery Systems; Humans; Inhalation Exposure; Nicotine; Smokers; Smoking Cessation; Surveys and Questionnaires; Tobacco Smoking; Vaping | 2019 |
Relative Risk Perceptions between Snus and Cigarettes in a Snus-Prevalent Society-An Observational Study over a 16 Year Period.
Topics: Adolescent; Adult; Aged; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Norway; Perception; Prevalence; Risk; Scandinavian and Nordic Countries; Smoking; Smoking Cessation; Tobacco Products; Tobacco Smoking; Tobacco, Smokeless; Young Adult | 2019 |
Pharmacokinetic Profile of Spectrum Reduced Nicotine Cigarettes.
Topics: Adolescent; Adult; Carbon Monoxide; Cigarette Smoking; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Tobacco Products; Young Adult | 2020 |
Electronic cigarettes.
Topics: Administration, Inhalation; Consumer Product Safety; Drug Approval; Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Patient Safety; Risk Assessment; Smoking Cessation; United States; United States Food and Drug Administration; Vaping | 2019 |
Prolonged exposure of rats to varenicline increases anxiety and alters serotonergic system, but has no effect on memory.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Cognition; gamma-Aminobutyric Acid; Hippocampus; Male; Memory; Models, Animal; Motor Activity; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Serotonergic Neurons; Serotonin; Smoking; Smoking Cessation; Varenicline | 2019 |
Enlighten e-cigarettes.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Risk Factors; Smoking Cessation | 2019 |
Exploring the interoceptive stimulus effects of nicotine and varenicline.
Topics: Animals; Appetitive Behavior; Conditioning, Classical; Discrimination Learning; Discrimination, Psychological; Drug Substitution; Extinction, Psychological; Injections, Subcutaneous; Interoception; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Saline Solution; Smoking Cessation; Substance Withdrawal Syndrome; Sucrose; Varenicline | 2019 |
Vaping for weight control: A cross-sectional population study in England.
Topics: Adolescent; Adult; Aged; Appetite Depressants; Body Weight Maintenance; Cigarette Smoking; Cross-Sectional Studies; England; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Smoking Cessation; Surveys and Questionnaires; Vaping; Weight Gain; Young Adult | 2019 |
The Alarming Increase in Vaping among Youth.
Topics: Adolescent; Child; Cross-Sectional Studies; Epidemics; Female; Humans; Male; Nicotine; Nurse's Role; Risk Factors; Smoking Cessation; Substance Withdrawal Syndrome; Vaping | 2019 |
E-Cigarettes versus Nicotine-Replacement Therapy for Smoking Cessation.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2019 |
E-Cigarettes versus Nicotine-Replacement Therapy for Smoking Cessation.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2019 |
E-Cigarettes versus Nicotine-Replacement Therapy for Smoking Cessation.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2019 |
E-Cigarettes versus Nicotine-Replacement Therapy for Smoking Cessation. Reply.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2019 |
Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches.
Topics: Adult; Breath Tests; Carbon Monoxide; Cigarette Smoking; Cotinine; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Recurrence; Saliva; Smoking Cessation; Smoking Reduction; Tobacco Use Cessation Devices; Young Adult | 2019 |
E-cigarettes were more effective than nicotine replacement for smoking cessation at 1 year.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2019 |
Brain Marker Links Stress and Nicotine Abstinence.
Topics: Adolescent; Adult; Aged; Brain; Female; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2020 |
[Analysis of electronic cigarettes safety].
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Risk Assessment; Safety; Smoking Cessation | 2019 |
The β3 subunit of the nicotinic acetylcholine receptor is required for nicotine withdrawal-induced affective but not physical signs or nicotine reward in mice.
Topics: Animals; Anxiety; Behavior, Animal; Female; Gene Knockout Techniques; Genotype; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Receptors, Nicotinic; Reward; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2019 |
Cross-country comparison of cigarette and vaping product marketing exposure and use: findings from 2016 ITC Four Country Smoking and Vaping Survey.
Topics: Adolescent; Adult; Advertising; Aged; Aged, 80 and over; Australia; Canada; Cigarette Smoking; Commerce; Consumer Behavior; Cross-Cultural Comparison; England; Female; Humans; Logistic Models; Male; Middle Aged; Nicotine; Prevalence; Smoking Cessation; Surveys and Questionnaires; Tobacco Industry; Tobacco Products; Tobacco Use Cessation Devices; United States; Vaping; Young Adult | 2020 |
White Paper on Electronic Nicotine Delivery System.
Topics: Electronic Nicotine Delivery Systems; Humans; India; Nicotine; Smoking Cessation; Solutions | 2019 |
Prolonging the Reduction of Nicotine Self-Administration in Rats by Coadministering Chronic Nicotine With Amitifadine, a Triple Monoamine Reuptake Inhibitor With CYP2B6 Inhibitory Actions.
Topics: Animals; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2B6 Inhibitors; Drug Therapy, Combination; Female; Nicotine; Rats; Rats, Sprague-Dawley; Self Administration; Smoking Cessation; Vesicular Monoamine Transport Proteins | 2020 |
Potential Moderating Effects of Sex/Gender on the Acute Relative Reinforcing and Subjective Effects of Reduced Nicotine Content Cigarettes in Vulnerable Populations.
Topics: Adolescent; Adult; Behavior, Addictive; Female; Humans; Male; Nicotine; Reinforcement, Psychology; Reward; Sex Factors; Smokers; Smoking Cessation; Tobacco Products; Tobacco Smoking; United States; Vulnerable Populations; Young Adult | 2020 |
A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior.
Topics: Adult; Affect; Anxiety; Benzamides; Cigarette Smoking; Craving; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Pyrrolidines; Random Allocation; Receptors, Opioid, kappa; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2020 |
Pharmacogenomics of Nicotine Metabolism: Novel CYP2A6 and CYP2B6 Genetic Variation Patterns in Alaska Native and American Indian Populations.
Topics: Adolescent; Adult; Aged; Alaska; Alaskan Natives; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Genetic Variation; Genotype; Humans; Indians, North American; Middle Aged; Nicotine; Pharmacogenetics; Smoking; Smoking Cessation; Smoking Cessation Agents; Young Adult | 2020 |
Nicotine Self-Administration as Paradigm for Medication Discovery for Smoking Cessation: Recent Findings in Medications Targeting the Cholinergic System.
Topics: Animals; Behavior, Addictive; Cholinergic Agents; Gene Knockout Techniques; Humans; Models, Animal; Nicotine; Nicotinic Antagonists; Receptors, Nicotinic; Self Administration; Smoking Cessation; Varenicline | 2019 |
Effect of Cigarette Smoking on Functional Outcomes in Patients with Spontaneous Intracerebral Hemorrhage.
Topics: Adult; Aged; Brain; Cerebral Hemorrhage; Databases, Factual; Disability Evaluation; Female; Health Status; Hospital Mortality; Humans; Male; Middle Aged; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Non-Smokers; Predictive Value of Tests; Prognosis; Protective Factors; Recovery of Function; Retrospective Studies; Risk Assessment; Risk Factors; Smokers; Smoking; Smoking Cessation; Time Factors | 2019 |
The Effects of Transdermal Nicotine Patches on the Cardiorespiratory and Lactate Responses During Exercise from Light to Moderate Intensity: Implications for Exercise Prescription during Smoking Cessation.
Topics: Adult; Cardiorespiratory Fitness; Exercise; Exercise Test; Heart Rate; Humans; Lactic Acid; Male; Nicotine; Oxygen Consumption; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices | 2019 |
Prescribing Prevalence, Effectiveness, and Mental Health Safety of Smoking Cessation Medicines in Patients With Mental Disorders.
Topics: Drug Prescriptions; Female; Humans; Male; Mental Disorders; Mental Health; Middle Aged; Nicotine; Nicotinic Agonists; Prospective Studies; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2020 |
Reply to 'Smoke free, but dependent on nicotine' (Karam-Hage 2019).
Topics: Electronic Nicotine Delivery Systems; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices | 2019 |
Smoke-free, but dependent on nicotine: comment on Jackson et al. (2019).
Topics: Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2019 |
Nicotine in thirdhand smoke residue predicts relapse from smoking cessation: A pilot study.
Topics: Adult; Air Pollution, Indoor; California; Chromatography, Liquid; Dust; Female; Humans; Male; Middle Aged; Nicotine; Pilot Projects; Recurrence; Smoking Cessation; Tandem Mass Spectrometry; Tobacco Smoke Pollution | 2019 |
Nicotine absorption during electronic cigarette use among regular users.
Topics: Adolescent; Adult; Blood Chemical Analysis; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Respiratory Tract Absorption; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Disorder; Vaping; Young Adult | 2019 |
Relating Nicotine Plasma Concentration to Momentary Craving Across Four Nicotine Replacement Therapy Formulations.
Topics: Adolescent; Adult; Craving; Drug Tolerance; Female; Humans; Male; Middle Aged; Models, Biological; Nicotine; Retrospective Studies; Sex Factors; Smoking Cessation; Tobacco Use Cessation Devices; Young Adult | 2020 |
CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers.
Topics: Adolescent; Adult; Aryl Hydrocarbon Hydroxylases; Child; Cytochrome P-450 CYP2A6; Genetic Variation; Humans; Male; Nicotine; Smoking; Smoking Cessation; White People | 2013 |
Making smokers different with nicotine: NRT and quitting.
Topics: Harm Reduction; Humans; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Psychological Theory; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2013 |
Adding very low nicotine content cigarettes to nicotine replacement therapy and behavioural support increases abstinence at 6 months after the quit date.
Topics: Behavior Therapy; Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices | 2014 |
Nicotine replacement therapy distribution to light daily smokers calling a quitline.
Topics: Adult; Female; Hotlines; Humans; Male; Nicotine; Outcome Assessment, Health Care; Smoking Cessation | 2013 |
Alternative tobacco product use and smoking cessation: a national study.
Topics: Adolescent; Adult; Cross-Sectional Studies; Electronics; Female; Harm Reduction; Humans; Intention; Logistic Models; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Tobacco, Smokeless; United States; Young Adult | 2013 |
Anhedonia and anxiety sensitivity: prospective relationships to nicotine withdrawal symptoms during smoking cessation.
Topics: Adult; Anhedonia; Anxiety; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2013 |
Multiple nicotine training doses in mice as a basis for differentiating the effects of smoking cessation aids.
Topics: Alkaloids; Animals; Azocines; Benzazepines; Dihydro-beta-Erythroidine; Discrimination Learning; Dose-Response Relationship, Drug; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Midazolam; Morphine; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2013 |
The effects of extended intravenous nicotine administration on body weight and meal patterns in male Sprague-Dawley rats.
Topics: Animals; Body Weight; Circadian Rhythm; Conditioning, Operant; Drug Administration Schedule; Feeding Behavior; Infusion Pumps; Infusions, Intravenous; Male; Nicotine; Rats; Rats, Sprague-Dawley; Smoking Cessation; Time Factors; Weight Gain | 2013 |
Perceived efficacy of e-cigarettes versus nicotine replacement therapy among successful e-cigarette users: a qualitative approach.
Topics: Adolescent; Adult; Attitude to Health; Boston; Female; Focus Groups; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Qualitative Research; Secondary Prevention; Smoking Cessation; Tobacco Use Cessation Devices; Young Adult | 2013 |
Greater BOLD activity but more efficient connectivity is associated with better cognitive performance within a sample of nicotine-deprived smokers.
Topics: Adult; Brain; Cognition Disorders; Female; Humans; Male; Memory, Short-Term; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2014 |
Was the expansion of the marketing license for nicotine replacement therapy in the United kingdom to include smoking reduction associated with changes in use and incidence of quit attempts?
Topics: Adult; Female; Humans; Male; Marketing; Middle Aged; Nicotine; Smoking Cessation; Smoking Prevention; United Kingdom | 2013 |
Predictors of success for smoking cessation at the workplace: a longitudinal study.
Topics: Adult; Age Factors; Aged; Antidepressive Agents; Bupropion; Counseling; Dyspnea; Educational Status; Female; Health Care Sector; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Motivational Interviewing; Multivariate Analysis; Nicotine; Nicotinic Agonists; Occupational Health Services; Prognosis; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Switzerland; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Workplace; Young Adult | 2014 |
Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal.
Topics: Animals; Anxiety; Azetidines; Benzazepines; Cerebral Cortex; Dose-Response Relationship, Drug; Drug Partial Agonism; Evoked Potentials; Hippocampus; Male; Mice; Microinjections; Motor Activity; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Up-Regulation; Varenicline | 2013 |
[Immune to nicotine addiction?].
Topics: Animals; Blood-Brain Barrier; Brain; Humans; Nicotine; Rats; Smoking Cessation; Tobacco Use Disorder; Vaccines | 2013 |
How soon they forget: changes to beliefs after learning about tobacco.
Topics: Analysis of Variance; Attitude of Health Personnel; Health Education; Health Knowledge, Attitudes, Practice; Humans; Information Dissemination; Nicotine; Retention, Psychology; Smoking; Smoking Cessation; Smoking Prevention; Students; Time Factors | 2013 |
[A poisonous argument].
Topics: Anecdotes as Topic; Choice Behavior; Germany; Humans; Male; Middle Aged; Nicotine; Physician-Patient Relations; Prescription Drugs; Smoking Cessation; Treatment Refusal | 2013 |
Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration.
Topics: Allosteric Regulation; Animals; Azetidines; Dose-Response Relationship, Drug; Galantamine; Hydrocarbons, Brominated; Indole Alkaloids; Male; Nicotine; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Reinforcement Schedule; Self Administration; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2013 |
Cigarette smoking substantially alters plasma microRNA profiles in healthy subjects.
Topics: Adult; Biomarkers; Cotinine; Humans; Indicators and Reagents; Male; MicroRNAs; Middle Aged; Nicotine; Principal Component Analysis; Smoking; Smoking Cessation; Young Adult | 2013 |
E-cigarettes, smokers and health policies.
Topics: Drug Delivery Systems; Electrical Equipment and Supplies; Health Policy; Humans; Italy; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices | 2013 |
Compensation predicts smoking cessation failure.
Topics: Adult; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Surveys and Questionnaires; Tars; Tobacco Products | 2013 |
Medicinal nicotine nonuse: smokers' rationales for past behavior and intentions to try medicinal nicotine in a future quit attempt.
Topics: Adolescent; Adult; Colorado; Costs and Cost Analysis; Demography; Female; Humans; Intention; Interviews as Topic; Logistic Models; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Young Adult | 2013 |
Up in smoke? A preliminary open-label trial of nicotine replacement therapy and cognitive behavioral motivational enhancement for smoking cessation among youth in Los Angeles.
Topics: Adolescent; Cognitive Behavioral Therapy; Female; Humans; Los Angeles; Male; Motivation; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Young Adult | 2013 |
Integrative variable selection via Bayesian model uncertainty.
Topics: Algorithms; Bayes Theorem; Computer Simulation; Humans; Models, Statistical; Nicotine; Polymorphism, Single Nucleotide; Receptors, Nicotinic; Smoking Cessation; Uncertainty | 2013 |
The regulatory challenge of electronic cigarettes.
Topics: Advertising; Drug Contamination; Electronics; Ganglionic Stimulants; Humans; Inhalation Exposure; Nicotine; Smoking; Smoking Cessation; Social Control, Formal; Tobacco Products; United States; United States Food and Drug Administration | 2013 |
Effectiveness of varenicline versus nicotine replacement therapy for smoking cessation with minimal professional support: evidence from an English population study.
Topics: Adult; Aged; Benzazepines; Cross-Sectional Studies; Data Collection; Data Interpretation, Statistical; England; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Population; Prescription Drugs; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2014 |
News media representations of electronic cigarettes: an analysis of newspaper coverage in the UK and Scotland.
Topics: Bibliometrics; Diffusion of Innovation; Electronic Nicotine Delivery Systems; Humans; Mass Media; Newspapers as Topic; Nicotine; Scotland; Smoking; Smoking Cessation; Tobacco Products; United Kingdom | 2014 |
Prevalence and smoking behavior characteristics of nonselected smokers with childhood and/or adult self-reported ADHD symptoms in a smoking-cessation program: a cross-sectional study.
Topics: Adult; Age of Onset; Attention Deficit Disorder with Hyperactivity; Child; Cross-Sectional Studies; Female; Humans; Male; Nicotine; Prevalence; Risk Factors; Self Report; Smoking; Smoking Cessation; Tobacco Use Disorder | 2015 |
Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving.
Topics: Administration, Cutaneous; Adult; Affect; Behavior, Addictive; Biomarkers; Carbon Monoxide; Comorbidity; Cotinine; Cues; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotine; Nicotinic Agonists; Ontario; Pilot Projects; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Transdermal Patch; Treatment Outcome | 2013 |
Cytisine, the world's oldest smoking cessation aid.
Topics: Alkaloids; Azocines; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Nicotine; Quinolizines; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome | 2013 |
Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat.
Topics: Animals; Brain; Clorgyline; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Isoenzymes; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nicotine; Rats; Rats, Sprague-Dawley; Selegiline; Smoking Cessation; Substance Withdrawal Syndrome | 2013 |
E-cigarettes as good as patches in helping to reduce smoking, study concludes.
Topics: Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2013 |
E-cigarette use doubles among US middle and high school students.
Topics: Adolescent; Adolescent Behavior; Electronics; Female; Humans; Inhalation Exposure; Internet; Male; Nicotine; Smoking; Smoking Cessation; Students; Tobacco Products; United States | 2013 |
Electronic cigarettes for smoking cessation.
Topics: Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2013 |
Forensic analysis of online marketing for electronic nicotine delivery systems.
Topics: Commerce; Electronic Nicotine Delivery Systems; Electronics; Government Regulation; Humans; Internet; Marketing; Nicotine; Product Labeling; Smoking; Smoking Cessation; Tobacco Industry; Tobacco Products | 2015 |
Effectiveness of nicotinic agonists as desensitizers at presynaptic α4β2- and α4α5β2-nicotinic acetylcholine receptors.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Dopamine; Dopaminergic Neurons; Dose-Response Relationship, Drug; Mice; Mice, Mutant Strains; Nicotine; Nicotinic Agonists; Pyridines; Receptors, Nicotinic; Smoking Cessation | 2014 |
The case for licensing cytosine now for smoking cessation is overwhelming.
Topics: Alkaloids; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices | 2013 |
Vaccines in trials for nicotine cessation therapy.
Topics: Clinical Trials as Topic; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Vaccines | 2013 |
Reexposure to nicotine during withdrawal increases the pacemaking activity of cholinergic habenular neurons.
Topics: Animals; Biological Clocks; Cardiotonic Agents; Cholinergic Neurons; Habenula; Humans; Mice; Nicotine; Nicotinic Agonists; Pyrimidines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2013 |
Adult smokers' receptivity to a television advert for electronic nicotine delivery systems.
Topics: Adolescent; Adult; Aged; Attitude to Health; Awareness; Electronic Nicotine Delivery Systems; Electronics; Female; Florida; Humans; Intention; Male; Marketing; Middle Aged; Nicotine; Smoking; Smoking Cessation; Television; Tobacco Products; Tobacco Use Disorder; Young Adult | 2015 |
Cigarette smoke induces molecular responses in respiratory tissues of ApoE(-/-) mice that are progressively deactivated upon cessation.
Topics: Airway Remodeling; Animals; Apolipoproteins E; Biomarkers; Bronchoalveolar Lavage Fluid; Dendritic Cells; Female; Flow Cytometry; Gene Expression; Lung; Mice; Mice, Knockout; Nicotine; Pregnancy; Respiratory Mucosa; Respiratory System; RNA; Signal Transduction; Smoking; Smoking Cessation; Tobacco Smoke Pollution; Transcriptome | 2013 |
Are serotonergic system genes associated to smoking cessation therapy success in addition to CYP2A6?
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Bupropion; Cytochrome P-450 CYP2A6; Dopamine Uptake Inhibitors; Female; Genetic Association Studies; Genotype; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Pharmacogenetics; Polymorphism, Genetic; Receptor, Serotonin, 5-HT2A; Serotonin Plasma Membrane Transport Proteins; Smoking Cessation; Tobacco Use Disorder | 2014 |
[Shedding light on the electronic cigarette (1)].
Topics: Electronics; Ganglionic Stimulants; Humans; Nicotine; Smoking Cessation; Tobacco Products | 2013 |
[Evaluation of a structured smoking cessation program for primary care medicine].
Topics: Adult; Attitude of Health Personnel; Combined Modality Therapy; Directive Counseling; Dose-Response Relationship, Drug; Drug Administration Routes; Female; Follow-Up Studies; General Practice; Germany; Humans; Male; Middle Aged; Nicotine; Primary Health Care; Secondary Prevention; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2014 |
Electronic cigarettes.
Topics: Humans; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2013 |
A longitudinal study of electronic cigarette users.
Topics: Adult; Chi-Square Distribution; Cohort Studies; Electronic Nicotine Delivery Systems; Female; Follow-Up Studies; Health Behavior; Humans; Longitudinal Studies; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Social Class; Surveys and Questionnaires; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2014 |
Looks like smoking, is it smoking?: children's perceptions of cigarette-like nicotine delivery systems, smoking and cessation.
Topics: Administration, Inhalation; Age Factors; Child; Data Interpretation, Statistical; Family; Female; Health; Humans; Judgment; Male; Nicotine; Nicotinic Agonists; Peer Group; Perception; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Video Recording | 2013 |
Effect of allopurinol on smoking.
Topics: Acetylcholine; Allopurinol; Benzazepines; Brain Chemistry; Bupropion; Causality; Comorbidity; Diabetic Nephropathies; Humans; Hypoxanthine; Molecular Structure; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Structure-Activity Relationship; Varenicline; Xanthine Oxidase | 2013 |
[Shedding light on the electronic cigarette (2)].
Topics: Commerce; Electronics; Ganglionic Stimulants; Humans; Nicotine; Smoking Cessation; Social Control, Formal; Tobacco Products | 2013 |
The effect of varenicline on the development and expression of nicotine-induced behavioral sensitization and cross-sensitization in rats.
Topics: Animals; Benzazepines; Motor Activity; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Smoking Cessation; Varenicline | 2015 |
CYP2B6 non-coding variation associated with smoking cessation is also associated with differences in allelic expression, splicing, and nicotine metabolism independent of common amino-acid changes.
Topics: Alleles; Aryl Hydrocarbon Hydroxylases; Cotinine; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Genotype; Haplotypes; Humans; Nicotine; Polymorphism, Genetic; RNA Splicing; Smoking Cessation | 2013 |
Effects of resistance exercise on the HPA axis response to psychological stress during short-term smoking abstinence in men.
Topics: Adolescent; Adrenocorticotropic Hormone; Exercise; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Nicotine; Nicotinic Agonists; Pituitary-Adrenal System; Resistance Training; Saliva; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Young Adult | 2014 |
Cigarette smoking and mental illness: a study of nicotine withdrawal.
Topics: Adult; Female; Humans; Male; Mental Disorders; Nicotine; Patient Acuity; Prevalence; Smoking; Smoking Cessation; Socioeconomic Factors; Substance Withdrawal Syndrome | 2014 |
Awareness of nicotine replacement therapy among South African smokers and their interest in using it for smoking cessation when provided for free.
Topics: Adolescent; Adult; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; South Africa; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2014 |
Clinical significance of early smoking withdrawal effects and their relationships with nicotine metabolism: preliminary results from a pilot study.
Topics: Adult; Affect; Anxiety; Attention; Cotinine; Craving; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Pilot Projects; Saliva; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2014 |
Position statement on electronic cigarettes or electronic nicotine delivery systems.
Topics: Administration, Inhalation; Advertising; Consumer Product Safety; Drug Delivery Systems; Electronics; Equipment Design; Humans; Marketing of Health Services; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2014 |
Quitting smoking unassisted: the 50-year research neglect of a major public health phenomenon.
Topics: Biomedical Research; Ganglionic Stimulants; Health Policy; History, 20th Century; History, 21st Century; Humans; Motivation; Nicotine; Public Health; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States | 2014 |
The science of tobacco addiction and cessation.
Topics: Genetic Variation; Humans; Nicotine; Receptors, Nicotinic; Sex Factors; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Vaccines | 2014 |
Commentary on Chen et al. (2014): another step on the road to clinical utility of pharmacogenetics for smoking cessation?
Topics: Bupropion; Cytochrome P-450 CYP2A6; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation | 2014 |
Electronic cigarettes and smoking cessation: a quandary?
Topics: Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2014 |
Electronic cigarettes and smoking cessation: a quandary?
Topics: Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2014 |
Electronic cigarettes and smoking cessation: a quandary?
Topics: Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2014 |
Electronic cigarettes and smoking cessation: a quandary? - Authors' reply.
Topics: Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2014 |
Acute myocardial infarction due to liquid nicotine in a young man.
Topics: Humans; Male; Myocardial Infarction; Nicotine; Smoking Cessation; Tobacco Products; Young Adult | 2014 |
[Safety of nicotine addiction treatment].
Topics: Abdominal Pain; Adult; Alkaloids; Azocines; Benzazepines; Boredom; Bupropion; Female; Headache; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Quinolizines; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Tobacco Use Disorder; Varenicline; Xerostomia | 2013 |
[Not Available].
Topics: Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2014 |
[Critically appraised article: A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation].
Topics: Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention | 2013 |
The promise and problems of e-cigarettes.
Topics: Electrical Equipment and Supplies; Ganglionic Stimulants; Humans; Nicotine; Smoking; Smoking Cessation; Substance-Related Disorders; Tobacco Products; United States | 2014 |
Electronic cigarettes are at least as effective as nicotine patches for smoking cessation.
Topics: Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2014 |
Comparison of the effectiveness of virtual cue exposure therapy and cognitive behavioral therapy for nicotine dependence.
Topics: Adaptation, Psychological; Adult; Aged; Cognitive Behavioral Therapy; Cues; Humans; Implosive Therapy; Male; Middle Aged; Nicotine; Patient Education as Topic; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2014 |
Amplified reacquisition of nicotine self-administration in rats by repeated stress during abstinence.
Topics: Animals; Circadian Rhythm; Conditioning, Operant; Dose-Response Relationship, Drug; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Recurrence; Reinforcement Schedule; Restraint, Physical; Self Administration; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2014 |
[2014 or year I of Nicotine era].
Topics: Drug and Narcotic Control; European Union; History, 21st Century; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Industry; Tobacco Use Cessation Devices | 2014 |
The emergence of e-cigarettes: a triumph of wishful thinking over science.
Topics: Drug Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Public Health; Smoking Cessation; Tobacco Use Disorder | 2014 |
Characterization of long-term users of nicotine replacement therapy: evidence from a national survey.
Topics: Adult; England; Female; Harm Reduction; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2014 |
European Union adds teeth to its anti-tobacco legislation.
Topics: Device Approval; European Union; Humans; Lobbying; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Industry; Tobacco Products | 2014 |
Large-scale brain network coupling as a potential neural metric for nicotine abstinence effects on craving and cognitive function.
Topics: Brain; Cognition Disorders; Female; Humans; Male; Motivation; Nerve Net; Neuropsychological Tests; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2014 |
Large-scale brain network coupling predicts acute nicotine abstinence effects on craving and cognitive function.
Topics: Adult; Brain; Brain Mapping; Cognition Disorders; Dominance, Cerebral; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Motivation; Nerve Net; Neuropsychological Tests; Nicotine; Oxygen; Psychometrics; Resource Allocation; Smoking; Smoking Cessation; Statistics as Topic; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Young Adult | 2014 |
Development and validation of a smoking expectancies measure for adolescents seeking to quit smoking.
Topics: Adolescent; Adolescent Behavior; Emotions; Female; Humans; Male; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Reinforcement, Psychology; Reproducibility of Results; Risk; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Young Adult | 2015 |
"Smoking revolution": a content analysis of electronic cigarette retail websites.
Topics: Advertising; Flavoring Agents; Humans; Internet; Nebulizers and Vaporizers; Nicotine; Smoking; Smoking Cessation; Tobacco Industry; United States | 2014 |
E-cigarette advertising expenditures in the U.S., 2011-2012.
Topics: Advertising; Flavoring Agents; Humans; Internet; Mass Media; Nebulizers and Vaporizers; Nicotine; Smoking; Smoking Cessation; Tobacco Industry; United States | 2014 |
If only electronic cigarettes were effective smoking cessation devices.
Topics: Drug Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2014 |
A longitudinal analysis of electronic cigarette use and smoking cessation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Drug Delivery Systems; Electronics; Follow-Up Studies; Humans; Longitudinal Studies; Middle Aged; Nicotine; Regression Analysis; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2014 |
The electronic cigarette. Official statement of the Spanish Society of Pneumology and Thoracic Surgery (SEPAR) on the efficacy, safety and regulation of electronic cigarettes.
Topics: Adolescent; Electronic Nicotine Delivery Systems; Equipment Design; Europe; Hot Temperature; Humans; Medical Device Legislation; Multicenter Studies as Topic; Nicotine; Organic Chemicals; Randomized Controlled Trials as Topic; Respiration Disorders; Smoke; Smoking Cessation; Solutions; Substance Withdrawal Syndrome; United States; Young Adult | 2014 |
Early changes in the components of the metabolic syndrome in a group of smokers after tobacco cessation.
Topics: Adolescent; Adult; Aged; Blood Glucose; Blood Pressure; Body Mass Index; Carbon Monoxide; Cholesterol, HDL; Cognitive Behavioral Therapy; Female; Homeostasis; Humans; Insulin; Male; Metabolic Syndrome; Middle Aged; Nicotine; Prevalence; Smoking; Smoking Cessation; Waist Circumference; Weight Gain; Young Adult | 2014 |
Is there any legal and scientific basis for classifying electronic cigarettes as medications?
Topics: Electronic Nicotine Delivery Systems; European Union; Government Regulation; Harm Reduction; Humans; Nicotine; Public Health; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2014 |
Estimating the harms of nicotine-containing products using the MCDA approach.
Topics: Humans; Nicotine; Risk Assessment; Smoking Cessation; Tobacco Products | 2014 |
E-cigarettes affect cells.
Topics: Electrical Equipment and Supplies; Gene Expression Regulation; Humans; Nicotiana; Nicotine; Smoke; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Products; Volatilization | 2014 |
E-cigarettes: still many questions.
Topics: Electrical Equipment and Supplies; Government Regulation; Humans; Nicotine; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices; United States | 2014 |
Promise or peril?
Topics: Consumer Product Safety; Drug Delivery Systems; Flavoring Agents; Humans; Minnesota; Nicotine; Propylene Glycol; Smoking Cessation; Tobacco Products | 2014 |
Smoking cessation outcomes among sexual and gender minority and nonminority smokers in extended smoking treatments.
Topics: Adult; Bisexuality; Bupropion; Counseling; Female; Homosexuality, Female; Homosexuality, Male; Humans; Male; Middle Aged; Minority Groups; Nicotine; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Transgender Persons; Treatment Outcome | 2014 |
Electronic cigarettes: navigating the vapor.
Topics: Electrical Equipment and Supplies; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder; Volatilization | 2014 |
Oxidative and pro-inflammatory impact of regular and denicotinized cigarettes on blood brain barrier endothelial cells: is smoking reduced or nicotine-free products really safe?
Topics: Blood-Brain Barrier; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Inflammation Mediators; Nicotine; Oxidative Stress; Reactive Oxygen Species; Smoking Cessation; Tobacco Products | 2014 |
Nicotine and non-nicotine smoking factors differentially modulate craving, withdrawal and cerebral blood flow as measured with arterial spin labeling.
Topics: Adolescent; Adult; Cerebrovascular Circulation; Craving; Female; Humans; Male; Middle Aged; Neuroimaging; Nicotine; Nicotinic Agonists; Self Report; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Cessation Devices; Young Adult | 2014 |
Use of e-cigarettes by individuals with mental health conditions.
Topics: Adolescent; Adult; Data Collection; Electronic Nicotine Delivery Systems; Female; Humans; Male; Mental Disorders; Mental Health; Middle Aged; Nicotine; Prevalence; Smoking; Smoking Cessation; Tobacco Products; United States; Young Adult | 2014 |
Electronic cigarettes: Another pediatric toxic hazard in the home?
Topics: Adolescent; Child; Electrical Equipment and Supplies; Humans; Nebulizers and Vaporizers; Nicotine; Smoking; Smoking Cessation; Tobacco Products | 2014 |
Effects of duration of electronic cigarette use.
Topics: Adult; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Smoking Cessation; Smoking Prevention; Time Factors | 2015 |
E-cigarette regulations in Italy: fluctuating and confusing.
Topics: Electrical Equipment and Supplies; Humans; Italy; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2014 |
Demographic characteristics, nicotine dependence, and motivation to quit as possible determinants of smoking behaviors and acceptability of shocking warnings in Italy.
Topics: Cross-Sectional Studies; Demography; Female; Health Promotion; Humans; Italy; Male; Middle Aged; Motivation; Nicotine; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Products; Tobacco Use Disorder | 2014 |
Nicotine poisoning increase due to e-cigarettes.
Topics: Attitude to Health; Humans; Nebulizers and Vaporizers; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices | 2014 |
Addressing the evidence for FDA nicotine replacement therapy label changes: a policy statement of the Association for the Treatment of Tobacco use and Dependence and the Society for Research on Nicotine and Tobacco.
Topics: Administration, Cutaneous; Guidelines as Topic; Health Policy; Nicotine; Nonprescription Drugs; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; United States; United States Food and Drug Administration | 2014 |
Nicotine replacement products: poisoning in children.
Topics: Adult; Child; Child, Preschool; France; Humans; Nicotine; Nicotinic Agonists; Poison Control Centers; Smoking Cessation; Tobacco Use Cessation Devices | 2014 |
Nicotine withdrawal and stress-induced changes in pain sensitivity: a cross-sectional investigation between abstinent smokers and nonsmokers.
Topics: Adult; Blood Pressure; Body Mass Index; Cross-Sectional Studies; Female; Heart Rate; Humans; Male; Nicotine; Pain; Pain Measurement; Pain Threshold; Physical Stimulation; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Young Adult | 2014 |
Electronic nicotine delivery systems (ENDS): new evidence from the State and Community Tobacco Control Research Initiative.
Topics: Electronic Nicotine Delivery Systems; Electronics; Humans; Nicotine; Research; Smoking; Smoking Cessation; Tobacco Products | 2014 |
A cross-sectional examination of marketing of electronic cigarettes on Twitter.
Topics: Algorithms; Bayes Theorem; Commerce; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Electronics; Humans; Internet; Marketing; Nicotine; Smoking; Smoking Cessation; Social Media; Tobacco Products | 2014 |
The impact of price and tobacco control policies on the demand for electronic nicotine delivery systems.
Topics: Commerce; Consumer Behavior; Electronic Nicotine Delivery Systems; Electronics; Humans; Nicotine; Smoke-Free Policy; Smoking; Smoking Cessation; Taxes; Tobacco Products | 2014 |
Reference interval determination for anabasine: a biomarker of active tobacco use.
Topics: Anabasine; Biomarkers; Calibration; Chromatography, Liquid; Female; Healthy Volunteers; Humans; Male; Nicotine; Patient Compliance; Reference Values; Reproducibility of Results; Smoking; Smoking Cessation; Substance Abuse Detection; Surveys and Questionnaires; Tandem Mass Spectrometry; Tobacco Use Cessation Devices | 2014 |
Cigarette users' interest in using or switching to electronic nicotine delivery systems for smokeless tobacco for harm reduction, cessation, or novelty: a cross-sectional survey of US adults.
Topics: Adult; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Female; Harm Reduction; Health Knowledge, Attitudes, Practice; Humans; Male; Nicotine; Smoking; Smoking Cessation; United States | 2015 |
Regulating E-cigarettes: a rule proposed by the FDA aims to extend authority to E-cigarettes, other tobacco products.
Topics: Adolescent; Adult; Age Factors; Electronics; Government Regulation; Harm Reduction; Humans; Legislation, Drug; Nicotine; Public Health; Smoking; Smoking Cessation; Tobacco Industry; Tobacco, Smokeless; United States; United States Food and Drug Administration | 2014 |
What should we tell our patients about e-cigarettes?
Topics: Attitude to Health; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Smoking Cessation | 2014 |
Electronic cigarettes. A position statement of the forum of international respiratory societies.
Topics: Adult; Electronic Nicotine Delivery Systems; Female; Harm Reduction; Health Knowledge, Attitudes, Practice; Humans; International Agencies; Male; Nicotine; Organizational Objectives; Risk Factors; Smoking; Smoking Cessation; Societies; Young Adult | 2014 |
An investigation of cigarettes smoking behavior and nicotine dependence among Chinese methamphetamine users in two provinces.
Topics: Adult; China; Female; Humans; Male; Methamphetamine; Nicotine; Psychometrics; Risk Factors; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Young Adult | 2014 |
Nicotine reduction as an increase in the unit price of cigarettes: a behavioral economics approach.
Topics: Commerce; Economics, Behavioral; Health Behavior; Health Policy; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Industry; Tobacco Products; United States; United States Food and Drug Administration | 2014 |
Should Australia reconsider its ban on the sale of electronic nicotine delivery systems?
Topics: Australia; Electronic Nicotine Delivery Systems; Harm Reduction; Humans; Legislation as Topic; Nicotine; Nicotinic Agonists; Smoking Cessation | 2014 |
Water pipe smoking: not risk free.
Topics: Adult; Carcinogens; Cotinine; Environmental Exposure; Female; Humans; Male; Middle Aged; Nicotine; Nitrosamines; Polycyclic Aromatic Hydrocarbons; Pyridines; Recreation; Smoking; Smoking Cessation; Students; United States; Young Adult | 2014 |
Duelling letters: which one would you sign?
Topics: Dissent and Disputes; Electronic Nicotine Delivery Systems; Harm Reduction; Humans; Nicotine; Public Health; Smoking; Smoking Cessation; Smoking Prevention | 2014 |
Electronic cigarette use among adult population: a cross-sectional study in Barcelona, Spain (2013-2014).
Topics: Adult; Aged; Consumer Behavior; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Electronics; Female; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Odds Ratio; Prevalence; Smoking; Smoking Cessation; Spain; Tobacco Products; Tobacco Use Disorder; Young Adult | 2014 |
Expectancies for cigarettes, e-cigarettes, and nicotine replacement therapies among e-cigarette users (aka vapers).
Topics: Adult; Electronic Nicotine Delivery Systems; Female; Health Knowledge, Attitudes, Practice; Humans; Internet; Male; Motivation; Nicotine; Smoking Cessation; Surveys and Questionnaires; United States | 2015 |
Electronic nicotine delivery systems (ENDS): the beginning of the end or the end of the beginning?
Topics: Electronic Nicotine Delivery Systems; Europe; Humans; Nicotine; Pulmonary Medicine; Respiration Disorders; Smoking; Smoking Cessation; Societies, Medical; Tobacco Products | 2014 |
A critique of a World Health Organization-commissioned report and associated paper on electronic cigarettes.
Topics: Adolescent; Electronic Nicotine Delivery Systems; Health Policy; Humans; Nicotine; Research; Research Report; Smoking Cessation; Social Marketing; World Health Organization; Young Adult | 2014 |
Differentiating the primary reinforcing and reinforcement-enhancing effects of varenicline.
Topics: Animals; Benzazepines; Conditioning, Operant; Cues; Dose-Response Relationship, Drug; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Reinforcement, Psychology; Self Administration; Smoking Cessation; Varenicline | 2015 |
Differential associations between components of anxiety sensitivity and smoking-related characteristics.
Topics: Adult; Anxiety; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Pirfenidone for idiopathic pulmonary fibrosis, thrombocytosis in chronic obstructive pulmonary disease exacerbations, and a longitudinal study on e-cigarettes.
Topics: Antifibrinolytic Agents; Aspirin; Drug Delivery Systems; Enzyme Inhibitors; Female; Humans; Idiopathic Pulmonary Fibrosis; Male; Nicotine; Platelet Aggregation Inhibitors; Pulmonary Disease, Chronic Obstructive; Pyridones; Smoking; Smoking Cessation; Thrombocytosis; Ticlopidine; Tobacco Use Cessation Devices | 2014 |
Trends in awareness and use of electronic cigarettes among US adults, 2010-2013.
Topics: Adolescent; Adult; Electronic Nicotine Delivery Systems; Ethnicity; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Socioeconomic Factors; United States | 2015 |
A profile of callers to the New South Wales Quitline, Australia, 2008-2011.
Topics: Adult; Female; Health Policy; Hotlines; Humans; Male; Middle Aged; Motivation; New South Wales; Nicotiana; Nicotine; Population Groups; Regression Analysis; Risk Factors; Smoking; Smoking Cessation; Telephone | 2015 |
Craving and nicotine withdrawal in a Spanish smoking cessation sample.
Topics: Adult; Craving; Female; Follow-Up Studies; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2014 |
Quantitative analysis of 3'-hydroxynorcotinine in human urine.
Topics: Adult; Biomarkers; Carcinogens; Chromatography, Liquid; Female; Humans; Male; Middle Aged; Nicotine; Nitrosamines; Reproducibility of Results; Smoking; Smoking Cessation; Spectrometry, Mass, Electrospray Ionization | 2015 |
Development of a questionnaire for assessing dependence on electronic cigarettes among a large sample of ex-smoking E-cigarette users.
Topics: Adult; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Retrospective Studies; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Time Factors | 2015 |
Effects of nicotine and nicotine expectancy on attentional bias for emotional stimuli.
Topics: Adolescent; Adult; Affect; Attention; Double-Blind Method; Emotions; Facial Expression; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Random Allocation; Reaction Time; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2015 |
NIH electronic cigarette workshop: developing a research agenda.
Topics: Adolescent; Adult; Education; Electronic Nicotine Delivery Systems; Harm Reduction; Humans; National Institutes of Health (U.S.); Nicotine; Research Design; Smoking Cessation; United States | 2015 |
Trends in E-Cigarette Awareness, Trial, and Use Under the Different Regulatory Environments of Australia and the United Kingdom.
Topics: Adolescent; Adult; Aged; Australia; Commerce; Electronic Nicotine Delivery Systems; Female; Health Knowledge, Attitudes, Practice; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Socioeconomic Factors; United Kingdom; Young Adult | 2015 |
Association between electronic cigarette use and openness to cigarette smoking among US young adults.
Topics: Adolescent; Adult; Behavior, Addictive; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation; Surveys and Questionnaires; United States; Young Adult | 2015 |
Prospective cohort study of the effectiveness of varenicline versus nicotine replacement therapy for smoking cessation in the "real world".
Topics: Adolescent; Adult; Benzazepines; Cohort Studies; Cross-Sectional Studies; Female; Humans; Longitudinal Studies; Male; Middle Aged; Netherlands; Nicotine; Nicotinic Agonists; Patient Compliance; Prospective Studies; Quinoxalines; Smoking Cessation; Surveys and Questionnaires; Treatment Outcome; Varenicline | 2014 |
Prevalence of NRT use and associated nicotine intake in smokers, recent ex-smokers and longer-term ex-smokers.
Topics: Demography; England; Humans; Linear Models; Nicotine; Prevalence; Smoking; Smoking Cessation; Smoking Prevention; Socioeconomic Factors; Tobacco Use Cessation Devices | 2014 |
First- versus second-generation electronic cigarettes: predictors of choice and effects on urge to smoke and withdrawal symptoms.
Topics: Adolescent; Adult; Choice Behavior; Craving; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Nicotinic Agonists; Patient Preference; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Young Adult | 2015 |
Biochemical estimation of noncompliance with smoking of very low nicotine content cigarettes.
Topics: Biomarkers; Cotinine; Humans; Nicotine; Patient Compliance; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2015 |
Multiple tobacco use and increased nicotine dependence among people with disabilities.
Topics: Adult; Attitude to Health; Disabled Persons; Female; Humans; Male; Middle Aged; Nicotine; Self Report; Smoking Cessation; Surveys and Questionnaires; Tobacco Products; Tobacco Use; Tobacco Use Disorder | 2015 |
Bitter taste and nicotine preference: evidence for sex differences in rats.
Topics: Animals; Choice Behavior; Female; Humans; Male; Nicotine; Rats; Rats, Sprague-Dawley; Sex Factors; Smoking Cessation; Taste | 2015 |
Electronic cigarettes have a potential for huge public health benefit.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Public Health; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2014 |
Cortical activity differs during nicotine deprivation versus satiation in heavy smokers.
Topics: Adolescent; Adult; Aged; Alpha Rhythm; Beta Rhythm; Cerebral Cortex; Cognition Disorders; Electroencephalography; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Theta Rhythm; Tobacco Use Disorder; Young Adult | 2015 |
Novel Anti-Nicotine Vaccine Using a Trimeric Coiled-Coil Hapten Carrier.
Topics: Adjuvants, Immunologic; Animals; Antibodies; Antibody Affinity; Brain; Female; Haptens; Mice; Mice, Inbred C57BL; Nicotine; Peptides; Smoking Cessation; Tobacco Use Disorder; Toll-Like Receptor 4; Vaccines, Synthetic | 2014 |
Cytisine--a tobacco treatment hiding in plain sight.
Topics: Alkaloids; Azocines; Female; Humans; Male; Nicotine; Quinolizines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2014 |
[Tobacco smoking and psychiatric intensive care unit: Impact of the strict smoking ban on the risk of violence].
Topics: Adult; Aggression; Female; France; Humans; Intensive Care Units; Male; Mentally Ill Persons; Nicotine; Patient Isolation; Psychiatric Department, Hospital; Retrospective Studies; Risk; Smoke-Free Policy; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Violence | 2015 |
Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population.
Topics: Adult; Cytochrome P-450 CYP2A6; Dopamine Plasma Membrane Transport Proteins; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Japan; Male; Middle Aged; Minisatellite Repeats; Nicotine; Polymorphism, Genetic; Protein Serine-Threonine Kinases; Receptors, Dopamine D2; Smoking Cessation; Tobacco Use Disorder | 2014 |
Knowledge About E-Cigarette Constituents and Regulation: Results From a National Survey of U.S. Young Adults.
Topics: Adolescent; Adult; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Female; Health Knowledge, Attitudes, Practice; Humans; Logistic Models; Male; Marketing; Nicotine; Smoking Cessation; Smoking Prevention; Socioeconomic Factors; United States; Young Adult | 2015 |
Countries vindicate cautious stance on e-cigarettes.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Industry; World Health Organization | 2014 |
The impact of anticipated and unanticipated smoking opportunities on cigarette smoking and nicotine lozenge responses.
Topics: Adolescent; Adult; Anticipation, Psychological; Craving; Female; Humans; Male; Nicotine; Random Allocation; Self Administration; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Cessation Devices; Treatment Outcome; Young Adult | 2015 |
Smoking status, nicotine dependence and happiness in nine countries of the former Soviet Union.
Topics: Adolescent; Adult; Cross-Sectional Studies; Female; Happiness; Humans; Male; Middle Aged; Nicotine; Pleasure; Self Report; Smoking; Smoking Cessation; Socioeconomic Factors; Tobacco Use Disorder; USSR; Young Adult | 2015 |
E-cigarettes: an asset or liability in efforts to lessen tobacco smoking and its consequences.
Topics: Directive Counseling; Elective Surgical Procedures; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Postoperative Complications; Smoking; Smoking Cessation; Tobacco Use Disorder | 2015 |
Attitudes, beliefs, and practices regarding electronic nicotine delivery systems in patients scheduled for elective surgery.
Topics: Cross-Sectional Studies; Drug Delivery Systems; Elective Surgical Procedures; Electronic Nicotine Delivery Systems; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Midwestern United States; Nicotine; Nicotinic Agonists; Perioperative Period; Postoperative Complications; Risk Assessment; Smoking; Smoking Cessation; Social Perception; Treatment Outcome | 2015 |
Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology.
Topics: Biomedical Research; Electronic Nicotine Delivery Systems; Government Regulation; Health Policy; Humans; Medical Oncology; Neoplasms; Nicotine; Smoking Cessation; Societies, Medical; United States | 2015 |
Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology.
Topics: American Medical Association; Electronic Nicotine Delivery Systems; Government Regulation; Health Policy; Humans; Nicotine; Public Health; Research; Smoking Cessation; United States | 2015 |
Importance of national context in the translation of personalised treatments for smoking cessation.
Topics: Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2015 |
Explaining the effects of electronic cigarettes on craving for tobacco in recent quitters.
Topics: Adult; Craving; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Female; Follow-Up Studies; Humans; Male; Nicotine; Smoking; Smoking Cessation; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder; Young Adult | 2015 |
Success of a smoking cessation programme in smoking behaviour of chronic periodontitis patients and identification of predictors of motivation for smoking cessation - a pilot study.
Topics: Adult; Chronic Periodontitis; Female; Health Promotion; Humans; Male; Middle Aged; Motivation; Nicotine; Pilot Projects; Risk Factors; Smoking; Smoking Cessation; Sociological Factors; Surveys and Questionnaires; Tobacco Use Disorder | 2016 |
Adolescents' and Young Adults' Perceptions of Electronic Cigarettes for Smoking Cessation: A Focus Group Study.
Topics: Adolescent; Age Factors; Connecticut; Electronic Nicotine Delivery Systems; Female; Focus Groups; Health Knowledge, Attitudes, Practice; Humans; Longitudinal Studies; Male; Marketing; Nicotine; Schools; Smoking; Smoking Cessation; Smoking Prevention; Students; Tobacco Use Disorder; Universities; Young Adult | 2015 |
Commentary: Enough is enough.
Topics: Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use | 2015 |
E-Cigarette: a modern Trojan horse?
Topics: Adolescent; Adolescent Behavior; Air Pollution; Child; Child Behavior; Clinical Trials as Topic; Electronic Nicotine Delivery Systems; Guidelines as Topic; Humans; Multicenter Studies as Topic; Nicotine; Prospective Studies; Research Design; Respiratory Tract Diseases; Smoke; Smoking Cessation; Young Adult | 2015 |
Electronic nicotine delivery systems.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Products | 2015 |
Electronic nicotine delivery systems.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; Tobacco Products | 2015 |
Electronic cigarettes: the pulmonologist's point of view.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2015 |
Factors Associated With Electronic Cigarette Users' Device Preferences and Transition From First Generation to Advanced Generation Devices.
Topics: Adult; Consumer Behavior; Electronic Nicotine Delivery Systems; Equipment Design; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Tobacco Use Disorder | 2015 |
Cytisine versus nicotine for smoking cessation.
Topics: Alkaloids; Female; Humans; Male; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2015 |
Examination of the metabolite hydroxybupropion in the reinforcing and aversive stimulus effects of nicotine in rats.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Bupropion; Male; Nicotine; Rats; Receptors, Nicotinic; Reward; Self Administration; Smoking Cessation; Tobacco Use Disorder | 2015 |
Sex differences in acute relief of abstinence-induced withdrawal and negative affect due to nicotine content in cigarettes.
Topics: Adult; Affective Symptoms; Female; Gender Identity; Humans; Male; Nicotine; Severity of Illness Index; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2015 |
Sex differences in time perception during smoking abstinence.
Topics: Adolescent; Adult; Aged; Decision Making; Female; Gender Identity; Humans; Male; Middle Aged; Nicotine; Recurrence; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Perception | 2015 |
Gender differences in medication use and cigarette smoking cessation: results from the International Tobacco Control Four Country Survey.
Topics: Adolescent; Adult; Australia; Benzazepines; Canada; Female; Gender Identity; Humans; Longitudinal Studies; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; United Kingdom; United States; Varenicline | 2015 |
Rewarding smoking cessation in pregnancy-will women cheat to gain incentives?
Topics: Female; Humans; Motivation; Nicotine; Pregnancy; Reward; Smoking; Smoking Cessation | 2015 |
Prospects for a nicotine-reduction strategy in the cigarette endgame: Alternative tobacco harm reduction scenarios.
Topics: Government Regulation; Harm Reduction; Humans; Nicotine; Smoking Cessation; United States; United States Food and Drug Administration | 2015 |
Reasons for smoking cessation attempts among Japanese male smokers vary by nicotine dependence level: a cross-sectional study after the 2010 tobacco tax increase.
Topics: Adult; Aged; Commerce; Cross-Sectional Studies; Habits; Health; Humans; Japan; Male; Middle Aged; Motivation; Nicotine; Odds Ratio; Self Report; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Taxes; Tobacco Products; Tobacco Use Disorder; Young Adult | 2015 |
POINT: Does the Risk of Electronic Cigarettes Exceed Potential Benefits? Yes.
Topics: Electronic Nicotine Delivery Systems; Harm Reduction; Humans; Nicotine; Risk; Safety; Smoking Cessation; Tobacco Use Disorder | 2015 |
COUNTERPOINT: Does the Risk of Electronic Cigarettes Exceed Potential Benefits? No.
Topics: Electronic Nicotine Delivery Systems; Harm Reduction; Humans; Nicotine; Risk; Safety; Smoking Cessation; Tobacco Use Disorder; United States | 2015 |
Ethical issues raised by a ban on the sale of electronic nicotine devices.
Topics: Adult; Australia; Beneficence; Commerce; Electronic Nicotine Delivery Systems; Government Regulation; Humans; Nicotine; Personal Autonomy; Smoke-Free Policy; Smoking Cessation; Smoking Prevention; Social Justice; Socioeconomic Factors; Tobacco Products; Tobacco Use Disorder | 2015 |
Nicotine replacement therapy in pregnancy and major congenital anomalies in offspring.
Topics: Abnormalities, Drug-Induced; Female; Humans; Infant, Newborn; Nicotine; Pregnancy; Pregnancy Complications; Smoking; Smoking Cessation; Tobacco Use Disorder | 2015 |
Flavour chemicals in electronic cigarette fluids.
Topics: Drug Compounding; Electronic Nicotine Delivery Systems; Flavoring Agents; Gas Chromatography-Mass Spectrometry; Nicotine; Nicotinic Agonists; Risk Assessment; Smoking Cessation; Vaping; Volatilization | 2016 |
Persistence of smoking-induced dysregulation of miRNA expression in the small airway epithelium despite smoking cessation.
Topics: Adult; Bronchoscopy; Cell Differentiation; Cluster Analysis; Cotinine; Down-Regulation; Epithelium; Female; Humans; Male; MicroRNAs; Middle Aged; Nicotine; Respiratory Mucosa; Smoking; Smoking Cessation; Up-Regulation; Wnt Signaling Pathway | 2015 |
Quitting experiences and preferences for a future quit attempt: a study among inpatient smokers.
Topics: Adult; Aged; Australia; Female; Hospitalization; Humans; Inpatients; Male; Middle Aged; Motivation; Nicotine; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2015 |
Nicotine: Science, regulation and policy.
Topics: Drug and Narcotic Control; Electronic Nicotine Delivery Systems; Health Policy; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices | 2015 |
The association of rs1051730 genotype on adherence to and consumption of prescribed nicotine replacement therapy dose during a smoking cessation attempt.
Topics: Alleles; Female; Genotype; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Smoking Cessation; Socioeconomic Factors; Treatment Outcome | 2015 |
Design strategy for a smoking cessation trial of survival.
Topics: Aged; Algorithms; Humans; Middle Aged; Motivation; Nicotine; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Research Design; Smoking; Smoking Cessation; Tobacco Use Disorder; Translational Research, Biomedical; Treatment Outcome; United Kingdom; United States; United States Food and Drug Administration | 2015 |
"Alarming" rise in popularity of e-cigarettes is seen among US teenagers as use triples in a year.
Topics: Adolescent; Adolescent Behavior; Electronic Nicotine Delivery Systems; Health Knowledge, Attitudes, Practice; Health Surveys; Humans; Nicotine; Prevalence; Smoking; Smoking Cessation; Surveys and Questionnaires; United States | 2015 |
The Relationship Between Young Adult Smokers' Beliefs About Nicotine Addiction and Smoking-Related Affect and Cognitions.
Topics: Adolescent; Adult; Attitude to Health; Cognition Disorders; Culture; Female; Follow-Up Studies; Health Knowledge, Attitudes, Practice; Humans; Male; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder; Young Adult | 2016 |
The effects of nicotine and non-nicotine smoking factors on working memory and associated brain function.
Topics: Adolescent; Adult; Brain; Executive Function; Female; Ganglionic Stimulants; Humans; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Nicotine; Psychomotor Performance; Smoking; Smoking Cessation; Young Adult | 2016 |
Cytisine is more effective than nicotine replacement for smoking cessation.
Topics: Alkaloids; Female; Humans; Male; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2015 |
Noribogaine reduces nicotine self-administration in rats.
Topics: Animals; Dose-Response Relationship, Drug; Ibogaine; Male; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Self Administration; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2015 |
E-cigarettes and pregnancy. Is a closer look appropriate?
Topics: Electronic Nicotine Delivery Systems; Female; Humans; Nicotine; Pregnancy; Smoking Cessation | 2015 |
Comparison of the characteristics of long-term users of electronic cigarettes versus nicotine replacement therapy: A cross-sectional survey of English ex-smokers and current smokers.
Topics: Adult; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; England; Female; Humans; Male; Nicotine; Patient Satisfaction; Self-Assessment; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Young Adult | 2015 |
Three Decades of High-Dose Nicotine Gum Dependence Treated With Nicotine Patches.
Topics: Administration, Cutaneous; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2016 |
A study of pyrazines in cigarettes and how additives might be used to enhance tobacco addiction.
Topics: Behavior, Addictive; Cues; Humans; Nicotine; Nicotinic Agonists; Pyrazines; Reinforcement, Psychology; Smoking Cessation; Tobacco Industry; Tobacco Products; Tobacco Use Disorder; United States; United States Food and Drug Administration | 2016 |
Nuances in the ethical regulation of electronic nicotine delivery systems.
Topics: Electronic Nicotine Delivery Systems; Electronics; Humans; Nicotine; Smoking Cessation; Tobacco Products | 2015 |
Commentary on Brose et al. (2015): Protecting individual and public health by regulating electronic cigarette nicotine delivery.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Public Health; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices | 2015 |
Amitifadine, a triple monoamine re-uptake inhibitor, reduces nicotine self-administration in female rats.
Topics: Animals; Aza Compounds; Behavior, Animal; Bridged Bicyclo Compounds, Heterocyclic; Female; Food; Motivation; Motor Activity; Neurotransmitter Uptake Inhibitors; Nicotine; Rats; Rats, Sprague-Dawley; Self Administration; Smoking Cessation; Time Factors | 2015 |
Food and Drug Administration Response to the ATTUD/SRNT Policy Statement on the Labeling of Nicotine Replacement Therapies.
Topics: Health Policy; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices | 2016 |
Nicotine and metabolites determination in human plasma by ultra performance liquid chromatography-tandem mass spectrometry: a simple approach for solving contamination problem and clinical application.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Biotransformation; Calibration; Charcoal; Chromatography, Liquid; Cotinine; Female; Humans; Liquid-Liquid Extraction; Male; Middle Aged; Nicotine; Nicotinic Agonists; Reference Standards; Reproducibility of Results; Smoking Cessation; Tandem Mass Spectrometry; Tobacco Use Cessation Devices; Transdermal Patch; Young Adult | 2015 |
Would Adding an Anesthesic to Nicotine Mouth Spray Increase Smoking Cessation Rates? Would this Justify Starting a Research Project?
Topics: Anesthetics; Biomedical Research; Humans; Nicotine; Oral Sprays; Smoking Cessation | 2015 |
Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption.
Topics: Adult; Alleles; Cytochrome P-450 CYP2A6; Female; Genetic Association Studies; Genetic Variation; Humans; Male; Middle Aged; Nicotine; Polymorphism, Single Nucleotide; Risk Factors; Smoking; Smoking Cessation | 2015 |
Policymakers work to develop e-cigarette guidelines and restrictions.
Topics: Advertising; California; Electronic Nicotine Delivery Systems; Guidelines as Topic; Health Education; Health Policy; Humans; Nicotine; Nicotinic Agonists; Public Policy; Smoking; Smoking Cessation; Smoking Prevention; Social Marketing; Substance-Related Disorders; Surveys and Questionnaires; United States | 2015 |
Liquid Nicotine Toxicity.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking Cessation; United States; United States Food and Drug Administration | 2015 |
Changes in circulating leptin levels during the initial stage of cessation are associated with smoking relapse.
Topics: Adult; Carbon Monoxide; Cotinine; Craving; Female; Humans; Leptin; Male; Nicotine; Nicotinic Agonists; Prognosis; Proportional Hazards Models; Prospective Studies; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Successful Nicotine Intake in Medical Assisted Use of E-Cigarettes: A Pilot Study.
Topics: Adolescent; Adult; Biomarkers; Carbon Monoxide; Cotinine; Craving; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Pilot Projects; Smoking; Smoking Cessation; Tobacco Use Disorder; Young Adult | 2015 |
Science and the evolving electronic cigarette.
Topics: Electronic Nicotine Delivery Systems; Humans; Inventions; Nicotine; Smoking Cessation | 2015 |
Nicotine replacement therapy and other interventions for pregnant smokers: Pregnancy Risk Assessment Monitoring System, 2009-2010.
Topics: Adult; Female; Humans; Maternal Behavior; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Prenatal Care; Risk Assessment; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; United States; Young Adult | 2015 |
Identifying e-cigarette vape stores: description of an online search methodology.
Topics: Commerce; Crowdsourcing; Electronic Nicotine Delivery Systems; Florida; Humans; Internet; Licensure; Nicotine; Nicotinic Agonists; Smoking Cessation; Vaping | 2016 |
A New Strategy for Smoking Cessation: Characterization of a Bacterial Enzyme for the Degradation of Nicotine.
Topics: Animals; Bacterial Proteins; Dinitrocresols; Enzyme Stability; Enzymes; Half-Life; Humans; Kinetics; Male; Mice; Nicotine; Pseudomonas putida; Smoking Cessation; Toxicity Tests | 2015 |
Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers.
Topics: Administration, Cutaneous; Analysis of Variance; Anxiety; Biomarkers; Cotinine; Craving; Depression; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Addiction: Protect the young from e-cigarettes.
Topics: Adolescent; Behavior, Addictive; Child; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation; Smoking Prevention | 2015 |
Acoustic startle and prepulse inhibition predict smoking lapse in posttraumatic stress disorder.
Topics: Acoustic Stimulation; Adult; Arousal; Attention; Humans; Male; Nicotine; Prepulse Inhibition; Recurrence; Reflex, Startle; Smoking; Smoking Cessation; Stress Disorders, Post-Traumatic; Substance Withdrawal Syndrome; Time Factors | 2015 |
Nicotine Replacement Therapy as a Maintenance Treatment.
Topics: Directive Counseling; Female; Humans; Male; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2015 |
A Culturally Adapted Smoking Cessation Intervention for Korean Americans: Preliminary Findings.
Topics: Adult; Aged; Asian; Counseling; Culturally Competent Care; Female; Hotlines; Humans; Male; Middle Aged; Nicotine; Psychometrics; Smoking Cessation; Tobacco Use Cessation Devices | 2017 |
Adolescent (Mis)Perceptions About Nicotine Addiction: Results From a Mixed-Methods Study.
Topics: Adolescent; Attitude to Health; Behavior, Addictive; Female; Humans; Longitudinal Studies; Male; Nicotine; Psychology, Adolescent; Qualitative Research; Risk Factors; Smoking; Smoking Cessation; Surveys and Questionnaires | 2016 |
[The use of electronic cigarettes should be carefully supervised].
Topics: Electronic Nicotine Delivery Systems; Ganglionic Stimulants; Humans; Nicotine; Smoke-Free Policy; Smoking Cessation | 2015 |
Effects of Switching to Electronic Cigarettes with and without Concurrent Smoking on Exposure to Nicotine, Carbon Monoxide, and Acrolein.
Topics: Acetylcysteine; Acrolein; Adult; Aerosols; Biomarkers; Breath Tests; Carbon Monoxide; Cohort Studies; Cotinine; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Smoke; Smoking; Smoking Cessation | 2015 |
Damage to the insula leads to decreased nicotine withdrawal during abstinence.
Topics: Brain Diseases; Brain Ischemia; Cerebral Cortex; Female; Hospitalization; Humans; Longitudinal Studies; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Stroke; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2015 |
Effect of smoking cessation for 1 year on periodontal biomarkers in gingival crevicular fluid.
Topics: Adult; Biomarkers; Cotinine; Dental Plaque Index; Enzyme-Linked Immunosorbent Assay; Female; Gingival Crevicular Fluid; Humans; Interleukin-1beta; Male; Matrix Metalloproteinase 8; Matrix Metalloproteinase 9; Middle Aged; Nicotine; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontium; Prospective Studies; Saliva; Smoking; Smoking Cessation | 2016 |
The effect of switching pharmacological intervention during extinction on nicotine-evoked conditioned responding in rats.
Topics: Animals; Conditioning, Psychological; Discrimination Learning; Dose-Response Relationship, Drug; Drug Substitution; Extinction, Psychological; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Smoking Cessation; Varenicline | 2015 |
Extenuating Circumstances: Smoking--A Deadly Addiction.
Topics: Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder | 2015 |
Nicotine lethal dose: ignorance or counterfeit?
Topics: Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation | 2015 |
The reply.
Topics: Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation | 2015 |
Understanding Pregnant Smokers' Adherence to Nicotine Replacement Therapy During a Quit Attempt: A Qualitative Study.
Topics: Female; Humans; Medication Adherence; Nicotine; Pregnancy; Pregnancy Complications; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2016 |
A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism.
Topics: Cytochrome P-450 CYP2A6; Epigenesis, Genetic; Female; Genome-Wide Association Study; Genotype; Humans; Male; Nicotine; Polymorphism, Single Nucleotide; Smoking; Smoking Cessation; Tobacco Use Disorder; Twins, Dizygotic | 2015 |
Sociodemographic Differences in the Use of Electronic Nicotine Delivery Systems in the European Union.
Topics: Adolescent; Adult; Aged; Electronic Nicotine Delivery Systems; European Union; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Social Class; Surveys and Questionnaires; Young Adult | 2016 |
Quitters Never Sleep: The Effect of Nicotine Withdrawal Upon Sleep.
Topics: Animals; Humans; Nicotine; Sleep Wake Disorders; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2015 |
Does reduced smoking if you can't stop make any difference?
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Reduction Behavior; Smoking; Smoking Cessation | 2015 |
What to advise to respiratory patients intending to use electronic cigarettes.
Topics: Electronic Nicotine Delivery Systems; Evidence-Based Medicine; Humans; Nicotine; Patient Safety; Respiration Disorders; Smoking; Smoking Cessation; Tobacco Use Disorder | 2015 |
The fMRI BOLD response to unisensory and multisensory smoking cues in nicotine-dependent adults.
Topics: Adolescent; Adult; Behavior, Addictive; Brain; Brain Mapping; Craving; Cues; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder; Young Adult | 2015 |
Cue-reactivity in experienced electronic cigarette users: Novel stimulus videos and a pilot fMRI study.
Topics: Adult; Craving; Cues; Electronic Nicotine Delivery Systems; Female; Humans; Magnetic Resonance Imaging; Male; Nicotine; Pilot Projects; Self Report; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Vaping | 2016 |
Consumer preferences for electronic cigarettes: results from a discrete choice experiment.
Topics: Adolescent; Adult; Age Factors; Canada; Choice Behavior; Consumer Behavior; Drug Compounding; Drug Costs; Drug Labeling; Electronic Nicotine Delivery Systems; Female; Flavoring Agents; Health Behavior; Humans; Male; Nicotine; Nicotinic Agonists; Perception; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Young Adult | 2016 |
CYP2A6 Effects on Subjective Reactions to Initial Smoking Attempt.
Topics: Adolescent; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2A6; Female; Genotype; Humans; Male; Nicotine; Pleasure; Risk Factors; Smoking; Smoking Cessation; Tobacco Use Disorder | 2016 |
Differences in the design and sale of e-cigarettes by cigarette manufacturers and non-cigarette manufacturers in the USA.
Topics: Administration, Inhalation; Adolescent; Commerce; Direct-to-Consumer Advertising; Drug Compounding; Electronic Nicotine Delivery Systems; Equipment Design; Flavoring Agents; Humans; Internet; Manufacturing Industry; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; United States; Vaping; Young Adult | 2016 |
Quantifying how smokers value attributes of electronic cigarettes.
Topics: Adult; Aged; Commerce; Consumer Behavior; Cross-Sectional Studies; Drug Costs; Electronic Nicotine Delivery Systems; Female; Florida; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Perception; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Vaping; Young Adult | 2016 |
Use of electronic nicotine delivery systems and other tobacco products among USA adults, 2014: results from a national survey.
Topics: Adolescent; Adult; Awareness; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Products; United States | 2016 |
Patterns of nicotine dependence in four Eastern European countries.
Topics: Adult; Age Factors; Attitude to Health; Female; Humans; Male; Middle Aged; Nicotine; Odds Ratio; Poland; Romania; Russia; Sex Factors; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Products; Tobacco Use Disorder; Ukraine | 2015 |
Stress response genes and the severity of nicotine withdrawal.
Topics: Animals; Humans; Nicotine; Polymorphism, Single Nucleotide; Severity of Illness Index; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Tacrolimus Binding Proteins; Tobacco Use Disorder | 2016 |
Nicotine replacement therapy as a smoking cessation aid among disadvantaged smokers: What answers do we need?
Topics: Humans; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2016 |
Electronic Cigarette Trial and Use among Young Adults: Reasons for Trial and Cessation of Vaping.
Topics: Adolescent; Adult; Age Factors; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Sex Factors; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Tobacco Use Disorder; United States; Young Adult | 2015 |
Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life setting.
Topics: Adult; Aged; Blood Pressure; Brazil; Bupropion; Cardiovascular Diseases; Comorbidity; Coronary Artery Disease; Diabetes Mellitus; Diastole; Dopamine Uptake Inhibitors; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nicotine; Nicotinic Agonists; Risk Factors; Smoking; Smoking Cessation; Systole; Tobacco Use Cessation Devices; Varenicline | 2016 |
A longitudinal study of cotinine in long-term daily users of e-cigarettes.
Topics: Cotinine; Electronic Nicotine Delivery Systems; Female; Follow-Up Studies; France; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Saliva; Smoking; Smoking Cessation; Switzerland; Time Factors; Tobacco Use Disorder; United States | 2016 |
Craving and Withdrawal Symptoms During Smoking Cessation: Comparison of Pregnant and Non-Pregnant Smokers.
Topics: Adolescent; Adult; Craving; Female; Humans; Middle Aged; Nicotine; Nicotinic Agonists; Pregnancy; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Young Adult | 2016 |
Chronic Pain Status, Nicotine Withdrawal, and Expectancies for Smoking Cessation Among Lighter Smokers.
Topics: Adult; Case-Control Studies; Chronic Pain; Female; Humans; Male; Nicotine; Self Efficacy; Smokers; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Young Adult | 2016 |
Use of electronic nicotine delivery systems and recent initiation of smoking among US youth.
Topics: Adolescent; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Prevalence; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Products; United States; Young Adult | 2016 |
Electronic Nicotine Delivery Systems, From Both Sides of the Atlantic.
Topics: Electronic Nicotine Delivery Systems; Equipment Design; Global Health; Humans; Incidence; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Products | 2016 |
Investigations of Enantiopure Nicotine Haptens Using an Adjuvanting Carrier in Anti-Nicotine Vaccine Development.
Topics: Animals; Antibody Formation; Drug Carriers; Flagellin; Haptens; Hypothermia; Male; Mice; Mice, Inbred BALB C; Nicotine; Pain Measurement; Serum Albumin, Bovine; Smoking Cessation; Structure-Activity Relationship; Vaccines | 2016 |
Impact of e-cigarette refill liquid exposure on rat kidney.
Topics: Acute Kidney Injury; Animals; Biomarkers; Catalase; Creatinine; Electronic Nicotine Delivery Systems; Injections, Intraperitoneal; Kidney; Lipid Peroxidation; Male; Nicotine; Nicotinic Agonists; Oxidative Stress; Rats, Wistar; Risk Assessment; Smoking Cessation; Species Specificity; Superoxide Dismutase; Time Factors; Toxicity Tests; Urea; Uric Acid | 2016 |
RECOMMENDATIONS FOR U.S. PUBLIC POLICIES REGULATING ELECTRONIC CIGARETTES.
Topics: Administration, Inhalation; Adolescent; Child; Drug and Narcotic Control; Electronic Nicotine Delivery Systems; Flavoring Agents; Government Regulation; Harm Reduction; Health Policy; Humans; Marketing; Nicotine; Product Labeling; Public Health Practice; Smoke-Free Policy; Smoking; Smoking Cessation; United States; United States Food and Drug Administration | 2016 |
Adolescents and adults differ in the immediate and long-term impact of nicotine administration and withdrawal on cardiac norepinephrine.
Topics: Age Factors; Animals; Female; Heart; Male; Myocardium; Nicotine; Nicotinic Agonists; Norepinephrine; Rats; Rats, Sprague-Dawley; Smoking Cessation; Substance Withdrawal Syndrome | 2016 |
Commentary on Roberts et al. (2016): Bupropion and varenicline are efficacious and well-tolerated cessation medications for smokers with serious mental illness.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2016 |
Assessing Discrimination of Nicotine in Humans Via Cigarette Smoking.
Topics: Adult; Choice Behavior; Discrimination Learning; Dose-Response Relationship, Drug; Female; Humans; Male; Nicotine; Reinforcement, Psychology; Smoking; Smoking Cessation; Smoking Prevention; Young Adult | 2016 |
A fully validated LC-MS/MS method for simultaneous determination of nicotine and its metabolite cotinine in human serum and its application to a pharmacokinetic study after using nicotine transdermal delivery systems with standard heat application in adul
Topics: Chromatography, Liquid; Cotinine; Drug Stability; Humans; Hyperthermia, Induced; Linear Models; Nicotine; Reproducibility of Results; Sensitivity and Specificity; Smoking Cessation; Tandem Mass Spectrometry; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2016 |
Does acute tobacco smoking prevent cue-induced craving?
Topics: Adult; Craving; Cues; Female; Humans; Male; Nicotiana; Nicotine; Self Administration; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Smoking; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2016 |
Using Cognitive Interviewing to Better Assess Young Adult E-cigarette Use.
Topics: Adolescent; Adult; Cognition; Electronic Nicotine Delivery Systems; Female; Health Surveys; Humans; Interviews as Topic; Male; Nicotine; Reproducibility of Results; Smoking Cessation; Texas; Young Adult | 2016 |
Evidence, Policy, and E-Cigarettes--Will England Reframe the Debate?
Topics: Conflict of Interest; Cross-Cultural Comparison; Electronic Nicotine Delivery Systems; Government Agencies; Harm Reduction; Health Policy; History, 20th Century; History, 21st Century; Humans; Nicotine; Public Health Administration; Smoking; Smoking Cessation; Tobacco Use Disorder; United Kingdom; United States | 2016 |
A protocadherin gene cluster regulatory variant is associated with nicotine withdrawal and the urge to smoke.
Topics: Adult; Black or African American; Cadherins; Diagnostic and Statistical Manual of Mental Disorders; Female; Gene Expression Regulation; Genome-Wide Association Study; Humans; Male; Multigene Family; Nicotine; Polymorphism, Single Nucleotide; Protocadherins; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; White People | 2017 |
Society of Behavioral Medicine's (SBM) position on emerging policy issues regarding electronic nicotine delivery systems (ENDS): A need for regulation.
Topics: Behavioral Medicine; Electronic Nicotine Delivery Systems; Government Regulation; Humans; Nicotine; Policy; Public Health; Smoking; Smoking Cessation; Tobacco Products | 2016 |
Nicotine Dependence and Urinary Nicotine, Cotinine and Hydroxycotinine Levels in Daily Smokers.
Topics: Adolescent; Adult; Biomarkers; Cotinine; Female; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Nicotine; Severity of Illness Index; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Tandem Mass Spectrometry; Tobacco Use Disorder; Young Adult | 2016 |
Sex differences in attenuation of nicotine reinstatement after individual and combined treatments of progesterone and varenicline.
Topics: Animals; Disease Models, Animal; Drug Combinations; Drug-Seeking Behavior; Extinction, Psychological; Female; Male; Nicotine; Nicotinic Agonists; Progesterone; Progestins; Rats; Rats, Wistar; Reinforcement Schedule; Self Administration; Sex Factors; Smoking Cessation; Varenicline | 2016 |
Rethinking therapeutic and recreational nicotine products: a commentary on Hatsukami et al.
Topics: Harm Reduction; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2016 |
The Moment Study: protocol for a mixed method observational cohort study of the Alternative Nicotine Delivery Systems (ANDS) initiation process among adult cigarette smokers.
Topics: Adult; Attitude; Biomarkers; Cohort Studies; Culture; Electronic Nicotine Delivery Systems; Humans; Longitudinal Studies; Menthol; Nicotiana; Nicotine; Racial Groups; Research Design; Smoking; Smoking Cessation; Social Control, Formal; Social Norms; Tobacco Products; Tobacco Use Disorder; United States | 2016 |
Modifying Risk Factors for Total Joint Arthroplasty: Strategies That Work Nicotine.
Topics: Adult; Arthroplasty, Replacement; Humans; Joint Diseases; Nicotine; Postoperative Complications; Risk Factors; Smoking; Smoking Cessation; Wound Healing | 2016 |
The Potential That Electronic Nicotine Delivery Systems Can be a Disruptive Technology: Results From a National Survey.
Topics: Adolescent; Adult; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Female; Health Surveys; Humans; Male; Middle Aged; Nicotine; Personal Satisfaction; Smoking Cessation; Smoking Prevention; United States; Young Adult | 2016 |
The potential impact of vaporized nicotine products on vulnerable subpopulations.
Topics: Electronic Nicotine Delivery Systems; Harm Reduction; Nicotine; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices | 2017 |
Editorial Commentary: Nicotine in electronic cigarettes: Cardiovascular harm reduction, not elimination.
Topics: Electronic Nicotine Delivery Systems; Harm Reduction; Humans; Nicotine; Smoking Cessation | 2016 |
Commentary on Pateman et al. (2016): Optimizing the wait for the 'right time'.
Topics: Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2016 |
Effects of aging on the effectiveness of smoking cessation medication.
Topics: Adult; Age Factors; Aged; Brazil; Bupropion; Drug Therapy, Combination; Female; Half-Life; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Precision Medicine; Smoking Cessation; Treatment Outcome; Varenicline | 2016 |
Knowledge and Perceptions about Nicotine, Nicotine Replacement Therapies and Electronic Cigarettes among Healthcare Professionals in Greece.
Topics: Adult; Electronic Nicotine Delivery Systems; Female; Greece; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Male; Nicotine; Perception; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder | 2016 |
The use of varenicline to treat nicotine dependence among patients with cancer.
Topics: Adult; Benzazepines; Bupropion; Counseling; Feasibility Studies; Female; Humans; Male; Middle Aged; Neoplasms; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2017 |
Questioning Nicotine Replacement Therapy Without Behavioral Support.
Topics: Administration, Cutaneous; Alcoholism; Humans; Nicotine; Smoking Cessation | 2016 |
Questioning Nicotine Replacement Therapy Without Behavioral Support-Reply.
Topics: Administration, Cutaneous; Alcoholism; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation | 2016 |
An Electronic Cigarette Vaping Machine for the Characterization of Aerosol Delivery and Composition.
Topics: Aerosols; Electronic Nicotine Delivery Systems; Equipment Design; Flavoring Agents; Humans; Nicotine; Smoking Cessation; Vaping | 2017 |
Cardiovascular Perspective of the Promises and Perils of E-Cigarettes.
Topics: Animals; Cardiovascular Diseases; Consumer Product Safety; Electronic Nicotine Delivery Systems; Humans; Inhalation Exposure; Nicotine; Nicotinic Agonists; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Vaping | 2016 |
Factors influencing sustainable efficacy of smoking cessation treatment with varenicline beyond nine months.
Topics: Adult; Aged; Aged, 80 and over; Bupropion; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Varenicline | 2016 |
Smoking Cessation and the Risk of Hyperactive Delirium in Hospitalized Patients: A Retrospective Study.
Topics: Aged; Aged, 80 and over; Delirium; Female; Hospitalization; Humans; Incidence; Length of Stay; Male; Middle Aged; Mortality; Multivariate Analysis; Nicotine; Nicotinic Agonists; Odds Ratio; Psychiatry; Psychomotor Agitation; Referral and Consultation; Retrospective Studies; Risk Factors; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2016 |
The nicotine + alcohol interoceptive drug state: contribution of the components and effects of varenicline in rats.
Topics: Animals; Central Nervous System Depressants; Conditioning, Classical; Cues; Dose-Response Relationship, Drug; Ethanol; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Long-Evans; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2016 |
Cigarette prohibition and the need for more prior testing of the WHO TobReg's global nicotine-reduction strategy.
Topics: Harm Reduction; Humans; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Products; Tobacco Smoking; World Health Organization | 2017 |
The case for the WHO Advisory Note, Global Nicotine Reduction Strategy.
Topics: Harm Reduction; Humans; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Products; Tobacco Smoking; World Health Organization | 2017 |
New insights into smoking cessation question the effectiveness of nicotine replacement therapy.
Topics: Nicotine; Smoking Cessation; Tobacco Use Cessation Devices | 2016 |
Adult attention-deficit/hyperactivity disorder and nicotine withdrawal: a qualitative study of patient perceptions.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Motivation; Nicotine; Qualitative Research; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2016 |
Success of smoking cessation interventions during pregnancy.
Topics: Adolescent; Adult; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Small for Gestational Age; Longitudinal Studies; Male; Middle Aged; Nicotine; Pregnancy; Pregnancy Outcome; Premature Birth; Prenatal Care; Retrospective Studies; Risk Factors; Smoking Cessation; Tobacco Use Cessation Devices; Young Adult | 2016 |
E-cigarettes and the need and opportunities for alternatives to animal testing.
Topics: Animal Testing Alternatives; Animals; Electronic Nicotine Delivery Systems; Humans; Nicotine; Product Surveillance, Postmarketing; Smoking; Smoking Cessation; Toxicity Tests | 2016 |
Why Pregnant Women Should Avoid Any Form of Nicotine during Pregnancy: An Elastin-based Perspective.
Topics: Elastin; Female; Humans; Nicotine; Pregnancy; Smoking; Smoking Cessation | 2016 |
Reply: Why Pregnant Women Should Avoid Any Form of Nicotine during Pregnancy: An Elastin-based Perspective.
Topics: Elastin; Female; Humans; Nicotine; Pregnancy; Smoking; Smoking Cessation | 2016 |
Getting cytisine licensed for use world-wide: a call to action.
Topics: Alkaloids; Azocines; Legislation, Drug; Nicotine; Quinolizines; Smoking Cessation | 2016 |
Is public health regulation the biggest factor influencing the use and uptake of vaporized nicotine products?
Topics: Electronic Nicotine Delivery Systems; Nicotine; Public Health; Smoking Cessation; Tobacco Products; Vaping | 2017 |
Cannabinoid receptor 1 (CNR1) gene variant moderates neural index of cognitive disruption during nicotine withdrawal.
Topics: Adult; Cannabinoids; Cognition; Electroencephalography; Female; Haplotypes; Humans; Male; Memory; Middle Aged; Nicotine; Receptor, Cannabinoid, CB1; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; White People | 2016 |
Reasons for using flavored liquids among electronic cigarette users: A concept mapping study.
Topics: Adult; Choice Behavior; Electronic Nicotine Delivery Systems; Female; Flavoring Agents; Health Surveys; Humans; Male; Middle Aged; Motivation; Nicotine; Smoking Cessation; Taste; Vaping; Virginia | 2016 |
After precessation nicotine replacement therapy, abrupt cessation increases abstinence more than gradual cessation in smokers ready to quit.
Topics: Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2016 |
Dyskinesia in an unmedicated adolescent with a 5-year history of tobacco use: a case report.
Topics: Adolescent; Appetite; Chewing Gum; Conduct Disorder; Directive Counseling; Dyskinesias; Humans; Hygiene; Male; Nicotine; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2016 |
Impact of self-reported lifetime depression or anxiety on effectiveness of mass distribution of nicotine patches.
Topics: Adult; Aged; Anxiety; Depression; Female; Humans; Male; Middle Aged; Nicotine; Randomized Controlled Trials as Topic; Self Report; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2016 |
Let actual markets help assess the worth of optional very-low-nicotine cigarettes before deciding on mandatory regulations.
Topics: Humans; Nicotine; Smoking Cessation; Tobacco Industry; Tobacco Products | 2017 |
Reduced nicotine content cigarettes, e-cigarettes and the cigarette end game.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Products | 2017 |
Orthopedic Surgeons' Management of Elective Surgery for Patients Who Use Nicotine.
Topics: Attitude of Health Personnel; Directive Counseling; Elective Surgical Procedures; Humans; Nicotine; Orthopedic Procedures; Orthopedics; Postoperative Care; Practice Patterns, Physicians'; Preoperative Care; Smoking; Smoking Cessation; Specialization; Surveys and Questionnaires | 2017 |
Exposure to Nicotine and Selected Toxicants in Cigarette Smokers Who Switched to Electronic Cigarettes: A Longitudinal Within-Subjects Observational Study.
Topics: Adult; Biomarkers; Carcinogens; Electronic Nicotine Delivery Systems; Female; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Poland; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Young Adult | 2017 |
Characterizing the relationship between increases in the cost of nicotine and decreases in nicotine content in adult male rats: implications for tobacco regulation.
Topics: Analysis of Variance; Animals; Economics, Behavioral; Government Regulation; Humans; Male; Nicotine; Rats; Smoking Cessation; Smoking Prevention | 2016 |
Transitioning From Cigarettes to Electronic Cigarettes Increases Alcohol Consumption.
Topics: Adult; Alcohol Drinking; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Smoking Cessation; Tobacco Products | 2016 |
Associations of cytochrome P450 oxidoreductase genetic polymorphisms with smoking cessation in a Chinese population.
Topics: Asian People; Female; Genetic Association Studies; Genetic Predisposition to Disease; Haplotypes; Humans; Male; Middle Aged; NADPH-Ferrihemoprotein Reductase; Nicotine; Polymorphism, Single Nucleotide; Risk Factors; Smoking; Smoking Cessation | 2016 |
Is nicotine replacement really ineffective? A reply to Stanley and Massey.
Topics: Nicotine; Smoking Cessation | 2017 |
Reducing the nicotine content of combusted tobacco products sold in New Zealand.
Topics: Electronic Nicotine Delivery Systems; Health Policy; Humans; New Zealand; Nicotine; Smokers; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Disorder | 2017 |
Concerns about the safety of nicotine replacement therapy during pregnancy on lung development in children.
Topics: Child; Female; Humans; Nicotine; Pregnancy; Smoking Cessation; Tobacco Use Cessation Devices | 2017 |
Nicotine levels, withdrawal symptoms, and smoking reduction success in real world use: A comparison of cigarette smokers and dual users of both cigarettes and E-cigarettes.
Topics: Adult; Craving; Electronic Nicotine Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Products; Tobacco Use Disorder; Young Adult | 2017 |
Medicalisation, smoking and e-cigarettes: evidence and implications.
Topics: Chronic Disease; Electronic Nicotine Delivery Systems; Humans; Medicalization; Nicotine; Smoking; Smoking Cessation; Tobacco Industry; Tobacco Use Disorder | 2017 |
Low Nicotine Content Descriptors Reduce Perceived Health Risks and Positive Cigarette Ratings in Participants Using Very Low Nicotine Content Cigarettes.
Topics: Adult; Advertising; Aged; Female; Humans; Male; Middle Aged; Nicotine; Product Labeling; Risk-Taking; Smoking; Smoking Cessation; Terminology as Topic; Tobacco Products; Young Adult | 2017 |
Use of Electronic Nicotine Delivery Systems among Adults with Mental Health Conditions, 2015.
Topics: Adolescent; Adult; Electronic Nicotine Delivery Systems; Female; Humans; Male; Mental Disorders; Mental Health; Middle Aged; Nicotine; Self Report; Smoking; Smoking Cessation; Young Adult | 2016 |
Negative affect subtypes and craving differentially predict long-term cessation success among smokers achieving initial abstinence.
Topics: Adult; Affective Symptoms; Anger; Anxiety; Craving; Depression; Female; Humans; Logistic Models; Male; Motivation; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Recurrence; Risk; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Smoking; Tobacco Use Cessation Devices; Tobacco Use Disorder; Young Adult | 2017 |
The Health Effects of Electronic Cigarettes.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation | 2016 |
The Health Effects of Electronic Cigarettes.
Topics: Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation | 2016 |
Relationship of nicotine deprivation and indices of alcohol use behavior to implicit alcohol and cigarette approach cognitions in smokers.
Topics: Adult; Alcohol Drinking; Alcohol-Related Disorders; Cognition; Comorbidity; Craving; Female; Humans; Male; Middle Aged; Motivation; Neuropsychological Tests; New England; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2017 |
Commentary on Nardone et al. (2016): Satisfaction, dissatisfaction and complicating the nicotine-reduction strategy with more nicotine.
Topics: Harm Reduction; Nicotine; Personal Satisfaction; Smoking Cessation; Tobacco Use Cessation Devices | 2016 |
Effect of Selective Inhibition of Reactivated Nicotine-Associated Memories With Propranolol on Nicotine Craving.
Topics: Adolescent; Adult; Animals; Association Learning; Conditioning, Classical; Craving; Female; Humans; Male; Memory Consolidation; Mental Recall; Middle Aged; Nicotine; Propranolol; Rats; Rats, Sprague-Dawley; Recurrence; Smoking Cessation; Tobacco Use Disorder; Translational Research, Biomedical; Young Adult | 2017 |
Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A Cross-sectional Study.
Topics: Adult; Biomarkers; Carcinogens; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Female; Humans; Male; Nicotine; Nitrosamines; Salvia; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Volatile Organic Compounds | 2017 |
Survey of community pharmacists' perception of electronic cigarettes in London.
Topics: Community Pharmacy Services; Electronic Nicotine Delivery Systems; Female; Health Knowledge, Attitudes, Practice; Humans; London; Male; Nicotine; Pharmacists; Qualitative Research; Safety; Smoking Cessation; Surveys and Questionnaires | 2016 |
Are e-cigarettes good or bad?
Topics: Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires | 2017 |
A debate: Can we recommend electronic cigarettes to our patients? Opinion 1.
Topics: Attitude to Health; Electronic Nicotine Delivery Systems; Humans; Nebulizers and Vaporizers; Nicotine; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2017 |
A debate: Can we recommend electronic cigarettes to our patients? Opinion 2.
Topics: Attitude to Health; Electronic Nicotine Delivery Systems; Humans; Nebulizers and Vaporizers; Nicotine; Public Opinion; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2017 |
Guidelines on smoking management during the perioperative period.
Topics: Behavior Therapy; Electronic Nicotine Delivery Systems; Guidelines as Topic; Humans; Nicotine; Nicotinic Agonists; Perioperative Care; Perioperative Period; Referral and Consultation; Smoking; Smoking Cessation; Tobacco Smoking | 2017 |
Combination nicotine replacement therapy: strategies for initiation and tapering.
Topics: Administration, Cutaneous; Behavior, Addictive; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2017 |
Preliminary findings from a clinical demonstration project for veterans returning from Iraq or Afghanistan.
Topics: Adult; Afghanistan; Female; Health Surveys; Hotlines; Humans; Iraq; Male; Military Medicine; Military Personnel; National Cancer Institute (U.S.); Nicotine; Program Evaluation; Prospective Studies; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Time Factors; United States; Veterans | 2008 |
Are the inhibitory effects of nicotine on erectile response in nonsmokers generalizable to long-term smokers? A reply.
Topics: Administration, Cutaneous; Arousal; Ganglionic Stimulants; Humans; Male; Nicotine; Penile Erection; Smoking; Smoking Cessation | 2008 |
Stability of the nicotine metabolite ratio in ad libitum and reducing smokers.
Topics: Adult; Aged; Analysis of Variance; Cotinine; Female; Humans; Linear Models; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation | 2008 |
Acute nicotine effects on sexual function in men.
Topics: Arousal; Carbon Monoxide; Chewing Gum; Double-Blind Method; Ganglionic Stimulants; Humans; Male; Nicotine; Penile Erection; Randomized Controlled Trials as Topic; Smoking Cessation | 2008 |
What's new in nicotine & tobacco research?
Topics: Ganglionic Stimulants; Humans; Nicotine; Research; Smoking; Smoking Cessation; Tobacco Use Disorder | 2008 |
Motives for smoking and their correlates in clients attending Stop Smoking treatment services.
Topics: Adult; Female; Humans; Logistic Models; London; Male; Middle Aged; Motivation; Nicotine; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2008 |
High rate of smoking abstinence in COPD patients: Smoking cessation by hospitalization.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Female; Follow-Up Studies; Ganglionic Stimulants; Hospitalization; Humans; Male; Middle Aged; Nicotine; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2008 |
Racial/Ethnic disparities in the use of nicotine replacement therapy and quit ratios in lifetime smokers ages 25 to 44 years.
Topics: Adult; Cross-Sectional Studies; Ethnicity; Female; Humans; Male; Nicotine; Nicotinic Agonists; Retrospective Studies; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; United States | 2008 |
Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls.
Topics: Administration, Cutaneous; Adult; Carbon Monoxide; Cues; Female; Humans; Male; Nicotine; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2008 |
Correspondence of Interactive Voice Response (IVR) reports of nicotine withdrawal, craving, and negative mood with questionnaire ratings.
Topics: Adult; Comorbidity; Depression; Female; Humans; Irritable Mood; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Self Disclosure; Self-Assessment; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2008 |
Nicotine replacement therapy does help smokers to quit.
Topics: Humans; Nicotine; Smoking Cessation | 2008 |
What's new in Nicotine & Tobacco Research?
Topics: Depression; Flavoring Agents; Humans; Nicotine; Primary Prevention; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Industry; United States | 2008 |
Varenicline: depression and suicide. Nicotine is a safer option.
Topics: Benzazepines; Depression; Humans; Nicotine; Quinoxalines; Smoking Cessation; Suicide | 2008 |
Enhanced immunogenicity of a bivalent nicotine vaccine.
Topics: Animals; Antigens, Bacterial; Bacterial Proteins; Cross Reactions; Hemocyanins; Nicotine; Rats; Smoking; Smoking Cessation; Vaccination; Vaccines, Conjugate | 2008 |
Pre-cessation varenicline treatment vs post-cessation NRT: an uneven playing field.
Topics: Benzazepines; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Smoking Prevention; Varenicline | 2008 |
Clinically significant outcomes in smoking cessation.
Topics: Benzazepines; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline | 2008 |
[Summary of the practice guideline 'Smoking cessation' from the Dutch College of General Practitioners].
Topics: Bupropion; Chronic Disease; Family Practice; Female; Humans; Male; Motivation; Netherlands; Nicotine; Nortriptyline; Practice Patterns, Physicians'; Smoking Cessation; Social Support; Societies, Medical | 2008 |
[The tobacco cessation consultation of the Salah-Azeiz Tunis cancer center: one year results].
Topics: Adult; Cholinergic Agents; Counseling; Female; Follow-Up Studies; Health Education; Hospitals, University; Humans; Male; Medical Oncology; Middle Aged; Multivariate Analysis; Nicotine; Psychotherapy, Group; Retrospective Studies; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Tunisia | 2008 |
Sex-related differences in serum cotinine concentrations in daily cigarette smokers.
Topics: Adult; Aged; Biomarkers; Canada; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Regression Analysis; Sex Distribution; Smoking; Smoking Cessation | 2008 |
Understanding why smokers do not want to use nicotine dependence medications to stop smoking: qualitative and quantitative studies.
Topics: Adult; Attitude to Health; Behavior, Addictive; Bupropion; Cross-Sectional Studies; England; Female; Health Knowledge, Attitudes, Practice; Humans; Intention; Male; Middle Aged; Nicotine; Patient Compliance; Qualitative Research; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires | 2008 |
'Breathe': the stop smoking service for pregnant women in Glasgow.
Topics: Breath Tests; Carbon Monoxide; Counseling; Female; Ganglionic Stimulants; Humans; Nicotine; Nurse Midwives; Nursing Evaluation Research; Patient Education as Topic; Pregnancy; Pregnancy Complications; Prenatal Care; Program Development; Program Evaluation; Referral and Consultation; Scotland; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Telephone | 2010 |
Dose-response relationship between cigarette smoking and risk of ischemic stroke in young women.
Topics: Adolescent; Adult; Baltimore; Brain Ischemia; Case-Control Studies; Cohort Studies; Comorbidity; District of Columbia; Dose-Response Relationship, Drug; Female; Humans; Logistic Models; Middle Aged; Nicotine; Smoking; Smoking Cessation; Stroke | 2008 |
Smoking characteristics and saliva cotinine levels in Taiwanese smokers: gender differences.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Cotinine; Female; Gender Identity; Humans; Male; Middle Aged; Nicotine; Saliva; Sex Factors; Smoking; Smoking Cessation; Substance-Related Disorders; Surveys and Questionnaires; Taiwan | 2008 |
Gender differences among hardcore smokers: an analysis of the tobacco use supplement of the current population survey.
Topics: Adult; Female; Health Surveys; Humans; Logistic Models; Male; Middle Aged; Nicotiana; Nicotine; Patient Acceptance of Health Care; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Socioeconomic Factors; Tobacco Use Disorder; United States | 2008 |
[Pathophysiological aspects of smoking in pregnancy].
Topics: Animals; Carbon Dioxide; Disease Models, Animal; Endothelium, Vascular; Female; Fetal Development; Fetal Growth Retardation; Humans; Infant, Newborn; Maternal-Fetal Exchange; Nicotine; Pregnancy; Prenatal Exposure Delayed Effects; Smoking; Smoking Cessation; Vascular Resistance | 2008 |
Chronic effect of nicotine on serotonin transporter mRNA in the raphe nucleus of rats: reversal by co-administration of bupropion.
Topics: Animals; Bupropion; Depression; Dose-Response Relationship, Drug; Drug Administration Routes; Gene Expression; Male; Nicotine; Raphe Nuclei; Rats; Rats, Wistar; RNA, Messenger; Serotonin Plasma Membrane Transport Proteins; Smoking Cessation; Substance Withdrawal Syndrome | 2008 |
Medication-related pharmacological manipulations of nicotine self-administration in the rat maintained on fixed- and progressive-ratio schedules of reinforcement.
Topics: Animals; Bupropion; Dopamine; Dopamine Uptake Inhibitors; Drug Administration Schedule; Infusions, Intravenous; Male; Nicotine; Nicotinic Agonists; Norepinephrine; Rats; Rats, Long-Evans; Receptors, Nicotinic; Reinforcement Schedule; Self Administration; Smoking Cessation | 2009 |
Is Australia headed for an epidemic of nicotine replacement therapy addicts?
Topics: Administration, Cutaneous; Australia; Drug Administration Schedule; Humans; Nicotine; Smoking Cessation; Substance-Related Disorders | 2008 |
Smokers' use of nicotine replacement therapy for reasons other than stopping smoking: findings from the ITC Four Country Survey.
Topics: Adolescent; Adult; Aged; Australia; Canada; Cohort Studies; Cross-Sectional Studies; Female; Health Behavior; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; United Kingdom; United States | 2008 |
Significance of off-label use of NRT.
Topics: Drug Labeling; Humans; Nicotine; Nicotinic Agonists; Nonprescription Drugs; Smoking Cessation | 2008 |
Increasing access to evidence-based smoking cessation treatment: effectiveness of a free nicotine patch program among Chinese immigrants.
Topics: Adolescent; Adult; China; Community Health Services; Cultural Competency; Evidence-Based Medicine; Female; Health Services Accessibility; Health Surveys; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Program Development; Program Evaluation; Prospective Studies; Regression Analysis; Smoking; Smoking Cessation; Smoking Prevention; United States; Young Adult | 2010 |
Smoking cessation: what is the evidence?
Topics: Evidence-Based Practice; Humans; Nicotine; Public Policy; Smoking Cessation | 2008 |
An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts.
Topics: Algorithms; Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Consensus; Decision Support Techniques; Delphi Technique; Humans; Nicotine; Nicotinic Agonists; Practice Patterns, Physicians'; Quinoxalines; Smoking Cessation; Varenicline | 2009 |
Sift through the ashes.
Topics: Chewing Gum; Culture; Health Policy; History, 20th Century; History, 21st Century; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; State Medicine; United Kingdom | 2008 |
Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: relationship with use and compliance.
Topics: Adult; Female; Humans; Male; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Patient Education as Topic; Smoking; Smoking Cessation; Surveys and Questionnaires | 2008 |
[Commentary] improving NRT labeling and correcting public misperceptions.
Topics: Drug Labeling; Humans; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Patient Education as Topic; Product Packaging; Smoking Cessation | 2008 |
The effects of environmental tobacco smoke exposure before starting to smoke on cigarette quitting therapies.
Topics: Adult; Aged; Aged, 80 and over; Air Pollution, Indoor; Case-Control Studies; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Nicotine; Patient Education as Topic; Smoking Cessation; Tobacco Smoke Pollution; Young Adult | 2008 |
Effects of a cannabinoid receptor (CB) 1 antagonist AM251 on behavioral sensitization to nicotine in a rat model of novelty-seeking behavior: correlation with hippocampal 5HT.
Topics: Animals; Behavior, Animal; Bupropion; Dose-Response Relationship, Drug; Exploratory Behavior; Hippocampus; Locomotion; Male; Microdialysis; Models, Animal; Nicotine; Nicotinic Agonists; Phenotype; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Serotonin; Smoking Cessation | 2009 |
Toward a nonhuman model of contingency management: effects of reinforcing abstinence from nicotine self-administration in rats with an alternative nondrug reinforcer.
Topics: Animals; Behavior, Addictive; Behavior, Animal; Conditioning, Operant; Male; Models, Animal; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Self Administration; Smoking Cessation; Sucrose; Time Factors; Tobacco Use Disorder | 2009 |
Smoking cessation trials.
Topics: Clinical Trials as Topic; Humans; Meta-Analysis as Topic; Nicotine; Nicotinic Agonists; Smoking Cessation | 2008 |
Psychosocial withdrawal characteristics of nicotine compared with alcohol and caffeine.
Topics: Adult; Aged; Behavior, Addictive; Blood Pressure; Caffeine; Central Nervous System Depressants; Central Nervous System Stimulants; Ethanol; Heart Rate; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Social Behavior; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2008 |
Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Biomarkers; Cotinine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Predictive Value of Tests; ROC Curve; Smoking Cessation; Treatment Outcome | 2009 |
Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzazepines; Brain; Bupropion; Dopamine; Dose-Response Relationship, Drug; Drugs, Investigational; Male; Neurons; Nicotine; Nicotinic Antagonists; Picolines; Quaternary Ammonium Compounds; Quinoxalines; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Receptors, Nicotinic; Reward; Smoking Cessation; Structure-Activity Relationship; Tobacco Use Disorder; Varenicline; Ventral Tegmental Area | 2009 |
The role of nicotine in smoking: a dual-reinforcement model.
Topics: Animals; Association Learning; Conditioning, Psychological; Cues; Disease Models, Animal; Ganglionic Stimulants; Humans; Motivation; Nicotine; Rats; Reward; Self Administration; Smoking; Smoking Cessation; Social Environment; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2009 |
The combination of a smoking cessation programme with rehabilitation increases stop-smoking rate.
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Follow-Up Studies; Humans; Middle Aged; Nicotine; Prognosis; Pulmonary Disease, Chronic Obstructive; Rehabilitation Centers; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2008 |
Dependence on the nicotine gum in former smokers.
Topics: Adult; Female; Humans; Internet; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance-Related Disorders; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder | 2009 |
Smoking cessation and inattention or hyperactivity/impulsivity: a post hoc analysis.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Comorbidity; Compulsive Behavior; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotine; Prevalence; Regression Analysis; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; United States | 2008 |
The impact of the 2006 Scottish smoke-free legislation on sales of nicotine replacement therapy.
Topics: Health Behavior; Health Policy; Health Promotion; Humans; Nicotine; Nonprescription Drugs; Scotland; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Industry; Tobacco Use Disorder | 2008 |
The impact of a free nicotine patch starter kit on quit rates in a state quit line.
Topics: Administration, Cutaneous; Adult; Combined Modality Therapy; Confidence Intervals; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Odds Ratio; Oregon; Smoking Cessation; Telephone; Tobacco Use Disorder; Treatment Outcome | 2008 |
Cue exposure treatment in a virtual environment to reduce nicotine craving: a functional MRI study.
Topics: Adolescent; Behavior, Addictive; Brain Mapping; Computer Simulation; Cues; Desensitization, Psychologic; Frontal Lobe; Generalization, Psychological; Humans; Magnetic Resonance Imaging; Male; Nicotine; Nicotinic Agonists; Photic Stimulation; Smoking Cessation; Therapy, Computer-Assisted; Tobacco Use Disorder; User-Computer Interface | 2009 |
Predictors of early abstinence in smokers with schizophrenia.
Topics: Administration, Cutaneous; Adult; Attention; Chewing Gum; Cognitive Behavioral Therapy; Female; Humans; Logistic Models; Male; Multivariate Analysis; Nicotine; Nicotinic Agonists; Polymethacrylic Acids; Polyvinyls; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Tobacco Use Cessation Devices; United States | 2008 |
Does the reaction of abstaining smokers to the smell of other people's cigarettes predict relapse?
Topics: Adult; Aged; Aged, 80 and over; Cues; Female; Humans; Male; Middle Aged; Nicotine; Olfactory Perception; Recurrence; Smell; Smoking; Smoking Cessation; Young Adult | 2008 |
[Diagnosis of lung cancer: an opportunity for smoking cessation?].
Topics: Antidepressive Agents; Humans; Lung Neoplasms; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation | 2008 |
[Drug treatment for smoking and marijuana abuse].
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Humans; Marijuana Abuse; Nicotine; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2008 |
Smoking cessation treatment in a real-life setting: the Greek experience.
Topics: Adult; Bupropion; Counseling; Dopamine Uptake Inhibitors; Female; Greece; Humans; Male; Middle Aged; Nicotine; Smoking Cessation | 2007 |
The smoking cessation medication varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system.
Topics: Animals; Benzazepines; Central Nervous System Depressants; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Limbic System; Male; Microdialysis; Nicotine; Nucleus Accumbens; Quinoxalines; Rats; Rats, Wistar; Smoking Cessation; Varenicline | 2009 |
Citations to trials of nicotine replacement therapy were biased toward positive results and high-impact-factor journals.
Topics: Humans; Journal Impact Factor; Nicotine; Periodicals as Topic; Publication Bias; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder | 2009 |
Nicotine withdrawal and reward responsivity in a card-sorting task.
Topics: Adult; Female; Humans; Inhibition, Psychological; Male; Motivation; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Psychomotor Performance; Reaction Time; Reinforcement Schedule; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Token Economy | 2009 |
Coronary heart disease risk reduction intervention among overweight smokers with a psychotic disorder: pilot trial.
Topics: Administration, Topical; Adult; Cognitive Behavioral Therapy; Coronary Disease; Feasibility Studies; Female; Humans; International Classification of Diseases; Life Style; Male; Motor Activity; Nicotine; Obesity; Pilot Projects; Psychotic Disorders; Risk Factors; Severity of Illness Index; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires | 2009 |
Do implementation issues influence the effectiveness of medications? The case of nicotine replacement therapy and bupropion in UK Stop Smoking Services.
Topics: Administration, Cutaneous; Adult; Benzazepines; Bupropion; Cohort Studies; Community Health Services; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nicotine; Nicotinic Agonists; Patient Participation; Probability; Program Evaluation; Quinoxalines; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; United Kingdom; Varenicline; Young Adult | 2009 |
Exploring the views of women on using nicotine replacement therapy in pregnancy.
Topics: Adult; England; Female; Ganglionic Stimulants; Humans; Nicotine; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications; Pregnant Women; Risk Reduction Behavior; Rural Population; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Surveys and Questionnaires; Young Adult | 2010 |
Of common nicotine withdrawal symptoms, depression and increased appetite are covered, with other contributions concerning endocrine, cardiovascular and respiratory changes. Preface.
Topics: Appetite; Depression; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 2009 |
Management of emergent psychiatric symptoms during smoking cessation.
Topics: Humans; Mental Disorders; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 2009 |
An examination of attitudes, knowledge, and clinical practices among Pennsylvania pediatricians regarding breastfeeding and smoking.
Topics: Adult; Attitude of Health Personnel; Breast Feeding; Bupropion; Female; Health Knowledge, Attitudes, Practice; Humans; Infant, Newborn; Male; Middle Aged; Milk, Human; Nicotine; Pediatrics; Pennsylvania; Practice Patterns, Physicians'; Safety; Smoking; Smoking Cessation; Surveys and Questionnaires | 2009 |
[Outpatient smoking cessation: a report on 3,260 cases].
Topics: Administration, Inhalation; Administration, Sublingual; Adult; Breath Tests; Carbon Monoxide; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Smoking Prevention; Tablets; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2009 |
Nocturnal sleep-disturbing nicotine craving and accomplishment with a smoking cessation program.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Behavior Therapy; Breath Tests; Bupropion; Carbon Monoxide; Chi-Square Distribution; Child; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Sleep Wake Disorders; Smoking Cessation; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder | 2009 |
A reader responds to "Seven pharmacotherapies do promote smoking abstinence at 6 and 12 months".
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Benzazepines; Bupropion; Chewing Gum; Female; Follow-Up Studies; Humans; Male; Multivariate Analysis; Nicotine; Nicotinic Agonists; Patient Compliance; Probability; Quebec; Quinoxalines; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
[Smoking cessation with special focus on primary health care].
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cardiovascular Diseases; Counseling; Evidence-Based Medicine; Family Practice; Humans; Nicotine; Nortriptyline; Outcome Assessment, Health Care; Primary Health Care; Psychotherapy, Group; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Smoking Prevention | 2009 |
[Why nicotine cannot help with weaning from tobacco].
Topics: Humans; Monoamine Oxidase Inhibitors; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder | 2009 |
World: E-cigarettes are here.
Topics: Drug Delivery Systems; Equipment Design; Humans; Nicotine; Smoking Cessation; Smoking Prevention | 2009 |
Nicotine deprivation and trait impulsivity affect smokers' performance on cognitive tasks of inhibition and attention.
Topics: Adult; Attention; Cognition; Female; Humans; Impulsive Behavior; Inhibition, Psychological; Male; Neuropsychological Tests; Nicotine; Reaction Time; Regression Analysis; Secondary Prevention; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Young Adult | 2009 |
Patterns of change in withdrawal symptoms, desire to smoke, reward motivation and response inhibition across 3 months of smoking abstinence.
Topics: Adolescent; Adult; Aged; Female; Humans; Inhibition, Psychological; London; Male; Middle Aged; Motivation; Nicotine; Reward; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Young Adult | 2009 |
Increasing hospital-wide delivery of smoking cessation care for nicotine-dependent in-patients: a multi-strategic intervention trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Delivery of Health Care; Female; Follow-Up Studies; Hospitalization; Humans; Male; Matched-Pair Analysis; Middle Aged; New South Wales; Nicotine; Nicotinic Agonists; Patient Care Management; Patient Education as Topic; Smoking; Smoking Cessation; Young Adult | 2009 |
Assessing the outcomes of prolonged cessation-induction and aid-to-cessation trials: floating prolonged abstinence.
Topics: Humans; Motivation; Nicotine; Outcome Assessment, Health Care; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors | 2009 |
Summaries for patients. Comparison of 3 strategies to quit smoking.
Topics: Administration, Cutaneous; Adult; Bupropion; Combined Modality Therapy; Counseling; Disease Management; Female; Humans; Male; Middle Aged; Nicotine; Primary Health Care; Single-Blind Method; Smoking Cessation; Social Support; Tobacco Use Disorder; Young Adult | 2009 |
Combination treatment with varenicline and nicotine replacement therapy.
Topics: Adult; Aged; Benzazepines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Outcome Assessment, Health Care; Quinoxalines; Smoking Cessation; Varenicline | 2009 |
Adherence to nicotine replacement therapy among pregnant smokers.
Topics: Adolescent; Adult; Female; Humans; Interviews as Topic; Middle Aged; Nicotine; Patient Compliance; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; United States; Young Adult | 2009 |
Nicotine replacement, effective?
Topics: Humans; Nicotine; Nicotinic Agonists; Smoking Cessation | 2009 |
Nicotine withdrawal symptoms following a quit attempt: an ecological momentary assessment study among adolescents.
Topics: Adolescent; Adolescent Behavior; Female; Follow-Up Studies; Humans; Linear Models; Male; Netherlands; Nicotine; Secondary Prevention; Smoking; Smoking Cessation; Social Environment; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2009 |
Progressive reduction using nicotine gum as a prelude to quitting.
Topics: Administration, Oral; Adult; Attitude to Health; Behavior, Addictive; Chewing Gum; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Treatment Outcome | 2009 |
Treatment of comorbid tobacco use in people with serious mental illness.
Topics: Adult; Benzazepines; Bupropion; Comorbidity; Counseling; Dopamine Uptake Inhibitors; Female; Follow-Up Studies; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Schizophrenia, Paranoid; Smoking; Smoking Cessation; Varenicline | 2009 |
Nicotine replacement therapy. Authors respond to criticism that treatment is ineffective.
Topics: Humans; Nicotine; Nicotinic Agonists; Secondary Prevention; Smoking Cessation; Smoking Prevention | 2009 |
What's new in Nicotine & Tobacco Research?
Topics: Advertising; Bupropion; Cardiovascular Diseases; Causality; Comorbidity; Dopamine Uptake Inhibitors; Global Health; Health Knowledge, Attitudes, Practice; Humans; Nicotine; Research Design; Smoking; Smoking Cessation; Tobacco Use Disorder | 2009 |
beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking.
Topics: Adult; Azetidines; Brain; Brain Mapping; Dominance, Cerebral; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Receptors, Nicotinic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tomography, Emission-Computed, Single-Photon | 2009 |
Cost-effectiveness of varenicline compared with nicotine patches for smoking cessation--results from four European countries.
Topics: Adolescent; Adult; Aged; Benzazepines; Cost-Benefit Analysis; Europe; Female; Heart Diseases; Humans; Incidence; Lung Neoplasms; Male; Markov Chains; Middle Aged; Models, Statistical; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quality-Adjusted Life Years; Quinoxalines; Smoking; Smoking Cessation; Stroke; Varenicline; Young Adult | 2009 |
Understanding of nicotinic acetylcholine receptors.
Topics: China; Humans; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Smoking; Smoking Cessation | 2009 |
[Current and future medical drugs for smoking cessation].
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Clinical Trials as Topic; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline | 2009 |
["Smoke smarts": how to help patients to stop smoking?].
Topics: Chewing Gum; Counseling; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation | 2009 |
Cost-effectiveness of varenicline for smoking cessation.
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cost Savings; Cost-Benefit Analysis; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2009 |
Varenicline: a British review. Unfavorable risk-benefit balance.
Topics: Benzazepines; France; Humans; Nicotine; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; United Kingdom | 2008 |
Smoking cessation in chronic obstructive pulmonary disease: an effective medical intervention.
Topics: Counseling; Germany; Health Promotion; Humans; Nicotine; Psychology; Pulmonary Disease, Chronic Obstructive; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Treatment Outcome | 2009 |
Factors associated with the use of aids to cessation in English smokers.
Topics: Adolescent; Adult; Aged; Cross-Sectional Studies; England; Female; Health Behavior; Humans; Male; Middle Aged; National Health Programs; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Young Adult | 2009 |
What's new in Nicotine & Tobacco Research?
Topics: Adolescent; Adolescent Behavior; Adult; Female; Humans; Male; Nicotine; Primary Prevention; Research Design; Secondary Prevention; Smoking Cessation; Smoking Prevention; Tobacco Industry; Tobacco Smoke Pollution; Tobacco Use Disorder; United States | 2009 |
Evaluation of structurally diverse neuronal nicotinic receptor ligands for selectivity at the alpha6( *) subtype.
Topics: Animals; Chemistry, Pharmaceutical; Dopamine; Drug Design; Humans; Kinetics; Ligands; Mice; Models, Chemical; Nicotine; Parkinson Disease; Protein Binding; Pyrimidines; Receptors, Nicotinic; Smoking Cessation; Structure-Activity Relationship | 2009 |
Impact of nicotine replacement therapy on postoperative mortality following coronary artery bypass graft surgery.
Topics: Aged; Cohort Studies; Coronary Artery Bypass; Female; Hospital Mortality; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Pilot Projects; Postoperative Complications; Retrospective Studies; Smoking Cessation; Tobacco Use Disorder | 2009 |
Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.
Topics: Administration, Cutaneous; Adult; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Antagonists; Premedication; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2009 |
Does nicotine replacement therapy cause cancer? Evidence from the Lung Health Study.
Topics: Administration, Cutaneous; Adult; Female; Gastrointestinal Neoplasms; Humans; Longitudinal Studies; Lung Neoplasms; Male; Middle Aged; Nicotine; Nicotinic Agonists; Proportional Hazards Models; Regression Analysis; Risk Factors; Smoking; Smoking Cessation; Young Adult | 2009 |
Using MIMIC models to examine the relationship between current smoking and early smoking experiences.
Topics: Adult; Black or African American; Female; Humans; Male; Middle Aged; Models, Psychological; Nicotine; Sensation; Smoking; Smoking Cessation; Surveys and Questionnaires; White People; Young Adult | 2009 |
[Contribution to the history of tobacco use].
Topics: Americas; Europe; Government; History, 15th Century; History, 16th Century; History, 17th Century; History, 18th Century; History, 19th Century; Humans; Hungary; Indians, North American; Nicotiana; Nicotine; Nicotinic Agonists; Public Policy; Smoking Cessation; Taxes; Tobacco Use Disorder | 2008 |
Nicotine-induced osteonecrosis. A case report.
Topics: Chewing Gum; Humans; Male; Mandibular Diseases; Middle Aged; Nicotine; Osteonecrosis; Smoking Cessation | 2009 |
Sensation seeking as a predictor of treatment compliance and smoking cessation treatment outcomes in heavy social drinkers.
Topics: Administration, Cutaneous; Adult; Alcohol Drinking; Counseling; Data Interpretation, Statistical; Exploratory Behavior; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Psychiatric Status Rating Scales; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 2009 |
The impact of changing nicotine replacement therapy licensing laws in the United Kingdom: findings from the International Tobacco Control Four Country Survey.
Topics: Australia; Canada; Commerce; Cross-Cultural Comparison; Cross-Sectional Studies; Female; Health Behavior; Humans; Licensure; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; United Kingdom; United States | 2009 |
[Genetic aspects of smoking and impact on clinical care].
Topics: Ganglionic Stimulants; Humans; Nicotine; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder | 2009 |
Quitting smoking is easy...Mark Twain said so.
Topics: Behavior Therapy; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder | 2009 |
Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Biomarkers; Cholesterol, LDL; Cross-Sectional Studies; Deoxyguanosine; Dinoprost; Female; Humans; Immunoglobulin G; Male; Middle Aged; Nicotine; Nitrosamines; Pyridines; Reproducibility of Results; Smoke; Smoking; Smoking Cessation; Thromboxane B2; Thymidine | 2009 |
Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.
Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents, Second-Generation; Belgium; Benzazepines; Bupropion; Computer Simulation; Cost-Benefit Analysis; Counseling; Female; Humans; Male; Markov Chains; Middle Aged; Models, Statistical; Nicotine; Nicotinic Agonists; Quinoxalines; Recurrence; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult | 2009 |
FDA: Electronic cigarettes may be risky.
Topics: Carcinogens; Humans; Nebulizers and Vaporizers; Nicotine; Risk; Smoking Cessation; United States; United States Food and Drug Administration; Volatilization | 2009 |
Smoking cessation: How compelling is the evidence? A review.
Topics: Evidence-Based Medicine; Humans; Nicotine; Smoking Cessation | 2009 |
Smoking cessation should have more emphasis within Tobacco Control? The case against.
Topics: Government Regulation; Humans; International Cooperation; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation; Tobacco Use Disorder | 2009 |
Smoking cessation should have more emphasis within Tobacco Control? The case for.
Topics: Cost-Benefit Analysis; Government Regulation; Humans; International Cooperation; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation; Tobacco Use Disorder | 2009 |
Public health clinical demonstration project for smoking cessation in veterans with posttraumatic stress disorder.
Topics: Bupropion; Cohort Studies; Counseling; Delivery of Health Care; Health Promotion; Hotlines; Humans; Internet; Nicotine; Patient Education as Topic; Public Health; Smoking; Smoking Cessation; Smoking Prevention; Stress Disorders, Post-Traumatic; United States; Veterans | 2010 |
Delay of smoking gratification as a laboratory model of relapse: effects of incentives for not smoking, and relationship with measures of executive function.
Topics: Adolescent; Executive Function; Extinction, Psychological; Female; Humans; Impulsive Behavior; Male; Motivation; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Predictive Value of Tests; Reaction Time; Regression Analysis; Reward; Self Administration; Smoking; Smoking Cessation; Time Factors; Young Adult | 2009 |
Smoking cessation: how to advise the patient.
Topics: Ambulatory Care; Behavior Therapy; Benzazepines; Bupropion; Counseling; Dopamine Uptake Inhibitors; Humans; Motivation; Nicotine; Nicotinic Agonists; Patient Education as Topic; Physician-Patient Relations; Quinoxalines; Secondary Prevention; Smoking Cessation; Smoking Prevention; Varenicline | 2009 |
Nicotinic acetylcholine receptor beta2 subunit (CHRNB2) gene and short-term ability to quit smoking in response to nicotine patch.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Nicotine; Receptors, Nicotinic; Smoking; Smoking Cessation; Treatment Outcome; Young Adult | 2009 |
Nicotine replacement therapy during pregnancy: recommended or not recommended?
Topics: Cognitive Behavioral Therapy; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Smoking Cessation | 2009 |
A comparison of abstinence outcomes among gay/bisexual and heterosexual male smokers in an intensive, non-tailored smoking cessation study.
Topics: Bisexuality; Bupropion; Female; Ganglionic Stimulants; Homosexuality, Female; Homosexuality, Male; Humans; Male; Nicotine; Smoking; Smoking Cessation; Treatment Outcome | 2009 |
Nicotine metabolism in African Americans and European Americans: variation in glucuronidation by ethnicity and UGT2B10 haplotype.
Topics: Adult; Black or African American; Cotinine; DNA; Female; Glucuronides; Glucuronosyltransferase; Haplotypes; Humans; Male; Microsomes, Liver; Middle Aged; Nicotine; Smoking Cessation; Tobacco Use Disorder; White People | 2010 |
Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Cohort Studies; Dopamine Uptake Inhibitors; Family Practice; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Smoking Cessation; Suicide; Varenicline; Young Adult | 2009 |
Anxiety sensitivity and panic reactivity to bodily sensations: relation to quit-day (acute) nicotine withdrawal symptom severity among daily smokers making a self-guided quit attempt.
Topics: Adolescent; Adult; Anxiety; Carbon Monoxide; Diagnostic and Statistical Manual of Mental Disorders; Female; Follow-Up Studies; Heart Rate; Humans; Male; Nicotine; Panic; Personality Inventory; Psychiatric Status Rating Scales; Regression Analysis; Respiration; Sensation; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors; Young Adult | 2009 |
Gender, smoking status, and risk behavior attitudes explain adolescents' patterns of nicotine replacement therapy use.
Topics: Administration, Cutaneous; Adolescent; Attitude to Health; Chewing Gum; Cross-Sectional Studies; Female; Humans; Male; Nicotine; Nicotinic Agonists; Risk Factors; Risk-Taking; Sex Factors; Smoking; Smoking Cessation; Socioeconomic Factors; Tennessee | 2010 |
What's new in nicotine & tobacco research?
Topics: Counseling; Humans; Nicotiana; Nicotine; Research; Smoking; Smoking Cessation | 2009 |
Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
Topics: Administration, Cutaneous; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Recurrence; Smoking Cessation; Smoking Prevention; Time Factors; Treatment Outcome | 2009 |
Presence of the carcinogen N'-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy products.
Topics: Biomarkers; Carcinogens; Humans; Nicotine; Nitrosamines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco, Smokeless | 2009 |
Employment, gender, and smoking cessation outcomes in low-income smokers using nicotine replacement therapy.
Topics: Adult; Cohort Studies; Counseling; Employment; Female; Health Promotion; Humans; Interpersonal Relations; Male; Middle Aged; Minnesota; Nicotine; Nicotinic Agonists; Poverty; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Social Environment; Tobacco Use Disorder; Treatment Outcome; Women's Health; Workplace; Young Adult | 2009 |
Smoking cessation aids and strategies among former smokers in Canada.
Topics: Adolescent; Adult; Aged; Behavior, Addictive; Canada; Chewing Gum; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Sex Factors; Smoking Cessation; Young Adult | 2010 |
The impact of repeated cycles of pharmacotherapy on smoking cessation: a longitudinal cohort study.
Topics: Administration, Cutaneous; Adult; Bupropion; Cohort Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Incidence; Longitudinal Studies; Male; Middle Aged; Nicotine; Odds Ratio; Patient Compliance; Probability; Risk Assessment; Smoking Cessation; Smoking Prevention; Treatment Outcome; Young Adult | 2009 |
[Drug treatment of tobacco dependence].
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Meta-Analysis as Topic; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2009 |
The effect of chewing gum on self-reported nicotine withdrawal: is it the flavor, the act of chewing, or both?
Topics: Adolescent; Adult; Chewing Gum; Female; Humans; Male; Mastication; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Taste; Texas; Young Adult | 2010 |
Cigarette smoking and bladder cancer: a new twist in an old saga?
Topics: Carcinogens; Dose-Response Relationship, Drug; Humans; Incidence; Nicotiana; Nicotine; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Time Factors; United States; Urinary Bladder Neoplasms | 2009 |
Smoking cessation patterns and predictors of quitting smoking among the Japanese general population: a 1-year follow-up study.
Topics: Adult; Attitude to Health; Cross-Cultural Comparison; Epidemiologic Methods; Female; Humans; Japan; Male; Middle Aged; Motivation; Nicotine; Patient Education as Topic; Smoking; Smoking Cessation; Young Adult | 2010 |
Comparing the predictive validity of five cigarette dependence questionnaires.
Topics: Adult; Female; Follow-Up Studies; Health Surveys; Humans; Internet; Male; Nicotine; Predictive Value of Tests; Psychometrics; Reproducibility of Results; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Switzerland; Time Factors; Tobacco Use Disorder | 2010 |
Evaluation of Rhodiola rosea L. extract on affective and physical signs of nicotine withdrawal in mice.
Topics: Animals; Anxiety; Dose-Response Relationship, Drug; Male; Mice; Motor Activity; Nicotine; Nicotinic Agonists; Plant Extracts; Rhodiola; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2011 |
Harm reduction policies for tobacco users.
Topics: Harm Reduction; Health Knowledge, Attitudes, Practice; Health Policy; Humans; Nicotine; Nitrosamines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Industry; Tobacco Use Disorder; Tobacco, Smokeless | 2010 |
The associative basis of cue-elicited drug taking in humans.
Topics: Anxiety; Association Learning; Attention; Behavior, Addictive; Conditioning, Psychological; Cues; Humans; Nicotine; Nicotinic Agonists; Pleasure; Recurrence; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2010 |
Questioning the methodologic superiority of 'placebo' over 'active' controlled trials.
Topics: Chewing Gum; Controlled Clinical Trials as Topic; Data Interpretation, Statistical; Double-Blind Method; Drug Synergism; Ethics, Clinical; Ethics, Medical; Ethics, Research; Hippocratic Oath; Humans; Moral Obligations; Nicotine; Physician-Patient Relations; Placebo Effect; Placebos; Randomized Controlled Trials as Topic; Research Design; Research Personnel; Research Subjects; Researcher-Subject Relations; Sample Size; Sensitivity and Specificity; Smoking Cessation | 2009 |
Off-label prescribing of the nicotine patch for psychiatric patients.
Topics: Adult; Female; Harm Reduction; Humans; Inpatients; Male; Nicotine; Nicotinic Agonists; Off-Label Use; Patient Selection; Psychotic Disorders; Smoking Cessation; Smoking Prevention | 2009 |
Acceptability and outcome of an Internet-based smoking cessation programme.
Topics: Adult; Aged; Breath Tests; Carbon Monoxide; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Internet; Male; Middle Aged; New Zealand; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Young Adult | 2010 |
Patterns of dual use of cigarettes and smokeless tobacco among US males: findings from national surveys.
Topics: Adolescent; Adult; Cotinine; Data Collection; Data Interpretation, Statistical; Humans; Male; Nicotine; Smoking; Smoking Cessation; Socioeconomic Factors; Substance-Related Disorders; Tobacco Use Disorder; Tobacco, Smokeless; United States; Young Adult | 2010 |
Disparities in tobacco cessation medication orders and fills among special populations.
Topics: Adult; Aged; Attitude to Health; Ethnicity; Female; Health Services Accessibility; Healthcare Disparities; Humans; Male; Middle Aged; Minnesota; Nicotine; Nicotinic Agonists; Patient Compliance; Pregnancy; Smoking; Smoking Cessation; Socioeconomic Factors; Young Adult | 2010 |
Estimating the risks and benefits of nicotine replacement therapy for smoking cessation in the United States.
Topics: Computer Simulation; Cost-Benefit Analysis; Humans; Monte Carlo Method; Nicotine; Risk; Smoking; Smoking Cessation; Smoking Prevention; Tobacco, Smokeless; United States | 2010 |
Nicotine gum causing pancreatitis: a case report.
Topics: Acute Disease; Chewing Gum; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Pancreatitis; Smoking Cessation | 2010 |
Are "e-cigarettes" safer than regular ones?
Topics: Carcinogens; Drug Delivery Systems; Drug Therapy, Computer-Assisted; Health Knowledge, Attitudes, Practice; Humans; Internet; Nebulizers and Vaporizers; Nicotine; Smoking Cessation; Tobacco, Smokeless; United States; United States Food and Drug Administration | 2010 |
'Do your best for me': The difficulties of finding a clinically effective endpoint in smoking cessation consultations in primary care.
Topics: Attitude of Health Personnel; Communication; Counseling; Humans; Life Style; Nicotine; Nicotinic Agonists; Physician-Patient Relations; Primary Health Care; Referral and Consultation; Smoking Cessation | 2010 |
Co-expression of nAChRs and molecules of the bitter taste transduction pathway by epithelial cells of intrapulmonary airways.
Topics: Animals; Epithelial Cells; Gene Expression Regulation; Male; Nicotine; Nicotinic Agonists; Phospholipase C beta; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Nicotinic; Respiratory Mucosa; Signal Transduction; Smoking; Smoking Cessation; Taste; Transducin | 2010 |
Brazil and tobacco use: a hard nut to crack.
Topics: Brazil; Counseling; Humans; Nicotine; Nicotinic Agonists; Prevalence; Public Health Administration; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Smoke Pollution; Tobacco Use Disorder | 2009 |
Effect of tobacco counseling by dental students on patient quitting rate.
Topics: Attitude of Health Personnel; Attitude to Health; Chewing Gum; Counseling; Curriculum; Education, Dental; Follow-Up Studies; Humans; Motivation; New York; Nicotine; Nicotinic Agonists; Patient Education as Topic; Professional-Patient Relations; Smoking Cessation; Smoking Prevention; Students, Dental | 2010 |
Few smokers in South Auckland access subsidised nicotine replacement therapy.
Topics: Adolescent; Adult; Age Distribution; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Native Hawaiian or Other Pacific Islander; New Zealand; Nicotine; Odds Ratio; Prevalence; Sex Distribution; Smoking; Smoking Cessation; Young Adult | 2010 |
Nicotine electronic cigarette sales are permitted under the Smokefree Environments Act.
Topics: Administration, Inhalation; Health Policy; Humans; Nebulizers and Vaporizers; New Zealand; Nicotine; Smoking Cessation; Tobacco Industry; Tobacco Smoke Pollution; Tobacco, Smokeless | 2010 |
Nicotine vaccines: will smokers take a shot at quitting?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Attitude to Health; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Vaccines; Young Adult | 2010 |
Combined nicotine replacement therapy provides best chance of smoking cessation.
Topics: Administration, Cutaneous; Administration, Oral; Antidepressive Agents, Second-Generation; Bupropion; Drug Therapy, Combination; Humans; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder | 2010 |
Effects of smoking cessation on gastric emptying in smokers.
Topics: Administration, Cutaneous; Adult; Aged; Appetite; Breath Tests; Female; Gastric Emptying; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Treatment Outcome; Weight Gain; Young Adult | 2010 |
Severity of dependence modulates smokers' neuronal cue reactivity and cigarette craving elicited by tobacco advertisement.
Topics: Adult; Advertising; Arousal; Brain; Brain Mapping; Cues; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Neurons; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Whole Body Imaging | 2011 |
Varenicline treatment decreases DNMT1 mRNA expression in lymphocytes of schizophrenic patients who are cigarette smokers.
Topics: Benzazepines; Cotinine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Gene Expression; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; RNA, Messenger; Schizophrenia; Smoking Cessation; Varenicline | 2010 |
Reinforcing effects of nicotine and non-nicotine components of cigarette smoke.
Topics: Adult; Behavior, Addictive; Choice Behavior; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Nicotine; Reinforcement, Psychology; Self Administration; Smoke; Smoking; Smoking Cessation; Young Adult | 2010 |
Does the number of free nicotine patches given to smokers calling a quitline influence quit rates: results from a quasi-experimental study.
Topics: Adult; Black People; Female; Follow-Up Studies; Hispanic or Latino; Hotlines; Humans; Male; Middle Aged; New York; Nicotine; Program Evaluation; Smoking; Smoking Cessation; Social Class; Surveys and Questionnaires; Transdermal Patch; White People | 2010 |
Electronic nicotine delivery systems: emerging science foundation for policy.
Topics: Drug Delivery Systems; Electronics; Humans; Nicotine; Nicotinic Agonists; Public Policy; Smoking; Smoking Cessation; United States; United States Food and Drug Administration | 2010 |
Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy.
Topics: Adolescent; Adult; Benzazepines; Counseling; Female; Humans; Male; Montana; Nicotine; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking Cessation; Telephone; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2010 |
[Help in smoking cessation in the neurovascular unit].
Topics: Humans; Nicotine; Nurse-Patient Relations; Peripheral Nervous System Diseases; Smoking Cessation; Vascular Diseases | 2010 |
Chipping away at the genetics of smoking behavior.
Topics: Chromosome Mapping; Family Health; Health Behavior; Humans; Models, Genetic; Nicotine; Pharmacogenetics; Receptors, Nicotinic; Sequence Analysis, DNA; Smoking; Smoking Cessation; Tobacco Use Disorder; Twin Studies as Topic | 2010 |
Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials.
Topics: Adolescent; Adult; Black People; Bupropion; Educational Status; Female; Humans; Male; Middle Aged; Nicotine; Racial Groups; Sex Factors; Smoking Cessation; Young Adult | 2010 |
Electronic cigarettes: a survey of users.
Topics: Adult; Aged; Consumer Behavior; Data Collection; Electronics; Female; Humans; Internet; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Smoking; Smoking Cessation; Surveys and Questionnaires; Young Adult | 2010 |
Use of nicotine replacement therapy to treat nicotine withdrawal syndrome and aid temporary abstinence.
Topics: Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2010 |
Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: a molecular insight into the importance of quitting smoking during treatment.
Topics: Animals; Carcinoma, Small Cell; Cell Adhesion; Chemokine CXCL12; Drug Resistance, Neoplasm; Female; Humans; Lung Neoplasms; Mice; Neoplasm Metastasis; Nicotine; Phenotype; Receptors, CXCR4; Receptors, Nicotinic; Smoking Cessation | 2010 |
Current treatment options in smoking cessation.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Patient Selection; Piperidines; Practice Guidelines as Topic; Pyrazoles; Quinoxalines; Rimonabant; Self-Help Groups; Smoking Cessation; Tobacco Use Disorder; United States; Vaccines; Varenicline | 2010 |
Measurement of nicotine withdrawal symptoms: linguistic validation of the Wisconsin Smoking Withdrawal Scale (WSWS) in Malay.
Topics: Humans; Language; Linguistics; Malaysia; Nicotine; Psychological Tests; Smoking Cessation; Substance Withdrawal Syndrome; Translations | 2010 |
Nicotine replacement therapy use among adolescent smokers seeking cessation treatment.
Topics: Adolescent; Age Factors; Baltimore; Black or African American; Child; Female; Healthcare Disparities; Humans; Interviews as Topic; Male; Nicotine; Nonprescription Drugs; Odds Ratio; Self Medication; Smoking Cessation; Tobacco Use Disorder; Urban Population; White People | 2010 |
Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.
Topics: Adrenergic Uptake Inhibitors; Analgesics; Animals; Body Temperature; Bupropion; Cell Line; Dopamine Uptake Inhibitors; Humans; Male; Mice; Mice, Inbred ICR; Motor Activity; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Selective Serotonin Reuptake Inhibitors; Smoking Cessation; Stereoisomerism; Structure-Activity Relationship | 2010 |
Validation of The Health Improvement Network (THIN) primary care database for monitoring prescriptions for smoking cessation medications.
Topics: Bupropion; Databases, Factual; Dopamine Uptake Inhibitors; England; Humans; Medical Records Systems, Computerized; Nicotine; Nicotinic Agonists; Practice Patterns, Physicians'; Primary Health Care; Smoking Cessation; United Kingdom | 2010 |
Temporal changes of smoking status and motivation among Chinese heroin-dependent, methadone-maintained smokers.
Topics: Adult; China; Drug Interactions; Female; Heroin Dependence; Humans; Male; Methadone; Motivation; Narcotics; Nicotine; Opiate Substitution Treatment; Smoking; Smoking Cessation; Time Factors | 2010 |
Motivation to quit smoking among hospitalised individuals with and without mental health disorders.
Topics: Administration, Cutaneous; Adult; Chi-Square Distribution; Female; Humans; Inpatients; Male; Mental Disorders; Middle Aged; Motivation; Nicotine; Smoking; Smoking Cessation; Surveys and Questionnaires; Treatment Outcome; Western Australia | 2010 |
The use of snus for quitting smoking compared with medicinal products.
Topics: Adult; Benzazepines; Chewing Gum; Data Collection; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Regression Analysis; Smoking Cessation; Tobacco, Smokeless; Varenicline | 2010 |
Conventional and electronic cigarettes (e-cigarettes) have different smoking characteristics.
Topics: Humans; Inhalation Exposure; Nebulizers and Vaporizers; Nicotine; Smoke; Smoking; Smoking Cessation; Spectrophotometry; Tobacco, Smokeless; Vacuum | 2010 |
Increased use of nicotine replacement therapy at Christchurch Hospital.
Topics: Administration, Cutaneous; Adolescent; Hospitals, Public; Humans; New Zealand; Nicotine; Patient Compliance; Prevalence; Retrospective Studies; Smoking Cessation; Tobacco Use Disorder | 2010 |
Quantification of smoking-induced occupancy of beta2-nicotinic acetylcholine receptors: estimation of nondisplaceable binding.
Topics: Administration, Cutaneous; Adolescent; Adult; Azetidines; Binding, Competitive; Brain Chemistry; Female; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nicotine; Nicotinic Agonists; Pyridines; Receptors, Nicotinic; Smoking; Smoking Cessation; Tobacco Use Disorder; Tomography, Emission-Computed, Single-Photon; Young Adult | 2010 |
Ask the doctor. I've tried to quit smoking three times. A friend suggested that instead of giving cigarettes up all at once that I try to kick the habit gradually. Which method is best?
Topics: Combined Modality Therapy; Humans; Nicotine; Secondary Prevention; Self-Help Groups; Smoking Cessation; Tobacco Use Disorder | 2010 |
Nicotine withdrawal increases threat-induced anxiety but not fear: neuroadaptation in human addiction.
Topics: Adult; Anxiety; Electric Stimulation; Fear; Female; Humans; Male; Nicotine; Reflex, Startle; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2010 |
Effectiveness of adding relapse prevention materials to telephone counseling.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Arkansas; Directive Counseling; Female; Hotlines; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Secondary Prevention; Smoking Cessation; Smoking Prevention; Telephone; Tobacco Use Disorder; Young Adult | 2010 |
[The management of patients with nicotine dependence - the role of the general practitioners].
Topics: Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Disease Management; Dopamine Uptake Inhibitors; Family Practice; Humans; Motivation; Nicotine; Nicotinic Agonists; Physician-Patient Relations; Quinoxalines; Secondary Prevention; Smoking Cessation; Switzerland; Tobacco Use Disorder; Varenicline | 2010 |
[Motivating discussions, change of attitude and handling with stress - nursing aspects of smoking cessation].
Topics: Attitude to Health; Humans; Motivation; Nicotine; Nurse-Patient Relations; Smoking Cessation; Social Support; Stress, Psychological; Substance Withdrawal Syndrome; Switzerland | 2010 |
[Medical therapy for smoking cessation].
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Antidepressive Agents; Benzazepines; Bupropion; Chewing Gum; Drug Therapy, Combination; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Double target concept for smoking cessation.
Topics: Dopamine; Humans; Nicotine; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder | 2010 |
Case studies of tobacco dependence treatment in Brazil, England, India, South Africa and Uruguay.
Topics: Adolescent; Adult; Advertising; Brazil; England; Evidence-Based Medicine; Female; Government Programs; Health Care Surveys; Health Policy; Health Services Accessibility; Health Services Needs and Demand; Hotlines; Humans; India; Internationality; Male; Nicotine; Primary Health Care; Program Development; Reimbursement Mechanisms; Smoking; Smoking Cessation; Smoking Prevention; South Africa; State Medicine; Tobacco Use Disorder; Uruguay | 2010 |
Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association.
Topics: American Heart Association; Cardiovascular Diseases; Health Policy; Humans; Nicotine; Prevalence; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Tobacco, Smokeless; United States | 2010 |
Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study.
Topics: Adult; Arousal; Attention; Brain; Brain Mapping; Cues; Dominance, Cerebral; Emotions; Female; Frontal Lobe; Gambling; Humans; Image Processing, Computer-Assisted; Limbic System; Magnetic Resonance Imaging; Male; Middle Aged; Motivation; Nerve Net; Nicotine; Oxygen Consumption; Pattern Recognition, Visual; Psychomotor Performance; Reaction Time; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2010 |
Using policy to increase prescribing of smoking cessation medications in the VA healthcare system.
Topics: Bupropion; Dopamine Uptake Inhibitors; Health Policy; Humans; Nicotine; Nicotinic Agonists; Prescriptions; Retrospective Studies; Smoking Cessation; United States; United States Department of Veterans Affairs | 2010 |
Early improvement in peripheral vascular tone following smoking cessation using nicotine replacement therapy: aortic wave reflection analysis.
Topics: Adult; Aorta; Blood Flow Velocity; Blood Pressure; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Prospective Studies; Pulsatile Flow; Recovery of Function; Smoking Cessation; Vasoconstriction | 2010 |
Associations between weight change over 8 years and baseline body mass index in a cohort of continuing and quitting smokers.
Topics: Adult; Aged; Body Mass Index; England; Family Practice; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Obesity; Prospective Studies; Recurrence; Regression Analysis; Smoking Cessation; Smoking Prevention; Time Factors; Transdermal Patch; Weight Gain; Weight Loss | 2011 |
Clinical practice and the tobacco epidemic: relevance of a global public health problem in the clinical setting.
Topics: Epidemics; Female; Humans; Internationality; Male; Nicotiana; Nicotine; Professional Practice; Smoking; Smoking Cessation; Stereotyping; Tobacco Use Disorder | 2010 |
Nicotine dependence and depression among women smokers on methadone maintenance.
Topics: Adult; Cross-Sectional Studies; Depression; Female; Humans; Linear Models; Methadone; Middle Aged; Nicotine; Opiate Substitution Treatment; Opioid-Related Disorders; Prevalence; Smoking; Smoking Cessation; Statistics, Nonparametric | 2010 |
Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies.
Topics: Adult; Aged; Benzazepines; Bupropion; Cohort Studies; Comorbidity; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Retrospective Studies; Smoking; Smoking Cessation; Stress, Psychological; Treatment Outcome; Varenicline; Young Adult | 2011 |
State medicaid coverage for tobacco-dependence treatments --- United States, 2009.
Topics: Bupropion; Dopamine Uptake Inhibitors; Eligibility Determination; Fee-for-Service Plans; Female; Ganglionic Stimulants; Health Care Surveys; Health Policy; Health Services Accessibility; Healthy People Programs; Humans; Insurance Coverage; Medicaid; Nicotine; Pregnancy; Smoking Cessation; Tobacco Use Disorder; United States | 2010 |
The effect of smoking nicotine tobacco versus smoking deprivation on motion sickness.
Topics: Adult; Female; Humans; Male; Motion Sickness; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation | 2011 |
Smoking withdrawal shifts the spatiotemporal dynamics of neurocognition.
Topics: Adult; Attention; Brain Mapping; Cerebral Cortex; Discrimination, Psychological; Dominance, Cerebral; Female; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Nerve Net; Nicotine; Oxygen Consumption; Pattern Recognition, Visual; Psychomotor Performance; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Young Adult | 2010 |
Industry funding and placebo quit rate in clinical trials of nicotine replacement therapy: a commentary on Etter et al. (2007).
Topics: Clinical Trials as Topic; Drug Industry; Humans; Nicotine; Nicotinic Agonists; Placebos; Smoking Cessation | 2010 |
Various facets of anxiety in nicotinic consumption and cessation.
Topics: Anxiety; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2010 |
Novel nicotine delivery systems and public health: the rise of the "e-cigarette".
Topics: Advertising; Consumer Product Safety; Drug Delivery Systems; Electronics; Humans; Nicotine; Nicotinic Agonists; Public Health; Public Policy; Smoking Cessation; United States; United States Food and Drug Administration | 2010 |
Quitting smoking: an action that does not bounce back.
Topics: Arteries; Elasticity; Hemodynamics; Humans; Nicotine; Nicotinic Agonists; Recovery of Function; Smoking Cessation; Vasoconstriction | 2010 |
Smoking-cessation strategies for American Indians: should smoking-cessation treatment include a prescription for a complete home smoking ban?
Topics: Adult; Behavior Therapy; Family Characteristics; Female; Humans; Indians, North American; Male; Middle Aged; Minnesota; Nicotine; Nicotinic Agonists; Prevalence; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Socioeconomic Factors | 2010 |
Spatial working memory impairments induced by cigarette smoking abstinence are correlated with plasma nicotine levels in schizophrenia.
Topics: Humans; Mecamylamine; Memory Disorders; Memory, Short-Term; Neuropsychological Tests; Nicotine; Nicotinic Antagonists; Schizophrenia; Smoking; Smoking Cessation | 2011 |
Use of nicotine replacement therapy for smoking reduction and during enforced temporary abstinence: a national survey of English smokers.
Topics: Adult; Age Factors; Chewing Gum; England; Female; Harm Reduction; Health Knowledge, Attitudes, Practice; Health Surveys; Humans; Male; Nicotine; Nicotinic Agonists; Sampling Studies; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Socioeconomic Factors; Time Factors; Tobacco Smoke Pollution; Tobacco Use Disorder; Transdermal Patch | 2011 |
Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline.
Topics: Animals; Benzazepines; Cerebral Cortex; Hippocampus; Male; Mice; Nicotine; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Thalamus; Up-Regulation; Varenicline | 2011 |
Children's loss of autonomy over smoking: the Global Youth Tobacco Survey.
Topics: Adolescent; Adolescent Behavior; Child; Child Behavior; Cyprus; Female; Greece; Health Behavior; Health Surveys; Humans; Male; Nicotine; Personal Autonomy; Prevalence; Regression Analysis; Smoking; Smoking Cessation; Tobacco Use Disorder | 2011 |
JAMA patient page. Smoking cessation.
Topics: Ganglionic Stimulants; Humans; Nicotine; Smoking; Smoking Cessation | 2010 |
Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey.
Topics: Adolescent; Adult; Aged; Australia; Benzazepines; Bupropion; Canada; Cohort Studies; Data Collection; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Nonprescription Drugs; Prescription Drugs; Prevalence; Quinoxalines; Smoking Cessation; Time Factors; Tobacco Use Disorder; Treatment Outcome; United Kingdom; United States; Varenicline; Young Adult | 2011 |
FDA considering data on long-term use of nicotine replacement therapy products.
Topics: Drug Administration Schedule; Drug Approval; Ganglionic Stimulants; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder; United States; United States Food and Drug Administration | 2010 |
Formulation and in vitro evaluation of xanthan gum or carbopol 934-based mucoadhesive patches, loaded with nicotine.
Topics: Acrylates; Adhesiveness; Adhesives; Administration, Buccal; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Stability; Excipients; Ganglionic Stimulants; In Vitro Techniques; Nicotine; Polysaccharides, Bacterial; Smoking Cessation | 2011 |
The COPD pipeline VII.
Topics: Animals; Biotechnology; Clinical Trials as Topic; Genotype; Humans; Industry; Isotretinoin; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Pyrazoles; Smoking Cessation; Stilbenes | 2010 |
The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.
Topics: Alkaloids; Animals; Azocines; Benzazepines; Conditioning, Operant; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Quinolizines; Quinoxalines; Receptors, Nicotinic; Reinforcement Schedule; Smoking Cessation; Time Factors; Varenicline | 2011 |
Developing a smoking cessation program for Turkish-speaking migrants in Switzerland: novel findings and promising effects.
Topics: Adult; Culture; Female; Health Plan Implementation; Humans; Interpersonal Relations; Language; Male; Middle Aged; Nicotine; Prevalence; Program Development; Program Evaluation; Smoking; Smoking Cessation; Smoking Prevention; Socioeconomic Factors; Surveys and Questionnaires; Switzerland; Transients and Migrants; Turkey; Young Adult | 2011 |
D-cycloserine selectively decreases nicotine self-administration in rats with low baseline levels of response.
Topics: Animals; Cycloserine; Female; Humans; Models, Animal; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Self Administration; Smoking; Smoking Cessation | 2011 |
One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services.
Topics: Community Health Services; Community Pharmacy Services; Cost-Benefit Analysis; Counseling; Follow-Up Studies; Health Promotion; Humans; Nicotine; Scotland; Smoking; Smoking Cessation; Time Factors; Treatment Outcome | 2011 |
Associations of CYP2A6 genotype with smoking behaviors in southern China.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Aryl Hydrocarbon Hydroxylases; Asian People; China; Cytochrome P-450 CYP2A6; Epidemiologic Methods; Female; Gene Frequency; Genetic Association Studies; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Phenotype; Polymerase Chain Reaction; Polymorphism, Genetic; Smoking; Smoking Cessation; Socioeconomic Factors; Time Factors; Young Adult | 2011 |
Waterpipe (hookah) tobacco smoking among youth.
Topics: Adolescent; Adolescent Behavior; Age Factors; Carbon Monoxide; Child; Child Welfare; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Nicotine; Prevalence; Public Health; Risk Factors; Risk-Taking; Smoking; Smoking Cessation; Tobacco Smoke Pollution; United States | 2011 |
Integrating results from smoking cessation drug research and development into clinical occupational health practice.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Occupational Health Nursing; Practice Guidelines as Topic; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2011 |
The effect of five smoking cessation pharmacotherapies on smoking cessation milestones.
Topics: Bupropion; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Nicotine; Nicotinic Agonists; Recurrence; Smoking; Smoking Cessation; Treatment Outcome | 2011 |
The effect of pictorial warnings on cigarette packages on attentional bias of smokers.
Topics: Adult; Anxiety; Attention; Behavior, Addictive; Cues; Female; Germany; Humans; Male; Middle Aged; Nicotine; Public Health; Smoking; Smoking Cessation; Young Adult | 2011 |
Tamoxifen and mifepriston modulate nicotine induced conditioned place preference in female rats.
Topics: Animals; Conditioning, Psychological; Female; Hormone Antagonists; Humans; Male; Mifepristone; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Smoking Cessation; Tamoxifen; Tobacco Use Disorder | 2011 |
Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists.
Topics: Acetylcholine; Alkaloids; alpha7 Nicotinic Acetylcholine Receptor; Animals; Azocines; Benzazepines; Bupropion; DNA, Complementary; Dopamine Uptake Inhibitors; Electrophysiological Phenomena; Humans; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Oocytes; Pyridinium Compounds; Quinolizines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline; Xenopus | 2011 |
[Tobacco smoking cessation as covered cost for COPD patients? Therapy goal: smoking cessation without relapse].
Topics: General Practice; Germany; Humans; Insurance Coverage; National Health Programs; Nicotine; Patient Compliance; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Social Support | 2010 |
Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.
Topics: Adrenergic Uptake Inhibitors; Animals; Behavior, Animal; Biogenic Monoamines; Body Temperature; Bupropion; Conditioning, Psychological; Dopamine; Dopamine Uptake Inhibitors; HEK293 Cells; Humans; Male; Mice; Mice, Inbred ICR; Morpholines; Motor Activity; Nicotine; Nicotinic Antagonists; Norepinephrine; Receptors, Nicotinic; Serotonin; Smoking Cessation; Stereoisomerism; Structure-Activity Relationship | 2011 |
Interactions between endocannabinoid and serotonergic systems in mood disorders caused by nicotine withdrawal.
Topics: Animals; Arachidonic Acids; Behavior, Animal; Cannabinoid Receptor Modulators; Disease Models, Animal; Drug Interactions; Endocannabinoids; Male; Mice; Mood Disorders; Motor Activity; Nicotine; Piperazines; Piperidines; Pyrazoles; Pyridines; Random Allocation; Receptor, Cannabinoid, CB1; Receptor, Serotonin, 5-HT1A; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists; Smoking Cessation; Substance Withdrawal Syndrome | 2011 |
[Comparing the effectiveness of different treatment modalities on the smoking cessation rates].
Topics: Adult; Bupropion; Combined Modality Therapy; Female; Humans; Male; Nicotine; Psychotherapy, Group; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2010 |
The relationship between nicotine dependence scores and biomarkers of exposure in adult cigarette smokers.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Carboxyhemoglobin; Cotinine; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Young Adult | 2011 |
Misleading conclusions from Altria researchers about population health effects of dual use.
Topics: Harm Reduction; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder; Tobacco, Smokeless | 2011 |
L-DOPA attenuates nicotine withdrawal-induced behaviors in rats.
Topics: Animals; Behavior, Animal; Depression; Dopamine Agents; Levodopa; Male; Motor Activity; Nicotine; Rats; Rats, Sprague-Dawley; Smoking Cessation; Substance Withdrawal Syndrome | 2011 |
Nicotine replacement therapy offered to UK smokers.
Topics: Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; United Kingdom | 2011 |
[Nicotine replacement therapy in cardiovascular disease].
Topics: Cardiovascular Diseases; Comorbidity; Humans; Nicotine; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention | 2010 |
Providing accurate safety information may increase a smoker's willingness to use nicotine replacement therapy as part of a quit attempt.
Topics: Adult; Female; Health Knowledge, Attitudes, Practice; Humans; Information Dissemination; Male; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; United States | 2011 |
[Abstinence rates with varenicline compared to bupropion and nicotine replacement therapy for quitting smoking in primary care].
Topics: Adolescent; Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Nicotinic Agonists; Primary Health Care; Quinoxalines; Retrospective Studies; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline; Young Adult | 2011 |
Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers.
Topics: Adult; Age Factors; Alleles; Clinical Trials as Topic; Female; Genotype; Haplotypes; Humans; Linear Models; Linkage Disequilibrium; Male; Middle Aged; Multigene Family; Nerve Tissue Proteins; Nicotine; Polymorphism, Single Nucleotide; Receptors, Nicotinic; Sex Factors; Smoking; Smoking Cessation | 2011 |
Prescribing of smoking cessation medication in England since the introduction of varenicline.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Drug Prescriptions; Electronic Health Records; England; Family Practice; Humans; Models, Statistical; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; State Medicine; Time Factors; Varenicline | 2011 |
Tracking the rise in popularity of electronic nicotine delivery systems (electronic cigarettes) using search query surveillance.
Topics: Drug Delivery Systems; Equipment Design; Humans; Internet; Nicotine; Smoking; Smoking Cessation | 2011 |
Electronic cigarettes as a smoking-cessation: tool results from an online survey.
Topics: Adolescent; Adult; Aged; Cross-Sectional Studies; Data Collection; Drug Delivery Systems; Female; Humans; Internet; Male; Middle Aged; Nicotine; Prevalence; Recurrence; Smoking; Smoking Cessation; Time Factors; Tobacco Use Disorder; Young Adult | 2011 |
Electronic nicotine delivery systems: a research agenda.
Topics: Administration, Inhalation; Biomedical Research; Consumer Product Safety; Drug Delivery Systems; Electrical Equipment and Supplies; Humans; Marketing; Nicotine; Smoking; Smoking Cessation | 2011 |
Widening inequalities in smoking initiation and cessation patterns: a cohort and gender analysis in France.
Topics: Adolescent; Adult; Aged; Cohort Studies; Data Collection; Databases, Factual; Educational Status; Female; France; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Random Allocation; Sex Factors; Smoking; Smoking Cessation; Socioeconomic Factors; Young Adult | 2011 |
A real-life study of the effectiveness of different pharmacological approaches to the treatment of smoking cessation: re-discussing the predictors of success.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Bupropion; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Nicotine; Nortriptyline; Retrospective Studies; Sex Factors; Smoking; Smoking Cessation; Time Factors; Treatment Outcome; Young Adult | 2011 |
Nicotine replacement prescribing trends in a large psychiatric hospital, before and after implementation of a hospital-wide smoking ban.
Topics: Health Promotion; Hospitals, Psychiatric; Humans; Nicotine; Organizational Policy; Pennsylvania; Practice Patterns, Physicians'; Retrospective Studies; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2011 |
Prescribing of nicotine replacement therapy to adolescents in England.
Topics: Adolescent; Child; Databases, Factual; Drug Prescriptions; England; Family Practice; Female; Humans; Male; Medical Records Systems, Computerized; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Practice Patterns, Physicians'; Regression Analysis; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2011 |
Early effects of smoking cessation and weight gain on plasma adiponectin levels and insulin resistance.
Topics: Adiponectin; Adult; Aged; Carotid Arteries; Follow-Up Studies; Homeostasis; Humans; Insulin Resistance; Male; Middle Aged; Nicotine; Smoking Cessation; Transdermal Patch; Tunica Intima; Tunica Media; Ultrasonography; Weight Gain | 2011 |
Nicotine replacement therapy in the psychiatric emergency department.
Topics: Antipsychotic Agents; Emergency Service, Hospital; Humans; Nicotine; Psychiatric Department, Hospital; Psychomotor Agitation; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Violence | 2011 |
Nicotine e-cigarette cartridges can be sold as tobacco products.
Topics: Aerosols; Drug Delivery Systems; Humans; Nebulizers and Vaporizers; New Zealand; Nicotine; Smoking Cessation | 2011 |
Smoking and chronic pain: a real-but-puzzling relationship.
Topics: Chronic Disease; Humans; Nicotine; Pain; Pain Threshold; Risk Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2011 |
Nicotine withdrawal-induced negative affect is a function of nicotine dependence and not liability to depression or anxiety.
Topics: Adult; Anxiety; Depression; Female; Humans; Male; Nicotine; Regression Analysis; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Disorder; Twins; Young Adult | 2011 |
Smoking cessation interventions: a primer for physicians: Comment on "Use of varenicline for 4 weeks before quitting smoking".
Topics: Benzazepines; Bupropion; Chewing Gum; Counseling; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Humans; Nasal Sprays; Nebulizers and Vaporizers; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Transdermal Patch; Treatment Outcome; Varenicline | 2011 |
[Modern aspects of war against smoking: are there any opportunities left?].
Topics: Behavior Control; Blood Flow Velocity; Forecasting; Health Promotion; Humans; Legislation, Medical; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Smoke Pollution; Tobacco Use Disorder | 2010 |
Availability of nicotine replacement therapy in substance use disorder treatment: longitudinal patterns of adoption, sustainability, and discontinuation.
Topics: Adult; Follow-Up Studies; Health Promotion; Humans; Interviews as Topic; Longitudinal Studies; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2011 |
Association between DRD2/ANKK1 Taq1A genotypes, depression and smoking cessation with nicotine replacement therapy.
Topics: Adult; Depression; Female; Genetic Association Studies; Genotype; Humans; Logistic Models; Male; Middle Aged; Nicotine; Polymorphism, Single Nucleotide; Protein Serine-Threonine Kinases; Receptors, Dopamine D2; Smoking; Smoking Cessation; Surveys and Questionnaires; Taq Polymerase; Tobacco Use Disorder; Young Adult | 2011 |
Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation.
Topics: Benzazepines; Bupropion; Cost-Benefit Analysis; Dopamine Uptake Inhibitors; England; Epidemiologic Methods; Health Care Costs; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Secondary Prevention; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Wales | 2011 |
The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Drug Prescriptions; Electronic Health Records; England; Family Practice; Female; Humans; Male; Middle Aged; Models, Statistical; Nicotine; Nicotinic Agonists; Practice Patterns, Physicians'; Quinoxalines; Smoking; Smoking Cessation; State Medicine; Time Factors; Varenicline; Young Adult | 2011 |
Interviews with "vapers": implications for future research with electronic cigarettes.
Topics: Adult; Aerosols; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; United States; Young Adult | 2011 |
Positive reactions to tobacco predict relapse after cessation.
Topics: Adult; Affect; Chronic Disease; Female; Humans; Male; Nicotine; Nicotinic Agonists; Phenotype; Predictive Value of Tests; Proportional Hazards Models; Recurrence; Severity of Illness Index; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2011 |
Response to Rose (2011): nicotine preloading: the importance of a pre-cessation reduction in smoking behavior.
Topics: Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder | 2011 |
Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy.
Topics: Adult; Analysis of Variance; Consumer Behavior; Data Collection; Electronics; Female; Health Knowledge, Attitudes, Practice; Humans; Linear Models; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Social Media; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2011 |
Is use of nicotine replacement therapy while continuing to smoke associated with increased nicotine intake? Evidence from a population sample.
Topics: Adult; Cotinine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Saliva; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Time Factors; Tobacco Use Cessation Devices | 2011 |
Anterior cingulate proton spectroscopy glutamate levels differ as a function of smoking cessation outcome.
Topics: Administration, Cutaneous; Creatine; Female; Glutamic Acid; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Nicotine; Nicotinic Agonists; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2011 |
Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats.
Topics: Animals; Behavior, Animal; Benzazepines; Dose-Response Relationship, Drug; Female; Food; Motivation; Motor Activity; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Reward; Self Administration; Serotonin 5-HT2 Receptor Agonists; Smoking Cessation; Tobacco Use Disorder | 2011 |
Previous chronic exposure eliminates the conditioning effect of nicotine in rats.
Topics: Age Factors; Animals; Conditioning, Operant; Drug Tolerance; Female; Humans; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Smoking Cessation; Tobacco Use Disorder | 2011 |
Nicotine preloading: the importance of a pre-cessation reduction in smoking behavior.
Topics: Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder | 2011 |
Outcomes and cost-effectiveness of two nicotine replacement treatment delivery models for a tobacco quitline.
Topics: Adolescent; Adult; Cost-Benefit Analysis; Female; Hotlines; Humans; Male; Nicotine; Nicotinic Agonists; Patient Satisfaction; Program Evaluation; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2011 |
Electronic nicotine delivery systems in the hands of Hollywood.
Topics: Administration, Inhalation; Advertising; Drug Delivery Systems; Humans; Marketing; Motion Pictures; Nicotine; Smoking Cessation; Technology Assessment, Biomedical; United States | 2011 |
Smoking cessation pharmacotherapy: a concise overview.
Topics: Adrenergic alpha-2 Receptor Agonists; Antidepressive Agents; Benzazepines; Bupropion; Clonidine; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2011 |
Nicotine replacement therapy in critically ill patients and the long-range risks of comfortable inaction.
Topics: Critical Illness; Humans; Nicotine; Smoking Cessation | 2011 |
Assessing preferences for improved smoking cessation medications: a discrete choice experiment.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Logistic Models; Male; Middle Aged; Models, Econometric; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Substance-Related Disorders; Surveys and Questionnaires; Switzerland; Varenicline; Young Adult | 2012 |
Ability of baclofen to prevent somatic manifestations and neurochemical changes during nicotine withdrawal.
Topics: Animals; Baclofen; Behavior, Animal; Disease Models, Animal; Drug Evaluation, Preclinical; Male; Mecamylamine; Mice; Motor Activity; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors | 2011 |
Promotion of nicotine replacement therapy and smoking cessation services at grocery stores.
Topics: Adult; Commerce; Female; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; New Zealand; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Social Marketing | 2011 |
Neuroscience: weight loss through smoking.
Topics: Animals; Appetite Depressants; Arcuate Nucleus of Hypothalamus; Humans; Mice; Neurons; Nicotine; Receptor, Melanocortin, Type 4; Receptors, Nicotinic; Smoking; Smoking Cessation; Synaptic Transmission; Weight Gain; Weight Loss | 2011 |
Public health clinical demonstration project for smoking cessation in american veterans who served since september 11, 2001.
Topics: Adult; Bupropion; Cohort Studies; Dopamine Uptake Inhibitors; Follow-Up Studies; Health Surveys; Hospitals, Veterans; Humans; Nicotine; Nicotinic Agonists; North Carolina; Patient Acceptance of Health Care; Public Health; Secondary Prevention; Smoking Cessation; Treatment Outcome; Veterans | 2011 |
Translating the smoking cessation properties of the antidepressant nortriptyline using reinforcing, discriminative and aversive stimulus effects of nicotine in rats.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Male; Nicotine; Nortriptyline; Rats; Reinforcement Schedule; Self Administration; Smoking Cessation | 2012 |
Breaking free from nicotine dependence. A combination of strategies boosts the odds of success.
Topics: Administration, Cutaneous; Administration, Intranasal; Adult; Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Cross-Sectional Studies; Female; Humans; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Self-Help Groups; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2011 |
Electronic cigarettes (e-cigs): views of aficionados and clinical/public health perspectives.
Topics: Adult; Attitude to Health; Equipment Design; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Pharmaceutical Vehicles; Propylene Glycol; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco, Smokeless | 2011 |
Combined active and passive immunization against nicotine: minimizing monoclonal antibody requirements using a target antibody concentration strategy.
Topics: Animals; Antibodies, Monoclonal; Antibody Affinity; Antibody Formation; Brain; Feasibility Studies; Immunization, Passive; Male; Motor Activity; Nicotine; Rats; Rats, Sprague-Dawley; Smoking; Smoking Cessation; Smoking Prevention; Tissue Distribution; Vaccination; Vaccines | 2011 |
Weight gain according to gum use in participants in the intervention groups: comment on Ferguson et al. 2011.
Topics: Chewing Gum; Female; Humans; Male; Nicotine; Nicotinic Agonists; Patient Compliance; Smoking Cessation; Weight Gain | 2011 |
Tar wars over smoking cessation.
Topics: Global Health; Humans; Nicotine; Nicotinic Agonists; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Industry | 2011 |
Predictors of short-term success in smoking cessation in relation to attendance at a smoking cessation program.
Topics: Adaptation, Psychological; Adult; Carbon Monoxide; Counseling; Depression; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Young Adult | 2011 |
Exposure to tobacco smoke before and after a partial smoking ban in prison: indoor air quality measures.
Topics: Air; Air Pollution, Indoor; Environmental Monitoring; Humans; Inhalation Exposure; Nicotine; Prisons; Smoking; Smoking Cessation; Switzerland; Tobacco Smoke Pollution | 2012 |
Negative reinforcement smoking outcome expectancies are associated with affective response to acute nicotine administration and abstinence.
Topics: Adolescent; Adult; Affect; Electromyography; Female; Galvanic Skin Response; Humans; Male; Middle Aged; Nicotine; Photic Stimulation; Reinforcement, Psychology; Smoking; Smoking Cessation; Surveys and Questionnaires; Young Adult | 2012 |
Nicotine replacement therapy after subarachnoid hemorrhage is not associated with increased vasospasm.
Topics: Adult; Cohort Studies; Female; Humans; Male; Middle Aged; Nicotine; Prospective Studies; Retrospective Studies; Smoking Cessation; Subarachnoid Hemorrhage; Tobacco Use Cessation Devices; Treatment Outcome; Vasospasm, Intracranial | 2011 |
[Clinical study of smoking cessation clinic subjects].
Topics: Adult; Aged; Aged, 80 and over; Benzazepines; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Outpatient Clinics, Hospital; Outpatients; Quinoxalines; Smoking Cessation; Varenicline | 2011 |
Electronic cigarettes as a method of tobacco control.
Topics: Drug Delivery Systems; Humans; Nicotine; Smoking Cessation; United Kingdom | 2011 |
[Smoking cessation--assistance for the general practitioner].
Topics: Benzazepines; Bupropion; Combined Modality Therapy; Complementary Therapies; Cost-Benefit Analysis; Drug Costs; Fee Schedules; Germany; Humans; Myocardial Infarction; National Health Programs; Nicotine; Nicotinic Agonists; Physician's Role; Polymethacrylic Acids; Polyvinyls; Psychotherapy, Group; Quinoxalines; Smoking Cessation; Social Support; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2011 |
[Nicotine withdrawal: best results with combination therapies].
Topics: Acupuncture; Administration, Cutaneous; Behavior Therapy; Chewing Gum; Combined Modality Therapy; Cross-Sectional Studies; Humans; Hypnosis; Motivation; Nasal Sprays; Nicotine; Patient Compliance; Psychotherapy, Group; Secondary Prevention; Self Care; Smoking Cessation; Tobacco Use Disorder | 2011 |
Varenicline dose dependently enhances responding for nonpharmacological reinforcers and attenuates the reinforcement-enhancing effects of nicotine.
Topics: Animals; Benzazepines; Dose-Response Relationship, Drug; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2012 |
5-Hydroxytryptophan attenuates somatic signs of nicotine withdrawal.
Topics: 5-Hydroxytryptophan; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Behavior, Animal; Hydrazines; Male; Nicotine; Rats; Rats, Sprague-Dawley; Serotonin Agents; Smoking Cessation; Substance Withdrawal Syndrome | 2011 |
Quantification of nicotine, cotinine, trans-3'-hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC-tandem mass-spectrometry procedure for a clinical study on smoking cessation.
Topics: Benzazepines; Chromatography, High Pressure Liquid; Cotinine; Drug Stability; Humans; Linear Models; Nicotine; Quinoxalines; Reproducibility of Results; Sensitivity and Specificity; Smoking Cessation; Tandem Mass Spectrometry; Varenicline | 2011 |
Electronic nicotine delivery systems: adult use and awareness of the 'e-cigarette' in the USA.
Topics: Adolescent; Adult; Aged; Awareness; Data Collection; Educational Status; Electrical Equipment and Supplies; Electronics; Female; Humans; Male; Middle Aged; Nicotine; Sex Factors; Smoking; Smoking Cessation; Tobacco Products; United States; Young Adult | 2013 |
The flying Dutchman and E-cigarettes.
Topics: Baseball; Child; Child Welfare; History, 20th Century; Humans; Nicotiana; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; United States | 2011 |
Affective reactivity during smoking cessation of never-quitters as compared with that of abstainers, relapsers, and continuing smokers.
Topics: Acoustic Stimulation; Adolescent; Adult; Anxiety; Electromyography; Emotions; Female; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Nicotinic Agonists; Psychiatric Status Rating Scales; Reflex, Startle; Self Report; Smoking; Smoking Cessation; Surveys and Questionnaires; Young Adult | 2012 |
Suicidal behavior and depression in smoking cessation treatments.
Topics: Adult; Benzazepines; Bupropion; Depression; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicide; Varenicline | 2011 |
Mining data on usage of electronic nicotine delivery systems (ENDS) from YouTube videos.
Topics: Administration, Inhalation; Adolescent; Adult; Advertising; Data Mining; Drug Delivery Systems; Exhalation; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Social Media; Time Factors; Tobacco Use Cessation Devices; Video Recording; Young Adult | 2013 |
Nicotine replacement therapy use at home after use during a hospitalization.
Topics: Counseling; Female; Health Surveys; Hospitalization; Humans; Male; Middle Aged; Nicotine; Patient Discharge; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Cessation Devices | 2012 |
Chronic disease management approach to treating tobacco addiction: comment on "Nicotine therapy sampling to induce quit attempts among smokers unmotivated to quit".
Topics: Female; Humans; Male; Motivation; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices | 2011 |
Public health challenges of electronic cigarettes in South Korea.
Topics: Adult; Electronics; Female; Government Regulation; Health Promotion; Humans; Male; Middle Aged; Nicotine; Prevalence; Public Health Practice; Republic of Korea; Safety; Smoking; Smoking Cessation; Smoking Prevention; Young Adult | 2011 |
Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Amygdala; Animals; Benzenesulfonates; Clonidine; Electrodes, Implanted; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Prazosin; Quinolines; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Reward; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2012 |
A direct method and ICER tables for the estimation of the cost-effectiveness of smoking cessation interventions in general populations: application to a new cytisine trial and other examples.
Topics: Adult; Aged; Aged, 80 and over; Alkaloids; Azocines; Cost-Benefit Analysis; Female; Health Promotion; Humans; Life Expectancy; Life Tables; Male; Middle Aged; Models, Statistical; Nicotine; Quality-Adjusted Life Years; Quinolizines; Smoking; Smoking Cessation | 2012 |
A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation.
Topics: Adolescent; Adult; Counseling; Female; Follow-Up Studies; Health Surveys; Humans; Interviews as Topic; Male; Massachusetts; Middle Aged; Nicotine; Nicotinic Agonists; Prospective Studies; Recurrence; Smoking Cessation; Smoking Prevention; Treatment Outcome; Young Adult | 2013 |
Smoking cessation treatment preferences, intentions, and behaviors among a large sample of Colorado gay, lesbian, bisexual, and transgendered smokers.
Topics: Adolescent; Adult; Bisexuality; Colorado; Evidence-Based Medicine; Female; Health Promotion; Homosexuality, Female; Homosexuality, Male; Humans; Intention; Male; Middle Aged; Motivation; Nicotine; Smoking; Smoking Cessation; Surveys and Questionnaires; Transgender Persons; Young Adult | 2012 |
Assessing the effects of chronic sazetidine-A delivery on nicotine self-administration in both male and female rats.
Topics: Animals; Azetidines; Dose-Response Relationship, Drug; Female; Male; Nicotine; Nicotinic Agonists; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Self Administration; Sex Factors; Smoking Cessation | 2012 |
Anhedonia predicts altered processing of happy faces in abstinent cigarette smokers.
Topics: Adult; Anhedonia; Attention; Cognition Disorders; Cues; Facial Expression; Female; Happiness; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Reward; Smoking; Smoking Cessation; Surveys and Questionnaires | 2012 |
Nicotine replacement therapy during pregnancy and infantile colic in the offspring.
Topics: Adult; Cohort Studies; Colic; Confidence Intervals; Denmark; Female; Follow-Up Studies; Gestational Age; Humans; Incidence; Infant; Infant, Newborn; Interviews as Topic; Logistic Models; Maternal Exposure; Nicotine; Odds Ratio; Pregnancy; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2012 |
Predictors of risk for smoking relapse in men and women: a prospective examination.
Topics: Adult; Anger; Anxiety; Depression; Female; Follow-Up Studies; Ganglionic Stimulants; Humans; Male; Motivation; Nicotine; Prospective Studies; Recurrence; Risk Factors; Sex Factors; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2012 |
Sex-specific differences in GABA(A) -benzodiazepine receptor availability: relationship with sensitivity to pain and tobacco smoking craving.
Topics: Adult; Affective Symptoms; Analysis of Variance; Animals; Brain; Female; Flumazenil; GABA Modulators; Humans; Male; Middle Aged; Nicotine; Pain Perception; Receptors, GABA-A; Sex Characteristics; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tomography, Emission-Computed, Single-Photon; Young Adult | 2013 |
Smokers' perceptions of smokeless tobacco and harm reduction.
Topics: Adolescent; Adult; California; Choice Behavior; Female; Focus Groups; Harm Reduction; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Tobacco, Smokeless; Young Adult | 2012 |
Comparison of tobacco control scenarios: quantifying estimates of long-term health impact using the DYNAMO-HIA modeling tool.
Topics: Adolescent; Adult; Algorithms; Commerce; Health; Health Promotion; Humans; Netherlands; Nicotiana; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Software; Time Factors; Tobacco Use Disorder | 2012 |
Explaining the stress-inducing effects of nicotine to cigarette smokers.
Topics: Adolescent; Adult; Affect; Cohort Studies; Depression; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Models, Psychological; Nicotine; Patient Education as Topic; Smoking; Smoking Cessation; Stress, Psychological; Tobacco Use Disorder; Young Adult | 2012 |
Simultaneous quantification of nicotine, cotinine, trans-3'-hydroxycotinine, norcotinine and mecamylamine in human urine by liquid chromatography-tandem mass spectrometry.
Topics: Calibration; Chromatography, Liquid; Cotinine; Humans; Mecamylamine; Nicotine; Sensitivity and Specificity; Smoking; Smoking Cessation; Tandem Mass Spectrometry | 2012 |
Effects of the combination of metyrapone and oxazepam on intravenous nicotine self-administration in rats.
Topics: Animals; Benzazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Hypnotics and Sedatives; Infusions, Intravenous; Male; Metyrapone; Nicotine; Oxazepam; Quinoxalines; Rats; Rats, Wistar; Reinforcement Schedule; Self Administration; Smoking Cessation; Varenicline | 2012 |
[The smoker is a very sweet squirrel in cage].
Topics: France; Health Behavior; Humans; Lung Neoplasms; Metaphor; Nicotine; Smoking; Smoking Cessation; Tobacco Industry; Tobacco Use Disorder | 2012 |
Nicotine replacement therapy: evidence from observational studies versus clinical trials.
Topics: Behavior Therapy; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking Cessation; Treatment Outcome | 2012 |
An unexpected consequence of electronic cigarette use.
Topics: Adult; Electronics; Female; Glycerol; Humans; Nicotine; Pneumonia, Lipid; Smoking Cessation | 2012 |
Student and school characteristics associated with use of nicotine replacement therapy: a multilevel analysis among Canadian youth.
Topics: Canada; Female; Humans; Male; Multilevel Analysis; Nicotine; Nicotinic Agonists; Residence Characteristics; Rural Health; Schools; Smoking; Smoking Cessation; Smoking Prevention; Students; Surveys and Questionnaires; Tobacco Use Cessation Devices; Urban Health | 2012 |
DRD1 associations with smoking abstinence across slow and normal nicotine metabolizers.
Topics: Adult; Humans; Linkage Disequilibrium; Middle Aged; Nicotine; Polymorphism, Single Nucleotide; Receptors, Dopamine D1; Smoking; Smoking Cessation; Tobacco Use Disorder | 2012 |
Use of nicotine replacement therapy for smoking reduction and temporary abstinence: an update of beard et al. (2011).
Topics: Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2012 |
Timing and risk factors associated with relapse among smokers attempting to quit in Malaysia.
Topics: Adolescent; Adult; Behavior Therapy; Female; Humans; Malaysia; Male; Middle Aged; Nicotine; Prospective Studies; Recurrence; Risk Factors; Smoking; Smoking Cessation; Surveys and Questionnaires; Time Factors; Tobacco Use Cessation Devices; Young Adult | 2012 |
Efficacy of harm reduction programs among patients of a smoking cessation clinic in Tehran, Iran.
Topics: Harm Reduction; Humans; Iran; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder | 2012 |
An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Benzazepines; Bupropion; Data Collection; Educational Status; Female; Humans; Internet; Male; Middle Aged; Nicotine; Patient Compliance; Patient Satisfaction; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2013 |
The regulation of nicotine in the United Kingdom: how nicotine gum came to be a medicine, but not a drug.
Topics: Drug and Narcotic Control; Drug Industry; History, 20th Century; Legislation as Topic; Nicotine; Prescription Drugs; Smoking; Smoking Cessation; Tobacco Industry; Tobacco Use Cessation Devices; United Kingdom | 2012 |
[Long-lived smoking mice and self mutilation. On the genealogy of the smoking ban at the work site in West Germany (1930-1990)].
Topics: Animals; Germany; History, 20th Century; Humans; Longevity; Mice; Nicotine; Occupational Exposure; Smoking Cessation; Tobacco Smoke Pollution; Workplace | 2012 |
[Nicotine, a killing faker].
Topics: Humans; Nicotine; Physician-Patient Relations; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2012 |
Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum.
Topics: Animals; Benzazepines; Corpus Striatum; Dopamine; Male; Nicotine; Protein Binding; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Saimiri; Smoking Cessation; Synaptosomes; Varenicline | 2012 |
Structural characterization of binding mode of smoking cessation drugs to nicotinic acetylcholine receptors through study of ligand complexes with acetylcholine-binding protein.
Topics: Acetylcholine; Alkaloids; alpha7 Nicotinic Acetylcholine Receptor; Animals; Aplysia; Azocines; Benzazepines; Binding Sites; Binding, Competitive; Carrier Proteins; Cell Line; HEK293 Cells; Humans; Kinetics; Ligands; Models, Molecular; Mutation; Nicotine; Nicotinic Agonists; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary; Quinolizines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2012 |
Long-term nicotine exposure depresses dopamine release in nonhuman primate nucleus accumbens.
Topics: Animals; Biological Transport; Dopamine; Female; Male; Nicotine; Nucleus Accumbens; Receptors, Nicotinic; Saimiri; Smoking Cessation; Synaptosomes | 2012 |
Bupropion and its main metabolite reverse nicotine chronic tolerance in the mouse.
Topics: Analgesics; Animals; Antidepressive Agents; Body Temperature; Bupropion; Dose-Response Relationship, Drug; Drug Tolerance; Hypothermia, Induced; Male; Mice; Nicotine; Smoking Cessation | 2012 |
Caring for the smoking asthmatic patient.
Topics: Asthma; Bronchial Spasm; Evidence-Based Practice; Humans; Nicotine; Practice Guidelines as Topic; Smoking; Smoking Cessation | 2012 |
Beliefs about the harms of long-term use of nicotine replacement therapy: perceptions of smokers in England.
Topics: Adolescent; Adult; Aged; Attitude to Health; England; Female; Harm Reduction; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Perception; Smoking; Smoking Cessation; Social Class; Tobacco Use Cessation Devices; Young Adult | 2012 |
Do e-cigarettes help smokers quit?
Topics: Administration, Inhalation; Electrical Equipment and Supplies; Harm Reduction; Humans; Nicotine; Smoking Cessation; Smoking Prevention; United States | 2012 |
Are tobacco dependence and withdrawal related amongst heavy smokers? Relevance to conceptualizations of dependence.
Topics: Adult; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2012 |
Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats.
Topics: Allosteric Regulation; Animals; Cholinesterase Inhibitors; Drug-Seeking Behavior; Extinction, Psychological; Galantamine; Male; Nicotine; Rats; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder | 2012 |
Circulating ghrelin levels are not associated with craving and withdrawal symptoms in acute nicotine withdrawal.
Topics: Acute Disease; Adult; Ghrelin; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2012 |
[Smoking cessation. The e-cigarette is not a way to smoke-free living].
Topics: Electronics; Germany; Humans; Nebulizers and Vaporizers; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder | 2012 |
AAV-directed persistent expression of a gene encoding anti-nicotine antibody for smoking cessation.
Topics: Animals; Antibodies, Monoclonal; Dependovirus; Male; Mice; Mice, Inbred C57BL; Nicotine; Smoking Cessation | 2012 |
Nicotine replacement therapy: evidence from observational studies versus clinical trials. Comment.
Topics: Behavior Therapy; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking Cessation | 2012 |
Just one shot to make quitting a success.
Topics: Animals; Antibodies; Humans; Mice; Nicotine; Smoking; Smoking Cessation; Vaccines, DNA | 2012 |
Breastfeeding and maternal smoking.
Topics: Breast Feeding; Child, Preschool; Contraindications; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Neonatal Abstinence Syndrome; Nicotine; Pregnancy; Respiratory Hypersensitivity; Smoking; Smoking Cessation; Tobacco Smoke Pollution | 2012 |
Associations of functional and dysfunctional impulsivity to smoking characteristics.
Topics: Adolescent; Adult; Awareness; Decision Making; Emotions; Female; Humans; Impulsive Behavior; Male; Nicotine; Personality Inventory; Psychometrics; Reproducibility of Results; Risk Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Young Adult | 2012 |
Life 1 year after a quit attempt: real-time reports of quitters and continuing smokers.
Topics: Adult; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Quality of Life; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome | 2012 |
Passion flower extract antagonizes the expression of nicotine locomotor sensitization in rats.
Topics: Animals; Arabidopsis Proteins; Drug Administration Schedule; Male; Motor Activity; Nicotine; Nicotinic Agonists; Nuclear Proteins; Passiflora; Plant Extracts; Rats; Rats, Wistar; Smoking Cessation; Tobacco Use Disorder | 2012 |
Cue reactivity as a predictor of successful abstinence initiation among adult smokers.
Topics: Adolescent; Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Models, Psychological; Motivation; Nicotine; Placebos; Smoking Cessation; Young Adult | 2012 |
Nornicotine nitrosation in saliva and its relation to endogenous synthesis of N'-nitrosonornicotine in humans.
Topics: Humans; Nicotine; Nitrosamines; Nitrosation; Saliva; Smoking; Smoking Cessation | 2013 |
Preliminary evidence that adherence to counseling mediates the effects of pretreatment self-efficacy and motivation on outcome of a cessation attempt in smokers with ADHD.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Counseling; Evidence-Based Medicine; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Patient Compliance; Placebos; Self Efficacy; Smoking Cessation | 2013 |
The effect of smoking cessation pharmacotherapies on pancreatic beta cell function.
Topics: Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Electron Transport; Gene Expression; Glucose; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mitochondria; Nicotine; Nicotinic Agonists; Oxidative Stress; Pancreatic Function Tests; Quinoxalines; Rats; Signal Transduction; Smoking; Smoking Cessation; Varenicline | 2012 |
Nicotine-replacement therapy in pregnancy-the end of the road?
Topics: Female; Humans; Infant; Nicotine; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2012 |
Probing the protective effects of a conformationally constrained nicotine vaccine.
Topics: Adjuvants, Immunologic; Animals; Antibodies; Antibody Affinity; Haptens; Humans; Immunoglobulin G; Male; Nicotine; Rats; Rats, Wistar; Smoking Cessation; Tobacco Use Disorder; Vaccines | 2012 |
It only gets better: a comment on Schlam et Al.
Topics: Female; Humans; Male; Nicotine; Quality of Life; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome | 2012 |
Lack of association of OPRM1 genotype and smoking cessation.
Topics: Adult; Female; Follow-Up Studies; Genotype; Humans; Logistic Models; Male; Middle Aged; Nicotine; Phenotype; Polymorphism, Single Nucleotide; Receptors, Opioid, mu; Smoking; Smoking Cessation; Treatment Outcome; United Kingdom | 2013 |
[E-cigarette without cardiovascular harm].
Topics: Cardiovascular Diseases; Humans; Nicotine; Smoking; Smoking Cessation | 2012 |
Drugs on the internet, part III: tobacco and smoking on the web.
Topics: Humans; Information Services; Internet; Nicotiana; Nicotine; Quality Control; Search Engine; Smoking; Smoking Cessation; Tobacco Use | 2013 |
Handling relapse in smoking cessation: strategies and recommendations.
Topics: Algorithms; Ganglionic Stimulants; Humans; Nicotine; Secondary Prevention; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2013 |
Transitions in smoking behaviour and the design of cessation schemes.
Topics: Humans; Models, Biological; Monte Carlo Method; Nicotine; Poisson Distribution; Smoking; Smoking Cessation; Tobacco Products | 2012 |
Time for NHS policy on electronic cigarettes.
Topics: Humans; Nicotine; Smoking Cessation | 2012 |
Associations between self-reported in-home smoking behaviours and surface nicotine concentrations in multiunit subsidised housing.
Topics: Adolescent; Adult; Air Pollution, Indoor; Child; Child, Preschool; Cross-Sectional Studies; Data Collection; Female; Housing; Humans; Male; Nicotine; Ohio; Policy; Public Assistance; Self Report; Smoking; Smoking Cessation; Surface Properties; Tobacco Smoke Pollution; Wood; Young Adult | 2014 |
Regulatory issues concerning the development and circulation of nicotine-containing products: a qualitative study.
Topics: Drug Industry; Harm Reduction; Humans; Nicotine; Perception; Qualitative Research; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Industry; Tobacco Use Cessation Devices; United Kingdom | 2013 |
Impact of tobacco control policy on quitting and nicotine dependence among women in five European countries.
Topics: Adolescent; Adult; Aged; Cross-Sectional Studies; Data Collection; Europe; Female; Humans; Logistic Models; Middle Aged; Nicotine; Public Health; Public Policy; Smoking; Smoking Cessation; Tobacco Use Disorder; Women; Young Adult | 2014 |
Effects of smoking cessation on hormonal levels in men.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Biomarkers; Body Mass Index; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Hormones; Humans; Hydrocortisone; Male; Middle Aged; Nicotine; Nicotinic Agonists; Radioimmunoassay; Sex Hormone-Binding Globulin; Smoking; Smoking Cessation; Smoking Prevention; Testosterone; Time Factors; Tobacco Use Cessation Devices; Transdermal Patch; Weight Gain | 2013 |
Electronic cigarettes for smoking cessation.
Topics: Electrical Equipment and Supplies; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Disorder | 2012 |
Varenicline and bupropion: suicide.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Patient Safety; Prescription Drug Misuse; Quinoxalines; Risk Assessment; Risk Factors; Smoking Cessation; Suicide; Varenicline | 2012 |
Electronic nicotine delivery systems: regulatory and safety challenges: Singapore perspective.
Topics: Administration, Inhalation; Deception; Drug Delivery Systems; Electronics; Glycerol; Humans; Marketing; Nicotine; Product Labeling; Propylene Glycol; Safety; Singapore; Smoking; Smoking Cessation; Tobacco Industry; Tobacco Products | 2014 |
Nicotine content and abstinence state have different effects on subjective ratings of positive versus negative reinforcement from smoking.
Topics: Adult; Behavior, Addictive; Female; Humans; Male; Nicotine; Reinforcement, Psychology; Smoking; Smoking Cessation; Young Adult | 2013 |
[Current concepts in tobacco cessation and prevention].
Topics: Counseling; Dentists; Humans; Interview, Psychological; Motivation; Nicotine; Nicotinic Agonists; Oral Hygiene; Physician's Role; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Cessation Devices | 2012 |
Project Exhale: preliminary evaluation of a tailored smoking cessation treatment for HIV-positive African American smokers.
Topics: Administration, Cutaneous; Adult; Aged; Black or African American; Community Health Centers; Follow-Up Studies; Health Promotion; HIV Seropositivity; Humans; Interviews as Topic; Male; Middle Aged; Motivation; Nicotine; Patient Acceptance of Health Care; Patient-Centered Care; Program Evaluation; Psychotherapy, Group; Smoking; Smoking Cessation; Surveys and Questionnaires; Treatment Outcome; United States | 2013 |
On-line solid-phase extraction with ultra performance liquid chromatography and tandem mass spectrometry for the detection of nicotine, cotinine and trans-3'-hydroxycotinine in urine to strengthen human biomonitoring and smoking cessation studies.
Topics: Chromatography, Liquid; Cotinine; Environmental Exposure; Humans; Nicotine; Reproducibility of Results; Sensitivity and Specificity; Smoking; Smoking Cessation; Solid Phase Extraction; Tandem Mass Spectrometry; Tobacco Smoke Pollution | 2013 |
Nicotine derived from the electronic cigarette improves time-based prospective memory in abstinent smokers.
Topics: Electrical Equipment and Supplies; Humans; Memory, Episodic; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2013 |
Plastic surgery and smoking: a prospective analysis of incidence, compliance, and complications.
Topics: Adult; Humans; Incidence; Nicotine; Patient Compliance; Plastic Surgery Procedures; Postoperative Complications; Predictive Value of Tests; Prospective Studies; Smoking; Smoking Cessation | 2013 |
The benefits of switching smoking cessation drugs to over-the-counter status.
Topics: Administration, Cutaneous; Administration, Oral; Cost-Benefit Analysis; Drug Costs; Drug Prescriptions; Health Services Needs and Demand; Health Services Research; Humans; Models, Econometric; Multivariate Analysis; Nicotine; Nonprescription Drugs; Quality-Adjusted Life Years; Smoking; Smoking Cessation; Smoking Prevention; United States; Value of Life | 2002 |
Treatment of tobacco use and dependence.
Topics: Bupropion; Dopamine Uptake Inhibitors; Humans; Myocardial Ischemia; Nicotine; Smoking Cessation | 2002 |
[Tobacco use disorder and use of nicotine substitutes during pregnancy and post-partum].
Topics: Adult; Female; Ganglionic Stimulants; Humans; Nicotine; Postpartum Period; Pregnancy; Pregnancy Complications; Smoking Cessation; Tobacco Use Disorder | 2002 |
Focus groups with pregnant smokers: barriers to cessation, attitudes to nicotine patch use and perceptions of cessation counselling by care providers.
Topics: Administration, Cutaneous; Attitude to Health; Counseling; Female; Focus Groups; Health Personnel; Humans; Interviews as Topic; Nicotine; Pregnancy; Self Concept; Smoking; Smoking Cessation; Weight Gain | 2002 |
Early emotional disturbances during nicotine patch therapy in subjects with and without a history of depression.
Topics: Administration, Cutaneous; Adult; Depressive Disorder; Female; Humans; Male; Mood Disorders; Nicotine; Smoking Cessation; Surveys and Questionnaires; Time Factors | 2002 |
Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation.
Topics: Adult; Antidepressive Agents; California; Counseling; Drug Utilization; Ganglionic Stimulants; Humans; Nicotine; Nonprescription Drugs; Pharmaceutic Aids; Proportional Hazards Models; Self-Help Groups; Smoking Cessation | 2002 |
Improving cessation rates?
Topics: Administration, Cutaneous; Adolescent; Adult; Bupropion; Combined Modality Therapy; Double-Blind Method; Follow-Up Studies; Humans; Nicotine; Patient Compliance; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Smoking Cessation; Treatment Outcome | 1999 |
Quit or die: nothing in between?
Topics: Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder | 2002 |
Reducing tobacco use: what works in the population?
Topics: Age Factors; California; Health Education; Health Policy; Humans; Logistic Models; Male; Mass Media; Massachusetts; Nicotine; Odds Ratio; Self Care; Smoking; Smoking Cessation; United States; Workplace | 2002 |
[Pharmacists' role in smoking cessation activities in Alsace].
Topics: Adult; Benchmarking; Education, Pharmacy; France; Ganglionic Stimulants; Health Care Surveys; Humans; Nicotine; Patient Education as Topic; Pharmacists; Smoking Cessation; Tobacco Use Disorder | 2002 |
Nicotine patch use in pregnant smokers: smoking abstinence and delivery outcomes.
Topics: Administration, Cutaneous; Adult; Embryonic and Fetal Development; Exanthema; Female; Fetal Blood; Gestational Age; Humans; Male; Nicotine; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Smoking Cessation; Ultrasonography, Prenatal | 2002 |
Smoking cessation in a blue-collar population: results from an evidence-based pilot program.
Topics: Administration, Cutaneous; Adult; Benchmarking; Bupropion; Chewing Gum; Cost-Benefit Analysis; Counseling; Dopamine Uptake Inhibitors; Evidence-Based Medicine; Health Benefit Plans, Employee; Humans; Insurance Carriers; Labor Unions; Male; Nicotine; Occupations; Outcome Assessment, Health Care; Patient Satisfaction; Pilot Projects; Program Evaluation; Smoking Cessation; Washington | 2002 |
[A new cause of false positives when analyzing expired air carbon monoxide].
Topics: Aged; Breath Tests; Candy; Carbon Monoxide; Central Nervous System Stimulants; Chewing Gum; False Positive Reactions; Humans; Male; Nicotine; Polymers; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices | 2002 |
Preclinical development of a vaccine 'against smoking'.
Topics: Administration, Intranasal; Animals; Brain; Carrier Proteins; Cholera Toxin; Female; Immunoglobulin A; Immunoglobulin G; Infusion Pumps; Mice; Mice, Inbred BALB C; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Vaccines, Synthetic | 2002 |
[Smoking cessation].
Topics: Administration, Cutaneous; Ganglionic Stimulants; Humans; Nicotine; Prognosis; Smoking Cessation; Tobacco Use Disorder | 2002 |
Effect of nicotine replacement and quitting smoking on circulating adhesion molecule profiles (sICAM-1, sCD44v5, sCD44v6).
Topics: Administration, Cutaneous; Adult; Breath Tests; Case-Control Studies; Cell Adhesion Molecules; Chi-Square Distribution; Cotinine; Female; Ganglionic Stimulants; Glycoproteins; Humans; Hyaluronan Receptors; Intercellular Adhesion Molecule-1; Male; Middle Aged; Nicotine; Smoking Cessation; Time Factors | 2002 |
Nicotine and familial vulnerability to schizophrenia: a discordant twin study.
Topics: Adult; Diseases in Twins; Family; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Risk; Schizophrenia; Smoking; Smoking Cessation; Tobacco Use Disorder | 2002 |
Acute effects of Advance: a potential reduced exposure product for smokers.
Topics: Adolescent; Adult; Air Pollutants; Carbon Monoxide; Cross-Over Studies; Environmental Exposure; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2002 |
Be wary of subsidising nicotine replacement therapy.
Topics: Drug Costs; Drug Prescriptions; Humans; Nicotine; Nicotinic Agonists; Nonprescription Drugs; Smoking Cessation | 2002 |
Information from your family doctor. Smoking: do I want to quit?
Topics: Attitude to Health; Humans; Motivation; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 2002 |
Information from your family doctor. Smoking: break the habit.
Topics: Humans; Nicotine; Smoking Cessation | 2002 |
Information from your family doctor. Heart disease and smoking: why you need to stop smoking.
Topics: Heart Diseases; Humans; Nicotine; Smoking Cessation; Social Support | 2002 |
Does physical exercise in addition to a multicomponent smoking cessation program increase abstinence rate and suppress weight gain? An intervention study.
Topics: Adult; Behavior Therapy; Combined Modality Therapy; Community Health Centers; Community Health Nursing; Exercise Therapy; Female; Humans; Male; Nicotine; Nursing Evaluation Research; Patient Education as Topic; Program Evaluation; Smoking Cessation; Smoking Prevention; Treatment Outcome; Weight Gain | 2001 |
Update in New Jersey tobacco-dependence treatment.
Topics: Dosage Forms; Humans; New Jersey; Nicotine; Practice Guidelines as Topic; Public Health; Smoking; Smoking Cessation; Tobacco Use Disorder | 2002 |
Nicotine intervention during detoxification and treatment for other substance use.
Topics: Adult; Female; Hospitalization; Humans; Male; Nicotine; Smoking Cessation; Smoking Prevention; Substance Abuse Treatment Centers; Substance-Related Disorders; Treatment Outcome | 2002 |
Effectiveness of over-the-counter nicotine replacement therapy.
Topics: Black or African American; Ganglionic Stimulants; Hispanic or Latino; Humans; Nicotine; Nonprescription Drugs; Pharmaceutic Aids; Rural Population; Smoking Cessation | 2002 |
Effectiveness of over-the-counter nicotine replacement therapy.
Topics: Ganglionic Stimulants; Humans; Nicotine; Nonprescription Drugs; Pharmaceutic Aids; Smoking Cessation | 2002 |
Effectiveness of over-the-counter nicotine replacement therapy.
Topics: Ganglionic Stimulants; Humans; Nicotine; Nonprescription Drugs; Pharmaceutic Aids; Smoking Cessation | 2002 |
Effectiveness of over-the-counter nicotine replacement therapy.
Topics: Ganglionic Stimulants; Humans; Nicotine; Nonprescription Drugs; Pharmaceutic Aids; Smoking Cessation | 2002 |
Optimizing smoking cessation outcomes among the methadone maintained.
Topics: Adult; Female; Heroin Dependence; Humans; Los Angeles; Male; Methadone; Middle Aged; Narcotics; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention | 2002 |
First experiences of prescribing nicotine replacement therapy as part of a smoking cessation service on an SSBN patrol.
Topics: Adult; Humans; Military Personnel; Naval Medicine; Nicotine; Nicotinic Agonists; Smoking Cessation | 2002 |
Evaluation of subclinical respiratory tract inflammation in heavy smokers who switch to a cigarette-like nicotine delivery device that primarily heats tobacco.
Topics: Adult; Female; Goblet Cells; Humans; Male; Metaplasia; Nicotine; Prevalence; Respiratory Tract Infections; Severity of Illness Index; Smoking; Smoking Cessation; Smoking Prevention | 2002 |
Hits and misses in nicotine psychopharmacology: a personal view of research over a period of 30 years.
Topics: Binding Sites; Dopamine; Humans; N-Methylaspartate; Nicotine; Psychopharmacology; Receptors, Nicotinic; Smoking Cessation; Smoking Prevention | 2002 |
[Smoking, nicotine dependence and detoxification therapies].
Topics: Administration, Cutaneous; Administration, Intranasal; Adrenergic alpha-Agonists; Antidepressive Agents; Bupropion; Chewing Gum; Clonidine; Dopamine Uptake Inhibitors; Health Promotion; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder | 2002 |
[How can we help pregnant women stop smoking?].
Topics: Behavior Therapy; Cotinine; Female; Humans; Nicotine; Pregnancy; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2003 |
What is the role of dentists in smoking cessation?
Topics: Dentist-Patient Relations; Dentists; Drug Prescriptions; Humans; Nicotine; Patient Education as Topic; Professional Role; Smoking Cessation | 2002 |
Disruption of nicotine conditioning by dopamine D(3) receptor ligands.
Topics: Animals; Conditioning, Psychological; Dopamine D2 Receptor Antagonists; Ligands; Male; Motor Activity; Nicotine; Nicotinic Agonists; Nitriles; Piperazines; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Smoking Cessation; Tetrahydroisoquinolines | 2003 |
Interest in nicotine replacement therapy among pregnant smokers.
Topics: Adult; Female; Humans; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Pregnancy; Pregnancy Complications; Smoking Cessation; Tobacco Use Disorder | 2003 |
Acute effects of nicotine withdrawal syndrome in pilots during flight.
Topics: Adult; Aerospace Medicine; Anxiety; Attention; Blood Pressure; Fatigue; Ganglionic Stimulants; Heart Rate; Humans; Male; Nicotine; Safety; Smoking Cessation; Substance Withdrawal Syndrome; Task Performance and Analysis; Tobacco Use Disorder | 2003 |
SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation.
Topics: Animals; Azepines; Behavior, Animal; Body Temperature; Brain; Cardiovascular System; Cells, Cultured; Dextroamphetamine; Discrimination Learning; Drug Interactions; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Mecamylamine; Microdialysis; Motor Activity; Nicotine; Nicotinic Agonists; Oocytes; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Self Administration; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Transfection; Xenopus laevis | 2003 |
Adolescent smoking cessation services of school-based health centers.
Topics: Adolescent; Attitude of Health Personnel; Drug Prescriptions; Female; Health Education; Health Services Accessibility; Humans; Male; Nicotine; Referral and Consultation; School Health Services; Smoking Cessation; United States | 2003 |
Hypericum perforatum attenuates nicotine withdrawal signs in mice.
Topics: Animals; Hypericum; Male; Mice; Models, Animal; Motor Activity; Nicotine; Phytotherapy; Plant Extracts; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2003 |
Symptoms of nicotine dependence and other predictors of student smoking at school: implications for school smoking policy.
Topics: Adolescent; Adolescent Behavior; Attitude to Health; Female; Humans; Male; Massachusetts; Nicotine; Organizational Policy; Outcome Assessment, Health Care; Prospective Studies; Psychology, Adolescent; Risk Factors; Schools; Smoking; Smoking Cessation; Smoking Prevention; Social Environment; Students; Substance-Related Disorders; Time Factors | 2003 |
Smoking: not for anyone.
Topics: Animals; Genetic Predisposition to Disease; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder | 2003 |
Improving the effectiveness of smoking cessation in primary care: lessons learned.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Family Practice; Female; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Primary Health Care; Program Evaluation; Smoking Cessation; Surveys and Questionnaires | 2003 |
What's new in Nicotine & Tobacco Research?
Topics: Administration, Cutaneous; Chewing Gum; Cognition; Health Promotion; History, 20th Century; Nicotine; Physician-Patient Relations; Psychopharmacology; Smoking; Smoking Cessation; Smoking Prevention; United States | 2003 |
A minimum 6-month prolonged abstinence should be required for evaluating smoking cessation trials.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Evaluation Studies as Topic; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2003 |
Discussion of NRT and other antismoking interventions in UK general practitioners' routine consultations.
Topics: Administration, Cutaneous; Adult; Female; Follow-Up Studies; Health Education; Health Promotion; Health Services; Humans; Male; Nicotine; Nicotinic Agonists; Physician-Patient Relations; Practice Patterns, Physicians'; Primary Health Care; Referral and Consultation; Retrospective Studies; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; United Kingdom | 2003 |
The demand for nicotine replacement therapies.
Topics: Administration, Cutaneous; Commerce; Cross-Sectional Studies; Health Services Needs and Demand; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation | 2003 |
The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit.
Topics: Adult; Humans; Logistic Models; Male; Middle Aged; Nicotine; Prevalence; Registries; Risk Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Failure; Twins | 2003 |
The need for dissemination of evidence-based results from research on nicotine and tobacco.
Topics: Evidence-Based Medicine; Health Services Needs and Demand; Humans; Information Dissemination; Neoplasms; Nicotine; Research; Smoking Cessation | 2003 |
Nicotine withdrawal and depressive symptomatology during short-term smoking abstinence: a comparison of postmenopausal women using and not using hormone replacement therapy.
Topics: Adult; Aged; Counseling; Depression; Female; Hormone Replacement Therapy; Humans; Middle Aged; Nicotine; Postmenopause; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors | 2003 |
Individual differences in nicotine intake per cigarette.
Topics: Adolescent; Adult; Affect; Aged; Biological Availability; District of Columbia; Ethnicity; Female; Humans; Male; Middle Aged; Nicotine; Sex Factors; Smoking; Smoking Cessation | 2003 |
Cost-effectiveness analysis of the first-line therapies for nicotine dependence.
Topics: Adult; Age Factors; Aged; Bupropion; Cohort Studies; Cost-Benefit Analysis; Counseling; Female; Humans; Male; Middle Aged; Models, Economic; Nicotine; Sex Factors; Smoking Cessation; Tobacco Use Disorder | 2003 |
Smoking cessation, smoking reduction, and delayed quitting among smokers given nicotine patches and a self-help pamphlet.
Topics: Female; Harm Reduction; Humans; Male; Middle Aged; Nicotine; Pamphlets; Patient Education as Topic; Smoking Cessation; Smoking Prevention; Time Factors | 2003 |
Estimating the health consequences of replacing cigarettes with nicotine inhalers.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Female; Health Status; Humans; Life Expectancy; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Prevalence; Prognosis; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention | 2003 |
Subsidised nicotine replacement therapy.
Topics: Adult; Aged; Financial Support; Humans; Middle Aged; New Zealand; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention | 2003 |
Nicotine replacement therapy in smoking cessation.
Topics: Hospitalization; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation | 2003 |
Use of nicotine replacement therapy in adolescent smokers and nonsmokers.
Topics: Adolescent; Chewing Gum; Cross-Sectional Studies; Female; Humans; Logistic Models; Male; Nicotine; Nicotinic Agonists; Smoking Cessation | 2003 |
Impact of economic policies on reducing tobacco use among Medicaid clients in New York.
Topics: Adult; Humans; Medicaid; Middle Aged; New York; Nicotine; Poverty; Smoking; Smoking Cessation; Taxes | 2003 |
[Arm wrestling, hypnosis or patches? Colleagues--tipps for smoking cessation (interview by Dr. Judith Neumaier)].
Topics: Administration, Cutaneous; Humans; Hypnosis; Motivation; Nicotine; Physical Fitness; Smoking Cessation; Treatment Outcome | 2003 |
[Nicotine replacement therapy. Sucking instead of smoking].
Topics: Administration, Oral; Dosage Forms; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2003 |
[Correlation between carbon-monoxide levels in exhaled air and nicotine-dependence measurements systems (DSM-IV, Fagerström test and ARU-SMQ-9) in adolescent smokers].
Topics: Adolescent; Carbon Monoxide; Carboxyhemoglobin; Child; Cross-Sectional Studies; Female; Humans; Male; Nicotine; Oximetry; Smoking Cessation; Substance-Related Disorders; Surveys and Questionnaires; Tobacco Use Disorder | 2003 |
C-reactive protein and depressed mood in a sub-group of smokers during nicotine abstinence.
Topics: Adolescent; Blood Pressure; C-Reactive Protein; Depression; Female; Heart Rate; Humans; Interleukin-1; Interleukin-6; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 2003 |
Diurnal variations in first lapses to smoking for nicotine patch users.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Circadian Rhythm; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation | 2003 |
A naturalistic cohort study on effectiveness, safety and usage pattern of an over-the-counter nicotine patch. Cohort study on smoking cessation.
Topics: Administration, Cutaneous; Adult; Cohort Studies; Contraindications; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Nonprescription Drugs; Patient Compliance; Smoking Cessation; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2003 |
Strategies for nicotine replacement therapy.
Topics: Behavior, Addictive; Humans; Nicotine; Smoking Cessation | 2003 |
Persistent use of nicotine replacement therapy: an analysis of actual purchase patterns in a population based sample.
Topics: Administration, Cutaneous; Chewing Gum; Female; Humans; Male; Middle Aged; Nicotine; Nonprescription Drugs; Patient Acceptance of Health Care; Smoking Cessation; Smoking Prevention | 2003 |
Sensations from initial exposure to nicotine predicting adolescent smoking in China: a potential measure of vulnerability to nicotine.
Topics: Adolescent; Adolescent Behavior; China; Cough; Dizziness; Female; Ganglionic Stimulants; Humans; Male; Nicotine; Odds Ratio; Regression Analysis; Risk Factors; Smoking; Smoking Cessation; Tobacco Use Disorder | 2003 |
Is nicotine addiction an answer or a question?
Topics: Ganglionic Stimulants; Humans; Nicotine; Research; Smoking; Smoking Cessation; Social Behavior; Tobacco Use Disorder | 2003 |
Bupropion-induced somnambulism.
Topics: Adult; Amnesia; Bupropion; Dopamine Uptake Inhibitors; Humans; Male; Nicotine; Smoking Cessation; Somnambulism; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2003 |
Comparative American and Japanese tobacco smoke uptake parameters after overnight tobacco deprivation.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Asian People; Black or African American; Cotinine; Cytochrome P-450 CYP2A6; Female; Hispanic or Latino; Humans; Japan; Male; Michigan; Middle Aged; Mixed Function Oxygenases; Nicotiana; Nicotine; Pilot Projects; Smoking; Smoking Cessation; United States; White People | 2003 |
Genes, smoking, and treatment response.
Topics: Humans; Nicotine; Pharmaceutical Preparations; Receptors, Nicotinic; Smoking; Smoking Cessation; Treatment Outcome | 2003 |
Smoke free hospitals: rising to the challenge.
Topics: Ambulatory Care; Behavior Therapy; Hospital Design and Construction; Humans; Inpatients; London; Nicotine; Nicotinic Agonists; Patients' Rooms; Smoking Cessation; Smoking Prevention | 2003 |
Smoke free hospitals: withdrawal from cigarettes should not be confused with withdrawal from nicotine.
Topics: Hospitals; Humans; Nicotine; Nicotinic Agonists; Patients' Rooms; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2003 |
Recent advances in nicotine and tobacco research. Ninth SRNT annual meeting. New Orleans, Louisiana, USA. 19-22 February 2003.
Topics: Ganglionic Stimulants; Humans; Nicotiana; Nicotine; Public Health; Research; Smoking; Smoking Cessation | 2003 |
The place of pharmacotherapy products in smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cost-Benefit Analysis; Drug Costs; Ganglionic Stimulants; Humans; Nicotine; Patient Selection; Smoking Cessation; Tobacco Use Disorder | 2003 |
Nicotine withdrawal induces subsensitivity of hypothalamic-pituitary-adrenal axis to stress in rats: implications for precipitation of depression during smoking cessation.
Topics: Adaptation, Physiological; Adrenal Cortex Function Tests; Animals; Corticosterone; Depression; Dexamethasone; Disease Models, Animal; Glucocorticoids; Hippocampus; Hypothalamo-Hypophyseal System; Male; Nicotine; Nicotinic Agonists; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal System; Rats; Rats, Wistar; Receptors, Glucocorticoid; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome | 2004 |
Stopping smoking can cause constipation.
Topics: Bupropion; Constipation; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotine; Psychiatric Status Rating Scales; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2003 |
The cost effectiveness of pharmacotherapies for smoking cessation: necessary but not sufficient?
Topics: Administration, Cutaneous; Australia; Bupropion; Cost-Benefit Analysis; Decision Making; Drug Costs; Health Services Needs and Demand; Humans; Nicotine; Patient Acceptance of Health Care; Smoking; Smoking Cessation; Treatment Outcome | 2003 |
A study of the use of free nicotine patches by Indigenous people.
Topics: Administration, Cutaneous; Adult; Carbon Monoxide; Counseling; Drug Prescriptions; Female; Humans; Male; Middle Aged; Native Hawaiian or Other Pacific Islander; Nicotine; Northern Territory; Patient Compliance; Patient Education as Topic; Smoking; Smoking Cessation; Smoking Prevention; Social Conformity | 2003 |
Nicotine replacement therapy products over the counter: real-life use in the Australian community.
Topics: Adult; Attitude to Health; Chewing Gum; Cross-Sectional Studies; Family Characteristics; Humans; Middle Aged; New South Wales; Nicotine; Nonprescription Drugs; Patient Satisfaction; Prevalence; Smoking; Smoking Cessation; Smoking Prevention; Time Factors | 2003 |
Patterns of over-the-counter nicotine gum use: persistent use and concurrent smoking.
Topics: Adult; Age Factors; Central Nervous System Stimulants; Chewing Gum; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Polymethacrylic Acids; Polyvinyls; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2003 |
[Self-medication with nicotine preparations. 3 of 10 smokers renounce the blue fumes].
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Chewing Gum; Clinical Trials as Topic; Follow-Up Studies; Humans; Middle Aged; Nicotine; Nonprescription Drugs; Self Medication; Smoking Cessation; Treatment Outcome | 2003 |
Eye movements to smoking-related cues: effects of nicotine deprivation.
Topics: Adult; Analysis of Variance; Attention; Behavior, Addictive; Cues; Eye Movements; Female; Humans; Male; Nicotine; Photic Stimulation; Reaction Time; Smoking; Smoking Cessation; Surveys and Questionnaires | 2004 |
What's new in nicotine & tobacco research?
Topics: Ganglionic Stimulants; Humans; Nicotiana; Nicotine; Research; Smoking; Smoking Cessation | 2003 |
Craving for cigarettes among low and high dependent smokers: impact of norharman.
Topics: Adult; Carbolines; Circadian Rhythm; Female; Harmine; Humans; Male; Middle Aged; Motivation; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2003 |
PREP Self-Assessment example.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Bupropion; Drug Therapy, Combination; Female; Humans; Nicotine; Smoking Cessation | 2004 |
Allocation of resources between smoking cessation methods and lovastatin treatment of hypercholesterolaemia: based on cost effectiveness and the social welfare function.
Topics: Administration, Cutaneous; Administration, Oral; Algorithms; Anticholesteremic Agents; Cost-Benefit Analysis; Female; Health Care Rationing; Humans; Hypercholesterolemia; Lovastatin; Male; Nicotine; Smoking Cessation; Social Welfare; Socioeconomic Factors; Spain | 2004 |
Smoking verification and the risk of myocardial infarction.
Topics: Biomarkers; Humans; Myocardial Infarction; Nicotine; Reproducibility of Results; Smoking; Smoking Cessation | 2004 |
[Delirium after sudden interruption of nicotine consumption].
Topics: Aged; Delirium; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 2004 |
Smoking reduction and tobacco-related cancers: the more things change, the more they stay the same.
Topics: Biomarkers, Tumor; Carcinogens; Global Health; Humans; International Agencies; Lung Neoplasms; Neoplasms; Nicotine; Nicotinic Agonists; Nitrosamines; Risk Factors; Smoking; Smoking Cessation; Tobacco Smoke Pollution; Tobacco Use Disorder; United States | 2004 |
Latinos report less use of pharmaceutical aids when trying to quit smoking.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Colorado; Counseling; Female; Health Care Surveys; Hispanic or Latino; Humans; Logistic Models; Male; Middle Aged; Nicotine; Nicotinic Agonists; Physician-Patient Relations; Physician's Role; Smoking Cessation; Tobacco Use Disorder; White People | 2004 |
Out of the ashes: the life, death, and rebirth of the "safer" cigarette in the United States.
Topics: American Medical Association; Consumer Product Safety; Deception; History, 20th Century; History, 21st Century; Humans; Marketing; National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; Nicotine; Politics; Public Health Practice; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Industry; United States; United States Public Health Service; Voluntary Health Agencies | 2004 |
Self-care secrets. Giving up smoking for good. Use these strategies to help you stop smoking.
Topics: Bupropion; Diabetes Complications; Humans; Nicotine; Self Care; Smoking; Smoking Cessation; Smoking Prevention; United States | 2003 |
An evidence-based approach to planning tobacco interventions for Aboriginal people.
Topics: Administration, Cutaneous; Australia; Culture; Evidence-Based Medicine; Health Planning; Humans; Native Hawaiian or Other Pacific Islander; Nicotine; Preventive Health Services; Smoking Cessation; Socioeconomic Factors; Tobacco Use Disorder | 2004 |
Misuse of and dependence on over-the-counter nicotine gum in a volunteer sample.
Topics: Chewing Gum; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Incidence; International Classification of Diseases; Male; Middle Aged; Nicotine; Nonprescription Drugs; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Tobacco Use Disorder | 2004 |
Quantitative comparisons between a nicotine delivery device (Eclipse) and conventional cigarette smoking.
Topics: Adult; Blood Pressure; Carbon Monoxide; Equipment Design; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Tobacco Use Disorder; Volatilization | 2004 |
Smoking cessation increases gingival blood flow and gingival crevicular fluid.
Topics: Adult; Analysis of Variance; Carbon Monoxide; Cotinine; Female; Follow-Up Studies; Gingiva; Gingival Crevicular Fluid; Humans; Laser-Doppler Flowmetry; Male; Microcirculation; Nicotine; Regional Blood Flow; Smoking; Smoking Cessation | 2004 |
Summaries for patients. Matching nicotine replacement treatment to particular smokers.
Topics: Administration, Cutaneous; Administration, Intranasal; Adult; Behavior Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Obesity; Smoking Cessation; Socioeconomic Factors; Tobacco Use Disorder; Treatment Outcome | 2004 |
Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agents.
Topics: Animals; Biological Assay; Male; Molecular Structure; Nicotine; Nicotinic Antagonists; Picolines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Smoking Cessation; Structure-Activity Relationship | 2004 |
Sensitivity of neuronal nicotinic acetylcholine receptors to the opiate antagonists naltrexone and naloxone: receptor blockade and up-regulation.
Topics: Cell Line; Gene Expression; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Neurons; Nicotine; Patch-Clamp Techniques; Receptors, Nicotinic; Sensitivity and Specificity; Smoking Cessation; Structure-Activity Relationship; Time Factors; Up-Regulation | 2004 |
[Depression, tobacco dependence and nicotine].
Topics: Aged; Alcoholism; Bipolar Disorder; Chewing Gum; Comorbidity; Cotinine; Creatinine; Depressive Disorder; Humans; Male; Nicotine; Psychiatric Status Rating Scales; Severity of Illness Index; Smoking Cessation; Substance Abuse Detection; Tobacco Use Disorder; Treatment Outcome | 2002 |
Time for major roadworks on the tobacco road?
Topics: Administration, Inhalation; History, 20th Century; History, 21st Century; Humans; New Zealand; Nicotine; Prevalence; Public Health; Smoking; Smoking Cessation; Smoking Prevention; Socioeconomic Factors; Tobacco Industry | 2004 |
Advances in pharmacotherapy for tobacco dependence.
Topics: Animals; Blood-Brain Barrier; Clinical Trials as Topic; Combined Modality Therapy; Comorbidity; Drug Administration Routes; Drug Design; Drug Evaluation, Preclinical; Drug Therapy, Combination; Health Education; Humans; Marketing; Mental Disorders; Nicotine; Nicotinic Antagonists; Rats; Smoking; Smoking Cessation; Social Support; Substance Withdrawal Syndrome; Tobacco Use Disorder; Vaccines | 2004 |
Development of a buccal bioadhesive nicotine tablet formulation for smoking cessation.
Topics: Adhesives; Administration, Buccal; Animals; Cattle; Chemistry, Pharmaceutical; Diffusion Chambers, Culture; In Vitro Techniques; Mouth Mucosa; Nicotine; Smoking Cessation; Tablets | 2004 |
Initial uptake and evidence of safe prescribing practice with Buproprion (Zyban).
Topics: Adolescent; Adult; Age Factors; Aged; Bupropion; Databases, Factual; Dopamine Uptake Inhibitors; Drug Interactions; Drug Prescriptions; Drug Utilization Review; Family Practice; Female; Humans; Ireland; Logistic Models; Male; Middle Aged; National Health Programs; Nicotine; Safety; Smoking Cessation; Tobacco Use Disorder | 2004 |
What is the role of pharmacotherapy in tobacco cessation in patients with schizophrenia?
Topics: Administration, Cutaneous; Health Promotion; Humans; Nicotine; Schizophrenia; Smoking Cessation; Tobacco Use Disorder | 2004 |
[Recommendation of good practice: Therapeutic strategies, with or without the assistance of medicine-based treatment, for stopping smoking (May 2003)].
Topics: Adolescent; Alcohol Drinking; Bupropion; Cotinine; Female; Humans; MEDLINE; Nicotine; Pregnancy; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2004 |
Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal.
Topics: Adult; Affect; Analysis of Variance; Female; Humans; Irritable Mood; Male; Middle Aged; Nicotine; Psychomotor Agitation; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2004 |
Substitutes for tobacco smoking: a behavioral economic analysis of nicotine gum, denicotinized cigarettes, and nicotine-containing cigarettes.
Topics: Adolescent; Adult; Analysis of Variance; Chewing Gum; Humans; Middle Aged; Nicotine; Polymethacrylic Acids; Polyvinyls; Self Administration; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2004 |
What's new in nicotine & tobacco research?
Topics: Antidepressive Agents; Counseling; Ganglionic Stimulants; Humans; Internet; Nicotine; Radon; Research; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2004 |
Effects of quitting smoking on EEG activation and attention last for more than 31 days and are more severe with stress, dependence, DRD2 A1 allele, and depressive traits.
Topics: Adolescent; Adult; Attention; Cognition; Depression; Electroencephalography; Female; Ganglionic Stimulants; Heart Rate; Humans; Nicotine; Polymorphism, Genetic; Receptors, Dopamine D2; Smoking Cessation; Stress, Psychological; Time Factors; Tobacco Use Disorder | 2004 |
Measurement properties of a nicotine dependence scale for adolescents.
Topics: Adolescent; Adolescent Behavior; Factor Analysis, Statistical; Female; Ganglionic Stimulants; Health Surveys; Humans; Longitudinal Studies; Male; Nicotine; Severity of Illness Index; Smoking Cessation; Tobacco Use Disorder | 2004 |
Nicotine dependence criteria of the DIS and DSM-III-R: a factor analysis.
Topics: Adolescent; Adult; Cross-Sectional Studies; Diagnostic and Statistical Manual of Mental Disorders; Factor Analysis, Statistical; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Prognosis; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2004 |
Level of nicotine replacement during a quit-smoking attempt.
Topics: Cotinine; Ganglionic Stimulants; Humans; Nicotine; Predictive Value of Tests; Reproducibility of Results; Saliva; Sensitivity and Specificity; Smoking; Smoking Cessation; Specimen Handling; Time Factors; Tobacco Smoke Pollution; Treatment Outcome | 2004 |
Giving up smoking.
Topics: Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention | 2004 |
Fagerstrom test for nicotine dependence: reliability in a Turkish sample and factor analysis.
Topics: Adult; Factor Analysis, Statistical; Female; Humans; Male; Nicotine; Psychometrics; Reproducibility of Results; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Turkey | 2004 |
Evaluating heterogeneity in cumulative meta-analyses.
Topics: Acupuncture; Clonidine; Counseling; Data Interpretation, Statistical; Effect Modifier, Epidemiologic; Humans; Meta-Analysis as Topic; Nicotine; Odds Ratio; Randomized Controlled Trials as Topic; Risk Factors; Smoking Cessation; Tobacco Use Disorder | 2004 |
Assessing harmful effects in systematic reviews.
Topics: Anticonvulsants; Antipsychotic Agents; Bupropion; Delayed-Action Preparations; Humans; Meta-Analysis as Topic; Nicotine; Observation; Quality Control; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Schizophrenia; Smoking Cessation; Treatment Outcome | 2004 |
Trial watch: Xenova's TA-NIC vaccine shows promise.
Topics: Clinical Trials as Topic; Humans; Nicotine; Smoking Cessation; Vaccines | 2004 |
[Nicotine replacement therapy versus gradual smoking withdrawal in smoking cessation].
Topics: Cognitive Behavioral Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Smoking Prevention | 2004 |
Nicotine conjugate vaccine: is there a right to a smoking future?
Topics: Adult; Child; Choice Behavior; Forecasting; Human Rights; Humans; Life Style; Morals; Nicotine; Parents; Smoking; Smoking Cessation; Tobacco Use Disorder; Vaccination; Vaccines, Conjugate | 2004 |
A case series of nicotine nasal spray in the treatment of tobacco dependence among patients with schizophrenia.
Topics: Administration, Intranasal; Adult; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Smoking Cessation; Social Support; Tobacco Use Disorder | 2004 |
Patients need more help to quit smoking: counseling and pharmacotherapy double success rate.
Topics: Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder | 2004 |
What's new in nicotine & tobacco research?
Topics: Ganglionic Stimulants; Genetic Predisposition to Disease; Humans; Indians, North American; Nicotine; Recurrence; Smoking; Smoking Cessation; Social Conditions; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2004 |
Tobacco cessation pharmacotherapy use among First Nations persons residing within British Columbia.
Topics: Adult; Age Factors; British Columbia; Bupropion; Databases, Factual; Dopamine Uptake Inhibitors; Female; Ganglionic Stimulants; Humans; Indians, North American; Male; Nicotine; Sex Factors; Smoking Cessation; Tobacco Use Disorder | 2004 |
Research on nicotine and tobacco: a decade of progress.
Topics: Biomedical Research; Ganglionic Stimulants; Humans; Nicotiana; Nicotine; Smoking Cessation; Societies, Medical | 2004 |
Targeting smoking cessation to high prevalence communities: outcomes from a pilot intervention for gay men.
Topics: Adult; Combined Modality Therapy; Community Health Services; Health Knowledge, Attitudes, Practice; Health Services Research; Homosexuality, Male; Humans; London; Male; Middle Aged; Nicotine; Pilot Projects; Prevalence; Primary Health Care; Self Efficacy; Self-Help Groups; Smoking; Smoking Cessation; Smoking Prevention; State Medicine; Treatment Outcome | 2004 |
Adolescents' beliefs about the risks involved in smoking "light" cigarettes.
Topics: Adolescent; Attitude to Health; Humans; Nicotine; Psychology, Adolescent; Risk; Smoking; Smoking Cessation; Surveys and Questionnaires; Tars | 2004 |
Make use of all resources to quit smoking.
Topics: Adaptation, Psychological; Administration, Cutaneous; Humans; Nicotine; Smoking Cessation; Smoking Prevention | 2004 |
Anxiety sensitivity: association with intensity of retrospectively-rated smoking-related withdrawal symptoms and motivation to quit.
Topics: Adult; Anxiety; Female; Humans; Male; Motivation; Nicotine; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2004 |
GP prescribing of nicotine replacement and bupropion to aid smoking cessation in England and Wales.
Topics: Bupropion; England; Health Care Surveys; Humans; Nicotine; Practice Patterns, Physicians'; Smoking Cessation; Wales | 2004 |
Recruiting pregnant smokers for a placebo-randomised controlled trial of nicotine replacement therapy.
Topics: Eligibility Determination; England; Feasibility Studies; Female; Hospitals, Teaching; Humans; Nicotine; Outpatient Clinics, Hospital; Patient Selection; Placebos; Pregnancy; Pregnancy Complications; Pregnant Women; Randomized Controlled Trials as Topic; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Ultrasonography, Prenatal | 2004 |
The influence of offering free transdermal nicotine patches on quit rates in a local health department's smoking cessation program.
Topics: Administration, Cutaneous; Adult; Age Factors; Aged; Counseling; Educational Status; Female; Health Education; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Recurrence; Smoking Cessation; Smoking Prevention; Time Factors | 2004 |
Smoking cessation services in U.S. methadone maintenance facilities.
Topics: Adult; Combined Modality Therapy; Comorbidity; Counseling; Cross-Sectional Studies; Female; Health Surveys; Humans; Male; Methadone; Middle Aged; Nicotine; Opioid-Related Disorders; Regression Analysis; Smoking Cessation; Statistics as Topic; Substance Abuse Treatment Centers; Tobacco Use Disorder; United States | 2004 |
Treatment of tobacco use in an inpatient psychiatric setting.
Topics: Adult; Alcoholism; Combined Modality Therapy; Comorbidity; Drug Administration Routes; Female; Humans; Inpatients; Male; Mental Disorders; Middle Aged; Nicotine; Patient Acceptance of Health Care; Patient Discharge; Psychiatric Department, Hospital; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Treatment Outcome | 2004 |
[Usefulness of biological markers in the evaluation of smoking at the first visit of a smoking cessation program].
Topics: Adolescent; Adult; Aged; Biomarkers; Breath Tests; Carbon Monoxide; Cotinine; Female; France; Humans; Male; Middle Aged; Nicotiana; Nicotine; Plants, Toxic; Smoking; Smoking Cessation; Tobacco Use Disorder | 2004 |
Role of gamma-aminobutyric acid (GABA) and metabotropic glutamate receptors in nicotine reinforcement: potential pharmacotherapies for smoking cessation.
Topics: Animals; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; GABA Agonists; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; Mice; Nicotine; Rats; Receptors, GABA-B; Receptors, Metabotropic Glutamate; Reinforcement Schedule; Self Administration; Smoking Cessation | 2004 |
Anesthesiologists, general surgeons, and tobacco interventions in the perioperative period.
Topics: Adult; Age Factors; Anesthesia; Anesthesiology; Attitude of Health Personnel; Data Collection; Female; General Surgery; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Education as Topic; Perioperative Care; Physicians; Smoking Cessation | 2004 |
Which smokers use the smoking cessation Quitline in Hong Kong, and how effective is the Quitline?
Topics: Adolescent; Adult; Age Factors; Attitude to Health; Counseling; Female; Hong Kong; Hotlines; Humans; Life Style; Male; Middle Aged; Nicotine; Smoking Cessation; Telephone; Time Factors | 2004 |
Merchandising of cigarettes in San Francisco pharmacies: 27 years later.
Topics: Advertising; Commerce; Humans; Marketing; Nicotine; Pharmacies; San Francisco; Smoking; Smoking Cessation | 2004 |
Get ready. Get set. Quit! Thinking about quitting smoking? Congratulations, you've already taken the first step.
Topics: Diabetes Mellitus; Humans; Nicotine; Smoking Cessation; Social Support; United States | 2004 |
[ABC of smoking cessation. Nicotine replacement therapy].
Topics: Humans; Nicotine; Smoking Cessation | 2004 |
Validation and application of a method for the determination of nicotine and five major metabolites in smokers' urine by solid-phase extraction and liquid chromatography-tandem mass spectrometry.
Topics: Chemical Fractionation; Chromatography, Liquid; Circadian Rhythm; Creatinine; Freezing; Humans; Mass Spectrometry; Nicotine; Reproducibility of Results; Sensitivity and Specificity; Smoking; Smoking Cessation | 2005 |
Audit of prescribed nicotine replacement therapy to hospital inpatients who smoke.
Topics: Drug Prescriptions; Hospitalization; Humans; Medical Audit; New South Wales; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2005 |
Smoking prevention and cessation.
Topics: Central Nervous System Stimulants; Communication; Counseling; Dental Hygienists; Dentist-Patient Relations; Dentists; Humans; Nicotine; Professional-Patient Relations; Referral and Consultation; Smoking Cessation; Smoking Prevention | 2003 |
[Drugs for smoking cessation].
Topics: Bupropion; Dopamine Uptake Inhibitors; Humans; Motivation; Nicotine; Smoking; Smoking Cessation; Smoking Prevention | 2005 |
What's new in nicotine & tobacco research?
Topics: Adolescent; Adult; Child; Female; Ganglionic Stimulants; Hair; Humans; Infant, Newborn; Male; Menopause; Nicotine; Pregnancy; Pregnancy Complications; Sex Factors; Smoking Cessation; Tobacco Use Disorder | 2004 |
Obstacles to determining individual differences in the efficacy of smoking cessation medications.
Topics: Clinical Trials as Topic; Endpoint Determination; Ganglionic Stimulants; Humans; Nicotine; Reproducibility of Results; Research Design; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2004 |
Smoke constituent exposure and smoking topography of adolescent daily cigarette smokers.
Topics: Adolescent; Adolescent Behavior; Carbon Monoxide; Cotinine; Cross-Sectional Studies; Female; Ganglionic Stimulants; Humans; Male; Nicotine; Sex Factors; Smoking; Smoking Cessation; Tobacco Use Disorder | 2004 |
Clarification of SRNT workgroup guidelines for measures in clinical trials of smoking cessation therapies.
Topics: Clinical Trials as Topic; Endpoint Determination; Ganglionic Stimulants; Guidelines as Topic; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2004 |
Medications work for severely addicted smokers: implications for addiction therapists and primary care physicians.
Topics: Administration, Cutaneous; Administration, Oral; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2005 |
The effectiveness of nicotine patch and nicotine lozenge in very heavy smokers.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Female; Humans; Male; Nicotine; Smoking Cessation; Statistics, Nonparametric; Tobacco Use Disorder | 2005 |
National trends in the provision of smoking cessation aids within the Veterans Health Administration.
Topics: Adult; Aged; Bupropion; Chewing Gum; Databases as Topic; Drug Utilization Review; Hospitals, Veterans; Humans; Middle Aged; Nicotine; Pharmacy Service, Hospital; Smoking; Smoking Cessation; Smoking Prevention; United States; United States Department of Veterans Affairs; Veterans | 2005 |
[ABC of smoking cessation. Bupropion and other drugs in non-nicotine therapy].
Topics: Administration, Cutaneous; Antidepressive Agents; Bupropion; Humans; Nicotine; Smoking Cessation | 2004 |
General practitioners' views on and referral to NHS smoking cessation services.
Topics: Adult; Antidepressive Agents, Second-Generation; Attitude of Health Personnel; Bupropion; Female; Financing, Government; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Physicians, Family; Referral and Consultation; Smoking Cessation; State Medicine; United Kingdom | 2005 |
Assessing missing data assumptions in longitudinal studies: an example using a smoking cessation trial.
Topics: Bias; Carbon Monoxide; Clinical Trials as Topic; Computer Graphics; Data Collection; Data Interpretation, Statistical; Humans; Longitudinal Studies; Methadone; Models, Statistical; Nicotine; Patient Dropouts; Reproducibility of Results; Secondary Prevention; Smoking Cessation | 2005 |
A comparison of the content-, construct- and predictive validity of the cigarette dependence scale and the Fagerström test for nicotine dependence.
Topics: Adolescent; Adult; Aged; Confidence Intervals; Female; Follow-Up Studies; Health Surveys; Humans; Internet; Male; Middle Aged; Nicotine; Personality Inventory; Psychometrics; Reproducibility of Results; ROC Curve; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Switzerland; Tobacco Use Disorder | 2005 |
A prospective study of off-label use of, abuse of, and dependence on nicotine inhaler.
Topics: Adult; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Prospective Studies; Smoking; Smoking Cessation; Substance-Related Disorders | 2005 |
Breathing life into the Framework Convention on Tobacco Control: smoking cessation and the right to health.
Topics: Behavior Therapy; Global Health; Human Rights; Humans; Nicotine; Organizational Policy; Personal Autonomy; Public Health; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Industry; United States; World Health Organization | 2005 |
The impact of advertising on nicotine replacement therapy demand.
Topics: Administration, Cutaneous; Advertising; Chewing Gum; Cross-Sectional Studies; Health Services Needs and Demand; Humans; Models, Econometric; Nicotine; Smoking Cessation; Time and Motion Studies; Tobacco Use Disorder; United States; Urban Population | 2005 |
Nicotine replacement.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Ganglionic Stimulants; Half-Life; Humans; Metabolic Clearance Rate; Nicotine; Smoking Cessation | 2005 |
[Veracity of smokers' reports of abstinence at smoking cessation clinics].
Topics: Adult; Breath Tests; Bupropion; Carbon Monoxide; Data Interpretation, Statistical; Dopamine Uptake Inhibitors; Female; Humans; Longitudinal Studies; Male; Middle Aged; Motivation; Nicotine; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Smoking Cessation; Spain; Time Factors | 2005 |
Outcomes from an outpatient smoking-cessation clinic.
Topics: Ambulatory Care Facilities; Antidepressive Agents, Second-Generation; Bupropion; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Treatment Outcome | 2005 |
Nicotine replacement therapy use among a cohort of smokers.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Cohort Studies; Female; Ganglionic Stimulants; Health Surveys; Humans; Male; Maryland; Middle Aged; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2005 |
Reliability and validity of the French version of the tobacco craving questionnaire.
Topics: Adult; Female; France; Humans; Language; Male; Nicotine; Reproducibility of Results; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2005 |
[Potential risk of the consumption of non-prescription drugs in an elderly hypertensive subject on nicotine substitute therapy--case presentation].
Topics: Aged; Antihypertensive Agents; Blood Pressure; Drug Antagonism; Female; Humans; Hypertension; Nicotine; Nonprescription Drugs; Risk Factors; Smoking Cessation; Treatment Outcome | 2004 |
Assigned versus perceived placebo effects in nicotine replacement therapy for smoking reduction in Swiss smokers.
Topics: Administration, Cutaneous; Adult; Female; Humans; Male; Nicotine; Placebo Effect; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Surveys and Questionnaires; Switzerland | 2005 |
Stop-smoking medications: who uses them, who misuses them, and who is misinformed about them?
Topics: Adult; Attitude to Health; Female; Harm Reduction; Health Education; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder; United States | 2004 |
Use of and beliefs about light cigarettes in four countries: findings from the International Tobacco Control Policy Evaluation Survey.
Topics: Adult; Australia; Canada; Cultural Characteristics; Female; Health Education; Health Knowledge, Attitudes, Practice; Health Policy; Health Promotion; Humans; Male; Middle Aged; Nicotine; Population Surveillance; Product Labeling; Risk Factors; Smoking; Smoking Cessation; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder; United Kingdom; United States | 2004 |
What do Marlboro Lights smokers know about low-tar cigarettes?
Topics: Adult; Behavior, Addictive; Cultural Characteristics; Female; Health Education; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Nicotine; Risk Factors; Smoking; Smoking Cessation; Socioeconomic Factors; Surveys and Questionnaires; Tars; Time Factors; Tobacco Use Disorder; United States | 2004 |
Are smokers adequately informed about the health risks of smoking and medicinal nicotine?
Topics: Adult; Behavior, Addictive; Female; Health Education; Health Knowledge, Attitudes, Practice; Health Promotion; Health Status; Humans; Male; Middle Aged; Nicotine; Risk Factors; Smoking; Smoking Cessation; Socioeconomic Factors; Surveys and Questionnaires; Tars; Time Factors; Tobacco Use Disorder; United States | 2004 |
The near-universal experience of regret among smokers in four countries: findings from the International Tobacco Control Policy Evaluation Survey.
Topics: Adult; Australia; Behavior, Addictive; Canada; Female; Guilt; Health Education; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Nicotine; Prevalence; Risk Factors; Smoking; Smoking Cessation; Socioeconomic Factors; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder; United Kingdom; United States | 2004 |
Smokers' responses to advertisements for regular and light cigarettes and potential reduced-exposure tobacco products.
Topics: Adult; Advertising; Australia; Behavior, Addictive; Canada; Cohort Studies; Female; Health Education; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Nicotine; Prevalence; Product Labeling; Research Design; Risk Factors; Smoking; Smoking Cessation; Socioeconomic Factors; Surveys and Questionnaires; Time Factors; Tobacco Industry; Tobacco Use Disorder; United Kingdom; United States | 2004 |
Predictors of cessation in a cohort of current and former smokers followed over 13 years.
Topics: Adult; Aged; Attitude to Health; Behavior, Addictive; Cohort Studies; Female; Follow-Up Studies; Health Education; Health Promotion; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Risk Factors; Smoking; Smoking Cessation; Socioeconomic Factors; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder; United States | 2004 |
Perceptions about cigarette smoking and risks among college students.
Topics: Adult; Attitude to Health; Behavior, Addictive; Cohort Studies; Female; Health Education; Health Promotion; Humans; Life Style; Male; New York; Nicotine; Risk Factors; Smoking; Smoking Cessation; Students; Surveys and Questionnaires; Time Factors | 2004 |
Accuracy and optimism in smokers' beliefs about quitting.
Topics: Adolescent; Adult; Attitude to Health; Behavior, Addictive; Cohort Studies; Female; Health Education; Health Promotion; Humans; Life Style; Male; Nicotine; Risk Factors; Smoking; Smoking Cessation; Surveys and Questionnaires; Time Factors; United States | 2004 |
[Factors affecting the success or failure of smoking cessation using nicotine patches].
Topics: Administration, Cutaneous; Adult; Aged; Counseling; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nicotine; Proportional Hazards Models; Smoking; Smoking Cessation; Treatment Outcome | 2005 |
Recent quitters' interest in recycling and harm reduction.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Bupropion; Cross-Sectional Studies; Databases as Topic; Dopamine Uptake Inhibitors; Female; Ganglionic Stimulants; Harm Reduction; Humans; Male; Middle Aged; Nicotine; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Tobacco Use Disorder | 2004 |
Nicotine dependence, depression, and gender: characterizing phenotypes based on withdrawal discomfort, response to smoking, and ability to abstain.
Topics: Adult; Aged; Aged, 80 and over; Anxiety; Depression; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Phenotype; Sex Factors; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2005 |
Nicotine patch and lozenge are effective for women.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Central Nervous System Stimulants; Female; Humans; Logistic Models; Male; Middle Aged; Nicotine; Polymethacrylic Acids; Polyvinyls; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Treatment Outcome; United Kingdom; United States | 2005 |
Child health care clinicians' use of medications to help parents quit smoking: a national parent survey.
Topics: Child; Data Collection; Female; Humans; Male; Nicotine; Parents; Pediatrics; Physician's Role; Smoking Cessation; Tobacco Use Disorder; United States | 2005 |
The impact of socioeconomic and demographic factors on the utilization of smoking cessation medications in patients hospitalized with cardiovascular disease in Nova Scotia, Canada.
Topics: Administration, Cutaneous; Bupropion; Cardiovascular Diseases; Chewing Gum; Data Collection; Demography; Female; Hospitalization; Humans; Inpatients; Male; Middle Aged; Nicotine; Nova Scotia; Smoking; Smoking Cessation; Socioeconomic Factors; Time Factors | 2005 |
Smoking cessation a byproduct of EEG telemetry monitoring.
Topics: Administration, Cutaneous; Adult; Attitude to Health; Electroencephalography; Epilepsy; Female; Hospitalization; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Smoking; Smoking Cessation; Smoking Prevention; Telemetry; Videotape Recording | 2005 |
The smoking gun: many conditions associated with tobacco exposure may be attributable to paradoxical compensatory autonomic responses to nicotine.
Topics: Anxiety; Autonomic Nervous System; Humans; Hypertension; Inflammation; Models, Biological; Neoplasms; Nicotine; Receptors, Nicotinic; Sleep Initiation and Maintenance Disorders; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Sympathetic Nervous System; Tachycardia; Th2 Cells; Tobacco, Smokeless; Tumor Escape; Vagus Nerve | 2005 |
Adherence to the Swiss guidelines for management of COPD: experience of a Swiss teaching hospital.
Topics: Adrenal Cortex Hormones; Aged; Bronchodilator Agents; Drug Utilization; Female; Guideline Adherence; Hospitals, Teaching; Humans; Male; Nicotine; Nicotinic Agonists; Oxygen Inhalation Therapy; Patient Education as Topic; Pneumonectomy; Practice Guidelines as Topic; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Smoking; Smoking Cessation; Surveys and Questionnaires; Switzerland | 2005 |
Latent class typology of nicotine withdrawal: genetic contributions and association with failed smoking cessation and psychiatric disorders.
Topics: Adult; Female; Ganglionic Stimulants; Humans; Male; Mental Disorders; Middle Aged; Nicotine; Risk Factors; Severity of Illness Index; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2005 |
Awareness and use of smoking cessation treatments among diabetic patients.
Topics: Aged; Antidepressive Agents, Second-Generation; Bupropion; Diabetes Mellitus, Type 2; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires | 2005 |
What's new in Nicotine and Tobacco Research?
Topics: Advertising; Bupropion; Deception; Dopamine Uptake Inhibitors; Emotions; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Industry | 2004 |
Placebo cigarettes in a spaced smoking paradigm.
Topics: Adult; Analysis of Variance; Behavior, Addictive; Carbon Monoxide; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Placebos; Smoking; Smoking Cessation; Time Factors | 2005 |
Unaided smoking cessation and predictors of failure to quit in a community sample: effects of gender.
Topics: Adaptation, Psychological; Adolescent; Adult; Affect; Aged; Female; Humans; Logistic Models; Male; Middle Aged; Nicotine; Personality Assessment; Prognosis; Psychometrics; Recurrence; Self Care; Self Efficacy; Sex Factors; Smoking; Smoking Cessation; Social Support; Socioeconomic Factors; Surveys and Questionnaires | 2005 |
Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women.
Topics: Aged; Case-Control Studies; Catechol O-Methyltransferase; Female; Humans; Middle Aged; Nicotine; Smoking Cessation | 2005 |
Free nicotine replacement therapy programs vs implementing smoke-free workplaces: a cost-effectiveness comparison.
Topics: Adolescent; Adult; Cost-Benefit Analysis; Financing, Government; Health Promotion; Humans; Middle Aged; Minnesota; Nicotine; Quality-Adjusted Life Years; Smoking; Smoking Cessation; Smoking Prevention; State Government; Tobacco Smoke Pollution; Workplace | 2005 |
Use of pharmacy data to evaluate smoking regulations' impact on sales of nicotine replacement therapies in New York City.
Topics: Health Promotion; Humans; New York City; Nicotine; Pharmacies; Poisson Distribution; Public Policy; Smoking; Smoking Cessation; Taxes; Tobacco Industry; Tobacco Use Disorder; Urban Population; Workplace | 2005 |
Impact of UK policy initiatives on use of medicines to aid smoking cessation.
Topics: Bupropion; Drug Utilization; Health Policy; Humans; Nicotine; Smoking Cessation; United Kingdom | 2005 |
Religiosity, social support, and smoking cessation among urban African American smokers.
Topics: Administration, Cutaneous; Black or African American; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Regression Analysis; Religion; Sex Factors; Smoking Cessation; Social Support; Telephone; Urban Health | 2005 |
Light smoking and dependence symptoms in high-school students.
Topics: Adolescent; Age Factors; Female; Ganglionic Stimulants; Humans; Male; Nicotine; Psychiatric Status Rating Scales; Respiration Disorders; Sex Factors; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder | 2005 |
Craving nicotine: It's in the genes.
Topics: Animals; Drug Tolerance; Humans; Mice; Nicotine; Point Mutation; Receptors, Nicotinic; Reward; Smoking; Smoking Cessation; Tobacco Use Disorder | 2005 |
What happens when GPs proactively prescribe NRT patches in a disadvantaged community.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Family Practice; Female; Humans; Male; Middle Aged; Nicotine; Outcome Assessment, Health Care; Poverty Areas; Practice Patterns, Physicians'; Scotland; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Vulnerable Populations | 2005 |
[Smoking and breastfeeding: how can we help mothers stop smoking?].
Topics: Breast Feeding; Female; Humans; Male; Mothers; Nicotine; Pregnancy; Smoking Cessation | 2005 |
PHARMAC and tobacco control in New Zealand: two licensed funded options are already available.
Topics: Administration, Cutaneous; Bupropion; Cost-Benefit Analysis; Drug Industry; Evidence-Based Medicine; Humans; Licensure; New Zealand; Nicotine; Nortriptyline; Practice Guidelines as Topic; Smoking Cessation; Tobacco Use Disorder; United States | 2005 |
[Medication for ending tobacco dependency. Current state].
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Humans; Nicotine; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Smoking Cessation; Time Factors; Tobacco Use Disorder; Varenicline | 2005 |
Oxygen as a therapy for reducing nicotine withdrawal symptoms.
Topics: Brain; Dopamine; Humans; Models, Biological; Nicotine; Oxygen; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2005 |
Effects of transdermal nicotine during imaginal exposure to anxiety and smoking cues in college smokers.
Topics: Administration, Cutaneous; Adult; Anxiety; Cues; Female; Humans; Imagination; Male; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Students; Universities | 2005 |
What to do with a patient who smokes.
Topics: Antidepressive Agents; Bupropion; Central Nervous System Stimulants; Clonidine; Counseling; Hotlines; Humans; Nicotine; Nortriptyline; Physician's Role; Smoking; Smoking Cessation; Tobacco Use Disorder; United States | 2005 |
Smoking cessation treatment in primary care: prospective cohort study.
Topics: Adolescent; Adult; Aged; Bupropion; Contraindications; Drug Prescriptions; England; Female; Health Services Research; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Selection; Poverty; Practice Patterns, Physicians'; Primary Health Care; Prospective Studies; Smoking Cessation; Smoking Prevention | 2005 |
U.K. general practitioners' beliefs, attitudes, and reported prescribing of nicotine replacement therapy in pregnancy.
Topics: Adult; Family Practice; Female; Health Education; Health Promotion; Humans; Male; Middle Aged; Nicotine; Physician-Patient Relations; Physician's Role; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications; Primary Health Care; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; United Kingdom | 2005 |
Over-the-counter availability of nicotine replacement therapy and smoking cessation.
Topics: Adult; Cohort Studies; Female; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Nicotine; Nonprescription Drugs; Prospective Studies; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Time Factors; United States | 2005 |
Could a novel vaccine help smokers quit?
Topics: Animals; Antibodies; Female; Humans; Nicotine; Pregnancy; Rats; Smoking Cessation; Tobacco Use Disorder; Vaccines | 2005 |
Subsidised nicotine replacement therapy in a community pharmacy setting.
Topics: Arabs; Drug Costs; Follow-Up Studies; Health Promotion; Humans; New South Wales; Nicotine; Patient Selection; Pharmacies; Pilot Projects; Program Evaluation; Smoking Cessation | 2005 |
Smoking status of Australian general practice patients and their attempts to quit.
Topics: Adolescent; Adult; Aged; Australia; Bupropion; Cross-Sectional Studies; Family Practice; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2006 |
Ask the doctor. On the day I stopped smoking a few weeks ago, I started using a nicotine patch. When I smoked, my blood pressure was great--100/70. NOw it is up to 160/90. I would hate to stop the patch, since it really helps, but I'm worried that it coul
Topics: Administration, Cutaneous; Humans; Hypertension; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome | 2005 |
Smoking cessation among Chinese young smokers: does gender and age difference matters and what are the predictors?
Topics: Adolescent; Adult; Age Factors; Asian People; Cross-Sectional Studies; Educational Status; Female; Hong Kong; Humans; Longitudinal Studies; Male; Motivation; Nicotine; Occupations; Patient Compliance; Prognosis; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Comorbid alcohol and nicotine dependence: from the biomolecular basis to clinical consequences.
Topics: Alcohol Deterrents; Alcoholism; Animals; Brain; Chromosome Mapping; Comorbidity; Genetic Predisposition to Disease; Humans; Mice; Motivation; Nicotine; Oligonucleotide Array Sequence Analysis; Pancreatitis, Alcoholic; Rats; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Tobacco Use Disorder | 2005 |
[Does nicotine add to the carcinogenic strain of tobacco smoke?].
Topics: Administration, Cutaneous; Adult; Cell Transformation, Neoplastic; Chewing Gum; Comet Assay; DNA Adducts; DNA Mutational Analysis; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Male; Middle Aged; Mutagenicity Tests; Nasal Mucosa; Nicotine; Otorhinolaryngologic Neoplasms; Respiratory Mucosa; Smoking; Smoking Cessation; Tobacco Use Disorder | 2006 |
The effect of over-the-counter sales of the nicotine patch and nicotine gum on smoking cessation in California.
Topics: Administration, Cutaneous; Administration, Oral; Adult; California; Chewing Gum; Decision Making; Female; Ganglionic Stimulants; Health Surveys; Humans; Male; Nicotine; Nonprescription Drugs; Public Policy; Smoking Cessation; Tobacco Use Disorder | 2005 |
Nicotine withdrawal and nicotine replacement in the palliative care setting.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Adenoid Cystic; Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Nicotine; Nicotinic Agonists; Palliative Care; Parotid Neoplasms; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2005 |
Survey of antenatal women's knowledge of maternal and fetal risks of tobacco smoking and acceptability of nicotine replacement products in pregnancy.
Topics: Adolescent; Adult; Female; Health Knowledge, Attitudes, Practice; Health Surveys; Humans; Maternal Exposure; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Pregnancy; Pregnancy Trimester, Third; Prenatal Care; Smoking; Smoking Cessation | 2005 |
Characteristics of selectors of nicotine replacement therapy.
Topics: Adolescent; Adult; Aged; Attitude to Health; Female; Health Surveys; Humans; Male; Mental Disorders; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Psychometrics; Smoking; Smoking Cessation; Socioeconomic Factors; Tobacco Use Disorder | 2005 |
When California smokers use nicotine replacement therapy, most are trying to quit smoking.
Topics: California; Drug Utilization; Humans; Motivation; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder | 2005 |
Nicotine as a typical drug of abuse in experimental animals and humans.
Topics: Animals; Conditioning, Operant; Disease Models, Animal; Humans; Nicotine; Recurrence; Reinforcement, Psychology; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Nicotine replacement therapy in pregnancy: use or avoid?
Topics: Abnormalities, Drug-Induced; Drug Prescriptions; Female; Fetus; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention | 2005 |
Evaluating the program of a smoking cessation support group for adult smokers: a longitudinal pilot study.
Topics: Administration, Cutaneous; Adult; Breath Tests; Carbon Monoxide; Carboxyhemoglobin; Cognitive Behavioral Therapy; Humans; Longitudinal Studies; Middle Aged; Nicotine; Nicotinic Agonists; Nursing Evaluation Research; Patient Education as Topic; Pilot Projects; Program Evaluation; Public Health Nursing; Self-Help Groups; Smoking; Smoking Cessation; Smoking Prevention; Taiwan; Treatment Outcome | 2005 |
Acute nicotine withdrawal symptoms and anxious responding to bodily sensations: a test of incremental predictive validity among young adult regular smokers.
Topics: Adult; Anxiety; Female; Humans; Male; Nicotine; Panic Disorder; Prospective Studies; Psychological Tests; Smoking Cessation; Substance Withdrawal Syndrome | 2005 |
Treating nondepressed smokers with alcohol dependence in sustained full remission: nicotine patch therapy tailored to baseline serum cotinine.
Topics: Administration, Cutaneous; Adult; Alcoholism; Community-Institutional Relations; Cotinine; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Ganglionic Stimulants; Humans; Male; Nicotine; Prevalence; Remission Induction; Smoking; Smoking Cessation; Temperance; Treatment Outcome | 2005 |
[Nicotine replacement therapies during pregnancy: what do we know about the balance between benefits and risks?].
Topics: Animals; Disease Models, Animal; Female; Fetus; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Treatment Outcome | 2005 |
What's new in nicotine & tobacco research?
Topics: Advertising; Bupropion; Deception; Dopamine Uptake Inhibitors; Humans; Nicotine; Research Design; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Industry; Tobacco Use Disorder; United States | 2005 |
Tolerance does not develop to the decrease in nicotine self-administration produced by repeated bupropion administration.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Bupropion; Central Nervous System Stimulants; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Tolerance; Male; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Self Administration; Smoking; Smoking Cessation; Sucrose | 2005 |
Comment on Shiffman and colleagues, "Nicotine patch and lozenge are effective for women".
Topics: Administration, Cutaneous; Administration, Oral; Central Nervous System Stimulants; Female; Humans; Nicotine; Polymethacrylic Acids; Polyvinyls; Research Design; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Women's Health | 2005 |
Assessing DSM-IV nicotine withdrawal symptoms: a comparison and evaluation of five different scales.
Topics: Adolescent; Adult; Aged; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Personality Inventory; Psychometrics; Recurrence; Reproducibility of Results; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death.
Topics: Adult; Age Factors; Databases as Topic; Family Practice; Female; Humans; Incidence; Male; Middle Aged; Mortality; Myocardial Infarction; Nicotine; Nicotinic Agonists; Sex Factors; Smoking Cessation; Stroke; Time Factors; Tobacco Use Disorder; United Kingdom | 2005 |
Is Swedish snus associated with smoking initiation or smoking cessation?
Topics: Adult; Aged; Diseases in Twins; Humans; Male; Middle Aged; Nicotine; Odds Ratio; Registries; Smoking; Smoking Cessation; Sweden; Tobacco Use Disorder; Tobacco, Smokeless | 2005 |
Why a nicotine vaccine?
Topics: Adolescent; Adult; Carrier Proteins; Humans; Nicotine; Nicotinic Agonists; Secondary Prevention; Smoking Cessation; Tobacco Use Disorder; Vaccines | 2005 |
Blood pressure circadian rhythm and endothelial function in heavy smokers: acute effects of transdermal nicotine.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Brachial Artery; Circadian Rhythm; Dose-Response Relationship, Drug; Endothelium, Vascular; Heart Rate; Humans; Male; Middle Aged; Nicotine; Nitrates; Nitrites; Smoking Cessation; Thromboxane B2; Vasodilation | 2005 |
Smoking, cortisol and nicotine.
Topics: Administration, Cutaneous; Adult; Behavior Therapy; Circadian Rhythm; Female; Follow-Up Studies; Humans; Hydrocortisone; Male; Middle Aged; Nicotine; Reference Values; Smoking; Smoking Cessation; Tobacco Use Disorder; Wakefulness | 2006 |
Drug counselor report of adolescents abuse of nicotine replacement therapy.
Topics: Administration, Topical; Adolescent; Counseling; Cross-Sectional Studies; Female; Health Promotion; Humans; Male; Nicotine; Smoking Cessation; Surveys and Questionnaires; Telephone; Tobacco Use Disorder | 2005 |
Pharmacotherapy and smoking cessation at a tobacco dependence clinic.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Behavior Therapy; Bupropion; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multivariate Analysis; New Jersey; Nicotine; Retrospective Studies; Smoking Cessation; Time Factors; Tobacco Use Disorder | 2006 |
Review of selected approaches to promoting smoking cessation.
Topics: Antidepressive Agents; Counseling; Evidence-Based Medicine; Humans; Nicotine; Self Care; Smoking Cessation; Social Support | 2005 |
Factors associated with successful smoking cessation among participants in a smoking cessation program involving use of the internet, e-mails, and mailing-list.
Topics: Adult; Electronic Mail; Female; Humans; Internet; Logistic Models; Male; Nicotine; Smoking Cessation; Social Support | 2005 |
Smoking and wound healing problems in reduction mammaplasty: is the introduction of urine nicotine testing justified?
Topics: Adolescent; Adult; Aged; Female; Humans; Mammaplasty; Middle Aged; Nicotine; Postoperative Complications; Risk Factors; Smoking; Smoking Cessation; Surgical Wound Dehiscence; Wound Healing | 2006 |
[Comparison of insurance coverage of tobacco cessation pharmacotherapies in five countries from the Organisation for Economic Co-operation and Development].
Topics: Australia; Dopamine Uptake Inhibitors; Follow-Up Studies; Health Personnel; Humans; Insurance Coverage; Insurance, Health; New Zealand; Nicotine; Quebec; Smoking Cessation; Smoking Prevention; United Kingdom; United States | 2005 |
Hypothalamic-pituitary-adrenocortical responses to psychological stress and risk for smoking relapse.
Topics: Adult; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Motivation; Nicotine; Pituitary-Adrenal System; Prognosis; Recurrence; Risk Factors; Sex Factors; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Tobacco cessation activities of UK dentists in primary care: signs of improvement.
Topics: Adult; Attitude of Health Personnel; Central Nervous System Stimulants; Counseling; Dental Care; Dentist-Patient Relations; Dentists; Female; Health Promotion; Humans; Male; Middle Aged; Nicotiana; Nicotine; Patient Education as Topic; Primary Health Care; Reimbursement Mechanisms; Smoking Cessation; Smoking Prevention; Teaching Materials; Time Factors; United Kingdom | 2006 |
A comparison of pharmacological tobacco cessation relapse rates.
Topics: Administration, Cutaneous; Adult; Ambulatory Care; Bupropion; Chewing Gum; Combined Modality Therapy; Dopamine Uptake Inhibitors; Female; Humans; Longitudinal Studies; Louisiana; Male; Middle Aged; Military Personnel; Naval Medicine; Nicotine; Nicotinic Agonists; Patient Education as Topic; Recurrence; Retrospective Studies; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2006 |
A dental hygienist's role in tobacco cessation.
Topics: Attitude to Health; Counseling; Dental Hygienists; Follow-Up Studies; Ganglionic Stimulants; Health Education, Dental; Humans; Motivation; Mouth Diseases; Mouth Neoplasms; Nicotine; Patient Education as Topic; Professional-Patient Relations; Smoking; Smoking Cessation; Tobacco, Smokeless | 2003 |
[The comparison of nicotine replacement therapy and behavioral education in smoking cessation: a study of naturalistic follow-up].
Topics: Adult; Behavior Therapy; Female; Follow-Up Studies; Humans; Male; Nicotine; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Treatment Outcome | 2005 |
Effects of nicotine replacement therapies on sleep.
Topics: Administration, Cutaneous; Administration, Topical; Humans; Nicotine; Sleep, REM; Smoking Cessation; Smoking Prevention | 2006 |
Nicotine and cognitive efficiency in alcoholics and illicit stimulant abusers: implications of smoking cessation for substance users in treatment.
Topics: Administration, Cutaneous; Adult; Alcoholism; Cognition; Cognition Disorders; Depression; Female; Humans; Illicit Drugs; Male; Mass Screening; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Severity of Illness Index; Smoking; Smoking Cessation; Substance-Related Disorders; Visual Perception | 2006 |
[Stopping smoking and constipation].
Topics: Cholinesterase Inhibitors; Constipation; Female; Follow-Up Studies; Humans; Magnesium; Middle Aged; Neostigmine; Nicotine; Parasympathomimetics; Peristalsis; Pyridostigmine Bromide; Smoking Cessation; Time Factors; Treatment Outcome | 2006 |
Acute effects of cigarette smoking on global cerebral blood flow in overnight abstinent tobacco smokers.
Topics: Adult; Arteries; Brain; Carbon Dioxide; Cerebrovascular Circulation; Circadian Rhythm; Dose-Response Relationship, Drug; Humans; Male; Nicotine; Positron-Emission Tomography; Smoking; Smoking Cessation | 2006 |
Adherence to nicotine replacement patch therapy in cardiovascular patients.
Topics: Administration, Cutaneous; Cardiovascular Diseases; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Netherlands; Nicotine; Patient Compliance; Smoking; Smoking Cessation; Smoking Prevention | 2006 |
Nicotine vaccines move toward pivotal trials.
Topics: Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Nicotine; Randomized Controlled Trials as Topic; Receptors, Nicotinic; Smoking Cessation; Vaccines | 2006 |
Smoking cessation advice for patients with chronic periodontitis.
Topics: Adult; Breath Tests; Bupropion; Carbon Monoxide; Central Nervous System Stimulants; Chronic Disease; Cohort Studies; Cotinine; Counseling; Dental Hygienists; Dopamine Uptake Inhibitors; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Nicotine; Patient Education as Topic; Periodontitis; Professional-Patient Relations; Saliva; Smoking; Smoking Cessation; Treatment Outcome | 2006 |
The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden.
Topics: Adult; Aged; Bupropion; Chewing Gum; Cost-Benefit Analysis; Dopamine Uptake Inhibitors; Female; Heart Failure; Humans; Lung Neoplasms; Male; Middle Aged; Nicotine; Quality-Adjusted Life Years; Smoking Cessation; Stroke; Sweden | 2006 |
Adolescents' perceptions about quitting and nicotine replacement therapy: findings from the California Tobacco Survey.
Topics: Adolescent; Adolescent Behavior; California; Child; Female; Ganglionic Stimulants; Health Surveys; Humans; Male; Multivariate Analysis; Nicotine; Smoking; Smoking Cessation | 2006 |
Histological changes in intervertebral discs after smoking and cessation: experimental study using a rat passive smoking model.
Topics: Animals; Animals, Newborn; Biopsy, Needle; Disease Models, Animal; Immunohistochemistry; Intervertebral Disc Displacement; Male; Nicotine; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Risk Assessment; Sensitivity and Specificity; Smoking; Smoking Cessation | 2006 |
Harm reduction: lessons learned from tobacco control.
Topics: Alcoholic Beverages; Alcoholic Intoxication; Harm Reduction; Humans; Nicotine; Public Policy; Smoking; Smoking Cessation | 2006 |
Effect of bupropion on physiological measures of stress in smokers during nicotine withdrawal.
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Pressure; Bupropion; Counseling; Epinephrine; Female; Heart Rate; Humans; Hydrocortisone; Male; Middle Aged; Nicotine; Norepinephrine; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Time Factors | 2006 |
Development and in vitro/in vivo evaluations of bioadhesive buccal tablets for nicotine replacement therapy.
Topics: Acrylic Resins; Adhesiveness; Adhesives; Adult; Chemistry, Pharmaceutical; Chitosan; Cotinine; Dosage Forms; Female; Humans; Kinetics; Magnesium Hydroxide; Male; Mouth Mucosa; Nicotine; Nicotinic Agonists; Smoking Cessation; Solubility | 2006 |
[Nicotine and the origin of cancer in the upper aerodigestive tract].
Topics: Administration, Cutaneous; Carcinogens; Cell Transformation, Neoplastic; Chewing Gum; Humans; Nicotine; Otorhinolaryngologic Neoplasms; Smoking; Smoking Cessation; Tobacco Smoke Pollution; Tobacco Use Disorder | 2006 |
Tobacco dependence treatment: time to change the paradigm.
Topics: Algorithms; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder | 2006 |
[Success of smoking cessation in patients with chronic obstructive pulmonary disease].
Topics: Bupropion; Case-Control Studies; Female; Humans; Male; Middle Aged; Nicotine; Outcome Assessment, Health Care; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Turkey | 2006 |
Smoking habits, nicotine use, and congenital malformations.
Topics: Congenital Abnormalities; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Risk Assessment; Risk Factors; Smoking; Smoking Cessation | 2006 |
Smoking habits, nicotine use, and congenital malformations.
Topics: Congenital Abnormalities; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Reproducibility of Results; Risk Assessment; Risk Factors; Smoking Cessation | 2006 |
Smoking habits, nicotine use, and congenital malformations.
Topics: Congenital Abnormalities; Female; Humans; Mass Media; Nicotine; Nicotinic Agonists; Pregnancy; Risk Assessment; Smoking; Smoking Cessation | 2006 |
Smoking habits, nicotine use, and congenital malformations.
Topics: Congenital Abnormalities; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Risk Assessment; Smoking; Smoking Cessation | 2006 |
[Predictors of abstinence from smoking among participants in a smoking cessation program in a health center in Japan].
Topics: Adult; Aged; Aged, 80 and over; Community Health Planning; Counseling; Female; Forecasting; Humans; Male; Middle Aged; Nicotine; Polymethacrylic Acids; Polyvinyls; Program Evaluation; Prospective Studies; Smoking Cessation; Tobacco Use Cessation Devices | 2006 |
Self-reported smoking cessation interventions were not associated with quitting in older women.
Topics: Age Distribution; Aged; Aged, 80 and over; Attitude to Health; Family; Family Practice; Female; Humans; Middle Aged; Nicotine; Prevalence; Prospective Studies; Referral and Consultation; Smoking; Smoking Cessation; Social Class; United Kingdom | 2006 |
Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison.
Topics: Adult; Age Factors; Americas; Bupropion; Cost-Benefit Analysis; Drug Costs; Europe; Female; Health Care Costs; Humans; Male; Markov Chains; Middle Aged; Nicotine; Primary Health Care; Recurrence; Sex Factors; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2006 |
Maximum yields might improve public health--if filter vents were banned: a lesson from the history of vented filters.
Topics: Carbon Monoxide; Consumer Product Safety; Filtration; History, 20th Century; Humans; Nicotiana; Nicotine; Public Health; Smoking Cessation; Smoking Prevention; Tars; Tobacco Industry; United States | 2006 |
[Smoking cessation after 12 months follow-up at a smoking cessation unit].
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Female; Follow-Up Studies; Humans; Male; Nicotine; Nicotinic Agonists; Psychotherapy, Group; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2006 |
Response to Perkins and Scott. Nicotine patch and lozenge are effective for women.
Topics: Administration, Cutaneous; Central Nervous System Stimulants; Female; Humans; Male; Meta-Analysis as Topic; Nicotine; Polymethacrylic Acids; Polyvinyls; Research Design; Smoking Cessation; Tobacco Use Cessation Devices; Women's Health | 2006 |
[Smoking in postoperative period].
Topics: Administration, Cutaneous; Cardiovascular Diseases; Health Promotion; Humans; Nicotine; Patient Education as Topic; Postoperative Period; Preoperative Care; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention | 2006 |
Do pharmacy staff recommend evidenced-based smoking cessation products? A pseudo patron study.
Topics: Australia; Data Collection; Evidence-Based Medicine; Humans; Nicotine; Nicotinic Agonists; Pharmacists; Smoking Cessation | 2006 |
Adolescent smokers screened for a nicotine replacement treatment trial: correlates of eligibility and enrollment.
Topics: Adolescent; Adolescent Behavior; Eligibility Determination; Female; Humans; Male; Nicotine; Patient Selection; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder | 2006 |
How to help smokers quit: Part 2.
Topics: Administration, Inhalation; Administration, Topical; Bupropion; Chewing Gum; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Polymethacrylic Acids; Polyvinyls; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2006 |
Nicotine replacement therapy: patterns of use after a quit attempt among methadone-maintained smokers.
Topics: Administration, Topical; Adult; Female; Follow-Up Studies; Humans; Male; Methadone; Middle Aged; Nicotine; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Treatment Outcome | 2006 |
Cessation among smokers of "light" cigarettes: results from the 2000 national health interview survey.
Topics: Adult; Aged; Female; Health Knowledge, Attitudes, Practice; Health Surveys; Humans; Male; Middle Aged; Nicotiana; Nicotine; Risk Factors; Risk Reduction Behavior; Smoking Cessation; Socioeconomic Factors; Surveys and Questionnaires; Tars; Tobacco Industry; Tobacco Use Cessation; United States | 2006 |
Nicotine gum withdrawal and migraine headaches.
Topics: Central Nervous System Stimulants; Chewing Gum; Female; Humans; Middle Aged; Migraine Disorders; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 2006 |
An exploration of Latino smokers and the use of pharmaceutical aids.
Topics: Bupropion; Dopamine Uptake Inhibitors; Female; Focus Groups; Hispanic or Latino; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Smoking; Smoking Cessation | 2006 |
Free nicotine patch giveaway program 12-month follow-up of participants.
Topics: Cost-Benefit Analysis; Follow-Up Studies; Health Promotion; Hotlines; Humans; New York City; Nicotine; Prevalence; Program Evaluation; Smoking; Smoking Cessation | 2006 |
Obstetricians and gynecologists' perceptions and use of nicotine replacement therapy.
Topics: Adult; Attitude of Health Personnel; Counseling; Drug Utilization; Female; Gynecology; Humans; Male; Middle Aged; Nicotine; Obstetrics; Ohio; Physician-Patient Relations; Practice Patterns, Physicians'; Pregnancy; Pregnant Women; Professional Practice; Safety; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder | 2006 |
Hemodynamic effects of a combination of bupropion and nicotine in anesthetized dogs.
Topics: Anesthesia; Animals; Antidepressive Agents, Second-Generation; Blood Pressure; Bupropion; Dogs; Drug Therapy, Combination; Female; Hemodynamics; Hypertension, Pulmonary; Male; Nicotine; Smoking Cessation | 2006 |
Do patients with ADHD have a harder time quitting cigarettes?
Topics: Attention; Attention Deficit Disorder with Hyperactivity; Humans; Nicotine; Smoking; Smoking Cessation | 2006 |
Physicians' counseling of patients when prescribing nicotine replacement therapy.
Topics: Attitude of Health Personnel; Counseling; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Nonprescription Drugs; Patient Education as Topic; Physician-Patient Relations; Physician's Role; Polymethacrylic Acids; Polyvinyls; Practice Patterns, Physicians'; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2007 |
Reliability of the Fagerström Test for Nicotine Dependence, Minnesota Nicotine Withdrawal Scale, and Tiffany Questionnaire for Smoking Urges in smokers with and without schizophrenia.
Topics: Adult; Comorbidity; Female; Humans; Male; Nicotine; Psychometrics; Reproducibility of Results; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Tobacco Use Disorder | 2007 |
Increased reach and effectiveness of a statewide tobacco quitline after the addition of access to free nicotine replacement therapy.
Topics: Administration, Cutaneous; Adult; Chewing Gum; Cohort Studies; Combined Modality Therapy; Confidence Intervals; Counseling; Female; Hotlines; Humans; Male; Middle Aged; Minnesota; Nicotiana; Nicotine; Nicotinic Agonists; Outcome Assessment, Health Care; Program Evaluation; Smoking; Smoking Cessation | 2006 |
Smoking cessation practices of Dutch general practitioners, cardiologists, and lung physicians.
Topics: Attitude of Health Personnel; Behavior Therapy; Bupropion; Cardiology; Family Practice; Female; Health Promotion; Health Surveys; Humans; Male; Middle Aged; Netherlands; Nicotine; Nicotinic Agonists; Physician's Role; Prevalence; Pulmonary Medicine; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention | 2007 |
Nurse-conducted smoking cessation in patients with COPD, using nicotine sublingual tablets and behavioral support.
Topics: Administration, Sublingual; Behavior Control; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2006 |
Barriers to tobacco cessation.
Topics: Ganglionic Stimulants; Health Surveys; Humans; Nicotine; Public Opinion; Smoking Cessation; Tobacco Use Disorder | 2006 |
Designing smoking cessation services for school-age smokers: A survey and qualitative study.
Topics: Adolescent; Counseling; England; Focus Groups; Ganglionic Stimulants; Health Surveys; Humans; Interviews as Topic; Nicotine; School Health Services; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder | 2006 |
Challenges and solutions for recruiting pregnant smokers into a nicotine replacement therapy trial.
Topics: Adolescent; Adult; Behavior Therapy; Female; Ganglionic Stimulants; Health Promotion; Humans; Interviews as Topic; Nicotine; Patient Acceptance of Health Care; Patient Selection; Postal Service; Pregnancy; Pregnant Women; Prenatal Care; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder | 2006 |
Readers' responses and the author's reply to "smoke out doctors who neglect their smoking patients"--part 2.
Topics: Chewing Gum; Humans; Nicotine; Polymethacrylic Acids; Polyvinyls; Refusal to Treat; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2006 |
[Factors associated with success of smoking cessation during 6 months].
Topics: Adult; Aged; Aged, 80 and over; Demography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Nicotine; Smoking Cessation | 2006 |
Acceptability and impact of a partial smoking ban in a psychiatric hospital.
Topics: Adult; Cooperative Behavior; Depressive Disorder; Female; Health Policy; Hospitals, Psychiatric; Humans; Male; Middle Aged; Nicotine; Patient Acceptance of Health Care; Personality Disorders; Personnel, Hospital; Pilot Projects; Psychotic Disorders; Smoking Cessation; Social Environment; Switzerland; Tobacco Smoke Pollution | 2007 |
Population effectiveness of pharmaceutical aids for smoking cessation: what is associated with increased success?
Topics: Bupropion; California; Cross-Sectional Studies; Environment; Humans; Nicotine; Pharmaceutic Aids; Program Evaluation; Proportional Hazards Models; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires | 2006 |
Determinants of the rate of nicotine metabolism and effects on smoking behavior.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Cohort Studies; Controlled Clinical Trials as Topic; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Female; Ganglionic Stimulants; Genotype; Humans; Linkage Disequilibrium; Male; Middle Aged; Mixed Function Oxygenases; Nicotine; Nicotinic Agonists; Oxidoreductases, N-Demethylating; Regression Analysis; Smoking; Smoking Cessation; United Kingdom | 2006 |
A shot at quitting.
Topics: Binding Sites, Antibody; Blood-Brain Barrier; Bupropion; Clinical Trials as Topic; Combined Modality Therapy; Counseling; Drug Administration Schedule; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder; Vaccines | 2006 |
[Smoking cessation counseling center in a French hospital: Effectiveness at one year and predictors of outcome].
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Cognitive Behavioral Therapy; Female; France; Humans; Male; Middle Aged; Multivariate Analysis; Nicotine; Outcome Assessment, Health Care; Outpatient Clinics, Hospital; Prospective Studies; Recurrence; Selective Serotonin Reuptake Inhibitors; Sex Factors; Smoking Cessation | 2006 |
[Risk reduction strategies in smoking].
Topics: Adolescent; Adult; Brain; Delayed-Action Preparations; Female; Health Behavior; Humans; Male; Middle Aged; Nicotiana; Nicotine; Nicotinic Agonists; Recurrence; Risk Adjustment; Risk-Taking; Smoke; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Tobacco, Smokeless | 2006 |
Smoking cessation and schizophrenia.
Topics: Administration, Cutaneous; Animals; Hippocampus; Humans; Interneurons; Nicotine; Rats; Receptors, Nicotinic; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking; Smoking Cessation; Smoking Prevention | 2006 |
Effects of acute smoking on brain activity vary with abstinence in smokers performing the N-Back task: a preliminary study.
Topics: Adult; Arousal; Attention; Brain; Dominance, Cerebral; Female; Humans; Magnetic Resonance Imaging; Male; Memory, Short-Term; Nicotine; Pattern Recognition, Visual; Prefrontal Cortex; Psychomotor Performance; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
[Nicotine dependence, smoking-related attitude, and subjective norms across the stages of change for smoking cessation among adults smokers in a rural area].
Topics: Adult; Aged; Aged, 80 and over; Attitude to Health; Female; Humans; Interviews as Topic; Male; Middle Aged; Motivation; Nicotine; Rural Population; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder | 2006 |
Self-reported nicotine exposure and plasma levels of cotinine in early and late pregnancy.
Topics: Cotinine; Female; Humans; Maternal Exposure; Nicotine; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Third; Prospective Studies; Self Disclosure; Smoking; Smoking Cessation; Tobacco Smoke Pollution | 2006 |
General practitioners' beliefs about effectiveness and intentions to prescribe smoking cessation medications: qualitative and quantitative studies.
Topics: Adult; Attitude of Health Personnel; Attitude to Health; Bupropion; Family Practice; Female; Health Care Surveys; Humans; Intention; Internet; London; Male; Middle Aged; Nicotine; Physicians, Family; Qualitative Research; Safety; Smoking Cessation; Surveys and Questionnaires; Treatment Outcome | 2006 |
A random-effects Markov transition model for Poisson-distributed repeated measures with non-ignorable missing values.
Topics: Algorithms; Behavior Therapy; Computer Simulation; Data Interpretation, Statistical; Humans; Longitudinal Studies; Markov Chains; Nicotine; Poisson Distribution; Randomized Controlled Trials as Topic; Smoking Cessation | 2007 |
Clinical laboratory evaluation of potential reduced exposure products for smokers.
Topics: Adult; Biomarkers; Carbon Monoxide; Carcinogens; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Nitrosamines; Respiratory Function Tests; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2006 |
Changes in markers of epithelial permeability and inflammation in chronic smokers switching to a nonburning tobacco device (Eclipse).
Topics: Adult; Cell Membrane Permeability; Epithelial Cells; Female; Humans; Leukocytes; Lipid Peroxidation; Lung; Lymphocyte Activation; Male; Middle Aged; Nicotine; Oxidative Stress; Reactive Oxygen Species; Smoking; Smoking Cessation | 2006 |
Are lung cancers triggered by stopping smoking?
Topics: Adrenocorticotropic Hormone; Aged; Cell Division; Corticotropin-Releasing Hormone; Female; Humans; Lung Neoplasms; Male; Middle Aged; Models, Biological; Nicotine; Retrospective Studies; Smoking Cessation; Time Factors; Tobacco Use Disorder | 2007 |
Effects of alternative reinforcer and craving on the choice to smoke cigarettes in the laboratory.
Topics: Adult; Choice Behavior; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Reinforcement, Psychology; Smoking; Smoking Cessation; Social Environment; Substance Withdrawal Syndrome; Tobacco Use Disorder; Token Economy | 2007 |
Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
Topics: Animals; Behavior, Animal; Benzazepines; Brain; Cell Line, Transformed; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; In Vitro Techniques; Male; Membrane Potentials; Nicotine; Nicotinic Agonists; Patch-Clamp Techniques; Protein Binding; Quinoxalines; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Self Administration; Smoking Cessation; Transfection; Varenicline | 2007 |
Toxicant exposure in cigarette reducers versus light smokers.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Chewing Gum; Environmental Exposure; Female; Humans; Male; Middle Aged; Nicotine; Nitrosamines; Pyridines; Smoking; Smoking Cessation | 2006 |
Varenicline: new drug. Smoking cessation: no better than nicotine.
Topics: Benzazepines; France; Humans; Nicotine; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; United States | 2006 |
Views on smoking cessation methods in ethnic minority communities: a qualitative investigation.
Topics: Asian; Black or African American; Community Health Services; Evidence-Based Medicine; Female; Focus Groups; Health Knowledge, Attitudes, Practice; Humans; Indians, North American; Laos; Male; Minnesota; Minority Groups; Nicotine; Qualitative Research; Smoking; Smoking Cessation; Vietnam | 2007 |
Can pharmacogenetics help smokers quit?
Topics: Antidepressive Agents, Second-Generation; Bupropion; Humans; Inactivation, Metabolic; Nicotine; Pharmacogenetics; Smoking; Smoking Cessation | 2006 |
Increased nicotine self-administration following prenatal exposure in female rats.
Topics: Animals; Female; Fetus; Nicotine; Phenelzine; Pregnancy; Rats; Rats, Sprague-Dawley; Self Administration; Smoking Cessation | 2006 |
Protocol for the smoking, nicotine and pregnancy (SNAP) trial: double-blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancy.
Topics: Adolescent; Adult; Cost-Benefit Analysis; Counseling; Double-Blind Method; Female; Follow-Up Studies; Humans; Nicotine; Pregnancy; Pregnancy Outcome; Prenatal Care; Randomized Controlled Trials as Topic; Safety; Self Disclosure; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Treatment Outcome; United Kingdom | 2007 |
Dependence potential of nicotine replacement treatments: effects of product type, patient characteristics, and cost to user.
Topics: Administration, Cutaneous; Administration, Intranasal; Administration, Sublingual; Adult; Cost-Benefit Analysis; Female; Humans; London; Male; Middle Aged; Nicotine; Program Evaluation; Smoking Cessation; Smoking Prevention; Social Support; Socioeconomic Factors; Substance Abuse Treatment Centers; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2007 |
[Weight gain and anxiety levels in recent ex-smokers].
Topics: Adult; Anxiety; Basal Metabolism; Breath Tests; Bupropion; Carbon Monoxide; Chewing Gum; Feeding Behavior; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Prospective Studies; Psychological Tests; Smoking Cessation; Weight Gain | 2007 |
Nicotine dependence and withdrawal symptoms among occasional smokers.
Topics: Adolescent; Adolescent Behavior; Analysis of Variance; Chi-Square Distribution; Cross-Sectional Studies; Depression; Female; Humans; Male; Nicotine; Psychology, Adolescent; Risk-Taking; Smoking Cessation; South Africa; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
Effects of high dose transdermal nicotine replacement in cigarette smokers.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Algorithms; Blood Pressure; Body Weight; Carbon Monoxide; Cotinine; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Leukocyte Count; Male; Middle Aged; Nicotine; Nicotinic Agonists; Nitrosamines; Pyridines; Smoking; Smoking Cessation | 2007 |
Successful tobacco dependence treatment in schizophrenia.
Topics: Administration, Cutaneous; Administration, Intranasal; Adult; Chewing Gum; Comorbidity; Humans; Male; Nebulizers and Vaporizers; Nicotine; Prognosis; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2007 |
[Environmental tobacco smoke exposure in pregnancy and postpartum period].
Topics: Adult; Cotinine; Environmental Monitoring; Female; Humans; Maternal Exposure; Nicotine; Poland; Postpartum Period; Pregnancy; Pregnancy Trimester, Third; Saliva; Self Disclosure; Smoking Cessation; Tobacco Smoke Pollution | 2006 |
Nicotine dependence among African American light smokers: a comparison of three scales.
Topics: Adult; Black or African American; Chewing Gum; Counseling; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Nicotine; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
[Seventy-five cases in which serum concentrations of cotinine were monitored prior to nicotine replacement therapy for smoking cessation].
Topics: Adult; Aged; Carbon Monoxide; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Abuse Detection; Tobacco Use Disorder | 2007 |
Lung cancer after quitting smoking: Is there a cause-effect relationship, or may some smokers decide to quit because they begin to feel ill from smoking-related pathologies?
Topics: Humans; Lung Neoplasms; Models, Biological; Nicotine; Smoking Cessation; Time Factors; Tobacco Use Disorder | 2007 |
[Design and early results of a proactive telephone-based smoking cessation treatment compared with face-to-face group sessions].
Topics: Adult; Age Factors; Behavior Therapy; Cognitive Behavioral Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Prospective Studies; Sex Factors; Smoking Cessation; Telephone; Time Factors; Treatment Outcome | 2007 |
[Nicotine substitutes during pregnancy].
Topics: Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Smoking; Smoking Cessation; Tobacco Use Disorder | 2007 |
Abstracts of the 12th Annual Meeting of the Society for Research on Nicotine and Tobacco. Orlando, Florida, USA. February 15-18, 2006.
Topics: Animals; Humans; Nicotiana; Nicotine; Smoking; Smoking Cessation; Tobacco Smoke Pollution | 2007 |
Nicotine, cotinine, withdrawal, and craving patterns during smoking and nicotine nasal spray use: results from a pilot study with African American men.
Topics: Administration, Intranasal; Adult; Algorithms; Black or African American; Cotinine; Disruptive, Impulse Control, and Conduct Disorders; Drug Administration Schedule; Ganglionic Stimulants; Humans; Male; Nicotine; Pilot Projects; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
What's new in Nicotine & Tobacco Research?
Topics: Age Factors; Antidepressive Agents; Counseling; Female; Ganglionic Stimulants; Humans; Internet; Male; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; United States | 2007 |
Long-term changes in sleep and depressive symptoms of smokers in abstinence.
Topics: Adult; Cotinine; Depression; Female; Follow-Up Studies; Humans; Logistic Models; Longitudinal Studies; Male; Mexico; Middle Aged; Nicotine; Polysomnography; Sleep Initiation and Maintenance Disorders; Sleep, REM; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
[Tobacco cessation. Action-stage result as a predictor of successful long-term maintenance].
Topics: Administration, Cutaneous; Adult; Behavior Therapy; Breath Tests; Carbon Monoxide; Cohort Studies; Combined Modality Therapy; Counseling; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Program Evaluation; Prospective Studies; Severity of Illness Index; Smoking Cessation; Treatment Outcome | 2007 |
Smoking characteristics and cessation in patients with thromboangiitis obliterans.
Topics: Adult; Amputation, Surgical; Bupropion; Chewing Gum; Combined Modality Therapy; Disease Progression; Dopamine Uptake Inhibitors; Female; Follow-Up Studies; Humans; Male; Nicotine; Nicotinic Agonists; Prevalence; Retrospective Studies; Smoking; Smoking Cessation; Spain; Thromboangiitis Obliterans; Time Factors; Treatment Outcome | 2006 |
Increases in impulsivity following smoking abstinence are related to baseline nicotine intake and boredom susceptibility.
Topics: Adult; Biomarkers; Boredom; Cotinine; Female; Humans; Impulsive Behavior; Intelligence Tests; Male; Nicotine; Psychological Tests; Saccades; Smoking; Smoking Cessation | 2007 |
[The path from cigarettes--with support it works better].
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2007 |
Nicotine dependence and reward differ between adolescent and adult male mice.
Topics: Age Factors; Animals; Brain; Dose-Response Relationship, Drug; Drug Tolerance; Male; Mice; Mice, Inbred ICR; Nicotine; Reward; Rubidium; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
Sex-based and hormonal contraception effects on the metabolism of nicotine among adolescent tobacco-dependent smokers.
Topics: Adolescent; Area Under Curve; Chromatography, Thin Layer; Cohort Studies; Contraceptives, Oral, Hormonal; Cotinine; Female; Humans; Male; Nicotine; Sex Factors; Smoking; Smoking Cessation | 2007 |
Tobacco cessation drug therapy among Canada's Aboriginal people.
Topics: Adult; Attitude to Health; Canada; Female; Health Services Research; Humans; Indians, North American; Male; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Professional-Patient Relations; Smoking Cessation; Socioeconomic Factors; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit.
Topics: Adult; Attitude to Health; Factor Analysis, Statistical; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Nicotine; Patient Compliance; Psychometrics; Reproducibility of Results; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
Patient education series. Smoking cessation.
Topics: Adaptation, Psychological; Counseling; Hotlines; Humans; Nicotine; Nicotinic Agonists; Self Care; Smoking; Smoking Cessation; Smoking Prevention | 2007 |
Development and evaluation of a buccal bioadhesive system for smoking cessation therapy.
Topics: Adhesives; Chemical Phenomena; Chemistry, Physical; Drug Stability; Indicators and Reagents; Kinetics; Membranes, Artificial; Mouth Mucosa; Nicotine; Nicotinic Agonists; Permeability; Smoking Cessation; Tensile Strength; Water | 2007 |
A new national smokefree law increased calls to a national quitline.
Topics: Adolescent; Adult; Aged; Health Care Surveys; Hotlines; Humans; Mass Media; Middle Aged; New Zealand; Nicotine; Program Evaluation; Public Health; Public Opinion; Restaurants; Smoking; Smoking Cessation; Smoking Prevention; Social Control Policies; Social Marketing; Tobacco Smoke Pollution | 2007 |
Can reducing nicotine help wean smokers?
Topics: Humans; Nicotiana; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder | 2007 |
Tobacco cessation and brief advice.
Topics: Attitude of Health Personnel; Counseling; Health Knowledge, Attitudes, Practice; Humans; Motivation; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Patient Education as Topic; Practice Guidelines as Topic; Smoking Cessation; Tuberculosis; Tuberculosis Societies | 2007 |
Reactivity to nicotine cues over repeated cue reactivity sessions.
Topics: Administration, Cutaneous; Adolescent; Adult; Behavior, Addictive; Conditioning, Psychological; Cues; Galvanic Skin Response; Ganglionic Stimulants; Heart Rate; Humans; Male; Nicotine; Predictive Value of Tests; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2007 |
[Nicotine substitutes during pregnancy].
Topics: Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Smoking Cessation | 2007 |
CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapy.
Topics: Administration, Cutaneous; Administration, Inhalation; Aryl Hydrocarbon Hydroxylases; Cotinine; Cytochrome P-450 CYP2B6; Genotype; Humans; Linkage Disequilibrium; Nicotine; Nicotinic Agonists; Oxidoreductases, N-Demethylating; Smoking Cessation | 2007 |
Take 30 seconds to save a life.
Topics: Dental Hygienists; Hotlines; Humans; Motivation; Nicotine; Nicotinic Agonists; Patient Education as Topic; Professional-Patient Relations; Referral and Consultation; Smoking; Smoking Cessation; Smoking Prevention | 2007 |
Nurses' knowledge about the risk of light cigarettes and other tobacco "harm reduction" strategies.
Topics: Adult; Counseling; Female; Health Education; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Middle Aged; Nicotine; Nurse-Patient Relations; Nurse's Role; Rhode Island; Risk Factors; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
Confirmatory factor analysis of the Minnesota Nicotine Withdrawal Scale.
Topics: Adult; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Minnesota; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Syndrome; Tobacco Use Disorder | 2007 |
Pharmacists on the front line in providing support for nicotine replacement therapy and bupropion purchasers.
Topics: Adult; Attitude of Health Personnel; Bupropion; Dopamine Uptake Inhibitors; Female; Health Education; Humans; Male; Middle Aged; New South Wales; Nicotine; Nicotinic Agonists; Pharmacies; Pharmacists; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Surveys and Questionnaires | 2007 |
The Cochrane review on nicotine replacement therapy: incorrect or uncertain classifications of additional support levels.
Topics: Administration, Cutaneous; Humans; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Prevention | 2007 |
Getting it right: designing adolescent-centred smoking cessation services.
Topics: Adolescent; Adolescent Health Services; Delivery of Health Care; Female; Health Planning; Humans; Male; Nicotine; Nicotinic Agonists; Patient Satisfaction; Research Design; Smoking Cessation; Smoking Prevention; Social Support | 2007 |
Pediatricians' use of the 5 A's and nicotine replacement therapy with adolescent smokers.
Topics: Adolescent; Female; Humans; Male; Nicotine; Nicotinic Agonists; Ohio; Pediatrics; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
Is nicotine replacement therapy for smoking cessation effective in the "real world"? Findings from a prospective multinational cohort study.
Topics: Administration, Cutaneous; Adult; Aged; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2007 |
Selectively reduced responses to smoking cues in amygdala following extinction-based smoking cessation: results of a preliminary functional magnetic resonance imaging study.
Topics: Administration, Cutaneous; Adult; Amygdala; Attention; Cues; Extinction, Psychological; Female; Humans; Magnetic Resonance Imaging; Male; Motivation; Nicotine; Oxygen; Recurrence; Smoking; Smoking Cessation; Thalamus; Treatment Outcome | 2007 |
[Factors associated with successful smoking cessation among adolescent smokers undergoing a smoking cessation program involving nicotine replacement therapy].
Topics: Adolescent; Female; Humans; Male; Nicotine; Patient Dropouts; Smoking Cessation | 2007 |
General practitioners' beliefs about effectiveness and intentions to recommend smoking cessation services: qualitative and quantitative studies.
Topics: Adult; Aged; Attitude of Health Personnel; Bupropion; Family Practice; Female; Health Care Surveys; Health Promotion; Health Services Accessibility; Humans; Intention; London; Male; Middle Aged; Nicotine; Physicians, Family; Practice Patterns, Physicians'; Qualitative Research; Smoking Cessation; Surveys and Questionnaires | 2007 |
Managing smoking cessation: Article skips over weaknesses of nicotine replacement.
Topics: Behavior Therapy; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Treatment Outcome | 2007 |
Analysis of [3',3'-d(2)]-nicotine and [3',3'-d(2)]-cotinine by capillary liquid chromatography-electrospray tandem mass spectrometry.
Topics: Administration, Oral; Biomarkers; Calibration; Capillary Electrochromatography; Chromatography, High Pressure Liquid; Cotinine; Deuterium; Humans; Injections, Intravenous; Molecular Structure; Nicotine; Radioactive Tracers; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Smoking; Smoking Cessation; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection; Tandem Mass Spectrometry | 2007 |
Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
Topics: Australia; Bupropion; Cost-Benefit Analysis; Decision Support Techniques; Drug Costs; Humans; Life Expectancy; Nicotine; Reimbursement Mechanisms; Smoking; Smoking Cessation | 2007 |
Exacerbation of schizophrenia by varenicline.
Topics: Acute Disease; Benzazepines; Cognition Disorders; Comorbidity; Female; Humans; Middle Aged; Nicotine; Quinoxalines; Recurrence; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking; Smoking Cessation; Varenicline | 2007 |
Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal.
Topics: Animals; Antidepressive Agents; Bupropion; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mecamylamine; Nicotine; Nortriptyline; Rats; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
Facial EMG as an index of affective response to nicotine.
Topics: Administration, Inhalation; Adolescent; Adult; Affect; Electrocardiography; Facial Muscles; Female; Galvanic Skin Response; Heart Rate; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Sex Factors; Smoking; Smoking Cessation | 2007 |
The acute effects of nicotine on positive and negative affect in adolescent smokers.
Topics: Adolescent; Affect; Drug Administration Schedule; Female; Humans; Male; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Smoking; Smoking Cessation | 2007 |
Tobacco control policy initiatives and UK resident Bangladeshi male smokers: community-based, qualitative study.
Topics: Adolescent; Adult; Bangladesh; Community Participation; Cross-Sectional Studies; Emigrants and Immigrants; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Qualitative Research; Religion; Smoking; Smoking Cessation; Social Support; Tobacco Smoke Pollution; Tobacco, Smokeless; United Kingdom; Workplace | 2007 |
[Smoking cessation and air travel: what problems, what solutions?].
Topics: Aerospace Medicine; Aviation; Central Nervous System Stimulants; Government Regulation; Humans; Industry; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder; Travel | 2007 |
Physician beliefs regarding effectiveness of tobacco dependence treatments: results from the NJ Health Care Provider Tobacco Survey.
Topics: Adult; Attitude of Health Personnel; Behavior Therapy; Bupropion; Female; Humans; Male; Middle Aged; New Jersey; Nicotine; Nicotinic Agonists; Patient Compliance; Practice Patterns, Physicians'; Risk Assessment; Sensitivity and Specificity; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2007 |
CHRNA4 and tobacco dependence: from gene regulation to treatment outcome.
Topics: Administration, Cutaneous; Adolescent; Adult; Binding Sites; Brain; Female; Gene Expression Regulation; Genetic Variation; Genotype; Humans; Male; Middle Aged; Nicotine; Nucleus Accumbens; Phenotype; Polymorphism, Single Nucleotide; Receptors, Nicotinic; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2007 |
Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning.
Topics: Animals; Bupropion; Conditioning, Psychological; Dopamine; Dose-Response Relationship, Drug; Fear; Male; Mental Recall; Mice; Mice, Inbred C57BL; Nicotine; Norepinephrine; Smoking Cessation; Substance Withdrawal Syndrome | 2007 |
Development of an anti-cotinine vaccine to potentiate nicotine-based smoking cessation strategies.
Topics: Animals; Corpus Striatum; Cotinine; Dopamine; Humans; In Vitro Techniques; Male; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Smoking Cessation; Vaccines, Conjugate | 2007 |
Nicotine replacement lozenges: abuse-related hyperkeratosis of the lateral border of the tongue. A case report.
Topics: Humans; Keratosis; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Tablets; Tongue Diseases | 2007 |
Nicotine vaccines for smoking cessation.
Topics: Bupropion; Canada; Clinical Trials as Topic; Humans; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Smoking; Smoking Cessation; Vaccination; Vaccines | 2007 |
Does free nicotine replacement therapy for young adults prompt them to call a quitline?
Topics: Adolescent; Adult; Hotlines; Humans; Nicotine; Smoking Cessation; Washington | 2007 |
Tobacco-free electronic cigarettes and cigars deliver nicotine and generate concern.
Topics: Drug Delivery Systems; Equipment Design; Humans; Nicotine; Smoking Cessation | 2007 |
Association between depressive mood and cigarette smoking in a large Italian sample of smokers intending to quit: implications for treatment.
Topics: Adult; Affect; Cross-Sectional Studies; Depression; Female; Health Status Indicators; Humans; Italy; Male; Nicotine; Prevalence; Psychological Tests; Psychometrics; Risk Factors; Sickness Impact Profile; Smoking; Smoking Cessation | 2007 |
Nicotine replacement therapy for smoking cessation in the "real world".
Topics: Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention | 2007 |
Up in smoke.
Topics: Administration, Cutaneous; Cooperative Behavior; Counseling; Humans; Minnesota; Nicotine; Outcome and Process Assessment, Health Care; Patient Care Team; Physician-Patient Relations; Primary Health Care; Smoking Cessation | 2007 |
An intensive group therapy programme for smoking cessation using nicotine patch and internet mailing supports in a university setting.
Topics: Administration, Cutaneous; Adult; Aged; Female; Humans; Internet; Male; Middle Aged; Nicotine; Nicotinic Agonists; Prospective Studies; Psychotherapy, Group; Smoking Cessation; Smoking Prevention | 2007 |
Evaluation of smoking cessation behaviors and interventions among Latino smokers at low-income clinics in a US-Mexico border county.
Topics: Adult; Aged; Female; Hispanic or Latino; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Poverty Areas; Prospective Studies; Sex Factors; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Texas; Tobacco Use Disorder | 2008 |
Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette.
Topics: Adolescent; Adult; Behavior, Addictive; Carcinogens; Cardiovascular System; Female; Humans; Male; Middle Aged; Nicotiana; Nicotine; Smoking; Smoking Cessation | 2007 |
Psychometric properties of the Minnesota Nicotine Withdrawal Scale: a Korean version.
Topics: Adult; Asian; Child; Factor Analysis, Statistical; Humans; Korea; Middle Aged; Nicotine; Psychological Tests; Psychometrics; Reproducibility of Results; Smoking Cessation; Substance Withdrawal Syndrome; Translating; United States | 2007 |
Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Theoretical; Netherlands; Nicotine; Nortriptyline; Quality of Life; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2008 |
Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
Topics: Adult; Benzazepines; Cohort Studies; Drug Combinations; Female; Follow-Up Studies; Humans; London; Male; Mental Disorders; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Implementing a hospital-based smoking cessation programme: evidence for a learning effect.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Cognitive Behavioral Therapy; Female; Follow-Up Studies; Germany; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nicotine; Nicotinic Agonists; Outcome Assessment, Health Care; Patient Education as Topic; Program Development; Program Evaluation; Self-Help Groups; Smoking; Smoking Cessation; Smoking Prevention; Statistics, Nonparametric; Time Factors | 2008 |
Addressing smoking cessation in tuberculosis control.
Topics: Counseling; Health Policy; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Smoke Pollution; Tuberculosis, Pulmonary | 2007 |
Use of nicotine replacement therapy to reduce or delay smoking but not to quit: prevalence and association with subsequent cessation efforts.
Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Health Behavior; Humans; Male; Massachusetts; Middle Aged; Nicotine; Nicotinic Agonists; Prevalence; Prospective Studies; Smoking; Smoking Cessation; Smoking Prevention | 2007 |
Nicotine replacement therapy, professional therapy, snuff use and tobacco smoking: a study of smoking cessation strategies in southern Sweden.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Prevalence; Smoking; Smoking Cessation; Smoking Prevention; Sweden; Tobacco, Smokeless | 2007 |
Quitlines.
Topics: Counseling; Financing, Organized; Hotlines; Humans; Nicotine; Smoking Cessation | 2007 |
Increasing reach of quitline services in a US state with comprehensive tobacco treatment.
Topics: Combined Modality Therapy; Communication; Counseling; Delivery of Health Care; Hotlines; Humans; Maine; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Taxes; Tobacco Use Disorder | 2007 |
Expanding access to nicotine replacement therapy through Minnesota's QUITLINE partnership.
Topics: Combined Modality Therapy; Counseling; Health Services Accessibility; Hotlines; Humans; Interinstitutional Relations; Minnesota; Nicotine; Private Sector; Referral and Consultation; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2007 |
Offering free NRT through a tobacco quitline: impact on utilisation and quit rates.
Topics: Adolescent; Adult; Age Distribution; Combined Modality Therapy; Counseling; Female; Health Promotion; Hotlines; Humans; Male; Middle Aged; Nicotine; Ohio; Program Evaluation; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2007 |
Cost effectiveness of the Oregon quitline "free patch initiative".
Topics: Adult; Advertising; Combined Modality Therapy; Cost-Benefit Analysis; Female; Health Promotion; Hotlines; Humans; Male; Middle Aged; Nicotine; Oregon; Program Evaluation; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2007 |
[New drugs; varenicline].
Topics: Benzazepines; Humans; Nausea; Nicotine; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2007 |
NMDA receptor blockade: a novel avenue for tobacco intervention?
Topics: Acamprosate; Central Nervous System Stimulants; Humans; Memantine; Models, Biological; Models, Theoretical; Neurons; Nicotiana; Nicotine; Prefrontal Cortex; Receptors, N-Methyl-D-Aspartate; Smoking Cessation; Taurine | 2008 |
A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation.
Topics: Alleles; Bupropion; Combined Modality Therapy; Cost of Illness; Cost-Benefit Analysis; Counseling; Dopamine Uptake Inhibitors; Genetic Testing; Humans; Models, Economic; Nicotine; Polymorphism, Genetic; Receptors, Dopamine D2; Smoking; Smoking Cessation | 2008 |
Heterogeneity in preferences for smoking cessation.
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Female; Ganglionic Stimulants; Humans; Likelihood Functions; Male; Models, Biological; Nicotine; Patient Satisfaction; Smoking Cessation; Tobacco Use Disorder | 2008 |
Knowledge and attitude of physicians in a major teaching hospital towards atherosclerotic risk reduction therapy in patients with peripheral arterial disease.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Attitude of Health Personnel; Blood Glucose; Blood Pressure; Cholesterol, LDL; Clinical Competence; Coronary Artery Disease; Cross-Sectional Studies; Female; Hospitals, Teaching; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mass Screening; Medicine; Nicotine; Nicotinic Agonists; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Risk Factors; Saudi Arabia; Smoking Cessation; Specialization; Surveys and Questionnaires | 2007 |
Effect of deregulation on the prices of nicotine replacement therapy products in Finland.
Topics: Adolescent; Adult; Commerce; Female; Finland; Government Regulation; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation | 2008 |
The truth about smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Counseling; Humans; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2007 |
What's new in Nicotine & Tobacco Research?
Topics: Adolescent; Adolescent Behavior; Adult; Advertising; Cognition; Deception; Female; Health Education; Humans; Male; Nicotine; Smoking Cessation; Smoking Prevention; Socioeconomic Factors; Tobacco Use Disorder | 2008 |
Smoking cessation pharmacotherapy preferences in rural primary care.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Choice Behavior; Female; Health Knowledge, Attitudes, Practice; Humans; Kansas; Male; Middle Aged; Nicotine; Nicotinic Agonists; Physician-Patient Relations; Primary Health Care; Rural Health Services; Rural Population; Secondary Prevention; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder | 2008 |
Smoking cessation in clinical practice: predictors of six-month continuous abstinence in a sample of Greek smokers.
Topics: Adult; Bupropion; Case-Control Studies; Female; Follow-Up Studies; Greece; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Sleep Initiation and Maintenance Disorders; Smoking; Smoking Cessation; Treatment Outcome | 2008 |
Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
Topics: Administration, Cutaneous; Administration, Topical; Australia; Bupropion; Dopamine Uptake Inhibitors; Drug Therapy; Female; Health Expenditures; Humans; Incidence; Insurance, Health, Reimbursement; Male; Middle Aged; Nicotine; Nicotinic Agonists; Prevalence; Smoking; Smoking Cessation; Smoking Prevention | 2008 |
Should doctors advocate snus and other nicotine replacements? Yes.
Topics: Attitude of Health Personnel; Humans; Nicotine; Safety; Smoking Cessation; Smoking Prevention; Tobacco, Smokeless | 2008 |
Should doctors advocate snus and other nicotine replacements? No.
Topics: Attitude of Health Personnel; Cardiovascular Diseases; Harm Reduction; Humans; Mouth Neoplasms; Nicotine; Pancreatic Neoplasms; Risk Factors; Smoking Cessation; Smoking Prevention; Tobacco, Smokeless | 2008 |
Does the nicotine patch help in the postoperative period for arterial vessel repair?
Topics: Administration, Cutaneous; Anastomosis, Surgical; Animals; Femoral Artery; Male; Models, Animal; Nicotine; Nicotinic Agonists; Postoperative Period; Rats; Smoking; Smoking Cessation; Vascular Patency | 2008 |
Nicotine replacement therapy: perceptions of African-American smokers seeking to quit.
Topics: Adult; Attitude to Health; Black or African American; Female; Health Behavior; Humans; Interviews as Topic; Male; Middle Aged; Nicotine; Perception; Pilot Projects; Program Evaluation; Qualitative Research; Risk-Taking; Smoking; Smoking Cessation; Smoking Prevention; Tape Recording; Tobacco Use Disorder; United States | 2008 |
Discontinuation of nicotine replacement therapy among smoking-cessation attempters.
Topics: Adolescent; Adult; Colorado; Data Collection; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Smoking Cessation; Tobacco Use Disorder | 2008 |
Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: a retrospective analysis.
Topics: Adult; Combined Modality Therapy; Counseling; Female; Follicular Phase; Humans; Luteal Phase; Male; Nicotine; Retrospective Studies; Sex Factors; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Women's Health | 2008 |
Evaluating screening performances of the Fagerstrom tolerance questionnaire, the Fagerstrom test for nicotine dependence and the heavy smoking index among Taiwanese male smokers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; Biomarkers; Female; Health Surveys; Humans; Male; Mass Screening; Middle Aged; Nicotine; Psychological Tests; Psychometrics; ROC Curve; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Taiwan; Tobacco Use Disorder | 2008 |
Pilot study of compliance with healthcare facility smoking laws in Georgia.
Topics: Ganglionic Stimulants; Georgia (Republic); Guideline Adherence; Health Facilities; Health Personnel; Health Promotion; Humans; Nicotine; Pilot Projects; Prevalence; Public Policy; Smoking Cessation; Smoking Prevention; Tobacco Smoke Pollution | 2008 |
What's new in nicotine & tobacco research?
Topics: Advertising; Affect; Cardiovascular Diseases; Causality; Comorbidity; Depression; Humans; Nicotine; Research Design; Smoking; Smoking Cessation; Tobacco Industry; Tobacco Use Disorder | 2008 |
Nicotine delivery, cardiovascular profile, and subjective effects of an oral tobacco product for smokers.
Topics: Administration, Sublingual; Adult; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tablets; Tobacco, Smokeless | 2008 |
Menthol cigarettes and smoking cessation during an aided quit attempt.
Topics: Adult; Age Factors; Aged; Black or African American; Ethnicity; Female; Flavoring Agents; Humans; Male; Menthol; Middle Aged; Nicotine; Prevalence; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; White People | 2008 |
Comparing the validity of the Cigarette Dependence Scale and the Fagerström Test for Nicotine Dependence.
Topics: Adult; Cues; Female; Follow-Up Studies; Health Surveys; Humans; Internet; Male; Motivation; Nicotine; Psychometrics; Reproducibility of Results; Self Efficacy; Smoking; Smoking Cessation; Social Environment; Substance Withdrawal Syndrome; Surveys and Questionnaires; Switzerland; Tobacco Use Disorder | 2008 |
Increase in anger symptoms after smoking cessation predicts relapse.
Topics: Administration, Cutaneous; Anger; Cognitive Behavioral Therapy; Combined Modality Therapy; Humans; Nicotine; Prognosis; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2008 |
Breaking away from a narrow prescribing protocol for medicinal nicotine.
Topics: Administration, Cutaneous; Adult; Benzazepines; Humans; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Quinoxalines; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2008 |
Intention to analyze in pharmacogenomics studies.
Topics: Administration, Cutaneous; Adult; Catechol O-Methyltransferase; Double-Blind Method; Female; Genotype; Humans; Male; Nicotine; Nicotinic Agonists; Polymerase Chain Reaction; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Sex Factors; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2008 |
Vaccines to combat smoking.
Topics: Antibodies; Drug Design; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Vaccines | 2008 |
Letter to the editor in response to "An epidemic that deserves more attention: epidemiology, prevention, and treatment of smokeless tobacco".
Topics: Humans; India; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder; Tobacco, Smokeless; United States | 2008 |
Smoking cessation 2008.
Topics: Benzazepines; Cannabinoid Receptor Antagonists; Drug Prescriptions; Humans; Marketing of Health Services; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking; Smoking Cessation; Smoking Prevention; Vaccines; Varenicline | 2008 |
Varenicline: myocardial infarction: nicotine replacement is a better option.
Topics: Benzazepines; Europe; Humans; Myocardial Infarction; Nicotine; Quinoxalines; Smoking Cessation | 2008 |
Distress tolerance treatment for early-lapse smokers: rationale, program description, and preliminary findings.
Topics: Adult; Female; Humans; Male; Nicotine; Pilot Projects; Program Development; Reinforcement, Psychology; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors | 2008 |
Immune to the high.
Topics: Humans; Methamphetamine; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Vaccines | 2008 |
[Students of the Faculty of Medicine and of the Division of Public Health of Medical University of Bialystok towards nicotine addiction against the background of the National Health Program in Poland].
Topics: Adult; Attitude to Health; Female; Humans; Male; National Health Programs; Nicotine; Poland; Smoking Cessation; Smoking Prevention; Students, Medical; Students, Public Health; Substance-Related Disorders; Surveys and Questionnaires; Tobacco Smoke Pollution; Tobacco Use Disorder | 2007 |
Correlates of household smoking bans in low-income families of children with and without asthma.
Topics: Asthma; Caregivers; Case-Control Studies; Child; Colorado; Environment; Family Characteristics; Female; Humans; Income; Male; Nicotine; Poverty; Psychological Tests; Risk Factors; Smoking; Smoking Cessation; Socioeconomic Factors; Tobacco Smoke Pollution | 2008 |
The effectiveness of the provision of free nicotine replacement therapy on quit rates among health staff.
Topics: Adolescent; Adult; Female; Health Personnel; Humans; Male; New South Wales; Nicotine; Occupational Health; Organizational Policy; Program Evaluation; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; Tobacco Smoke Pollution; Workplace | 2008 |
[Smoking during pregnancy in Argentina and Uruguay].
Topics: Adolescent; Adult; Argentina; Environmental Exposure; Female; Health Knowledge, Attitudes, Practice; Humans; Maternal Welfare; Middle Aged; Nicotine; Pregnancy; Saliva; Smoking; Smoking Cessation; Socioeconomic Factors; Surveys and Questionnaires; Tobacco Smoke Pollution; Urban Population; Uruguay; Young Adult | 2008 |
[Recommendations for pharmacological tobacco cessation treatments: proposals for financing].
Topics: Financing, Organized; Humans; Nicotine; Practice Guidelines as Topic; Smoking; Smoking Cessation | 2008 |
Smoking cessation in primary care.
Topics: Drug Therapy, Combination; Evidence-Based Medicine; Humans; Nicotine; Nortriptyline; Primary Health Care; Randomized Controlled Trials as Topic; Smoking Cessation | 2008 |
Hooked from the first cigarette.
Topics: Adolescent; Brain; Humans; Nicotine; Receptors, Nicotinic; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2008 |
Pharmacological effects of nicotine on norepinephrine metabolism in rat brown adipose tissue: relevance to nicotinic therapies for smoking cessation.
Topics: Adipose Tissue, Brown; Animals; Benzazepines; Dose-Response Relationship, Drug; Female; Lipoma; Male; Mediastinal Neoplasms; Nicotine; Nicotinic Agonists; Norepinephrine; Quinoxalines; Rats; Rats, Sprague-Dawley; Sex Factors; Smoking Cessation; Varenicline | 2008 |
Acute effects of nicotine and smoking on blood flow, tissue oxygen, and aerobe metabolism of the skin and subcutis.
Topics: Adult; Aerobiosis; Arteries; Blood Flow Velocity; Cotinine; Glucose; Humans; Lactates; Male; Nicotine; Oxygen; Skin; Skin Physiological Phenomena; Smoking; Smoking Cessation; Young Adult | 2009 |
Effectiveness of a smoke-free policy in lowering secondhand smoke concentrations in offices in China.
Topics: Air Pollutants, Occupational; China; Government; Health Policy; Health Surveys; Humans; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Smoke Pollution; Workplace | 2008 |
[Factors associated with abstinence in a smoking cessation program].
Topics: Bupropion; Epidemiologic Methods; Female; Humans; Interview, Psychological; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation | 2008 |
Variability of healthcare practitioner intervention among 18- to 24-year-old tobacco users.
Topics: Adolescent; Adult; Counseling; Female; Health Personnel; Humans; Male; Nicotine; Pennsylvania; Professional-Patient Relations; Rural Population; Smoking; Smoking Cessation | 2008 |
Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokers.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Costs and Cost Analysis; Drug Costs; Female; Humans; Male; Markov Chains; Middle Aged; Models, Statistical; Nicotine; Quinoxalines; Smoking; Smoking Cessation; United States; Varenicline | 2008 |
Attenuated beta endorphin response to acute stress is associated with smoking relapse.
Topics: Acute Disease; Adult; beta-Endorphin; Cotinine; Data Interpretation, Statistical; Female; Humans; Male; Nicotine; Nicotinic Agonists; Psychomotor Performance; Recurrence; Risk; Smoking; Smoking Cessation; Social Environment; Stress, Psychological; Substance Withdrawal Syndrome | 2008 |
Smoking cessation and nicotine substitution modulate eicosanoid synthesis ex vivo in man.
Topics: Adult; Dinoprostone; Eicosanoids; Female; Humans; Leukotrienes; Male; Middle Aged; Nicotine; Smoking Cessation; Thromboxanes; Time Factors | 1995 |
The role of nicotine in tobacco smoking: implications for tobacco control policy.
Topics: Adolescent; Adult; Child; Drug and Narcotic Control; Ganglionic Stimulants; Health Policy; Humans; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Substance-Related Disorders | 1995 |
Treatment of nicotine dependence. Is more better?
Topics: Administration, Cutaneous; Behavior Therapy; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1995 |
Nicotine uses and abuses: from brain probe to public health menace.
Topics: Animals; Arousal; Brain; Humans; Nicotine; Public Health; Smoking; Smoking Cessation; Smoking Prevention; Synaptic Transmission; Tobacco Smoke Pollution | 1989 |
Implications of a nicotine-free society.
Topics: Cause of Death; Cost-Benefit Analysis; Health Education; Humans; Nicotine; Quality of Life; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Socioeconomic Factors; Survival Rate; Tobacco Smoke Pollution | 1989 |
Nicotine addiction counseling for chemically dependent patients.
Topics: Adult; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance-Related Disorders; Tobacco Use Disorder | 1995 |
Smoking cessation and the nicotine patch.
Topics: Administration, Cutaneous; Humans; Nicotine; Smoking Cessation | 1995 |
[Nicotine as therapy of obstructive sleep apnea?].
Topics: Administration, Cutaneous; Female; Humans; Male; Middle Aged; Nicotine; Sleep Apnea Syndromes; Smoking Cessation | 1995 |
Nicotine skin patch treatment and adverse reactions: skin irritation, skin sensitization, and nicotine as a hapten.
Topics: Dermatitis, Seborrheic; Desensitization, Immunologic; Drug Eruptions; Humans; Nicotiana; Nicotine; Plants, Toxic; Smoking Cessation | 1995 |
[Fetuses and newborn infants exposed to Nicorette].
Topics: Administration, Cutaneous; Central Nervous System Stimulants; Chewing Gum; Female; Fetus; Humans; Infant, Newborn; Nicotine; Polymethacrylic Acids; Polyvinyls; Pregnancy; Prenatal Exposure Delayed Effects; Smoking Cessation; Tobacco Use Cessation Devices | 1995 |
Nicotine consumption and Parkinson's disease--does the smoke clear up?
Topics: Aged; Animals; Brain; Carrier Proteins; Dopamine Plasma Membrane Transport Proteins; Humans; Liver; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Nicotine; Parkinson Disease; Smoking; Smoking Cessation | 1995 |
The axial distribution of nicotine content along hair shaft as an indicator of changes in smoking behaviour: evaluation in a smoking-cessation programme with or without the aid of nicotine chewing gum.
Topics: Adult; Breath Tests; Carbon Monoxide; Chewing Gum; Female; Hair; Humans; Male; Middle Aged; Nicotine; Smoking Cessation | 1995 |
Pharmacist counseling and outcomes of smoking cessation.
Topics: Administration, Cutaneous; Adult; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Outcome Assessment, Health Care; Patient Education as Topic; Pharmacists; Smoking Cessation | 1995 |
[The contents of tobacco smoke. Pharmacology of nicotine].
Topics: Brain; Drug Interactions; Humans; Nicotiana; Nicotine; Plants, Toxic; Smoking Cessation; Tobacco Smoke Pollution; Tobacco Use Disorder | 1995 |
Nicotine patches: a doubtful key to tobacco control?
Topics: Administration, Cutaneous; Clinical Trials as Topic; Humans; Nicotine; Physician's Role; Research Design; Smoking; Smoking Cessation; Social Support | 1995 |
Nicotine patch use in the general population: results from the 1993 California Tobacco Survey.
Topics: Actuarial Analysis; Administration, Cutaneous; Adult; Aged; California; Female; Humans; Male; Middle Aged; Nicotine; Proportional Hazards Models; Smoking; Smoking Cessation; Surveys and Questionnaires; Time Factors | 1995 |
Helping patients to stop smoking.
Topics: Counseling; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1995 |
Use and effectiveness of transdermal nicotine in primary care settings.
Topics: Administration, Cutaneous; Advertising; Humans; Nicotine; Patient Compliance; Primary Health Care; Smoking; Smoking Cessation | 1995 |
[Smoking cessation and nicotine therapy].
Topics: Humans; Nicotine; Smoking Cessation | 1995 |
A case of nicotine psychosis?
Topics: Administration, Cutaneous; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Neurologic Examination; Nicotine; Psychoses, Substance-Induced; Smoking Cessation | 1995 |
Survey details stranglehold of nicotine addiction on teenagers.
Topics: Adolescent; Adult; Health Surveys; Humans; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; United States | 1995 |
Pharmacists' role in a smoking-cessation program at a health maintenance organization.
Topics: Administration, Cutaneous; Behavior Therapy; Health Maintenance Organizations; Humans; Nicotine; Pharmacists; Program Development; Role; Smoking; Smoking Cessation | 1995 |
Pharmacists' role in a smoking-cessation program at a managed health care organization.
Topics: Behavior Therapy; Health Maintenance Organizations; Humans; Nicotine; Patient Education as Topic; Pharmacists; Role; Smoking; Smoking Cessation | 1995 |
Smoking cessation in adults. U.S. Public Health Service.
Topics: Administration, Cutaneous; Adult; Chewing Gum; Counseling; Health Resources; Humans; Nicotine; Physician's Role; Physicians, Family; Smoking Cessation | 1995 |
[Smoking cessation and nicotine therapy].
Topics: Humans; Nicotine; Smoking Cessation | 1995 |
[Psychological and physiological dependence in smokers and there effect on motivation for smoking cessation].
Topics: Austria; Cross-Sectional Studies; Female; Humans; Incidence; Male; Motivation; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1995 |
A computer-directed program for smoking cessation treatment.
Topics: Cotinine; Drug Administration Schedule; Follow-Up Studies; Health Promotion; Humans; Metabolic Clearance Rate; Nicotine; Smoking Cessation; Software; Substance Withdrawal Syndrome; Treatment Outcome; Workplace | 1994 |
Gender differences in prospectively versus retrospectively assessed smoking withdrawal symptoms.
Topics: Adult; Cotinine; Female; Humans; Male; Neurologic Examination; Nicotine; Prospective Studies; Retrospective Studies; Sex Factors; Smoking Cessation; Substance Withdrawal Syndrome | 1994 |
Acute myocardial infarction while using the nicotine patch.
Topics: Administration, Cutaneous; Adult; Humans; Male; Myocardial Infarction; Nicotine; Smoking Cessation | 1995 |
Smoking cessation: lights out.
Topics: Administration, Cutaneous; Chewing Gum; Follow-Up Studies; Humans; Medical Records; Nicotine; Smoking Cessation | 1995 |
Relationship between obesity and the metabolic effects of smoking in women.
Topics: Adolescent; Adult; Body Weight; Energy Metabolism; Female; Humans; Nicotine; Obesity; Reference Values; Smoking; Smoking Cessation | 1995 |
[Detection of nicotine in eccrine sweat after stimulation of sweat glands during nicotine withdrawal].
Topics: Adolescent; Adult; Cotinine; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nicotine; Pilocarpine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Smoke Pollution | 1995 |
Is smoking good for you?
Topics: Aged; Aortic Aneurysm, Abdominal; Humans; Male; Nicotine; Postoperative Care; Smoking Cessation; Substance Withdrawal Syndrome | 1995 |
Conversation with Ove Fernö.
Topics: Chewing Gum; Clinical Trials as Topic; Humans; Nicotine; Smoking Cessation; Sweden; Treatment Outcome | 1994 |
OTC nicotine gum.
Topics: Chewing Gum; Humans; Nicotine; Nonprescription Drugs; Smoking Cessation; Tobacco Use Disorder; United States | 1995 |
OTC nicotine gum.
Topics: Chewing Gum; Humans; Nicotine; Nonprescription Drugs; Smoking Cessation; United States | 1995 |
Using the nicotine patch to stop smoking.
Topics: Administration, Cutaneous; Bias; Humans; Meta-Analysis as Topic; Nicotine; Patient Education as Topic; Smoking Cessation | 1995 |
Using the nicotine patch to stop smoking.
Topics: Administration, Cutaneous; Humans; Nicotine; Patient Education as Topic; Smoking Cessation | 1995 |
Metabolic interactions between surplus dietary energy intake and cigarette smoking or its cessation.
Topics: Adult; Body Weight; Cotinine; Energy Intake; Energy Metabolism; Fatty Acids, Nonesterified; Glucose; Humans; Lipids; Liver; Male; Nicotine; Oxidation-Reduction; Smoking; Smoking Cessation | 1994 |
Use of nicotine to stop smoking.
Topics: Administration, Cutaneous; Administration, Intranasal; Chewing Gum; Counseling; Humans; Nebulizers and Vaporizers; Nicotine; Smoking Cessation | 1995 |
[Smoking and smoking weaning].
Topics: Counseling; Female; Humans; Male; Nicotine; Pregnancy; Pregnancy Complications; Primary Health Care; Smoking Cessation; Smoking Prevention | 1994 |
[Is nicotine therapy hazardous?].
Topics: Humans; Nicotine; Risk Factors; Smoking Cessation | 1995 |
Smoking cessation. Cornerstone of prevention in primary care.
Topics: Health Promotion; Humans; Nicotine; Primary Health Care; Smoking; Smoking Cessation; Smoking Prevention | 1995 |
[Cost-effectiveness of the methods of smoking cessation].
Topics: Adult; Aged; Cost-Benefit Analysis; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation | 1995 |
Smokers: why do they start--and continue?
Topics: Adolescent; Adult; Advertising; Child; Female; Global Health; Humans; Industry; Male; Nicotine; Smoking; Smoking Cessation; Social Behavior; Substance-Related Disorders; Tobacco Smoke Pollution | 1995 |
Using the nicotine patch to stop smoking.
Topics: Administration, Cutaneous; Administration, Inhalation; Humans; Nicotine; Smoking Cessation | 1995 |
Treatment session frequency and smoking cessation.
Topics: Adult; Analysis of Variance; Central Nervous System Stimulants; Chronic Disease; Female; Humans; Male; Nicotine; Polymethacrylic Acids; Polyvinyls; Recurrence; Severity of Illness Index; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome | 1994 |
Nicotine addiction. How can we help?
Topics: Family Practice; Health Behavior; Humans; Models, Psychological; Nicotine; Physician-Patient Relations; Smoking Cessation; Substance-Related Disorders | 1994 |
[Nicotine substitution therapy. Sleep disorders and dreams].
Topics: Dreams; Humans; Nicotine; Sleep Wake Disorders; Smoking Cessation | 1994 |
Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Blood Pressure; Counseling; Female; Follow-Up Studies; Humans; Male; Marijuana Smoking; Middle Aged; Nicotine; Patient Compliance; Prospective Studies; Recurrence; Sex Factors; Smoking; Smoking Cessation; Treatment Outcome; Weight Gain | 1994 |
Use and effectiveness of transdermal nicotine in primary care settings.
Topics: Administration, Cutaneous; Adult; Female; Humans; Male; Middle Aged; New York; Nicotine; Practice Patterns, Physicians'; Primary Health Care; Smoking Cessation | 1994 |
[Smoking cessation with nicotine patch. Low success rates in general practice].
Topics: Administration, Cutaneous; Family Practice; Female; Follow-Up Studies; Humans; Male; Nicotine; Smoking Cessation; Treatment Outcome | 1994 |
Regulation of the nicotine content of cigarettes.
Topics: Adolescent; Humans; Nicotine; Smoking; Smoking Cessation; United States | 1994 |
Patient management in a tobacco-cessation program in the dental practice.
Topics: Administration, Cutaneous; Dentist-Patient Relations; Health Education, Dental; Humans; Nicotine; Patient Compliance; Patient Education as Topic; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Cessation Devices; Tobacco Use Disorder | 1994 |
Nicotine patch for smoking cessation.
Topics: Administration, Topical; Confounding Factors, Epidemiologic; Humans; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation | 1994 |
Smoking and cancer: smoking cessation.
Topics: Adolescent; Adult; Age Factors; Child; Counseling; Family Practice; Female; Health Promotion; Humans; Life Expectancy; Male; Neoplasms; Nicotine; Risk Factors; Smoking; Smoking Cessation; Socioeconomic Factors | 1994 |
Comments on Foulds's editorial "does nicotine replacement therapy work"?
Topics: Health Promotion; Humans; Nicotine; Pharmacy; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; United Kingdom; Workforce | 1994 |
Do nicotine replacement medications work? A unique standard for nicotine.
Topics: Counseling; Health Promotion; Humans; Nicotine; Smoking; Smoking Cessation; Terminology as Topic; Treatment Outcome | 1994 |
The future of nicotine replacement in smoking cessation?
Topics: Health Promotion; Humans; Nicotine; Smoking; Smoking Cessation; Treatment Outcome | 1994 |
Beneficial effects of nicotine: fact or fiction?
Topics: Adult; Arousal; Central Nervous System; Cognition; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation | 1994 |
Nicotine patch.
Topics: Administration, Cutaneous; Aged; Drug Prescriptions; Female; Humans; Male; Nicotine; Pennsylvania; Reproducibility of Results; Smoking Cessation | 1994 |
Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI.
Topics: Adult; Analysis of Variance; Breath Tests; Drug Tolerance; Female; Humans; Male; Middle Aged; Nicotine; Personality Inventory; Psychometrics; Smoking; Smoking Cessation; Substance-Related Disorders; Treatment Outcome | 1994 |
Detrimental effects of nicotine on mood?
Topics: Affect; Cognition; Humans; Nicotine; Smoking Cessation | 1994 |
Smoking cessation in patients with HIV.
Topics: HIV Infections; Humans; Nicotine; Smoking; Smoking Cessation | 1994 |
Alexithymia and negative affect: relationship to cigarette smoking, nicotine dependence, and smoking cessation.
Topics: Adolescent; Adult; Affective Symptoms; Aged; Depression; Female; Humans; Male; Middle Aged; Nicotine; Personality Inventory; Smoking; Smoking Cessation; Substance-Related Disorders | 1994 |
[Focus on smoking].
Topics: Administration, Cutaneous; Female; Heart Diseases; Humans; Male; Nicotine; Physician-Patient Relations; Smoking; Smoking Cessation; Smoking Prevention; Socioeconomic Factors; Tobacco Smoke Pollution | 1994 |
Psychotic affective disorder after nicotine withdrawal.
Topics: Adult; Affective Disorders, Psychotic; Humans; Male; Nicotine; Recurrence; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders | 1994 |
Nicotine replacement therapy.
Topics: Administration, Cutaneous; Humans; Nicotine; Smoking Cessation | 1994 |
Myocardial infarction and nicotine patch: a contributing or causative factor?
Topics: Administration, Cutaneous; Adult; Humans; Male; Myocardial Infarction; Nicotine; Smoking; Smoking Cessation | 1993 |
Transdermal nicotine after smoking cessation.
Topics: Administration, Cutaneous; Chewing Gum; Depressive Disorder; Female; Humans; Microsomes, Liver; Middle Aged; Nicotine; Polymethacrylic Acids; Polyvinyls; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 1994 |
The role of transdermal nicotine therapy in smoking cessation.
Topics: Administration, Cutaneous; Drug Interactions; Humans; Nicotine; Patient Education as Topic; Smoking Cessation; Substance-Related Disorders | 1993 |
[Minimal intervention in smoking in the outpatient pneumonology consultation].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Chewing Gum; Chi-Square Distribution; Female; Humans; Male; Middle Aged; Nicotine; Pulmonary Medicine; Referral and Consultation; Smoking; Smoking Cessation; Smoking Prevention; Spain | 1994 |
Smoking cessation methods: recommendations for health professionals. Advisory Group of the European School of Oncology.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Female; Health Personnel; Humans; Male; Middle Aged; Nicotine; Patient Education as Topic; Smoking Cessation | 1994 |
Protracted withdrawal.
Topics: Humans; Hunger; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Weight Gain | 1994 |
The reality of the beneficial effects of nicotine.
Topics: Arousal; Cognition; Humans; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1994 |
Do the benefits of nicotine help beat the addiction rap?
Topics: Arousal; Cognition; Humans; Nicotine; Self Administration; Smoking Cessation | 1994 |
Beneficial effects of nicotine: fact or fiction?
Topics: Adult; Arousal; Cognition; Cross-Cultural Comparison; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation; Social Facilitation; Substance Withdrawal Syndrome | 1994 |
Cognitive benefits of nicotine: fact or fiction?
Topics: Arousal; Cognition; Humans; Neuropsychological Tests; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1994 |
Does cigarette smoking increase stress?
Topics: Affect; Anxiety; Arousal; Humans; Nicotine; Smoking; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome | 1994 |
Characteristics and perceptions of nicotine patch users.
Topics: Administration, Cutaneous; Adult; Advertising; Aged; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Patient Education as Topic; Physician-Patient Relations; Smoking Cessation; Tobacco Use Disorder | 1994 |
Will the nicotine patch really stick?
Topics: Administration, Cutaneous; Humans; Nicotine; Research Design; Smoking Cessation; Treatment Outcome | 1994 |
Helping patients stop smoking.
Topics: Behavior Therapy; Humans; Nicotine; Smoking Cessation | 1994 |
Temporal stability and within-subject consistency of nicotine withdrawal symptoms.
Topics: Adult; Affective Symptoms; Female; Humans; Male; Neurologic Examination; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
The female weight-control smoker: a profile.
Topics: Adult; Appetite; Diet, Reducing; Female; Humans; Middle Aged; Motivation; Nicotine; Personality Inventory; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Weight Gain | 1993 |
Stroke following application of a nicotine patch.
Topics: Administration, Cutaneous; Adult; Cerebrovascular Disorders; Humans; Male; Nicotine; Smoking; Smoking Cessation; Treatment Refusal | 1994 |
The pros and cons of transdermal nicotine therapy.
Topics: Administration, Cutaneous; Humans; Nicotine; Smoking Cessation | 1994 |
Routine hospital-based quit-smoking treatment for the postmyocardial infarction patient: an idea whose time has come.
Topics: Costs and Cost Analysis; Hospital Administration; Hospitalization; Humans; Myocardial Infarction; Nicotine; Smoking Cessation; Time Factors | 1993 |
Use of nicotine patches for schizophrenic patients.
Topics: Administration, Cutaneous; Adult; Female; Humans; Nicotine; Psychotic Disorders; Smoking; Smoking Cessation; Smoking Prevention | 1993 |
Introduction to special section: clinical research in smoking cessation.
Topics: Humans; Nicotine; Smoking; Smoking Cessation; Treatment Outcome | 1993 |
Nicotine dependence: intervention strategies for the physician.
Topics: Administration, Cutaneous; Adolescent; Adult; Child; Delayed-Action Preparations; Hospitalization; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
Contact allergy to nicotine from a nicotine patch.
Topics: Administration, Cutaneous; Administration, Oral; Dermatitis, Allergic Contact; Drug Eruptions; Female; Humans; Middle Aged; Nicotine; Smoking; Smoking Cessation | 1993 |
Use of transdermal nicotine in a state-level prescription plan for the elderly. A first look at 'real-world' patch users.
Topics: Administration, Cutaneous; Aged; Counseling; Data Collection; Female; Follow-Up Studies; Humans; Male; Nicotine; Patient Compliance; Patient Education as Topic; Pennsylvania; Population Surveillance; Poverty; Self-Help Groups; Smoking; Smoking Cessation | 1994 |
Wisconsin's experience with the national nicotine patch giveaway.
Topics: Administration, Cutaneous; Cost-Benefit Analysis; Drug Industry; Humans; Medical Indigency; Nicotine; Smoking Cessation; Wisconsin | 1993 |
Pharmacology of smoking cessation.
Topics: Humans; Nicotine; Smoking Cessation | 1993 |
Smoking reduction and biological markers of response.
Topics: Bronchoalveolar Lavage Fluid; Bronchoscopy; Humans; Lung Diseases, Obstructive; Nicotine; Smoking; Smoking Cessation | 1993 |
Side effects of transdermal nicotine patches.
Topics: Administration, Cutaneous; Dreams; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Snoring | 1993 |
Nicotine inhaler for smoking cessation.
Topics: Humans; Nebulizers and Vaporizers; Nicotine; Smoking Cessation | 1993 |
Weight change after smoking cessation in general practice.
Topics: Adult; Attitude; Chewing Gum; Dependency, Psychological; Family Practice; Female; Forecasting; Health Status; Humans; Male; Nicotine; Sex Factors; Smoking; Smoking Cessation; Time Factors; Weight Gain | 1993 |
GPs are best placed to help people stop smoking.
Topics: Administration, Cutaneous; Family Practice; Humans; Nicotine; Risk Factors; Smoking Cessation | 1993 |
GPs should surrender some of their sovereignty.
Topics: Administration, Cutaneous; Family Practice; Health Promotion; Humans; Nicotine; Professional Practice; Smoking Cessation | 1993 |
Allergic contact dermatitis from transdermal nicotine systems.
Topics: Administration, Cutaneous; Adult; Dermatitis, Allergic Contact; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation | 1993 |
Nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) in women and obese men compared with normal-sized men.
Topics: Administration, Cutaneous; Adult; Body Weight; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Obesity; Sex Characteristics; Smoking Cessation | 1993 |
Factors associated with nicotine dependence among African American women cigarette smokers.
Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Analysis of Variance; Black or African American; Cognitive Behavioral Therapy; Cotinine; Educational Status; Female; Humans; Middle Aged; Models, Psychological; Motivation; Nicotine; Peer Group; Poverty; Predictive Value of Tests; Regression Analysis; Risk Factors; Saliva; Smoking; Smoking Cessation; Smoking Prevention; Socioeconomic Factors; Substance-Related Disorders; Surveys and Questionnaires; Women | 1993 |
The relationship between quitting smoking and changes in drinking in World War II veteran twins.
Topics: Adult; Alcohol Drinking; Alcoholism; Cohort Studies; Comorbidity; Cross-Sectional Studies; Diseases in Twins; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Veterans | 1993 |
The favorite cigarette of the day.
Topics: Adolescent; Adult; Aged; Circadian Rhythm; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Smoking; Smoking Cessation; Substance-Related Disorders | 1993 |
[Preparations for smoking cessation to pregnant women?].
Topics: Administration, Topical; Female; Humans; Nicotine; Pregnancy; Smoking Cessation | 1993 |
[No nicotine patch to pregnant women!].
Topics: Administration, Topical; Female; Humans; Nicotine; Pregnancy; Risk Factors; Smoking Cessation | 1993 |
[Thoughts during nicotine withdrawal].
Topics: Administration, Cutaneous; England; Humans; Nicotine; Smoking Cessation; Sweden | 1993 |
The nicotine patch.
Topics: Administration, Cutaneous; Humans; Nicotine; Physician's Role; Recurrence; Smoking Cessation | 1993 |
Nicotine dependency treatment: a role for the nurse practitioner.
Topics: Humans; Nicotine; Nurse Practitioners; Role; Smoking Cessation; Substance-Related Disorders | 1993 |
Transdermal nicotine: clarifications, side effects, and funding.
Topics: Administration, Cutaneous; Humans; Nicotine; Smoking Cessation | 1993 |
Transdermal nicotine: clarifications, side effects, and funding.
Topics: Administration, Cutaneous; Atrial Fibrillation; Female; Humans; Middle Aged; Nicotine; Smoking Cessation | 1993 |
Transdermal nicotine: clarifications, side effects, and funding.
Topics: Administration, Cutaneous; Humans; Nicotine; Smoking Cessation | 1993 |
[Nicotine supplementation to pregnant women, in spite of all].
Topics: Chewing Gum; Female; Fetus; Humans; Nicotine; Pregnancy; Prenatal Exposure Delayed Effects; Smoking Cessation | 1993 |
Analysis of nicotine content of hair for assessing individual cigarette-smoking behavior.
Topics: Adult; Animals; Chromatography, Gas; Hair; Hair Color; Humans; Male; Middle Aged; Nicotine; Rats; Smoking; Smoking Cessation | 1993 |
Smoking and nicotine dependence in young adults: differences between blacks and whites.
Topics: Adult; Black or African American; Cross-Sectional Studies; Female; Humans; Male; Michigan; Nicotine; Personality Inventory; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; White People | 1993 |
The physician's role in preventing nicotine addiction. Interview by Juli C. McGreevy.
Topics: Humans; Nicotine; Physician's Role; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 1993 |
Glycerol particle cigarettes: a less harmful option for chronic smokers.
Topics: Carbon Monoxide; Cotinine; Female; Glycerol; Humans; Male; Nicotine; Patient Satisfaction; Risk Factors; Smoking; Smoking Cessation; Time Factors | 1993 |
Nicotine patches in general practice.
Topics: Administration, Cutaneous; Family Practice; Humans; Motivation; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1993 |
CEASE (Collaborative European Anti-Smoking Evaluation): a challenging multicentre trail organized by the European Respiratory Society.
Topics: Administration, Cutaneous; Adult; Aged; Clinical Protocols; Europe; Humans; International Cooperation; Middle Aged; Multicenter Studies as Topic; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation | 1993 |
Smoking patterns and cessation motivations during adolescence.
Topics: Adolescent; Comorbidity; Female; Humans; Juvenile Delinquency; Male; Motivation; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Substance-Related Disorders; Washington | 1995 |
Nicotine toxicity misdiagnosed as lithium toxicity.
Topics: Administration, Cutaneous; Adult; Bipolar Disorder; Diagnosis, Differential; Drug Overdose; Humans; Lithium; Male; Nicotine; Smoking Cessation | 1996 |
Nicotine dependence and the stages of change.
Topics: Humans; Nicotine; Nurse Practitioners; Smoking; Smoking Cessation; Substance-Related Disorders | 1995 |
From the Food and Drug Administration.
Topics: Animals; Campylobacter; Campylobacter Infections; Central Nervous System Stimulants; Chewing Gum; Drug Approval; Drug Resistance, Microbial; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Infections; Humans; Immunoglobulins, Intravenous; Nicotine; Nonprescription Drugs; Polymethacrylic Acids; Polyvinyls; Population Surveillance; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Salmonella; Salmonella Infections; Salmonella Infections, Animal; Smoking Cessation; Tobacco Use Cessation Devices; United States; United States Food and Drug Administration | 1996 |
From the Food and Drug Administration.
Topics: Administration, Inhalation; Adverse Drug Reaction Reporting Systems; Analgesics, Opioid; Antineoplastic Agents; Drug Labeling; Drugs, Investigational; Health Care Reform; Humans; Medical Oncology; Neoplasms; Nicotine; Smoking Cessation; Tramadol; United States; United States Food and Drug Administration | 1996 |
Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling.
Topics: Administration, Cutaneous; Adult; Aged; Cost-Benefit Analysis; Counseling; Decision Support Techniques; Female; Humans; Male; Middle Aged; Nicotine; Primary Health Care; Quality-Adjusted Life Years; Smoking Cessation; United States | 1996 |
Nicorette finds new place in smoking cessation.
Topics: Adolescent; Adult; Central Nervous System Stimulants; Chewing Gum; Consumer Product Safety; Humans; Nicotine; Nonprescription Drugs; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Tobacco Use Cessation Devices; United States | 1996 |
The benefits and risks of over-the-counter availability of nicotine polacrilex ("nicotine gum").
Topics: Adolescent; Adult; Aged; Chewing Gum; Drug and Narcotic Control; Drug Prescriptions; Female; Humans; Male; Markov Chains; Middle Aged; Models, Theoretical; Nicotine; Nonprescription Drugs; Polymethacrylic Acids; Polyvinyls; Risk Assessment; Sensitivity and Specificity; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; United States | 1996 |
Nicotine is hazardous to your heart.
Topics: Humans; Myocardial Infarction; Nicotine; Smoking Cessation | 1996 |
Tobacco smoking induces expression of very-high-affinity nicotine binding sites on blood polymorphonuclear cells.
Topics: Adult; Binding Sites; Female; Gene Expression Regulation; Humans; Male; Middle Aged; Nicotine; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Time Factors; Tritium | 1996 |
Smoking cessation in young adults: age at initiation of cigarette smoking and other suspected influences.
Topics: Adolescent; Adult; Age Factors; Depression; Educational Status; Ethnicity; Female; Humans; Longitudinal Studies; Male; Michigan; Multivariate Analysis; Nicotine; Proportional Hazards Models; Risk Factors; Sampling Studies; Smoking Cessation; Social Behavior; Substance-Related Disorders | 1996 |
[Results of a smoking cessation program among Spanish pulmonologists and thoracic surgeons].
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Male; Middle Aged; Motivation; Nicotine; Pulmonary Medicine; Smoking Cessation; Spain; Thoracic Surgery; Time Factors | 1996 |
Smoking cessation: information for specialists. Smoking Cessation Guideline Panel. Agency for Health Care Policy and Research.
Topics: Humans; Motivation; Nicotine; Problem Solving; Smoking; Smoking Cessation | 1996 |
Do heavy smokers need a higher replacement dose of nicotine to quit?
Topics: Dose-Response Relationship, Drug; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation | 1996 |
Effect of 21 mg transdermal nicotine patches and smoking cessation on heart rate variability.
Topics: Administration, Cutaneous; Adult; Aged; Circadian Rhythm; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Ganglionic Stimulants; Heart Rate; Humans; Male; Middle Aged; Nicotine; Recurrence; Respiration; Smoking Cessation; Smoking Prevention | 1996 |
Oral tobacco use.
Topics: Child; Female; Humans; Nicotine; Plants, Toxic; Smoking Cessation; Tobacco, Smokeless | 1996 |
Effectiveness of nicotine patches in a workplace smoking cessation program. An eleven-month follow-up study.
Topics: Administration, Cutaneous; Adolescent; Adult; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Treatment Outcome; Workplace | 1996 |
[Smoking cessation program using nicotine patch among physicians and pharmacists of Catalonia: results after 3-12 months].
Topics: Administration, Cutaneous; Adult; Female; Follow-Up Studies; Ganglionic Stimulants; Humans; Interviews as Topic; Male; Nicotine; Pharmacists; Physicians; Smoking Cessation; Spain; Time Factors | 1996 |
Advising your client on nicotine replacement aids.
Topics: Humans; Models, Psychological; Nicotine; Patient Education as Topic; Smoking Cessation | 1995 |
Use of over-the-counter nicotine patch for smoking cessation: prudent or premature?
Topics: Administration, Cutaneous; Humans; Nicotine; Nonprescription Drugs; Smoking Cessation | 1996 |
Nicotine poisoning as a cause of cardiac arrest?
Topics: Administration, Cutaneous; Adult; Fatal Outcome; Ganglionic Stimulants; Heart Arrest; Humans; Male; Nicotine; Self Care; Smoking Cessation | 1996 |
Cost-effectiveness of the nicotine patch.
Topics: Administration, Cutaneous; Adult; Aged; Cost-Benefit Analysis; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Quality-Adjusted Life Years; Reproducibility of Results; Smoking Cessation; United States | 1996 |
[Tobacco smoking cessation. Methods and aids].
Topics: Follow-Up Studies; Humans; Nicotine; Patient Care Team; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1996 |
Pharmacoeconomic analysis of smoking-cessation interventions.
Topics: Behavior Therapy; Cost-Benefit Analysis; Decision Trees; Humans; Nicotine; Nicotinic Agonists; Sensitivity and Specificity; Smoking; Smoking Cessation; Treatment Outcome | 1996 |
Individualizing medical treatment for tobacco dependence.
Topics: Clinical Trials as Topic; Cotinine; Dose-Response Relationship, Drug; Humans; Individuality; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder | 1996 |
Combining behavioral therapy and pharmacotherapy for smoking cessation: an update.
Topics: Assertiveness; Behavior Therapy; Combined Modality Therapy; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation | 1995 |
Depression following smoking cessation in women.
Topics: Administration, Cutaneous; Adult; Depressive Disorder; Female; Humans; Middle Aged; Nicotine; Personality Inventory; Recurrence; Self Medication; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1996 |
Nicotine nasal spray is newest smoking cessation aid.
Topics: Administration, Intranasal; Drug Approval; Ganglionic Stimulants; Humans; Nicotine; Smoking Cessation | 1996 |
Strategies for smoking cessation.
Topics: Administration, Cutaneous; Adult; Bronchodilator Agents; Health Education; Humans; Lung Diseases; Middle Aged; Motivation; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Smoke Pollution; Tobacco Use Disorder | 1996 |
Community patterns of transdermal nicotine use and provider counseling.
Topics: Administration, Cutaneous; Cohort Studies; Counseling; Drug Prescriptions; Female; Humans; Male; Middle Aged; Nicotine; Pharmacies; Practice Patterns, Physicians'; Random Allocation; Retrospective Studies; Smoking Cessation; Surveys and Questionnaires | 1995 |
Recent problems with paracervical vasopressin: a possible synergistic reaction with nicotine.
Topics: Administration, Cutaneous; Adult; Bradycardia; Cervix Uteri; Conization; Drug Synergism; Female; Heart Rate; Humans; Hypotension; Nicotine; Smoking Cessation; Tobacco Use Disorder; Uterine Cervical Dysplasia; Vasopressins; Vulvar Diseases | 1996 |
Effective smoking cessation treatments available but underused.
Topics: Humans; Nicotine; Practice Guidelines as Topic; Smoking Cessation; Tobacco Use Disorder; United States; United States Agency for Healthcare Research and Quality | 1996 |
Nicotine dependence: perspectives on a new guideline from APA.
Topics: Health Policy; Humans; Nicotine; Practice Guidelines as Topic; Psychiatry; Recurrence; Smoking Cessation; Societies, Medical; Substance-Related Disorders; United States | 1996 |
A two-year follow-up on the effects of a smoking ban in an inpatient psychiatric service.
Topics: Adolescent; Adult; Aged; Anxiety; Female; Humans; Kentucky; Male; Middle Aged; Nicotine; Organizational Policy; Patient Acceptance of Health Care; Patient Admission; Prospective Studies; Psychiatric Department, Hospital; Psychotic Disorders; Risk Management; Smoking; Smoking Cessation; Smoking Prevention; Social Behavior; Substance Withdrawal Syndrome; Tobacco Smoke Pollution; Violence | 1996 |
The relationship of gender, diet patterns, and body type to weight change following smoking reduction: a multivariate approach.
Topics: Adult; Body Mass Index; Energy Intake; Feeding Behavior; Female; Humans; Male; Middle Aged; Nicotine; Regression Analysis; Sex Factors; Smoking Cessation; Substance Withdrawal Syndrome; Weight Gain | 1995 |
Another case of nicotine psychosis?
Topics: Administration, Cutaneous; Adult; Depressive Disorder; Female; Humans; Male; Nicotine; Psychoses, Substance-Induced; Smoking Cessation | 1996 |
A role for dopamine in nicotine psychosis?
Topics: Administration, Cutaneous; Brain; Dopamine; Humans; Monoamine Oxidase; Nicotine; Psychoses, Substance-Induced; Smoking Cessation | 1996 |
OTC products help smokers quit.
Topics: Central Nervous System Stimulants; Humans; Nicotine; Nonprescription Drugs; Patient Education as Topic; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Tobacco Use Cessation Devices | 1996 |
Smoking cessation programmes are neglecting the needs of persons with neuropsychiatric disorders.
Topics: Health Policy; Humans; Mental Disorders; Nicotine; Smoking Cessation | 1996 |
Progression from a smoking lapse to relapse: prediction from abstinence violation effects, nicotine dependence, and lapse characteristics.
Topics: Adult; Female; Humans; Internal-External Control; Male; Middle Aged; Motivation; Nicotine; Personality Assessment; Recurrence; Smoking; Smoking Cessation; Substance-Related Disorders; Treatment Outcome | 1996 |
Symptomatology and energy intake during the menstrual cycle in smoking women.
Topics: Adolescent; Adult; Appetite; Energy Intake; Female; Humans; Menstrual Cycle; Motivation; Nicotine; Personality Inventory; Premenstrual Syndrome; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1996 |
Adolescents' experiences of smoking cessation.
Topics: Adolescent; Cross-Sectional Studies; Female; Health Education; Humans; Incidence; Male; Nicotine; Peer Group; Queensland; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 1996 |
Is sleep apnea a predisposing factor for tobacco use?
Topics: Adolescent; Adult; Child; Female; Humans; Male; Models, Biological; Nicotine; Risk Factors; Sleep Apnea Syndromes; Smoking; Smoking Cessation; Snoring; Social Environment; Substance-Related Disorders | 1996 |
The National Medical Association--an advocate for a smoke-free environment.
Topics: Consumer Advocacy; Environmental Health; Humans; Nicotine; Public Health; Smoking Cessation; Smoking Prevention; Societies, Medical; United States | 1996 |
Nicotine dependence and depression among methadone maintenance patients.
Topics: Adult; Aged; Depression; Female; Humans; Logistic Models; Male; Methadone; Middle Aged; Nicotine; Odds Ratio; Opioid-Related Disorders; Smoking; Smoking Cessation; Substance Abuse Treatment Centers; Substance-Related Disorders; Treatment Outcome | 1996 |
Major depression following smoking cessation.
Topics: Depressive Disorder; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Nicotine; Odds Ratio; Personality Inventory; Recurrence; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1997 |
[Nicotine patches. Are they really useful?].
Topics: Administration, Cutaneous; Humans; Nicotine; Smoking; Smoking Cessation | 1996 |
Smoking cessation with a 16 h nicotine patch: results in a group of hospital workers.
Topics: Administration, Cutaneous; Adult; Drug Administration Schedule; Female; Humans; Male; Medical Staff, Hospital; Nicotine; Nursing Staff, Hospital; Personnel, Hospital; Smoking Cessation; Treatment Outcome | 1997 |
[Diagnosis and therapy of nicotine dependence].
Topics: Adolescent; Adult; Aged; Austria; Female; Humans; Male; Middle Aged; Nicotine; Patient Care Team; Smoking; Smoking Cessation; Substance-Related Disorders | 1997 |
Aids to smoking cessation.
Topics: Administration, Cutaneous; Humans; Nicotine; Nicotinic Agonists; Pentanoic Acids; Quinine; Smoking Cessation; Terpenes; Treatment Outcome | 1997 |
Effects of a 2-day abstinence from smoking on dietary, cognitive, subjective, and physiologic parameters among younger and older female smokers.
Topics: Adult; Aged; Aging; Arousal; Blood Pressure; Body Weight; Cotinine; Energy Intake; Female; Food Preferences; Heart Rate; Humans; Middle Aged; Nicotine; Problem Solving; Reaction Time; Saliva; Smoking Cessation; Substance Withdrawal Syndrome | 1997 |
[Nicotine replacement therapy for cessation of smoking].
Topics: Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder | 1997 |
Transdermal nicotine replacement in pregnancy: maternal pharmacokinetics and fetal effects.
Topics: Administration, Cutaneous; Adult; Apgar Score; Birth Weight; Cotinine; Female; Gestational Age; Humans; Hydrogen-Ion Concentration; Maternal-Fetal Exchange; Nicotine; Pregnancy; Prospective Studies; Saliva; Smoking Cessation | 1997 |
Patterns of use of a free nicotine patch program for Medicaid and uninsured patients.
Topics: Administration, Cutaneous; Adult; Aged; Community Health Services; Female; Humans; Male; Medicaid; Medically Uninsured; Middle Aged; New York; Nicotine; Smoking Cessation; United States | 1997 |
Aortic dissection and use of the nicotine patch: a case involving a temporal relationship.
Topics: Adult; Aortic Aneurysm, Thoracic; Aortic Dissection; Female; Humans; Nicotine; Smoking; Smoking Cessation | 1997 |
Smoking cessation interventions in rural family practices: an UPRNet study.
Topics: Acute Disease; Adult; Attitude to Health; Counseling; Cross-Sectional Studies; Family Practice; Female; Humans; Male; Michigan; Nicotine; Office Visits; Physician-Patient Relations; Practice Patterns, Physicians'; Preventive Medicine; Referral and Consultation; Rural Health; Single-Blind Method; Smoking; Smoking Cessation; Surveys and Questionnaires; Wounds and Injuries | 1997 |
Smoking cessation for the hospitalized cardiac patient: rationale for and report of a model program.
Topics: Administration, Cutaneous; Coronary Disease; Gingiva; Humans; Motivation; Myocardial Infarction; Nicotine; Nursing Assessment; Smoking Cessation; Social Support; Tobacco Use Disorder | 1995 |
Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia.
Topics: Administration, Cutaneous; Coronary Disease; Exercise Test; Female; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Nicotine; Pilot Projects; Prospective Studies; Smoking; Smoking Cessation; Tomography, Emission-Computed, Single-Photon | 1997 |
Managing nicotine dependence.
Topics: Carbon Monoxide; Exercise Test; Humans; Myocardial Ischemia; Nicotine; Smoking; Smoking Cessation | 1997 |
Factors affecting smoking cessation in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Alcohol Drinking; Attitude to Health; Counseling; Demography; Female; Forecasting; Head and Neck Neoplasms; Health Status; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Nicotine; Regression Analysis; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires | 1997 |
Two products join ranks of smoking cessation treatments.
Topics: Administration, Inhalation; Bupropion; Cholinergic Agents; Humans; Neurotransmitter Uptake Inhibitors; Nicotine; Smoking Cessation | 1997 |
Society for Research on Nicotine and Tobacco.
Topics: Adolescent; Brain; Humans; Nicotine; Receptors, Nicotinic; Smoking; Smoking Cessation | 1997 |
Nicotine replacement therapy should be prescribable on NHS.
Topics: Humans; Nicotine; Smoking Cessation; State Medicine; United Kingdom | 1997 |
The Tripler Tobacco-Cessation Program: predictors for success and improved efficacy.
Topics: Administration, Cutaneous; Adult; Cognitive Behavioral Therapy; Female; Follow-Up Studies; Humans; Male; Military Personnel; Nicotine; Patient Education as Topic; Prevalence; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; United States | 1997 |
Craving is associated with smoking relapse: findings from three prospective studies.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Drug Tolerance; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Prospective Studies; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires | 1997 |
Smoking cessation is associated with an increase in exhaled nitric oxide.
Topics: Administration, Cutaneous; Adult; Breath Tests; Case-Control Studies; Female; Humans; Male; Nicotine; Nitric Oxide; Smoking; Smoking Cessation; Time Factors | 1997 |
Antidepressant effects of nicotine.
Topics: Administration, Cutaneous; Affect; Antidepressive Agents; Depressive Disorder; Humans; Nicotine; Research; Self Medication; Smoking; Smoking Cessation; Tobacco Industry | 1997 |
Smoking cessation for pregnant women and their partners: a pilot study.
Topics: Administration, Topical; Clinical Nursing Research; Female; Home Care Services; Humans; Male; Nicotine; Pilot Projects; Pregnancy; Smoking Cessation | 1997 |
UCSF case raises questions about grant idea ownership.
Topics: Administration, Cutaneous; Biomedical Research; California; Federal Government; Government Regulation; Heart; Humans; Intellectual Property; Nicotine; Plagiarism; Research Support as Topic; Smoking Cessation; United States; United States Office of Research Integrity; Universities | 1997 |
Smoking cessation via telephone counseling & tools for helping your patients quit smoking once and for all.
Topics: Administration, Cutaneous; Combined Modality Therapy; Counseling; Humans; Nicotine; Smoking Cessation; Telephone; Treatment Outcome | 1997 |
Usefulness of markers in managing tobacco withdrawal.
Topics: Administration, Cutaneous; Adult; Biomarkers; Carbon Monoxide; Carboxyhemoglobin; Cotinine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Personality Inventory; Psychometrics; Smoking Cessation; Tobacco Use Disorder | 1997 |
Impact of promotion of the Great American Smokeout and availability of over-the-counter nicotine medications, 1996.
Topics: Health Promotion; Humans; Nicotine; Nicotinic Agonists; Nonprescription Drugs; Smoking Cessation; Smoking Prevention; United States | 1997 |
Treating tobacco addiction--nicotine or no nicotine?
Topics: Antidepressive Agents; Bupropion; Humans; Nicotine; Nortriptyline; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1997 |
The Lung Health Study.
Topics: Adult; Behavior Therapy; Bronchial Provocation Tests; Bronchoconstrictor Agents; Bronchodilator Agents; Chewing Gum; Follow-Up Studies; Forced Expiratory Volume; Humans; Ipratropium; Lung; Lung Diseases, Obstructive; Methacholine Chloride; Middle Aged; Motivation; Multicenter Studies as Topic; Nicotine; Placebos; Randomized Controlled Trials as Topic; Single-Blind Method; Smoking; Smoking Cessation | 1996 |
Predictors of smoking cessation among elderly smokers treated for nicotine dependence.
Topics: Aged; Ambulatory Care; Female; Hospitalization; Humans; Male; Nicotine; Prognosis; Retrospective Studies; Severity of Illness Index; Smoking Cessation; Substance-Related Disorders | 1997 |
Nicotine replacement therapy on the NHS. Nicotine treatment cannot be regarded as replacement therapy.
Topics: Humans; Nicotine; Smoking Cessation; Smoking Prevention; State Medicine | 1997 |
Nicotine replacement therapy on the NHS. Success rates of different smoking cessation treatments need to be compared.
Topics: Humans; Nicotine; Smoking Cessation; Smoking Prevention; State Medicine | 1997 |
From the Centers for Disease Control and Prevention. Impact of promotion of the Great American Smokeout and availability of over-the-counter nicotine medications, 1996.
Topics: Health Promotion; Humans; Nicotine; Nicotinic Agonists; Nonprescription Drugs; Smoking Cessation; Smoking Prevention; United States | 1997 |
Smoking cessation interventions for dental patients--attitudes and reported practices of dentists in the Oxford region.
Topics: Attitude of Health Personnel; Attitude to Health; Clinical Competence; Confidence Intervals; Counseling; Dental Records; Dentist-Patient Relations; Dentists; England; Female; General Practice, Dental; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Male; Medical History Taking; Nicotine; Nicotinic Agonists; Periodontal Diseases; Private Practice; Smoking; Smoking Cessation; Smoking Prevention; State Medicine; Surveys and Questionnaires | 1997 |
[The acceptance of treatment with nicotine substitutes].
Topics: Humans; Nicotine; Patient Acceptance of Health Care; Smoking Cessation; Spain; Tobacco Use Disorder | 1997 |
Nicotine replacement therapy and smoking reduction as an interim goal.
Topics: Ganglionic Stimulants; Humans; Nicotine; Nonprescription Drugs; Risk; Smoking Cessation | 1998 |
Smoking deterrents can help kick the habit, but side effects need to be closely monitored.
Topics: Cardiovascular Diseases; Cardiovascular System; Humans; Nicotine; Nicotinic Agonists; Patient Education as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1996 |
Depression and self-medication with nicotine: the modifying influence of the dopamine D4 receptor gene.
Topics: Adult; Depression; Female; Genetic Markers; Genotype; Humans; Linear Models; Male; Middle Aged; Nicotine; Receptors, Dopamine D2; Receptors, Dopamine D4; Self Medication; Smoking; Smoking Cessation | 1998 |
The evolving pharmacotherapy of smoking cessation.
Topics: Drug Evaluation; Follow-Up Studies; Humans; Medicaid; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Smoking Cessation; United States; United States Food and Drug Administration | 1998 |
Changes of smoking habits and beliefs during nurse training: a longitudinal study.
Topics: Adolescent; Adult; Asthma; Attitude to Health; Bronchitis; Cohort Studies; Coronary Artery Disease; Education, Nursing; Female; Health Behavior; Health Education; Health Knowledge, Attitudes, Practice; Health Promotion; Humans; Italy; Longitudinal Studies; Lung Neoplasms; Male; Middle Aged; Nicotine; Nurses; Personnel, Hospital; Prevalence; Prospective Studies; Recurrence; Smoking; Smoking Cessation; Students, Nursing; Substance-Related Disorders; Surveys and Questionnaires | 1997 |
Nicotine dependence among adolescent smokers.
Topics: Adolescent; Cotinine; Cross-Sectional Studies; Depression; Female; Humans; Linear Models; Male; Nicotine; Prevalence; Psychological Tests; Saliva; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1998 |
Nicotine replacement therapy in the Czech Republic.
Topics: Administration, Cutaneous; Chewing Gum; Czech Republic; Humans; Nicotine; Smoking Cessation | 1997 |
Smoking cessation: information for specialists. Agency for Health Care Policy and Research.
Topics: Administration, Cutaneous; Chewing Gum; Counseling; Humans; Nicotine; Smoking Cessation | 1996 |
Utilization of nicotine nasal spray in smoking cessation.
Topics: Administration, Inhalation; Aerosols; Female; Humans; Male; Nicotine; Smoking Cessation | 1998 |
Public health benefit of over-the-counter nicotine medications.
Topics: Health Promotion; Humans; Marketing of Health Services; Nicotine; Nonprescription Drugs; Public Health; Risk Assessment; Smoking Cessation; Tobacco Use Disorder | 1997 |
Use of the nicotine skin patch by smokers in 20 communities in the United States, 1992-1993.
Topics: Administration, Topical; Adult; Cohort Studies; Cross-Sectional Studies; Female; Health Promotion; Humans; Male; Middle Aged; Nicotiana; Nicotine; Plants, Toxic; Prevalence; Retrospective Studies; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; United States | 1997 |
[Vienna standard in diagnosis of nicotine dependence: Vienna Standard Smoking Inventory].
Topics: Adult; Female; Humans; Male; Nicotine; Personality Inventory; Psychometrics; Reproducibility of Results; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders | 1998 |
Plasma nitric oxide before and after smoking cessation with nicotine nasal spray.
Topics: Administration, Intranasal; Adult; Aged; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Nitric Oxide; Smoking Cessation | 1998 |
Smoking cessation: principles and practice based upon the AHCPR Guideline, 1996. Agency for Health Care Policy and Research.
Topics: Administration, Cutaneous; Adult; Behavior Therapy; Contraindications; Female; Humans; Male; Motivation; Nicotine; Patient Education as Topic; Pregnancy; Smoking; Smoking Cessation; Treatment Outcome | 1997 |
[Acceptance of nicotine-substitute treatment].
Topics: Ganglionic Stimulants; Humans; Nicotine; Smoking Cessation | 1998 |
Smokers' misperceptions of light and ultra-light cigarettes may keep them smoking.
Topics: Adult; Advertising; Behavior, Addictive; Confidence Intervals; Female; Health Knowledge, Attitudes, Practice; Humans; Logistic Models; Male; Massachusetts; Nicotine; Odds Ratio; Product Labeling; Sampling Studies; Smoking; Smoking Cessation; Tars; United States | 1998 |
Nicotine patch needs to breathe.
Topics: Adult; Carcinoma; Drug Overdose; Humans; Kidney Neoplasms; Male; Nicotine; Smoking; Smoking Cessation; Temperature | 1998 |
Taking smoking cessation treatment seriously: the American Psychiatric Association's Practice Guideline for the Treatment of Patients with Nicotine Dependence.
Topics: Female; Humans; Male; Middle Aged; Nicotine; Practice Guidelines as Topic; Psychotherapy; Smoking; Smoking Cessation | 1998 |
[Anti-smoking intervention performed by cardiologists during ambulatory care].
Topics: Adhesives; Adult; Ambulatory Care; Cardiology; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Time Factors; Treatment Outcome | 1998 |
Nicotine-induced limbic cortical activation in the human brain: a functional MRI study.
Topics: Adolescent; Adult; Affect; Brain; Cerebral Cortex; Cognition; Dose-Response Relationship, Drug; Female; Humans; Injections, Intravenous; Limbic System; Magnetic Resonance Imaging; Male; Nicotine; Receptors, Nicotinic; Reinforcement, Psychology; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 1998 |
[Epidemiological studies on tobacco smoking and dependence in Hokkaido prefecture--relation to alcoholism].
Topics: Adult; Alcoholism; Female; Humans; Japan; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 1998 |
Promoting tobacco cessation in the military: an example for primary care providers.
Topics: Administration, Cutaneous; Adult; Arizona; Central Nervous System Stimulants; Chewing Gum; Cost-Benefit Analysis; Female; Follow-Up Studies; Humans; Male; Military Personnel; Nicotine; Primary Health Care; Smoking; Smoking Cessation; Smoking Prevention; United States | 1998 |
Clinical status of ulcerative colitis in patients who smoke.
Topics: Adult; Aged; Colitis, Ulcerative; Female; Humans; Male; Middle Aged; Nicotine; Retrospective Studies; Severity of Illness Index; Sigmoidoscopy; Smoking; Smoking Cessation; United Kingdom | 1998 |
Smoking cessation and clozapine side effects.
Topics: Antipsychotic Agents; Clozapine; Drug Interactions; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Schizophrenia; Smoking Cessation | 1998 |
Smoking habits and cessation programme in an Australian teaching hospital.
Topics: Australia; Central Nervous System Stimulants; Chi-Square Distribution; Female; Hospitals, Teaching; Humans; Logistic Models; Male; Nicotine; Occupational Health Services; Personnel, Hospital; Polymethacrylic Acids; Polyvinyls; Prevalence; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Cessation Devices; Treatment Outcome | 1998 |
Low back pain and lifestyle. Part I: Smoking. Information from a population-based sample of 29,424 twins.
Topics: Adolescent; Adult; Child; Cross-Sectional Studies; Denmark; Dose-Response Relationship, Drug; Female; Humans; Life Style; Low Back Pain; Male; Nicotine; Nicotinic Agonists; Prevalence; Risk Factors; Smoking; Smoking Cessation; Socioeconomic Factors; Twins, Monozygotic | 1998 |
Nicotine replacement therapy for a healthier nation. Nicotine replacement is cost effective and should be prescribable on the NHS.
Topics: Cost-Benefit Analysis; Drug Prescriptions; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; State Medicine; United Kingdom | 1998 |
"Either I kill the cigarettes or they kill me". Interview by Pat Scowen.
Topics: Adaptation, Psychological; Central Nervous System Stimulants; Chewing Gum; Humans; Nicotine; Nurse Administrators; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Tobacco Use Cessation Devices | 1998 |
Evaluation of side effects after nicotine nasal spray in patients with chronic rhinitis.
Topics: Administration, Intranasal; Adult; Aerosols; Aged; Cell Nucleus; Chronic Disease; Cilia; Cytoplasm; Epithelial Cells; Evaluation Studies as Topic; Female; Follow-Up Studies; Goblet Cells; Humans; Irritants; Male; Middle Aged; Nasal Mucosa; Nicotine; Nicotinic Agonists; Nose; Peak Expiratory Flow Rate; Rhinitis; Safety; Smell; Smoking; Smoking Cessation; Smoking Prevention | 1998 |
Reasons for quitting and smoking temptation among adolescent smokers: gender differences.
Topics: Adolescent; Adolescent Behavior; Adult; Affect; Female; Humans; Male; Nicotine; Nicotinic Agonists; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1998 |
Drug may suppress the craving for nicotine.
Topics: Animals; Behavior, Animal; Brain; Cocaine-Related Disorders; Conditioning, Psychological; Dopamine; gamma-Aminobutyric Acid; Humans; Nicotine; Papio; Smoking Cessation; Tobacco Use Disorder; Vigabatrin | 1998 |
Olfactory thresholds for nicotine and menthol in smokers (abstinent and nonabstinent) and nonsmokers.
Topics: Administration, Inhalation; Adult; Carbon Monoxide; Humans; Male; Menthol; Nicotine; Sensory Thresholds; Smell; Smoking; Smoking Cessation | 1998 |
Managing smoking cessation.
Topics: Family Practice; Humans; Nicotine; Practice Guidelines as Topic; Smoking Cessation | 1999 |
Obligatory cessation of smoking by psychiatric inpatients.
Topics: Adult; Female; Humans; Male; Mental Disorders; Middle Aged; New York; Nicotine; Patient Admission; Psychiatric Status Rating Scales; Psychopathology; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome | 1999 |
Smoking and Parkinson's disease: a dose-response relationship.
Topics: Aged; Alcohol Drinking; Case-Control Studies; Dose-Response Relationship, Drug; Female; Humans; Male; Michigan; Middle Aged; Nicotine; Nicotinic Agonists; Parkinson Disease; Smoking; Smoking Cessation | 1999 |
Nicotine absorption and dependence in unlicensed lozenges available over the counter.
Topics: Humans; Intestinal Absorption; Male; Middle Aged; Nicotine; Nicotinic Agonists; Nonprescription Drugs; Smoking Cessation; Tablets; Tobacco Use Disorder | 1998 |
[What is the value of one year of life saved with nicotine preparations? How did the SBU calculate?].
Topics: Drug Costs; Humans; Nicotine; Smoking Cessation; Value of Life | 1999 |
Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.
Topics: Adult; Animals; Carcinogens; Cotinine; Female; Glucuronates; Humans; Lung Neoplasms; Male; Middle Aged; Nicotine; Nitrosamines; Rats; Rats, Inbred F344; Smoking Cessation | 1999 |
Zyban: a new aid to smoking cessation treatment--will it work for psychiatric patients?
Topics: Antidepressive Agents, Second-Generation; Bupropion; Drug Interactions; Drug Therapy, Combination; Humans; Mental Disorders; Nicotine; Psychotropic Drugs; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1999 |
An alternative tobacco control system.
Topics: Austria; Health Promotion; Humans; Nicotine; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention | 1998 |
Alternative nicotine delivery systems (ANDS)--public health-aspects.
Topics: Austria; Drug Approval; Drug Delivery Systems; Humans; Nicotine; Public Health; Smoking; Smoking Cessation; Treatment Outcome | 1998 |
Interventions for smoking cessation: the outcomes are determined by the questions asked.
Topics: Administration, Cutaneous; Humans; Nicotine; Research Design; Smoking Cessation; Treatment Outcome | 1999 |
Commentary: Progress on nicotine replacement therapy for smokers.
Topics: Administration, Cutaneous; Administration, Intranasal; Administration, Oral; Chewing Gum; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Treatment Outcome | 1999 |
[Accessibility of nicotine substitution products and prevention of cancers].
Topics: Adolescent; Adult; France; Humans; Neoplasms; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention | 1999 |
Does over-the-counter nicotine replacement therapy improve smokers' life expectancy?
Topics: Adult; Aged; Computer Simulation; Decision Trees; Drug and Narcotic Control; Female; Humans; Life Expectancy; Male; Markov Chains; Middle Aged; Nicotine; Nonprescription Drugs; Smoking; Smoking Cessation; United States | 1998 |
Nicotine intervention for hospitalized smokers.
Topics: Clinical Protocols; Hospitals; Humans; Nicotine; Patient Education as Topic; Program Development; Respiratory Therapy; Smoking Cessation; Smoking Prevention; Societies; United States | 1992 |
Nicotine gum assisted group therapy in smokers with an increased risk of coronary disease--evaluation in a primary care setting format.
Topics: Adult; Chewing Gum; Coronary Disease; Female; Follow-Up Studies; Health Education; Health Promotion; Health Status; Humans; Male; Middle Aged; Nicotine; Primary Health Care; Program Evaluation; Psychotherapy, Group; Risk Factors; Smoking Cessation; Treatment Outcome | 1992 |
Report of two smoking cessation programs: telephone intervention and group sessions.
Topics: Health Maintenance Organizations; Health Promotion; Humans; Motivation; Nicotine; Program Evaluation; Psychotherapy, Group; Smoking Cessation; Smoking Prevention; Telephone; Time Factors; United States | 1995 |
Awakening the sleeping giant: mainstreaming efforts to decrease tobacco use in an HMO.
Topics: Community Health Planning; Health Education; Health Maintenance Organizations; Health Promotion; Humans; Mainstreaming, Education; Nicotine; Outcome Assessment, Health Care; Prevalence; Smoking Cessation; Smoking Prevention; Washington | 1995 |
Telephone smoking cessation intervention: the free and clear program.
Topics: Cost-Benefit Analysis; Fee-for-Service Plans; Health Care Costs; Health Maintenance Organizations; Health Promotion; Humans; Nicotine; Organizational Objectives; Patient Participation; Program Evaluation; Smoking; Smoking Cessation; Smoking Prevention; Telephone; Washington | 1995 |
Smoking cessation benefits in HMOs.
Topics: Administration, Cutaneous; Administration, Oral; Health Benefit Plans, Employee; Health Maintenance Organizations; Health Policy; Humans; Massachusetts; Nicotine; Occupational Health Services; Smoking Cessation; State Government | 1997 |
A successful tobacco cessation program led by primary care nurses in a managed care setting.
Topics: Administration, Cutaneous; Follow-Up Studies; Health Maintenance Organizations; Health Promotion; Humans; Inservice Training; Motivation; Nicotine; Nurse-Patient Relations; Nursing Staff; Outcome Assessment, Health Care; Pennsylvania; Primary Health Care; Program Evaluation; Smoking Cessation | 1997 |
Should managed care organizations pay for nicotine replacement therapy?
Topics: Cost-Benefit Analysis; Humans; Managed Care Programs; Nicotine; Smoking Cessation; United States | 1997 |
[Diagnosis of nicotine dependence. Vienna Standard Smoking Questionnaire].
Topics: Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Surveys and Questionnaires | 1998 |
Tranquilizing effects of smoking cessation.
Topics: Anxiety; Emotions; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder | 1999 |
Tobacco memos reveal efforts to disrupt smoking cessation.
Topics: Humans; Nicotine; Smoking Cessation; Tobacco Industry | 1999 |
Opening the window of opportunity: encouraging patients to stop smoking.
Topics: Administration, Cutaneous; Family Practice; Heart Diseases; Humans; Nicotine; Risk Factors; Smoking Cessation | 1999 |
Dentists' attitudes and practice regarding smoking.
Topics: Administration, Cutaneous; Adult; Aged; Attitude of Health Personnel; Attitude to Health; Dentist-Patient Relations; Dentists; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Mouth Diseases; New South Wales; Nicotine; Patient Education as Topic; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires | 1999 |
Ask the doctor. I am trying to help my husband stop smoking. He tried to use the antidepressant Zyban, but it didn't work. He has also tried the nicotine patch, and that didn't work either. Is there any reason why he shouldn't try both together?
Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Bupropion; Drug Therapy, Combination; Humans; Male; Nicotine; Smoking Cessation | 1999 |
Prospective study on the effect of smoking and nicotine substitution on leucocyte blood counts and relation between blood leucocytes and lung function.
Topics: Chewing Gum; Cross-Sectional Studies; Female; Forced Expiratory Volume; Humans; Leukocyte Count; Leukocytes; Male; Middle Aged; Nicotine; Prospective Studies; Regression Analysis; Smoking; Smoking Cessation | 1998 |
Weight gain and insulin resistance during nicotine replacement therapy.
Topics: Administration, Cutaneous; Adult; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Treatment Outcome; Weight Gain | 1999 |
Smoking cessation: a job for the health professional.
Topics: Administration, Cutaneous; Humans; Nicotine; Nicotinic Agonists; Nursing Care; Smoking Cessation; Smoking Prevention | 1999 |
Treatment of tobacco dependence: innovative regulatory approaches to reduce death and disease: preface.
Topics: Humans; Legislation, Drug; Nicotine; Public Health; Smoking Cessation; Tobacco Industry; Tobacco Use Disorder; United States | 1998 |
Tobacco-dependence medications: public health and regulatory issues.
Topics: Drug Delivery Systems; Humans; Legislation, Drug; Nicotine; Public Health; Smoking Cessation; Tobacco Use Disorder; United States | 1998 |
Adding behavioral therapy to medication for smoking cessation.
Topics: Drug Therapy, Combination; Humans; Mecamylamine; Nicotine; Nicotinic Antagonists; Smoking; Smoking Cessation; Smoking Prevention | 1999 |
Acupuncture and nicotine withdrawal.
Topics: Acupuncture Therapy; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1999 |
Antidepressants and smoking cessation.
Topics: Adrenergic Uptake Inhibitors; Affect; Animals; Antidepressive Agents, Tricyclic; Appetite; Humans; Nicotine; Nortriptyline; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome | 1999 |
World Bank evaluates the economics of tobacco.
Topics: Financing, Organized; Health Status; Humans; International Agencies; Nicotine; Smoking; Smoking Cessation; State Medicine; World Health Organization | 1999 |
Bupropion or patch for smoking cessation?
Topics: Administration, Cutaneous; Adolescent; Adult; Bupropion; Combined Modality Therapy; Double-Blind Method; Humans; Nicotine; Randomized Controlled Trials as Topic; Reproducibility of Results; Smoking Cessation; Treatment Outcome | 1999 |
Predictors and timing of adverse experiences during trandsdermal nicotine therapy.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Cohort Studies; Cotinine; Erythema; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Predictive Value of Tests; Severity of Illness Index; Sleep Wake Disorders; Smoking Cessation; Substance Withdrawal Syndrome | 1999 |
[Practical guides for stopping the tobacco habit: what are they, why and how to use them?].
Topics: Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Social Support | 1999 |
New strategies for smoking cessation.
Topics: Algorithms; Antidepressive Agents, Second-Generation; Bupropion; Counseling; Decision Trees; Humans; Nicotine; Practice Guidelines as Topic; Smoking Cessation; Smoking Prevention; United States; United States Agency for Healthcare Research and Quality | 1999 |
Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness.
Topics: Administration, Cutaneous; Adult; Aged; Cost-Benefit Analysis; Counseling; Drug Prescriptions; Family Practice; Humans; Middle Aged; Nicotine; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Smoking Cessation; State Medicine; United Kingdom | 1999 |
Eliminating nicotine in cigarettes.
Topics: Adolescent; Adult; Behavior, Addictive; Humans; New Zealand; Nicotiana; Nicotine; Plants, Toxic; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Industry | 1999 |
Smoking cessation.
Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Bupropion; Drug Therapy, Combination; Humans; Nicotine; Odds Ratio; Smoking Cessation | 1999 |
Nicotine patch use in pregnant smokers: nicotine and cotinine levels and fetal effects.
Topics: Administration, Cutaneous; Adult; Cotinine; Female; Fetus; Heart Rate, Fetal; Humans; Nicotine; Pregnancy; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1999 |
Plasma leptin concentrations and lipid profiles during nicotine abstinence.
Topics: Cholesterol, HDL; Cotinine; Energy Intake; Female; Humans; Leptin; Lipids; Male; Nicotine; Obesity; Prospective Studies; Proteins; Smoking Cessation; Weight Gain | 1999 |
An examination of cigarette brand switching to reduce health risks.
Topics: Adaptation, Psychological; Adult; Female; Health Behavior; Humans; Male; Military Personnel; Nicotine; Population Surveillance; Prospective Studies; Self Efficacy; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; United States | 1999 |
Lack of efficacy of transdermal nicotine in smoking cessation.
Topics: Administration, Cutaneous; Humans; Middle Aged; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation; Treatment Failure | 1999 |
The effect of cigarette smoking and nicotine chewing gum on platelet function and fibrinolytic activity.
Topics: Adult; Blood Platelets; Chewing Gum; Female; Fibrinolysis; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Pilot Projects; Smoking; Smoking Cessation | 1999 |
[Nicotine substitutes: with or without drug prescription?].
Topics: Adolescent; Adult; Child; Double-Blind Method; Drug Prescriptions; France; Humans; Meta-Analysis as Topic; Nicotine; Randomized Controlled Trials as Topic; Self Medication; Smoking Cessation; Time Factors | 1999 |
[Nicotine replacement therapy and smoking cessation: what choice for its status?].
Topics: Depression; Humans; Mental Disorders; Nicotine; Self Medication; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 1999 |
[Help in stopping smoking. The time for action has come].
Topics: Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder | 1999 |
The long-term effect of nicotine on the oral mucosa.
Topics: Adult; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mouth Mucosa; Nicotine; Nicotinic Agonists; Prospective Studies; Smoking Cessation; Time Factors | 1999 |
Missed opportunities to assist hospitalized smokers.
Topics: Hospitalization; Humans; Nicotine; Physician's Role; Smoking Cessation | 1999 |
Pharmacological aids to smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Humans; Nicotine; Smoking Cessation | 1999 |
[Therapeutic nicotinic replacement and list of approved drugs].
Topics: Adult; Comorbidity; Drug Evaluation; Female; Humans; Male; Nicotine; Nonprescription Drugs; Pregnancy; Smoking Cessation; Tobacco Use Disorder | 1999 |
Doctors told to treat nicotine addiction as a disease.
Topics: Ganglionic Stimulants; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; State Medicine; Substance-Related Disorders | 2000 |
Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation.
Topics: Administration, Cutaneous; Adult; Bupropion; Cost-Benefit Analysis; Decision Trees; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Nicotinic Agonists; Occupational Health; Smoking Cessation; United States | 2000 |
Computer tailored intervention for older smokers using transdermal nicotine.
Topics: Administration, Cutaneous; Aged; Female; Humans; Male; Middle Aged; Nicotine; Random Allocation; Smoking; Smoking Cessation; Therapy, Computer-Assisted; Tobacco Use Disorder | 2000 |
Tobacco withdrawal symptoms and treatment.
Topics: Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1999 |
Development of major depression after treatment for smoking cessation.
Topics: Adult; Central Nervous System Stimulants; Chewing Gum; Combined Modality Therapy; Comorbidity; Depressive Disorder; Female; Humans; Incidence; Logistic Models; Male; Nicotine; Nortriptyline; Odds Ratio; Personality Inventory; Placebos; Polymethacrylic Acids; Polyvinyls; Prospective Studies; Psychotherapy; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2000 |
"Women and smoking towards the millennium".
Topics: Autoimmune Diseases; Autoimmunity; Breast Neoplasms; Cell Transformation, Neoplastic; Female; Herpesviridae Infections; Humans; Lung Neoplasms; Mosaicism; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Skin Aging; Smoking; Smoking Cessation; Women's Health | 1999 |
Pharmacotherapy for smoking cessation.
Topics: Bupropion; Contraindications; Humans; Nicotine; Smoking; Smoking Cessation | 2000 |
Treatment resistant smokers: a pilot study of nicotine nasal spray and inhaler.
Topics: Administration, Intranasal; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Pilot Projects; Retreatment; Smoking Cessation; Treatment Failure | 2000 |
Which of the new smoking cessation treatments is best?
Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Bupropion; Nicotine; Smoking Cessation | 2000 |
Are there any new strategies to increase the success rate for smoking cessation?
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Humans; Nicotine; Smoking; Smoking Cessation; Smoking Prevention | 1998 |
Effects of smoking abstinence on movement regulation.
Topics: Adult; Humans; Male; Motor Skills; Nicotine; Psychomotor Performance; Smoking Cessation; Substance Withdrawal Syndrome | 2000 |
Helping Wisconsin women quit smoking: a successful collaboration.
Topics: Administration, Cutaneous; Adult; Aged; Demography; Ethnicity; Female; Health Promotion; Humans; Middle Aged; Nicotine; Patient Satisfaction; Program Evaluation; Smoking Cessation; Socioeconomic Factors; Wisconsin; Women's Health | 2000 |
[Smoking cessation. Power act with patches, spray and chewing gum].
Topics: Administration, Cutaneous; Administration, Intranasal; Chewing Gum; Humans; Nicotine; Smoking Cessation | 2000 |
Continued dependence on nicotine replacement therapy should be reported and discussed in smoking cessation trials.
Topics: Clinical Trials as Topic; Drug Delivery Systems; Humans; Nicotine; Research Design; Smoking Cessation; Tobacco Use Disorder | 2000 |
The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acoustic Stimulation; Animals; Body Temperature; Columbidae; Corticosterone; Depression; Discrimination Learning; Drug Interactions; Fluoxetine; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Lip; Male; Microdialysis; Neurons; Nicotine; Piperidines; Posture; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Sulfur Radioisotopes | 2000 |
The use of nicotine patches with minimal intervention.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Female; Health Education; Humans; Male; Middle Aged; Motivation; Nicotine; Prospective Studies; Smoking Cessation | 2000 |
Nicotine replacement prescription practices of obstetric and pediatric clinicians.
Topics: Adult; Boston; Drug Utilization; Female; Humans; Infant; Infant, Newborn; Male; Nicotine; Obstetrics; Pediatrics; Practice Patterns, Physicians'; Pregnancy; Smoking Cessation | 2000 |
A 36-year-old woman who smokes cigarettes.
Topics: Adult; Age of Onset; Antidepressive Agents, Second-Generation; Bupropion; Central Nervous System Stimulants; Child; Cognitive Behavioral Therapy; Cost of Illness; Female; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder | 2000 |
Use of FDA-approved pharmacologic treatments for tobacco dependence--United States, 1984-1998.
Topics: Drug Approval; Drug Utilization; Humans; Nicotine; Nicotinic Agonists; Nonprescription Drugs; Smoking Cessation; Tobacco Use Disorder; United States; United States Food and Drug Administration | 2000 |
Would-be quitters get help winning against nicotine.
Topics: Adolescent; Adult; Behavior, Addictive; Female; Humans; Male; Nicotine; Smoking Cessation | 2000 |
Taking the nicotine out of cigarettes--why it is a bad idea.
Topics: Humans; Nicotine; Primary Prevention; Sensitivity and Specificity; Smoking Cessation; Tobacco Use Disorder; World Health Organization | 2000 |
Telephone counseling as adjuvant treatment for nicotine replacement therapy in a "real-world" setting.
Topics: Adolescent; Adult; Aged; California; Counseling; Feasibility Studies; Female; Hotlines; Humans; Male; Middle Aged; Nicotine; Retrospective Studies; Smoking Cessation; Telephone; Tobacco Use Disorder | 2000 |
Near-patient test for nicotine and its metabolites in saliva to assess smoking habit.
Topics: Adult; Colorimetry; Cotinine; Female; Humans; Male; Nicotine; Point-of-Care Systems; Radioimmunoassay; Saliva; Sensitivity and Specificity; Smoking; Smoking Cessation; Statistics as Topic | 2000 |
The opioid antagonist naltrexone inhibits activity and alters expression of alpha7 and alpha4beta2 nicotinic receptors in hippocampal neurons: implications for smoking cessation programs.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Cells, Cultured; Electrophysiology; Female; Hippocampus; In Vitro Techniques; Naltrexone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Patch-Clamp Techniques; Pregnancy; Rats; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic; Smoking Cessation; Up-Regulation | 2000 |
The availability of smoking cessation advice from health professionals--a census from one East London District.
Topics: Adult; Attitude of Health Personnel; Humans; London; Nicotine; Nicotinic Agonists; Patient Education as Topic; Smoking; Smoking Cessation | 2000 |
Smoking cessation: which aids are worthwhile?
Topics: Antidepressive Agents, Second-Generation; Bupropion; Counseling; Family Practice; Humans; Netherlands; Nicotine; Nicotinic Agonists; Patient Education as Topic; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Treatment Outcome | 2000 |
Behavioral and pharmacological treatment methods for pregnant smokers: issues for clinical practice.
Topics: Adult; Benchmarking; Counseling; Female; Ganglionic Stimulants; Health Promotion; Humans; Infant Welfare; Infant, Newborn; Nicotine; Physician-Patient Relations; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Research Design; Risk Assessment; Smoking; Smoking Cessation; Tobacco Smoke Pollution; Tobacco Use Disorder | 2000 |
History and symptoms of depression among smokers during a self-initiated quit attempt.
Topics: Adult; Depressive Disorder; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Prognosis; Prospective Studies; Recurrence; Risk Factors; Smoking Cessation; Substance Withdrawal Syndrome | 1999 |
Conference summary Fifth Annual Meeting. Society for Research on Nicotine and Tobacco. San Diego, CA, USA. 5-7 March 1999.
Topics: Ganglionic Stimulants; Humans; Nicotiana; Nicotine; Plants, Toxic; Smoking; Smoking Cessation | 1999 |
Pharmacodynamic effects of new de-nicotinized cigarettes.
Topics: Adult; Blood Pressure; Carbon Monoxide; Electroencephalography; Female; Ganglionic Stimulants; Heart Rate; Humans; Male; Nicotine; Smoking; Smoking Cessation | 1999 |
Abstinence effects and reactivity to nicotine during 11 days of smoking deprivation.
Topics: Adult; Affect; Anxiety; Blood Pressure; Female; Galvanic Skin Response; Ganglionic Stimulants; Heart Rate; Humans; Hydrocortisone; Male; Middle Aged; Nicotine; Smoking Cessation; Smoking Prevention; Thinking; Time Factors | 2000 |
Action on smoking--opportunities for the dental team.
Topics: Dental Staff; Health Policy; Humans; Mouth Neoplasms; Nicotine; Periodontal Diseases; Smoking; Smoking Cessation; State Dentistry; United Kingdom | 2000 |
Smoking cessation guidelines for health professionals: an update. Health Education Authority.
Topics: Behavior Therapy; Bupropion; Evidence-Based Medicine; Family Practice; Female; Humans; National Health Programs; Nicotine; Patient Education as Topic; Pregnancy; Smoking Cessation; State Medicine; United Kingdom | 2000 |
Nicotine-sensitive writer's cramp.
Topics: Acetylcholine; Adult; Dopamine; Dystonic Disorders; Electromyography; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Treatment Outcome | 2000 |
Pharmacologic aids to smoking cessation.
Topics: Bupropion; Humans; Nicotine; Smoking Cessation | 2000 |
[Nicotine and smoking cessation].
Topics: Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2000 |
Female smokers have increased postoperative narcotic requirements.
Topics: Adult; Analgesics, Opioid; Dose-Response Relationship, Drug; Female; Gynecologic Surgical Procedures; Humans; Medical Records; Morphine; Nicotine; Pain, Postoperative; Postoperative Care; Retrospective Studies; Smoking; Smoking Cessation; Theophylline; Therapeutic Equivalency | 2000 |
Dissociating nicotine and nonnicotine components of cigarette smoking.
Topics: Adolescent; Adult; Blood Pressure; Euphoria; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Sensation; Smoking; Smoking Cessation | 2000 |
Melatonin treatment attenuates symptoms of acute nicotine withdrawal in humans.
Topics: Adult; Female; Humans; Male; Melatonin; Middle Aged; Nicotine; Psychomotor Performance; Saliva; Smoking Cessation; Substance Withdrawal Syndrome | 2000 |
Clinical pharmacology of eicosanoids, nicotine induced changes in man.
Topics: Blood Cells; Cotinine; Eicosanoids; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation | 2000 |
What's new in Nicotine & Tobacco Research?
Topics: Administration, Cutaneous; Adolescent; Adolescent Behavior; Adult; Age Factors; Child; Ethnicity; Female; Ganglionic Stimulants; Humans; Information Services; Male; Nicotine; Oxidation-Reduction; Plants, Toxic; Smoking Cessation; Tobacco, Smokeless; Women's Health | 2000 |
Effects of nicotine replacement therapy on markers of oxidative stress in cigarette smokers enrolled in a smoking cessation program.
Topics: Adult; Biomarkers; Female; Ganglionic Stimulants; Humans; Male; Nicotine; Oxidative Stress; Smoking; Smoking Cessation | 2000 |
Reducing tobacco use: a report of the Surgeon General--executive summary.
Topics: Adolescent; Adult; Advertising; Aged; Child; Female; Ganglionic Stimulants; Health Policy; Humans; Male; Middle Aged; Nicotine; Policy Making; Public Health; Smoking Cessation; Tobacco Industry; Tobacco Smoke Pollution; Tobacco Use Disorder | 2000 |
[A drug for smoking cessation?].
Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Bupropion; Cholinergic Agents; Humans; Nicotine; Smoking; Smoking Cessation | 2001 |
Nicotine dependence among the population of a big Polish city.
Topics: Adult; Cross-Cultural Comparison; Cross-Sectional Studies; Female; Humans; Incidence; Male; Middle Aged; Nicotine; Poland; Smoking; Smoking Cessation; Substance-Related Disorders | 2000 |
Why does smoking so often produce dependence? A somewhat different view.
Topics: Dopamine; Health Promotion; Humans; Nicotine; Smoking; Smoking Cessation; Substance-Related Disorders; Time Factors | 2001 |
Gabapentin for misuse of homemade nicotine nasal spray.
Topics: Acetates; Administration, Intranasal; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Internet; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Prescription Fees; Smoking Cessation; Tobacco Use Disorder | 2001 |
Promoting adolescent smoking cessation is worth the effort.
Topics: Adolescent; Health Promotion; Humans; Nicotine; Physician's Role; Smoking Cessation | 2001 |
Attitudes toward nicotine replacement therapy in smokers and ex-smokers in the general public.
Topics: Adult; Attitude to Health; Female; Humans; Male; Nicotine; Pharmacoepidemiology; Reproducibility of Results; Smoking Cessation; Surveys and Questionnaires; Switzerland | 2001 |
Individual differences in responses to the first cigarette following overnight abstinence in regular smokers.
Topics: Adult; Affect; Cluster Analysis; Female; Heart Rate; Humans; Male; Nicotine; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors | 2001 |
Emergence of depression during early abstinence in depressed and non-depressed women smokers.
Topics: Administration, Cutaneous; Adult; Behavior Therapy; Clinical Trials as Topic; Depressive Disorder; Female; Follow-Up Studies; Humans; Motivation; Nicotine; Recurrence; Smoking Cessation; Substance Withdrawal Syndrome | 2001 |
Nicotine replacement for smokers.
Topics: Commerce; Drug Prescriptions; Health Policy; Humans; Insurance, Health, Reimbursement; Nicotine; Smoking Cessation; United Kingdom | 2001 |
Psychosocial versus nicotine-only self-report measures for predicting follow-up smoking status.
Topics: Adult; Female; Follow-Up Studies; Forecasting; Humans; Interpersonal Relations; Male; Nicotine; Recurrence; Self Disclosure; Severity of Illness Index; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder | 2001 |
Nicotine in hair of bar and restaurant workers.
Topics: Adolescent; Adult; Data Collection; Environmental Monitoring; Female; Hair; Humans; Male; Middle Aged; New Zealand; Nicotine; Occupational Exposure; Reference Values; Restaurants; Risk Assessment; Smoking Cessation; Smoking Prevention; Statistics, Nonparametric; Workplace | 2001 |
Risk of acute first myocardial infarction and use of nicotine patches in a general population.
Topics: Administration, Cutaneous; Adult; Aged; Case-Control Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nicotine; Philadelphia; Risk Factors; Smoking; Smoking Cessation | 2001 |
Availability of smoking cessation resources for U.S. Army general medical officers.
Topics: Health Services Accessibility; Humans; Military Personnel; Nicotine; Patient Education as Topic; Self-Help Groups; Smoking Cessation; United States | 2001 |
[The physician and the patient in the decision to quit smoking. Effect of the initiative on the result of the intervention].
Topics: Administration, Cutaneous; Adult; Cohort Studies; Female; Humans; Male; Middle Aged; Nicotine; Patient Acceptance of Health Care; Patient Compliance; Patient Education as Topic; Patients; Physician-Patient Relations; Physician's Role; Physicians; Primary Health Care; Program Evaluation; Prospective Studies; Pulmonary Medicine; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Urban Health | 2001 |
[Two-month results are predictors of outcome in a smoking cessation program].
Topics: Adult; Counseling; Female; Humans; Longitudinal Studies; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Time Factors; Treatment Outcome | 2001 |
Newly available treatments for nicotine addiction. Smokers wanting help with stopping now have effective treatment options.
Topics: Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2001 |
A nicotine fix on the NHS.
Topics: National Health Programs; Nicotine; Smoking Cessation; United Kingdom | 2001 |
Smoking cessation. The key to treating older smokers? Don't quit helping.
Topics: Aged; Antidepressive Agents, Second-Generation; Bupropion; Drug Administration Schedule; Female; Humans; Male; Nicotine; Smoking Cessation; Treatment Outcome | 2001 |
Guide to nicotine replacement therapies. Breath of fresh air.
Topics: Dosage Forms; Humans; Nicotine; Smoking Cessation; State Medicine; United Kingdom | 2001 |
Effects of smoking cessation and nicotine substitution on systemic eicosanoid production in man.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Central Nervous System Stimulants; Eicosanoids; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Tobacco Use Cessation Devices | 2001 |
[Tobacco addiction. Epidemiology and pathology associated with tobacco].
Topics: Adolescent; Adult; Aged; Female; France; Ganglionic Stimulants; Health Status; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Mouth Neoplasms; Nicotine; Public Health; Smoking; Smoking Cessation; Tobacco Smoke Pollution; Tobacco Use Disorder | 2001 |
Nicotine dependence, withdrawal symptoms, and adolescents' readiness to quit smoking.
Topics: Adolescent; Adolescent Behavior; Attitude; Cross-Sectional Studies; Female; Humans; Male; Nicotine; Prevalence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2001 |
Smoking reduction in smokers compliant to a smoking cessation trial with nicotine patch.
Topics: Administration, Cutaneous; Adult; Carbon Dioxide; Cotinine; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Retrospective Studies; Smoking; Smoking Cessation; Treatment Outcome | 2001 |
[Several features of nicotine substitution therapy that may lead to clinical problems, based on the information in the technical cards].
Topics: Humans; Medical Records; Nicotine; Smoking Cessation | 2001 |
Should we recommend nicotine replacement therapy?
Topics: Adult; Behavior, Addictive; Evidence-Based Medicine; Female; Humans; Nicotine; Respiratory Tract Infections; Risk Assessment; Sensitivity and Specificity; Smoking; Smoking Cessation; Smoking Prevention | 2001 |
Information from your family doctor. Using the nicotine patch, nicotine gum, nicotine nasal spray or nicotine inhaler.
Topics: Administration, Inhalation; Administration, Intranasal; Delayed-Action Preparations; Drug Delivery Systems; Family Practice; Female; Health Education; Humans; Male; Nicotine; Sensitivity and Specificity; Smoking Cessation; Smoking Prevention; Substance-Related Disorders | 2001 |
Smoking and quitting with the aid of nicotine replacement therapies in the English adult population. Results from the Health Education Monitoring Survey 1995.
Topics: Adolescent; Adult; Aged; Cross-Sectional Studies; England; Female; Health Knowledge, Attitudes, Practice; Health Surveys; Humans; Male; Middle Aged; Models, Statistical; Nicotine; Regression Analysis; Smoking Cessation; Socioeconomic Factors; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Failure; Volition | 2001 |
New tools to help you quit smoking.
Topics: Antidepressive Agents; Behavior Therapy; Combined Modality Therapy; Humans; Nicotine; Smoking Cessation | 1999 |
Anti-Smoking therapies: is harm reduction a viable alternative to smoking cessation?
Topics: Attitude of Health Personnel; Ganglionic Stimulants; Health Personnel; Health Policy; Humans; Nicotine; Public Health; Risk Factors; Smoking; Smoking Cessation; Tobacco Industry | 2001 |
Aids to quitting tobacco use: how important are they outside controlled trials?
Topics: Bupropion; Female; Humans; Male; Middle Aged; Minnesota; Nicotine; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires | 2001 |
Nicotine replacement methods on a psychiatric unit.
Topics: Adolescent; Adult; Cohort Studies; Female; Hospitalization; Humans; Male; Middle Aged; Nicotine; Psychiatric Department, Hospital; Retrospective Studies; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2001 |
Temporal analysis of the relationship of smoking behavior and urges to mood states in men versus women.
Topics: Adolescent; Adult; Affect; Anger; Anxiety; Brain; Dopamine; Female; Humans; Male; Mood Disorders; Nicotine; Regression Analysis; Retrospective Studies; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Time Factors | 2001 |
Effect of smoking reduction and cessation on cardiovascular risk factors.
Topics: Adult; Cardiovascular Diseases; Cotinine; Female; Fibrinogen; Hematocrit; Hemoglobins; Humans; Lipoproteins, HDL; Male; Nicotine; Retrospective Studies; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Triglycerides | 2001 |
Epidemiological studies of tobacco smoking and dependence in Japan.
Topics: Adult; Aged; Humans; Japan; Middle Aged; Nicotine; Prevalence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2001 |
Acute myocardial infarction soon after nicotine replacement therapy.
Topics: Administration, Cutaneous; Angina Pectoris; Humans; Male; Middle Aged; Myocardial Infarction; Nicotine; Nicotinic Agonists; Smoking Cessation | 2001 |
Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction.
Topics: Cardiovascular Diseases; Female; Humans; Male; Nicotine; Public Health; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention | 2001 |
Sensitivity of nicotine-containing and de-nicotinized cigarette consumption to alternative non-drug reinforcement: a behavioral economic analysis.
Topics: Adult; Choice Behavior; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Reinforcement Schedule; Smoking; Smoking Cessation | 2001 |
Smoking cessation strategies for the 21st century.
Topics: Counseling; Humans; Nicotine; Smoking; Smoking Cessation; Smoking Prevention | 2001 |
Quitting smoking harder for women than for men.
Topics: Female; Humans; Interpersonal Relations; Male; Menstrual Cycle; Nicotine; Smoking Cessation; Spouses; Treatment Outcome | 2001 |
Quitting cigarette smoking produces minimal loss of chronic tolerance to nicotine.
Topics: Administration, Intranasal; Adult; Analysis of Variance; Drug Tolerance; Female; Humans; Male; Nicotine; Prospective Studies; Reinforcement, Psychology; Self Administration; Smoking Cessation | 2001 |
[Known methods can reduce tobacco dependence drastically].
Topics: Antidepressive Agents, Second-Generation; Bupropion; Global Health; Humans; Nicotine; Psychotherapy; Smoking; Smoking Cessation; Smoking Prevention | 2001 |
Oral nicotine solution for smoking cessation: a pilot tolerability study.
Topics: Administration, Oral; Adult; Cotinine; Drug Tolerance; Female; Follow-Up Studies; Humans; Male; Nicotine; Pilot Projects; Saliva; Smoking Cessation; Smoking Prevention; Solutions | 2001 |
General Practitioners' views on the provision of nicotine replacement therapy and bupropion.
Topics: Antidepressive Agents, Second-Generation; Attitude of Health Personnel; Bupropion; Data Collection; Drug Prescriptions; Female; Humans; Insurance Benefits; Insurance, Pharmaceutical Services; Male; Nicotine; Physicians, Family; Practice Patterns, Physicians'; Smoking Cessation; State Medicine; Surveys and Questionnaires; United Kingdom | 2001 |
Nicotine substitutes and pregnancy.
Topics: Clinical Trials as Topic; Contraindications; Cross-Over Studies; Female; Fetus; France; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Smoking Cessation; Smoking Prevention | 2001 |
Pregnancy categories of nicotine replacement products.
Topics: Adult; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Smoking Cessation | 2001 |
Updating a systematic review--what difference did it make? Case study of nicotine replacement therapy.
Topics: Delayed-Action Preparations; Drug Delivery Systems; Follow-Up Studies; Humans; Meta-Analysis as Topic; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation; Systematic Reviews as Topic | 2001 |
Smoking cessation in the workplace: results of an intervention programme using nicotine patches.
Topics: Administration, Cutaneous; Follow-Up Studies; Humans; Nicotine; Nicotinic Agonists; Occupational Diseases; Occupational Health Services; Patient Satisfaction; Program Evaluation; Recurrence; Smoking Cessation; Social Support; Tobacco Smoke Pollution; Treatment Outcome; Workplace | 2001 |
Supplement on smoking cessation.
Topics: Europe; Humans; Lobbying; Nicotine; Publishing; Research; Smoking Cessation; Tobacco Industry | 2001 |
Nicotine-environmental risk factors for initiation. Two principles, one host.
Topics: Adolescent; Adult; Behavior; Child; Environment; Humans; Nicotine; Smoking; Smoking Cessation; Smoking Prevention | 1999 |
Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans.
Topics: Adult; Asian; Cotinine; Female; Hispanic or Latino; Humans; Lung Neoplasms; Male; Nicotine; Smoking; Smoking Cessation; White People | 2002 |
Amfebutamone/bupropion for smoking cessation: new preparation. Nicotine replacement therapy is safer.
Topics: Antidepressive Agents, Second-Generation; Behavior, Addictive; Bupropion; Clinical Trials as Topic; France; Ganglionic Stimulants; Nicotine; Smoking Cessation; Treatment Outcome | 2001 |
[The efficacy of a comprehensive smoking cessation class, combined with nicotine patch and gum replacement therapy].
Topics: Administration, Cutaneous; Adult; Aged; Chewing Gum; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Smoking Cessation; Smoking Prevention | 2001 |
Smoking cessation in schizophrenia. General practice guidelines.
Topics: Diagnosis, Dual (Psychiatry); Humans; Nicotine; Physicians, Family; Schizophrenic Psychology; Smoking; Smoking Cessation; Tobacco Use Disorder | 2002 |
Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation.
Topics: Administration, Intranasal; Adsorption; Animals; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Evaluation, Preclinical; Female; Models, Chemical; Nicotine; Nicotinic Agonists; Powders; Resins, Synthetic; Sheep; Smoking Cessation; Technology, Pharmaceutical | 2002 |
Treatment of nicotine addiction.
Topics: Administration, Cutaneous; Administration, Intranasal; Adult; Behavior Therapy; Bupropion; Central Nervous System Stimulants; Chewing Gum; Cost-Benefit Analysis; Counseling; Dentist-Patient Relations; Dopamine Uptake Inhibitors; Humans; Medical History Taking; Nebulizers and Vaporizers; Nicotine; Patient Education as Topic; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2000 |
Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status.
Topics: Adolescent; Adult; Aged; Behavior, Addictive; Data Collection; Drug and Narcotic Control; Drug Prescriptions; Female; Ganglionic Stimulants; Humans; Interviews as Topic; Male; Massachusetts; Middle Aged; Nicotine; Nonprescription Drugs; Population Surveillance; Risk Assessment; Smoking Cessation | 2002 |
[Nicotine substitution per inhaler. The "cigarette" against addiction].
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Nebulizers and Vaporizers; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder | 2002 |
Nerve growth factor and smoking cessation.
Topics: Adult; Arousal; Female; Humans; Male; Middle Aged; Nerve Growth Factor; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 2002 |
Pilot study of enhanced tobacco-cessation services coverage for low-income smokers.
Topics: Adolescent; Adult; Community Health Centers; Counseling; Feasibility Studies; Female; Humans; Insurance Coverage; Male; Medicaid; Medical Records; Middle Aged; Nicotine; Pharmacies; Pilot Projects; Poverty; Prospective Studies; Smoking Cessation; Tobacco Use Disorder; Washington | 2002 |
Academic profiling of tobacco-related performance measures in primary care.
Topics: Adult; Diagnosis-Related Groups; Feasibility Studies; Feedback; Female; Health Promotion; Humans; Maine; Male; Medical Records; Nicotine; Outcome and Process Assessment, Health Care; Patient Education as Topic; Pilot Projects; Primary Health Care; Smoking Cessation; Tobacco Use Disorder | 2002 |
Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy.
Topics: Adhesives; Administration, Buccal; Animals; Cattle; Delayed-Action Preparations; Humans; In Vitro Techniques; Mouth Mucosa; Nicotine; Nicotinic Agonists; Smoking Cessation; Tablets | 2002 |
Licking the habit.
Topics: Candy; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder; United States; United States Food and Drug Administration | 2002 |
Smoking: tools for quitting. One-third of American smokers try to quit each year, but few take advantage of effective smoking-cessation aids.
Topics: Counseling; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Social Support; Weight Gain | 2002 |
Smoking cessation--time to move forward.
Topics: Family Practice; Humans; Nicotine; Physician's Role; Smoking Cessation | 2002 |
The effect of smoking on sensory and attentional masking.
Topics: Adolescent; Adult; Attention; Discrimination Learning; Female; Humans; Male; Nicotine; Pattern Recognition, Visual; Perceptual Masking; Smoking; Smoking Cessation | 2002 |
[Zyban in smoking cessation--where is physician's ethic?].
Topics: Antidepressive Agents, Second-Generation; Bupropion; Ethics, Medical; Humans; Nicotine; Smoking Cessation | 2001 |
Nicotine and bupropion share a similar discriminative stimulus effect.
Topics: Animals; Antidepressive Agents; Bupropion; Central Nervous System Stimulants; Discrimination Learning; Dose-Response Relationship, Drug; Generalization, Stimulus; Injections, Subcutaneous; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Smoking Cessation | 2002 |
The power of the press in smokers' attempts to quit.
Topics: Bupropion; Humans; Mass Media; Nicotine; Smoking Cessation; Smoking Prevention | 2002 |
Smoking cessation. Put your addiction in the ashtray for good.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation | 2002 |
Asthma exacerbation after administration of nicotine nasal spray for smoking cessation.
Topics: Asthma; Blood Gas Analysis; Emergency Medical Services; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Oxygen Inhalation Therapy; Smoking Cessation | 2002 |
[Bupropion. An antidepressant used to help smoking cessation].
Topics: Antidepressive Agents, Second-Generation; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Patient Education as Topic; Patient Selection; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2002 |
[Nicotine replacement and pregnancy].
Topics: Female; Humans; Nicotine; Pregnancy; Smoking Cessation | 2002 |
The effects of menstrual phase and nicotine abstinence on nicotine intake and on biochemical and subjective measures in women smokers: a preliminary report.
Topics: Adult; Estradiol; Female; Humans; Hydrocortisone; Menstrual Cycle; Methoxyhydroxyphenylglycol; Nicotine; Norepinephrine; Progesterone; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1992 |
[Clinical psychopathological types associated with smoking].
Topics: Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder | 1992 |
A comprehensive model for the treatment of nicotine dependence in a medical setting.
Topics: Counseling; Follow-Up Studies; Humans; Models, Biological; Nicotine; Physician's Role; Referral and Consultation; Smoking Cessation; Substance Abuse Treatment Centers; Substance-Related Disorders | 1992 |
Smoking cessation. Putting prevention into practice.
Topics: Administration, Cutaneous; Family Practice; Humans; Nicotine; Physician's Role; Smoking Cessation | 1992 |
Tobacco withdrawal in self-quitters.
Topics: Adult; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Prospective Studies; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1992 |
Smoking cessation among self-quitters.
Topics: Adult; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Nicotine; Recurrence; Self Care; Smoking Cessation; Substance Withdrawal Syndrome | 1992 |
Cigarette smoking in pregnancy and fetal growth. Does the type of tobacco play a role?
Topics: Adolescent; Adult; Denmark; Female; Fetal Growth Retardation; Humans; Nicotine; Pregnancy; Smoking; Smoking Cessation; Surveys and Questionnaires; Time Factors; Weight Gain | 1992 |
How to help patients stop smoking.
Topics: Adolescent; Adult; Family Practice; Follow-Up Studies; Humans; Nicotine; Patient Education as Topic; Physician-Patient Relations; Smoking Cessation; Smoking Prevention; Teaching Materials | 1992 |
[Therapy for smoking: consensus in German-speaking countries].
Topics: Acupuncture Therapy; Combined Modality Therapy; Counseling; Humans; Nicotine; Self Care; Smoking; Smoking Cessation | 1992 |
Successful use of a transdermal nicotine patch to manage a smoker with dementia.
Topics: Administration, Cutaneous; Aged; Dementia; Humans; Male; Nicotine; Smoking Cessation | 1992 |
A time series investigation of three nicotine regulation models.
Topics: Adult; Attitude to Health; Behavior, Addictive; Carbon Monoxide; Cotinine; Female; Humans; Male; Models, Statistical; Nicotine; Saliva; Smoking; Smoking Cessation | 1992 |
Smoking habits in relapsed subjects from a smoking cessation trial after one year.
Topics: Administration, Cutaneous; Adult; Body Weight; Carbon Monoxide; Cotinine; Female; Follow-Up Studies; Humans; Male; Nicotine; Patient Compliance; Recurrence; Smoking; Smoking Cessation | 1992 |
Nicotine cessation, mania, and depression.
Topics: Adult; Bipolar Disorder; Depressive Disorder; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1992 |
Nicotine patches: up in smoke?
Topics: Administration, Cutaneous; Humans; Nicotine; Smoking Cessation; Smoking Prevention | 1992 |
Low tar, high toll.
Topics: Advertising; Health Policy; Humans; Nicotine; Smoking Cessation; United States | 1992 |
Human avoidance responding with added point loss: effects of tobacco and abstinence.
Topics: Adult; Avoidance Learning; Carbon Monoxide; Chewing Gum; Chromatography, Gas; Cotinine; Humans; Male; Nicotine; Reinforcement Schedule; Reward; Smoking; Smoking Cessation; Spirometry | 1992 |
Nicotine replacement therapy during pregnancy.
Topics: Female; Fetus; Humans; Nicotine; Pregnancy; Pregnancy Complications; Smoking Cessation; Smoking Prevention | 1992 |
Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults.
Topics: Adult; Alcoholism; Anxiety Disorders; Black or African American; Comorbidity; Depressive Disorder; Educational Status; Female; Humans; Male; Marriage; Nicotine; Severity of Illness Index; Sex Factors; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Substance-Related Disorders | 1992 |
The 'nicotine replacement paradox' in smoking cessation: how does nicotine gum really work?
Topics: Anxiety; Chewing Gum; Humans; Nicotine; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 1992 |
From smoking behaviour to nicotine addiction: the history of research.
Topics: Humans; Nicotine; Smoking Cessation; Substance-Related Disorders | 1992 |
Nicotine patches.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Delayed-Action Preparations; Humans; Nicotine; Smoking Cessation | 1992 |
[Tobacco dependence and its implications in the physician-smoking patient relationship].
Topics: Behavior Therapy; Humans; Nicotine; Physician-Patient Relations; Smoking Cessation; Social Behavior; Tobacco Use Disorder | 1992 |
Smoking cessation: treatment options and the pharmacist's role.
Topics: Drug Interactions; Female; Humans; Male; Nicotine; Patient Education as Topic; Pharmacists; Smoking; Smoking Cessation; Substance-Related Disorders | 1992 |
Phase-out filter perforation: effects on human tobacco smoke exposure.
Topics: Adult; Carbon Monoxide; Female; Filtration; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation | 1992 |
[Intervention against tobacco dependence in primary care. A study of 4 modalities of action].
Topics: Chewing Gum; Follow-Up Studies; Humans; Nicotine; Patient Care Team; Primary Health Care; Psychotherapy, Group; Smoking Cessation; Social Support; Spain; Tobacco Use Disorder | 1992 |
Behavioral relapse prevention strategies in smoking cessation.
Topics: Adaptation, Psychological; Administration, Cutaneous; Adult; Behavior Therapy; Cognitive Behavioral Therapy; Decision Making; Female; Humans; Male; Nicotine; Recurrence; Smoking Cessation; Smoking Prevention | 1992 |
From the Food and Drug Administration.
Topics: Food Microbiology; Humans; Listeria monocytogenes; Listeriosis; Nicotine; Smoking Cessation; United States; United States Food and Drug Administration | 1992 |
Smoking cessation in women: effects of the menstrual cycle.
Topics: Adaptation, Psychological; Adult; Affective Symptoms; Female; Humans; Male; Menstrual Cycle; Motivation; Nicotine; Personality Inventory; Smoking Cessation; Substance Withdrawal Syndrome | 1992 |
Effects of smoking abstinence and chain-smoking on puffing topography and diurnal nicotine exposure.
Topics: Adult; Circadian Rhythm; Cotinine; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation | 1992 |
Compliance to nicotine gum recommendations in a multicomponent group smoking cessation program: an exploratory study.
Topics: Adult; Breath Tests; Carbon Monoxide; Chewing Gum; Combined Modality Therapy; Female; Humans; Male; Nicotine; Patient Compliance; Patient Dropouts; Smoking; Smoking Cessation | 1992 |
Alcohol and addictions.
Topics: Alcoholism; Behavior Therapy; Humans; Nicotine; Smoking; Smoking Cessation; Substance-Related Disorders | 1992 |
Nicotine chewing gum use in the outpatient care setting.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Behavior Therapy; Chewing Gum; Female; Health Maintenance Organizations; Humans; Male; Middle Aged; Nicotine; Oregon; Patient Compliance; Smoking Cessation; Tobacco Use Disorder; Washington | 1992 |
Transdermal nicotine patch for smoking cessation.
Topics: Administration, Cutaneous; Behavior Therapy; Humans; Nicotine; Smoking Cessation | 1992 |
The nicotine transdermal patch: a cautionary note.
Topics: Administration, Cutaneous; Humans; Nicotine; Smoking Cessation | 1992 |
Unsuccessful outpatient counselling to help patients with peripheral vascular disease to stop smoking.
Topics: Attitude to Health; Counseling; Humans; Nicotine; Outpatient Clinics, Hospital; Peripheral Vascular Diseases; Prognosis; Smoking Cessation | 1992 |
Dream of absent-minded transgression: an empirical study of a cognitive withdrawal symptom.
Topics: Adult; Dreams; Female; Guilt; Humans; Male; Mental Recall; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome | 1991 |
Guidelines for conducting a hospital-based smoker's consult service.
Topics: Ancillary Services, Hospital; Humans; Nicotine; Patient Admission; Smoking; Smoking Cessation; Smoking Prevention; United States | 1991 |
Evaluation of a mass media community smoking cessation campaign.
Topics: Adolescent; Adult; Aged; Chewing Gum; Female; Health Promotion; Humans; Male; Mass Media; Middle Aged; Newspapers as Topic; Nicotine; Outcome and Process Assessment, Health Care; Smoking; Smoking Cessation; Smoking Prevention; Television | 1991 |
Sweet taste preference in women smokers: comparison with nonsmokers and effects of menstrual phase and nicotine abstinence.
Topics: Adolescent; Adult; Female; Food Preferences; Humans; Menstrual Cycle; Nicotine; Smoking; Smoking Cessation; Sucrose; Taste | 1991 |
Low-nicotine regenerated smoke aerosol reduces desire for cigarettes.
Topics: Adult; Aerosols; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Particle Size; Smoke; Smoking Cessation | 1990 |
The effects of varying cigarette deprivation duration on cognitive and performance tasks.
Topics: Adolescent; Adult; Arousal; Attention; Cognition; Female; Humans; Male; Neuropsychological Tests; Nicotine; Psychomotor Performance; Reaction Time; Serial Learning; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors | 1989 |